Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,Vascular Endothelial Growth Factor Receptor Signaling Pathway (GO:0048010),-0.8306408856112137,-2.2803477638727654,0.0,0.0,0.0,5/26,2.75%,KDR;VEGFC;FLT1;VEGFA;FLT4
prerank,Cellular Response To Vascular Endothelial Growth Factor Stimulus (GO:0035924),-0.812682385154181,-2.0804072385973704,0.0,0.015428105030557603,0.03,6/31,2.75%,KDR;VEGFC;FLT1;VEGFA;SPRY2;FLT4
prerank,Positive Regulation Of Focal Adhesion Assembly (GO:0051894),-0.8140638199832951,-2.023332583692149,0.0,0.04799854898395698,0.11,2/16,0.24%,KDR;VEGFA
prerank,Positive Regulation Of Mitochondrial Fission (GO:0090141),-0.7734840452952512,-1.9937757261204587,0.0,0.053998367606951606,0.16,6/19,11.35%,KDR;DCN;DDHD1;PRKN;MIEF1;MUL1
prerank,Regulation Of Mitochondrial Fission (GO:0090140),-0.7613183504727424,-1.9709370284850674,0.0,0.05554117811000736,0.18,9/26,11.35%,KDR;DCN;DDHD1;LRRK2;PPARG;MAPT;PRKN;MIEF1;MUL1
prerank,Positive Regulation Of Blood Vessel Endothelial Cell Migration (GO:0043536),-0.6988147355082973,-1.9692858585511108,0.0,0.0462843150916728,0.18,4/45,1.24%,NOS3;KDR;VEGFA;THBS1
prerank,Positive Regulation Of Mitotic Sister Chromatid Separation (GO:1901970),0.7994891623371153,1.9361910879302773,0.0,0.35582942271217527,0.29,8/15,14.50%,DLGAP5;AURKB;UBE2C;ESPL1;CDC20;BIRC5;CDCA8;ANAPC7
prerank,Neuromuscular Synaptic Transmission (GO:0007274),0.7367592415014195,1.93378912044806,0.0,0.18753172278074104,0.3,3/18,7.03%,RIMBP3C;CHRNA3;RIMBP3B
prerank,Positive Regulation Of Vasculature Development (GO:1904018),-0.6158774938285918,-1.9221585723930126,0.0,0.09109928684710202,0.4,11/95,3.24%,NOS3;KDR;VEGFC;FLT1;VEGFA;THBS1;GATA6;IL1B;CXCL8;CHI3L1;CD34
prerank,Positive Regulation Of Cell-Substrate Junction Organization (GO:0150117),-0.7530521908585983,-1.9194705793656825,0.0,0.08614025308727995,0.42,3/21,5.09%,KDR;VEGFA;PIK3R1
prerank,Calcium-Mediated Signaling Using Intracellular Calcium Source (GO:0035584),-0.8164126743914932,-1.9193736297166197,0.0,0.07771193645021607,0.43,5/17,7.91%,KDR;AZU1;VCAM1;STIMATE;PRNP
prerank,Sprouting Angiogenesis (GO:0002040),-0.6512970410499697,-1.918079072042683,0.0,0.0740549041466765,0.44,6/47,3.47%,KDR;VEGFC;VEGFA;THBS1;FLT4;CDH13
prerank,Regulation Of Blood Vessel Endothelial Cell Migration (GO:0043535),-0.6411357431879421,-1.894628947887266,0.0,0.10472410687408795,0.57,4/52,1.24%,NOS3;KDR;VEGFA;THBS1
prerank,Positive Regulation Of Angiogenesis (GO:0045766),-0.57714506098875,-1.8842323107766525,0.0,0.10971096910618738,0.61,12/110,4.26%,NOS3;KDR;VEGFC;FLT1;VEGFA;THBS1;GATA6;IL1B;CXCL8;CHI3L1;CD34;FUT1
prerank,Positive Regulation Of Kinase Activity (GO:0033674),-0.5652383012214894,-1.883883442975955,0.0,0.10127166379032683,0.61,13/99,5.78%,KDR;FLT1;ROR2;AZU1;INSRR;DDR2;FLT4;LTK;MST1R;LRRK2;CSF1R;EEF1A2;CDKN1A
prerank,Sodium Ion Import Across Plasma Membrane (GO:0098719),-0.7642032937556761,-1.8655443966849599,0.01694915254237288,0.1168127952313647,0.7,7/21,8.20%,SLC5A1;SLC6A1;SLC9A3;SCNN1B;SCNN1A;SLC8A1;SLC9C2
prerank,Positive Regulation Of Phosphatidylinositol 3-Kinase Signaling (GO:0014068),-0.6048856039970798,-1.8611260189000507,0.0,0.11519651756149676,0.71,12/64,8.27%,KDR;FLT1;ROR2;DCN;TGFB2;DDR2;IL18;PIK3AP1;IGF1;NEDD4;PDGFD;NCF1
prerank,Positive Regulation Of Positive Chemotaxis (GO:0050927),-0.8089860246431215,-1.8545182935597748,0.0,0.12149632711564111,0.74,5/15,3.47%,KDR;VEGFC;VEGFA;CXCL8;CDH13
prerank,Regulation Of Peptidyl-Threonine Phosphorylation (GO:0010799),-0.6589161362291952,-1.8511390117832125,0.0,0.11858465043095257,0.75,9/36,7.34%,AZU1;STOX1;SPRY2;PARD3;CEMIP;IRGM;CHI3L1;RIPK2;SPRED1
prerank,Positive Regulation Of Peptidyl-Threonine Phosphorylation (GO:0010800),-0.6890342583965052,-1.837931774681554,0.03636363636363636,0.13942435657244645,0.83,6/24,5.21%,AZU1;STOX1;CEMIP;IRGM;CHI3L1;RIPK2
prerank,Neuromuscular Junction Development (GO:0007528),-0.6887681842925483,-1.8055566346899103,0.017543859649122806,0.19812934881347655,0.94,8/24,12.20%,DOK7;PPFIBP2;LRRK2;CACNB4;NEDD4;GPHN;CACNB1;F2R
prerank,Negative Regulation Of Biomineral Tissue Development (GO:0070168),-0.6920209708137963,-1.8050529215067204,0.0,0.18976569187585848,0.94,1/21,0.01%,NOS3
prerank,Positive Regulation Of Cell Migration Involved In Sprouting Angiogenesis (GO:0090050),-0.7542158941824658,-1.8021751590623636,0.017241379310344827,0.18905550926334078,0.94,2/16,0.24%,KDR;VEGFA
prerank,Protein Kinase B Signaling (GO:0043491),-0.6955302608634998,-1.7988969783768143,0.0,0.18607229703520983,0.94,6/24,11.61%,KDR;IL1B;IGF1;PIK3R3;MT3;CCL2
prerank,Dopaminergic Neuron Differentiation (GO:0071542),-0.7846550131230802,-1.7973897652244664,0.0,0.18200692021556358,0.94,4/15,10.10%,VEGFA;OTX2;NR4A2;FGF8
prerank,Regulation Of Cytokine Production Involved In Immune Response (GO:0002718),0.6543207845491277,1.7945784867214183,0.025,0.7469212206480796,0.9,9/24,9.50%,FFAR2;SCIMP;CLC;CCR2;IRF5;F2RL1;LILRB1;TRIL;NOD2
prerank,Blood Vessel Endothelial Cell Migration (GO:0043534),-0.7328956269759321,-1.792311269490341,0.0,0.18770861120511748,0.95,2/20,0.24%,KDR;VEGFA
prerank,Blood Vessel Morphogenesis (GO:0048514),-0.6065975414444624,-1.7718676223672805,0.0,0.2262788737815115,0.97,7/50,7.59%,KDR;FLT1;VEGFA;FLT4;CDH2;GLMN;HEY2
prerank,Pulmonary Valve Morphogenesis (GO:0003184),-0.7238998070549258,-1.764214120048145,0.0,0.2385422393186214,0.98,3/18,1.87%,NOS3;TGFB2;SMAD6
prerank,Positive Regulation Of Epithelial Cell Proliferation (GO:0050679),-0.5329669326264102,-1.7604709560199876,0.0,0.240373685784737,0.98,21/115,8.99%,KDR;VEGFC;VEGFA;NR4A3;SCN5A;FGF9;HRAS;FLT4;CDH13;PLXNB3;IGF1;REG3A;FZD7;FOXE3;WNT7A;C5AR1;ANG;HPN;PPP1R16B;NELL2;TCF7L2
prerank,Bile Acid And Bile Salt Transport (GO:0015721),0.6443300943445862,1.752527288697713,0.0,0.8895735567804383,0.97,4/20,1.87%,ATP8B1;CEACAM1;SLC10A4;ABCC11
prerank,Regulation Of Myeloid Cell Differentiation (GO:0045637),-0.6332465297522594,-1.7454954365419466,0.0,0.2677878230303926,0.98,9/26,15.04%,MEIS2;MEIS1;HOXB8;LYN;ZBTB16;HOXA5;RBM15;PEX2;PURB
prerank,Nitric Oxide Mediated Signal Transduction (GO:0007263),-0.7547026505521199,-1.743573551658086,0.03571428571428571,0.266356479952845,0.98,3/17,4.32%,NOS3;FPR1;KLRG1
prerank,Cell Migration Involved In Sprouting Angiogenesis (GO:0002042),-0.7760560291195582,-1.7431706931580575,0.0,0.2591921645133677,0.98,2/16,0.24%,KDR;VEGFA
prerank,Regulation Of Kinase Activity (GO:0043549),-0.5810766128520561,-1.737726580876351,0.0,0.26509797676162417,0.98,14/76,9.51%,KDR;FLT1;ROR2;LDB2;INSRR;DDR2;FLT4;LTK;MST1R;CSF1R;MAPT;PLCE1;IRS2;RET
prerank,Actin Filament-Based Transport (GO:0099515),0.662058107663999,1.7323299805904475,0.0,0.8636076259338743,0.98,10/19,17.81%,MYO1C;MYO1E;MYO5C;MYO7A;MYO5B;FNBP1L;MYO1A;MYO7B;MYO15A;SYNE2
prerank,Water Transport (GO:0006833),-0.7274260330274545,-1.731517896280808,0.037037037037037035,0.2760987962760204,0.99,3/15,4.66%,SLC5A1;CFTR;AQP8
prerank,Positive Regulation Of Chemotaxis (GO:0050921),-0.6073362348045965,-1.7307612397724743,0.0,0.2699139183123815,0.99,7/41,3.47%,KDR;VEGFA;THBS1;EDN2;EDN3;XCL1;CDH13
prerank,Vesicle Transport Along Actin Filament (GO:0030050),0.6763292266916425,1.7286223451390927,0.0,0.7517297263604064,0.98,9/17,15.92%,MYO1C;MYO1E;MYO5C;MYO7A;MYO5B;FNBP1L;MYO1A;MYO7B;MYO15A
prerank,Ribosomal Small Subunit Assembly (GO:0000028),-0.7579038530810125,-1.7204493145819422,0.02127659574468085,0.28738627017705337,0.99,1/16,0.08%,RPS27L
prerank,Pulmonary Valve Development (GO:0003177),-0.7067524070578247,-1.718579506274363,0.0,0.28152618322427014,0.99,3/20,1.87%,NOS3;TGFB2;SMAD6
prerank,Male Meiosis I (GO:0007141),-0.7395968357160693,-1.7102641030692294,0.04838709677419355,0.298848108554875,0.99,10/15,20.77%,MEIOC;MYBL1;SYCP3;HSF2BP;FOXJ3;ZSCAN21;MOV10L1;DDX4;ING2;TDRD9
prerank,Positive Regulation Of Epithelial Cell Differentiation (GO:0030858),0.6551212999007483,1.7091204083273068,0.0,0.774856349072073,0.99,7/18,12.54%,SULT2B1;BMP4;FGF2;FOXJ1;TP73;IL13;ATOH8
prerank,Antigen Processing And Presentation Of Peptide Antigen Via MHC Class II (GO:0002495),0.6045706595500471,1.708367694261764,0.0,0.6876163168627172,0.99,11/25,15.20%,MARCHF1;CTSV;HLA-DRB1;HLA-DMB;FCER1G;CTSL;IFI30;LGMN;HLA-DQA1;HLA-DQA2;HLA-DPA1
prerank,Positive Regulation Of Leukocyte Chemotaxis (GO:0002690),-0.5816573470030243,-1.7009036265719548,0.0,0.3180135523415837,1.0,10/51,5.29%,VEGFC;VEGFA;IL34;THBS1;MSTN;EDN2;EDN3;XCL1;IL12A;CSF1R
prerank,Regulation Of Vascular Endothelial Growth Factor Signaling Pathway (GO:1900746),-0.6664138386446996,-1.7003029086189438,0.02040816326530612,0.31181012272284836,1.0,4/19,3.43%,VEGFA;SPRY2;DCN;IL12A
prerank,Organic Cation Transport (GO:0015695),-0.6542551044753747,-1.6907296442360535,0.0,0.3325613751031305,1.0,8/31,8.42%,SLC6A12;SLC19A3;SLC44A4;PDZK1;SLC44A5;SLC47A2;SLC22A1;SLC22A4
prerank,Regulation Of Interleukin-4 Production (GO:0032673),0.5921949841562372,1.6903352986590925,0.02,0.7244815273238885,0.99,9/23,12.62%,CD86;HLA-DRB1;FOXP3;FCER1G;ZP3;LGALS9;NLRP3;IRF4;LEF1
prerank,Regulation Of Angiogenesis (GO:0045765),-0.48226420551033333,-1.6853846408348876,0.0,0.3383897703368967,1.0,27/189,8.85%,NOS3;KDR;VEGFC;FLT1;VEGFA;SPRY2;THBS1;DCN;PRL;TGFB2;GATA6;IL1B;CXCL8;CHI3L1;CD34;HOXA5;PPARG;PLXND1;TNFAIP3;ADAMTS1;GAB1;SPRED1;NINJ1;PPP1R16B;SEMA6A;ZC3H12A;BRCA1
prerank,Cardiac Conduction System Development (GO:0003161),-0.6759054159283793,-1.6837303703248643,0.0,0.33540449472935796,1.0,7/22,10.54%,SCN5A;GATA6;GJB6;MSX2;HEY2;SMAD5;HEY1
prerank,Monocyte Chemotaxis (GO:0002548),-0.6144631902682951,-1.6805638860469254,0.0,0.33843874844810484,1.0,5/36,4.01%,FLT1;CCL7;CCL22;XCL1;CCL14
prerank,Regulation Of Endothelial Cell Proliferation (GO:0001936),-0.5452307308224384,-1.6792774283500709,0.0,0.33463440213566026,1.0,9/86,4.26%,KDR;VEGFC;VEGFA;THBS1;PRL;FLT4;CDH13;PLXNB3;FUT1
prerank,Peptidyl-Tyrosine Modification (GO:0018212),-0.5623549093702322,-1.6759852395297408,0.0,0.33918455150513754,1.0,11/51,10.68%,KDR;FLT1;DDR2;FLT4;LYN;CSF1R;CLK1;BTK;SRC;TPST2;CLK4
prerank,Positive Regulation Of Transferase Activity (GO:0051347),-0.4955469373795989,-1.6749397596480629,0.0,0.33484702029284275,1.0,15/135,5.35%,KDR;FLT1;PRIM2;ROR2;INSRR;GINS3;DSCC1;DDR2;FLT4;LTK;MST1R;APOA1;MAPK15;CSF1R;ARRDC4
prerank,Immunoglobulin Mediated Immune Response (GO:0016064),0.6002576179173182,1.668770603928528,0.0,0.8010970516736271,1.0,12/28,15.20%,IL9R;CSF2RB;HLA-DRB1;HLA-DMB;FCER1A;FCER1G;CD27;ZP3;TLR8;HLA-DQA1;HLA-DQA2;HLA-DPA1
prerank,Determination Of Left/Right Symmetry (GO:0007368),-0.5911682862396983,-1.6663315281414501,0.01639344262295082,0.3595419259295163,1.0,8/41,7.60%,DNAH11;CFAP52;PIERCE1;CFAP45;DNAAF4;CCDC103;ODAD4;CFAP53
prerank,Multicellular Organismal-Level Water Homeostasis (GO:0050891),-0.7062017615151711,-1.6646842997866493,0.0,0.35648770347203307,1.0,5/17,3.77%,CFTR;PRKACG;SCNN1B;CYP4F12;SCNN1A
prerank,Mesenchyme Morphogenesis (GO:0072132),-0.7270615529884574,-1.6635707566296252,0.04,0.3524893441009341,1.0,3/16,4.03%,NOS3;TGFB2;ACVRL1
prerank,Positive Regulation Of Endothelial Cell Proliferation (GO:0001938),-0.5643978289180284,-1.663359445958117,0.0,0.34550559020813343,1.0,10/73,8.43%,KDR;VEGFC;VEGFA;FLT4;CDH13;PLXNB3;ANG;FGFBP1;PPP1R16B;NELL2
prerank,Regulation Of Focal Adhesion Assembly (GO:0051893),-0.5618045253174248,-1.6619125928523693,0.02,0.3447667204161939,1.0,5/52,4.03%,KDR;VEGFA;PEAK1;THBS1;ACVRL1
prerank,Regulation Of Phosphatidylinositol 3-Kinase Signaling (GO:0014066),-0.5238959183427186,-1.6598985581586254,0.0,0.3442585004857755,1.0,14/83,8.35%,KDR;FLT1;ROR2;DCN;TGFB2;DDR2;IL18;PIK3AP1;IGF1;NEDD4;PDGFD;NCF1;FBXL2;PPP1R16B
prerank,Mucosal Immune Response (GO:0002385),0.5825830867117687,1.6570061945957633,0.0,0.8244401612225585,1.0,6/26,9.68%,H2BC12;FFAR2;PIGR;IL4;IFNL2;PLA2G1B
prerank,Positive Regulation Of Glial Cell Differentiation (GO:0045687),-0.6729185756706293,-1.656934032644223,0.0,0.3467367707508651,1.0,7/17,15.25%,IL34;CLCF1;CXCR4;ID2;DICER1;TENM4;BMP2
prerank,Long-Term Synaptic Potentiation (GO:0060291),0.683554837036549,1.6537250743732086,0.0,0.78298501349053,1.0,7/19,14.01%,NOL3;TSHZ3;GRIN2D;SLC8A2;RGS14;PLK2;FOXM1
prerank,Apoptotic Cell Clearance (GO:0043277),-0.6314187644032944,-1.6525382023914015,0.01694915254237288,0.3543612551672727,1.0,6/26,7.57%,THBS1;XKR9;TYROBP;ALOX15;FCN2;MEGF10
prerank,Positive Regulation Of MAPK Cascade (GO:0043410),-0.4457349326215067,-1.6501101045519952,0.0,0.356560649595109,1.0,40/289,7.45%,KDR;FLT1;CCL7;VEGFA;ROR2;IL34;BCAR3;IL26;GHR;SPRY2;DENND2B;THBS1;ALOX15;TGFB2;ART4;CCL22;AVPI1;DDR2;HRAS;ACKR3;IL1B;FLT4;EDN3;NDRG4;XCL1;CHI3L1;ARHGAP8;MST1R;CCL14;LRRK2;IGF1;GAREM1;ADRA2C;CSF1R;ADAM9;PELI2;ADRA2B;C5AR1;PDGFD;SEMA4C
prerank,Epiboly Involved In Wound Healing (GO:0090505),0.6183308601506866,1.6495187578985886,0.03636363636363636,0.7501268911229643,1.0,7/15,17.69%,CEACAM1;PDPN;CCNA2;PDCD10;MRTFA;DDR1;CD151
prerank,Calcium-Mediated Signaling (GO:0019722),-0.5444973934874371,-1.6460438466962894,0.017543859649122806,0.36148517604930724,1.0,22/80,12.82%,KDR;AZU1;EDN2;IRGM;CXCL8;VCAM1;LRRK2;STIMATE;MCTP2;RCAN2;SLC8A1;PPP3CA;PRNP;BTK;CXCR4;PLCE1;PLA2G4B;EDN1;CCR6;PLCG2;P2RY12;NCALD
prerank,Positive Regulation Of Phosphorylation (GO:0042327),-0.4712925489777405,-1.6447550976935148,0.0,0.35851977404343377,1.0,28/217,6.43%,KDR;VEGFC;FLT1;VEGFA;ROR2;IL34;INSRR;KNDC1;THBS1;FGF9;DDR2;HRAS;CLDN19;IL1B;FLT4;IRGM;LYN;MOB2;LTK;MST1R;LRRK2;FZD7;CSF1R;GLMN;CDKN1A;CARD14;PELI2;FGF17
prerank,DNA Integrity Checkpoint Signaling (GO:0031570),0.5414523666227351,1.6432795916631302,0.0,0.735014444598509,1.0,22/42,28.31%,CAMSAP3;CDT1;FBXO6;CHEK2;ATRIP;DTX3L;H2AX;DOT1L;INTS7;RHNO1;CDC45;CDC6;PRPF19;CLSPN;TP53BP1;E2F1;TIMELESS;DNA2;MAP3K20;MRPL36;PARP9;RPA4
prerank,Regulation Of Extrinsic Apoptotic Signaling Pathway Via Death Domain Receptors (GO:1902041),-0.6432471215136605,-1.6432574924172763,0.01818181818181818,0.35764332363234114,1.0,5/29,8.85%,NOS3;THBS1;TNFAIP3;FAIM;BRCA1
prerank,Positive Regulation Of Cell-Matrix Adhesion (GO:0001954),-0.5921121409181362,-1.6411117627084295,0.0,0.35626509202747375,1.0,6/41,6.50%,KDR;VEGFA;ENC1;CDH13;FUT1;UTRN
prerank,Sodium Ion Transport (GO:0006814),-0.5248000319959808,-1.640966837723969,0.0,0.3505753583779812,1.0,20/84,10.35%,SLC5A1;SLC6A12;SLC6A1;SCNN1B;SCN5A;SCN4A;ASIC4;FGF13;SCNN1A;SLC4A4;ASIC1;ATP1A2;PKD2L1;SLC34A3;SLC8A1;SCN3B;SLC9A8;SLC34A1;SLC17A3;SLC6A11
prerank,Peripheral Nervous System Development (GO:0007422),0.6076790866188249,1.6405005766343919,0.046511627906976744,0.7020418339996973,1.0,5/18,9.19%,ADGRG6;NFASC;SERPINI1;ALDH3A2;GSTM3
prerank,Positive Regulation Of G Protein-Coupled Receptor Signaling Pathway (GO:0045745),0.6794298454322779,1.636962418518832,0.0,0.673791862939778,1.0,8/16,14.85%,PDE6G;F2;SLC39A14;KLK5;GSK3A;GPER1;PHB1;PRMT5
prerank,Antigen Processing And Presentation Of Exogenous Peptide Antigen (GO:0002478),0.59221612103764,1.636837988685473,0.0,0.635288460581515,1.0,11/28,15.20%,HLA-A;CTSV;HLA-DRB1;HLA-DMB;FCER1G;CTSL;IFI30;LGMN;HLA-DQA1;HLA-DQA2;HLA-DPA1
prerank,Positive Regulation Of Synapse Assembly (GO:0051965),0.6027432629851562,1.6367236748932268,0.0,0.5999946572158752,1.0,4/28,1.78%,SLITRK2;GPRASP3;EPHB1;EPHB3
prerank,Positive Regulation Of Neuron Apoptotic Process (GO:0043525),-0.6198047240533341,-1.6363638876387958,0.016666666666666666,0.3575891899304795,1.0,5/22,7.93%,NUPR1;TYROBP;TGFB2;PRNP;ITGAM
prerank,Positive Regulation Of Peptidase Activity (GO:0010952),0.5806020906802104,1.6278536819227476,0.023255813953488372,0.6220687916262638,1.0,9/25,16.20%,MAPK12;CTSV;CTSL;CTSH;GRN;APH1B;PSME2;VCP;PRELID1
prerank,External Encapsulating Structure Organization (GO:0045229),-0.4919214682346172,-1.625632705890674,0.0,0.38426941382121066,1.0,20/95,11.76%,ADAMTS19;COL1A1;MMP17;ADAMTS15;COLQ;COL5A1;MATN2;COL1A2;ST7;COL23A1;MANSC4;COL7A1;ADAMTS1;COL4A5;COL9A2;COL5A3;SPOCK2;SLC39A8;TGFBI;COL9A1
prerank,Muscle Cell Development (GO:0055001),-0.6303030322226711,-1.6229544937784666,0.015873015873015872,0.3865320937763356,1.0,9/30,8.64%,CXADR;VEGFA;IGF1;ACTN3;ALPK3;SLC8A1;MEGF10;HEY2;MYH11
prerank,Positive Regulation Of Phospholipase Activity (GO:0010518),-0.689581375079722,-1.621897563782617,0.0196078431372549,0.3857842559492869,1.0,2/17,2.41%,FLT1;HRAS
prerank,Positive Regulation Of Endothelial Cell Migration (GO:0010595),-0.5246519687422817,-1.619607772250168,0.0,0.3852204974817351,1.0,6/80,4.26%,NOS3;KDR;VEGFA;THBS1;FLT4;FUT1
prerank,Heart Morphogenesis (GO:0003007),-0.5602219102803586,-1.6189246024845003,0.018867924528301886,0.3807181610617599,1.0,10/54,10.54%,NOS3;VEGFA;RBM20;TGFB2;ACVRL1;HEY2;TH;TGFBR3;FGF8;HEY1
prerank,Negative Regulation Of Extrinsic Apoptotic Signaling Pathway Via Death Domain Receptors (GO:1902042),-0.6784276055872315,-1.6109008056774656,0.0196078431372549,0.40565007469233777,1.0,4/21,8.85%,NOS3;TNFAIP3;FAIM;BRCA1
prerank,Blood Vessel Diameter Maintenance (GO:0097746),-0.6175981398495907,-1.6106734413434556,0.03773584905660377,0.4003631633800421,1.0,6/32,10.65%,NOS3;EDN2;EDN3;NPR1;SERPINF2;EDN1
prerank,Antigen Processing And Presentation Of Exogenous Peptide Antigen Via MHC Class II (GO:0019886),0.5896085158787137,1.6100158488625897,0.0,0.6977141788586032,1.0,10/23,15.20%,CTSV;HLA-DRB1;HLA-DMB;FCER1G;CTSL;IFI30;LGMN;HLA-DQA1;HLA-DQA2;HLA-DPA1
prerank,Sodium Ion Transmembrane Transport (GO:0035725),-0.5276437232220995,-1.6098482364364224,0.0,0.39629054098098937,1.0,19/77,10.35%,SLC5A1;SLC6A12;SLC6A1;SLC9A3;SCNN1B;SCN5A;SCN4A;ASIC4;SCNN1A;SLC4A4;ASIC1;ATP1A2;PKD2L1;SLC8A1;SLC9C2;SCN3B;SLC9A8;ATP12A;SLC6A11
prerank,Embryonic Organ Development (GO:0048568),-0.5072955794742634,-1.609097113374883,0.01639344262295082,0.39233596560799616,1.0,14/73,11.60%,KDR;GLI3;TGFB2;NKX2-6;NDRG4;CXCL8;PBX1;COL27A1;HEY2;RARRES2;FGF8;SH2B3;HEY1;FOXE1
prerank,Regulation Of Peptidase Activity (GO:0052547),0.552763828676501,1.603931995514018,0.0,0.7079952220244827,1.0,8/26,11.72%,MAPK12;CTSV;CTSL;CTSH;CSTB;EPPIN;CTSB;PSMA3
prerank,Detection Of Chemical Stimulus Involved In Sensory Perception (GO:0050907),-0.4863276050567744,-1.6032026101432582,0.017241379310344827,0.40965292214471044,1.0,33/121,9.73%,OR13D1;OR2A25;OR10K2;OR2T4;OR2AG1;OR2D3;OR2T33;OR2T11;OR2F1;OR2T10;OR10R2;OR13C9;OR6Q1;OR10S1;OR10A3;PKD2L1;OR10A2;OR10H2;OR10T2;OR10G2;OR13H1;OR2A12;OR6P1;OR10J1;OR6B1;OR10P1;OR2A5;OR2I1P;OR2AG2;OR10H5;OR10G3;OR10C1;OR6K3
prerank,Positive Regulation Of MAP Kinase Activity (GO:0043406),-0.5004357861264163,-1.6010141807457876,0.0,0.410836674804332,1.0,13/86,5.37%,FLT1;VEGFA;IL34;GHR;THBS1;HRAS;IL1B;EDN3;MST1R;TRAF6;LRRK2;ADAM9;FZD10
prerank,Detection Of Chemical Stimulus Involved In Sensory Perception Of Smell (GO:0050911),-0.48268348825653895,-1.5957987287122501,0.01694915254237288,0.41927303948783845,1.0,32/119,9.73%,OR13D1;OR2A25;OR10K2;OR2T4;OR2AG1;OR2D3;OR2T33;OR2T11;OR2F1;OR2T10;OR10R2;OR13C9;OR6Q1;OR10S1;OR10A3;OR10A2;OR10H2;OR10T2;OR10G2;OR13H1;OR2A12;OR6P1;OR10J1;OR6B1;OR10P1;OR2A5;OR2I1P;OR2AG2;OR10H5;OR10G3;OR10C1;OR6K3
prerank,Extracellular Structure Organization (GO:0043062),-0.4890810553457666,-1.5907959887304943,0.0,0.4305779814920916,1.0,20/96,11.76%,ADAMTS19;COL1A1;MMP17;ADAMTS15;COLQ;COL5A1;MATN2;COL1A2;ST7;COL23A1;MANSC4;COL7A1;ADAMTS1;COL4A5;COL9A2;COL5A3;SPOCK2;SLC39A8;TGFBI;COL9A1
prerank,Second-Messenger-Mediated Signaling (GO:0019932),-0.5255955548315534,-1.590641664071286,0.0,0.4251763359322135,1.0,19/69,12.82%,NOS3;EDN2;EDN3;CXCL8;FPR1;LRRK2;KLRG1;MCTP2;RCAN2;BTK;CXCR4;PLCE1;PLA2G4B;EDN1;GPR62;CCR6;PLCG2;P2RY12;NCALD
prerank,Eye Morphogenesis (GO:0048592),-0.7203180064553271,-1.5905709352074464,0.020833333333333332,0.4197815955425495,1.0,3/15,3.62%,VEGFA;COL5A1;MFAP5
prerank,Regulation Of Blood Circulation (GO:1903522),0.5510982921122034,1.5891681391369679,0.0,0.7737322828016588,1.0,8/28,12.98%,TNNT2;CYP2J2;KCNE5;CAMK2D;CELF2;KCNMB4;SRI;BDKRB2
prerank,Carboxylic Acid Transport (GO:0046942),-0.5572657376821492,-1.5885725847534187,0.015873015873015872,0.4200775264460596,1.0,10/50,2.81%,SLC6A12;SLC16A12;SLC16A7;SLC3A1;SLC16A14;SLC7A3;SLC16A2;SLC16A8;SLC43A2;SLC7A8
prerank,Positive Regulation Of BMP Signaling Pathway (GO:0030513),0.5921997955755112,1.587973071998475,0.022222222222222223,0.7501268911229642,1.0,5/21,8.21%,BMP4;SCUBE3;FOXD1;CCNA2;NOTCH1
prerank,Positive Regulation Of Cell Motility (GO:2000147),-0.428676222376754,-1.5862815395142742,0.0,0.4222358441696327,1.0,34/208,10.65%,KDR;FLT1;CCL7;VEGFA;ROR2;CLEC7A;SEMA3C;SEMA3F;SPRY2;COL1A1;THBS1;CEMIP;DUOX2;VIL1;HRAS;IL1B;FLT4;CDH13;PODXL;IGF1;CSF1R;ADAM9;WNT5B;PDGFD;SEMA4C;PPP3CA;CXCL16;CXCR4;PIK3R3;CASS4;RET;SPOCK2;TCAF2;EDN1
prerank,Inositol Phosphate-Mediated Signaling (GO:0048016),-0.6659331919828336,-1.5768594712812658,0.046875,0.4501841929429372,1.0,6/19,10.81%,EDN2;EDN3;PPP3CA;PLCE1;EDN1;GPR62
prerank,Regulation Of Voltage-Gated Calcium Channel Activity (GO:1901385),-0.6164105829136367,-1.5764325363482266,0.018867924528301886,0.4461781935841426,1.0,9/28,11.44%,CRHR1;CACNB4;CABP4;PPP3CA;STAC2;CACNB1;CACNA1A;GPR35;PDE4B
prerank,Endothelial Cell Migration (GO:0043542),-0.5676556152504169,-1.576250097291033,0.0196078431372549,0.4416295064997114,1.0,4/37,5.50%,NOS3;VEGFA;CDH13;PLXND1
prerank,Eosinophil Migration (GO:0072677),-0.6280938055081392,-1.5750041629362852,0.08333333333333333,0.4338684170788516,1.0,4/21,4.01%,CCL7;CCL22;XCL1;CCL14
prerank,Eosinophil Chemotaxis (GO:0048245),-0.6280938055081392,-1.5750041629362852,0.08333333333333333,0.4338684170788516,1.0,4/21,4.01%,CCL7;CCL22;XCL1;CCL14
prerank,Renal Absorption (GO:0070293),-0.6943459696712988,-1.5724674504408265,0.034482758620689655,0.4359523975702943,1.0,2/16,1.09%,SLC5A1;CLCNKA
prerank,Lymphocyte Migration (GO:0072676),-0.563302574359015,-1.5724458970293576,0.015873015873015872,0.4307624880754099,1.0,8/37,11.61%,CCL7;CCL22;XCL1;CCL14;RET;TBX21;CCR6;CCL2
prerank,Cellular Response To Growth Factor Stimulus (GO:0071363),-0.47015260617811666,-1.5717428497134271,0.0,0.42920383171284554,1.0,19/147,9.41%,KDR;FLT1;VEGFA;SPRY2;MAGI2;VIL1;FLT4;XCL1;CXCL8;MTSS2;ACVRL1;GAREM1;WNT7A;MAPT;PDE2A;SEMA6A;SLC4A7;ACVR1B;ZPR1
prerank,One-Carbon Compound Transport (GO:0019755),-0.5546535292639757,-1.5714615448230849,0.05555555555555555,0.4258874574714389,1.0,13/34,13.45%,SLC14A2;SLC4A3;CA2;CFTR;SLC4A4;AQP8;SLC14A1;SLC4A7;HBE1;SLC39A8;HBG2;RHAG;SLC4A8
prerank,Nitric Oxide Metabolic Process (GO:0046209),-0.6507910312442869,-1.570443055742154,0.06896551724137931,0.4240659980429894,1.0,1/16,0.01%,NOS3
prerank,Base Conversion Or Substitution Editing (GO:0016553),0.6656196318962943,1.569894525341148,0.021739130434782608,0.8507048022724641,1.0,3/16,0.92%,AICDA;RBM47;APOBEC3D
prerank,Mitotic Cytokinesis (GO:0000281),0.5073879489147726,1.568548903508639,0.02040816326530612,0.8266783020632051,1.0,21/59,15.75%,KIF20A;AURKB;EXOC4;KIF4A;APC;ESPL1;PLK1;ANLN;TRIM36;MYH10;RTKN;BIRC5;CIT;KLHDC8B;RACGAP1;CDCA8;PDCD6IP;CNTROB;ARL3;NUSAP1;SNX18
prerank,Regulation Of Cellular Response To Heat (GO:1900034),-0.7356456290281119,-1.5675055562148197,0.03125,0.4292987104336217,1.0,9/15,17.64%,IER5;MAPT;DNAJB1;DNAJC2;MAPKAPK2;EP300;CREBBP;SIRT1;DNAJB6
prerank,Peptidyl-Tyrosine Phosphorylation (GO:0018108),-0.5174646581760881,-1.5632847683056788,0.01694915254237288,0.44007658394279664,1.0,12/63,10.68%,KDR;FLT1;DDR2;FLT4;LYN;LTK;CSF1R;CLK1;BTK;IL15;SRC;CLK4
prerank,Negative Regulation Of Epithelial Cell Apoptotic Process (GO:1904036),-0.535338554776608,-1.563070235087527,0.03333333333333333,0.4361011021970948,1.0,7/34,12.39%,KDR;NUPR1;TNFAIP3;TCF7L2;IL11;YAP1;NFE2L2
prerank,Positive Regulation Of Collagen Metabolic Process (GO:0010714),0.6517047594201932,1.5627800706721307,0.061224489795918366,0.8315016031777236,1.0,6/16,9.66%,CREB3L1;LARP6;BMP4;F2;RGCC;HDAC2
prerank,Negative Regulation Of T Cell Activation (GO:0050868),0.4831217027949107,1.560238884805975,0.024390243902439025,0.8210078271787428,1.0,16/47,14.00%,CEACAM1;CD86;CR1;HLA-DRB1;FOXP3;CTSG;TIGIT;CD80;HLA-G;LILRB1;TNFAIP8L2;PDCD1LG2;LILRB4;IFNL1;JAK3;RIPOR2
prerank,Regulation Of Nervous System Process (GO:0031644),-0.6875573387455789,-1.5587133152375665,0.03636363636363636,0.4462282685761276,1.0,3/17,4.60%,NOS3;BEGAIN;NPTX2
prerank,Negative Regulation Of Platelet Activation (GO:0010544),-0.6674138799759415,-1.558372252231967,0.07692307692307693,0.44227234420931794,1.0,2/15,1.55%,NOS3;ALOX12
prerank,Regulation Of Ubiquitin Protein Ligase Activity (GO:1904666),0.5917293211451884,1.5574109465574197,0.057692307692307696,0.8098897478333102,1.0,3/17,5.92%,UBE2C;PLK1;CDC20
prerank,Nitric Oxide Biosynthetic Process (GO:0006809),-0.653585188374748,-1.555696591312535,0.06896551724137931,0.4463643864038027,1.0,1/15,0.01%,NOS3
prerank,Regulation Of Defense Response To Virus (GO:0050688),-0.6714889655948162,-1.5534647760534042,0.02040816326530612,0.4490563336553787,1.0,4/18,7.21%,ZMPSTE24;IRGM;TNFAIP3;ITCH
prerank,Positive Regulation Of Collagen Biosynthetic Process (GO:0032967),0.6602855534891199,1.5526117886528117,0.0625,0.8147930024266681,1.0,6/15,9.66%,CREB3L1;LARP6;BMP4;F2;RGCC;HDAC2
prerank,Glucose 6-Phosphate Metabolic Process (GO:0051156),0.5738616217885961,1.552518202103168,0.0,0.7882743697740894,1.0,10/18,26.45%,HK3;HKDC1;HK2;HK1;SHPK;DERA;RPE;PGD;G6PC1;RPIA
prerank,Steroid Hormone Biosynthetic Process (GO:0120178),-0.627226571232977,-1.5524614067537075,0.07272727272727272,0.44692784256941603,1.0,2/18,4.56%,HSD17B2;CYP21A2
prerank,Neutrophil Chemotaxis (GO:0030593),-0.5047850332940252,-1.5458774657228083,0.0,0.4640216867176734,1.0,16/66,11.61%,CCL7;CXADR;TGFB2;CCL22;EDN2;EDN3;XCL1;CXCL8;CXCL2;CCL14;CXCL11;CXCL3;PF4V1;EDN1;PDE4B;CCL2
prerank,Regulation Of Cell Migration Involved In Sprouting Angiogenesis (GO:0090049),-0.5841968474526488,-1.5454790075927152,0.05263157894736842,0.4608284842804353,1.0,3/30,1.24%,KDR;VEGFA;THBS1
prerank,Chemokine-Mediated Signaling Pathway (GO:0070098),-0.5094919526949493,-1.544883691493152,0.01639344262295082,0.45906483948067306,1.0,20/54,17.65%,CCL7;CCL22;XCL1;CXCL8;LYN;CXCL2;CCL14;CXCL11;CXCL3;RBM15;GPR35;SH2B3;PF4V1;CCL2;PPBP;PF4;CCR1;CXCL12;CCL25;CCL16
prerank,Pharyngeal System Development (GO:0060037),-0.6668852167353776,-1.5447960592938332,0.041666666666666664,0.45473949978956646,1.0,3/15,2.28%,TGFB2;SIX4;NKX2-6
prerank,Embryonic Digestive Tract Development (GO:0048566),-0.6252493370967861,-1.5442473658273745,0.0851063829787234,0.4515292072276525,1.0,5/18,9.60%,GLI3;TGFB2;RBPMS2;RARRES2;ID2
prerank,Antibacterial Humoral Response (GO:0019731),0.4888989384696614,1.542441019006557,0.02040816326530612,0.8279936610451577,1.0,9/41,16.77%,H2BC12;HLA-A;CTSG;JCHAIN;PLA2G1B;RNASE6;WFDC3;WFDC5;RNASE3
prerank,Positive Regulation Of CREB Transcription Factor Activity (GO:0032793),-0.6371684225935916,-1.5407974738249515,0.05555555555555555,0.45826054546210704,1.0,1/16,0.24%,VEGFA
prerank,Activation Of Adenylate Cyclase Activity (GO:0007190),-0.6075165202681683,-1.5366698609588683,0.03636363636363636,0.4666749678524221,1.0,2/18,3.01%,CRHR1;ADRB1
prerank,Positive Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071902),-0.4624454233448708,-1.5362260546227366,0.018518518518518517,0.4634423006266526,1.0,17/112,7.44%,FLT1;VEGFA;IL34;GHR;THBS1;CEMIP;HRAS;IL1B;IRGM;EDN3;MST1R;LRRK2;CSF1R;ADAM9;IFNG;ETAA1;PDGFD
prerank,Sensory Perception Of Smell (GO:0007608),-0.44158844283257803,-1.534469275919832,0.015873015873015872,0.4648211131001329,1.0,50/198,9.73%,OR13D1;OR2A25;OR10K2;OR2T4;OR2AG1;OR2D3;OR2T33;OR2T11;OR5M8;OR6C2;OR2F1;OR8D1;OR2T10;OR8G1;OR8B4;OR8A1;OR10R2;OR5D14;OR9Q2;OR13C9;OR6Q1;OR8B8;OR10S1;OR10A3;OR10A2;OR8J3;OR51I2;OR10H2;OR10T2;OR51V1;OR5D18;OR10G2;OR13H1;OR2A12;OR8B3;OR6P1;OR10J1;OR6B1;OR8K3;OR10P1;OR2A5;OR8B12;OR2I1P;OR9I1;OR2AG2;OR10H5;OR10G3;OR10C1;OR5T1;OR6K3
prerank,Cellular Response To Chemokine (GO:1990869),-0.49574147354883125,-1.534444506037764,0.01639344262295082,0.46039424535632206,1.0,21/56,17.65%,CCL7;CCL22;XCL1;LRCH1;CXCL8;CXCL2;CCL14;CXCL11;CXCL3;ZC3H12A;GPR35;SH2B3;PF4V1;DUSP1;CCL2;PPBP;PF4;CCR1;CXCL12;CCL25;CCL16
prerank,Granulocyte Chemotaxis (GO:0071621),-0.49587515649260505,-1.532802917739019,0.015625,0.46090250877451955,1.0,16/69,11.61%,CCL7;CXADR;TGFB2;CCL22;EDN2;EDN3;XCL1;CXCL8;CXCL2;CCL14;CXCL11;CXCL3;PF4V1;EDN1;PDE4B;CCL2
prerank,Sensory Perception Of Taste (GO:0050909),-0.6369450749524793,-1.5309958172366347,0.0851063829787234,0.4612090214119338,1.0,5/15,9.44%,SCNN1B;SCNN1A;PKD2L1;TAS2R60;CALHM1
prerank,Regulation Of Mononuclear Cell Migration (GO:0071675),-0.6116581243521194,-1.530931805952748,0.06666666666666667,0.4573195083749235,1.0,7/22,10.88%,IL34;THBS1;MSTN;LYN;CSF1R;RARRES2;SLIT2
prerank,Negative Regulation Of Protein Processing (GO:0010955),-0.6543404603015956,-1.530147258997373,0.034482758620689655,0.45557731552007397,1.0,5/15,9.50%,MAGEA3;THBS1;LRRK2;PRNP;SERPINF2
prerank,Positive Regulation Of Cell Migration (GO:0030335),-0.41039765787498167,-1.529944679354659,0.0,0.45190322189505994,1.0,60/258,15.78%,KDR;FLT1;CCL7;VEGFA;ROR2;CLEC7A;SEMA3C;SEMA3F;SPRY2;COL1A1;THBS1;TGFB2;CEMIP;VIL1;DDR2;HRAS;IL1B;FLT4;CDH13;PODXL;IGF1;SRGAP2C;CSF1R;ADAM9;IFNG;GAB1;NSMF;WNT5B;PDGFD;SEMA4C;PPP3CA;CXCL16;CXCR4;PIK3R3;SEMA6A;CASS4;ACVR1B;RET;SMURF2;SRC;TCAF2;EDN1;CAPN7;PLCG2;F2R;VTN;RHOC;SPAG9;CLDN3;DAAM2;SNAI1;APELA;CCR1;FERMT1;BMP2;SEMA3A;CXCL12;LAMC2;ADAM17;GRB7
prerank,Positive Regulation Of Release Of Cytochrome C From Mitochondria (GO:0090200),0.5511435203361201,1.52819208416751,0.0,0.8946825940997855,1.0,8/25,13.09%,TNFSF10;PLAUR;BID;BIK;PYCARD;HRK;BBC3;GPER1
prerank,Negative Regulation Of Myeloid Cell Differentiation (GO:0045638),-0.5991237386557651,-1.5263437589549673,0.018867924528301886,0.4596926670065842,1.0,5/22,5.07%,MEIS2;MEIS1;HOXB8;ZBTB16;HOXA5
prerank,Negative Regulation Of Rho Protein Signal Transduction (GO:0035024),0.603132258513428,1.523411935343206,0.02127659574468085,0.8978791575562753,1.0,6/16,14.05%,RASIP1;DYNLL1;ITGA3;MET;RIPOR2;KANK1
prerank,Cellular Response To Lectin (GO:1990858),-0.6527797435268496,-1.522506124523718,0.018867924528301886,0.4629341721853449,1.0,11/18,14.99%,CLEC7A;TYROBP;LYN;KLRD1;KLRC3;TRAF6;SRC;PLCG2;KLRC2;EP300;CREBBP
prerank,Stimulatory C-type Lectin Receptor Signaling Pathway (GO:0002223),-0.6527797435268496,-1.522506124523718,0.018867924528301886,0.4629341721853449,1.0,11/18,14.99%,CLEC7A;TYROBP;LYN;KLRD1;KLRC3;TRAF6;SRC;PLCG2;KLRC2;EP300;CREBBP
prerank,Regulation Of Apoptotic Signaling Pathway (GO:2001233),0.48062287707607826,1.5215188819303243,0.045454545454545456,0.885330757622503,1.0,10/44,9.16%,FAIM2;CTSV;TPD52L1;CTSL;CX3CR1;CTSH;PYCARD;STYXL1;ETFA;CX3CL1
prerank,Regulation Of Mitotic Metaphase/Anaphase Transition (GO:0030071),0.47490362356992755,1.5199077315646392,0.0,0.8732246373585276,1.0,13/49,18.88%,CENPE;DLGAP5;UBE2C;ESPL1;PLK1;CDC20;ACTL6A;CCNB1;DPF3;ANAPC7;SMARCB1;CDC6;HECW2
prerank,Determination Of Bilateral Symmetry (GO:0009855),-0.5638457426478302,-1.5194777821529906,0.05454545454545454,0.47078276052309687,1.0,6/25,11.22%,DNAH11;PIERCE1;DNAAF4;CCDC103;CFAP53;ODAD2
prerank,Negative Regulation Of Endocytosis (GO:0045806),0.514775809150618,1.5187030460225643,0.045454545454545456,0.861256800918959,1.0,14/30,25.10%,APOC1;ADIPOQ;SIRPA;PLSCR1;LILRB1;DYSF;TLR2;SCAMP5;PIP4P2;RACK1;UNC119;SYT11;PACSIN3;EPHA3
prerank,Positive Regulation Of Potassium Ion Transmembrane Transport (GO:1901381),0.6114651885706599,1.5180247642952753,0.046511627906976744,0.8429180554094846,1.0,5/17,14.92%,AKAP6;ATP1B2;KCNE5;KCNN4;KCNH2
prerank,Fatty Acid Derivative Biosynthetic Process (GO:1901570),-0.6056979046788902,-1.5176486383763061,0.034482758620689655,0.4730391159804009,1.0,7/24,10.35%,PAM;ACSS3;GGTLC3;HTD2;GGT2P;AWAT1;GGT5
prerank,Regulation Of mRNA Stability (GO:0043488),-0.49711696369321756,-1.5166474637933762,0.03125,0.47233054883781805,1.0,21/73,21.26%,RBM24;SLC11A1;IGF2BP1;RBM38;MEIOC;CELF1;METTL16;MAPKAPK2;IREB2;PRKCD;FASTKD5;FASTKD2;YTHDF3;ZFP36L2;TBRG4;TENT5C;DHX36;FUS;TENT5A;FXR1;PAIP1
prerank,Branching Morphogenesis Of An Epithelial Tube (GO:0048754),-0.543797729272883,-1.5162049252470233,0.043478260869565216,0.46917262990362346,1.0,3/36,1.09%,KDR;VEGFA;PAX8
prerank,Negative Regulation Of mRNA Catabolic Process (GO:1902373),-0.5642389257295504,-1.515535087400931,0.0,0.46763719485277705,1.0,5/38,5.41%,RBM24;SLC11A1;IGF2BP1;RBM38;MEIOC
prerank,Collagen Fibril Organization (GO:0030199),-0.5030241179200079,-1.5151005028533662,0.0,0.4649175179796602,1.0,9/38,10.22%,COL1A1;TGFB2;COL5A1;DDR2;COL1A2;COL11A2;COL27A1;SERPINF2;COL5A3
prerank,Meiosis I (GO:0007127),-0.6144923335567136,-1.5135549942159037,0.05263157894736842,0.46584306022822536,1.0,11/21,20.77%,MEI1;MEIOC;MYBL1;SYCP3;HSF2BP;FOXJ3;ZSCAN21;MOV10L1;DDX4;ING2;TDRD9
prerank,Negative Regulation Of Macromolecule Metabolic Process (GO:0010605),-0.4397527135376385,-1.5125568360320043,0.0,0.4647132242537654,1.0,49/179,16.43%,KDR;VEGFA;STOX1;TGFB2;MARK1;MSR1;CCDC3;HRAS;KRT17;CLDN19;CXCL8;CD34;UPK3B;ACVRL1;AURKA;IGF1;PPARG;REL;TERT;IFNG;MAPT;HEY2;HAVCR2;SMAD5;ZC3H12A;CD46;PRKN;ID2;TIPARP;IFNA2;ZNF148;CELF1;EDN1;YAP1;DICER1;SFMBT2;SH3GL2;APLN;PTPN22;SLC24A3;CLDN3;SMCR8;AP1AR;CCR1;FGF19;BMP2;PICALM;PCSK9;MTMR2
prerank,Positive Regulation Of Response To Biotic Stimulus (GO:0002833),0.5194666244781813,1.5120976826516241,0.021739130434782608,0.8536363035619966,1.0,16/40,16.70%,SCIMP;MYO1C;SH2D1B;TASL;LY86;LY96;CD1D;PLSCR1;TLR8;GRN;CYBA;CD180;POLR3G;POLR3B;IFI35;BMP6
prerank,Superoxide Metabolic Process (GO:0006801),-0.6273597104048252,-1.5112047919738816,0.09259259259259259,0.46469789578378967,1.0,4/28,3.61%,NOS3;NOX4;DUOX2;NOX5
prerank,Negative Regulation Of Endothelial Cell Proliferation (GO:0001937),-0.5241319942177882,-1.509240343934817,0.05263157894736842,0.467358693852501,1.0,5/32,5.23%,FLT1;THBS1;PRL;IL12A;PPARG
prerank,Regulation Of T Cell Receptor Signaling Pathway (GO:0050856),0.5034989523392921,1.508841140757564,0.0425531914893617,0.8534481164288558,1.0,10/34,14.32%,CEACAM1;IKBKG;PTPN2;GBP1;TRAT1;DGKZ;LILRB4;KCNN4;TESPA1;UBASH3A
prerank,Endocardial Cushion Morphogenesis (GO:0003203),-0.6570494193684002,-1.5072106090621324,0.037037037037037035,0.4694788950158926,1.0,3/18,4.03%,NOS3;TGFB2;ACVRL1
prerank,"Positive Regulation Of DNA Damage Response, Signal Transduction By P53 Class Mediator (GO:0043517)",-0.6087739919039857,-1.5063578806435407,0.08163265306122448,0.4681915606606547,1.0,4/15,9.87%,PLA2R1;HIC1;SPRED1;PYHIN1
prerank,Positive Regulation Of Macromolecule Biosynthetic Process (GO:0010557),-0.4489694912352568,-1.5057692130424087,0.03389830508474576,0.4663532488866433,1.0,11/121,5.80%,KDR;RPS27L;AZU1;THBS1;TGFB2;IL1B;IGF1;PRR16;SOX4;GUF1;IFNG
prerank,Cardiac Muscle Cell Action Potential (GO:0086001),-0.5826997160463712,-1.502248567505876,0.07142857142857142,0.47345250398236083,1.0,6/26,8.34%,SLC4A3;SCN5A;ATP1A2;SLC8A1;SCN3B;KCNE2
prerank,Endocardial Cushion Development (GO:0003197),-0.6485351558360004,-1.5021437878901922,0.057692307692307696,0.47023578457720355,1.0,3/19,4.03%,NOS3;TGFB2;ACVRL1
prerank,piRNA Processing (GO:0034587),-0.5573750938759854,-1.5010630480175542,0.03773584905660377,0.46993928191269513,1.0,3/19,2.29%,ANKRD34C;TDRD1;FKBP6
prerank,Negative Regulation Of Natural Killer Cell Mediated Cytotoxicity (GO:0045953),0.5889642982086669,1.5004815947247825,0.0392156862745098,0.8874097292098914,1.0,6/16,8.05%,CEACAM1;HLA-A;KLRC1;HLA-G;LILRB1;LGALS9
prerank,Regulation Of Defense Response (GO:0031347),-0.4550471921654651,-1.5002459170784201,0.015384615384615385,0.46933086687829584,1.0,21/93,13.21%,ZMPSTE24;NLRP13;ALOX15;IGF2BP1;GATA6;NLRP14;XCL1;PIK3AP1;CASP8;DAGLB;RNF135;SPATA2;GGT2P;FBXL2;NR1D2;BCL6;CELF1;FCGR2B;PTGES;NFE2L2;PTPN22
prerank,Regulation Of Macrophage Chemotaxis (GO:0010758),-0.6214663207994654,-1.4974083703164756,0.06382978723404255,0.475483990152961,1.0,5/20,5.29%,MTUS1;IL34;THBS1;MSTN;CSF1R
prerank,Negative Regulation Of GTPase Activity (GO:0034260),-0.6046639811618502,-1.497360257267096,0.038461538461538464,0.47203767815716136,1.0,6/21,5.72%,HRAS;LRCH1;PLXNB3;LRRK2;FZD10;RASA4
prerank,RNA Stabilization (GO:0043489),-0.531171801082618,-1.4970743584331132,0.03125,0.47018986759794595,1.0,10/36,21.26%,RBM24;SLC11A1;RBM38;MEIOC;IREB2;TENT5C;DHX36;FUS;TENT5A;PAIP1
prerank,Mitotic Cytokinetic Process (GO:1902410),0.61077685566876,1.4968081508963558,0.0196078431372549,0.8899253986618282,1.0,6/18,19.18%,CHMP4C;KIF20A;KLHDC8B;PDCD6IP;CNTROB;MITD1
prerank,Regulation Of Smooth Muscle Cell Proliferation (GO:0048660),-0.489934355606355,-1.4965384240215065,0.03508771929824561,0.46821612281791725,1.0,17/53,10.65%,THBS1;NR4A3;IL18;NDRG4;IL12A;CDH13;RBPMS2;IGF1;PPARG;TNFAIP3;IFNG;ANG;TCF7L2;APOD;SERPINF2;ID2;EDN1
prerank,Positive Regulation Of Notch Signaling Pathway (GO:0045747),-0.5887087773541003,-1.4953811923294356,0.04838709677419355,0.4676430058151238,1.0,2/30,1.48%,NOS3;TGFB2
prerank,Positive Regulation Of ERK1 And ERK2 Cascade (GO:0070374),-0.43955020381054904,-1.4931351100039407,0.0,0.47169162291954786,1.0,20/166,5.29%,KDR;CCL7;ROR2;IL26;SPRY2;DENND2B;ALOX15;CCL22;DDR2;HRAS;ACKR3;FLT4;NDRG4;XCL1;CHI3L1;ARHGAP8;CCL14;IGF1;GAREM1;CSF1R
prerank,Response To Retinoic Acid (GO:0032526),-0.4768845003090904,-1.4906739356071352,0.014925373134328358,0.47635681955663245,1.0,12/58,9.55%,HSD17B2;WNT11;GATA6;LYN;LTK;FZD7;FZD10;PTK7;WNT5B;ZNF35;RET;WNT10B
prerank,Regulation Of Collagen Biosynthetic Process (GO:0032965),0.6179923782515397,1.4900385023500122,0.08695652173913043,0.9076626973172864,1.0,6/18,9.66%,CREB3L1;LARP6;BMP4;F2;RGCC;HDAC2
prerank,Regulation Of Cytoplasmic Translation (GO:2000765),-0.5712426563791901,-1.488365748429829,0.037037037037037035,0.4802836174730105,1.0,6/24,17.73%,RBM24;IGF2BP1;CSDE1;LIN28A;DHX36;ZCCHC13
prerank,Negative Regulation Of Small GTPase Mediated Signal Transduction (GO:0051058),-0.5897376427894184,-1.4865414191342232,0.07142857142857142,0.48260000484075144,1.0,3/20,1.70%,SPRY2;TGFB2;CGNL1
prerank,Regulation Of Protein Processing (GO:0070613),-0.5897169536276522,-1.4855741225177552,0.03389830508474576,0.4823854172887677,1.0,6/23,7.91%,MAGEA3;RHBDD1;LRRK2;TNP2;ASTL;PRNP
prerank,Actin Filament Polymerization (GO:0030041),-0.5750820755930124,-1.48423591714935,0.06349206349206349,0.48334101150106223,1.0,12/31,18.50%,VIL1;PSTPIP2;GAS7;SPIRE2;ANG;DIAPH3;DIAPH1;WASF3;FHDC1;JAK2;SPIRE1;WASL
prerank,Response To Ketone (GO:1901654),-0.624491175360599,-1.4840936395276851,0.05172413793103448,0.4800820663968816,1.0,6/18,15.30%,THBS1;TGFB2;TGFBR3;SLIT2;YAP1;SLIT1
prerank,cAMP-mediated Signaling (GO:0019933),0.5246446604287667,1.4836542391416896,0.045454545454545456,0.9243513539091267,1.0,3/25,1.01%,AKAP6;ADGRG6;PDE7B
prerank,Regulation Of Osteoblast Proliferation (GO:0033688),0.5879673599916027,1.4834217645323147,0.058823529411764705,0.9039990739174184,1.0,7/16,13.18%,NPR3;PLXNB1;CCNA2;HPSE;SFRP1;MN1;TNN
prerank,Oxoacid Metabolic Process (GO:0043436),0.5343192093379637,1.4833435710628282,0.10256410256410256,0.8843376283381271,1.0,10/22,20.41%,SULT2B1;ENPP1;SULT1B1;AMH;TPST1;SULT1A1;MTARC1;SULT1C4;BPNT1;SULT2A1
prerank,Protein Localization To Chromatin (GO:0071168),0.487232604781397,1.48243896845513,0.0425531914893617,0.8699214029996248,1.0,21/31,36.74%,PLK1;PPHLN1;H4C9;TONSL;H1-5;LEF1;RUVBL2;MSH2;SGF29;PARP1;MACROH2A1;H2BC11;NIPBL;CENPA;H2AC8;ESR1;CHMP7;TASOR;MACROH2A2;LRWD1;WAPL
prerank,Positive Regulation Of mRNA Catabolic Process (GO:0061014),-0.46998746171952754,-1.4791006680531087,0.07017543859649122,0.49441861995362685,1.0,17/45,24.44%,RBM24;TNRC6B;NANOS2;ZC3H12A;CNOT1;CELF1;METTL16;YTHDF3;ZFP36L2;UPF1;DHX36;FXR1;ZFP36L1;GTPBP1;NANOS1;TNRC6A;YTHDF2
prerank,Negative Regulation Of Endothelial Cell Apoptotic Process (GO:2000352),-0.5567202484044165,-1.478791699715243,0.07407407407407407,0.4921279799099161,1.0,1/24,0.03%,KDR
prerank,Endocrine System Development (GO:0035270),-0.6541187172264942,-1.478539561555528,0.03571428571428571,0.48915959673896653,1.0,2/19,1.09%,WNT11;PAX8
prerank,Positive Regulation Of Peptidyl-Serine Phosphorylation (GO:0033138),-0.44407824195406387,-1.478471554324351,0.03225806451612903,0.4859500844784765,1.0,13/85,10.43%,VEGFA;IFNA6;BCAR3;STOX1;SPRY2;IFNA7;IRGM;RIPK2;IFNG;DOCK7;IL11;IFNA2;TBK1
prerank,Inorganic Cation Import Across Plasma Membrane (GO:0098659),-0.46987643064099427,-1.4740646010501013,0.038461538461538464,0.4979674535259794,1.0,21/95,10.44%,SLC5A1;KCNJ14;SLC6A1;SLC9A3;KCNJ13;SCNN1B;SCN5A;SCN4A;KCNJ11;SCNN1A;ATP1A2;TRPV3;AQP8;TRPV1;SLC8A1;KCNJ9;SLC9C2;KCNE2;CACNA1A;ATP12A;SLC39A8
prerank,Chloride Transmembrane Transport (GO:1902476),-0.49382682788135546,-1.4734526584953733,0.08333333333333333,0.4977301271569979,1.0,3/45,1.42%,SLC5A1;SLC6A1;CFTR
prerank,Negative Regulation Of Cell Cycle Process (GO:0010948),0.4865555439662742,1.473090083415223,0.023255813953488372,0.9048175429748356,1.0,7/33,13.09%,CHMP4C;BMP4;AURKB;ESPL1;HLA-G;E2F7;GPER1
prerank,Atrioventricular Valve Morphogenesis (GO:0003181),-0.5930937132648445,-1.4728509154530247,0.08163265306122448,0.49646054308622045,1.0,9/18,17.57%,TGFB2;SMAD6;SOX4;HEY2;HEY1;BMP2;SLIT1;EFNA1;BMPR2
prerank,Neutrophil Migration (GO:1990266),-0.48471557799553383,-1.472821766023711,0.0,0.4932879448436951,1.0,16/72,11.61%,CCL7;CXADR;TGFB2;CCL22;EDN2;EDN3;XCL1;CXCL8;CXCL2;CCL14;CXCL11;CXCL3;PF4V1;EDN1;PDE4B;CCL2
prerank,Regulation Of T Cell Cytokine Production (GO:0002724),0.563300002667958,1.4714403163268843,0.04878048780487805,0.8955841889208466,1.0,6/18,5.10%,HLA-A;CLC;MAP3K7;CCR2;FOXP3;HFE
prerank,Regulation Of Establishment Or Maintenance Of Cell Polarity (GO:0032878),0.5662038974575181,1.4698954997653129,0.08333333333333333,0.8863351753823407,1.0,5/16,17.53%,KRIT1;SHTN1;RIPOR2;KANK1;RACK1
prerank,Regulation Of MAP Kinase Activity (GO:0043405),-0.4409754846572997,-1.4695691658301069,0.015384615384615385,0.5016007304416167,1.0,15/108,5.31%,FLT1;VEGFA;IL34;GHR;SPRY2;THBS1;HRAS;IL1B;EDN3;LYN;MST1R;LRRK2;RGS2;PPARG;ADAM9
prerank,Positive Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042531),-0.47075272836463966,-1.468797990913745,0.0,0.5006014079651979,1.0,11/52,9.97%,VEGFA;GHR;IL18;LYN;IL12A;IGF1;CLCF1;CSF1R;IFNG;IL15;IFNA2
prerank,Vascular Transport (GO:0010232),-0.45706735745673027,-1.4687652748489461,0.028985507246376812,0.49746395305501634,1.0,11/81,4.10%,SLC5A1;SLC16A12;SLC16A7;SLC6A1;SLC4A3;SLC7A3;SLC16A2;SLC7A8;ABCB1;SLC4A4;ATP1A2
prerank,Epithelial Structure Maintenance (GO:0010669),-0.6478447634624865,-1.468169921130358,0.05,0.4961037409826055,1.0,5/17,4.87%,CXADR;MUC13;PBLD;MUC6;ILDR1
prerank,Blood Circulation (GO:0008015),-0.5152626780686068,-1.4665946543804627,0.08620689655172414,0.4980125946423002,1.0,5/48,5.59%,NOS3;EDN3;ACVRL1;HTR7;MYL7
prerank,Gonad Development (GO:0008406),-0.5137883420732942,-1.4661030779494615,0.03333333333333333,0.496072915597929,1.0,16/46,16.79%,TGFB2;PRKACG;SIX4;FGF9;GATA6;SOX15;IRX5;ADAM29;ADAM30;AKR1C3;FGF8;MAMLD1;CSDE1;WNT2B;ADAM20;SOX8
prerank,Positive Regulation Of Neuron Differentiation (GO:0045666),0.49207738878770146,1.4644380121507665,0.045454545454545456,0.9005369498045431,1.0,8/39,10.10%,NRCAM;GPRC5B;ASCL1;TCF4;DLX2;FGF20;FGFR1;HEYL
prerank,Toll-Like Receptor Signaling Pathway (GO:0002224),0.4911381091036907,1.4633197852246702,0.05714285714285714,0.8898564100576339,1.0,11/29,13.16%,SCIMP;MAP3K7;TLR5;LY96;TLR8;TLR1;IRAK3;HSPD1;MAPKAPK3;TLR2;TLR4
prerank,Peptidyl-Threonine Phosphorylation (GO:0018107),0.4263489945821128,1.463090877767832,0.0,0.8744082695338695,1.0,16/58,17.97%,CDC42BPA;TTBK1;DYRK4;MAPK8;CAMK2D;CDK5;CDK1;CSNK2B;GSK3A;MYLK2;HIPK1;DYRK1B;CDK10;MARK2;WNK3;AKT1
prerank,Protein Autophosphorylation (GO:0046777),-0.4125402921477483,-1.4628969009623298,0.015384615384615385,0.5021504248799321,1.0,19/157,7.64%,KDR;FLT1;AATK;INSRR;PEAK1;DDR2;FLT4;LYN;LTK;AURKA;LRRK2;MAK;CAMK2B;MAPK15;CSF1R;GRK7;FAM20C;SIK1;VRK2
prerank,Embryonic Heart Tube Development (GO:0035050),-0.6368539918266423,-1.4617517124959714,0.0196078431372549,0.5019667421545556,1.0,8/16,22.39%,NKX2-6;NDRG4;FGF8;APELA;IFT122;MEGF8;RYR2;SOX18
prerank,Regulation Of Intrinsic Apoptotic Signaling Pathway (GO:2001242),0.43806641927884316,1.4610516560200373,0.022222222222222223,0.8709746195912502,1.0,11/46,10.31%,NOL3;S100A8;GSDME;PLAUR;SIAH1;BID;PYCARD;STYXL1;BCL2L1;S100A9;BBC3
prerank,Cellular Response To pH (GO:0071467),-0.6079299086469492,-1.4603353844176268,0.07272727272727272,0.5026263148320024,1.0,6/20,6.15%,INSRR;SCNN1B;SCNN1A;ASIC1;PKD2L1;TRPV1
prerank,Positive Regulation Of Immune Response (GO:0050778),0.43400886539298356,1.459329734709903,0.02564102564102564,0.8637501001772022,1.0,29/78,17.33%,MYO1C;GSDME;HLA-DRB1;SH2D1B;RSAD2;HLA-DMB;TASL;CD1D;PLSCR1;F2RL1;PYCARD;LILRB1;ZP3;TLR8;LGALS9;CCR7;GPR151;NOD2;PLA2G1B;NLRP3;IL12RB1;IFNL1;POLR3G;CFP;POLR3B;C8G;C7;IFI35;IL6ST
prerank,Regulation Of Leukocyte Chemotaxis (GO:0002688),-0.6443023009583756,-1.4568672666598048,0.06349206349206349,0.5105417089695353,1.0,5/16,3.26%,MTUS1;EDN2;EDN3;XCL1;LYN
prerank,Negative Regulation Of T Cell Proliferation (GO:0042130),0.484260244194275,1.4547482278267068,0.05,0.8744486206307562,1.0,10/34,12.00%,CD86;CR1;HLA-DRB1;FOXP3;CD80;HLA-G;LILRB1;LGALS9;PDCD1LG2;LILRB4
prerank,Negative Regulation Of Myeloid Leukocyte Differentiation (GO:0002762),0.4893426298943668,1.453436321282563,0.0625,0.8684504781155746,1.0,9/27,13.16%,CEACAM1;MYC;PTPN2;LRRC17;IL4;FSTL3;FBN1;LILRB4;TLR4
prerank,Regulation Of Cholesterol Transport (GO:0032374),-0.5940463880991131,-1.4494474136943354,0.06,0.5303051753981725,1.0,6/21,7.95%,ABCB4;OSBPL6;APOA1;ABCA8;ABCA5;ABCA2
prerank,Midbody Abscission (GO:0061952),0.6032978614705948,1.448879383240818,0.037037037037037035,0.881390661094549,1.0,2/15,1.55%,CHMP4C;KIF20A
prerank,Transport Across Blood-Brain Barrier (GO:0150104),-0.44913524450585696,-1.4484392147017275,0.028169014084507043,0.5305871347340324,1.0,11/83,4.10%,SLC5A1;SLC16A12;SLC16A7;SLC6A1;SLC4A3;SLC7A3;SLC16A2;SLC7A8;ABCB1;SLC4A4;ATP1A2
prerank,Negative Regulation Of Cysteine-Type Endopeptidase Activity (GO:2000117),-0.4928302579666233,-1.4479401669861551,0.03389830508474576,0.5296667223987751,1.0,17/50,20.41%,MAGEA3;VEGFA;THBS1;CST7;CST1;SFN;SRC;MT3;SIAH2;CARD18;AVP;DNAJB6;TRIAP1;RAF1;CAST;CDKN2D;MAP2K5
prerank,Alpha-Beta T Cell Activation (GO:0046631),0.5929580019882389,1.447929841642222,0.043478260869565216,0.8719976393491752,1.0,7/15,29.51%,HLA-A;RSAD2;TRBC1;CD3D;STOML2;CD3G;CD3E
prerank,Adrenergic Receptor Signaling Pathway (GO:0071875),-0.6406719809303095,-1.4474141879529963,0.06382978723404255,0.528255807611328,1.0,4/17,6.75%,GPR101;ADRB1;ADRA2C;ADRA2B
prerank,Positive Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050731),-0.4211491022690719,-1.4469157209990215,0.01818181818181818,0.5266126517096995,1.0,26/121,12.35%,VEGFA;IL34;GHR;NOX4;BANK1;DOK7;IL18;LYN;IL12A;IGF1;CLCF1;RIPK2;CSF1R;IFNG;FCGR1A;PRNP;CASS4;ACE;IL11;IL15;IFNA2;SRC;ANGPT1;PLCG2;IL31RA;VTN
prerank,Stress-Activated Protein Kinase Signaling Cascade (GO:0031098),0.5472508747885906,1.4463824344916,0.06818181818181818,0.8671610301551868,1.0,6/20,15.54%,MAPK8;MAP3K7;MAPK11;PDCD10;MAP3K13;IKBKB
prerank,Regulation Of DNA-templated DNA Replication (GO:0090329),0.5218672780186083,1.4451464447167808,0.08163265306122448,0.8607225225064782,1.0,3/17,3.62%,TICRR;CDT1;MCM4
prerank,Regulation Of Granulocyte Chemotaxis (GO:0071622),-0.5917495892168526,-1.4446865888948313,0.08928571428571429,0.5313092395061504,1.0,5/18,9.29%,IL34;THBS1;MSTN;CSF1R;RARRES2
prerank,Regulation Of Interleukin-1 Production (GO:0032652),0.5712876747065279,1.4431121290299558,0.10869565217391304,0.8579635438190776,1.0,5/16,13.16%,CEACAM1;SIRPA;CCR7;ORM2;TLR4
prerank,Positive Regulation Of Antigen Receptor-Mediated Signaling Pathway (GO:0050857),0.5650759732443653,1.4422188953948512,0.07317073170731707,0.8484685885944198,1.0,10/20,27.01%,IKBKG;NFAM1;TRAT1;KCNN4;TESPA1;LCK;SLC39A10;RPS3;PTPRC;UXT
prerank,Aminoglycan Biosynthetic Process (GO:0006023),0.5562322916277147,1.4421882064217701,0.06976744186046512,0.8354587861448887,1.0,10/20,24.95%,B3GNT3;EXT2;HS3ST3A1;HEXA;UGDH;B4GAT1;HS3ST1;GALNT5;HS3ST3B1;B3GNT4
prerank,Positive Regulation Of Receptor Internalization (GO:0002092),-0.6121884908240379,-1.4419185213384058,0.038461538461538464,0.5372429548165827,1.0,7/21,16.38%,VEGFA;MAGI2;CCL14;ANGPT1;APLN;APELA;PCSK9
prerank,Glycolipid Metabolic Process (GO:0006664),0.5037875796065978,1.4411363711521197,0.05,0.8285656405552932,1.0,12/31,18.72%,B3GNT5;GBGT1;ST6GALNAC4;ST6GALNAC3;NEU3;GM2A;NAGA;GBA2;ST3GAL2;PGAP1;UGCG;GLB1
prerank,Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0007179),-0.46336044007253685,-1.4409555027962082,0.019230769230769232,0.5375347705091101,1.0,15/69,10.29%,ITGB5;TGFB2;SMAD6;COL1A2;USP9Y;ACVRL1;APOA1;ADAM9;SMAD5;LTBP2;BAMBI;GDF15;PSG4;TGFBR3;SRC
prerank,Neuron Migration (GO:0001764),-0.46602672930796973,-1.4409314632506003,0.05555555555555555,0.5344758121434195,1.0,8/51,6.40%,VEGFA;MARK1;AUTS2;FGF13;KIAA0319;NR4A2;DNAAF4;SOX1
prerank,"Regulation Of Nuclear-Transcribed mRNA Catabolic Process, Deadenylation-Dependent Decay (GO:1900151)",-0.5804539365705136,-1.4401736431887677,0.058823529411764705,0.5341149459206372,1.0,10/23,23.81%,IGF2BP1;TNRC6B;NANOS2;CNOT1;CSDE1;ZFP36L2;DHX36;PAIP1;ZFP36L1;NANOS1
prerank,Regulatory ncRNA Processing (GO:0070918),-0.49450816921535456,-1.4397170676114477,0.017857142857142856,0.5332169633368153,1.0,13/35,20.77%,ANKRD34C;TDRD1;FKBP6;TERT;ANKRD34A;DICER1;SNIP1;MOV10L1;TSN;DDX4;ZC3H7A;AGO4;TDRD9
prerank,Hexose Metabolic Process (GO:0019318),0.4672357280014055,1.4394159399032644,0.06521739130434782,0.8242518561037542,1.0,13/45,11.97%,FPGT;CHST15;HK3;SLC35A2;HKDC1;BRAT1;HK2;OAS1;GALK2;CHST1;HK1;SORD;GALK1
prerank,Endothelial Cell Development (GO:0001885),0.5306773185891801,1.4390264504567634,0.04081632653061224,0.8143860129149664,1.0,6/20,9.41%,RAPGEF1;F2RL1;ROBO4;MARVELD2;GSTM3;MET
prerank,Heterotypic Cell-Cell Adhesion (GO:0034113),-0.5464186325864652,-1.438811111183722,0.08823529411764706,0.5329274109780208,1.0,10/29,16.97%,CXADR;VCAM1;DSG2;IZUMO1;NINJ1;ITGAD;DSC2;ITGB3;PARVA;RNASE10
prerank,Regulation Of Blood Vessel Endothelial Cell Proliferation Involved In Sprouting Angiogenesis (GO:1903587),-0.6268893895411012,-1.4384325693827993,0.06557377049180328,0.5312143292795074,1.0,8/16,14.38%,VEGFA;THBS1;IL12A;FGFBP1;PPP1R16B;NGFR;MMRN2;APELA
prerank,Prostaglandin Metabolic Process (GO:0006693),-0.5737897095677534,-1.437446402671785,0.07547169811320754,0.5314125066080951,1.0,9/29,12.38%,AKR1C2;PTGS1;EDN2;AKR1C3;CYP4F8;DAGLB;CES1;EDN1;PTGES
prerank,Regulation Of Vascular Endothelial Cell Proliferation (GO:1905562),-0.6003763268843194,-1.437191758786782,0.03508771929824561,0.5294337909152872,1.0,2/18,5.23%,FLT1;PPARG
prerank,Male Gonad Development (GO:0008584),-0.5165962990577748,-1.437081384684344,0.04918032786885246,0.5267178433349078,1.0,14/40,16.79%,TGFB2;PRKACG;SIX4;FGF9;GATA6;SOX15;ADAM29;ADAM30;AKR1C3;MAMLD1;CSDE1;WNT2B;ADAM20;SOX8
prerank,Energy Reserve Metabolic Process (GO:0006112),-0.6177606592156423,-1.4369904687483153,0.09259259259259259,0.5240906940512203,1.0,2/16,1.02%,PYGL;GFPT2
prerank,Positive Regulation Of Epithelial Cell Migration (GO:0010634),-0.4626004465832564,-1.4364538770111404,0.04411764705882353,0.5225909434320709,1.0,16/90,11.92%,KDR;VEGFA;THBS1;TGFB2;VIL1;FLT4;FUT1;ADAM9;IFNG;NELL2;ZC3H12A;SRC;EDN1;ANGPT1;CAPN7;PLCG2
prerank,Positive Regulation Of Protein Phosphorylation (GO:0001934),-0.3916397971145544,-1.4336566946377582,0.0,0.5292098597073949,1.0,49/358,10.94%,KDR;VEGFC;VEGFA;IL34;BCAR3;AZU1;STOX1;GHR;SPRY2;BANK1;KNDC1;MSTN;TGFB2;FGF9;CEMIP;DDR2;HRAS;CLDN19;IL1B;FLT4;IRGM;CHI3L1;LYN;MOB2;ACVRL1;LRRK2;IGF1;RIPK2;PPARG;CSF1R;CDKN1A;CARD14;PELI2;FGF17;DOCK7;INHBE;PDGFD;PRNP;PIK3R3;IL11;GDF15;IL15;RARRES2;FGF8;SRC;TBK1;AKAP9;ANGPT1;MT3
prerank,Epithelial Cell Differentiation (GO:0030855),-0.43429606762051987,-1.4322550912853491,0.04477611940298507,0.5304982485322103,1.0,11/123,6.80%,KDR;VEGFA;AKR1C2;KRT23;GATA6;VIL1;KRT17;PPARG;FZD7;KRT15;EHF
prerank,Branching Involved In Ureteric Bud Morphogenesis (GO:0001658),0.5657608936229557,1.4303242268761376,0.05263157894736842,0.8483065301447987,1.0,4/16,4.36%,BMP4;MYC;FOXD1;FGF2
prerank,Cellular Nitrogen Compound Biosynthetic Process (GO:0044271),-0.5159606014579214,-1.4280427079568918,0.11864406779661017,0.5400120887859627,1.0,1/32,0.01%,NOS3
prerank,Cellular Response To Estrogen Stimulus (GO:0071391),0.5598000103316044,1.427971724918822,0.08695652173913043,0.8461555787309003,1.0,3/15,10.98%,NCOA4;ESR2;SFRP1
prerank,Positive Regulation Of Stem Cell Differentiation (GO:2000738),-0.6781667316590497,-1.4265654687378595,0.0,0.5411704533795589,1.0,3/15,7.95%,RBM24;TGFB2;LTBP2
prerank,Glutamine Family Amino Acid Catabolic Process (GO:0009065),-0.6554197682254529,-1.4262793766960655,0.0784313725490196,0.5392249168057182,1.0,1/15,0.01%,NOS3
prerank,Epithelium Development (GO:0060429),-0.4327040008395456,-1.4257603776521832,0.016666666666666666,0.5381949102688717,1.0,15/144,6.80%,KDR;VEGFA;AKR1C2;PAX8;KRT23;GATA6;VIL1;NKX2-6;KRT17;NDRG4;CD34;MANSC4;PPARG;KRT15;EHF
prerank,Negative Regulation Of B Cell Activation (GO:0050869),-0.6027095478226436,-1.425015209355774,0.06451612903225806,0.537176038937829,1.0,8/20,13.42%,BANK1;TYROBP;LYN;TNFAIP3;ID2;FCGR2B;CD300A;SAMSN1
prerank,DNA Damage Checkpoint Signaling (GO:0000077),0.4778710494085064,1.424919976814932,0.06818181818181818,0.851453953524747,1.0,18/34,29.67%,STK33;FBXO6;CHEK2;ATRIP;DTX3L;H2AX;DOT1L;INTS7;RHNO1;PRPF19;CLSPN;TP53BP1;E2F1;MAP3K20;MRPL36;PARP9;RPA4;CHEK1
prerank,Negative Regulation Of Calcium Ion Transmembrane Transporter Activity (GO:1901020),-0.5427874836234755,-1.4244423177406458,0.08,0.5359469317425244,1.0,5/29,9.81%,CRHR1;CASQ2;ATP1A2;PPP3CA;GPR35
prerank,Negative Regulation Of Response To Wounding (GO:1903035),0.5621372204362585,1.4240978685164953,0.04,0.8428623584321219,1.0,8/23,7.56%,RTN4RL1;SIGLEC10;ALOX5;RTN4R;FGF2;EPHA4;CD109;PTPN6
prerank,Aortic Valve Development (GO:0003176),-0.501362870574375,-1.423428221828633,0.07142857142857142,0.5361060240030122,1.0,2/38,1.87%,NOS3;SMAD6
prerank,Negative Regulation Of Innate Immune Response (GO:0045824),0.4527671021225878,1.4233359924048863,0.025,0.8357318378888929,1.0,23/50,27.27%,MYO1C;CR1;AURKB;SUSD4;PTPN2;IRAK3;OAS1;SLAMF8;ISG15;GRN;TTLL12;TRAFD1;SAMHD1;AKT1;OAS3;BANF1;USP18;YWHAZ;METTL3;PARP1;DCST1;CNOT7;STAT2
prerank,Monocarboxylic Acid Transport (GO:0015718),-0.4441481798664341,-1.423013758626601,0.03278688524590164,0.5342938784695942,1.0,7/65,2.70%,SLC6A12;SLC16A12;ABCB4;SLC16A7;SLC16A14;SLC16A2;SLC16A8
prerank,Ameboidal-Type Cell Migration (GO:0001667),-0.5729344936086737,-1.4220915355258266,0.06896551724137931,0.5343511932805823,1.0,9/18,25.13%,PDLIM1;AMOTL1;TNS1;PKN2;MEGF8;PKN3;PKN1;NANOS1;AMOT
prerank,Negative Regulation Of Cation Channel Activity (GO:2001258),-0.5597672417982319,-1.4213186672331237,0.04081632653061224,0.5343537710759091,1.0,5/27,9.81%,CRHR1;CASQ2;KCNAB1;PPP3CA;GPR35
prerank,Regulation Of Establishment Of Planar Polarity (GO:0090175),0.5106984284148978,1.4209906724923098,0.09302325581395349,0.8386835379916474,1.0,8/28,8.14%,DACT1;VANGL2;FZD6;SAPCD2;VANGL1;PRICKLE2;PRICKLE1;TIAM1
prerank,Adenylate Cyclase-Activating G Protein-Coupled Receptor Signaling Pathway (GO:0007189),-0.4630449643484047,-1.420614550253235,0.018867924528301886,0.5341947710405983,1.0,22/95,15.01%,ADGRE2;CRHR1;ADGRF1;GPR101;ADCY2;ADRB1;ADCY1;ADRA2C;GPHA2;ADRA2B;ADM5;GPR65;CXCL11;ADGRD1;MC3R;GPR161;ADGRG3;PTGER4;GPR157;PF4;ADM;CALCB
prerank,Regulation Of Supramolecular Fiber Organization (GO:1902903),0.5485098312034805,1.419962068171217,0.07317073170731707,0.8323325778213712,1.0,12/22,22.79%,CAMSAP3;CHRNA7;MAP1A;CAMSAP2;GBA2;PARK7;HSPA8;MAPRE3;HAX1;MAP2;MAP1S;ARL2
prerank,Carbohydrate Derivative Biosynthetic Process (GO:1901137),0.4739257811629997,1.419478999871821,0.043478260869565216,0.8239439517878713,1.0,10/28,17.30%,B3GNT5;GBGT1;RRM2B;GALK2;GCNT1;PDCD6;GAL3ST4;TPI1;ST3GAL2;B4GAT1
prerank,Positive Regulation Of Lamellipodium Assembly (GO:0010592),-0.5638147160445002,-1.4187796658534242,0.06976744186046512,0.537305185612822,1.0,7/22,11.46%,MSTN;AUTS2;NCKAP1;PIK3R1;WNT1;PLCE1;PIK3CA
prerank,Regulation Of Neuroinflammatory Response (GO:0150077),-0.5846510328530861,-1.4187780284474525,0.109375,0.5345212209205277,1.0,6/17,13.10%,NUPR1;IL1B;IL18;IGF1;PLCG2;NR1D1
prerank,Innate Immune Response Activating Cell Surface Receptor Signaling Pathway (GO:0002220),-0.5685649956366446,-1.417930146000785,0.09433962264150944,0.5347349393065429,1.0,13/26,14.99%,CLEC7A;LILRA2;TYROBP;LYN;KLRD1;KLRC3;FCN2;TRAF6;SRC;PLCG2;KLRC2;EP300;CREBBP
prerank,Regulation Of Epithelial Cell Proliferation (GO:0050678),-0.4605326633974412,-1.4166903867785172,0.047619047619047616,0.5365288354558357,1.0,21/86,13.10%,VEGFA;IL26;NUPR1;NR4A3;TGFB2;SCN5A;SIX4;FGF9;HRAS;FUT1;IGF1;C5AR1;RUNX3;HPN;TCF7L2;TGFBR3;ANGPT1;YAP1;PEX2;CDKN1C;NR1D1
prerank,Protein Localization To Cilium (GO:0061512),-0.5169871243252578,-1.415995995495299,0.1,0.5360479349902921,1.0,9/39,17.75%,DNAH11;TUB;MAPK15;ODAD4;CFAP58;CC2D2B;CSNK1D;TTC21B;IFT122
prerank,Positive Regulation Of Heart Contraction (GO:0045823),-0.5505728154833428,-1.414319052504375,0.11538461538461539,0.5391744184452397,1.0,11/21,16.77%,TGFB2;EDN2;EDN3;ATP1A2;RGS2;ADM5;SCN3B;EDN1;APLN;APELA;TRPM4
prerank,Regulation Of Regulated Secretory Pathway (GO:1903305),0.47751508586923935,1.4135430117125634,0.08333333333333333,0.8427066544376274,1.0,14/34,14.82%,SYT3;SYN1;SYT5;RPH3A;RPH3AL;RAB15;RIMS2;SYT13;SEPTIN5;SNAPIN;SYT9;RAB3D;TRPV6;SYT17
prerank,Regulation Of Platelet Activation (GO:0010543),-0.5397133964381154,-1.4135011473639374,0.05357142857142857,0.5385811210667381,1.0,3/27,3.26%,NOS3;CELA2A;LYN
prerank,Negative Regulation Of Type II Interferon Production (GO:0032689),0.44431840174774784,1.4128897794758424,0.022727272727272728,0.834655359960707,1.0,11/28,15.08%,CR1;HLA-DRB1;LGALS9C;FOXP3;LILRB1;LGALS9;PDCD1LG2;LILRB4;TLR4;C1QBP;NR1H4
prerank,Positive Regulation Of Natural Killer Cell Activation (GO:0032816),-0.5946297812077244,-1.4124456349990429,0.09615384615384616,0.5392342371316833,1.0,7/16,17.05%,TYROBP;IL18;IL12A;ZBTB1;KLRC2;JAK2;IL23A
prerank,Positive Regulation Of Apoptotic Signaling Pathway (GO:2001235),0.43329051184082623,1.4123748162844678,0.05128205128205128,0.8268131900156548,1.0,23/60,22.09%,CTSV;S100A8;TPD52L1;GSDME;TNFSF10;SIAH1;BID;CTSL;CTSH;PYCARD;STYXL1;S100A9;BBC3;GPER1;TLR4;LTB;RACK1;SEPTIN4;HYAL2;IFNB1;LCK;FAS;TNFSF12
prerank,Intracellular Steroid Hormone Receptor Signaling Pathway (GO:0030518),0.44255531254226443,1.4123080821753877,0.07317073170731707,0.8164596109494197,1.0,10/42,15.48%,RHOXF1;PMEPA1;NCOA4;ESR2;EGLN2;PLPP1;PADI2;GPER1;PHB1;DAXX
prerank,Muscle Cell Differentiation (GO:0042692),-0.5102912447713377,-1.4113847056435898,0.11538461538461539,0.5401379571198216,1.0,9/32,7.85%,GATA6;RORA;ACTN3;GLMN;WNT5B;SEMA4C;MEGF10;HEY2;NINJ1
prerank,Negative Regulation Of ATP-dependent Activity (GO:0032780),0.6085001525817244,1.4090041985840824,0.09433962264150944,0.8232892185434286,1.0,2/15,2.41%,TNNT2;IFIT1
prerank,Regulation Of Mitotic Spindle Assembly (GO:1901673),0.5591056886507849,1.4070205022283169,0.044444444444444446,0.823937453807179,1.0,3/20,4.39%,CHMP4C;HSPA1A;PLK1
prerank,Response To Molecule Of Bacterial Origin (GO:0002237),-0.4623335307005204,-1.4067968904219124,0.08064516129032258,0.552392682603215,1.0,16/68,13.21%,NOS3;SLC11A1;SMAD6;IL1B;CXCL8;IL12A;CXCL2;FZD5;TNFAIP3;PALM3;GPR31;PELI1;FCGR2B;MAPKAPK2;F2R;PTPN22
prerank,Limb Morphogenesis (GO:0035108),-0.5914145361141789,-1.4059063984355415,0.11538461538461539,0.5535787389182253,1.0,4/19,10.10%,GLI3;TGFB2;CYP26B1;FGF8
prerank,Regulation Of Monoatomic Ion Transport (GO:0043269),-0.5612201237975597,-1.4053625552210118,0.06896551724137931,0.5523717604043972,1.0,8/24,9.44%,KCNJ14;KCNJ13;PDZK1;KCNJ11;NEDD4;KCNJ9;HTR1A;CALHM1
prerank,Negative Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043124),-0.4938489525496535,-1.4045963000086095,0.03508771929824561,0.5524874997544124,1.0,14/41,17.41%,IRGM;PER1;RORA;TLE1;CASP8;TNFAIP3;ZC3H12A;SLC39A8;TRIM39;NR1D1;PPM1A;CARD19;SIRT1;PPM1B
prerank,Regulation Of Release Of Cytochrome C From Mitochondria (GO:0090199),0.4677986769379514,1.4045215986353219,0.024390243902439025,0.8269442539840844,1.0,10/40,10.31%,NOL3;TNFSF10;PLSCR3;PLAUR;BID;BIK;PYCARD;HRK;BCL2L1;BBC3
prerank,Innate Immune Response In Mucosa (GO:0002227),0.5283294275633424,1.404489068819914,0.10416666666666667,0.817328690468408,1.0,3/19,9.68%,H2BC12;IL4;PLA2G1B
prerank,Regulation Of Establishment Of Cell Polarity (GO:2000114),0.5341448636342333,1.4032209974169318,0.16,0.8136223400471817,1.0,5/16,17.53%,KRIT1;SHTN1;RIPOR2;KANK1;RACK1
prerank,Peptide Hormone Secretion (GO:0030072),-0.5436140340947263,-1.3983316998568764,0.08163265306122448,0.5696106549981153,1.0,3/23,4.32%,CRHR1;EDN3;KLRG1
prerank,Regulation Of Immunoglobulin Production (GO:0002637),0.4829435072387859,1.3972974825228361,0.11627906976744186,0.831871488232518,1.0,5/27,5.53%,CD86;CR1;IL21;TNFRSF4;IL4
prerank,Vasculogenesis (GO:0001570),-0.5277762513685661,-1.3960111757439713,0.12962962962962962,0.5744847135326724,1.0,5/32,7.59%,KDR;VEGFA;GLMN;SPRED1;HEY2
prerank,Regulation Of mRNA Processing (GO:0050684),-0.5191863667248561,-1.395709957186851,0.08333333333333333,0.5725044320840087,1.0,12/35,23.33%,RBM20;SRPK3;LARP7;SAFB2;METTL16;RBM39;CDK9;CDK11B;SRRM1;SRPK2;ZFP36L1;SRSF10
prerank,Artery Development (GO:0060840),-0.533086214769442,-1.395390287373501,0.05454545454545454,0.5707409880214611,1.0,3/22,8.58%,VEGFA;ACVRL1;PDE2A
prerank,Monoatomic Anion Transmembrane Transport (GO:0098656),-0.45395631847030454,-1.3951695438727867,0.11475409836065574,0.5688467816529995,1.0,3/51,1.42%,SLC5A1;SLC6A1;CFTR
prerank,Positive Regulation Of Nervous System Development (GO:0051962),0.44480653514770846,1.3950505349850675,0.0425531914893617,0.8333988959293746,1.0,12/44,17.05%,SLITRK2;GPRASP3;EPHB1;EPHB3;CX3CR1;RGS14;GPER1;SOX11;PTPRD;OPRM1;NLGN2;SLITRK1
prerank,Negative Regulation Of Protein Binding (GO:0032091),0.4169769914126088,1.3943344772854653,0.024390243902439025,0.8278457625198724,1.0,21/70,21.16%,PTPRF;DACT1;TTBK1;MAPK8;IFIT1;AURKB;ADIPOQ;HFE;EFHB;XIRP1;DAB2;CAMK1;PARK7;RACK1;AKT1;GTF2F1;CARD16;MITD1;MAP2;KDM1A;ITGB1BP1
prerank,Carbohydrate Catabolic Process (GO:0016052),0.4860007937725954,1.3942596138451986,0.09523809523809523,0.8184408343463639,1.0,25/39,26.95%,HK3;HKDC1;HK2;PGAM4;PFKFB2;NEU3;HK1;NAGA;PFKL;TPI1;ENO1;PKLR;DERA;LDHA;UCP2;MANBA;NEU4;ENO3;ALDOC;GAPDH;PFKFB1;AMY2A;PGAM1;NEU1;ENOSF1
prerank,Positive Regulation Of Protein Modification Process (GO:0031401),-0.40299520228924995,-1.393822665724268,0.014925373134328358,0.5705460174633824,1.0,49/214,17.44%,KDR;VEGFC;VEGFA;IL34;KNDC1;FGF9;HRAS;CLDN19;IL1B;FLT4;IRGM;LYN;MOB2;LRRK2;CSF1R;CDKN1A;IFNG;CARD14;PELI2;FGF17;NSMF;PPP1R16B;PIK3R3;ACE;RARRES2;PPP2R5A;FGF8;ANGPT1;MT3;P2RY1;FAXDC2;PRKCD;RAP2A;CLDN3;ITGB3;SMARCA5;BMAL1;FPR2;FGF19;BMP2;CSNK1D;ADAM17;ALG10B;SLCO3A1;EFNA1;CCND1;ANKLE2;SIRT1;RB1CC1
prerank,RNA Polymerase II Preinitiation Complex Assembly (GO:0051123),-0.46606992653559304,-1.3927186653230115,0.05172413793103448,0.5715954489362352,1.0,5/45,10.16%,TAF7L;MED26;MED21;TAF5;TAF13
prerank,Left/Right Pattern Formation (GO:0060972),-0.5176493250482455,-1.3919293431123243,0.08771929824561403,0.5715191108804042,1.0,6/29,11.22%,DNAH11;PIERCE1;DNAAF4;CCDC103;CFAP53;ODAD2
prerank,Positive Regulation Of Production Of Molecular Mediator Of Immune Response (GO:0002702),0.45996111246747184,1.3915736918307093,0.02702702702702703,0.8244401612225585,1.0,7/38,5.96%,FFAR2;CD86;SCIMP;IL21;TNFRSF4;IRF5;F2RL1
prerank,Energy Derivation By Oxidation Of Organic Compounds (GO:0015980),-0.4782787426043593,-1.3894323251602554,0.034482758620689655,0.5779624072323755,1.0,4/40,2.29%,ADGRF1;GFPT2;NR4A3;COX7A2
prerank,Prostaglandin Biosynthetic Process (GO:0001516),-0.5936273370951303,-1.3891260829977385,0.06896551724137931,0.5760306504399777,1.0,5/17,12.38%,PTGS1;EDN2;DAGLB;EDN1;PTGES
prerank,Defense Response To Symbiont (GO:0140546),0.3574411809062008,1.3878215257358313,0.0,0.8366799939448448,1.0,46/145,19.06%,AICDA;APOBEC3D;CD207;IL21;IFIT1;TRIM5;RSAD2;TRIM52;IFITM1;OAS2;GARIN5A;PLSCR1;F2RL1;IRF7;PYCARD;LILRB1;TLR8;CD40;EXOSC5;PQBP1;OAS1;IFNL2;BCL2L1;SERINC3;ISG15;IFI27;SKP2;TLR2;IRF2;IFNL1;RNASE6;IFNE;BST2;EXOSC4;SAMHD1;RIPK3;DDX60;IFIT3;RIGI;APOBEC3B;GBP2;IFITM2;RAB2B;ISG20;MYD88;OAS3
prerank,Positive Regulation Of Macrophage Migration (GO:1905523),-0.5828295147739996,-1.387164600089723,0.07692307692307693,0.5798097146367694,1.0,6/17,12.72%,IL34;THBS1;MSTN;CSF1R;RARRES2;P2RY12
prerank,Regulation Of Synapse Assembly (GO:0051963),0.46350333049011266,1.3869458035702937,0.023255813953488372,0.8331537564224718,1.0,5/45,5.11%,SLITRK2;GPRASP3;EPHB1;EPHB3;SNCA
prerank,Response To Acidic pH (GO:0010447),-0.6069896701973332,-1.3860209559575862,0.09433962264150944,0.5808872014437414,1.0,6/16,8.20%,SCNN1B;SCNN1A;PKD2L1;TRPV1;GPR65;GPR31
prerank,Positive Regulation Of Adenylate Cyclase Activity (GO:0045762),-0.5385578855022966,-1.3840669914568025,0.10714285714285714,0.5842298697593025,1.0,2/24,3.01%,CRHR1;ADRB1
prerank,Aortic Valve Morphogenesis (GO:0003180),-0.5137737608514263,-1.3837541466568384,0.11764705882352941,0.5827766157108486,1.0,2/35,1.87%,NOS3;SMAD6
prerank,Natural Killer Cell Mediated Immunity (GO:0002228),-0.5760249837044544,-1.3826765892511017,0.14285714285714285,0.5838727602432028,1.0,9/22,16.35%,KLRD1;KIR3DL1;ULBP1;LYST;SLAMF7;GZMB;KLRC2;CEBPG;ULBP2
prerank,Cell Surface Toll-Like Receptor Signaling Pathway (GO:0140895),0.5511336063605533,1.3820231393587041,0.0975609756097561,0.8486219971424912,1.0,9/16,15.08%,SCIMP;MYO1C;LY96;LGALS9;TRIL;OAS1;TLR4;S100A14;NR1H4
prerank,Immunoglobulin Production Involved In Immunoglobulin-Mediated Immune Response (GO:0002381),0.5465307745803144,1.3810530809241388,0.09615384615384616,0.8447290143763481,1.0,6/17,15.20%,HLA-DRB1;HLA-DMB;HLA-DQA1;SHLD1;HLA-DQA2;HLA-DPA1
prerank,Positive Regulation Of Telomerase Activity (GO:0051973),0.4894411798903483,1.3808861678371185,0.04878048780487805,0.8366799939448447,1.0,4/33,2.92%,PARM1;MYC;AURKB;KLF4
prerank,Megakaryocyte Differentiation (GO:0030219),0.5230870487235768,1.380833844910784,0.125,0.8279837602097857,1.0,6/16,18.43%,GP9;GP5;GP1BA;ZNF385A;KIT;MPIG6B
prerank,Inorganic Anion Transmembrane Transport (GO:0098661),-0.45895430587546754,-1.3789886518128354,0.16666666666666666,0.5929535033410972,1.0,4/60,2.17%,SLC5A1;SLC6A1;CFTR;SLC37A2
prerank,Photoperiodism (GO:0009648),-0.5813501174541124,-1.3789855527688224,0.09803921568627451,0.5902704558146669,1.0,8/22,17.66%,PDE6B;PER1;PER3;SIK1;ID2;BHLHE40;CRY2;FBXL3
prerank,Intracellular Estrogen Receptor Signaling Pathway (GO:0030520),0.5210239348065142,1.3787543882828,0.08888888888888889,0.8307073236916389,1.0,4/16,11.94%,NCOA4;ESR2;EGLN2;PADI2
prerank,NADH Dehydrogenase Complex Assembly (GO:0010257),0.41297852473336555,1.3773488506358054,0.0625,0.8195280044967514,1.0,23/53,23.98%,NDUFA9;NDUFB3;NDUFAF2;BCS1L;DMAC1;TMEM186;FOXRED1;NDUFC1;NDUFS7;NDUFB10;NDUFS2;NDUFAF8;NDUFB2;NDUFAF3;NDUFAF1;NDUFB5;NDUFC2;NDUFA6;TAFAZZIN;NDUFB4;NDUFB8;DMAC2;NDUFB11
prerank,Mitochondrial Respiratory Chain Complex I Assembly (GO:0032981),0.41297852473336555,1.3773488506358054,0.0625,0.8195280044967514,1.0,23/53,23.98%,NDUFA9;NDUFB3;NDUFAF2;BCS1L;DMAC1;TMEM186;FOXRED1;NDUFC1;NDUFS7;NDUFB10;NDUFS2;NDUFAF8;NDUFB2;NDUFAF3;NDUFAF1;NDUFB5;NDUFC2;NDUFA6;TAFAZZIN;NDUFB4;NDUFB8;DMAC2;NDUFB11
prerank,Regulation Of Cytoskeleton Organization (GO:0051493),0.3919101773994133,1.375209269703529,0.023809523809523808,0.8209787508025534,1.0,30/111,18.34%,CAMSAP3;CAPN6;S100A8;PEAK3;ARHGAP44;SYDE1;HCK;EFNA5;TRIM36;CDK2AP2;DYNLL1;PLXNB1;ESAM;S100A9;PTK2;MAP6;PDGFA;PAK1;P2RX7;ARHGEF19;NEDD9;BST2;CDK10;MARK2;SLC4A2;CLIC4;CORO1A;TWF2;SIGLEC15;SH3BP1
prerank,Regulation Of Telomerase RNA Localization To Cajal Body (GO:1904872),0.5245640103322443,1.3734114769685146,0.06818181818181818,0.8240515951043907,1.0,11/17,26.81%,NOP10;CCT5;DCP2;RUVBL2;DKC1;SHQ1;NHP2;RUVBL1;CCT7;CCT4;CCT3
prerank,Secretory Granule Organization (GO:0033363),-0.47839299959562775,-1.3732483348494156,0.12,0.60503190268484,1.0,12/25,27.59%,AP1S3;LYST;AP1G1;F2R;SRGN;AP3D1;AP3B1;BLOC1S2;HPS6;HPS4;VPS33B;F2RL3
prerank,Establishment Of Mitotic Spindle Localization (GO:0040001),0.46214251029274356,1.369161739501356,0.09090909090909091,0.8367761640590913,1.0,6/34,7.83%,SAPCD2;ESPL1;INSC;PLK1;HTT;GPSM2
prerank,RNA Destabilization (GO:0050779),-0.5542620905529169,-1.3690270505448194,0.09615384615384616,0.6160172519824435,1.0,8/19,28.93%,RBM24;METTL16;LIN28B;YTHDF3;FXR1;YTHDF2;METTL14;RBM27
prerank,Cellular Response To Estradiol Stimulus (GO:0071392),0.5189173754852263,1.3687895381694388,0.05,0.8302051743718109,1.0,7/19,19.40%,SSTR2;ZNF703;POU4F1;SFRP1;GPER1;RUVBL2;RAMP3
prerank,Regulation Of Protein Kinase C Signaling (GO:0090036),-0.6652790721531728,-1.3666582170393227,0.11538461538461539,0.6219454840443532,1.0,3/16,2.75%,VEGFA;WNT11;FLT4
prerank,Regulation Of Dopamine Secretion (GO:0014059),0.5107314709398328,1.3659362275964255,0.045454545454545456,0.8364914250933809,1.0,8/21,16.61%,SYT3;SYT5;FGF20;SNCA;SYT13;SYT9;SYT17;KCNA2
prerank,Development Of Primary Male Sexual Characteristics (GO:0046546),-0.48946658202813526,-1.3652752462828996,0.07936507936507936,0.6241639884066178,1.0,9/40,6.67%,TGFB2;PRKACG;SIX4;FGF9;GATA6;SOX15;ADAM29;ADAM30;AKR1C3
prerank,Gliogenesis (GO:0042063),-0.5556865254928638,-1.365050238495245,0.1346153846153846,0.621993839093306,1.0,5/23,5.64%,AZU1;GCM1;TGFB2;VCAN;CDH2
prerank,mRNA Destabilization (GO:0061157),-0.46100160406075286,-1.3642642001123053,0.06451612903225806,0.6216099057686336,1.0,14/43,24.44%,RBM24;ZC3H12A;CNOT1;CELF1;METTL16;RC3H2;YTHDF3;ZFP36L2;UPF1;DHX36;AGO4;FXR1;ZFP36L1;YTHDF2
prerank,Regulation Of Protein Localization To Cell Periphery (GO:1904375),0.5268093898926833,1.363966658030043,0.12,0.8384540057610429,1.0,8/20,25.83%,PLK1;GBP1;CDK5;ACTB;LDLRAP1;SIRT6;SPTBN1;VAMP8
prerank,Regulation Of Protein Polymerization (GO:0032271),0.4842066285002496,1.3639186222014266,0.1111111111111111,0.8306693618044363,1.0,14/33,22.79%,TPPP3;CAMSAP3;ARHGAP28;TTBK1;ESAM;CAMSAP2;GBA2;COTL1;MAPRE3;HAX1;MAP2;PFN1;PLEKHG2;ARL2
prerank,Regulation Of Protein Secretion (GO:0050708),-0.41872202481816956,-1.3623377079827483,0.05454545454545454,0.6254247021744169,1.0,15/98,7.03%,TGFB2;SYTL4;CELA2A;SNAP25;IL1B;KCNJ11;STX1A;IL12A;DNAJC1;IGF1;CD33;ADAM9;IFNG;CYP51A1;ANG
prerank,Negative Regulation Of Catalytic Activity (GO:0043086),0.5060294785332177,1.3623300729004852,0.13043478260869565,0.831092968260046,1.0,6/25,11.59%,IFIT1;HP;NOTCH1;TIMP1;CCAR2;NOSIP
prerank,Regulation Of Peptide Hormone Secretion (GO:0090276),-0.4718798721066477,-1.3620124054345628,0.07142857142857142,0.6239062794162319,1.0,9/49,5.80%,PAX8;CELA2A;RASL10B;SNAP25;IL1B;KCNJ11;STX1A;ILDR1;IFNG
prerank,Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway (GO:0007169),-0.37974727663744756,-1.361530324793772,0.046875,0.6229376900743983,1.0,40/267,10.67%,KDR;VEGFC;FLT1;VEGFA;ROR2;BCAR3;GHR;INSRR;NR4A3;ART4;FGF9;DDR2;FLT4;ARHGEF28;LYN;CHN1;LTK;MST1R;IGF1;YES1;PIK3R1;CSF1R;PLCB1;GALNT3;FGF17;GAB1;FRK;SH2D6;PDGFD;PIK3R3;CASS4;GDF15;RARRES2;IRS2;RET;FGF8;RHOQ;SRC;GFRA2;ANGPT1
prerank,Cellular Response To Ketone (GO:1901655),-0.49207661385606016,-1.360457802025269,0.09803921568627451,0.6239366112357971,1.0,7/41,6.67%,AKR1C2;CFTR;SCNN1B;ADCY2;SCNN1A;ADCY1;AKR1C3
prerank,Digestive Tract Development (GO:0048565),-0.5036504918202638,-1.3602633466347487,0.10344827586206896,0.6220895683585754,1.0,8/33,9.29%,GLI3;TGFB2;GATA6;NKX2-6;CLMP;CXCL8;CCDC103;RARRES2
prerank,Regulation Of Vasculature Development (GO:1901342),0.4764220212304249,1.3594094107531443,0.05,0.8374965326507113,1.0,11/30,19.04%,CXCL13;KRIT1;VASH1;FGF2;PDCD10;SFRP1;HTATIP2;HMOX1;LEP;ETS1;OR10J5
prerank,Positive Regulation Of T Cell Activation (GO:0050870),0.3805342044766939,1.357722116242275,0.04878048780487805,0.8377585372821889,1.0,31/104,17.90%,HLA-A;CD86;IL21;HLA-DRB1;CCR2;HLA-DMB;SIRPA;NCK2;CD1D;IL4;CD80;PYCARD;ZP3;LGALS9;CCR7;HSPD1;ACTL6A;NOD2;DOCK8;PDCD1LG2;HLA-DQA1;TNFSF11;SIRPG;HLA-DQA2;HLA-DPA1;ACTB;PNP;IL6ST;SMARCB1;GATA3;LEP
prerank,Outflow Tract Septum Morphogenesis (GO:0003148),-0.5552789310928521,-1.3562074013926377,0.10909090909090909,0.6342076823291017,1.0,6/23,10.10%,SEMA3C;TGFB2;SMAD6;GATA6;NELL2;FGF8
prerank,Response To Endoplasmic Reticulum Stress (GO:0034976),-0.4041129112887987,-1.3561453359240945,0.05,0.6318490308098732,1.0,21/114,14.78%,RHBDD1;THBS1;ALOX15;CFTR;RNF186;CXCL8;ATP2A1;CREB3L3;ANKS4B;TMEM117;PIK3R1;CCDC47;ERP27;HERPUD1;PRKN;ATF3;PPP1R15B;DNAJB9;BRSK2;P4HB;TNFRSF10B
prerank,Positive Regulation Of Interleukin-4 Production (GO:0032753),0.5204214840885362,1.3559983451988098,0.06382978723404255,0.839173293203088,1.0,6/18,11.51%,CD86;FCER1G;ZP3;LGALS9;NLRP3;IRF4
prerank,Transepithelial Transport (GO:0070633),-0.5676941725471241,-1.3557672011407622,0.1694915254237288,0.6303858063975067,1.0,2/16,1.09%,CXADR;CLCNKA
prerank,Regulation Of Dendritic Spine Development (GO:0060998),-0.5620827695202338,-1.355737017514498,0.11666666666666667,0.6278890089696141,1.0,6/19,13.90%,SHANK1;SRGAP2C;CAMK2B;DLG5;LLPH;TANC2
prerank,NIK/NF-kappaB Signaling (GO:0038061),-0.48687568393333014,-1.3552641177024534,0.11764705882352941,0.6270190196385267,1.0,11/31,14.99%,CHI3L1;TRAF6;REL;CARD14;NFKBIA;TLR3;AMFR;DICER1;NFKB2;TNFRSF10B;CREBBP
prerank,ERK1 And ERK2 Cascade (GO:0070371),-0.5239656311421114,-1.3549549735763804,0.125,0.6254216694740325,1.0,2/23,4.38%,KDR;IGF1
prerank,Response To Lipid (GO:0033993),-0.4212020585185352,-1.35463001117801,0.045454545454545456,0.6238807214169974,1.0,11/106,6.04%,NOS3;HSD17B2;SLC11A1;SMAD6;GATA6;IL1B;IL12A;FFAR1;ILDR1;PPARG;STRN3
prerank,Regulation Of Epidermal Cell Differentiation (GO:0045604),0.5418335612742325,1.3526230582682466,0.11363636363636363,0.8502673311870155,1.0,3/17,2.21%,SULT2B1;BMP4;MAFG
prerank,Long-Chain Fatty Acid Biosynthetic Process (GO:0042759),-0.5203373664937789,-1.3525989892998442,0.061224489795918366,0.6280524422856156,1.0,9/22,15.71%,ALOX15;ALOX12;ALOXE3;ACSBG1;ELOVL6;LTC4S;CYP3A4;CYP2E1;CYP2C9
prerank,Ribosome Assembly (GO:0042255),-0.4694468268980685,-1.3517067844144046,0.10606060606060606,0.6278790628203691,1.0,1/48,0.08%,RPS27L
prerank,Regulation Of Lamellipodium Assembly (GO:0010591),-0.5265102386581232,-1.3516182268549397,0.12195121951219512,0.6255820329057227,1.0,10/32,12.29%,MSTN;AUTS2;PLXNB3;NCKAP1;PIK3R1;WNT1;PLCE1;SLIT2;PIK3CA;TWF1
prerank,Regulation Of Endothelial Cell Apoptotic Process (GO:2000351),-0.47785488880282007,-1.3509524481751118,0.11538461538461539,0.6252509396746143,1.0,7/40,12.39%,KDR;THBS1;TNFAIP3;IL11;ANGPT1;CCL2;NFE2L2
prerank,Regulation Of Developmental Growth (GO:0048638),-0.4795452129517265,-1.3490656581364247,0.12195121951219512,0.6293908093203704,1.0,5/28,5.91%,GHR;SIX4;MBD5;LATS2;PLCB1
prerank,Tumor Necrosis Factor-Mediated Signaling Pathway (GO:0033209),0.4501454425866457,1.3487624015574806,0.06976744186046512,0.8630830616743476,1.0,9/38,12.57%,PLVAP;TNFRSF11A;TXNDC17;LIMS1;PYCARD;ST18;TNFSF11;ILK;COMMD7
prerank,Regulation Of Response To External Stimulus (GO:0032101),-0.4051400054126188,-1.3480840223086534,0.03125,0.6304322537248531,1.0,26/120,13.21%,ZMPSTE24;NLRP13;GRK4;ALOX15;IGF2BP1;GATA6;NLRP14;XCL1;PIK3AP1;CASP8;GRK7;DAGLB;RNF135;SPATA2;GGT2P;CXCR4;FBXL2;NR1D2;BCL6;CELF1;FCGR2B;F2R;PTGES;NFE2L2;P2RY12;PTPN22
prerank,Antigen Processing And Presentation Of Peptide Antigen Via MHC Class I (GO:0002474),0.5248278672445017,1.3461457810509014,0.08333333333333333,0.869083257663947,1.0,5/18,11.26%,HLA-A;FCER1G;HFE;IFI30;TAP1
prerank,Regulation Of Endothelial Cell Migration (GO:0010594),-0.4337650766833164,-1.3437040839744048,0.1111111111111111,0.6427540884410895,1.0,7/82,4.26%,KDR;VEGFA;THBS1;DCN;FLT4;ACVRL1;FUT1
prerank,Phosphatidylinositol-Mediated Signaling (GO:0048015),-0.4321307062907359,-1.342053307099829,0.057692307692307696,0.6468977372461872,1.0,15/60,11.92%,MYO16;LTK;IGF1;PIK3R1;CSF1R;PLCB1;PLCH2;PTAFR;PLCE1;NYAP2;PLCB4;EDN1;PLCD1;PIK3CA;PLCG2
prerank,Intrinsic Apoptotic Signaling Pathway In Response To DNA Damage By P53 Class Mediator (GO:0042771),-0.5516739168718503,-1.3418733250325925,0.16666666666666666,0.6448284328363161,1.0,1/19,0.08%,RPS27L
prerank,Regulation Of Myoblast Differentiation (GO:0045661),-0.4430662368875627,-1.3410831178306237,0.08928571428571429,0.6452128529512978,1.0,6/51,5.91%,RBM24;MSTN;EID2B;BOC;SOX4;PLCB1
prerank,Cellular Response To Alcohol (GO:0097306),-0.43546123629805483,-1.3407889327429454,0.1111111111111111,0.643495975421204,1.0,9/51,8.85%,AKR1C2;CFTR;SCNN1B;ADCY2;SCNN1A;ADCY1;AKR1C3;CES1;BRCA1
prerank,Heterophilic Cell-Cell Adhesion Via Plasma Membrane Cell Adhesion Molecules (GO:0007157),-0.45319632254358205,-1.3407586805794605,0.08196721311475409,0.6410551795432753,1.0,14/46,18.79%,CXADR;VCAM1;SCARF2;REG3A;CRB2;CD209;ALCAM;CEACAM8;TENM4;NECTIN3;TENM2;JAML;CRB1;CEACAM6
prerank,Negative Regulation Of Fatty Acid Metabolic Process (GO:0045922),0.5342633147508263,1.3407114494586878,0.18181818181818182,0.8900887538210447,1.0,4/18,8.10%,CEACAM1;APOC1;UGT1A8;TRIB3
prerank,Cellular Response To Transforming Growth Factor Beta Stimulus (GO:0071560),-0.41652377288426445,-1.3402660166160365,0.05,0.6404704342315077,1.0,18/91,10.29%,ITGB5;TGFB2;SMAD6;XCL1;COL1A2;USP9Y;ACVRL1;APOA1;ADAM9;WNT7A;SMAD5;LTBP2;BAMBI;PDE2A;GDF15;PSG4;TGFBR3;SRC
prerank,Entrainment Of Circadian Clock By Photoperiod (GO:0043153),-0.5831050153230829,-1.3399815277289382,0.13725490196078433,0.6391178898165903,1.0,8/21,17.66%,PDE6B;PER1;PER3;SIK1;ID2;BHLHE40;CRY2;FBXL3
prerank,Positive Regulation Of Lamellipodium Organization (GO:1902745),-0.5127768976652269,-1.3392180527514101,0.09302325581395349,0.639031300491416,1.0,9/30,11.46%,MSTN;VIL1;AUTS2;NCKAP1;PIK3R1;WNT1;PLCE1;SRC;PIK3CA
prerank,Transcription Preinitiation Complex Assembly (GO:0070897),-0.45451018843619906,-1.3385963769740328,0.05555555555555555,0.6387840506377536,1.0,5/48,10.16%,TAF7L;MED26;MED21;TAF5;TAF13
prerank,Negative Regulation Of T Cell Receptor Signaling Pathway (GO:0050860),0.5253353380655716,1.3384639978095585,0.08928571428571429,0.8935309995348311,1.0,6/18,14.32%,CEACAM1;PTPN2;GBP1;DGKZ;LILRB4;UBASH3A
prerank,"Regulation Of mRNA Splicing, Via Spliceosome (GO:0048024)",-0.40506226922159755,-1.3382286270587844,0.03773584905660377,0.6378155400002654,1.0,24/90,19.63%,RBM24;CELF4;RBM20;RBFOX3;STH;RBM38;RBFOX2;CELF5;RBM15;LARP7;CELF1;DDX17;METTL16;NOVA2;WTAP;HNRNPL;RBM39;NSRP1;RBM25;SNW1;RBM11;SFSWAP;SRRM1;SRPK2
prerank,Positive Regulation Of Dendrite Extension (GO:1903861),0.5200699902893087,1.338165432244645,0.15555555555555556,0.8872958435482835,1.0,4/16,8.51%,SYT3;RASAL1;CPNE9;RIMS2
prerank,Regulation Of Chondrocyte Differentiation (GO:0032330),-0.5127555790462098,-1.3376871863555517,0.11475409836065574,0.637334818707211,1.0,3/23,5.70%,SCIN;ZBTB16;MBOAT2
prerank,Toll-Like Receptor 4 Signaling Pathway (GO:0034142),0.5819490450543792,1.337065062002377,0.14285714285714285,0.8841796677640023,1.0,9/16,15.08%,SCIMP;MYO1C;LY96;LGALS9;TRIL;OAS1;TLR4;S100A14;NR1H4
prerank,Negative Regulation Of Blood Coagulation (GO:0030195),-0.5337820702113046,-1.336683728699419,0.09090909090909091,0.6386119237325639,1.0,1/29,0.01%,NOS3
prerank,Dicarboxylic Acid Transport (GO:0006835),0.49546519844638054,1.3361263650710509,0.1282051282051282,0.8821949876701438,1.0,8/23,19.50%,SLC26A7;SLC1A1;SLC1A7;PDPN;SLC46A1;SLC19A1;UCP2;SLC13A3
prerank,Positive Regulation Of RNA Metabolic Process (GO:0051254),-0.500068813036797,-1.3339502137481243,0.125,0.6450814365929928,1.0,8/33,10.92%,RBM20;HRAS;IL1B;PIK3R1;ZPR1;SUPV3L1;WDR75;UTP15
prerank,Positive Regulation Of Cell Population Proliferation (GO:0008284),-0.34726698738026207,-1.3336485125411033,0.014285714285714285,0.6437475722109329,1.0,63/455,10.10%,KDR;VEGFC;VEGFA;POU3F2;AKR1C2;INSL4;IL34;CLEC7A;THBS1;PRL;NR4A3;TGFB2;MEIS2;SCN5A;FGF9;SOX15;MEIS1;NKX2-6;EDN2;DDR2;HRAS;IL1B;FLT4;IL18;EDN3;LYN;CDH13;EPOR;MST1R;CCL14;RBPMS2;IGF1;CLCF1;REG3A;GAREM1;SOX4;MAPK15;CSF1R;TERT;CDKN1A;IFNG;FGF17;AKR1C3;PRC1;C5AR1;MLXIPL;WNT1;PDGFD;MEGF10;RPRD1B;IL12RB2;BAMBI;IL7;TCF7L2;IL11;HTR1A;IL15;IRS2;HMGN5;SERPINF2;ID2;TGFBR3;FGF8
prerank,Phosphate Ion Transport (GO:0006817),-0.5935098599262422,-1.3322246907412867,0.08196721311475409,0.646207065877608,1.0,6/18,12.81%,SLC37A2;SLC34A2;SLC34A3;SLC34A1;SLC17A3;SLC20A2
prerank,Regulation Of ERK1 And ERK2 Cascade (GO:0070372),-0.3834977316802426,-1.3305445983179918,0.046875,0.6497077309306063,1.0,24/226,5.29%,KDR;CCL7;ROR2;IL26;SPRY2;RPS6KA6;DENND2B;ALOX15;PSCA;CCL22;DDR2;HRAS;ACKR3;IL1B;FLT4;NDRG4;XCL1;CHI3L1;LYN;ARHGAP8;CCL14;IGF1;GAREM1;CSF1R
prerank,Regulation Of Oxidative Phosphorylation (GO:0002082),-0.5861493761195105,-1.3304485125448131,0.14583333333333334,0.6475111153129081,1.0,4/16,7.14%,NUPR1;COX7A2;ACTN3;MLXIPL
prerank,Negative Regulation Of Monoatomic Ion Transport (GO:0043271),-0.5344711566766955,-1.330212005952855,0.1875,0.645837618918064,1.0,3/17,6.69%,CASQ2;CD33;NEDD4
prerank,Actin Nucleation (GO:0045010),-0.5352291819333019,-1.3296749676240343,0.1206896551724138,0.6446036939559765,1.0,5/19,16.18%,SCIN;JMY;MAGEL2;WHAMM;ARPC5L
prerank,Signal Transduction In Response To DNA Damage (GO:0042770),0.3962958149259276,1.329657874039226,0.06818181818181818,0.9093418580422258,1.0,28/57,31.27%,MAPK12;BID;BATF;FBXO6;CHEK2;ATRIP;USP10;DTX3L;CASP9;E2F7;H2AX;DOT1L;INTS7;RHNO1;ATM;PRPF19;CLSPN;TP53BP1;E2F1;MAP3K20;MRPL36;PARP9;RPA4;MAPK14;CHEK1;CRY1;SESN2;USP28
prerank,Regulation Of Neuron Differentiation (GO:0045664),0.39386897407414845,1.3294638062965005,0.05128205128205128,0.9022875718842173,1.0,13/74,13.69%,ZFHX2;NRCAM;GPRC5B;ASCL1;TCF4;DTX1;DISP3;FGFR1;TIAM1;HEYL;YWHAH;NREP;SOX11
prerank,Positive Regulation Of Cell Junction Assembly (GO:1901890),-0.42029044666800963,-1.3290615578778302,0.12727272727272726,0.6443070529428103,1.0,3/51,2.53%,KDR;VEGFA;CLDN19
prerank,Long-Chain fatty-acyl-CoA Biosynthetic Process (GO:0035338),0.5284198447190948,1.3283531019301202,0.12195121951219512,0.9014938020336851,1.0,1/16,0.13%,ELOVL7
prerank,Acylglycerol Homeostasis (GO:0055090),-0.522185771376673,-1.3271054248631338,0.08695652173913043,0.6489434640318934,1.0,4/20,7.14%,IL18;RORA;APOA1;MLXIPL
prerank,Negative Regulation Of Amyloid Precursor Protein Catabolic Process (GO:1902992),0.5102615511806351,1.326134360215262,0.06666666666666667,0.9046402080123953,1.0,2/18,2.65%,RTN3;CHRNA7
prerank,protein-DNA Complex Assembly (GO:0065004),0.41724653105523496,1.325899613733489,0.06382978723404255,0.8981970752893218,1.0,17/58,19.52%,ASF1B;TCF4;H2BC13;H2BC17;H2BC3;GTF2H5;H2BC9;H4C9;NASP;H3C1;H3C14;H2AX;H3-4;DAXX;H2BC15;H2BC14;H4C7
prerank,Positive Regulation Of Mitochondrion Organization (GO:0010822),-0.4292702719137002,-1.3248652159757346,0.14035087719298245,0.655349058462193,1.0,4/57,4.21%,KDR;DCN;DDHD1;AURKA
prerank,Cyclic-Nucleotide-Mediated Signaling (GO:0019935),0.4355482975240048,1.324564188003486,0.044444444444444446,0.8980869767301314,1.0,6/38,10.10%,AKAP6;ADGRG6;PDE7B;CD36;IRAG1;PRSS8
prerank,Outer Dynein Arm Assembly (GO:0036158),-0.5338733896742437,-1.3237767723631344,0.1694915254237288,0.6571952150315342,1.0,7/20,16.52%,DNAAF4;DNAAF6;ODAD4;ODAD2;ZMYND10;CCDC63;DNAAF1
prerank,Glycolytic Process (GO:0006096),0.4835403779704303,1.3235988545333996,0.12195121951219512,0.8956330558488175,1.0,17/29,26.44%,HK3;HKDC1;HK2;PGAM4;PFKFB2;HK1;PFKL;TPI1;ENO1;PKLR;LDHA;UCP2;ENO3;ALDOC;GAPDH;PFKFB1;PGAM1
prerank,Vesicle Cytoskeletal Trafficking (GO:0099518),0.4457949365437497,1.3228020765426565,0.09090909090909091,0.8925982619865792,1.0,16/37,24.84%,MYO1C;MYO1E;MYO5C;MYO7A;HTT;MYO5B;FNBP1L;BICDL2;MYO1A;MYO7B;MYO15A;APEX1;TRAK2;FBXW11;NDEL1;BICDL1
prerank,Regulation Of mRNA Metabolic Process (GO:1903311),-0.5642468564999945,-1.3225173864024977,0.11864406779661017,0.6589134141075428,1.0,4/15,19.63%,SRPK3;SAFB2;CDK11B;SRPK2
prerank,Androgen Receptor Signaling Pathway (GO:0030521),0.5630629672596862,1.3210932535615267,0.09090909090909091,0.8939973820357789,1.0,4/17,15.48%,RHOXF1;PMEPA1;PLPP1;DAXX
prerank,Microtubule Cytoskeleton Organization Involved In Mitosis (GO:1902850),0.416909531634998,1.3210177189626482,0.08823529411764706,0.8871311411805263,1.0,17/59,15.36%,CENPE;DLGAP5;AURKB;KIF4A;ESPL1;PLK1;BIRC5;FAM110A;CDK1;GPSM2;PLK2;CCNB1;TBCE;CDCA8;EML1;NUSAP1;KIF2A
prerank,Regulation Of Golgi Organization (GO:1903358),0.5193621382338764,1.3196478638021572,0.09090909090909091,0.8873396840479401,1.0,3/16,8.85%,CAMSAP3;PDCD10;CAMSAP2
prerank,Negative Regulation Of Blood Vessel Endothelial Cell Migration (GO:0043537),0.4418141704575983,1.3195668669098322,0.14285714285714285,0.8807830072750911,1.0,10/32,9.95%,STARD13;KLF4;VASH1;FGF2;RGCC;PDCD10;NOTCH1;CSNK2B;ANGPT4;JUP
prerank,DNA Replication Initiation (GO:0006270),-0.5435928887808216,-1.3175184351514133,0.16666666666666666,0.6737128964266371,1.0,2/21,3.66%,PRIM2;ORC6
prerank,Membrane Depolarization During Cardiac Muscle Cell Action Potential (GO:0086012),-0.5883244694498814,-1.3161672833790405,0.21568627450980393,0.6760383866086,1.0,4/15,8.26%,SCN5A;ATP1A2;SLC8A1;SCN3B
prerank,Positive Regulation Of Dendrite Morphogenesis (GO:0050775),0.5491181052856906,1.3156133046123648,0.16666666666666666,0.8932638053503633,1.0,2/17,3.01%,GPRASP3;OBSL1
prerank,Regulation Of Dendrite Extension (GO:1903859),0.5087772062971937,1.3144269595603522,0.175,0.8930504762955053,1.0,4/17,8.51%,SYT3;RASAL1;CPNE9;RIMS2
prerank,Brain Development (GO:0007420),0.33261842436214173,1.3140214809491537,0.03125,0.8882154292128346,1.0,33/155,16.28%,B3GNT5;RTN3;ZFHX2;NRCAM;SMARCA1;SHROOM4;NFASC;DLX2;CENPF;PCDH18;ABCB6;SCTR;CX3CR1;VCX;GRIN2D;FOXJ1;CNTNAP2;VCX3B;IER3IP1;PLXNB2;PHGDH;MAST1;CLN5;CTNS;ADGRG1;EML1;MKKS;ANAPC7;AMIGO3;ROGDI;SOX6;PAFAH1B3;NNAT
prerank,Positive Regulation Of Biosynthetic Process (GO:0009891),0.42269483650700895,1.3138781161987556,0.11904761904761904,0.8821422297704788,1.0,15/44,19.13%,CREB3L1;LARP6;BMP4;SLC5A3;F2;RGCC;CD36;HDAC2;CYBA;TLR4;ZBTB20;VIM;CREBL2;AKT1;RUNX1
prerank,Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042509),-0.41153738637443327,-1.3136965297561753,0.09090909090909091,0.6819636853678221,1.0,12/61,10.20%,VEGFA;GHR;IL18;LYN;IL12A;IGF1;CLCF1;CSF1R;IFNG;IL15;IFNA2;SH2B3
prerank,Regulation Of Biomineral Tissue Development (GO:0070167),-0.5225737041795181,-1.313070495796472,0.17543859649122806,0.6812015133565177,1.0,4/25,7.59%,NOS3;DDR2;NOTUM;HEY2
prerank,Branched-Chain Amino Acid Metabolic Process (GO:0009081),0.5160099126714337,1.3128457391473727,0.15789473684210525,0.8804988580301075,1.0,5/15,20.49%,BCAT1;SLC25A44;ECHS1;BCKDK;BCAT2
prerank,Positive Regulation Of Protein Kinase Activity (GO:0045860),-0.3796196943306579,-1.3126720486326695,0.06451612903225806,0.6804448844143866,1.0,20/140,8.93%,VEGFA;IL34;AZU1;STOX1;NOX4;SLC11A1;TGFB2;DOK7;DDR2;IRGM;TRAF6;LRRK2;CSF1R;CDKN1A;IFNG;ETAA1;FCGR1A;PRNP;CASS4;ACE
prerank,Actin Polymerization Or Depolymerization (GO:0008154),-0.44561667110013964,-1.3123239364708887,0.0625,0.679097483023795,1.0,16/53,18.50%,SCIN;VIL1;PSTPIP2;GAS7;SPIRE2;ANG;DIAPH3;DIAPH1;CFL2;TWF1;WASF3;FHDC1;GHSR;JAK2;SPIRE1;WASL
prerank,Extracellular Matrix Organization (GO:0030198),-0.36695711168566464,-1.3119246603369217,0.046875,0.677945467263347,1.0,27/158,11.76%,ADAMTS19;COL1A1;MMP17;TGFB2;ADAMTS15;COLQ;COL5A1;DDR2;MATN2;COL1A2;ST7;COL23A1;KLK7;MANSC4;COL11A2;COL7A1;NID2;ADAMTS1;COL27A1;COL4A5;COL9A2;SERPINF2;COL5A3;SPOCK2;SLC39A8;TGFBI;COL9A1
prerank,Adenylate Cyclase-Modulating G Protein-Coupled Receptor Signaling Pathway (GO:0007188),-0.38832699846692986,-1.3089879223103023,0.07692307692307693,0.6843493015592901,1.0,29/141,15.75%,ADGRE2;CRHR1;ADGRF1;ADCY2;NPY1R;VIPR2;FPR1;ADCY1;RGS1;GPHA2;OPRL1;ADM5;GPR65;PDE2A;CXCL11;ADGRD1;MC3R;GPR161;FFAR3;P2RY12;GNAO1;ADGRG3;PTGER4;GPR157;PF4;ADM;CALCB;FPR2;CHRM2
prerank,Cardiac Muscle Cell Development (GO:0055013),-0.5240527899064221,-1.3080375117842022,0.14925373134328357,0.6849193867687687,1.0,8/26,10.93%,CXADR;VEGFA;NKX2-6;ALPK3;SLC8A1;HEY2;MYH11;FHOD3
prerank,Mitotic Cell Cycle Phase Transition (GO:0044772),0.34987223799524264,1.3076318193513066,0.0,0.8994058744310167,1.0,17/111,7.76%,CDK14;BCAT1;MYC;TPD52L1;CDKN3;CCNP;PKMYT1;UBE2C;PIM2;CCNB2;PLK1;USP26;CDK4;CCNF;EPS8;CCNA2;CDK1
prerank,Negative Regulation Of Macroautophagy (GO:0016242),-0.5162789143025774,-1.3065852273474419,0.16666666666666666,0.6876526813619961,1.0,10/22,25.22%,NUPR1;TMEM39A;LRRK2;FEZ1;PIK3CA;SMCR8;FEZ2;USP36;TSC1;SCFD1
prerank,Negative Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050732),0.44411675440116755,1.3060787361914363,0.1388888888888889,0.9009358776858621,1.0,10/27,18.63%,SOCS3;PTPN2;PTPN6;SFRP1;SRCIN1;LILRB4;PTK6;MVP;OCRL;HYAL2
prerank,Regulation Of Protein Kinase A Signaling (GO:0010738),0.5245863883967432,1.3053092271445992,0.16666666666666666,0.8978470151384123,1.0,4/16,9.77%,AKAP6;ADIPOQ;AMH;MC1R
prerank,Sarcomere Organization (GO:0045214),-0.5018554074673388,-1.3052531418573492,0.11940298507462686,0.6897442732997092,1.0,4/27,2.54%,MYOM2;FLNC;SIX4;TNNT1
prerank,Positive Regulation Of RNA Splicing (GO:0033120),-0.4779166508919967,-1.3037197761461707,0.12244897959183673,0.6921492888058902,1.0,5/34,9.41%,CELF4;RBM20;STH;PIK3R1;ZPR1
prerank,Regulation Of Fatty Acid Biosynthetic Process (GO:0042304),0.48812037615587966,1.3023533075609686,0.15555555555555556,0.9072983406105476,1.0,6/24,12.12%,CEACAM1;APOC1;SLC45A3;TRIB3;PDK4;EIF6
prerank,Mitochondrial Respiratory Chain Complex Assembly (GO:0033108),0.3657697098042101,1.3022120007882563,0.05128205128205128,0.9016993537941318,1.0,36/90,25.20%,COX14;NDUFA9;NDUFB3;CHCHD4;COA5;UQCC2;COA3;NDUFAF2;LYRM7;BCS1L;DMAC1;TMEM186;FOXRED1;SMIM20;SDHAF2;NDUFC1;NDUFS7;NDUFB10;NDUFS2;NDUFAF8;NDUFB2;NDUFAF3;NDUFAF1;NDUFB5;NDUFC2;TMEM223;AIFM1;NDUFA6;SDHAF4;TAFAZZIN;NDUFB4;NDUFB8;DMAC2;NDUFB11;UQCC1;PET100
prerank,Microglial Cell Activation (GO:0001774),-0.563730850241873,-1.3020685514174652,0.16326530612244897,0.6964635493535344,1.0,7/19,7.93%,AZU1;TYROBP;IFNGR1;IFNG;C5AR1;MAPT;ITGAM
prerank,Neuron Differentiation (GO:0030182),-0.37171884360047946,-1.3020345939787106,0.05555555555555555,0.6940474291211405,1.0,40/147,18.09%,VEGFA;POU3F2;WNT11;FUT9;TGFB2;OTX2;VAX2;IRX5;BHLHE23;ATP2B2;NR4A2;SOX4;ISL2;FZD7;FZD10;FZD5;PBX1;WNT7A;WNT1;WNT5B;RUNX3;WNT10B;ID2;FGF8;CDNF;RORB;FZD8;TENM4;NOVA2;BRSK2;WNT2B;INSM2;TENM2;PAX6;BHLHE22;PCSK9;ERCC3;INSM1;NLGN4X;LHX1
prerank,Regulation Of T Cell Proliferation (GO:0042129),0.3946818545553728,1.3018005823454977,0.10810810810810811,0.8977722319877867,1.0,15/74,7.53%,CD86;CLC;CR1;IL21;HLA-DRB1;ARG1;HLA-DMB;FOXP3;NCK2;CD1D;IL4;CD80;HLA-G;LILRB1;ZP3
prerank,Cardiac Muscle Cell Differentiation (GO:0055007),-0.5337232465414408,-1.301504624108776,0.16129032258064516,0.6935609882508912,1.0,6/26,8.64%,CXADR;VEGFA;ALPK3;SLC8A1;SIK1;MYH11
prerank,Establishment Of Mitotic Spindle Orientation (GO:0000132),0.4552839522015681,1.3008132621323056,0.16216216216216217,0.8954124565739778,1.0,5/29,7.83%,SAPCD2;INSC;PLK1;HTT;GPSM2
prerank,Regulation Of Rho Protein Signal Transduction (GO:0035023),0.3883957924050354,1.3006092947187158,0.06451612903225806,0.8900168941865393,1.0,16/66,14.05%,RASIP1;STARD13;RTN4R;KANK2;EPS8;F2RL1;DYNLL1;PRAG1;PDCD10;ITGA3;MET;STARD8;EPS8L2;ADGRG1;RIPOR2;KANK1
prerank,Gastrulation (GO:0007369),-0.5352645116510168,-1.3003975375177061,0.18518518518518517,0.6959190220193943,1.0,2/16,1.46%,GSC;NR4A3
prerank,Protein K48-linked Deubiquitination (GO:0071108),-0.48367761334171483,-1.2998996088638852,0.1,0.695357774466688,1.0,15/24,36.04%,YOD1;TNFAIP3;USP29;VCPIP1;USP8;MINDY2;OTUD7B;USP17L2;OTUD7A;USP37;USP5;USP25;MINDY1;OTUB1;USP27X
prerank,Cell Junction Assembly (GO:0034329),-0.3958096112843364,-1.2995350000068322,0.10714285714285714,0.6944432924055383,1.0,16/87,11.07%,FARP1;ADGRF1;CDH18;CDH4;CDH8;PCDHB13;CDH13;FZD5;PLXND1;CDH2;CTNND1;CDH22;PCDHB10;CTNND2;SPOCK2;PCDHB11
prerank,Positive Regulation Of Cytokine Production (GO:0001819),0.3187301474075522,1.2994856163262687,0.0,0.8892349296175984,1.0,90/305,18.16%,TWIST1;CRLF2;AIRE;FFAR2;ZBTB7B;HLA-A;CD86;SCIMP;POU2AF1;EGR1;NFAM1;IL1R1;IL21;EBI3;CLEC9A;HILPDA;MAP3K7;CCR2;SULF2;ADIPOQ;IRF5;HSPA1A;TLR5;FCER1G;MAPK11;BATF;GARIN5A;AMH;TIGIT;IL4;F2RL1;CD80;HLA-G;CYP1B1;IRF7;PYCARD;RGCC;LILRB1;ZP3;CXCL17;TLR8;CD40;CD200;IL6R;LGALS9;CCR7;TLR1;HSPD1;IL16;PQBP1;IL13;TRAF3IP3;NOD2;PLA2G1B;POU2F2;HPSE;LY9;NLRP3;ISG15;AFAP1L2;IL12RB1;CYBA;IRF4;TSLP;CADM1;TLR2;ORM2;IFNL1;TLR4;FCN1;HTR2B;PHB1;NR1H4;HMOX1;HLA-DPA1;BTN3A2;SCAMP5;LTB;XIAP;PARK7;PNP;FLOT1;IL6ST;GATA3;RIGI;LEP;IL17RA;INAVA;CCBE1;RAB2B
prerank,Glucose Transmembrane Transport (GO:1904659),-0.5363046841239968,-1.299448012202641,0.11290322580645161,0.6921827329626639,1.0,1/21,0.10%,SLC5A1
prerank,Negative Regulation Of Antigen Receptor-Mediated Signaling Pathway (GO:0050858),0.476156086315552,1.299282982509124,0.09803921568627451,0.8839580291303784,1.0,8/24,14.32%,CEACAM1;PTPN2;GBP1;DGKZ;CD22;LILRB4;FCRL3;UBASH3A
prerank,Negative Regulation Of Amyloid-Beta Formation (GO:1902430),0.5385484365069679,1.298389192001776,0.11363636363636363,0.8824943678150685,1.0,2/16,2.65%,RTN3;CHRNA7
prerank,Cell-Cell Junction Organization (GO:0045216),-0.4477378864447036,-1.2980648522525324,0.0847457627118644,0.6947967299968355,1.0,11/64,6.23%,CXADR;CDH18;CDH4;TGFB2;CDH8;CDH13;DSG2;CSF1R;CDH2;CTNND1;CDH22
prerank,Negative Regulation Of Immune Effector Process (GO:0002698),0.5074700449791407,1.2978349687242308,0.09523809523809523,0.8785305746962672,1.0,5/15,12.96%,CR1;LILRB1;SLAMF8;GRN;IFNL1
prerank,Cytoskeleton-Dependent Cytokinesis (GO:0061640),0.39305689712280645,1.2974395566975707,0.06382978723404255,0.8745552101720755,1.0,28/81,19.73%,KIF20A;AURKB;EXOC4;KIF4A;APC;ESPL1;PLK1;ANLN;TRIM36;MYH10;RTKN;BIRC5;CIT;RACGAP1;CECR2;SEPTIN5;CDCA8;SEPTIN3;PDCD6IP;ARL3;NUSAP1;SNX18;SEPTIN4;CFL1;BIN3;MITD1;ECT2;SEPTIN1
prerank,Steroid Metabolic Process (GO:0008202),-0.40247878793721614,-1.2972390886565182,0.08196721311475409,0.6949539544348764,1.0,11/88,9.07%,HSD17B2;AKR1C2;CYP3A5;UGT1A10;CYP21A2;CYP46A1;CYP26B1;CYP51A1;AKR1C3;HSD11B2;NPC1
prerank,Mitotic Chromosome Condensation (GO:0007076),0.5475515155126642,1.2961657849515529,0.13333333333333333,0.8750826177970321,1.0,6/15,17.34%,PLK1;CDCA5;NCAPG;NUSAP1;TTN;NCAPD2
prerank,Epithelial Cell Migration (GO:0010631),-0.42925683453055113,-1.296104005529357,0.09259259259259259,0.6966247333089902,1.0,3/45,5.50%,NOS3;CDH13;PLXND1
prerank,Regulation Of Interleukin-10 Production (GO:0032653),0.4060134221288184,1.2954584948305714,0.0967741935483871,0.8731986454357582,1.0,19/45,13.63%,HLA-DRB1;FOXP3;TIGIT;IL4;F2RL1;PYCARD;LILRB1;LGALS9;HSPD1;IL13;NOD2;PDCD1LG2;ISG15;TRIB2;IRF4;TSLP;LILRB4;TLR4;JAK3
prerank,Negative Regulation Of Type I Interferon-Mediated Signaling Pathway (GO:0060339),0.5271322295702848,1.2952947433196966,0.17073170731707318,0.8677900577480858,1.0,11/15,27.27%,PTPN2;OAS1;ISG15;TTLL12;SAMHD1;OAS3;USP18;METTL3;DCST1;CNOT7;STAT2
prerank,Positive Regulation Of Response To External Stimulus (GO:0032103),0.33665546921044404,1.2948235400459018,0.0425531914893617,0.8634793991148788,1.0,44/145,18.68%,SCIMP;S100A8;GPRC5B;MYO1C;IL21;SH2D1B;CCR2;PLAU;LGALS2;TASL;LY86;SNCA;LY96;CD1D;PLSCR1;F2RL1;F2;PYCARD;ZP3;SCARF1;TLR8;IL16;CX3CL1;S100A9;NLRP3;PLG;GRN;NAPEPLD;CYBA;TSLP;TLR2;PLAT;CD180;TLR4;POLR3G;POLR3B;DDT;IFI35;BMP6;S100A12;IL17RA;ETS1;HYAL2;TRADD
prerank,Activation Of GTPase Activity (GO:0090630),0.3627940501377047,1.2945062520952086,0.10526315789473684,0.8592258352980056,1.0,15/99,8.14%,CXCL13;EVI5;TBC1D4;TBC1D30;SYDE1;TBC1D8;SIPA1L3;ARHGAP42;SLC27A4;ARHGEF15;FOXJ1;ARHGEF26;ARHGAP24;CCR7;TIAM1
prerank,Negative Regulation Of Gene Expression (GO:0010629),-0.356968320540389,-1.2939824413410723,0.02857142857142857,0.702461455668915,1.0,71/330,16.28%,KDR;VEGFA;STOX1;SLC11A1;TDRD1;TGFB2;IGF2BP1;MARK1;ENC1;MSR1;CCDC3;FKBP6;HRAS;KRT17;CLDN19;CIDEA;CXCL8;CD34;UPK3B;ACVRL1;AURKA;IGF1;PPARG;REL;TERT;IFNG;TNRC6B;NANOS2;HSPA1B;MAPT;HEY2;HAVCR2;SMAD5;ZC3H12A;CD46;PRKN;ID2;TIPARP;IFNA2;CNOT1;ZNF148;CELF1;ZC3H10;FCGR2B;GZMB;YAP1;DICER1;INSL6;METTL16;SFMBT2;SH3GL2;APLN;PTPN22;SLC24A3;PTGER4;IGFBP5;CLDN3;PCIF1;PPM1D;SMCR8;LGR4;NUDT12;CCR1;LIN28A;FGF19;BMP2;PTBP2;EPC1;GRB7;SRGN;PICALM
prerank,Positive Chemotaxis (GO:0050918),-0.5265646301816347,-1.2926133577122514,0.1509433962264151,0.704969942110581,1.0,2/15,3.90%,VEGFA;PLXNB3
prerank,Positive Regulation Of Fat Cell Differentiation (GO:0045600),-0.4768689885751098,-1.2906118961163766,0.09433962264150944,0.7096579656315694,1.0,10/46,10.06%,FRZB;METRNL;ADIRF;ZBTB16;PPARG;ZC3H12A;RARRES2;SOX13;ID2;MEDAG
prerank,Cellular Response To Retinoic Acid (GO:0071300),-0.4385822630493409,-1.2892194832898736,0.16417910447761194,0.7122294342597729,1.0,11/39,11.53%,WNT11;LYN;LTK;FZD7;FZD10;PTK7;WNT5B;ZNF35;RET;WNT10B;RORB
prerank,Hemopoiesis (GO:0030097),-0.41337553515991715,-1.2881051424038004,0.06779661016949153,0.7133290851165555,1.0,14/97,11.34%,KDR;TGFB2;MEIS1;CD34;LYN;EPOR;MFAP5;ZBTB16;CSF1R;RUNX3;WNT10B;TGFBR3;SH2B3;SNRK
prerank,Sympathetic Nervous System Development (GO:0048485),-0.5590450465297578,-1.2873386579035837,0.12,0.7141107227790532,1.0,5/15,17.68%,SEMA3F;SOX4;NELL2;SEMA3A;INSM1
prerank,Positive Regulation Of Interleukin-1 Beta Production (GO:0032731),-0.4259136080883437,-1.2863299087110571,0.13114754098360656,0.7151279274922229,1.0,8/55,5.80%,AZU1;CLEC7A;LILRA2;TYROBP;CASP8;RIPK2;FZD5;IFNG
prerank,Protein Polymerization (GO:0051258),-0.4463602093841962,-1.2861684296074973,0.15942028985507245,0.7133612919351379,1.0,20/63,19.29%,CASQ2;VIL1;PSTPIP2;FGF13;GAS7;SPIRE2;ANG;MAPT;RNF135;PRKN;DIAPH3;DIAPH1;ZNF207;TPPP;WASF3;FHDC1;JAK2;SPIRE1;WASL;TRIM6
prerank,Canonical Wnt Signaling Pathway (GO:0060070),-0.4310568989078214,-1.2859487758261516,0.10714285714285714,0.7118455902471229,1.0,19/59,14.53%,FRZB;WNT11;CCL14;LRRK2;NR4A2;TCF7;FZD7;FZD10;FZD5;WNT7A;WNT1;WNT5B;TCF7L2;FRAT1;WNT10B;FZD8;SIAH2;WNT2B;CDH3
prerank,Regulation Of Cell Migration (GO:0030334),-0.33581440794917256,-1.2856999753984748,0.02564102564102564,0.7105783297076244,1.0,53/411,10.30%,KDR;FLT1;CCL7;VEGFA;ROR2;CLEC7A;SEMA3C;WNT11;SEMA3F;SPRY2;LDB2;COL1A1;MAGI2;THBS1;FGF9;CEMIP;VIL1;HRAS;CLDN19;IL1B;FLT4;CDH13;PLXNB3;PIP5KL1;ACVRL1;PODXL;IGF1;OSGIN1;CAMK2B;KIF26A;MAPK15;CSF1R;ADAM9;PLXND1;FGF17;WNT5B;PDGFD;SEMA4C;PPP3CA;CXCL16;CXCR4;PIK3R3;CASS4;DACH1;ACE;RET;SRGAP1;DLG5;AMOTL1;PLXNA2;FGF8;SRC;TCAF2
prerank,Regulation Of Cartilage Development (GO:0061035),-0.5665728360217235,-1.2852701831135458,0.21568627450980393,0.7098286123080088,1.0,8/17,17.57%,SCIN;WNT11;ZBTB16;MBOAT2;BMP2;BMPR1B;TRPS1;BMPR2
prerank,Negative Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001237),-0.44215043785730923,-1.284764918446767,0.12307692307692308,0.7091853279506971,1.0,11/67,10.29%,NOS3;THBS1;IL1B;IGF1;TERT;TNFAIP3;HSPA1B;FAIM;BRCA1;TCF7L2;SRC
prerank,Activation Of Protein Kinase B Activity (GO:0032148),-0.5221831826034338,-1.2847125159532555,0.21428571428571427,0.7070624659578169,1.0,6/24,10.94%,IL18;IGF1;ADRA2C;ADRA2B;ANG;MT3
prerank,Regulation Of Protein Phosphorylation (GO:0001932),-0.35982013042686833,-1.2843094175109058,0.06944444444444445,0.7061971387625603,1.0,40/246,13.59%,KDR;VEGFC;VEGFA;IL34;KNDC1;FGF9;HRAS;CLDN19;IL1B;FLT4;IRGM;LYN;MOB2;PIP5KL1;LRRK2;IGF1;CSF1R;CDKN1A;CARD14;PELI2;FGF17;PRNP;PIK3R3;PLCE1;ZC3H12A;RARRES2;PRKN;FGF8;ANGPT1;SLIT2;MT3;P2RY1;TERF2IP;FAXDC2;TWF1;SH3GL2;PPP1R15B;RAP2A;CLDN3;ITGB3
prerank,Enzyme-Linked Receptor Protein Signaling Pathway (GO:0007167),-0.38722422234595993,-1.2842724857981096,0.07246376811594203,0.704064337062254,1.0,18/118,9.51%,KDR;FLT1;ROR2;INSRR;ART4;DDR2;FLT4;LYN;LTK;MST1R;YES1;CSF1R;FRK;SH2D6;CASS4;ACVR1B;NPR1;RET
prerank,Mismatch Repair (GO:0006298),0.474998282211277,1.2839881273683564,0.18181818181818182,0.9043154229774398,1.0,11/24,27.38%,EXO1;TP73;RNASEH2A;PMS2;RPA2;RPA3;MSH2;MSH6;PCNA;RPA1;RNASEH2C
prerank,Regulation Of Cardiac Muscle Cell Proliferation (GO:0060043),0.5478816286142113,1.2835697866257723,0.18421052631578946,0.9007934034425339,1.0,9/19,20.58%,PIM1;GLI1;FGF2;NOTCH1;TP73;VGLL4;TBX2;RUNX1;MEF2C
prerank,Chloride Transport (GO:0006821),-0.4045789192407233,-1.2829756870688425,0.10606060606060606,0.7065203855660329,1.0,12/73,13.45%,SLC5A1;SLC6A1;CLCNKA;CFTR;SLC26A1;FXYD1;GABRG2;TTYH1;BEST1;GABRB3;FXYD3;SLC4A8
prerank,Macrophage Differentiation (GO:0030225),-0.5429709225478296,-1.2826982888664888,0.17647058823529413,0.7053656390561945,1.0,6/19,12.17%,VEGFA;CASP8;CSF1R;IFNG;IL15;IL31RA
prerank,RNA Biosynthetic Process (GO:0032774),-0.5246837965282677,-1.2818865931247008,0.18032786885245902,0.7059436359896216,1.0,16/28,27.86%,PRIM2;TAF5;TAF13;TBPL2;FOXE1;TBPL1;SMARCA5;TAF7;ZFP36L2;SETX;ZFP36L1;RSF1;SMN1;MTERF1;POLA2;HELB
prerank,Myeloid Cell Development (GO:0061515),0.4991275325363689,1.281634473368577,0.19047619047619047,0.9037492814128819,1.0,10/26,20.10%,GP9;GP5;ANXA2;GP1BA;TLR2;ZNF385A;KIT;MPIG6B;ALAS1;NRROS
prerank,"Regulation Of Alternative mRNA Splicing, Via Spliceosome (GO:0000381)",-0.42039504272112277,-1.2801171270451843,0.16,0.7100235517707205,1.0,13/51,16.28%,RBM24;CELF4;RBFOX3;RBM38;RBFOX2;CELF5;RBM15;DDX17;NOVA2;WTAP;HNRNPL;NSRP1;RBM25
prerank,Sensory Organ Development (GO:0007423),-0.45650333217321326,-1.2797862441911068,0.19696969696969696,0.7088686804958976,1.0,11/58,7.34%,PAX8;TGFB2;MEIS2;OLIG3;SIX4;MEIS1;NKX2-6;BHLHE23;FOXE3;PBX1;FREM2
prerank,Positive Regulation Of Neuron Death (GO:1901216),-0.5253861805489884,-1.279400126501617,0.11538461538461539,0.7076883278766529,1.0,7/33,7.93%,NUPR1;TYROBP;TGFB2;IFNG;MAPT;PRNP;ITGAM
prerank,Positive Regulation Of Activated T Cell Proliferation (GO:0042104),-0.48800358321834875,-1.2792693915122297,0.14583333333333334,0.7057293479476933,1.0,7/19,17.60%,IGFBP2;IL18;IGF1;PPP3CA;TNFSF9;IL23A;FADD
prerank,Positive Regulation Of Phosphatidylinositol 3-Kinase Activity (GO:0043552),-0.5172989500291715,-1.2790425875738207,0.16,0.7041419788020629,1.0,1/24,0.06%,FLT1
prerank,Phagosome Maturation (GO:0090382),0.5172724495392359,1.278989007360224,0.125,0.9120649544671277,1.0,3/15,10.52%,RAB31;RAB38;SLAMF8
prerank,Positive Regulation Of Regulatory T Cell Differentiation (GO:0045591),0.4831462818898665,1.2786878582906007,0.16279069767441862,0.9075129819379648,1.0,4/16,6.10%,CR1;HLA-DRB1;FOXP3;HLA-G
prerank,Negative Regulation Of Chemokine Production (GO:0032682),0.5205178847841179,1.2786552953824029,0.1891891891891892,0.9019164090229074,1.0,6/16,12.00%,KLF4;SIRPA;F2RL1;LGALS9;OAS1;LILRB4
prerank,Positive Regulation Of Signal Transduction By P53 Class Mediator (GO:1901798),-0.4839765144744659,-1.278441056458689,0.0784313725490196,0.7045175809840071,1.0,3/21,7.34%,PLA2R1;HIC1;SPRED1
prerank,Regulation Of Mitotic Spindle Organization (GO:0060236),0.4321840141575113,1.2779923712783643,0.125,0.8987036309177675,1.0,9/39,13.47%,CHMP4C;TPX2;PSRC1;HSPA1A;PLK1;GPSM2;CENPJ;FSD1;PDCD6IP
prerank,Positive Regulation Of Secretion (GO:0051047),-0.5530991800755974,-1.277554360403359,0.10416666666666667,0.7048908134360965,1.0,4/15,9.37%,SCIN;PRL;PPP3CA;NPR1
prerank,Cell Surface Receptor Signaling Pathway Involved In Cell-Cell Signaling (GO:1905114),0.47057584994181684,1.2764113283161935,0.14285714285714285,0.9004909816996203,1.0,6/26,15.15%,WNT7B;BMP4;CD24;NXN;P2RX7;PORCN
prerank,Positive Regulation Of Intrinsic Apoptotic Signaling Pathway (GO:2001244),0.4134097063201029,1.2763808347848336,0.10204081632653061,0.8949831257068059,1.0,9/37,10.31%,MYC;S100A8;GSDME;NCK2;SIAH1;BID;STYXL1;S100A9;BBC3
prerank,Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901990),0.378564157985084,1.2748891302502414,0.07317073170731707,0.897906308915464,1.0,23/86,18.88%,CENPE;CDKN2B;UBE2C;CENPF;PLK1;ANLN;CDK4;CDKN2A;KIF14;KCNH5;RGCC;PTPN6;ACTL6A;CDC14C;DPF3;PPP1R9B;PSME2;TM4SF5;ERCC2;SMARCB1;CDC6;DDB1;HECW2
prerank,Positive Regulation Of Macroautophagy (GO:0016239),-0.40199798564878614,-1.274586420116675,0.09523809523809523,0.7135741156900667,1.0,13/61,17.95%,KDR;DCN;IRGM;ATG2A;SNX7;TBK1;RUFY4;SMCR8;PIP4K2A;MOAP1;SIRT1;PRKAA2;BAG3
prerank,"Synaptic Transmission, Glutamatergic (GO:0035249)",0.48533004296003884,1.2743213747448172,0.13953488372093023,0.8949757051732992,1.0,5/22,12.87%,SLC1A4;GRIK4;GRIN2D;GRIN3B;SLC17A7
prerank,Negative Regulation Of ERBB Signaling Pathway (GO:1901185),0.5115079368522558,1.2737549157469978,0.13725490196078433,0.892612060390068,1.0,6/18,18.32%,PTPN3;PTPN2;LGMN;PTPN18;CBL;MVP
prerank,Positive Regulation Of Smoothened Signaling Pathway (GO:0045880),0.47773147098773755,1.2727079091309168,0.08571428571428572,0.8917432483823419,1.0,9/21,18.70%,GLI1;EVC;TEDC2;CIBAR1;SFRP1;STK36;GAS8;PDCL;TUBD1
prerank,Positive Regulation Of Gene Expression (GO:0010628),-0.3240172799485926,-1.2718829751916654,0.012195121951219513,0.7200104774030968,1.0,79/456,15.46%,NOS3;RPS27L;VEGFA;RBM24;AZU1;STOX1;CLEC7A;PLA2R1;IL26;SPRY2;RBM20;THBS1;SLC11A1;TYROBP;MARK1;FGF9;CLDN19;IL1B;LURAP1;CXCL8;CD34;NOX5;TLE1;TCF23;IGF1;PRR16;SOX4;HOXA5;PIK3R1;PPARG;IFNGR1;GUF1;GLMN;IFNG;FGF17;MED26;HSPA1B;HPN;PIK3R3;PDE2A;RIMS1;ZC3H12A;TENT4B;BRCA1;CD46;IL15;PSG4;PRKN;ZPR1;HMGN5;C1QTNF1;ID2;FGF8;CELF1;TLR3;ANGPT1;MT3;BCL3;C1QTNF3;YAP1;POU3F1;PLCG2;NFE2L2;PTPN22;SLC24A3;PTGER4;CLDN3;ANK3;PCIF1;MBIP;CDH3;EP300;RPL17;ZCCHC4;PF4;FGF19;BMP2;CITED1;BMPR1B
prerank,Regulation Of Lipopolysaccharide-Mediated Signaling Pathway (GO:0031664),0.46362793717667183,1.271622533993547,0.16666666666666666,0.8911763920178803,1.0,8/21,13.41%,SCIMP;TRIM5;LY86;LY96;CD36;CX3CL1;CD180;TRIB1
prerank,Amide Biosynthetic Process (GO:0043604),-0.4370439071705114,-1.2713452646888843,0.0847457627118644,0.7195603902481105,1.0,10/48,9.53%,PAM;DEGS2;ALOXE3;TLCD3B;SPTSSB;ABCA8;ASS1;PNPLA1;GLUD2;CERS3
prerank,Negative Regulation Of Neuron Death (GO:1901215),0.3699952029659376,1.270310804765347,0.1111111111111111,0.8918329751271942,1.0,28/83,21.92%,GPRASP3;IKBKG;FGF20;SNCA;KIF14;CDK5;LGMN;CD200;POU4F1;UNC5B;GRN;NTRK1;CD200R1;RETREG1;WFS1;PRKCI;PARK7;IL27RA;GBA1;IL6ST;AGAP2;AKT1;ATP13A2;CNTFR;NDNF;MEF2C;SNX6;MSH2
prerank,Arachidonic Acid Metabolic Process (GO:0019369),-0.4038746341669162,-1.2690220005919282,0.15254237288135594,0.7257457506586286,1.0,9/49,9.48%,PTGS1;ALOX15;ALOX12;ALOXE3;CYP4F12;AKR1C3;DAGLB;PLA2G4B;AWAT1
prerank,Negative Regulation Of Actin Filament Polymerization (GO:0030837),-0.5026945238581195,-1.268879259876921,0.15789473684210525,0.7239071310714843,1.0,6/23,12.43%,SCIN;VIL1;PFN4;SLIT2;TWF1;PRKCD
prerank,Regulation Of Spindle Assembly (GO:0090169),0.46003263162767066,1.2676757112914645,0.08333333333333333,0.8982403844415782,1.0,6/29,13.47%,CHMP4C;HSPA1A;PLK1;GPSM2;CENPJ;PDCD6IP
prerank,Prostanoid Metabolic Process (GO:0006692),-0.5522674329353292,-1.2666014958937886,0.16666666666666666,0.7304546982372773,1.0,5/15,12.38%,AKR1C2;AKR1C3;CYP4F8;CES1;PTGES
prerank,Regulation Of Cardiac Muscle Hypertrophy (GO:0010611),-0.49459336572793045,-1.2658676973197298,0.16666666666666666,0.7307398141942497,1.0,6/23,12.78%,NR4A3;GLRX3;IGF1;RGS2;EDN1;MEF2A
prerank,"Alternative mRNA Splicing, Via Spliceosome (GO:0000380)",-0.5475319517436809,-1.2654009269330833,0.09259259259259259,0.7302003433231908,1.0,4/16,14.01%,CELF4;RSRC1;DDX17;SLU7
prerank,Cytoplasmic Translation (GO:0002181),0.3690411402190679,1.265198714099774,0.025,0.9049149797673853,1.0,52/92,36.15%,RPL34;RPS2;RPL41;RPL31;RPL14;RPL13;RPL23A;RPS24;SARS1;EIF4A2;RACK1;EIF3I;RPS15A;RPL22;RPS3A;RPL18A;RPL35A;FTSJ1;RPS27;RPS3;RPS18;RPS8;RPLP2;RPS16;RPS5;RPS6;UBA52;RPL4;RPS10;RPS26;RPL7A;RPS21;RPL38;RPS9;RPL26;RPL19;RWDD1;RPS23;RPS25;RPL32;EIF3M;RPL21;RPL10A;RPS13;RPS11;DRG2;RPL36;FAU;RPL12;RPL26L1;RPS20;RPL24
prerank,protein-DNA Complex Disassembly (GO:0032986),0.5034051387660485,1.265069937912714,0.20454545454545456,0.8998449802251125,1.0,2/19,1.50%,NFE2;MYC
prerank,Defense Response To Virus (GO:0051607),0.31170752270074986,1.2647338208857313,0.09523809523809523,0.8963620354331348,1.0,51/186,19.06%,AICDA;APOBEC3D;CD207;IL21;IFIT1;ATAD3A;TRIM5;RSAD2;TRIM52;IFITM1;OAS2;GARIN5A;PLSCR1;F2RL1;IRF7;PYCARD;ZDHHC1;DHX16;LILRB1;TLR8;CD40;EXOSC5;PQBP1;OAS1;IFNL2;BCL2L1;SERINC3;ISG15;IFI27;SKP2;TLR2;IRF2;IFNL1;RNASE6;IFNE;BST2;PHB1;EXOSC4;SAMHD1;RIPK3;DDX60;IFIT3;RIGI;AKAP1;APOBEC3B;GBP2;IFITM2;RAB2B;ISG20;MYD88;OAS3
prerank,Establishment Of Spindle Orientation (GO:0051294),0.41646098702736944,1.264234926928851,0.21621621621621623,0.8936509446651598,1.0,5/35,7.83%,SAPCD2;INSC;PLK1;HTT;GPSM2
prerank,Regulation Of Canonical Wnt Signaling Pathway (GO:0060828),-0.35765922476687506,-1.2640484936381164,0.07692307692307693,0.7336395220359017,1.0,45/192,17.47%,FRZB;AMER3;IGFBP2;WNT11;DKK4;DKK2;COL1A1;GLI3;APC2;RNF220;LATS2;TLE1;CCL14;LRRK2;SOX4;FZD7;CTNND1;PTK7;KREMEN1;BAMBI;TCF7L2;FRAT1;PRKN;SOX13;CTNND2;SMURF2;TPBGL;AMFR;SIAH2;NRARP;DKK3;DAAM2;PPM1A;BMAL1;ZEB2;CDH3;WNK2;LGR4;BMP2;CSNK1D;TNKS;TRPM4;NOG;PPM1B;CSNK1E
prerank,T Cell Mediated Immunity (GO:0002456),0.4552290145520903,1.2638953209631218,0.18604651162790697,0.8901885982087591,1.0,5/18,15.47%,HLA-A;CR1;CTSH;CADM1;BTN3A2
prerank,Positive Regulation Of Interleukin-1 Production (GO:0032732),-0.40538926598874914,-1.2638047542603024,0.13636363636363635,0.7322137757519885,1.0,8/62,5.80%,AZU1;CLEC7A;LILRA2;TYROBP;CASP8;RIPK2;FZD5;IFNG
prerank,Mitotic Cell Cycle Checkpoint Signaling (GO:0007093),0.4558701938650958,1.2629739326450968,0.16129032258064516,0.8896013516111454,1.0,5/25,10.11%,CHMP4C;AURKB;RBBP8;ZWINT;INIP
prerank,Positive Regulation Of Smooth Muscle Cell Proliferation (GO:0048661),-0.4312933309162336,-1.260912620010004,0.12280701754385964,0.7404863255926569,1.0,11/46,10.65%,THBS1;NR4A3;FGF9;IL18;CDH13;RBPMS2;IGF1;SERPINF2;ID2;MEF2D;EDN1
prerank,Regulation Of Toll-Like Receptor 4 Signaling Pathway (GO:0034143),-0.515807822414556,-1.2602354329284657,0.1694915254237288,0.7408929303326942,1.0,6/20,13.21%,LILRA2;LYN;TNFAIP3;NINJ1;NR1D1;PTPN22
prerank,Regulation Of Macrophage Derived Foam Cell Differentiation (GO:0010743),-0.46436051919556115,-1.2600254369551727,0.1694915254237288,0.739551669020345,1.0,9/26,17.55%,MSR1;IL18;PPARG;ABCA5;NFKBIA;ABCG1;ITGB3;PF4;PPARA
prerank,Cortical Cytoskeleton Organization (GO:0030865),-0.4667808320515239,-1.2598871566452132,0.14545454545454545,0.7376902586615054,1.0,8/27,21.19%,EPB41L3;NCKAP1;RHOQ;FHOD3;FMNL2;DLG1;RAB13;RAC3
prerank,Negative Regulation Of Canonical Wnt Signaling Pathway (GO:0090090),-0.38510644439584607,-1.2583868927543904,0.13846153846153847,0.7410447235561001,1.0,16/103,10.27%,FRZB;IGFBP2;WNT11;DKK4;DKK2;GLI3;APC2;LATS2;TLE1;CCL14;CTNND1;KREMEN1;TCF7L2;PRKN;SOX13;TPBGL
prerank,Amide Transport (GO:0042886),-0.4655775309277034,-1.2581822773930635,0.1724137931034483,0.7394988801633836,1.0,4/31,5.34%,SLC14A2;GLTPD2;AQP8;SLC14A1
prerank,Cognition (GO:0050890),0.4190037637370213,1.2579477457611261,0.1282051282051282,0.9079232567401218,1.0,11/42,13.81%,SHROOM4;SLC1A4;CHRNA7;JAKMIP1;LINS1;CBR3;SLC8A2;METTL23;CYFIP1;CTNS;MGAT3
prerank,Neuron Fate Commitment (GO:0048663),-0.5503388097112463,-1.2566253137934045,0.1568627450980392,0.7433513519613373,1.0,6/16,16.21%,POU3F2;BHLHE23;ISL2;ID2;PAX6;BHLHE22
prerank,Positive Regulation Of Smooth Muscle Cell Migration (GO:0014911),-0.5647648553845381,-1.2559339813903085,0.19607843137254902,0.7431280679793357,1.0,6/15,13.42%,NR4A3;FGF9;IGF1;DOCK7;VTN;IGFBP5
prerank,Regulation Of Axon Extension (GO:0030516),0.41681504202407105,1.2540986947435107,0.09615384615384616,0.9198808813558459,1.0,9/35,10.94%,NRCAM;SEMA3G;RTN4R;L1CAM;SHTN1;SEMA7A;CTTN;MAP3K13;TRIM46
prerank,Negative Regulation Of Cell Junction Assembly (GO:1901889),-0.486986913343984,-1.2532760942093828,0.22413793103448276,0.7503140523888836,1.0,5/24,10.29%,THBS1;IL1B;ACVRL1;APOD;SRC
prerank,Endoderm Formation (GO:0001706),-0.5023065332120913,-1.2526331263755512,0.21875,0.7507428833662828,1.0,9/35,18.09%,ITGB5;DUSP2;COL7A1;DUSP5;DUSP1;VTN;COL6A1;MMP14;LHX1
prerank,Cellular Response To Epidermal Growth Factor Stimulus (GO:0071364),-0.46752430448014004,-1.252163861579279,0.1694915254237288,0.7502258410717298,1.0,10/26,30.85%,VIL1;GAREM1;ZPR1;ZFP36L2;PTPN12;ZFP36L1;PDE8A;FOXC1;SYAP1;MED1
prerank,Positive Regulation Of Fatty Acid Metabolic Process (GO:0045923),-0.48389460115247707,-1.250694538178312,0.23255813953488372,0.7530492956901468,1.0,3/16,7.35%,NR4A3;MLXIPL;MLYCD
prerank,Positive Regulation Of Myoblast Differentiation (GO:0045663),-0.4415523950069008,-1.2501638000657194,0.18181818181818182,0.7526495160005355,1.0,4/35,5.91%,RBM24;BOC;SOX4;PLCB1
prerank,3'-UTR-mediated mRNA Destabilization (GO:0061158),-0.566801450073902,-1.2490463772419986,0.15,0.7542428042895862,1.0,5/15,17.71%,RBM24;ZC3H12A;ZFP36L2;UPF1;DHX36
prerank,Positive Regulation Of Cell Adhesion (GO:0045785),-0.39407381064656877,-1.2489624250399576,0.1016949152542373,0.7523080844822582,1.0,12/83,9.51%,VEGFA;AZU1;ALOX15;TGFB2;FBLN2;IL12A;ZFHX3;ADAM9;MEGF10;PPP3CA;LAMA2;RET
prerank,Regulation Of Osteoblast Differentiation (GO:0045667),0.3623063620710981,1.2486500237327167,0.10526315789473684,0.9403907194220725,1.0,18/82,14.08%,TWIST1;WNT7B;HEMGN;BMP4;SCUBE3;CHRD;TP63;IFITM1;SUFU;CCNA2;IL6R;NOTCH1;LRP3;PTK2;WWTR1;TNN;SOX11;ACVR2A
prerank,Positive Regulation Of Morphogenesis Of An Epithelium (GO:1905332),-0.5305271328182478,-1.24856986391336,0.1724137931034483,0.7514941499918447,1.0,3/23,1.81%,VEGFA;PAX8;SIX4
prerank,"Mitochondrial Electron Transport, NADH To Ubiquinone (GO:0006120)",0.42333944182683697,1.2478822992103207,0.17391304347826086,0.9392614491411475,1.0,18/34,33.09%,NDUFA9;NDUFB3;NDUFC1;NDUFS7;NDUFB10;NDUFS2;NDUFB2;NDUFAF1;NDUFB5;NDUFC2;NDUFA6;NDUFB4;NDUFB8;NDUFA8;NDUFS5;NDUFB6;NDUFS4;NDUFS8
prerank,Retinal Metabolic Process (GO:0042574),0.5160895489738249,1.2477983040126062,0.24489795918367346,0.9346330372757244,1.0,4/15,6.61%,ALDH8A1;BCO2;CYP1B1;DHRS4L1
prerank,Carboxylic Acid Biosynthetic Process (GO:0046394),0.4773968015160953,1.2477927857898494,0.2222222222222222,0.9295190763012751,1.0,9/17,24.44%,CDO1;PYCARD;PAH;UGDH;FADS1;BCAT2;CYP4A22;CYP2C8;CASP1
prerank,Regulation Of T Cell Activation (GO:0050863),0.3775721989017614,1.247068211672751,0.16666666666666666,0.9277744632728115,1.0,17/60,16.20%,HLA-DRB1;CCR2;HLA-DMB;SIRPA;CTSG;TIGIT;SIT1;PYCARD;TNFAIP8L2;HSPD1;HLA-DQA1;TNFSF11;SIRPG;JAK3;HLA-DQA2;HLA-DPA1;PRELID1
prerank,Muscle Tissue Development (GO:0060537),-0.4479002151160239,-1.2469677893063091,0.21568627450980393,0.7548110687915246,1.0,4/31,2.46%,SRPK3;SIX4;MYL11;PGM5
prerank,Positive Regulation Of T Cell Mediated Cytotoxicity (GO:0001916),0.42870511258269073,1.2467644201635697,0.14285714285714285,0.9239238213441865,1.0,8/33,6.10%,HLA-A;HLA-DRB1;MR1;PVR;HFE;CD1D;CD1E;HLA-G
prerank,Positive Regulation Of Calcium Ion Transport (GO:0051928),-0.4856536373619136,-1.2466337479004153,0.14754098360655737,0.7536070318114686,1.0,8/28,15.51%,LILRA2;ATP2A1;FFAR1;CCL2;F2R;STIM2;CCR1;CXCL12
prerank,Response To Estradiol (GO:0032355),0.42996625885835305,1.2453708907711445,0.10416666666666667,0.9253995663733778,1.0,9/30,19.40%,SOCS2;GH1;SSTR2;ZNF703;POU4F1;SFRP1;GPER1;RUVBL2;RAMP3
prerank,Regulation Of Intracellular Protein Transport (GO:0033157),0.41467409549776707,1.245335189605625,0.15384615384615385,0.9206054980168198,1.0,8/36,14.79%,BMP4;PRR5L;PTPN14;PDCD10;IFI27;RIPOR1;MBD1;ERGIC3
prerank,Positive Regulation Of Developmental Process (GO:0051094),-0.3465800818646031,-1.243457782458664,0.07462686567164178,0.7624575451421424,1.0,46/223,18.95%,KDR;VEGFA;DCN;PRL;OTX2;VIL1;ZDHHC15;EDN3;DDHD1;SHANK1;ZBTB16;AURKA;CAMK2B;PPARG;PLCB1;ACVR1B;PHLDB1;PRKN;SERPINF2;DLG5;FGF8;SMURF2;SRC;MIEF1;MUL1;LLPH;INSL6;MMRN2;BCL7A;BMP1;NCOA1;APELA;VLDLR;BMP2;BMPR1B;RREB1;TRPM4;SOX8;SIRT1;SPIRE1;BMPR2;INSM1;LHX1;ARID4A;BICRAL;TMEM119
prerank,Mitotic G1 DNA Damage Checkpoint Signaling (GO:0031571),-0.47252886337870087,-1.2428048099913236,0.24074074074074073,0.7627797403580582,1.0,7/25,17.80%,RPS27L;CDKN1A;CDKN1B;SDE2;CCND1;TRIAP1;PIDD1
prerank,Apoptotic Process (GO:0006915),0.3124780697059423,1.2417870735390215,0.038461538461538464,0.9317002481297352,1.0,72/223,22.95%,PAK6;MYC;IKBKG;EMP1;EGLN3;TNFRSF19;MAP3K7;TP63;PDCD1;PLSCR3;EFNA5;ESPL1;IL2RA;SIAH1;BID;BIK;DAPK1;RFK;PLSCR1;TNFSF14;ATCAY;BRAT1;CDK5;CIT;DYNLL1;HK2;PYCARD;MAL;ADORA2A;HSPD1;CASP6;PDCD2L;CEL;BCL2L1;BBC3;NLRP3;IFI27;IFI27L2;TLR2;CASP9;CASP10;DAP;VDAC1;ZNF385A;PHLDA2;TBX1;PLAGL1;ERCC2;AKAP1;BCL2L14;BCL2L13;AKT1;SEPTIN4;AIFM2;MAGEH1;TRADD;MAGI3;MYD88;CASP2;PPIA;DDX41;AIFM1;SFRP5;BNIP3;FAS;RTN4;TNFSF12;BNIPL;RNF152;CIDEC;CASP3;TCHP
prerank,tRNA Wobble Uridine Modification (GO:0002098),0.5104331409316656,1.2416304966952987,0.21052631578947367,0.9274437882553571,1.0,6/15,23.50%,TRMT9B;CTU1;ELP5;TRMU;DPH3;GTPBP3
prerank,Regulation Of Histone Acetylation (GO:0035065),0.46583168048489143,1.2405605954895251,0.21428571428571427,0.9276796719415649,1.0,2/22,3.39%,TWIST1;FOXP3
prerank,Positive Regulation Of Leukocyte Activation (GO:0002696),-0.4959777630089969,-1.2398827210812289,0.24561403508771928,0.7719076993928599,1.0,3/18,2.83%,CLEC7A;THBS1;IRGM
prerank,"Phagocytosis, Engulfment (GO:0006911)",-0.45565360306962155,-1.2389459384869552,0.21818181818181817,0.7726135653889171,1.0,12/29,21.19%,THBS1;XKR9;MSR1;MEGF10;ITGAM;FCGR2B;XKR5;ARHGAP12;XKR4;VAMP7;XKR6;RAC3
prerank,Hematopoietic Progenitor Cell Differentiation (GO:0002244),0.4499823333549136,1.2387771029593793,0.18421052631578946,0.9313587000025285,1.0,8/27,12.16%,BMP4;BATF;MEOX1;FSTL3;SFRP1;ARMC6;PLD4;MIXL1
prerank,Calcium Ion Transmembrane Transport (GO:0070588),0.3808552308370534,1.2387598738985772,0.1388888888888889,0.9266092816285716,1.0,17/74,14.46%,TRPM8;CACNA2D4;TRPM3;ATP2C1;TRPM6;SLC24A4;SLC35G1;GRIN2D;NALCN;RYR3;SLC8A2;ORAI1;FKBP1A;P2RX7;MCOLN3;TRPV6;TRPV2
prerank,Linoleic Acid Metabolic Process (GO:0043651),-0.5001489142169958,-1.2376675440899243,0.1896551724137931,0.7754900260026372,1.0,3/19,1.62%,ALOX15;ALOX12;ALOXE3
prerank,Regulation Of Metaphase/Anaphase Transition Of Cell Cycle (GO:1902099),0.43738019443791626,1.2374899593902424,0.17777777777777778,0.9274564404082396,1.0,8/32,18.88%,CENPE;UBE2C;PLK1;ACTL6A;DPF3;SMARCB1;CDC6;HECW2
prerank,Muscle Contraction (GO:0006936),-0.39774903970568465,-1.2371413629791141,0.17142857142857143,0.7745992941647857,1.0,14/85,8.71%,MYOM2;CHRNG;CASQ2;SCN4A;MYL11;MYH2;CHRND;FXYD1;OXTR;CHRNE;UTRN;SLC8A1;MYH11;CKMT2
prerank,Transcription Initiation At RNA Polymerase II Promoter (GO:0006367),-0.37694291317323003,-1.237138385408274,0.12307692307692308,0.7723987279881811,1.0,12/65,18.29%,TAF7L;MED26;MED21;TAF5;TAF13;ELOA;TAF7;ERCC3;MED27;CDK9;MED9;MED30
prerank,Mitotic Spindle Assembly (GO:0090307),0.3771078192820903,1.2362227817798221,0.13513513513513514,0.9288008402231033,1.0,9/44,15.36%,AURKB;TPX2;KIF4A;BIRC5;STAG2;CHEK2;RACGAP1;CDCA8;KIF2A
prerank,Late Endosome To Lysosome Transport (GO:1902774),0.5081929284563736,1.2353564766771006,0.28846153846153844,0.9275129186049218,1.0,1/15,0.98%,CHMP4C
prerank,Regulation Of Receptor Recycling (GO:0001919),0.49448640919600867,1.2351202697845418,0.2,0.9237339827784259,1.0,8/17,25.88%,BVES;SNCA;TRAT1;TBC1D16;OCRL;RAMP3;KIF16B;SCRIB
prerank,Negative Regulation Of Developmental Process (GO:0051093),-0.39126342980108514,-1.234786170597451,0.11428571428571428,0.7782816118436716,1.0,27/105,20.82%,NOS3;WNT11;RPS6KA6;KIAA0319;SRGAP2C;PPARG;KLF7;MAPT;HEY2;PRKN;HEY1;MUL1;SFMBT1;BCL7A;THY1;HOPX;ALPK2;BMP2;SPRY3;NFIB;TENT5C;ARID4A;BICRAL;ARPIN;ARID4B;ING2;SAP30L
prerank,Positive Regulation Of Monoatomic Ion Transport (GO:0043270),-0.4429604489920196,-1.234491143961229,0.11538461538461539,0.7771290494394052,1.0,14/38,23.79%,LILRA2;SCN5A;FFAR1;SCN3B;F2R;STIM2;ANK3;CCR1;GPD1L;DLG1;FHL1;KIF5B;MYLK;CCL5
prerank,Cardiac Muscle Cell Contraction (GO:0086003),-0.537753134846811,-1.2340069153505708,0.2765957446808511,0.7767652504586842,1.0,4/16,11.46%,SCN5A;SCN3B;KCNE2;PIK3CA
prerank,Positive Regulation Of Phospholipase C Activity (GO:0010863),-0.46400319235570164,-1.234006351781672,0.24074074074074073,0.7745833255978452,1.0,4/34,7.03%,FLT1;HRAS;C5AR1;ANG
prerank,Regulation Of Nuclear Division (GO:0051783),0.48624329940681243,1.2336913222804506,0.2653061224489796,0.9249272853078558,1.0,11/19,30.54%,OBSL1;PKMYT1;MKI67;PRMT5;CDCA2;RCC1;CCDC8;PDXP;CAV2;DAPK3;KIF20B
prerank,Regulation Of Cell Adhesion (GO:0030155),-0.3570477758014482,-1.2335854711512282,0.12903225806451613,0.7740846423175007,1.0,25/140,10.67%,VEGFA;AZU1;NUAK1;IL18;C2CD4B;CXCL8;LYN;IL12A;CDH13;ZFHX3;PLXNB3;ACVRL1;PODXL;FUT1;PLXND1;RND1;PPP3CA;ADAM22;LAMA2;CXCR4;RET;PLXNA2;SRC;DUSP1;ANGPT1
prerank,Cell-Cell Adhesion Mediated By Cadherin (GO:0044331),-0.5205953597671241,-1.2335213631807966,0.21568627450980393,0.7720947757750558,1.0,7/25,6.23%,CDH18;CDH4;CDH8;CDH13;CDH2;CTNND1;CDH22
prerank,Adherens Junction Organization (GO:0034332),-0.45485659859475425,-1.2330127479487805,0.1935483870967742,0.7715198521223504,1.0,6/34,6.23%,CDH18;CDH4;CDH8;CDH13;CDH2;CDH22
prerank,Cell-Cell Junction Assembly (GO:0007043),-0.40830077681871046,-1.2325367608481745,0.1935483870967742,0.770690987406095,1.0,9/65,6.23%,CDH18;CDH4;EPB41L3;CDH8;GJB6;CDH13;CDH2;CTNND1;CDH22
prerank,Positive Regulation Of Heart Rate (GO:0010460),-0.5003065382419263,-1.2323091947998606,0.2391304347826087,0.7693253777195131,1.0,6/17,10.65%,EDN2;EDN3;ADRB1;ADM5;SCN3B;EDN1
prerank,Negative Regulation Of Endoplasmic Reticulum Stress-Induced Intrinsic Apoptotic Signaling Pathway (GO:1902236),-0.5055384867116087,-1.2320079164835136,0.2,0.7684503290174234,1.0,4/15,9.30%,MAGEA3;LRRK2;HERPUD1;PRKN
prerank,Regulation Of Oligodendrocyte Differentiation (GO:0048713),-0.5308516109621316,-1.2315698686976968,0.25,0.7679767837433118,1.0,5/17,13.72%,IL34;SOX1;TMEM98;TENM4;DAAM2
prerank,Positive Regulation Of Protein Tyrosine Kinase Activity (GO:0061098),-0.44492454711190255,-1.230984235398991,0.18518518518518517,0.768099229021332,1.0,10/32,10.29%,IL34;NOX4;DOK7;CSF1R;FCGR1A;PRNP;NCF1;CASS4;ACE;SRC
prerank,Regulation Of MAPK Cascade (GO:0043408),-0.34634470845592763,-1.230974101227551,0.06666666666666667,0.7660793851337698,1.0,25/190,10.52%,KDR;FLT1;BCAR3;ART4;AVPI1;HRAS;IL1B;FLT4;LYN;IGF1;DUSP2;ADRA2C;CSF1R;PELI2;ADRA2B;SPRED1;VRK2;DUSP5;PLCE1;IL11;GDF15;RET;DUSP8;TGFBR3;DUSP1
prerank,Macrophage Activation (GO:0042116),-0.46126112753005916,-1.2302077182245728,0.21153846153846154,0.7671899222845584,1.0,9/34,7.93%,AZU1;SLC11A1;EDN2;CD93;IFNGR1;IFNG;C5AR1;MAPT;ITGAM
prerank,Positive Regulation Of T Cell Migration (GO:2000406),0.4619910295983788,1.2298498376995985,0.175,0.9377081861275437,1.0,4/24,9.74%,CXCL13;CCR2;PYCARD;DOCK8
prerank,Dendritic Spine Organization (GO:0097061),0.46106477526715184,1.2294890833110717,0.23404255319148937,0.9347735104763092,1.0,6/24,9.01%,EPHB1;NOL3;EPHB3;CHRNA7;LGMN;ITGA3
prerank,Regulation Of T Cell Mediated Cytotoxicity (GO:0001914),0.40985367929298855,1.2291695219195857,0.17307692307692307,0.9314271830316083,1.0,9/36,7.50%,CEACAM1;HLA-A;HLA-DRB1;HFE;CD1D;CD1E;KLRC1;HLA-G;LILRB1
prerank,Regulation Of Plasma Membrane Bounded Cell Projection Organization (GO:0120035),-0.47978309336895825,-1.2288089519031897,0.2,0.7701721241503241,1.0,10/26,23.53%,MARK1;NCS1;KIF26A;TBR1;FCGR2B;BRSK2;BRSK1;ZNF804A;FBXO7;CCDC88A
prerank,Regulation Of Protein Tyrosine Kinase Activity (GO:0061097),-0.44632037112373846,-1.2286411639783124,0.1836734693877551,0.7686103049643732,1.0,8/35,8.93%,IL34;NOX4;DOK7;CSF1R;FCGR1A;PRNP;CASS4;ACE
prerank,Negative Regulation Of Protein Catabolic Process (GO:0042177),0.39300220163078997,1.2282791568074738,0.2,0.9307021462488164,1.0,16/52,21.64%,PTPN3;ANXA2;SNCA;AZIN2;IRAK3;CTSA;PHF20L1;TIMP1;NQO1;TIMP2;PHB1;OPHN1;AGAP2;HMGCR;LAMP3;RIC1
prerank,Anaphase-Promoting Complex-Dependent Catabolic Process (GO:0031145),0.48875432776223365,1.2270731720282306,0.18604651162790697,0.9322672590141269,1.0,5/21,14.50%,UBE2C;CDC20;CDC20B;ECRG4;ANAPC7
prerank,Positive Regulation Of Reactive Oxygen Species Metabolic Process (GO:2000379),-0.43767834945342177,-1.2266594575334973,0.2,0.773495780664812,1.0,11/44,12.43%,CLEC7A;THBS1;TYROBP;CDKN1A;AKR1C3;MAPT;ITGAM;ZC3H12A;GADD45A;PLCG2;PRKCD
prerank,Positive Regulation Of Phosphoprotein Phosphatase Activity (GO:0032516),-0.5253178119340259,-1.2259673501739332,0.2826086956521739,0.7733233402614089,1.0,4/18,12.97%,MAGI2;CD33;CD300A;PPP1R15B
prerank,Glycosaminoglycan Metabolic Process (GO:0030203),0.44420327211769156,1.2255960680893538,0.16666666666666666,0.9334783551688685,1.0,10/27,24.89%,EXT2;GUSB;HS3ST3A1;HEXA;CLN6;UGDH;HYAL2;HS3ST1;GALNT5;HS3ST3B1
prerank,Regulation Of Autophagosome Assembly (GO:2000785),-0.42271469458902167,-1.2251097488151406,0.16071428571428573,0.7742884912820185,1.0,9/39,14.94%,NUPR1;RNF186;TMEM39A;LRRK2;SNX7;FEZ1;SMCR8;PIP4K2A;MOAP1
prerank,Regulation Of Interleukin-1 Beta Production (GO:0032651),-0.3931658414956446,-1.2246224768179168,0.16393442622950818,0.7737001130288411,1.0,13/81,5.80%,AZU1;CLEC7A;LILRA2;TYROBP;FFAR1;IGF1;CD33;APOA1;CASP8;RIPK2;FZD5;TNFAIP3;IFNG
prerank,B Cell Activation Involved In Immune Response (GO:0002312),-0.5238157233000387,-1.2245855473981924,0.1694915254237288,0.7718464484545806,1.0,5/15,11.25%,SANBR;EXOSC3;RNF168;EXOSC6;FCGR2B
prerank,Negative Regulation Of Wnt Signaling Pathway (GO:0030178),-0.3698740701207047,-1.2244735551748167,0.12121212121212122,0.7700851997605597,1.0,23/129,13.32%,FRZB;IGFBP2;WNT11;DKK4;DKK2;GLI3;HIC1;CXXC4;APC2;LATS2;TLE1;CCL14;CTNND1;NOTUM;KREMEN1;TCF7L2;PRKN;SOX13;TPBGL;AMFR;SIAH2;TSKU;DKK3
prerank,Regulation Of Phosphatidylinositol 3-Kinase Activity (GO:0043551),-0.4441242712927713,-1.2234025871809793,0.23076923076923078,0.7723377947652826,1.0,3/32,8.42%,FLT1;PIK3R1;PIK3R3
prerank,Positive Regulation Of mRNA Processing (GO:0050685),-0.47611878617130154,-1.2231908600113541,0.19607843137254902,0.7710769939740384,1.0,11/26,28.29%,CELF4;STH;PEX2;SNW1;DHX36;SF3B4;RBM3;PRDX6;RBMY1B;CELF3;CIRBP
prerank,Negative Regulation Of Hydrolase Activity (GO:0051346),-0.40908879575980395,-1.2230208836360628,0.11475409836065574,0.769468212699994,1.0,7/46,5.72%,HRAS;LRCH1;PLXNB3;LRRK2;CST7;FZD10;RASA4
prerank,Heart Development (GO:0007507),-0.36742024255648953,-1.2227470343374993,0.1232876712328767,0.768657035287869,1.0,22/158,10.10%,CXADR;VEGFA;PDLIM3;TGFB2;LDB3;NKX2-6;NDRG4;ACVRL1;SOX4;CASP8;ALPK3;MYL7;CDKN1A;DNAAF4;PDLIM1;TH;PLCE1;ID2;NDUFV2;TGFBR3;FGF8;MEF2D
prerank,Regulation Of Calcium Ion-Dependent Exocytosis (GO:0017158),0.46201981124639846,1.2223037441077034,0.2127659574468085,0.9447271173008255,1.0,10/27,15.52%,SYT3;KCNB1;SYT5;RPH3A;RPH3AL;SYT13;SYT9;TRPV6;SYT17;SCAMP5
prerank,Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0007178),-0.3640742663896154,-1.2220791778151527,0.12280701754385964,0.7686914247854777,1.0,21/122,10.29%,ITGB5;MAGI2;MSTN;TGFB2;SMAD6;COL1A2;USP9Y;ACVRL1;APOA1;PPARG;ADAM9;INHBE;SMAD5;LTBP2;BAMBI;GDF15;ACVR1B;PSG4;TGFBR3;SMURF2;SRC
prerank,Monoatomic Ion Transport (GO:0006811),0.33878608780748154,1.2219309954849058,0.14285714285714285,0.9421800446481318,1.0,24/100,16.40%,CHRNA3;TRPM3;SLC26A7;CHRNA7;SLC1A1;SLC36A2;SLC24A4;SLC15A2;CNGB1;SLC1A7;SLC12A3;SLC8A2;SLC1A2;SLC26A11;CTNS;SLC39A1;SLC17A7;SLC12A5;SLC36A1;VDAC1;SLC4A2;GLRA1;PLP2;SLC12A7
prerank,Establishment Of Vesicle Localization (GO:0051650),0.48723065110600156,1.2213440490299214,0.19607843137254902,0.9404675429831832,1.0,10/17,29.90%,IKBKG;CDK5;SNAPIN;KIF5A;RAB11A;SYT11;RAB27A;TOR1A;TESK1;LIMK2
prerank,Chordate Embryonic Development (GO:0043009),-0.4094498976572995,-1.2209509510022218,0.10714285714285714,0.7704037780434405,1.0,5/56,2.28%,VEGFA;WNT11;COL1A1;SIX4;NKX2-6
prerank,Mitochondrion Organization (GO:0007005),-0.36346310065815896,-1.2202161079057818,0.14285714285714285,0.7712432766719162,1.0,22/158,12.78%,NOS3;CXADR;RAB5IF;GABPB1;COX7A2;AFG1L;ATP2A1;LRRK2;TERT;AGTPBP1;MTFP1;MYH7B;TMEM242;PRKN;SLC25A36;SUPV3L1;MIEF1;MUL1;HIGD1C;MTX3;RHOT2;MEF2A
prerank,Phosphatidylcholine Biosynthetic Process (GO:0006656),-0.48148515750513177,-1.2200242410702682,0.19642857142857142,0.7699243688460639,1.0,5/18,10.20%,SLC44A4;SLC44A5;APOA1;PCYT1B;CHKB
prerank,Mesonephric Tubule Development (GO:0072164),-0.5634070741023101,-1.2199681100205582,0.23529411764705882,0.7680752514864717,1.0,3/15,18.09%,WNT11;SLIT2;LHX1
prerank,Regulation Of Insulin-Like Growth Factor Receptor Signaling Pathway (GO:0043567),-0.5344893682487759,-1.219534744327608,0.25,0.7676553648885084,1.0,7/18,19.94%,IGFBP2;IGF1;WNT1;IGFBP5;CDH3;INPPL1;IGFBP3
prerank,Regulation Of Smooth Muscle Contraction (GO:0006940),0.47360036443901193,1.218565583890998,0.16666666666666666,0.9477256825132561,1.0,6/18,19.06%,CHRNA3;CNN1;CTTN;SRF;CHRM3;SETD3
prerank,Regulation Of Chemokine Production (GO:0032642),0.39807994764949406,1.2178589997379685,0.21568627450980393,0.9461913544324418,1.0,12/39,15.17%,AIRE;FFAR2;EGR1;F2RL1;PYCARD;IL6R;LGALS9;TSLP;TLR2;LILRB4;TLR4;HMOX1
prerank,Regulation Of Notch Signaling Pathway (GO:0008593),-0.42160431826752653,-1.2175116888498319,0.19117647058823528,0.7731951788647586,1.0,9/67,11.47%,NOS3;TGFB2;TSPAN15;WNT1;CCNC;CD46;SRC;HEY1;YAP1
prerank,Neuron Projection Guidance (GO:0097485),0.3486479880246218,1.2171156396035638,0.06666666666666667,0.9454695036705578,1.0,36/116,15.94%,SEMA6B;EPHB1;NRCAM;DRAXIN;NFASC;EPHB3;VASP;KALRN;PLEKHG4B;EFNA5;SEMA3G;SIAH1;SEMA5A;EPHA4;ENAH;EFNA4;ROBO4;NOTCH1;EPHA10;NIBAN2;L1CAM;IGSF9;SEMA7A;TUBB3;ARHGEF40;CYFIP1;PTK2;SEMA5B;SEMA4G;SOS1;EFNB1;MYPN;KIF5A;LRTM1;SEMA4F;OPHN1
prerank,Macromolecule Modification (GO:0043412),0.3476291455808387,1.2160976461353177,0.13513513513513514,0.9453615599477236,1.0,27/79,26.03%,PHEX;USP6;ST6GAL2;NEDD8;FBXO22;ADPRH;ST6GAL1;PLAT;SLC35A1;GGCX;LOXL2;UBE2L6;RIPK3;ST8SIA4;ST3GAL2;NTAQ1;CHRM3;PARP4;TGM1;MANBA;CSNK1G3;STK38;UBA3;ICMT;PLOD2;MMP15;PARP1
prerank,Protein Methylation (GO:0006479),0.4283896862137557,1.215929916954234,0.20512820512820512,0.9416308577530185,1.0,15/33,28.99%,EEF1AKMT3;EEF1AKMT1;CSKMT;EEF1AKMT2;PRMT2;CARM1;PRMT5;TRMT112;PRMT1;SETD3;ICMT;FAM98B;PRMT8;CAMKMT;PRMT7
prerank,Negative Regulation Of Cell Population Proliferation (GO:0008285),-0.32637156856005745,-1.2157979240980752,0.07692307692307693,0.7770808756582925,1.0,49/364,10.38%,NOS3;FRZB;SCIN;IL26;NOX4;NUPR1;MAGI2;THBS1;MSTN;TGFB2;SMAD6;GATA6;MYO16;SLC16A2;HRAS;CLDN19;NUP62;IL1B;NDRG4;CXCL8;LYN;IL12A;CDH13;NUPR2;ACVRL1;CD33;PPP2R5C;SOX4;PPARG;GLMN;TNFAIP3;CDKN1A;IFNG;CGRRF1;ADAMTS1;KLF10;HSPA1B;ANG;FGFBP1;KLF11;RUNX3;HPN;ZBTB49;APOD;DLG5;INCA1;TGFBR3;SH2B3;CELF1
prerank,Endoplasmic Reticulum Tubular Network Organization (GO:0071786),0.4611175745369821,1.2153394567665794,0.21052631578947367,0.9399241598643208,1.0,2/16,6.87%,RTN3;RAB10
prerank,Metanephros Development (GO:0001656),0.4419602406807058,1.2152434905010001,0.16279069767441862,0.935887059167585,1.0,4/24,6.51%,WNT7B;BMP4;FOXD1;CTSH
prerank,Nervous System Development (GO:0007399),-0.32087620149555474,-1.2151692759394865,0.07575757575757576,0.7776243326254692,1.0,67/397,12.98%,NAV2;FARP1;VEGFA;POU3F2;ADGRF1;SCIN;SDHA;RPS6KA6;LDB2;ADGRV1;PAX8;IGF2BP1;PCDH1;ENC1;ZIC2;MBD5;MELTF;PCDHB13;FGF13;RBFOX3;VAX2;APC2;BOC;RNF103;MST1R;ZBTB16;NCKAP1;DSCAML1;LGI1;SOX4;CRMP1;CYP46A1;SH3GL3;RAPGEF5;FZD5;PLXND1;CDH2;NPAS1;DMBX1;FGF17;FGF14;DAGLB;POU6F2;RBFOX2;NINJ1;ADAM22;CXCR4;SEMA6A;HOXB2;FEZ1;ACVR1B;PRKN;PCDHB10;NDUFV2;SPOCK2;GFRA2;ADNP2;MAMDC2;PCDHB11;GMFB;ARTN;PCDHB9;NRSN1;JARID2;CABLES1;SH3GL2;SCRG1
prerank,Metaphase Plate Congression (GO:0051310),0.38628818350183863,1.2140230725425,0.13513513513513514,0.9372006609787217,1.0,12/51,15.24%,CENPE;CHMP4C;PSRC1;CENPF;KIF2C;CDCA5;KIF14;CCNB1;CDCA8;PDCD6IP;KIF18A;SPDL1
prerank,Actomyosin Structure Organization (GO:0031032),-0.39721030783694417,-1.213800428031359,0.15384615384615385,0.7802856899904863,1.0,15/74,10.93%,MYOM2;ITGB5;FLNC;EPB41L4A;SIX4;EPB41L3;PGM5;TNNT1;EPB41L2;PDLIM1;MYH7B;EPB41L5;MYH11;SRC;FHOD3
prerank,"Retrograde Protein Transport, ER To Cytosol (GO:0030970)",-0.5245458757060643,-1.2137752435237998,0.21153846153846154,0.7783855766830937,1.0,3/17,13.29%,RHBDD1;HERPUD1;FAF2
prerank,Regulation Of Axon Extension Involved In Axon Guidance (GO:0048841),-0.47932834674897223,-1.213596903507279,0.19672131147540983,0.7769435456414137,1.0,3/22,0.85%,VEGFA;SEMA3C;SEMA3F
prerank,Positive Regulation Of Type I Interferon Production (GO:0032481),0.3628625061523214,1.2129149747838506,0.11904761904761904,0.9380004508026858,1.0,21/62,19.06%,IRF5;OAS2;GARIN5A;IRF7;TLR8;HSPD1;PQBP1;OAS1;TRAF3IP3;ISG15;TLR2;TLR4;POLR3G;POLR3B;XIAP;TRIM65;FLOT1;RIGI;RAB2B;MYD88;OAS3
prerank,Dendritic Cell Migration (GO:0036336),0.4486035348570014,1.21265560256288,0.24444444444444444,0.9346646386488603,1.0,5/18,10.55%,ASB2;CCR2;EPS8;CCR7;GPR183
prerank,Positive Regulation Of Stress-Activated Protein Kinase Signaling Cascade (GO:0070304),-0.5116810674536436,-1.2123952323787124,0.2857142857142857,0.7791127276983035,1.0,4/18,7.45%,IL26;TGFB2;LYN;SEMA4C
prerank,Regulation Of Tubulin Deacetylation (GO:0090043),-0.49363603210770457,-1.2123538168939607,0.30158730158730157,0.7772039100512699,1.0,6/17,18.17%,MAPT;TPPP;MBIP;EP300;PRKAA2;KAT14
prerank,Positive Regulation Of Cell Differentiation (GO:0045597),-0.32996830006585975,-1.2122255917017977,0.109375,0.7758544081948772,1.0,35/264,10.10%,KDR;FRZB;RBM24;COL1A1;PAX8;ZHX3;TGFB2;MSR1;DDR2;ADIRF;IL1B;IL18;EDN3;CD34;BOC;ZBTB16;ACVRL1;IGF1;SOX4;HOXA5;PPARG;ADRA2C;PLCB1;CRB2;ADRA2B;PPP3CA;LAMA2;BAMBI;KCTD11;ZC3H12A;RARRES2;SERPINF2;ID2;MEDAG;FGF8
prerank,Positive Regulation Of Actin Filament Polymerization (GO:0030838),0.4001010032857892,1.2115987706499034,0.13953488372093023,0.934610969438146,1.0,8/38,11.20%,VASP;HCK;NCK2;PYCARD;CARMIL1;CCR7;CTTN;CDC42EP1
prerank,Membrane Lipid Metabolic Process (GO:0006643),0.45723049274030914,1.211292716193681,0.20454545454545456,0.931951322076925,1.0,7/17,17.98%,GAL3ST1;CYP1B1;ALOX12B;ST6GALNAC4;SMPDL3B;AGMO;ARV1
prerank,Negative Regulation Of Reactive Oxygen Species Metabolic Process (GO:2000378),-0.4976769662198214,-1.211088478254878,0.27586206896551724,0.7779837328607067,1.0,9/20,26.62%,SLC18A2;BRCA1;PRKN;PLIN5;MT3;PPARA;COA8;MMP3;PAGE4
prerank,Positive Regulation Of Synaptic Transmission (GO:0050806),0.37799142051112306,1.2108353378210852,0.2,0.9294506064784778,1.0,16/73,16.87%,NOL3;TSHZ3;CHRNA7;CCR2;LGMN;GRIN2D;NALCN;SLC8A2;RGS14;RIMS2;PLK2;GPER1;FOXM1;DLG4;NLGN2;FLOT1
prerank,SMAD Protein Signal Transduction (GO:0060395),-0.4348544343921015,-1.2107548406925044,0.17543859649122806,0.7772900645859493,1.0,7/47,9.06%,MAGI2;MSTN;TGFB2;SMAD6;INHBE;SMAD5;GDF15
prerank,Regulation Of Secretion (GO:0051046),-0.5208319290034784,-1.210546468425091,0.21875,0.7759505686665124,1.0,3/15,8.33%,SCIN;PTPRN2;CES1
prerank,Regulation Of Megakaryocyte Differentiation (GO:0045652),-0.47925049586988533,-1.209984433934277,0.22,0.7761463820410489,1.0,10/18,25.69%,SCIN;RBM15;ZNF16;FAXDC2;PF4;HMGB2;MYB;MTURN;PRMT6;TESC
prerank,Regulation Of Bone Resorption (GO:0045124),-0.4578865251127725,-1.2097650126431467,0.18181818181818182,0.7751007607730556,1.0,6/26,13.59%,DEF8;CSF1R;GPR137;TNFAIP3;SRC;ITGB3
prerank,Golgi To Vacuole Transport (GO:0006896),-0.5120432065435999,-1.2090675706498593,0.22413793103448276,0.7754781681441342,1.0,7/17,28.14%,VPS54;AP1G1;RBSN;AP3D1;SORT1;VPS52;VTI1A
prerank,Regulation Of Response To Biotic Stimulus (GO:0002831),-0.4615406866390922,-1.208962205887772,0.23076923076923078,0.7737708942992323,1.0,7/30,13.21%,ZMPSTE24;GATA6;CASP8;RNF135;FCGR2B;NFE2L2;PTPN22
prerank,Positive Regulation Of Cholesterol Transport (GO:0032376),-0.46179181036535755,-1.2080897619142597,0.16666666666666666,0.775637400040003,1.0,7/29,8.33%,ABCB4;APOA1;PPARG;ABCA8;ABCA5;NFKBIA;CES1
prerank,Positive Regulation Of Intracellular Signal Transduction (GO:1902533),-0.3067104343885006,-1.2079182792553742,0.0759493670886076,0.7742452509613658,1.0,71/499,12.72%,KDR;FLT1;VEGFA;ROR2;AKR1C2;BCAR3;CLEC7A;IL26;WNT11;SPRY2;ADGRV1;NUPR1;THBS1;DCN;TGFB2;ART4;AVPI1;DDR2;HRAS;NUP62;IL1B;FLT4;IL18;LURAP1;CHI3L1;LYN;CDH13;HTR6;MST1R;PIK3AP1;TRAF6;KIAA0319;IGF1;GPR61;CASP8;RIPK2;PPARG;ADRA2C;REL;PELI2;AKR1C3;NEDD4;ADRA2B;PDGFD;LARS1;NCF1;PLCE1;CASS4;TCF7L2;IL11;GDF15;FRMD6;PRKN;RET;DLG5;SRC;TBK1;TLR3;ANGPT1;PELI1;GPR62;TERF2IP;MUL1;PIK3CA;BCL10;PLCG2;F2R;GPR89A;NOD1;DOK6;P2RY12
prerank,Calcium-Dependent Cell-Cell Adhesion Via Plasma Membrane Cell Adhesion Molecules (GO:0016339),-0.433301628625657,-1.2075649324231301,0.22580645161290322,0.7737788061479658,1.0,14/37,17.27%,CDH18;CDH4;CDH8;PCDHB13;CDH13;CDH2;CDH22;PCDHGC3;PCDHB10;PCDHB11;PCDHB9;CDH3;CDH11;PCDHB3
prerank,Axonogenesis (GO:0007409),0.3211691057031872,1.2068790652939037,0.02857142857142857,0.9424225964149918,1.0,38/175,11.90%,SLITRK2;SEMA6B;EPHB1;S100B;NRCAM;DRAXIN;NFASC;EPHB3;VASP;KALRN;PLEKHG4B;MAP1A;EFNA5;SEMA3G;SIAH1;SEMA5A;EPHA4;ENAH;CDK5;RAB10;EFNA4;ROBO4;NOTCH1;EPHA10;NIBAN2;POU4F1;L1CAM;SHTN1;IGSF9;SEMA7A;TUBB3;ARHGEF40;CYFIP1;PTK2;TRIM46;SEMA5B;SEMA4G;S100A6
prerank,Stress-Activated MAPK Cascade (GO:0051403),0.38177562228095596,1.2068637095159633,0.14285714285714285,0.9382125892161852,1.0,10/42,15.54%,MAPK8;TNFRSF19;MAP3K7;MAPK11;SH2D3C;LGALS9;MAP3K13;TRIB1;DAXX;IKBKB
prerank,Long-Chain fatty-acyl-CoA Metabolic Process (GO:0035336),0.4289480244902487,1.2068166906559958,0.16666666666666666,0.934173550130551,1.0,2/22,1.52%,ELOVL7;DGAT2
prerank,Natural Killer Cell Mediated Cytotoxicity (GO:0042267),-0.48680886064305634,-1.206459379720479,0.21052631578947367,0.7760387748208859,1.0,14/24,30.99%,KIR3DL1;ULBP1;LYST;SLAMF7;GZMB;CEBPG;ULBP2;VAMP7;KIF5B;ULBP3;CD2;MICA;FCGR3A;VAMP2
prerank,Regulation Of p38MAPK Cascade (GO:1900744),-0.4677774681627662,-1.2061799854465687,0.1724137931034483,0.7750114917160927,1.0,13/36,17.28%,VEGFA;IL1B;PER1;GADD45G;NCF1;ZC3H12A;DUSP1;GADD45A;PTPN22;RELL1;BMP2;PHLPP1;DLG1
prerank,Circulatory System Development (GO:0072359),-0.3710289602130972,-1.2054048567893452,0.1388888888888889,0.7761426171119756,1.0,25/124,15.25%,CXADR;PDLIM3;TGFB2;LDB3;FLT4;ACVRL1;SOX4;CASP8;ALPK3;CDKN1A;DNAAF4;CRB2;PDLIM1;HEY2;TH;PLCE1;ID2;HEY1;PIK3CA;MEF2A;APELA;HSPG2;CDKN1B;BORCS8-MEF2B;BMP2
prerank,Regulation Of Toll-Like Receptor Signaling Pathway (GO:0034121),0.4602512127597023,1.205324915286568,0.17391304347826086,0.9371536110206755,1.0,7/19,15.57%,TLR5;IRF7;CD36;IRAK3;TLR2;GPR108;SMPDL3B
prerank,Regulation Of Wnt Signaling Pathway (GO:0030111),-0.37636978902082735,-1.2052396020492224,0.12121212121212122,0.7749179568501529,1.0,15/99,9.98%,FRZB;AMER3;DKK4;HIC1;CXXC4;TLE1;LRRK2;FZD7;TERT;TNFAIP3;DEPDC1B;NOTUM;KREMEN1;PRKN;CTNND2
prerank,Regulation Of Catecholamine Secretion (GO:0050433),0.436175290156897,1.204313951471696,0.1794871794871795,0.9369591948910032,1.0,9/26,16.61%,SYT3;KCNB1;SYT5;FGF20;SNCA;SYT13;SYT9;SYT17;KCNA2
prerank,Regulation Of Telomerase Activity (GO:0051972),0.3829476758543733,1.204264694099239,0.16279069767441862,0.9329371399689772,1.0,4/44,2.92%,PARM1;MYC;AURKB;KLF4
prerank,Peptidyl-Tyrosine Dephosphorylation (GO:0035335),0.4517849317592303,1.2041030023609296,0.2692307692307692,0.9296011178452118,1.0,6/28,8.85%,PTPRF;PTPN2;PTPRB;PTPN13;PTPN6;DUSP7
prerank,Positive Regulation Of Interferon-Beta Production (GO:0032728),0.3853798947944262,1.2037788982784567,0.14583333333333334,0.927157527437772,1.0,15/36,21.12%,IRF5;OAS2;IRF7;TLR8;OAS1;ISG15;TLR2;TLR4;POLR3G;POLR3B;TRIM65;FLOT1;RIGI;OAS3;STING1
prerank,Positive Regulation Of Translation (GO:0045727),-0.3463208804969783,-1.203513867000978,0.15873015873015872,0.7787411642139785,1.0,35/104,26.33%,RPS27L;THBS1;IGF2BP1;PRR16;SOX4;GUF1;BCL3;CSDE1;UHMK1;PCIF1;ZCCHC4;LIN28A;FASTKD2;USP16;YTHDF3;PASK;DHX36;ZCCHC13;MPV17L2;FXR1;PAIP1;RPUSD4;TRMT10C;PIWIL2;RBM3;EIF3C;CCL5;METTL8;SAMD4A;UPF3A;YTHDF2;PKM;LARP1B;EIF5A;METTL14
prerank,Chromosome Condensation (GO:0030261),0.41869817419399974,1.2033599679101334,0.21428571428571427,0.9252509518424338,1.0,15/31,21.13%,PLK1;CDCA5;ERN2;TOP2A;NCAPG;H1-5;H1-3;GPER1;NUSAP1;TTN;H1-0;H1-2;NCAPD2;DFFB;AIFM1
prerank,Golgi To Plasma Membrane Protein Transport (GO:0043001),0.431330010446885,1.202861947532199,0.2894736842105263,0.9234040658587189,1.0,4/28,6.87%,RAB31;KIF13A;GOLPH3L;RAB10
prerank,NLS-bearing Protein Import Into Nucleus (GO:0006607),-0.4951042708149916,-1.2027697603015022,0.24561403508771928,0.7795782493028292,1.0,7/17,23.18%,RGPD5;KPNA7;RGPD8;KPNA5;NUP54;KPNA1;NUP35
prerank,Glial Cell Differentiation (GO:0010001),0.410637698737754,1.2023839238290004,0.13636363636363635,0.921147992519787,1.0,4/33,6.29%,ADGRG6;HAPLN4;HAPLN2;CDK5
prerank,Phosphatidylinositol 3-Kinase Signaling (GO:0014065),-0.4449337700003122,-1.2022766817012287,0.21428571428571427,0.7794328834136987,1.0,7/32,11.46%,MYO16;LTK;IGF1;PIK3R1;NYAP2;EDN1;PIK3CA
prerank,Regulation Of Mitotic Cell Cycle Spindle Assembly Checkpoint (GO:0090266),0.48596468284241745,1.2021196811699728,0.29545454545454547,0.9180644826970875,1.0,4/17,12.66%,AURKB;BIRC5;CCNB1;CDCA8
prerank,Cardiac Muscle Tissue Morphogenesis (GO:0055008),0.43547105840037614,1.2016066449964504,0.2,0.9158094388248874,1.0,6/29,15.81%,TNNT2;NOTCH1;FKBP1A;MYLK2;TCAP;TTN
prerank,Calcium Ion Transport (GO:0006816),0.3420498984941062,1.201039749575528,0.10526315789473684,0.914665977418999,1.0,21/104,14.46%,TRPM8;CACNA2D4;TRPM3;RYR1;CHRNA7;ATP2C1;CASR;TRPM6;CRACR2B;SLC24A4;NALCN;RYR3;SLC8A2;ORAI1;FKBP1A;KCNN4;P2RX7;MCOLN3;CALCRL;TRPV6;TRPV2
prerank,Positive Regulation Of Protein Polymerization (GO:0032273),0.3615807567863243,1.200815050223629,0.14285714285714285,0.9112327390324837,1.0,13/67,12.71%,TPPP3;TTBK1;VASP;HCK;PSRC1;NCK2;PYCARD;CARMIL1;CCR7;MET;CTTN;CDC42EP1;PAK1
prerank,Positive Regulation Of Cytokine Production Involved In Immune Response (GO:0002720),0.4017539153881424,1.2007101432925207,0.16216216216216217,0.9076210652331969,1.0,7/33,6.10%,FFAR2;HLA-A;SCIMP;MAP3K7;IRF5;F2RL1;HLA-G
prerank,Regulation Of Neuron Death (GO:1901214),0.36061249297402026,1.2002771305900861,0.10714285714285714,0.9057815372418153,1.0,11/58,7.96%,FAIM2;EGR1;IKBKG;EGLN3;TRIM2;CHRNA7;EGLN2;SNCA;KIF14;CDK5;CD200
prerank,Positive Regulation Of ATP-dependent Activity (GO:0032781),0.40640699509418393,1.200116614264285,0.21621621621621623,0.902348084831641,1.0,5/37,6.41%,TNNT2;ATP1B2;MYL4;PLSCR1;UHRF1
prerank,Bicarbonate Transport (GO:0015701),-0.49621530197681224,-1.2000511786025556,0.20408163265306123,0.7853693757891148,1.0,7/19,13.45%,SLC4A3;CFTR;SLC4A4;SLC4A7;SLC39A8;RHAG;SLC4A8
prerank,Positive Regulation Of Protein Processing (GO:0010954),-0.5021581229605536,-1.19977075555748,0.2,0.7845366160037268,1.0,5/19,8.34%,RHBDD1;MELTF;TNP2;ASTL;HPN
prerank,Neuron Projection Organization (GO:0106027),0.4768468032359457,1.1997384855270674,0.21052631578947367,0.8999303383146803,1.0,3/16,6.58%,CHRNA7;MAP1A;LGMN
prerank,Positive Regulation Of Monocyte Chemotaxis (GO:0090026),0.45490948313539403,1.1991378482549984,0.1794871794871795,0.8987608719499476,1.0,5/17,13.39%,CCR2;LGMN;CXCL17;MOSPD2;S100A14
prerank,Potassium Ion Transport (GO:0006813),0.34545767251640713,1.1982049321625718,0.075,0.899068318059863,1.0,32/108,17.36%,KCNJ15;KCNH1;KCNG4;KCNA10;KCNB1;KCNK1;KCNJ16;KCNH4;SLC24A4;HCN2;KCNJ5;KCNG1;KCNH5;NALCN;KCNN3;KCNMB4;KCNH8;KCNH3;KCNH6;KCNK15;KCNQ5;KCNN4;SLC17A7;KCNV2;KCNK12;KCNS1;KCNH2;KCNC2;SLC12A7;KCNA2;KCNQ2;SLC9A5
prerank,Platelet Aggregation (GO:0070527),0.39547729805111165,1.1974332780118688,0.20930232558139536,0.8983992951131898,1.0,12/35,22.31%,GNAS;CLIC1;GP1BA;ACTG1;ILK;FERMT3;MYH9;FIBP;MYL12A;MYL9;PPIA;VCL
prerank,Negative Regulation Of Neuron Differentiation (GO:0045665),0.4882042068992403,1.1970518798705727,0.1568627450980392,0.8962812202110788,1.0,3/22,6.46%,DLX2;DTX1;DISP3
prerank,Cardiac Atrium Morphogenesis (GO:0003209),-0.5234274687577826,-1.19691694367872,0.22641509433962265,0.7922749077274075,1.0,7/15,18.05%,TGFB2;HEY2;BMP2;NOG;SHOX2;BMPR2;MYH6
prerank,Negative Regulation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0043154),-0.4158158842946976,-1.19679640140449,0.2,0.7907587037320739,1.0,3/47,1.24%,MAGEA3;VEGFA;THBS1
prerank,Positive Regulation Of Protein Autophosphorylation (GO:0031954),-0.5095348637606163,-1.1958735031802838,0.25,0.7923230356978247,1.0,10/22,28.46%,VEGFA;PDGFD;RAP2A;RAP2C;TNKS1BP1;PDGFB;GPNMB;MRE11;PDGFC;TAOK2
prerank,Negative Chemotaxis (GO:0050919),-0.4484695745792673,-1.195799136938396,0.23333333333333334,0.7905914847069069,1.0,11/29,15.52%,SEMA3C;SEMA3F;UNC5C;SEMA4C;SEMA6A;LRTM2;SLIT2;ITGB3;SLIT1;SEMA3A;NTN1
prerank,Response To Epidermal Growth Factor (GO:0070849),-0.4294759281022306,-1.1956648441291429,0.21875,0.7891395561113667,1.0,10/29,30.85%,VIL1;GAREM1;ZPR1;ZFP36L2;PTPN12;ZFP36L1;PDE8A;FOXC1;SYAP1;MED1
prerank,Positive Regulation Of Muscle Hypertrophy (GO:0014742),-0.5081185452209267,-1.1955694153842593,0.22413793103448276,0.7875961496301239,1.0,4/15,12.78%,NR4A3;IGF1;EDN1;MEF2A
prerank,Negative Regulation Of Phosphate Metabolic Process (GO:0045936),0.49543491429903624,1.1951063111946778,0.21052631578947367,0.901061660386039,1.0,4/20,6.66%,BMP4;CDKN2B;CDKN2A;DYNLL1
prerank,Positive Regulation Of Signaling Receptor Activity (GO:2000273),0.4107378292862343,1.1949152053278307,0.24444444444444444,0.8981086544198181,1.0,6/32,10.83%,HBEGF;NOL3;CCR2;HFE;HDAC2;TGFA
prerank,Lysosome Localization (GO:0032418),-0.42651135678541807,-1.194859691944492,0.22807017543859648,0.7884903129459677,1.0,4/40,3.82%,DEF8;NR4A3;SYTL4;MRGPRX2
prerank,"Positive Regulation Of Synaptic Transmission, Glutamatergic (GO:0051968)",0.5008698504687625,1.194813210707435,0.2619047619047619,0.8947012993865293,1.0,3/19,6.67%,TSHZ3;CCR2;GRIN2D
prerank,Dendritic Cell Differentiation (GO:0097028),0.4571459906007057,1.1947345615531113,0.24390243902439024,0.8913618440288243,1.0,7/19,9.58%,BATF;IL4;F2RL1;LILRB1;LGALS9;CCR7;DHRS2
prerank,Regulation Of Interferon-Beta Production (GO:0032648),0.3687163665846328,1.194398541058162,0.15384615384615385,0.8890788545466598,1.0,17/50,19.06%,IRF5;SIRPA;OAS2;IRF7;PYCARD;LILRB1;TLR8;OAS1;ISG15;TLR2;TLR4;POLR3G;POLR3B;TRIM65;FLOT1;RIGI;OAS3
prerank,Regulation Of Immune Response (GO:0050776),0.341807838799518,1.1941245970131447,0.09090909090909091,0.886420438280552,1.0,23/74,16.13%,CXCL13;HLA-DRB1;PDCD1;RSAD2;FOXP3;IL4;PLSCR1;HLA-G;IRF7;GPR151;PLA2G1B;CSK;FKBP1A;IRF4;CD22;IFNL1;GPR108;CFP;C8G;SAMHD1;XIAP;RIPK3;C7
prerank,"Positive Regulation Of mRNA Splicing, Via Spliceosome (GO:0048026)",-0.4983814808838544,-1.1925926897324066,0.25,0.794792299629757,1.0,2/21,3.15%,CELF4;STH
prerank,Wnt Signaling Pathway (GO:0016055),-0.38690269509085384,-1.1909087562890301,0.203125,0.7987678447728912,1.0,17/71,12.33%,FRZB;WNT11;LRRK2;NR4A2;TCF7;FZD7;FZD10;FZD5;WNT7A;WNT1;WNT5B;TCF7L2;FRAT1;WNT10B;PLCG2;FZD8;SIAH2
prerank,Adenine Nucleotide Transport (GO:0051503),0.46514393992211306,1.1907341684979214,0.2608695652173913,0.897129780042666,1.0,9/20,26.34%,LRRC8D;SLC25A4;SLC25A41;SLC35B3;SLC19A1;SLC25A5;SLC35B2;ABCC6;SLC25A17
prerank,Regulation Of Fatty Acid Oxidation (GO:0046320),-0.486979754706637,-1.190681713254075,0.32608695652173914,0.7975818467929967,1.0,7/16,22.12%,NR4A3;MLYCD;SIRT4;PPARA;PRKAG2;APLP2;ACADVL
prerank,Neuron Apoptotic Process (GO:0051402),0.502636842975166,1.1898102986190204,0.25,0.8971186104591299,1.0,4/18,6.57%,SIAH1;BID;CDK5;CIT
prerank,Positive Regulation Of Phagocytosis (GO:0050766),-0.4082411308774284,-1.1896138685272317,0.1774193548387097,0.7999758163992831,1.0,12/56,11.92%,AZU1;CLEC7A;TUB;SLC11A1;IL1B;FCN2;APOA1;IFNG;IL15;FCGR2B;CCL2;PLCG2
prerank,Regulation Of Cellular Component Organization (GO:0051128),0.31348365522749283,1.1894444776524442,0.11764705882352941,0.8949271562577251,1.0,18/146,8.85%,CISH;SLITRK2;RAPGEF1;CAMSAP3;SOCS2;CEACAM1;PAK6;ATAD3A;HJURP;PACSIN1;MKI67;EGLN2;KIF14;CAMK2D;CD36;LAMTOR2;IRAK3;CAMSAP2
prerank,"DNA Damage Response, Signal Transduction By P53 Class Mediator (GO:0030330)",-0.4526134499114531,-1.1890246740419959,0.21818181818181817,0.8004663676074524,1.0,2/35,0.91%,RPS27L;RPS6KA6
prerank,Regulation Of Cell Cycle Process (GO:0010564),0.3266452981840525,1.188916306995686,0.11428571428571428,0.8935289405115457,1.0,19/128,13.09%,AICDA;MYC;KIF20A;CDKN2B;AURKB;OBSL1;PKMYT1;APC;KIF2C;PLK1;KIF13A;MKI67;ACTL6A;RACGAP1;BCL2L1;SFRP1;DPF3;FSD1;GPER1
prerank,Negative Regulation Of Receptor-Mediated Endocytosis (GO:0048261),0.4499178248613838,1.1877111249009582,0.1956521739130435,0.8947296653153427,1.0,7/25,15.74%,APOC1;ADIPOQ;ANXA2;ANKRD13B;NEU3;DLG4;ANKRD13D
prerank,miRNA Metabolic Process (GO:0010586),-0.49168365592068486,-1.1873520678498173,0.2682926829268293,0.8046089536485469,1.0,6/15,15.77%,ZC3H12A;TENT4B;DDX17;DICER1;LIN28A;LIN28B
prerank,Regulation Of Cardiac Muscle Cell Action Potential (GO:0098901),-0.4618346019747286,-1.1868201847772217,0.23636363636363636,0.8045792989644781,1.0,3/26,4.15%,CXADR;FGF13;DSG2
prerank,Response To Interferon-Alpha (GO:0035455),0.48141329110435704,1.186561978150571,0.22727272727272727,0.8954976358180248,1.0,10/17,29.96%,IFITM1;AXL;BST2;GATA3;IFITM2;LAMP3;RO60;IFNAR1;IFNAR2;IFITM3
prerank,Regulation Of Lymphocyte Activation (GO:0051249),-0.4898646521612061,-1.186286142201452,0.23076923076923078,0.8048147467306644,1.0,3/18,3.64%,CLEC7A;KLRD1;KLRC3
prerank,Positive Regulation Of Mononuclear Cell Migration (GO:0071677),0.39658796360020326,1.185976009125373,0.1794871794871795,0.8942671181331078,1.0,9/30,13.39%,CCR2;IL4;LGMN;CXCL17;LGALS9;CCR7;MOSPD2;C1QBP;S100A14
prerank,Protein Localization To Endoplasmic Reticulum (GO:0070972),-0.5001900209628973,-1.1859692678441915,0.23333333333333334,0.8038955910937895,1.0,6/16,26.34%,LRRK2;BCAP29;SEC16B;RYR2;VAPA;PPP1R15A
prerank,Peptide Antigen Assembly With MHC Protein Complex (GO:0002501),0.48318056921237057,1.1854755799595806,0.28,0.893160854692809,1.0,5/16,15.20%,HLA-DRB1;HLA-DMB;HLA-DQA1;HLA-DQA2;HLA-DPA1
prerank,Regulation Of Ossification (GO:0030278),0.3729405426511753,1.1847396239538344,0.15217391304347827,0.8923674316409601,1.0,7/36,10.98%,TWIST1;BMP4;SGMS2;ENPP1;ANKH;NOTCH1;SFRP1
prerank,Cellular Response To Acid Chemical (GO:0071229),-0.43898586340219997,-1.1845008894903826,0.21666666666666667,0.8075839780097936,1.0,3/27,7.97%,VEGFA;NSMF;LARS1
prerank,Regulation Of Peptidyl-Serine Phosphorylation (GO:0033135),-0.37537146727603715,-1.1829989335167905,0.13559322033898305,0.8109920946683031,1.0,9/87,7.14%,VEGFA;BCAR3;STOX1;SPRY2;IRGM;RIPK2;DOCK7;INPP5J;MLXIPL
prerank,DNA Replication Checkpoint Signaling (GO:0000076),0.429711858978141,1.1812709145931473,0.23404255319148937,0.9032039666736479,1.0,7/17,26.20%,TICRR;CDT1;CDC45;CDC6;CLSPN;TIMELESS;DNA2
prerank,Positive Regulation Of Secretion By Cell (GO:1903532),-0.3775363005411545,-1.1803390264453428,0.203125,0.8182026435849928,1.0,13/70,10.65%,CFTR;TGFB2;SYTL4;IL1B;EDN3;STX1A;IGF1;CD33;ADAM9;ANG;RAB9A;NMB;EDN1
prerank,Positive Regulation Of Transmembrane Transport (GO:0034764),-0.47873970245560005,-1.179776133711028,0.3018867924528302,0.818641918781933,1.0,2/15,1.46%,CA2;NR4A3
prerank,Peptidyl-Threonine Modification (GO:0018210),0.3434507348757625,1.1797050212182802,0.18421052631578946,0.9069407480002536,1.0,14/66,14.82%,CDC42BPA;TTBK1;DYRK4;MAPK8;CAMK2D;CDK5;CDK1;CSNK2B;GSK3A;MYLK2;HIPK1;DYRK1B;CDK10;MARK2
prerank,Cellular Response To Glucose Starvation (GO:0042149),-0.42264376600783066,-1.1796610986636524,0.30612244897959184,0.8171313518878852,1.0,19/40,35.50%,NUAK1;ZC3H12A;PMAIP1;SIRT1;PRKAA2;SESN1;ATG14;TBL2;PIK3R4;SZT2;ATF4;KAT5;MYBBP1A;RRP8;EIF2AK3;ITFG2;KICS2;XBP1;PICK1
prerank,Regulation Of Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0032434),0.32482860897368765,1.1792037968709652,0.08333333333333333,0.9053138996981327,1.0,25/104,16.30%,FHIT;MAP1A;HSPA1A;PLK1;HFE;FBXO22;CBFA2T3;NKD2;PRICKLE1;TRIB3;DESI1;HECTD1;RNF180;PHF20L1;GSK3A;RNF19A;CCAR2;TRIB2;TRIB1;DAB2;RBX1;KEAP1;VCP;PARK7;SH3RF2
prerank,Regulation Of Adenylate Cyclase Activity (GO:0045761),-0.5201329515331226,-1.1791495053274477,0.27450980392156865,0.8168600986071571,1.0,1/16,0.23%,CRHR1
prerank,Barbed-End Actin Filament Capping (GO:0051016),-0.47183213739348184,-1.1783834254682821,0.2413793103448276,0.8161561922663628,1.0,4/18,12.29%,SCIN;VIL1;CAPZA3;TWF1
prerank,Actin Filament Capping (GO:0051693),-0.47183213739348184,-1.1783834254682821,0.2413793103448276,0.8161561922663628,1.0,4/18,12.29%,SCIN;VIL1;CAPZA3;TWF1
prerank,Positive Regulation Of Amide Metabolic Process (GO:0034250),-0.35271468820544427,-1.177415352356963,0.18840579710144928,0.8176307256392686,1.0,17/85,16.88%,RPS27L;THBS1;PRR16;SOX4;IFNGR1;GUF1;IFNG;GSAP;ABCG1;BCL3;PRKCD;PCIF1;ZCCHC4;PICALM;YTHDF3;EFNA1;PASK
prerank,Myofibril Assembly (GO:0030239),-0.44422292161757093,-1.1759752293675576,0.25806451612903225,0.8213998262768255,1.0,5/44,2.54%,MYOM2;FLNC;SIX4;PGM5;TNNT1
prerank,Regulation Of Cholesterol Efflux (GO:0010874),-0.4455193389095959,-1.1753863837621432,0.21052631578947367,0.821871672538998,1.0,7/30,8.33%,APOA1;PPARG;ABCA8;ABCA5;NFKBIA;ABCA2;CES1
prerank,Positive Regulation Of Nervous System Process (GO:0031646),-0.49685926906228134,-1.1749937302116424,0.23333333333333334,0.8215699687939052,1.0,9/18,22.50%,PARD3;CST7;RIMS1;DICER1;TENM4;TPPP;UNC13B;RNF10;MYRF
prerank,Myelination (GO:0042552),0.3760246600872759,1.1749007048410929,0.1956521739130435,0.9194536486971142,1.0,5/45,1.74%,GAL3ST1;BCAS1;ADGRG6;CMTM8;NFASC
prerank,Positive Regulation Of Pattern Recognition Receptor Signaling Pathway (GO:0062208),0.38767082753634075,1.1748201734291468,0.1875,0.9161880767695952,1.0,11/37,16.96%,RSAD2;TLR5;TASL;F2RL1;TLR1;MFHAS1;CYBA;TLR2;IFI35;FLOT1;DDX60
prerank,Protein K63-linked Ubiquitination (GO:0070534),-0.4000107562881756,-1.1745149390740028,0.2463768115942029,0.8215961540611528,1.0,17/52,17.58%,RNF186;TRAF6;ARRDC4;NEDD4;RNF168;MAGEL2;ITCH;RNF135;PRKN;PELI1;RNF115;RNF4;TRIM21;UBE2E3;UBE2E2;TRAF4;PELI3
prerank,Amino Acid Transport (GO:0006865),-0.4249732386068779,-1.173952370979364,0.2542372881355932,0.8216454909863625,1.0,6/44,4.39%,SLC6A12;SLC3A1;SLC7A3;SLC43A2;SLC7A8;SLC7A9
prerank,Intrinsic Apoptotic Signaling Pathway In Response To DNA Damage (GO:0008630),-0.40084560172143974,-1.1739344448535092,0.22807017543859648,0.8198836312175779,1.0,10/49,17.50%,RPS27L;HIC1;SFN;BRCA1;TOPORS;BCL3;EP300;MOAP1;SIRT1;SNW1
prerank,Regulation Of Adaptive Immune Response (GO:0002819),-0.4659972533838496,-1.1735765795335245,0.24528301886792453,0.8194038005118371,1.0,7/18,17.60%,ALOX15;IL4I1;FCGR2B;SAMSN1;AKIRIN2;SIRT1;FADD
prerank,Positive Regulation Of Macrophage Derived Foam Cell Differentiation (GO:0010744),-0.505154030512343,-1.1734455085799553,0.28,0.8182558416356558,1.0,2/15,2.77%,MSR1;IL18
prerank,Artery Morphogenesis (GO:0048844),-0.44598613870328296,-1.1734274821531965,0.23636363636363636,0.8165364944946981,1.0,2/28,1.48%,VEGFA;TGFB2
prerank,Positive Regulation Of Defense Response (GO:0031349),0.3208114962211206,1.1732466766290799,0.15217391304347827,0.9197798841702279,1.0,33/114,18.68%,S100A8;GPRC5B;MYO1C;IL21;SH2D1B;CCR2;LGALS2;TASL;SNCA;CD1D;PLSCR1;PYCARD;ZP3;TLR8;IL16;CX3CL1;S100A9;NLRP3;GRN;NAPEPLD;CYBA;TSLP;TLR2;TLR4;POLR3G;POLR3B;DDT;IFI35;S100A12;IL17RA;ETS1;HYAL2;TRADD
prerank,Potassium Ion Transmembrane Transport (GO:0071805),0.33086488221016797,1.1726964108238183,0.15,0.918461579559878,1.0,35/120,17.36%,ATP1B2;KCNJ15;KCNH1;KCNG4;KCNA10;KCNB1;KCNK1;KCNJ16;KCNH4;SLC24A4;HCN2;KCNJ5;KCNE5;KCNG1;SLC12A3;KCNH5;NALCN;KCNN3;KCNH8;KCNH3;KCNH6;KCNK15;FXYD2;KCNQ5;KCNN4;SLC12A5;KCNV2;KCNK12;KCNS1;KCNH2;KCNC2;SLC12A7;KCNA2;KCNQ2;SLC9A5
prerank,"Chemical Synaptic Transmission, Postsynaptic (GO:0099565)",0.4529313108123719,1.172561424491831,0.24561403508771928,0.915421577908386,1.0,10/23,21.73%,CHRNA3;INSYN1;GRIN2D;GSK3A;FOXM1;GLRA1;RAB3GAP1;NPAS4;MEF2C;NPFF
prerank,Epithelial Cell Development (GO:0002064),0.46481574021443917,1.1724132924876298,0.30434782608695654,0.9125149008277985,1.0,3/16,7.05%,WNT7B;SIPA1L3;TMEM79
prerank,Negative Regulation Of Blood Vessel Morphogenesis (GO:2000181),-0.37971080102127547,-1.172192348288247,0.19642857142857142,0.819403800511837,1.0,10/68,9.37%,SPRY2;THBS1;DCN;PRL;TGFB2;HOXA5;PPARG;SPRED1;SEMA6A;NPR1
prerank,Positive Regulation Of Cytosolic Calcium Ion Concentration Involved In Phospholipase C-activating G Protein-Coupled Signaling Pathway (GO:0051482),-0.45790083030449114,-1.1714870665344295,0.24193548387096775,0.8200772495409486,1.0,7/22,13.65%,OPRL1;GPR65;F2RL2;GPR35;F2R;P2RY8;GPR157
prerank,Regulation Of Signal Transduction By P53 Class Mediator (GO:1901796),-0.37621262544644596,-1.1714667569217598,0.19642857142857142,0.8183424262979061,1.0,7/47,14.73%,NUAK1;AURKA;SOX4;MLF1;PIP4P1;EP300;RPL17
prerank,mRNA Stabilization (GO:0048255),-0.4245609495432553,-1.170478034872634,0.3,0.8199980682611622,1.0,8/48,12.20%,RBM24;SLC11A1;IGF2BP1;RBM38;MEIOC;CSDE1;MAPKAPK2;IREB2
prerank,Negative Regulation Of Multicellular Organismal Process (GO:0051241),-0.3292433235913944,-1.1678352284154143,0.1125,0.827233782370164,1.0,57/216,20.82%,WNT11;SPRY2;RPS6KA6;SLC11A1;MARK1;SMAD6;TNNT1;IL1B;CIDEA;TRPV3;ACTN3;APOA1;REG3A;RGS2;IFNGR1;IFNG;FOXE3;CYP51A1;KLF7;DOCK7;SPRED1;IL18R1;PROCR;ALDH1A1;HPN;GDF15;IL15;WNT10B;FCGR2B;SFMBT1;F2R;NOVA2;NR1D1;PTGER4;PAEP;BMAL1;LGR4;ADM;IP6K1;ALPK2;BMP2;ADAM17;SRGN;EFNA1;NFIB;PLCL1;BMPR2;ACVR1C;MCC;ARID4A;ASB1;ARID4B;ING2;NPTN;N4BP1;SPRED3;SAP30L
prerank,Retrograde Axonal Transport (GO:0008090),0.479280659470081,1.1675356305126792,0.2641509433962264,0.9306195466061928,1.0,3/15,5.07%,TMEM108;MAP1A;DST
prerank,Regulation Of Cell Division (GO:0051302),0.32985757284305506,1.1674599514839656,0.17073170731707318,0.9273130410074872,1.0,9/79,5.21%,MYC;KIF20A;AURKB;TP63;INSC;PLK1;KIF13A;OOEP;CDK2AP2
prerank,Phosphatidylglycerol Metabolic Process (GO:0046471),-0.47193965090253287,-1.1670257377245867,0.2857142857142857,0.8282025231448,1.0,11/18,31.84%,PLA2G4F;MBOAT2;PLA2G4B;GPAM;PLA2G15;PNPLA8;SERAC1;SLC27A1;PLA2G4A;LPCAT1;CRLS1
prerank,Skeletal System Development (GO:0001501),-0.35998398700800804,-1.1665345573011419,0.1746031746031746,0.8283041937009152,1.0,16/131,7.53%,FRZB;WNT11;PRELP;COL1A1;TGFB2;LAMA5;CHI3L1;COL1A2;RFLNA;ZBTB16;IGF1;COL11A2;COL27A1;WNT1;NOTUM;COL9A2
prerank,Extrinsic Apoptotic Signaling Pathway In Absence Of Ligand (GO:0097192),0.45336708950645255,1.1662954702446502,0.2608695652173913,0.9282049102202251,1.0,12/16,36.83%,IL4;BCL2L1;GSK3A;CASP2;FAS;BCL2A1;MCL1;BOK;BCL2L2;BCL2;BAX;GSK3B
prerank,Inner Ear Morphogenesis (GO:0042472),-0.45241115870283066,-1.1661275507019417,0.23076923076923078,0.8275898337243307,1.0,6/22,16.73%,PAX8;SOBP;HPN;MYO3B;HOXA1;TMIE
prerank,Excitatory Postsynaptic Potential (GO:0060079),0.46497173847815465,1.1656709238761989,0.3103448275862069,0.9271015938435595,1.0,8/17,21.73%,CHRNA3;GRIN2D;GSK3A;FOXM1;RAB3GAP1;NPAS4;MEF2C;NPFF
prerank,Positive Regulation Of p38MAPK Cascade (GO:1900745),-0.4870954545656423,-1.1655553166648858,0.27586206896551724,0.827941062050114,1.0,8/24,15.25%,VEGFA;IL1B;GADD45G;NCF1;ZC3H12A;GADD45A;RELL1;BMP2
prerank,Negative Regulation Of Signal Transduction By P53 Class Mediator (GO:1901797),0.4631312114700898,1.1651799538000684,0.20930232558139536,0.9252501478520457,1.0,1/18,0.17%,TWIST1
prerank,ERAD Pathway (GO:0036503),-0.357906298659887,-1.1649654076872489,0.16923076923076924,0.828516306991874,1.0,13/89,14.30%,FBXO27;RHBDD1;RNF103;CCDC47;YOD1;HERPUD1;PRKN;FAM8A1;MAN1A1;FAF2;RHBDD2;DNAJB9;BRSK2
prerank,Inositol Lipid-Mediated Signaling (GO:0048017),-0.41380102100963057,-1.1647914955725507,0.22916666666666666,0.8272885262045752,1.0,9/31,11.92%,IGF1;CSF1R;PLCB1;PLCH2;PTAFR;PLCE1;PLCB4;PLCD1;PLCG2
prerank,Regulation Of Intracellular Signal Transduction (GO:1902531),-0.31145694699351906,-1.1642424606481467,0.1095890410958904,0.8272114247461271,1.0,29/286,8.58%,KDR;VEGFA;PLEKHG6;FBXO9;NUAK1;CLEC7A;ARHGAP29;IL1B;FLT4;ARHGEF28;CHN2;LYN;ARHGAP8;CHN1;TRAF6;AURKA;LRRK2;MLF1;CSF1R;ARHGEF10;MCF2;MAPT;NFKBIA;SPRED1;VRK2;FBXL2;PPP1R16B;ARHGAP21;PDE2A
prerank,Platelet Dense Granule Organization (GO:0060155),-0.41622811227067447,-1.1641868466251188,0.3,0.8256557123542851,1.0,9/22,27.59%,AP1S3;AP1G1;F2R;AP3D1;AP3B1;BLOC1S2;HPS6;HPS4;F2RL3
prerank,Positive Regulation Of Interleukin-10 Production (GO:0032733),0.37612230661385865,1.163074745794124,0.21951219512195122,0.9316300395778031,1.0,12/29,13.16%,TIGIT;IL4;F2RL1;PYCARD;LGALS9;HSPD1;IL13;NOD2;ISG15;IRF4;TSLP;TLR4
prerank,Membrane Lipid Biosynthetic Process (GO:0046467),0.3611016563479512,1.1624685121489544,0.225,0.9307408008528858,1.0,10/56,13.03%,B3GNT5;ELOVL7;ALDH3B1;GBGT1;SGMS2;SPTLC3;KDSR;ORMDL2;PLPP1;SPTLC2
prerank,Positive Regulation Of Transcription From RNA Polymerase II Promoter In Response To Stress (GO:0036003),-0.49118271188384344,-1.161342295264724,0.2653061224489796,0.8337884588253521,1.0,2/17,3.99%,VEGFA;CREB3L3
prerank,Mitotic Sister Chromatid Segregation (GO:0000070),0.33166451932939867,1.160411352581872,0.15625,0.9357352116187746,1.0,26/111,17.34%,SGO1;CENPE;CHMP4C;DLGAP5;TPX2;PSRC1;ESPL1;KIF2C;PLK1;CDCA5;KIF14;STAG2;CHEK2;ZWINT;NCAPG;CCNB1;TEX14;CDCA8;PDCD6IP;KIF18A;NUSAP1;SPDL1;KIF2A;TTN;BOD1;NCAPD2
prerank,Synaptic Vesicle Cycle (GO:0099504),-0.4277774816498101,-1.1603998625416894,0.24074074074074073,0.8352372233173598,1.0,7/32,8.58%,SNAP25;SLC18A2;STX1A;CDH2;WNT7A;CPLX1;RIMS1
prerank,Axon Development (GO:0061564),0.3340506133415756,1.1603363338710304,0.15151515151515152,0.9325662111751526,1.0,18/87,12.50%,SLITRK2;RTN4RL1;S100B;NRCAM;EPHB3;MAP1A;SEMA5A;CDK5;RAB10;RTN4RL2;CAMSAP2;POU4F1;L1CAM;SHTN1;TRIM46;S100A6;DHFR;NREP
prerank,Regulation Of Interleukin-12 Production (GO:0032655),0.35503204935813615,1.1602966153978351,0.21052631578947367,0.9293144422264324,1.0,18/48,13.63%,SCIMP;IRF5;MAPK11;TIGIT;HLA-G;LILRB1;TLR8;CD40;LGALS9;CCR7;IRAK3;HSPD1;IL16;CMKLR1;TLR2;TLR4;C1QBP;JAK3
prerank,Lipopolysaccharide-Mediated Signaling Pathway (GO:0031663),-0.4952068167119798,-1.1602930454750937,0.2727272727272727,0.8336519783178356,1.0,8/18,19.41%,IL1B;IL18;LYN;CCL2;PLCG2;PTPN22;PRKCE;EHHADH
prerank,Fc Receptor Mediated Stimulatory Signaling Pathway (GO:0002431),-0.4339332739142864,-1.1582422823156666,0.25,0.8389379214960516,1.0,7/21,12.43%,NR4A3;LYN;YES1;SRC;FCGR2B;VAV3;PRKCD
prerank,G1/S Transition Of Mitotic Cell Cycle (GO:0000082),0.3449004498725785,1.1578944886837064,0.2391304347826087,0.9361966872585656,1.0,9/63,6.29%,CDK14;BCAT1;MYC;CDKN3;E2F2;PIM2;USP26;CDK4;CDK5
prerank,Non-Canonical Wnt Signaling Pathway (GO:0035567),-0.41761128946133763,-1.1576049312111982,0.22950819672131148,0.8389032110365695,1.0,6/39,6.78%,FRZB;WNT11;FZD7;FZD10;FZD5;WNT7A
prerank,Regulation Of Lipid Metabolic Process (GO:0019216),-0.39734561616617503,-1.1576004818504213,0.24561403508771928,0.8371212372566066,1.0,12/50,13.10%,ADGRF1;CCDC3;IL1B;RORA;PPARG;NR1D2;RARRES2;IRS2;ID2;PLCG2;RORC;NR1D1
prerank,JNK Cascade (GO:0007254),0.377750428076474,1.1566491839343422,0.225,0.9374831209944962,1.0,7/29,15.48%,MAPK8;TNFRSF19;MAP3K7;SH2D3C;MAP3K13;TRIB1;DAXX
prerank,Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001236),0.3673027363025813,1.1562740088936379,0.11428571428571428,0.9353680166371059,1.0,18/58,18.63%,NOL3;BMP4;TNFSF10;BID;ITGA6;IL4;HTT;PYCARD;FGFR1;ETFA;GPER1;TLR4;LTB;PARK7;BCL2L12;MEN1;BCL2L14;HYAL2
prerank,Regulation Of Cardiac Muscle Cell Contraction (GO:0086004),-0.46272327097259824,-1.155890134772428,0.2978723404255319,0.8418359856516415,1.0,9/25,19.45%,SCN5A;FGF13;ATP2A1;DSG2;PDE4B;DSC2;TRPM4;DLG1;ATP2A2
prerank,Negative Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000134),0.4042019673665738,1.1547426355033004,0.26,0.9381812775680886,1.0,6/32,5.21%,DACT1;GFI1B;KLF4;APC;KANK2;CDK2AP2
prerank,Ephrin Receptor Signaling Pathway (GO:0048013),0.39112290471683264,1.1544148859222283,0.2692307692307692,0.936217798112647,1.0,12/41,15.65%,EPHB1;EPHB3;KALRN;EFNA5;EPHA4;EFNA4;TIAM1;EPHA10;PTK2;PAK1;EFNB1;EPHA1
prerank,Nucleosome Organization (GO:0034728),0.3437969059440322,1.1535444989526844,0.1590909090909091,0.9367245876142604,1.0,17/73,19.52%,NFE2;ASF1B;H2BC13;H2BC17;H2BC3;H2BC9;H4C9;NASP;H3C1;H3C14;H2AX;H3-4;DAXX;SMARCB1;H2BC15;H2BC14;H4C7
prerank,Positive Regulation Of Osteoblast Differentiation (GO:0045669),0.3682425406426886,1.152336070809416,0.24489795918367346,0.9380550140161908,1.0,11/43,14.08%,WNT7B;BMP4;SCUBE3;TP63;IFITM1;CCNA2;IL6R;LRP3;WWTR1;SOX11;ACVR2A
prerank,Neutrophil Activation (GO:0042119),-0.4921904005202333,-1.1522390668790896,0.25925925925925924,0.8534241853377252,1.0,6/18,14.07%,LILRA2;TYROBP;CXCL8;IL15;PRKCD;KMT2E
prerank,Visual System Development (GO:0150063),-0.4408250543570237,-1.152080903101689,0.25806451612903225,0.8519083123924562,1.0,7/35,7.93%,TGFB2;MEIS2;MEIS1;FOXE3;PBX1;FREM2;ITGAM
prerank,Regulation Of Phosphoprotein Phosphatase Activity (GO:0043666),-0.41060728222526904,-1.1519125608157021,0.2909090909090909,0.8505962782021425,1.0,7/36,14.61%,NUAK1;MAGI2;PPP1R2C;CD300A;MASTL;PPP1R15B;CRY2
prerank,Regulation Of Cytosolic Calcium Ion Concentration (GO:0051480),0.39292161987637664,1.1516504916930212,0.2222222222222222,0.9377273068424528,1.0,5/35,7.71%,HRC;RYR1;SLC35G1;F2;SLC8A2
prerank,Positive Regulation Of Endocytosis (GO:0045807),-0.35958476916775944,-1.151504213129419,0.2641509433962264,0.8500557614283397,1.0,9/77,7.28%,AZU1;CLEC7A;TUB;SLC11A1;IL1B;CALY;APOA1;IFNG;SGIP1
prerank,Regulation Of Nucleic Acid-Templated Transcription (GO:1903506),-0.2959077082092372,-1.1512120100357779,0.16,0.8496267267146561,1.0,110/431,21.33%,BNC2;GCM1;ZIM2;ZNF98;HIC1;ZNF736;SOX15;ZNF676;ZNF492;BACH1;RORA;ZFHX3;ZBTB11;ACVRL1;KLRG1;ZNF722;ZNF66;SOX4;MLF1;TCF7;ZNF506;ZNF716;FZD7;CRX;ZNF479;ZNF146;SOX1;OR7D2;ZNF727;MLXIPL;ASCC1;POU6F2;ZNF90;JADE3;ZNF350;RUNX3;NR1D2;IGSF1;ZNF35;ACVR1B;DMTF1;SOX13;HMGN5;POU5F1;DENND4A;SLC39A8;ZNF114;ZNF628;ZNF85;PATZ1;TERF2IP;RORB;ZNF138;ZNF678;ZNF212;APBB2;ZSCAN21;SERTAD3;SNAI1;BTG1;SMARCA5;BMAL1;BHLHE40;ATP1B4;NFKB2;MBIP;ZNF680;FOXN3;ZNF516;ZNF395;BRPF1;CREBBP;PPIE;BMP2;ATXN1L;BRD1;RBAK;TGFBRAP1;AKAP17A;RREB1;NFXL1;SPTY2D1;PHF1;NR3C1;MIER1;KAT7;KAT14;ZNF280C;THAP7;DNM2;DLX4;ZNF37A;CDK11B;MITF;ZNF488;ZNF519;MSC;IFNK;ING5;PRRX2;ING2;ACTR6;HCFC2;ZNF273;SAP30L;ZNF431;FUS;TGIF2;MYB;NSD1
prerank,Neuron Development (GO:0048666),-0.3325146948482253,-1.1512096807151344,0.15625,0.8478266700902607,1.0,23/140,12.96%,POU3F2;ADGRF1;TGFB2;SLC44A4;LYN;LGI1;ISL2;RP1L1;PBX1;DOCK7;NEDD4;MAPT;RUNX3;PALS1;RAB6B;LGI4;CDNF;TENM4;STMND1;NOVA2;UHMK1;SH3GL2;B4GALT6
prerank,Leukotriene Biosynthetic Process (GO:0019370),-0.4994746716643973,-1.151116412567144,0.21568627450980393,0.8464256353973991,1.0,4/17,13.18%,GGTLC3;GGT2P;GGT5;LTC4S
prerank,Camera-Type Eye Development (GO:0043010),-0.5037905891664141,-1.1507483745688847,0.35555555555555557,0.8455729913231625,1.0,3/21,5.96%,VEGFA;FOXL2;FOXE3
prerank,Cellular Response To Hormone Stimulus (GO:0032870),-0.3836087015431578,-1.1506584636151491,0.21212121212121213,0.8440743329068994,1.0,14/88,10.88%,AKR1C2;GHR;PAX8;NR4A3;ATP1A2;OXTR;NPFFR2;AKR1C3;HSPA1B;NSMF;GAS2L1;SRC;ARID5A;SLIT2
prerank,Negative Regulation Of Cell Cycle G1/S Phase Transition (GO:1902807),0.40157892455670113,1.1501248169886107,0.2727272727272727,0.9414746166576157,1.0,9/34,13.11%,DACT1;GFI1B;KLF4;APC;KANK2;CDK2AP2;PRMT2;E2F7;METTL13
prerank,Regulation Of Protein Binding (GO:0043393),0.31841087864725004,1.1495507967952256,0.1,0.9406937699916277,1.0,34/115,21.16%,DACT1;BMP4;TTBK1;MAPK8;IFIT1;AURKB;PLK1;HFE;BLK;TRIB3;TIAM1;EFHB;FKBP1A;DTX3L;SNAPIN;AKTIP;XIRP1;DAB2;CAMK1;MARK2;SPPL3;PARK7;GAS8;FLOT1;RACK1;LDLRAP1;AKT1;GTF2F1;CARD16;MITD1;DERL1;KDM1A;STING1;ITGB1BP1
prerank,Nucleosome Assembly (GO:0006334),0.37711151644933294,1.1493920880766795,0.21951219512195122,0.9381853406778471,1.0,15/53,19.52%,ASF1B;H2BC13;H2BC17;H2BC3;H2BC9;H4C9;NASP;H3C1;H3C14;H2AX;H3-4;DAXX;H2BC15;H2BC14;H4C7
prerank,Purine Ribonucleotide Transport (GO:0015868),0.4495011611300855,1.1491890864794383,0.2978723404255319,0.9354575373452458,1.0,8/19,26.34%,LRRC8D;SLC25A4;SLC25A41;SLC35B3;SLC19A1;SLC35B2;ABCC6;SLC25A17
prerank,Regulation Of Cellular Respiration (GO:0043457),0.4628153016178889,1.1489414950514572,0.25,0.9331538032889991,1.0,8/16,27.60%,IL4;CBFA2T3;IL10RB;VCP;PRELID1;ARL2;SHMT2;IFNAR1
prerank,Regulation Of Neurotransmitter Secretion (GO:0046928),0.3696252570378884,1.1483744806620892,0.3333333333333333,0.9317740789410677,1.0,8/36,13.09%,CHRNA3;SYN1;DYSF;KCNMB4;RIMS2;SEPTIN5;SNAPIN;GPER1
prerank,Synapse Assembly (GO:0007416),-0.36907276069915784,-1.148225562628695,0.23333333333333334,0.8511603434995723,1.0,15/64,12.67%,FARP1;ADGRF1;PCDHB13;FGF13;SRGAP2C;FZD5;PLXND1;CDH2;WNT7A;GABRG2;PCDHB10;SPOCK2;PCDHB11;PCDHB9;GABRB3
prerank,Hepaticobiliary System Development (GO:0061008),-0.46551496961758254,-1.1466861358133877,0.28846153846153844,0.8550900532380046,1.0,7/21,17.37%,UGT1A10;TGFBR3;UGT1A9;UGT1A7;CEBPG;PCSK9;PHF1
prerank,Regulation Of Type II Interferon Production (GO:0032649),0.3366446313170591,1.1461624913181678,0.21875,0.9374072982741412,1.0,29/85,15.85%,HLA-A;CR1;IL1R1;IL21;HLA-DRB1;EBI3;LGALS9C;CCR2;FOXP3;SIRPA;F2RL1;PYCARD;LILRB1;ZP3;TLR8;LGALS9;CCR7;HSPD1;PDCD1LG2;ISG15;IL12RB1;LILRB4;IFNL1;TLR4;C1QBP;NR1H4;HLA-DPA1;BTN3A2;RIPK3
prerank,Negative Regulation Of Cell-Substrate Junction Organization (GO:0150118),-0.4882287478558377,-1.1457885840904098,0.34545454545454546,0.8548265292505194,1.0,3/15,10.29%,THBS1;APOD;SRC
prerank,Negative Regulation Of Focal Adhesion Assembly (GO:0051895),-0.4882287478558377,-1.1457885840904098,0.34545454545454546,0.8548265292505194,1.0,3/15,10.29%,THBS1;APOD;SRC
prerank,Nicotinamide Nucleotide Metabolic Process (GO:0046496),-0.47830355856007234,-1.1456739333293415,0.2698412698412698,0.8535384828919458,1.0,6/15,18.37%,ME1;KRT17;NADK2;QPRT;GPD1L;NOX1
prerank,Positive Regulation Of Cytokinesis (GO:0032467),0.40988293664975467,1.145147200279153,0.2962962962962963,0.9383598543200862,1.0,16/37,25.41%,KIF14;BIRC5;CIT;RACGAP1;CDC14C;CDCA8;CDC25B;CDC6;OR2A4;ECT2;PKP4;CXCR5;MAP10;RXFP3;SPAST;CDC14B
prerank,Positive Regulation Of Signal Transduction (GO:0009967),0.286481248785482,1.1444384227663886,0.15384615384615385,0.9383075125984482,1.0,67/251,17.73%,DACT1;CRLF2;ZBTB7B;SCIMP;F7;CTSV;MYO1C;TPD52L1;TSPAN5;TMEM108;CHRNA7;TP63;GLI1;LIMS2;PDE6G;SULF2;ADIPOQ;CTBP2;LY86;CTSL;LY96;GH1;EVC;HTT;CD80;AXL;LIMS1;TEDC2;P2RY6;CTSH;GRIN2D;ERFE;PDCD10;GRB10;RIMS2;CIBAR1;SLC39A14;UBE2V1;NOD2;MYORG;KLK5;NID1;SFRP1;SPRING1;MN1;TNFSF11;TSLP;TRIM16;TLR2;ILK;CD180;LOXL3;GPER1;KANK1;PHB1;PRKCI;DLG4;STK36;NLGN2;RXRB;GAS8;BMP6;IL6ST;SMARCB1;GATA3;TSPAN14;PDCL
prerank,Gland Development (GO:0048732),-0.39163142950326213,-1.1421912363966795,0.25,0.8645512328350303,1.0,14/63,17.60%,UGT1A10;WNT11;PAX8;PRL;TGFBR3;ZBTB1;UGT1A9;FOXE1;UGT1A7;DKK3;CEBPG;PCSK9;PHF1;FADD
prerank,Glycosphingolipid Biosynthetic Process (GO:0006688),-0.4744207429445087,-1.1420873676549985,0.3148148148148148,0.8630776432447202,1.0,7/18,14.28%,FUT9;FUT6;ST8SIA6;ST3GAL5;B4GALT4;B4GALT6;B4GALNT1
prerank,Regulation Of RNA Splicing (GO:0043484),-0.3464877674266405,-1.1415406351911366,0.22807017543859648,0.8634202161062644,1.0,29/99,20.99%,RBM20;AHNAK2;ILDR1;PIK3R1;RBM38;TMEM98;CLK1;CCNL2;MBNL2;ZPR1;LARP7;CELF1;CLK4;ZC3H10;METTL4;ATXN7;ILDR2;METTL16;HNRNPL;PTBP2;AKAP17A;RBM39;HNRNPH2;HNRNPLL;MBNL3;SRRM1;SRPK2;SETX;FUS
prerank,Chemical Synaptic Transmission (GO:0007268),0.2873636623658999,1.1403994386339784,0.06060606060606061,0.9525152384493767,1.0,66/250,20.53%,RIMBP3C;CHRNA3;SYN1;HAPLN4;LPAR3;PDE7B;SLC1A4;SYT5;HRH4;CHRNA7;CHRNA6;EXOC4;SLC1A1;MYCBPAP;CHRNA5;PCDHB6;MTNR1B;GABBR1;SNCA;GRIK4;SYN2;CHRNA9;GABRR2;CDK5;NRXN2;GABRR1;GRIN2D;RIMBP3B;DRD5;GRIN3B;SLC1A2;KCNMB4;PCDHB14;RPS6KA1;PCDHB5;AMPH;HTR3A;CHRNA10;CNP;SNAPIN;SLC17A7;NQO1;SLC12A5;RPS6KA2;HTR2B;KIF5A;DLG4;NLGN2;SLC6A9;GLRA1;SLC12A7;KCNQ2;PCDHB2;MPZ;NPTX1;GRIK2;CHRM3;CACNA1E;HRH3;GABBR2;GABRR3;HTR1B;SNCG;CACNA1B;APBA2;SLC6A2
prerank,Negative Regulation Of Protein Localization To Cell Periphery (GO:1904376),0.44769097153765086,1.1398659522908527,0.32,0.9517206013992037,1.0,5/18,13.86%,SAPCD2;GBP1;BCL2L1;DAB2;PID1
prerank,Negative Regulation Of Mitotic Cell Cycle (GO:0045930),0.38693380580981207,1.1383946795756885,0.21052631578947367,0.9546859937206428,1.0,4/33,9.82%,PTPN3;BMP4;RGCC;ZWINT
prerank,mRNA Methylation (GO:0080009),-0.4930713199368902,-1.1379878288441245,0.2857142857142857,0.8736217600636681,1.0,11/15,29.71%,METTL4;METTL16;WTAP;PCIF1;CMTR1;TRMT61A;TRMT10C;METTL8;VIRMA;METTL14;ZC3H13
prerank,Negative Regulation Of Cell Differentiation (GO:0045596),-0.33072175673648935,-1.1376211546606678,0.23728813559322035,0.873029278065931,1.0,45/194,17.55%,SPRY2;ADGRV1;MSTN;MEIS2;EID2B;MARK1;SMAD6;COL5A1;MEIS1;HOXB8;RORA;ZBTB16;TCF23;SOX4;PPARG;IFNG;ABCA5;WNT1;NFKBIA;SPRED1;BAMBI;HPN;WNT10B;ID2;ABCG1;HEY1;TRIO;YAP1;RORB;PEX2;TSKU;BCL7A;ITGB3;BMAL1;HOPX;BMP2;CITED1;ZFP36L2;EFNA1;TRPM4;SOX8;NOG;SIRT1;TENT5C;PPARA
prerank,Positive Regulation Of Telomere Capping (GO:1904355),-0.4773112178152942,-1.1375968678579804,0.2830188679245283,0.8712964116708595,1.0,8/16,34.32%,MAPK15;PKIB;TNKS;TNKS2;MAP2K7;PRKCQ;MAP3K4;MAPK3
prerank,Positive Regulation Of Epidermal Growth Factor Receptor Signaling Pathway (GO:0045742),0.3731933337843883,1.1370446302638202,0.35,0.9567121126477711,1.0,12/29,19.65%,HBEGF;FAM83B;PDE6G;PLAUR;NEU3;TGFA;AFAP1L2;GPER1;PTK6;CBL;SHKBP1;CNOT9
prerank,Carboxylic Acid Transmembrane Transport (GO:1905039),-0.43753199850561575,-1.1362667359569492,0.27586206896551724,0.8742592850649308,1.0,4/38,4.39%,SLC16A12;SLC16A7;SLC7A8;SLC7A9
prerank,Response To Cytokine (GO:0034097),0.3143431288015798,1.1360937330097558,0.21951219512195122,0.9580048081422577,1.0,28/122,14.06%,AKAP6;FOXH1;IL1R1;TNFRSF11A;ADIPOQ;IFITM1;SNCA;PLSCR1;CH25H;AFF3;CD40;IL6R;LGALS9;CCR7;IRAK3;POU4F1;MAPKAPK3;SELL;BCL2L1;GCH1;ISG15;TIMP1;SRF;LEF1;JAK3;TIMP2;PID1;BST2
prerank,Skin Epidermis Development (GO:0098773),-0.47114248960965055,-1.1354273289336083,0.3728813559322034,0.8753131173757612,1.0,5/20,7.05%,ALOX12;ALOXE3;GATA6;IL18;SFN
prerank,Regulation Of Necroptotic Process (GO:0060544),-0.4742666840291292,-1.1350085094981697,0.32727272727272727,0.8749744255844113,1.0,6/20,10.81%,IGF2BP1;CASP8;ITCH;SPATA2;PRKN;PELI1
prerank,Cell Cycle G2/M Phase Transition (GO:0044839),0.372403564603125,1.1349197036830632,0.24,0.9597125401029528,1.0,11/40,15.21%,CDK14;TPD52L1;AURKB;PKMYT1;PLK1;CCNA2;CDK1;CHEK2;CCNB1;FOXM1;CDC25B
prerank,Response To Metal Ion (GO:0010038),-0.38352269675641665,-1.1348378523051421,0.2727272727272727,0.8737765008258794,1.0,13/63,9.82%,PAM;THBS1;MELTF;ITPKA;SLC30A4;SEC31A;NEDD4;HAAO;GPHN;MAPT;PPP3CA;SLC34A1;TRPC3
prerank,Inflammatory Response (GO:0006954),-0.31552122863946813,-1.1348322280813046,0.16455696202531644,0.8720178631528198,1.0,53/222,15.25%,CCL7;AZU1;NOX4;THBS1;SLC11A1;ALOX15;CCL22;VNN1;IL1B;IL18;XCL1;CXCL8;CHI3L1;VCAM1;CXCL2;PTGDR;CCL14;FPR1;KLRG1;ADCY1;GPR32;RIPK2;CSF1R;REL;IFNG;C5AR1;ITCH;CXCR4;CXCL11;CXCL3;PLA2G4B;IFNA2;GGT5;TBK1;PF4V1;TLR3;FCGR2B;CCL2;MAPKAPK2;F2R;AOC3;CARD18;NOD1;PPBP;PTGER4;NCR3;NFKB2;HSPG2;PF4;CCR1;ADM;FPR2;BMP2
prerank,Regulation Of Phagocytosis (GO:0050764),-0.3904405725634571,-1.1341029939137304,0.25862068965517243,0.8730258728741408,1.0,7/55,5.80%,AZU1;CLEC7A;TUB;SLC11A1;IL1B;APOA1;IFNG
prerank,Sensory Perception Of Chemical Stimulus (GO:0007606),-0.3526595011133781,-1.1328982402317502,0.3103448275862069,0.8755110582925621,1.0,30/97,16.41%,OR5M8;OR6C2;OR8D1;OR8G1;OR8B4;OR8A1;OR3A2;OR5D14;OR9Q2;OR8B8;OR10A3;OR8J3;OR51I2;OR51V1;OR5D18;OR8B3;C5AR1;OR10J1;OR8K3;OR8B12;OR9I1;OR5T1;NXNL2;OR8I2;OR1Q1;OR5M1;OR52A5;OR8K5;OR5B12;OR10A5
prerank,Regulation Of AMPA Receptor Activity (GO:2000311),0.41792893927553665,1.132318244595938,0.3333333333333333,0.9683290827715187,1.0,5/22,15.36%,NOL3;GSG1L;PRRT1;CNIH4;NLGN2
prerank,Regulation Of Cyclin-Dependent Protein Serine/Threonine Kinase Activity (GO:0000079),0.33252017524925837,1.1322973283324869,0.20408163265306123,0.9651982375288489,1.0,12/78,7.46%,CDKN2B;CDKN3;CCNP;PKMYT1;APC;PSRC1;CCNB2;PLK1;CDKN2A;CCNF;RGCC;CCNA2
prerank,Regulation Of Cytokinesis (GO:0032465),0.332142647846369,1.1315320153760011,0.2391304347826087,0.9649928712080053,1.0,21/78,21.56%,CHMP4C;KIF20A;AURKB;DCDC1;PLK1;KIF13A;KIF14;CIT;RACGAP1;BCL2L1;CDC14C;E2F7;FSD1;CDC25B;CDC6;OR2A4;ECT2;PKP4;CXCR5;MAP10;RAB11A
prerank,Negative Regulation Of Viral Entry Into Host Cell (GO:0046597),0.4415598560893452,1.1313718185347292,0.3191489361702128,0.9623444208215028,1.0,5/15,18.16%,TRIM5;IFITM1;CH25H;FCN1;IFITM2
prerank,Cell-Cell Signaling By Wnt (GO:0198738),0.4340666143567724,1.1302334000461807,0.35714285714285715,0.9643618489594928,1.0,3/22,9.88%,WNT7B;CD24;NXN
prerank,Epoxygenase P450 Pathway (GO:0019373),0.45017062013054165,1.129869744852196,0.2926829268292683,0.9628833000158774,1.0,6/16,12.17%,CYP2F1;CYP2J2;CYP1B1;CYP4F2;CYP2A7;CYP1A2
prerank,Response To Lipopolysaccharide (GO:0032496),-0.32803022443926555,-1.1295026240583768,0.20634920634920634,0.8860229548925489,1.0,28/153,13.23%,NOS3;SLC11A1;SMAD6;IL1B;IRGM;CXCL8;IL12A;CXCL2;TRAF6;ADAM9;GFI1;TNFAIP3;PALM3;CXCL11;CXCL3;ZC3H12A;PF4V1;PELI1;PDE4B;CCL2;BCL10;PEX2;MAPKAPK2;CASP7;F2R;NR1D1;PTPN22;PPBP
prerank,Membrane Repolarization (GO:0086009),0.467134780501136,1.1294913086543978,0.23809523809523808,0.9614145427871206,1.0,5/16,14.92%,ATP1B2;SLC24A4;KCNE5;KCNH6;KCNH2
prerank,Regulation Of Fat Cell Differentiation (GO:0045598),-0.3747631181839567,-1.1291039540624566,0.3559322033898305,0.8853966107166195,1.0,20/72,17.17%,FRZB;ADIRF;RORA;ZBTB16;PPARG;WNT1;ZC3H12A;RARRES2;WNT10B;ID2;MEDAG;TRIO;YAP1;RORC;NR1D1;BMAL1;BMP2;ZFP36L2;TRPM4;SIRT1
prerank,Organic Hydroxy Compound Transport (GO:0015850),-0.37683941690628087,-1.1282812977180912,0.29411764705882354,0.8864109914465259,1.0,5/42,6.83%,SLC5A1;SLC5A11;SLC16A8;SLC22A1;SLCO1A2
prerank,Regulation Of Interleukin-6 Production (GO:0032675),0.2961781400882103,1.1280190150021245,0.25,0.9637324584098199,1.0,25/107,12.00%,TWIST1;SCIMP;POU2AF1;SIRPA;F2RL1;PYCARD;FOXJ1;PTPN6;TLR8;CD200;IL6R;LGALS9;TLR1;IRAK3;HSPD1;IL16;CX3CL1;NOD2;POU2F2;ELF4;CYBA;TSLP;CD200R1;TLR2;LILRB4
prerank,Positive Regulation Of Innate Immune Response (GO:0045089),0.37540680198456466,1.127764508458453,0.2127659574468085,0.9613531584993149,1.0,7/45,7.88%,RBM47;MYO1C;SH2D1B;TASL;CD1D;PLSCR1;TLR8
prerank,Endodermal Cell Differentiation (GO:0035987),-0.45953685038282976,-1.1266918267506754,0.31666666666666665,0.8902978919042093,1.0,6/31,16.74%,ITGB5;COL7A1;PEX2;VTN;COL6A1;MMP14
prerank,Cellular Response To Heat (GO:0034605),-0.4273048210602567,-1.1264517296133874,0.27941176470588236,0.8895634695731545,1.0,11/34,17.95%,THBS1;IER5;CLPB;TRPV1;HSPA1B;MAPT;DNAJB1;SLU7;TCIM;DHX36;BAG3
prerank,Positive Regulation Of Lipid Storage (GO:0010884),-0.4667810731169212,-1.1251005842474584,0.34615384615384615,0.8920680796493017,1.0,7/18,20.57%,MSR1;CIDEA;ZC3H12A;PLIN5;FITM1;SREBF2;C3
prerank,Autophagosome Organization (GO:1905037),-0.3879967681005453,-1.1250470139751294,0.3,0.8904485099436626,1.0,22/60,27.89%,IRGM;MAP1LC3C;ATG16L1;ATG2A;UBXN2A;GABARAPL1;RUFY4;TP53INP2;EMC6;WDR45B;TMEM41B;RB1CC1;ATG5;ATP2A2;UBQLN1;ULK2;ATG14;WDR45;ULK1;ZFYVE26;ATG12;MAP1LC3B
prerank,Carboxylic Acid Metabolic Process (GO:0019752),0.3625269725470637,1.124193391751218,0.25,0.9735253368399125,1.0,7/32,12.63%,CYP4F22;CYP2J2;AMH;CYP4F2;ST6GAL1;CYP1A2;GSTO2
prerank,Positive Regulation Of Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0032436),0.32510292347814784,1.1238512440739195,0.19444444444444445,0.9719152885862941,1.0,21/80,17.53%,HSPA1A;PLK1;FBXO22;CBFA2T3;CDC20;NKD2;CDC20B;PRICKLE1;TRIB3;HECTD1;RNF180;GSK3A;RNF19A;TRIB2;TRIB1;DAB2;RBX1;KEAP1;VCP;SH3RF2;RACK1
prerank,Positive Regulation Of Cation Transmembrane Transport (GO:1904064),0.43516198317137567,1.1233159424597794,0.24390243902439024,0.9711615250394275,1.0,5/18,14.92%,AKAP6;KCNE5;STAC;KCNN4;KCNH2
prerank,Liver Development (GO:0001889),-0.41725856133210104,-1.1232165160615235,0.2857142857142857,0.8958155196385641,1.0,9/33,17.37%,UGT1A10;AURKA;TGFBR3;UGT1A9;UGT1A7;CEBPG;PCSK9;DNAAF1;PHF1
prerank,Cellular Response To cAMP (GO:0071320),0.3923819191268507,1.122528748006555,0.30952380952380953,0.9717240667098638,1.0,3/30,4.25%,AKAP6;RAPGEF1;HCN2
prerank,Negative Regulation Of Ubiquitin-Dependent Protein Catabolic Process (GO:2000059),0.3731256101981761,1.1224298339758285,0.34782608695652173,0.9688905587730894,1.0,9/36,22.32%,FHIT;MAP1A;HFE;PHF20L1;CCAR2;PARK7;EIF3H;PDCL3;TAF1
prerank,Odontogenesis (GO:0042476),-0.40816676884518127,-1.1222997511780093,0.2833333333333333,0.8971248431181874,1.0,6/39,10.10%,COL1A1;TGFB2;SCN5A;COL1A2;SSUH2;FGF8
prerank,Regulation Of Receptor Internalization (GO:0002090),-0.43045466302363844,-1.1211095347061142,0.3333333333333333,0.8989197153722236,1.0,3/34,4.01%,VEGFA;MAGI2;CCL14
prerank,Retina Homeostasis (GO:0001895),0.403691527126084,1.1205010334726024,0.32,0.9736448502024082,1.0,10/35,14.53%,ATP1B2;PIGR;CNGB1;JCHAIN;PRR4;PRDX1;POTEF;ACTG1;LYZ;POC1B
prerank,Establishment Of Endothelial Barrier (GO:0061028),0.4064195963606976,1.120427099894763,0.2653061224489796,0.9707615422962822,1.0,7/28,15.43%,RAPGEF1;F2RL1;ROBO4;MARVELD2;TJP2;RAB1B;MYADM
prerank,Negative Regulation Of mRNA Processing (GO:0050686),-0.4829549297359009,-1.1198522532315642,0.2857142857142857,0.901809472619498,1.0,1/15,0.96%,RBM20
prerank,Positive Regulation Of DNA Binding (GO:0043388),0.3856962038636827,1.1197978493381593,0.225,0.9703009699893076,1.0,9/32,17.38%,TWIST1;NME1;PLAUR;NIBAN2;POU4F1;SUMO4;PARK7;H1-0;GATA3
prerank,Mononuclear Cell Differentiation (GO:1903131),-0.4615182343911615,-1.1196310276913568,0.3548387096774194,0.9006143582128404,1.0,7/22,12.17%,VEGFA;LYN;PPARG;CSF1R;PDE1B;BATF3;IL31RA
prerank,Oligosaccharide Biosynthetic Process (GO:0009312),-0.44522637180078406,-1.1191783214987008,0.38181818181818183,0.9003996580152561,1.0,7/19,13.55%,FUT9;FUT6;FUT1;ST3GAL3;B3GALT2;FUT4;B4GALT1
prerank,Central Nervous System Development (GO:0007417),0.2823460785928715,1.118453400772379,0.12121212121212122,0.9724242638302079,1.0,34/264,8.90%,B3GNT5;RTN3;ZFHX2;SEMA6B;S100B;NRCAM;GLIS2;NOTO;SMARCA1;SHROOM4;NFASC;ADAM23;DLX2;DNER;MOG;PCDH18;CAPG;ABCB6;SCTR;CX3CR1;SERPINI1;CDK5;VCX;GRIN2D;NHEJ1;FOXJ1;ALDH3A2;MAL;CNTNAP2;ADORA2A;VCX3B;ECRG4;IER3IP1;PLXNB2
prerank,Regulation Of Lymphocyte Proliferation (GO:0050670),-0.4807961548611508,-1.1183998075650663,0.3076923076923077,0.9012407179257349,1.0,7/17,16.60%,IL12A;CD209;MZB1;ZNF335;PTPN22;TNFSF9;TNFSF18
prerank,Regulation Of Cell Development (GO:0060284),0.3507112485139408,1.1179489159393818,0.26666666666666666,0.9711956441903149,1.0,12/50,13.27%,GFI1B;ASCL1;ANXA2;CX3CR1;FBXO22;HES2;CX3CL1;HEYL;SLAMF8;GRN;LEF1;HLTF
prerank,Regulation Of Fibroblast Growth Factor Receptor Signaling Pathway (GO:0040036),-0.4691899922392755,-1.117606823131132,0.3050847457627119,0.9023214288606694,1.0,3/18,1.57%,SPRY2;THBS1;OTX2
prerank,Lysosome Organization (GO:0007040),0.367710871421984,1.117440043707644,0.2,0.9698832347250437,1.0,16/42,21.84%,CLVS1;MYO7A;TASL;GRN;CLN5;ATP10B;SNAPIN;AKTIP;ZKSCAN3;LYSET;GBA1;CORO1A;TFEB;HOOK2;PI4KB;TMEM106B
prerank,Positive Regulation Of Cellular Metabolic Process (GO:0031325),-0.3769036120005914,-1.1168414079604987,0.265625,0.9030745801187292,1.0,13/53,12.76%,PAX8;THBS1;CXCL8;ACTN3;CDKN1A;IFNG;AKR1C3;HPN;ZC3H12A;ARG2;MT3;GADD45A;LIPT2
prerank,Receptor Signaling Pathway Via JAK-STAT (GO:0007259),0.37247006858007725,1.1164568607173504,0.27906976744186046,0.9703747128958015,1.0,6/35,5.53%,CSF2RA;MYO1C;IL21;CSF2RB;CCR2;GH1
prerank,Cellular Response To Hypoxia (GO:0071456),-0.366641876600903,-1.1161435176364054,0.265625,0.9040264524180066,1.0,8/70,5.61%,VEGFA;STOX1;GATA6;FMN2;RORA;EPAS1;PPARG;TERT
prerank,Establishment Of Protein Localization To Extracellular Region (GO:0035592),0.3703094827976988,1.115558523691301,0.2682926829268293,0.9710451157107433,1.0,13/41,22.37%,RAB3B;MON1A;CTAGE6;CTAGE9;OLFM2;STEAP3;PDIA4;RAB3D;TANGO2;MEN1;MIA2;PREB;GSDMD
prerank,Positive Regulation Of Endopeptidase Activity (GO:0010950),0.4080565670547538,1.114541293573991,0.3137254901960784,0.9725883252102292,1.0,7/29,16.20%,CR1;TTBK1;EPHA4;PYCARD;APH1B;PSME2;PRELID1
prerank,Positive Regulation Of Peptide Hormone Secretion (GO:0090277),-0.38661167013450326,-1.114377469901354,0.2982456140350877,0.9091410933075353,1.0,7/42,9.34%,RASL10B;DOC2B;FFAR1;SOX4;ILDR1;TCF7L2;IRS2
prerank,Activation Of Protein Kinase Activity (GO:0032147),-0.3585749998885202,-1.1141979473752983,0.2711864406779661,0.9079680874624251,1.0,14/77,10.94%,VEGFA;SLC11A1;TGFB2;IL18;CHI3L1;TRAF6;IGF1;ADRA2C;CARD14;ADRA2B;ANG;TLR3;ANGPT1;MT3
prerank,Cellular Response To Virus (GO:0098586),0.3333901259346187,1.1141310371574344,0.2765957446808511,0.9709865328063834,1.0,17/62,11.12%,VWCE;POU2AF1;IL21;IFNA21;GSDME;IFNA10;IRF5;MAPK11;IFNGR2;IL10RB;IFNW1;LGALS9;OAS1;IFNL2;POU2F2;NLRP3;IFNA4
prerank,Generation Of Neurons (GO:0048699),-0.31332558502037827,-1.113810637225065,0.31343283582089554,0.9075615364694221,1.0,25/154,10.10%,POU3F2;WNT11;FUT9;TGFB2;MARK1;SIX4;AUTS2;FGF13;VAX2;IRX5;KIAA0319;ATP2B2;NR4A2;FZD7;FZD10;FZD5;DNAAF4;WNT7A;MAPT;WNT1;WNT5B;RUNX3;PALS1;WNT10B;FGF8
prerank,Positive Regulation Of Phosphatase Activity (GO:0010922),-0.44785503995068865,-1.113575965145011,0.3148148148148148,0.9067963781643946,1.0,5/22,15.25%,MAGI2;IFNG;CD300A;PPP1R15B;BMP2
prerank,Organelle Organization (GO:0006996),-0.2977119575983034,-1.1130888440541953,0.2236842105263158,0.9069528875698145,1.0,93/407,21.61%,NOS3;CCL7;CXADR;PALLD;SH3D19;MARK1;CEP55;GABPB1;AFG1L;ZNF135;LRRK2;MAPK15;TERT;SPTBN5;TNFAIP3;SEC31A;SPTSSB;AGTPBP1;ATL1;UBXN2A;GOLGA6B;GOLGA8N;PEX1;ARHGAP21;SEMA6A;PLCE1;GARIN4;BAG5;RAB6B;PRKN;GOLGA8M;DIAPH3;SLC25A36;RAB30;DIAPH1;PLIN5;GOLGB1;ATXN7;VPS18;CFAP126;CFAP61;CCL2;PEX2;PRR5;MTX3;PEX12;RHOT2;FMNL2;FGD5;FAF2;THY1;CNTNAP1;WASF3;TRIP11;LYSMD3;ZMYM6;TMEM135;FITM1;GOLGA8A;TRAPPC11;SAR1A;CSNK1D;PEX14;BRWD1;RICTOR;YTHDF3;GOLGA8S;PI4K2A;VPS13C;DYNC2H1;SIRT4;CEP78;CSPG5;WASL;HACE1;BNIP1;SEC16B;SYNE1;GEM;KIF3A;KIF5C;ARFGEF1;SAR1B;PEX3;SEC31B;JAGN1;ARHGAP4;SORT1;ZRANB1;ATP8B4;SMPD4;PRPF40A;RANBP9
prerank,Positive Regulation Of Stress-Activated MAPK Cascade (GO:0032874),-0.3366476235705351,-1.1127621093672535,0.22727272727272727,0.9060523438811315,1.0,25/103,15.39%,VEGFA;IL26;TGFB2;HRAS;IL1B;FLT4;TRAF6;FZD7;GADD45G;PLCB1;WNT7A;SEMA4C;NCF1;ZC3H12A;SERPINF2;TLR3;GADD45A;FCGR2B;RELL1;MBIP;TAOK3;LTBR;FGF19;BMP2;SEMA3A
prerank,Regulation Of Tissue Remodeling (GO:0034103),-0.4572498953577074,-1.1125910188735886,0.2765957446808511,0.904777290373603,1.0,4/19,9.18%,DDR2;FLT4;IL18;IL15
prerank,Signal Transduction By P53 Class Mediator (GO:0072331),0.37648598816324147,1.1122993768010427,0.2631578947368421,0.9758261279952984,1.0,7/33,12.48%,FHIT;BATF;PYCARD;POU4F1;CASP6;USP10;E2F7
prerank,Peptide Cross-Linking (GO:0018149),-0.4480097362942302,-1.1118881580426963,0.3148148148148148,0.9060288707134406,1.0,2/24,2.14%,THBS1;F13A1
prerank,Bone Development (GO:0060348),0.35604676185868894,1.1114911075536145,0.19230769230769232,0.9759319226108539,1.0,7/39,9.29%,SULF2;ATG9B;GNAS;LRRC17;GH1;OGN;VKORC1
prerank,Positive Regulation Of Macromolecule Metabolic Process (GO:0010604),-0.29686890533557125,-1.1111004933384443,0.2,0.9073152634733701,1.0,61/340,15.46%,NOS3;VEGFA;AZU1;STOX1;CLEC7A;SPRY2;SLC11A1;TYROBP;MARK1;FGF9;CLDN19;IL1B;CXCL8;CD34;TLE1;TCF23;IGF1;HOXA5;PPARG;IFNGR1;IFNG;FGF17;MED26;WNT7A;HSPA1B;NFKBIA;ITCH;HPN;PIK3R3;PDE2A;RIMS1;ZC3H12A;BRCA1;CD46;PSG4;PRKN;ZPR1;HMGN5;C1QTNF1;ID2;FGF8;CELF1;TLR3;ANGPT1;MT3;YAP1;POU3F1;PLCG2;NFE2L2;PTPN22;SLC24A3;CLDN3;ANK3;MBIP;CDH3;RPL17;PF4;FGF19;BMP2;CITED1;BMPR1B
prerank,Lipid Transport (GO:0006869),0.3107529424197339,1.111067776286044,0.18181818181818182,0.9747528008273681,1.0,22/100,16.72%,ATP8B1;CEACAM1;SLC10A4;ABCC11;TNFAIP8L3;SLC27A4;SLCO2A1;PRELID2;ABCG8;FABP2;CD36;RBP7;SLC51A;ABCA13;SCP2;GM2A;NPC2;CHKA;PRELID1;GOT2;SLCO2B1;PLPPR4
prerank,Negative Regulation Of Growth (GO:0045926),-0.3340304610593783,-1.1109617180894056,0.25,0.9062231539487525,1.0,33/117,20.49%,FRZB;WNT11;MT1M;TGFB2;WFDC1;ACVRL1;OSGIN1;CDKN1A;CGRRF1;HSPA1B;OSGIN2;BRCA1;NPR1;BCL6;SLIT2;MT3;MUL1;SERTAD2;DCBLD2;SERTAD3;BTG1;CDKN1B;SLIT1;SIRT1;BMPR2;TSPYL2;PRDM11;IP6K2;CDKN2AIP;FHL1;CDKN2D;ING5;FBP1
prerank,Regulation Of Dendritic Spine Morphogenesis (GO:0061001),0.4004848163190276,1.1107621532455003,0.325,0.9729557254948094,1.0,5/29,6.29%,GPRASP3;NOL3;ARHGAP44;EPHA4;CDK5
prerank,Cilium Movement (GO:0003341),-0.37442619820681733,-1.1104090404278433,0.3064516129032258,0.9064974111236647,1.0,14/53,12.86%,DNAH11;PIERCE1;CFAP251;TEKT3;DNAAF4;CCDC103;CABYR;DNAAF6;ODAD4;CFAP53;RSPH4A;ODAD2;CFAP61;DNHD1
prerank,Positive Regulation Of Leukocyte Proliferation (GO:0070665),-0.48033085230781125,-1.1102155535320914,0.32,0.9054504603693657,1.0,6/17,11.68%,IL34;LYN;IL12A;CSF1R;NMB;IL5RA
prerank,Phosphatidylcholine Metabolic Process (GO:0046470),-0.3723643934066931,-1.109878328926121,0.3148148148148148,0.904820502678043,1.0,7/50,8.96%,LPCAT2;SLC44A4;SLC44A5;APOA1;MBOAT2;PLAAT2;PCYT1B
prerank,Immune Response-Activating Cell Surface Receptor Signaling Pathway (GO:0002429),-0.43369611362987015,-1.1096969099549459,0.32653061224489793,0.9037414908612381,1.0,5/22,6.86%,LILRA2;LYN;FPR1;GPR32;C5AR1
prerank,Regulation Of Actin Polymerization Or Depolymerization (GO:0008064),0.41446519688933725,1.1096716197103778,0.32653061224489793,0.9747315993030635,1.0,16/27,31.64%,ARHGAP28;ESAM;NAA80;WDR1;GBA2;COTL1;SH3BP1;HAX1;PFN1;PLEKHG2;WAS;HCLS1;TMSB4Y;BRK1;ARHGAP35;ARHGAP40
prerank,T-helper Cell Differentiation (GO:0042093),0.42358393711201403,1.1096203991053637,0.33962264150943394,0.9719691515864302,1.0,7/18,17.38%,IL21;BATF;IL4;GPR183;LEF1;MEN1;GATA3
prerank,Amino Acid Import Across Plasma Membrane (GO:0089718),0.40071546221102583,1.1092789684730677,0.2708333333333333,0.9701381524881941,1.0,12/26,20.76%,SLC1A4;SLC1A5;SLC1A1;SLC1A2;SLC38A3;SLC38A5;SLC36A1;SLC6A9;SLC6A14;SLC6A20;SLC6A2;SLC6A6
prerank,Positive Regulation Of NIK/NF-kappaB Signaling (GO:1901224),0.35641442458653916,1.1085343837322417,0.3541666666666667,0.9702594003386541,1.0,16/52,19.17%,CD86;MYO1C;TNFSF14;LIMS1;CD27;PYCARD;LGALS9;NOD2;NLRP3;TLR2;ILK;TLR4;PHB1;IFI35;TRADD;TRIP6
prerank,DNA-templated DNA Replication Maintenance Of Fidelity (GO:0045005),0.3470437017355556,1.1076579999269756,0.3181818181818182,0.9713767942035572,1.0,5/42,6.15%,CAMSAP3;EXD2;EME2;OOEP;EME1
prerank,Fatty Acid Beta-Oxidation (GO:0006635),0.36037363052610066,1.1072468370917272,0.2765957446808511,0.9702658365304555,1.0,21/49,28.85%,ADIPOQ;MCAT;ETFA;ECI2;SCP2;ETFB;ACADM;ECHS1;DECR2;HADHB;AMACR;ACOX1;ABCD3;DECR1;ACAT1;ECI1;SLC25A17;GCDH;HSD17B4;ACADS;ACOX3
prerank,Positive Regulation Of Receptor Signaling Pathway Via JAK-STAT (GO:0046427),-0.39204650529550156,-1.1063046299347858,0.36,0.9141666500773066,1.0,3/35,1.32%,IL26;GHR;PRL
prerank,Cell Projection Organization (GO:0030030),-0.47174990706065756,-1.1062950804918026,0.3709677419354839,0.9125069066615983,1.0,3/20,4.30%,SCIN;MTSS2;NCKAP1
prerank,Superoxide Anion Generation (GO:0042554),-0.5104312180423872,-1.1060447631205252,0.3793103448275862,0.9117122054363919,1.0,5/16,8.92%,NOX4;DUOX2;NOX5;NCF1;NOXA1
prerank,Negative Regulation Of Lipid Storage (GO:0010888),-0.4568997005976766,-1.1057809348571674,0.3,0.9108620746513167,1.0,12/16,31.45%,PPARG;NFKBIA;CES1;ABCG1;ITGB3;PPARA;PNPLA2;NR1H2;IL6;ABHD5;ITGAV;NR1H3
prerank,Modified Amino Acid Transport (GO:0072337),-0.428107555063279,-1.1057572229030712,0.31666666666666665,0.9092568768166682,1.0,4/29,8.88%,SLC16A12;SLC7A3;SLC7A9;SLC7A11
prerank,Positive Regulation Of Wnt Signaling Pathway (GO:0030177),-0.33754193889211115,-1.1056975582294768,0.24193548387096775,0.9077547684394495,1.0,31/101,19.60%,DKK2;COL1A1;RNF220;LRRK2;SOX4;TERT;TNFAIP3;PTK7;DEPDC1B;WNT5B;BAMBI;FRAT1;SMURF2;NRARP;DAAM2;PPM1A;BMAL1;ZEB2;CDH3;WNK2;LGR4;RSPO4;BMP2;CSNK1D;TNKS;TRPM4;PPM1B;CSNK1E;MRPS12;CDC73;USP8
prerank,Defense Response To Protozoan (GO:0042832),-0.46584358309124596,-1.1055047665993085,0.3673469387755102,0.9067231947086402,1.0,3/15,6.99%,CLEC7A;SLC11A1;LYST
prerank,Actin Filament Bundle Organization (GO:0061572),-0.3977207163144433,-1.1052226537306205,0.2916666666666667,0.9061788356983276,1.0,5/33,11.41%,CALD1;RFLNA;ESPN;MYO1B;PAWR
prerank,Positive Regulation Of Ubiquitin-Protein Transferase Activity (GO:0051443),0.3891347123563512,1.1049545873568734,0.3409090909090909,0.9761558020611814,1.0,5/27,9.62%,UBE2C;PLK1;CDC20;TRIB3;RPS2
prerank,Negative Regulation Of Metabolic Process (GO:0009892),-0.38187446694635707,-1.104797345956301,0.27692307692307694,0.9058680856153414,1.0,16/50,16.98%,CCDC3;IL1B;CIDEA;ACTN3;DOCK7;IL18R1;ALDH1A1;IL15;WNT10B;NOVA2;NR1D1;BMAL1;LGR4;IP6K1;ADAM17;PLCL1
prerank,Regulation Of Substrate Adhesion-Dependent Cell Spreading (GO:1900024),0.34568869442588873,1.104759782079281,0.2564102564102564,0.9737006159347704,1.0,12/50,15.43%,LIMS2;EFNA5;GBP1;LIMS1;PDPN;CARMIL1;PTK2;ILK;C1QBP;NEDD9;KANK1;MYADM
prerank,Positive Regulation Of Embryonic Development (GO:0040019),-0.45172627930360565,-1.1047446258194138,0.38636363636363635,0.904325791872297,1.0,4/18,12.23%,OTX2;PLCB1;WNT1;TENM4
prerank,Pattern Recognition Receptor Signaling Pathway (GO:0002221),0.32461392533548017,1.104478076692966,0.20588235294117646,0.9718685250257404,1.0,14/53,14.59%,FFAR2;MAP3K7;TLR5;LY96;PYCARD;TLR8;TLR1;NOD2;COLEC11;MAPKAPK3;NLRP3;TLR2;TLR4;FCN1
prerank,Positive Regulation Of Lipid Kinase Activity (GO:0090218),-0.44907337582799867,-1.1037868436030955,0.34,0.9060190726169322,1.0,3/28,7.04%,FLT1;EEF1A2;MAPT
prerank,Regulation Of Monoatomic Ion Transmembrane Transport (GO:0034765),-0.44953674483261324,-1.1034039770050437,0.38181818181818183,0.905902251725863,1.0,6/24,9.44%,KCNJ14;KCNJ13;KCNJ11;NEDD4;KCNJ9;CALHM1
prerank,Regulation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0043281),-0.3561085472071057,-1.1031608114339544,0.20634920634920634,0.9052878761878399,1.0,18/81,17.93%,MAGEA3;VEGFA;CLEC7A;THBS1;FOXL2;SFN;BLID;SRC;BCL10;F2R;SIAH2;NOD1;PMAIP1;AVP;SIRT1;DNAJB6;TRIAP1;RAF1
prerank,Protein Targeting To Peroxisome (GO:0006625),-0.47114285388276533,-1.1028935404581655,0.36065573770491804,0.9045228417729514,1.0,8/16,27.00%,PEX1;PEX2;PEX12;PEX14;RAB8B;PEX3;PEX16;PEX10
prerank,Positive Regulation Of Cyclin-Dependent Protein Serine/Threonine Kinase Activity (GO:0045737),0.4436794351094217,1.1026789570219762,0.34615384615384615,0.9769497371566809,1.0,5/15,18.20%,PSRC1;RGCC;CCND3;AKT1;MAPRE3
prerank,Carbohydrate Biosynthetic Process (GO:0016051),-0.41634783862831204,-1.102049427838062,0.3508771929824561,0.9053635660789183,1.0,8/22,13.55%,FUT9;FUT6;FUT1;ST8SIA6;ST3GAL3;B3GALT2;FUT4;B4GALT1
prerank,"G Protein-Coupled Receptor Signaling Pathway, Coupled To Cyclic Nucleotide Second Messenger (GO:0007187)",0.34677844840793104,1.1016226803836355,0.2857142857142857,0.9780846140241045,1.0,6/45,4.62%,XCR1;LPAR3;TSHR;HRH4;PTGIR;MTNR1B
prerank,Receptor Signaling Pathway Via STAT (GO:0097696),0.3625382373299416,1.101433345192362,0.24390243902439024,0.9760261833635538,1.0,5/31,5.53%,CSF2RA;MYO1C;CSF2RB;CCR2;GH1
prerank,Positive Regulation Of Cytoskeleton Organization (GO:0051495),0.3113865992259419,1.1013271291064342,0.28205128205128205,0.9733789420524178,1.0,16/75,11.20%,VASP;HCK;MYLK3;NCK2;SEMA5A;F2RL1;CDK5;PYCARD;CARMIL1;GPSM2;CCR7;SYNPO2;CX3CL1;CENPJ;CTTN;CDC42EP1
prerank,Proton Transmembrane Transport (GO:1902600),0.3490122366391431,1.1010848714973238,0.3333333333333333,0.9714323023935487,1.0,21/49,28.10%,COX15;SLC36A2;HVCN1;SLC46A1;FXYD2;ATP6V0E1;SLC36A1;ATP6V0D1;ATP5MF;UCP2;ATP6V0B;ATP1A4;SLC4A11;NNT;ATP6V0E2;ATP4A;SLC9A1;TCIRG1;ATP6AP1;ATP5F1B;ATP1A1
prerank,Positive Regulation Of Vascular Associated Smooth Muscle Cell Proliferation (GO:1904707),-0.45791675298872964,-1.100969498101722,0.41509433962264153,0.9070201994508061,1.0,5/20,13.42%,NR4A3;FGF9;IGF1;MEF2D;IGFBP5
prerank,Regulation Of Microtubule Polymerization (GO:0031113),0.3711012418387685,1.1009292741223946,0.2553191489361702,0.9693264651334073,1.0,14/38,25.28%,CAMSAP3;PSRC1;SNCA;CAMSAP2;MET;CLIP3;PAK1;EML2;GBA2;MAPRE3;MAP2;ARL2;TUBB4A;RPS3
prerank,Water-Soluble Vitamin Metabolic Process (GO:0006767),0.3710097740494469,1.100776787032507,0.37142857142857144,0.9674316330487605,1.0,14/39,16.47%,DHFR2;MMACHC;RFK;SLC52A1;SLC46A1;SLC52A2;DHFR;GSTO2;SLC25A19;MTHFD2;CUBN;HLCS;MMAB;SLC19A1
prerank,Lipid Modification (GO:0030258),-0.3859618096431868,-1.1007300383000258,0.3333333333333333,0.9064082999838129,1.0,10/40,13.85%,CYP3A5;DGKB;ALOX15;MBOAT2;PLPPR2;DGKE;PLPPR3;PLPP5;CYP3A4;CYP2E1
prerank,Late Endosome To Vacuole Transport (GO:0045324),0.4503775330350507,1.1004680810654737,0.4090909090909091,0.9656328030183587,1.0,1/18,0.98%,CHMP4C
prerank,Autophagosome Assembly (GO:0000045),-0.37190350178533044,-1.100340478830127,0.29508196721311475,0.906197170386491,1.0,19/64,22.98%,IRGM;MAP1LC3C;ATG16L1;ATG2A;UBXN2A;GABARAPL1;RUFY4;TP53INP2;EMC6;WDR45B;TMEM41B;RB1CC1;ATG5;ATP2A2;ATG4D;UBQLN1;ULK2;SMURF1;ATG14
prerank,Purine Ribonucleotide Metabolic Process (GO:0009150),0.3086769559518768,1.0988261922289373,0.25,0.9699644396718589,1.0,24/81,21.32%,SULT2B1;NT5E;HSPA1A;ENPP1;SULT1B1;GIMAP7;ACSM2B;FIGNL1;AMPD2;TPST1;SULT1A1;CTNS;ACOT1;AK4;ACSM3;NADK;SULT1C4;HSPA8;BPNT1;NT5C2;ACOT7;SULT2A1;EPHA2;MFN1
prerank,Regulation Of Transferase Activity (GO:0051338),-0.4647370346686747,-1.0988128346106134,0.41304347826086957,0.9099267151110203,1.0,7/20,23.96%,LDB2;SPTSSB;BAG5;EMP2;HPF1;PUM3;LDB1
prerank,Positive Regulation Of Cardiac Muscle Tissue Growth (GO:0055023),0.4507518190173577,1.0985987288887604,0.2826086956521739,0.9677750444177513,1.0,4/16,8.21%,PIM1;GLI1;FGF2;NOTCH1
prerank,Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050730),-0.3612308329681845,-1.0981294154323071,0.35294117647058826,0.9099556849395544,1.0,15/84,13.59%,VEGFA;GHR;BANK1;IGF1;RIPK2;PRNP;IL11;IL15;SRC;ANGPT1;PLCG2;VTN;PRKCD;SAMSN1;ITGB3
prerank,Negative Regulation Of Stress-Activated MAPK Cascade (GO:0032873),0.36643143073885465,1.0978937924077887,0.3181818181818182,0.9676732224462459,1.0,11/36,21.15%,DACT1;MYC;SIRPA;F2RL1;MARVELD3;FOXM1;PRMT1;SH3RF2;MEN1;PPIA;NCOR1
prerank,Regulation Of Androgen Receptor Signaling Pathway (GO:0060765),0.39092352110208967,1.0977997129710884,0.32,0.9651677396067835,1.0,8/27,21.15%,FOXH1;PRMT2;HEYL;SFRP1;PHB1;PARK7;KDM1A;NCOR1
prerank,Regulation Of Signal Transduction (GO:0009966),0.2829597164949318,1.0976881893392771,0.2777777777777778,0.9627325320963885,1.0,32/182,11.06%,GNG4;RGS16;SOCS2;PIGBOS1;IGFBP7;TMEM108;CHRNA7;GLI1;PTPN2;TRIM5;ADIPOQ;DOK5;DTX1;SLC24A4;IFT81;NCK2;SEMA5A;FRMPD1;PLSCR1;CD80;PRAG1;CD36;SLC8A2;RGS14;CD24;ITGA3;CX3CL1;RASGRP4;FRRS1L;CSK;GSKIP;TIMP1
prerank,Negative Regulation Of Cell-Matrix Adhesion (GO:0001953),-0.40092795414443805,-1.0970795905616455,0.3090909090909091,0.9124190751221631,1.0,4/27,10.29%,THBS1;ACVRL1;APOD;SRC
prerank,Negative Regulation Of Double-Strand Break Repair (GO:2000780),0.36567791129344096,1.095423086069,0.3333333333333333,0.9693169260790816,1.0,2/33,2.77%,TWIST1;RMI2
prerank,Negative Regulation Of Lymphocyte Proliferation (GO:0050672),0.3580808020249437,1.0953653563306158,0.3,0.9668006528461347,1.0,11/37,13.69%,CD86;CR1;HLA-DRB1;FOXP3;CD80;HLA-G;LILRB1;PDCD1LG2;LILRB4;LST1;SOX11
prerank,Response To Estrogen (GO:0043627),0.375532577567647,1.0947878899305992,0.3170731707317073,0.966647823629169,1.0,11/33,23.06%,NCOA4;ESR2;ZNF366;CD24;GSTM3;SFRP1;KMT2D;GATA3;CYP27B1;CITED4;TRIM25
prerank,Regulation Of Protein Kinase B Signaling (GO:0051896),-0.3264465181709632,-1.0942363653931764,0.3333333333333333,0.9209580303283645,1.0,21/131,11.46%,AKR1C2;IL26;SPRY2;MAGI2;BANK1;THBS1;MSTN;IL18;CHI3L1;MST1R;IGF1;AKR1C3;CASS4;TCF7L2;GDF15;RET;SH2B3;SRC;ANGPT1;MUL1;PIK3CA
prerank,Cytoskeleton Organization (GO:0007010),-0.3353207785035709,-1.094195301713968,0.29411764705882354,0.9194060006997494,1.0,20/110,14.54%,CCL7;PALLD;SH3D19;MARK1;EPB41L3;ZNF135;TNFAIP3;ARHGAP21;SEMA6A;PLCE1;DIAPH3;DIAPH1;CCL2;PRR5;FMNL2;FGD5;THY1;CNTNAP1;WASF3;ZMYM6
prerank,Positive Regulation Of Protein Catabolic Process (GO:0045732),-0.3466309535837847,-1.094169713853618,0.3181818181818182,0.9178220974444006,1.0,14/89,9.72%,NUPR1;SH3D19;ASB9;IL1B;APC2;ADAM9;TNFAIP3;IFNG;ASB11;NEDD4;KCNE2;ASB5;PRKN;TIPARP
prerank,Neutral Amino Acid Transport (GO:0015804),0.37249209393090105,1.093362581539282,0.3170731707317073,0.9697750231169818,1.0,12/33,16.91%,SLC1A4;SLC1A5;SLC1A1;SLC36A2;SLC38A3;SLC7A10;SLC38A5;SLC36A1;SLC6A9;SLC6A14;SLC38A9;SLC6A20
prerank,Negative Regulation Of Inflammatory Response (GO:0050728),0.307927667773437,1.0933303850623006,0.4117647058823529,0.9670866688631446,1.0,32/101,17.38%,SIGLEC10;HLA-DRB1;ALOX5;KLF4;HCK;PTPN2;ADIPOQ;SIRPA;IL4;MVK;PTPN6;TNFAIP8L2;CXCL17;CD200;IL13;MFHAS1;NLRP3;PLK2;SLAMF8;ELF4;GRN;CD200R1;FNDC4;PROC;GPER1;NR1H4;SMPDL3B;PYDC2;IL10RA;TRIM65;GBA1;GATA3
prerank,Regulation Of Cardiac Muscle Contraction (GO:0055117),-0.4051769473944709,-1.0930267764737653,0.32,0.9195787581297988,1.0,5/34,11.44%,SCN5A;RGS2;SLC8A1;ZC3H12A;PDE4B
prerank,Action Potential (GO:0001508),-0.39711092789703456,-1.092953902309423,0.36363636363636365,0.9181125048184551,1.0,6/31,8.34%,SLC4A3;SCN5A;SCN4A;MYH7B;SCN3B;KCNE2
prerank,Positive Regulation Of Chemokine Production (GO:0032722),0.3233801042320811,1.0921073033115074,0.1891891891891892,0.9698112147778668,1.0,13/52,13.16%,TWIST1;AIRE;FFAR2;EGR1;ADIPOQ;F2RL1;PYCARD;IL6R;LGALS9;OAS1;TSLP;TLR2;TLR4
prerank,Positive Regulation Of Ubiquitin-Dependent Protein Catabolic Process (GO:2000060),0.32000132384665264,1.0919785310498014,0.2571428571428571,0.9675751693298286,1.0,21/81,17.64%,HSPA1A;PLK1;FBXO22;CBFA2T3;NKD2;PRICKLE1;TRIB3;HECTD1;PTK2;RNF180;GSK3A;RNF19A;TRIB2;TRIB1;DAB2;RBX1;KEAP1;VCP;SH3RF2;RACK1;CCDC22
prerank,Stress Granule Assembly (GO:0034063),-0.4430865128303415,-1.0918186681957098,0.36065573770491804,0.9199555961536241,1.0,11/23,28.29%,MAPT;CSDE1;GRB7;YTHDF3;DDX6;G3BP2;DAZAP2;YTHDF2;DYNC1H1;BICD1;CIRBP
prerank,Protein Monoubiquitination (GO:0006513),-0.3686690671701374,-1.091576004615352,0.2982456140350877,0.9193697225999307,1.0,14/47,20.00%,RNF220;KBTBD8;FANCL;ITCH;TOPORS;PRKN;PEX2;FANCB;PEX12;TRIM21;FANCC;FAAP20;MARCHF7;OBI1
prerank,Membrane Assembly (GO:0071709),0.37146996785277697,1.0913102138185353,0.3333333333333333,0.9672588487844018,1.0,11/37,24.28%,CHMP4C;DMKN;ANXA2;NRXN2;PTPRD;NLGN2;UGCG;PTEN;CHMP2A;SPAST;SPTBN1
prerank,Branched-Chain Amino Acid Catabolic Process (GO:0009083),0.42762350393015336,1.0912730274324471,0.30612244897959184,0.9647709794455246,1.0,7/16,26.82%,HMGCL;SLC25A44;ECHS1;BCKDK;ACAT1;HIBADH;ALDH6A1
prerank,Negative Regulation Of Binding (GO:0051100),0.3068332399030766,1.0911385352964749,0.27906976744186046,0.9625409378291817,1.0,23/82,23.01%,DACT1;ARHGAP28;TTBK1;MAPK8;IFIT1;AURKB;EFHB;SUMO4;LEF1;XIRP1;DAB2;CAMK1;PARK7;RACK1;AKT1;GTF2F1;CARD16;MITD1;KDM1A;ITGB1BP1;SMO;PPP1CA;E2F1
prerank,Negative Regulation Of Smoothened Signaling Pathway (GO:0045879),0.39124582456874313,1.0909091531888586,0.34210526315789475,0.9608366920002013,1.0,10/25,17.53%,GLIS2;GLI1;ENPP1;SUFU;RFX8;RFX4;KCTD21;VCP;HERC4;RACK1
prerank,Response To Tumor Necrosis Factor (GO:0034612),-0.3231276441569021,-1.0905320910145924,0.24193548387096775,0.9214084668038863,1.0,13/101,8.85%,CCL7;CCL22;XCL1;CXCL8;CHI3L1;CCL14;LRRK2;CASP8;ADAM9;NFKBIA;CXCL16;ZC3H12A;BRCA1
prerank,Potassium Ion Homeostasis (GO:0055075),0.4162437805916049,1.090138459549022,0.32727272727272727,0.9608929902447796,1.0,6/21,16.40%,ATP1B2;SLC12A3;FXYD2;SLC12A5;KCNH2;SLC12A7
prerank,T Cell Activation Involved In Immune Response (GO:0002286),-0.40848725717412104,-1.0898665620205334,0.3333333333333333,0.9221773826387805,1.0,3/27,1.82%,IFNA6;SLC11A1;IFNA7
prerank,Positive Regulation Of Tumor Necrosis Factor Production (GO:0032760),-0.34434350821255016,-1.0895314674875538,0.3125,0.9214238824256143,1.0,8/74,5.80%,AZU1;CLEC7A;LILRA2;THBS1;TYROBP;IFNGR1;FZD5;IFNG
prerank,Regulation Of Bone Mineralization (GO:0030500),0.32495820760286187,1.089506627545571,0.3023255813953488,0.9606803423699843,1.0,13/58,16.70%,TWIST1;BMP4;ALOX5;SGMS2;ENPP1;ANKH;CCNA2;KL;ISG15;P2RX7;ACVR2A;RXRB;BMP6
prerank,Negative Regulation Of Cellular Senescence (GO:2000773),0.40335695213140077,1.0893775355751296,0.3333333333333333,0.9586472725421896,1.0,6/17,21.25%,TWIST1;AMH;ZKSCAN3;TBX2;SIRT6;PTEN
prerank,Cell-Cell Adhesion Via Plasma-Membrane Adhesion Molecules (GO:0098742),-0.32413404923641637,-1.0892629397966243,0.3181818181818182,0.9207470883524502,1.0,31/155,12.39%,CXADR;CDH18;PALLD;CDH4;TGFB2;CLDN19;CDH8;PCDHB13;CLDN16;CDH13;VCAM1;SCARF2;PLXNB3;DSG2;DSCAML1;REG3A;CDH2;CDH22;CRB2;PTK7;PCDHGC3;ITGAM;CLDN8;PCDHB10;CD209;ALCAM;PCDHB11;CEACAM8;TENM4;PCDHB9;CLDN9
prerank,Regulation Of Platelet Aggregation (GO:0090330),-0.4334150832530051,-1.0883842472316736,0.34545454545454546,0.9219931587980144,1.0,10/25,17.66%,ALOX12;CELA2A;MFSD2B;LYN;C1QTNF1;SH2B3;PRKCD;JAK2;GP6;PRKG1
prerank,Eye Development (GO:0001654),-0.38290656421652275,-1.0883722468823216,0.2903225806451613,0.9203961391766221,1.0,7/49,7.34%,TGFB2;MEIS2;COL5A1;MEIS1;FOXE3;PBX1;FREM2
prerank,Cortical Actin Cytoskeleton Organization (GO:0030866),-0.45217663257842905,-1.0873234208456246,0.36,0.9225031626917907,1.0,6/19,21.14%,NCKAP1;RHOQ;FHOD3;FMNL2;DLG1;RAB13
prerank,Positive Regulation Of Histone Methylation (GO:0031062),-0.4669725504276794,-1.0863829797841287,0.40816326530612246,0.9243822596225401,1.0,8/19,30.20%,BRCA1;INSL6;SMARCA5;KANSL2;SIRT1;KANSL1;RRP8;BAZ2A
prerank,Positive Regulation Of Striated Muscle Cell Differentiation (GO:0051155),-0.4331843468189612,-1.0863373648334886,0.3877551020408163,0.9228628577755763,1.0,2/20,4.38%,RBM24;IGF1
prerank,Lung Development (GO:0030324),-0.45073959662355945,-1.085993202137476,0.31666666666666665,0.9223554416726476,1.0,4/29,3.21%,VEGFA;WNT11;FGF9;CHI3L1
prerank,Negative Regulation Of Protein Kinase B Signaling (GO:0051898),-0.40272268678511314,-1.0846144575870484,0.32075471698113206,0.9255584193761277,1.0,3/35,1.41%,MAGI2;BANK1;MSTN
prerank,"Regulation Of DNA Damage Response, Signal Transduction By P53 Class Mediator (GO:0043516)",-0.4127083791019004,-1.0843862822197874,0.32,0.924738002233469,1.0,9/27,19.78%,PLA2R1;HIC1;SOX4;SPRED1;SNAI1;PMAIP1;SIRT1;YJU2;MARCHF7
prerank,Regulation Of Protein Sumoylation (GO:0033233),0.42545823863308113,1.084135419236177,0.3783783783783784,0.9776493530778889,1.0,8/17,26.40%,EGR1;RASD2;PARK7;UBA2;PIAS3;SAE1;GNL3L;RWDD3
prerank,Regulation Of Sprouting Angiogenesis (GO:1903670),0.36285038750515414,1.0841152284076077,0.36363636363636365,0.9749944629664524,1.0,6/32,4.36%,CREB3L1;CEACAM1;E2F2;ALOX5;KLF4;FGF2
prerank,Positive Regulation Of Epidermal Cell Differentiation (GO:0045606),0.4310694227414961,1.083909355627881,0.4339622641509434,0.9731246643233523,1.0,3/18,11.86%,SULT2B1;ZBED2;TRIM16
prerank,Heme Biosynthetic Process (GO:0006783),0.45710492573365813,1.0834442216800273,0.4222222222222222,0.9723778796668132,1.0,8/19,26.07%,COX15;ABCB6;HMBS;ALAS1;COX10;ALAD;CPOX;UROD
prerank,Negative Regulation Of Apoptotic Process (GO:0043066),-0.28349315909276407,-1.0833175388397605,0.2222222222222222,0.9270516208627091,1.0,58/449,12.43%,KDR;MAGEA3;CLEC5A;VEGFA;AZU1;RHBDD1;SPRY2;NUPR1;THBS1;ALOX12;SIX4;SMAD6;GATA6;MAGEA4;NKX2-6;FMN2;NUP62;FLT4;CIDEA;LTK;TLE1;IGF1;CLCF1;NR4A2;PIK3R1;CARD14;FOXE3;HSPA1B;SFN;WNT1;ITCH;TNFRSF6B;SMAD5;HPN;PIK3R3;ARHGAP21;ZC3H12A;IL7;PRKN;HMGN5;SUPV3L1;SRC;ZNF830;ASNS;ANGPT1;MT3;BCL3;PIK3CA;YAP1;CCL2;PRKCG;ZNF16;PRR5;MAPK8IP2;IL31RA;F2R;SIAH2;PRKCD
prerank,Regulation Of Mitochondrion Organization (GO:0010821),-0.3861878506358981,-1.0832946811262782,0.3220338983050847,0.9255409251076087,1.0,12/49,21.04%,STOX1;LRRK2;FZD5;MAPT;PDE2A;PRKN;MUL1;EP300;SREBF2;SFI1;RAP1GDS1;USP36
prerank,Ganglioside Metabolic Process (GO:0001573),0.40523602401936865,1.0821899648984585,0.3181818181818182,0.9748056415494818,1.0,8/17,16.92%,ST6GALNAC5;HEXA;ST6GALNAC4;ST6GALNAC3;NEU3;GM2A;CLN6;ST8SIA4
prerank,Regulation Of Hydrolase Activity (GO:0051336),0.34220210606458756,1.0816317124607333,0.2708333333333333,0.9747433908357591,1.0,12/69,10.54%,RASIP1;PLXNA4;EPHB3;ARHGAP44;BVES;EFNA5;FGD6;EPHA4;PLXNB1;PLXNB2;ARHGAP27;PTK2
prerank,RNA Phosphodiester Bond Hydrolysis (GO:0090501),0.3997198675922192,1.0813104292611095,0.3225806451612903,0.9736567167774077,1.0,12/28,21.48%,ZC3H12C;POP1;ZC3H12D;LACTB2;CSTF3;NYNRIN;RNASE6;ZC3H12B;RPP30;XRN1;NHP2;PCF11
prerank,Regulation Of Myelination (GO:0031641),-0.4238880656986556,-1.0810510663566533,0.3076923076923077,0.9322711367847699,1.0,7/25,13.63%,PARD3;TMEM98;LGI4;ZPR1;DICER1;TENM4;TPPP
prerank,Regulation Of Cholesterol Metabolic Process (GO:0090181),-0.4319615011951063,-1.0808574138546991,0.32142857142857145,0.9314627871676673,1.0,6/23,9.82%,APOA1;AQP8;CES1;SEC14L2;FMO5;ABCG1
prerank,Negative Regulation Of Apoptotic Signaling Pathway (GO:2001234),0.31370627104008236,1.0808250419385292,0.36585365853658536,0.9728118041657557,1.0,12/80,10.24%,NOL3;BMP4;FAIM2;HSPA1A;PLAUR;ITGA6;CX3CR1;IL4;HTT;CX3CL1;SLC25A4;BCL2L1
prerank,Response To Hexose (GO:0009746),-0.44013310682911305,-1.0807779569308373,0.37037037037037035,0.930133066728028,1.0,4/22,9.34%,THBS1;KLRG1;TCF7L2;IRS2
prerank,Negative Regulation Of RNA Splicing (GO:0033119),-0.44716669010284815,-1.0807301463350747,0.3877551020408163,0.9286817000031317,1.0,1/19,0.96%,RBM20
prerank,Renal System Development (GO:0072001),-0.37647208562113454,-1.080212008146281,0.3103448275862069,0.9288745967434486,1.0,3/52,1.48%,VEGFA;PAX8;TGFB2
prerank,Cellular Response To Organonitrogen Compound (GO:0071417),0.3030759117039185,1.0800689265152437,0.34375,0.972860011699923,1.0,12/103,8.04%,AKAP6;RAPGEF1;TSHR;EGR1;CDH1;HCN2;SH3BP4;SPAAR;P2RY6;AOC1;RYR3;LAMTOR2
prerank,Positive Regulation Of Protein Secretion (GO:0050714),-0.3456476026125103,-1.079571876930159,0.3389830508474576,0.9292466337635849,1.0,14/73,11.41%,TGFB2;SYTL4;DOC2B;FFAR1;IGF1;CD33;SOX4;PPARG;ADAM9;ANG;TCF7L2;IRS2;ABCG1;C1QTNF3
prerank,Regulation Of NMDA Receptor Activity (GO:2000310),0.4241228045207873,1.0795572793835015,0.28888888888888886,0.9724388354381224,1.0,6/15,15.57%,CCR2;DAPK1;CAPN1;OPRM1;DLG4;SLC6A9
prerank,Positive Regulation Of Phosphate Metabolic Process (GO:0045937),-0.405635541502093,-1.0794069725183357,0.36585365853658536,0.9282711152417171,1.0,7/28,11.78%,THBS1;FZD7;GLMN;IFNG;ANG;SRC;BCL10
prerank,Positive Regulation Of Proteolysis (GO:0045862),-0.3584440501236162,-1.0791422624765625,0.3384615384615385,0.9274244274873052,1.0,10/57,8.73%,RHBDD1;SH3D19;IL1B;CASP8;ADAM9;IFNG;TNP2;PERP;ASTL;ZC3H12A
prerank,Sensory Perception Of Light Stimulus (GO:0050953),-0.3149382933349175,-1.0782832146605317,0.29310344827586204,0.9290670691966739,1.0,15/89,10.96%,ADGRV1;COL1A1;CRYBB1;ZIC2;VAX2;DHRS3;RDH12;CABP4;POU6F2;TH;WHRN;BEST1;CRYBB2;NXNL2;ATXN7
prerank,Positive Regulation Of Cellular Component Organization (GO:0051130),-0.3324709923670695,-1.0781174872371986,0.2903225806451613,0.9280076602292575,1.0,8/105,5.80%,VEGFA;CLEC7A;TGFB2;SLC18A3;CLDN19;CALY;CAMK2B;IFNG
prerank,Response To Interleukin-1 (GO:0070555),-0.3401361152147123,-1.077853107712171,0.3333333333333333,0.9272371338815885,1.0,8/80,4.19%,CCL7;CCL22;IL1B;XCL1;CXCL8;CHI3L1;CCL14;TRAF6
prerank,Positive Regulation Of Proteolysis Involved In Protein Catabolic Process (GO:1903052),-0.4119418556836266,-1.0776852376544148,0.2807017543859649,0.9263980944530895,1.0,4/29,9.87%,NUPR1;KCNE2;PRKN;PYHIN1
prerank,Mitotic Spindle Assembly Checkpoint Signaling (GO:0007094),0.39733339583227373,1.0775590036714515,0.3333333333333333,0.9726366151336946,1.0,11/26,23.09%,CENPF;PLK1;CDC20;TRIP13;ZWINT;TEX14;SPC24;ATM;HASPIN;BUB1B;BUB1
prerank,Mitotic Spindle Checkpoint Signaling (GO:0071174),0.39733339583227373,1.0775590036714515,0.3333333333333333,0.9726366151336946,1.0,11/26,23.09%,CENPF;PLK1;CDC20;TRIP13;ZWINT;TEX14;SPC24;ATM;HASPIN;BUB1B;BUB1
prerank,Spindle Assembly Checkpoint Signaling (GO:0071173),0.39733339583227373,1.0775590036714515,0.3333333333333333,0.9726366151336946,1.0,11/26,23.09%,CENPF;PLK1;CDC20;TRIP13;ZWINT;TEX14;SPC24;ATM;HASPIN;BUB1B;BUB1
prerank,Regulation Of Protein Deacetylation (GO:0090311),-0.42846438154337124,-1.0774070536571474,0.4074074074074074,0.9257218299970268,1.0,6/18,18.17%,IFNG;SPRED1;MBIP;EP300;NNMT;KAT14
prerank,Regulation Of Fibroblast Migration (GO:0010762),-0.4297882774992784,-1.0773835600811976,0.32653061224489793,0.9242321586006909,1.0,2/19,2.41%,THBS1;DDR2
prerank,Regulation Of Cell Communication (GO:0010646),-0.4029742930295493,-1.077326411175303,0.35714285714285715,0.9229246444785887,1.0,6/46,7.29%,CXADR;GRK4;CASQ2;NUP62;GRK7;SLC8A1
prerank,Axon Extension (GO:0048675),-0.43089593415804717,-1.0772347834790297,0.2222222222222222,0.9219043837618187,1.0,9/22,21.49%,SEMA3F;AUTS2;NELL2;SLIT2;SLIT1;SEMA3A;NLGN3;PPP3CB;ULK2
prerank,"Protein Localization To Chromosome, Centromeric Region (GO:0071459)",0.44912188406551445,1.0771888595366292,0.32608695652173914,0.9716533312318701,1.0,9/18,30.65%,CDK1;H4C9;KNL1;SPDL1;BOD1;HASPIN;H2BC11;CENPA;H2AC8
prerank,Positive Regulation Of Plasma Membrane Bounded Cell Projection Assembly (GO:0120034),-0.34539028498561175,-1.0765803140738925,0.3275862068965517,0.9226871276136794,1.0,16/82,15.78%,DEF8;MSTN;CDC42EP4;AUTS2;HRAS;NCKAP1;PIK3R1;WNT1;PLCE1;RHOQ;PIK3CA;P2RY12;MYO3B;CEP120;CROCC;TENM2
prerank,Positive Regulation Of Alpha-Beta T Cell Activation (GO:0046635),0.42923496115329396,1.0765729671567357,0.30357142857142855,0.9715238653643163,1.0,3/18,2.14%,HLA-A;HLA-DRB1;EBI3
prerank,Negative Regulation Of DNA-binding Transcription Factor Activity (GO:0043433),0.2828972612211868,1.0760144108351248,0.3,0.9715233168003847,1.0,34/142,17.56%,FZD6;GLIS2;FOXH1;PIM1;E2F2;KLF4;TNFRSF4;FOXP3;CDKN2A;CYP1B1;SUFU;PYCARD;FOXJ1;CD200;IRAK3;HDAC2;PRMT2;HEYL;NLRP3;NWD1;PARP10;CMKLR1;COMMD7;DAP;TRIB1;TAX1BP1;WFS1;KEAP1;HIF1AN;PYDC2;ID3;TMSB4X;MEN1;RBCK1
prerank,Positive Regulation Of Leukocyte Cell-Cell Adhesion (GO:1903039),0.3352853890543343,1.0759235401351384,0.36585365853658536,0.9693487127205817,1.0,11/41,15.20%,HLA-DRB1;CCR2;HLA-DMB;SIRPA;PYCARD;HSPD1;HLA-DQA1;TNFSF11;SIRPG;HLA-DQA2;HLA-DPA1
prerank,Actin Filament Bundle Assembly (GO:0051017),-0.3768252752416532,-1.0757934980942658,0.3584905660377358,0.9239251026290546,1.0,4/33,11.41%,CALD1;ESPN;MYO1B;PAWR
prerank,Response To Zinc Ion (GO:0010043),-0.440190310399364,-1.0752973274949558,0.36507936507936506,0.924051186428508,1.0,4/23,6.76%,PAM;MT1M;SLC30A4;HAAO
prerank,Embryonic Skeletal System Development (GO:0048706),-0.41622635825321985,-1.0744822315357032,0.3584905660377358,0.9252475047620523,1.0,3/31,4.34%,WNT11;COL1A1;DSCAML1
prerank,Positive Regulation Of Lymphocyte Migration (GO:2000403),0.40310179921054934,1.0743920527938855,0.34782608695652173,0.9726191289103032,1.0,5/16,22.42%,PYCARD;DOCK8;NEDD9;JAM2;AIF1
prerank,Ruffle Organization (GO:0031529),0.41809094743010067,1.0742957159980624,0.4222222222222222,0.9705040153566882,1.0,4/16,10.44%,CARMIL1;CCR7;CORO1B;CYFIP1
prerank,Positive Regulation Of Neuron Projection Development (GO:0010976),-0.33075603450826296,-1.0740341572782868,0.36507936507936506,0.9251080764319701,1.0,10/88,4.86%,ROR2;FUT9;MAGI2;ZDHHC15;DDR2;NDRG4;LYN;LTK;PLXNB3;CAMK2B
prerank,Negative Regulation Of Epithelial To Mesenchymal Transition (GO:0010719),-0.43639035564979134,-1.073162520432243,0.4,0.9264734500493008,1.0,4/26,8.34%,SPRY2;MARK1;SPRED1;HPN
prerank,Response To Steroid Hormone (GO:0048545),-0.39317205839626096,-1.072980620083546,0.3333333333333333,0.9254942145042697,1.0,4/28,6.79%,THBS1;TGFB2;ATP1A2;HSPA1B
prerank,Intracellular Monoatomic Cation Homeostasis (GO:0030003),-0.30045118426103173,-1.0728726253367837,0.3561643835616438,0.924204506435041,1.0,53/181,23.79%,CCL7;CASQ2;SLC11A1;SCNN1B;EDN2;EDN3;GLRX3;CLDN16;SCNN1A;ATP2A1;CTRC;CCL14;ANKRD9;ATP1A2;SLC8A1;PRNP;ATP13A4;ATP12A;SLC39A8;EDN1;MT3;CYBRD1;FTMT;IREB2;LETM2;STIM2;SLC24A3;SLC30A1;CCR1;CALCB;CXCL12;SCNN1D;PICALM;CNNM4;SLC30A8;HTR2A;HAMP;FLVCR1;DRD4;ATP2A2;TMEM199;NPTN;COX19;FTH1;SCARA5;ARF1;RYR2;PKHD1;SLC30A2;ALAS2;ATP6V1G1;TRDN;CCL5
prerank,Response To Insulin (GO:0032868),0.3164934229867003,1.072428993658711,0.3333333333333333,0.9757841011478787,1.0,23/78,22.05%,TBC1D4;CEACAM1;ZBTB7B;RAB31;ENPP1;RAB10;MEAK7;TRIB3;SLC39A14;PLA2G1B;GSK3A;EIF6;GPLD1;LPIN3;PRKCI;INSR;LEP;AKT1;PKLR;IRS1;HDAC9;PIK3R2;LPIN2
prerank,Regulation Of Protein Targeting To Membrane (GO:0090313),-0.3921391149114654,-1.0722878613249407,0.38636363636363635,0.9248683425142952,1.0,8/28,13.82%,CEMIP;HRAS;PDZK1;PRNP;ITGAM;TCAF2;MIEF1;ANK3
prerank,Positive Regulation Of Cation Channel Activity (GO:2001259),0.35066069721914156,1.0718764361433064,0.32432432432432434,0.9751396505350517,1.0,4/34,7.56%,AKAP6;HTT;P2RY6;STAC
prerank,Secondary Alcohol Metabolic Process (GO:1902652),0.33423968933073733,1.0716953332315422,0.37142857142857144,0.9734636813731823,1.0,13/44,20.41%,SULT2B1;IL4;CH25H;CYP27A1;LCAT;OSBPL1A;SOAT2;GBA2;CLN6;GBA1;LDLRAP1;GLB1;SULT2A1
prerank,Intrinsic Apoptotic Signaling Pathway By P53 Class Mediator (GO:0072332),-0.38824686739546055,-1.0716633582564514,0.3333333333333333,0.9250955861003041,1.0,1/35,0.08%,RPS27L
prerank,Negative Regulation Of MAP Kinase Activity (GO:0043407),-0.370928496795167,-1.0716514425952508,0.3582089552238806,0.9236049385915597,1.0,12/50,16.29%,SPRY2;IL1B;LYN;RGS2;PPARG;SH2B3;DUSP1;CD300A;PRKCD;PTPN22;BMP2;SPRY3
prerank,Base-Excision Repair (GO:0006284),0.3473702060194215,1.0712730364245076,0.3269230769230769,0.9730049072026932,1.0,16/36,29.45%,APEX2;POLL;RPA2;UNG;SMUG1;RPA3;OGG1;APEX1;NTHL1;XRCC1;MPG;DNA2;PARG;RPA1;POLD1;HUWE1
prerank,Positive Regulation Of Protein-Containing Complex Assembly (GO:0031334),0.3046792894640356,1.0709374555919615,0.2682926829268293,0.9717701283172604,1.0,11/96,7.54%,CXCL13;RASIP1;TPPP3;TTBK1;MAPK8;BID;CAPG;BIK;SNCA;TCL1A;CD36
prerank,Negative Regulation Of Cell Development (GO:0010721),-0.4316047794471005,-1.0702806429007115,0.46808510638297873,0.9266559694896975,1.0,6/21,16.20%,IL1B;RFLNA;IGF1;WNT7A;DYNLT1;PAX6
prerank,Cellular Defense Response (GO:0006968),-0.3910219805561565,-1.0701094723330489,0.36065573770491804,0.9255480106959273,1.0,9/46,11.34%,CLEC5A;TYROBP;KLRC3;KLRG1;C5AR1;NCF1;ZNF148;CCR6;NCR1
prerank,Negative Regulation Of Intracellular Signal Transduction (GO:1902532),-0.29679954957593385,-1.0688706314239182,0.34328358208955223,0.9279297622965126,1.0,50/223,17.55%,NUAK1;MAGI2;BANK1;THBS1;MSTN;CGNL1;PBLD;IRGM;LYN;PER1;RORA;TLE1;CASP8;DUSP2;PPARG;TNFAIP3;SPRED1;DUSP5;PDE2A;ZC3H12A;PDE11A;HERPUD1;DLG5;DUSP8;AKT1S1;SH2B3;SRC;SLC39A8;DUSP1;TRIM60;SLIT2;TRIM40;TRIM39;MUL1;C1QTNF3;ADGRG3;NR1D1;PPM1A;BMAL1;ARHGAP12;GPD1L;SPRY3;PHLPP1;CARD19;UBR1;DGKG;SIRT1;PPM1B;PRKAA2;PPARA
prerank,Positive Regulation Of Cold-Induced Thermogenesis (GO:0120162),0.3023834947103952,1.0685037461241733,0.35294117647058826,0.9787813554643323,1.0,18/94,11.51%,TRPM8;ZBTB7B;TSHR;CCR2;ADIPOQ;APC;GNAS;IL4;DIO2;CD36;GRB10;ADIPOR2;IL13;YBX2;MUC1;CMKLR1;BSCL2;IRF4
prerank,Negative Regulation Of Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0032435),0.40098818801763997,1.0679047185500012,0.3888888888888889,0.9786120950224565,1.0,6/29,16.06%,FHIT;MAP1A;HFE;PHF20L1;CCAR2;PARK7
prerank,Adaptive Immune Response Based On Somatic Recombination Of Immune Receptors Built From Immunoglobulin Superfamily Domains (GO:0002460),0.39339018995700825,1.0671390469909352,0.34146341463414637,0.9790416604745582,1.0,3/21,2.14%,CR1;HLA-DRB1;EBI3
prerank,Hexose Transmembrane Transport (GO:0008645),-0.427469293263429,-1.0667787780454223,0.31343283582089554,0.933387432987738,1.0,1/21,0.10%,SLC5A1
prerank,Mitotic Spindle Organization (GO:0007052),0.3167782666690981,1.0665752789807708,0.21212121212121213,0.9789720027757627,1.0,16/85,13.24%,CENPE;DLGAP5;AURKB;TPX2;KIF4A;PLK1;BIRC5;FAM110A;GPSM2;STAG2;CHEK2;PLK2;CCNB1;TBCE;CDCA8;EML1
prerank,Protein Autoubiquitination (GO:0051865),-0.34570444148791774,-1.0664430133906928,0.35185185185185186,0.9332541571438746,1.0,18/71,20.00%,RNF186;RNF220;TRAF6;DEPDC1B;ITCH;BRCA1;PRKN;RNF115;RNF4;TRIM21;TRIM11;SH3RF3;KLHL24;RNFT1;ASB4;MARCHF7;RNF141;OBI1
prerank,Positive Regulation Of Exocytosis (GO:0045921),-0.377847922759672,-1.06640164522259,0.3333333333333333,0.9317476497196963,1.0,6/36,10.76%,CFTR;SYTL4;IFNG;RAB9A;TSG101;SMPD3
prerank,Regulation Of Insulin Secretion (GO:0050796),-0.35141373458247327,-1.0654914401087343,0.4,0.9330917922481237,1.0,20/79,17.74%,CELA2A;SNAP25;IL1B;KCNJ11;STX1A;DOC2B;FFAR1;SOX4;IFNG;MIDN;TCF7L2;PRKN;IRS2;NR1D1;BMAL1;BRSK2;KCNA5;EIPR1;SIRT4;SLC30A8
prerank,Positive Regulation Of Receptor-Mediated Endocytosis (GO:0048260),-0.37795953153960243,-1.0652348617110854,0.36363636363636365,0.9322751209535499,1.0,6/42,12.35%,VEGFA;MAGI2;CCL14;SGIP1;ANGPT1;VTN
prerank,Positive Regulation Of Lymphocyte Chemotaxis (GO:0140131),-0.46216106775180754,-1.064169204284893,0.44680851063829785,0.9347586426653787,1.0,2/16,3.07%,CCL7;XCL1
prerank,Regulation Of Cell Junction Assembly (GO:1901888),0.3798911228771618,1.0636578913684123,0.35714285714285715,0.9876274155328321,1.0,2/23,1.63%,RAPGEF1;MYO1C
prerank,Negative Regulation Of Interleukin-6 Production (GO:0032715),0.34924386833053206,1.0633841001743873,0.35135135135135137,0.9862257577179253,1.0,10/34,13.16%,SIRPA;FOXJ1;PTPN6;CD200;IRAK3;CX3CL1;ELF4;CD200R1;LILRB4;TLR4
prerank,Positive Regulation Of Myeloid Cell Differentiation (GO:0045639),-0.37102105421784176,-1.0632519623320535,0.3392857142857143,0.9368075008162351,1.0,7/35,15.39%,SCIN;HOXA5;HSPA1B;ACVR1B;ZNF16;FAXDC2;BRD1
prerank,Plasma Membrane Bounded Cell Projection Morphogenesis (GO:0120039),-0.3751040294981391,-1.0628871886338247,0.3709677419354839,0.9362782238301525,1.0,11/47,14.69%,EPB41L3;MYO16;GAS7;LRRK2;NCKAP1;NYAP2;TRIO;DICER1;ZNF335;CNTNAP1;TAOK3
prerank,Negative Regulation Of Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0090101),-0.31959558721989717,-1.0624489834143975,0.296875,0.9361927138542655,1.0,31/101,22.64%,SPRY2;MAGI2;SMAD6;PBLD;CIDEA;RBPMS2;PPARG;WNT1;SPRED1;BAMBI;IGSF1;SMURF2;PEG10;PPM1A;CHRDL1;BMP2;ADAM17;NOG;SIRT1;PPARA;STRAP;ARID4A;BMPER;ARID4B;ING2;SPRED3;SAP30L;SKIL;LRP2;SMURF1;SPRY1
prerank,NAD Metabolic Process (GO:0019674),-0.4483481319192009,-1.062098653452633,0.4,0.9359038147359815,1.0,7/21,15.73%,ME1;KRT17;NADK2;HAAO;QPRT;NUDT12;GPD1L
prerank,Monoatomic Cation Homeostasis (GO:0055080),-0.3197687950043322,-1.061872953541657,0.4098360655737705,0.9350058600616896,1.0,14/73,16.28%,UNC80;SLC11A1;SCNN1B;CYP4F12;CLDN16;SCNN1A;SLC8A1;SLC39A8;MT3;CYBRD1;LETM2;ANK3;TRPV5;PICALM
prerank,Positive Regulation Of Calcium Ion Transmembrane Transporter Activity (GO:1901021),0.38187136850587633,1.0612139322472092,0.38095238095238093,0.9920317169584764,1.0,4/26,7.56%,AKAP6;HTT;P2RY6;STAC
prerank,Axon Guidance (GO:0007411),0.296289104254171,1.0609045922395355,0.41025641025641024,0.9909211157965107,1.0,32/140,10.95%,SEMA6B;EPHB1;NRCAM;PLXNA4;DRAXIN;NFASC;EPHB3;VASP;KALRN;PLEKHG4B;EFNA5;SEMA3G;SIAH1;SEMA5A;EPHA4;ENAH;PLXNB1;EFNA4;ROBO4;NOTCH1;EPHA10;NIBAN2;PLXNB2;L1CAM;IGSF9;SEMA7A;TUBB3;UNC5B;ARHGEF40;CYFIP1;PTK2;SEMA5B
prerank,Sterol Metabolic Process (GO:0016125),0.3057188986618566,1.0608343906964666,0.34375,0.9888103200782008,1.0,21/58,20.97%,SULT2B1;CYP7B1;IL4;CYP1B1;CH25H;CYP27A1;LCAT;CEL;PMVK;CYP8B1;OSBPL1A;SOAT2;GBA2;CLN6;GBA1;LDLRAP1;ARV1;GLB1;SULT2A1;CYP4V2;HMGCR
prerank,Negative Regulation Of Signal Transduction (GO:0009968),-0.30184170341324995,-1.0602618590123751,0.37142857142857144,0.9391689769533622,1.0,57/253,17.28%,FRZB;LILRA2;SPRY2;DKK4;THBS1;GLI3;DCN;HIC1;CXXC4;IL1B;NDRG4;CXCL8;LYN;IL12A;TLE1;NR4A2;KIF26A;RGS2;PPARG;KIF7;CYP26B1;TNFAIP3;TSPAN15;NEDD4;ENTREP1;NOTUM;SMAD5;PALM3;CCNC;SEMA6A;GDF15;APOD;CNOT1;PLIN5;HEY1;PTCH2;MAPK8IP2;PRKCD;MMRN2;TSKU;NRARP;NR1D1;APLN;DKK3;IGFBP5;LGR4;PIP4K2A;SOCS5;BMP2;CITED1;GRB7;SPRY3;MMP14;SLAMF1;NOG;TCIM;PTPRE
prerank,Ventricular Septum Development (GO:0003281),-0.39536772389557623,-1.059956469647512,0.37777777777777777,0.9386570568016753,1.0,10/35,17.57%,TGFB2;SOX4;HEY2;PDE2A;TGFBR3;HEY1;SLIT2;SLIT1;NOG;BMPR2
prerank,Positive Regulation Of Glycolytic Process (GO:0045821),-0.4338229063645985,-1.0599562951736217,0.4375,0.9371182747413446,1.0,4/18,7.14%,SLC4A4;IGF1;IFNG;MLXIPL
prerank,Protein Modification By Small Protein Conjugation (GO:0032446),-0.2821463367497773,-1.0596242942284981,0.3013698630136986,0.9367628900605232,1.0,82/349,20.75%,RNF38;FBXO9;ENC1;ASB9;RNF212;TRIML1;STX1A;RNF220;RNF103;ANKRD9;KLHL13;TRIM72;ARRDC4;ASB11;NEDD4;RNF168;TRIM23;ITCH;RNF135;BSPRY;FBXL2;ASB5;TRIM7;BRCA1;TOPORS;PRKN;TRIM51G;SPSB4;SMURF2;TRIM60;VPS18;TRIM40;TRIM39;FBXO11;MUL1;VCPIP1;NFE2L2;RNF115;TRPC4AP;TRIM10;RNF25;DCUN1D2;KLHL21;CUL5;FBXO24;TRIM21;SMC5;SDE2;LMO7;PIAS1;MSL2;SENP5;KLHL7;GAN;RCHY1;UBR1;TRPM4;UBE2E2;UFM1;EIPR1;SIRT1;TRIM11;KIAA1586;TRIM61;FBXL3;SH3RF3;KLHL24;HACE1;COPS2;RLIM;TRAIP;ASB1;UBR3;OTULIN;NAE1;DTX4;CBLC;KCTD10;DCUN1D5;KCTD13;BIRC7;FBXO32
prerank,Neural Tube Development (GO:0021915),0.4281584517206612,1.059127330159335,0.3148148148148148,0.9928034873018132,1.0,1/17,0.58%,DACT1
prerank,Regulation Of Metal Ion Transport (GO:0010959),0.38965241974962816,1.0590816596827939,0.3953488372093023,0.9904301334471078,1.0,9/32,12.93%,CASR;NKAIN1;HFE;GRIN3B;IL16;ORAI1;SRI;YWHAH;P2RX7
prerank,Phosphatidylserine Metabolic Process (GO:0006658),0.4061225591155556,1.0586498549438803,0.35714285714285715,0.9897000364864814,1.0,2/17,5.85%,OSBPL10;PLSCR1
prerank,Negative Regulation Of Cellular Catabolic Process (GO:0031330),0.2976922489604727,1.0583237305286386,0.2564102564102564,0.988415063089376,1.0,14/65,16.50%,PTPN3;RASIP1;APOC1;HP;MET;FOXK2;TIMP1;GSK3A;GPLD1;DAP;TIMP2;ZKSCAN3;WDR6;IL10RA
prerank,Glycogen Metabolic Process (GO:0005977),-0.42408552094392316,-1.0578882366890925,0.3387096774193548,0.9413833062980974,1.0,1/17,0.32%,PYGL
prerank,Antigen Processing And Presentation Of Endogenous Peptide Antigen (GO:0002483),0.4162498066073369,1.0578387775638123,0.44680851063829785,0.9879844104647063,1.0,5/21,11.26%,HLA-A;HLA-DRB1;HFE;HLA-G;TAP1
prerank,Positive Regulation Of Protein Dephosphorylation (GO:0035307),-0.3847196041728965,-1.0574895805777542,0.36363636363636365,0.9412234690529192,1.0,9/32,18.97%,MAGI2;NSMF;PPP1R16B;PPP2R5A;CD300A;PRKCD;PPP1R15B;ANKLE2;CAMTA1
prerank,Positive Regulation Of Canonical Wnt Signaling Pathway (GO:0090263),-0.3341135134464514,-1.057440333846295,0.31666666666666665,0.9397910406344653,1.0,22/79,17.47%,DKK2;COL1A1;RNF220;LRRK2;SOX4;PTK7;BAMBI;FRAT1;SMURF2;NRARP;DAAM2;PPM1A;BMAL1;ZEB2;CDH3;WNK2;LGR4;CSNK1D;TNKS;TRPM4;PPM1B;CSNK1E
prerank,Regulation Of mRNA Catabolic Process (GO:0061013),-0.37393347469151184,-1.056882768200185,0.32786885245901637,0.9400356938293567,1.0,13/45,24.44%,RBM24;ZC3H12A;CNOT1;MAPKAPK2;PRKCD;YTHDF3;ZFP36L2;UPF1;DHX36;FXR1;ZFP36L1;GTPBP1;YTHDF2
prerank,Phosphatidylinositol Phosphate Biosynthetic Process (GO:0046854),0.34977091107767033,1.0568790810960496,0.36363636363636365,0.9894164995107594,1.0,3/41,1.51%,CISH;SOCS2;SOCS3
prerank,Negative Regulation Of Cell Growth (GO:0030308),-0.32302854444012424,-1.0563157959837703,0.3,0.9405133118628232,1.0,34/121,20.49%,FRZB;WNT11;TGFB2;FGF13;WFDC1;ACVRL1;KIAA0319;OSGIN1;CDKN1A;CGRRF1;HSPA1B;OSGIN2;BRCA1;NPR1;BCL6;SLIT2;MT3;CDHR2;MUL1;SERTAD2;DCBLD2;SERTAD3;BTG1;CDKN1B;SLIT1;SIRT1;BMPR2;TSPYL2;PRDM11;IP6K2;CDKN2AIP;FHL1;CDKN2D;FBP1
prerank,Regulation Of Neuron Apoptotic Process (GO:0043523),0.2980445151387807,1.0561674088692918,0.39215686274509803,0.9897085792459082,1.0,29/98,21.92%,GPRASP3;FAIM2;KCNB1;EGR1;EGLN3;TRIM2;FGF20;EGLN2;KIF14;CDK5;LGMN;POU4F1;UNC5B;GRN;NTRK1;RETREG1;WFS1;PRKCI;PARK7;SIGMAR1;IL27RA;IL6ST;AGAP2;ATP13A2;CNTFR;NDNF;MEF2C;SNX6;MSH2
prerank,Striated Muscle Cell Differentiation (GO:0051146),0.40045893062379845,1.0552179797336616,0.35714285714285715,0.9912734525961479,1.0,6/19,20.58%,ASB2;BVES;CBY1;MYEF2;SIRT6;MEF2C
prerank,Negative Regulation Of Reproductive Process (GO:2000242),-0.4512379452305839,-1.05516219879643,0.37254901960784315,0.9425563637361296,1.0,6/19,13.53%,SPINK13;IGF1;ASTL;DUSP1;WEE2;PAEP
prerank,Negative Regulation Of Viral Life Cycle (GO:1903901),0.4075938963915291,1.054138444755485,0.425531914893617,0.9929024688081668,1.0,6/17,20.83%,TRIM5;IFITM1;BST2;FCN1;IFITM2;PPIA
prerank,protein-RNA Complex Assembly (GO:0022618),-0.3070086474707989,-1.0538738832885883,0.3870967741935484,0.9458743184484144,1.0,32/147,25.45%,RPS27L;CELF4;SRPK3;LUC7L2;EIF2S3B;CRNKL1;CELF5;CELF1;DENR;DICER1;SF3B1;TGS1;BRIX1;SNRPG;STRAP;EIF2S3;GEMIN4;CDC73;SRPK2;EIF5;SETX;AGO4;XAB2;NUDT21;COIL;SRSF10;EIF3C;POLR2D;TSSC4;SF3A2;RPSA;SMN1
prerank,Regulation Of Actin Filament-Based Process (GO:0032970),0.32752955783777776,1.0535151425408835,0.3191489361702128,0.992896622310483,1.0,19/68,19.43%,PEAK3;ARHGAP44;HCK;EFNA5;DYNLL1;ESAM;PDGFA;PAK1;ARHGEF19;NEDD9;ABRACL;BST2;CDK10;SLC4A2;CORO1A;TWF2;SIGLEC15;SH3BP1;OR2A4
prerank,Negative Regulation Of Mitotic Metaphase/Anaphase Transition (GO:0045841),0.38911632152696707,1.0531218548868793,0.425531914893617,0.9920555805103984,1.0,11/28,23.09%,CENPF;PLK1;CDC20;TRIP13;ZWINT;TEX14;SPC24;ATM;HASPIN;BUB1B;BUB1
prerank,Notch Signaling Pathway (GO:0007219),0.3411502543924533,1.0525843598493778,0.34782608695652173,0.9918138143766915,1.0,9/40,12.75%,NOTCH4;ASCL1;DTX1;DLL3;DTX2;NOTCH1;HEYL;APH1B;SORBS2
prerank,Homotypic Cell-Cell Adhesion (GO:0034109),-0.35946356673731567,-1.0523068671097517,0.4,0.9497132699262792,1.0,8/46,13.59%,CXADR;CDHR5;MEGF10;CDHR2;XG;DSC2;P2RY12;ITGB3
prerank,Regulation Of Cell Motility (GO:2000145),0.2897525625479914,1.0522231323881424,0.3548387096774194,0.9905759224465203,1.0,14/118,8.90%,TWIST1;CAMSAP3;CEACAM1;PLXNA4;FRMD5;FGF2;FGF20;KIF14;PRAG1;PLXNB1;MEAK7;ROBO4;CCR7;PLXNB2
prerank,Cellular Lipid Catabolic Process (GO:0044242),0.41554340024457076,1.051650074242893,0.40476190476190477,0.9904574278582676,1.0,8/21,22.05%,CYP1B1;LIPG;PLD1;LPIN3;SMPDL3B;ACOX1;ENPP2;LPIN2
prerank,Phospholipid Translocation (GO:0045332),0.350533801588273,1.0511053051643544,0.34782608695652173,0.9900795963253111,1.0,8/29,12.93%,ATP8B1;PLSCR3;ATP9A;PLSCR1;PLSCR4;ATP9B;ATP10B;P2RX7
prerank,Apoptotic Mitochondrial Changes (GO:0008637),0.354893336514976,1.0510979377300425,0.45,0.987676501754476,1.0,7/33,11.46%,BID;BIK;HK2;HSPD1;BCL2L1;BBC3;CCAR2
prerank,Positive Regulation Of Actin Filament Bundle Assembly (GO:0032233),-0.34452458804807645,-1.0510213492618403,0.3584905660377358,0.9523454037518497,1.0,7/48,10.31%,WNT11;VIL1;APOA1;ARHGEF10;GPR65;SERPINF2;SORBS3
prerank,Lymphocyte Chemotaxis (GO:0048247),-0.3813561850778471,-1.0507307471440812,0.3870967741935484,0.9520209094540536,1.0,6/40,8.70%,CCL7;CCL22;XCL1;CCL14;CXCL16;CXCL11
prerank,Cellular Response To Cytokine Stimulus (GO:0071345),0.25921347472175715,1.0505190361177084,0.3333333333333333,0.9873308306141704,1.0,83/293,18.74%,AKAP6;CRLF2;CSF2RA;FOXH1;IL9R;EGR1;IFNA21;CSF2RB;GSDME;IFNA10;EBI3;IFIT1;GREM2;HCK;CCR2;MYLK3;IRF5;IL3RA;SIRPA;CTSG;GBP1;GBP6;DAPK1;MAPK11;AXL;TCL1A;PYCARD;IFNW1;LILRB1;CCL18;PTPN6;CD40;IL6R;LGALS9;CCR7;IRAK3;POU4F1;OAS1;CX3CL1;DOCK8;LILRA1;USP10;SFRP1;GSK3A;IFNA4;IL12RB1;TNFSF11;TLR2;LILRB4;SOS1;LEF1;LILRA4;GPER1;TLR4;SELPLG;JAK3;PID1;IFNE;RIPOR2;YBX3;PHB1;HLA-DPA1;IL4R;IKBKB;KIT;PLP2;IL27RA;GBP4;GBA1;SHPK;IL2RG;CSF3R;IL6ST;GATA3;LDLRAP1;GBP2;AKT1;IFITM2;CBL;XCL2;HYAL2;TRADD;NFKB1
prerank,Positive Regulation Of Protein Kinase B Signaling (GO:0051897),-0.3208951927842945,-1.0498346604180506,0.4067796610169492,0.9535825646271866,1.0,16/90,11.46%,AKR1C2;IL26;SPRY2;THBS1;IL18;CHI3L1;MST1R;IGF1;AKR1C3;CASS4;TCF7L2;GDF15;RET;SRC;ANGPT1;PIK3CA
prerank,Phosphatidylethanolamine Metabolic Process (GO:0046337),-0.41469068239545376,-1.0498093589644422,0.4166666666666667,0.9521014629344643,1.0,5/24,10.20%,ALOX15;PLAAT5;ETNK2;PLAAT2;CHKB
prerank,Nucleic Acid Metabolic Process (GO:0090304),0.3816041283093451,1.0497369991863463,0.3023255813953488,0.9881361958204224,1.0,4/29,9.33%,NT5E;EXD2;ENPP1;TREX2
prerank,Homologous Chromosome Pairing At Meiosis (GO:0007129),0.3564286061552156,1.049325067573254,0.38095238095238093,0.9873699053189756,1.0,7/24,12.68%,TERB1;PRDM9;TRIP13;KASH5;STAG3;P3H4;PSMC3IP
prerank,Regulation Of Membrane Depolarization (GO:0003254),0.39183163667749077,1.0490734210794503,0.48936170212765956,0.9859770936343666,1.0,4/19,9.45%,PTPN3;HCN2;CAMK2D;RANGRF
prerank,Negative Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901991),0.35797393088500296,1.049006447385058,0.45652173913043476,0.9838225973162362,1.0,8/40,9.85%,DACT1;GFI1B;KLF4;APC;KANK2;CDK2AP2;RGCC;PRMT2
prerank,Positive Regulation Of Cytokine Production Involved In Inflammatory Response (GO:1900017),-0.4576131646723785,-1.0489796922915415,0.3877551020408163,0.9534437044739037,1.0,1/16,0.71%,CLEC7A
prerank,Sodium Ion Homeostasis (GO:0055078),-0.43247706615536724,-1.047481023977012,0.3181818181818182,0.9569210147379877,1.0,5/24,7.29%,SCNN1B;CYP4F12;SCNN1A;ATP1A2;SLC8A1
prerank,Protein Localization To Mitochondrion (GO:0070585),-0.4397817088786776,-1.0474243336768665,0.40625,0.955556690486868,1.0,3/16,8.07%,RNF186;LRRK2;MAIP1
prerank,Regulation Of Anoikis (GO:2000209),-0.4037044018718746,-1.047357755069868,0.4074074074074074,0.9542951430597106,1.0,5/20,11.46%,TLE1;SIK1;PIK3R3;SRC;PIK3CA
prerank,Primary Neural Tube Formation (GO:0014020),0.3827123222060284,1.0468574673517468,0.3142857142857143,0.9902501932887662,1.0,5/27,8.90%,VANGL2;VASP;DYNLL1;PRICKLE1;PLXNB2
prerank,Regulation Of Cell Cycle G2/M Phase Transition (GO:1902749),0.41077480971766456,1.0467442828453752,0.4117647058823529,0.9883043451532955,1.0,4/18,6.61%,CENPF;CDK4;KIF14;KCNH5
prerank,Negative Regulation Of Response To External Stimulus (GO:0032102),0.2746696229293756,1.0461386921611155,0.35135135135135137,0.9884022198583066,1.0,38/137,18.53%,RTN4RL1;MYO1C;AURKB;ALOX5;KLF4;PTPN2;ADIPOQ;SIRPA;RTN4R;FGF2;EPHA4;IL4;MVK;CD109;TNFAIP8L2;CXCL17;IRAK3;IL13;MFHAS1;NLRP3;ELF4;TRAFD1;FNDC4;PROC;GPER1;C1QBP;TRIB1;NR1H4;SMPDL3B;PYDC2;IL10RA;TRIM65;GBA1;GATA3;AKT1;IL22RA1;CARD16;OCRL
prerank,Cellular Response To Type II Interferon (GO:0071346),-0.3254599382380578,-1.0457665103447247,0.32786885245901637,0.9579182664832835,1.0,6/61,5.80%,CCL7;CCL22;XCL1;CCL14;IFNGR1;IFNG
prerank,Myotube Differentiation (GO:0014902),-0.40397335500722287,-1.0455459376244924,0.3559322033898305,0.956918607724675,1.0,3/19,4.38%,ADAMTS15;SIX4;IGF1
prerank,Acute Inflammatory Response (GO:0002526),0.36273862448109295,1.0454445950018794,0.42857142857142855,0.9885688122728236,1.0,5/24,9.45%,HP;MYLK3;PLSCR1;IL6R;C2CD4A
prerank,Cellular Response To Osmotic Stress (GO:0071470),0.36915065460174723,1.0453515566376879,0.45098039215686275,0.9864799015666587,1.0,14/27,34.26%,LRRC8D;PYCARD;NLRP3;YBX3;WNK3;SLC4A11;CAPN3;CASP1;RPTOR;MLST8;RCSD1;ARHGEF2;MTOR;PKD2
prerank,Exocytosis (GO:0006887),-0.3230733896316186,-1.0452334248152175,0.3333333333333333,0.9562649692643921,1.0,10/79,9.69%,PRSS12;SYTL4;SNAP25;SYTL2;STX1A;DOC2B;STEAP2;CPLX1;RIMS1;SYTL3
prerank,Sensory Perception (GO:0007600),-0.36694201133358934,-1.0451047624202845,0.3103448275862069,0.95518959829971,1.0,11/47,12.38%,ALOXE3;OR3A2;TMEM150C;MRGPRX2;OPRL1;C5AR1;OR10J1;WHRN;NMB;CCL2;PTGES
prerank,Peroxisomal Membrane Transport (GO:0015919),-0.4362877050817943,-1.0450754255786585,0.42592592592592593,0.9537595942150088,1.0,8/17,27.00%,PEX1;PEX2;PEX12;PEX14;RAB8B;PEX3;PEX16;PEX10
prerank,Regulation Of Carbohydrate Metabolic Process (GO:0006109),-0.44908190842503576,-1.0447691694693717,0.48148148148148145,0.9532602820723779,1.0,6/15,17.17%,RORA;MLYCD;PRKN;RORC;FOXK1;SIRT1
prerank,Metal Ion Transport (GO:0030001),-0.3130282301176834,-1.0446896409455688,0.39705882352941174,0.9520649545986366,1.0,17/154,5.99%,SLC5A1;SLC11A1;KCNJ13;SCNN1B;SCN5A;SCN4A;FGF13;CLDN16;KCNAB1;KCNF1;ATP2A1;SLC4A4;ASIC1;ATP1A2;ATP2B2;NIPAL2;SLC34A3
prerank,Regulation Of Integrin-Mediated Signaling Pathway (GO:2001044),0.41431907971848714,1.044640866618016,0.36,0.9867420958407489,1.0,5/19,12.73%,LIMS2;LIMS1;NID1;TIMP1;LOXL3
prerank,Regulation Of Ruffle Assembly (GO:1900027),-0.42821292379337805,-1.044557632408222,0.3559322033898305,0.9510353667918,1.0,2/23,2.41%,DEF8;HRAS
prerank,Intracellular Sodium Ion Homeostasis (GO:0006883),-0.45031012917085894,-1.0445113209146546,0.3829787234042553,0.9496047162361759,1.0,4/17,7.29%,SCNN1B;SCNN1A;ATP1A2;SLC8A1
prerank,Regulation Of Cellular Response To Stress (GO:0080135),-0.3139633865531228,-1.0444311967284448,0.38666666666666666,0.9483723170798543,1.0,21/106,17.64%,NUPR1;SOX4;ETAA1;DEPDC1B;MAPT;TMEM98;TAF5;DNAJB1;BRCA1;PRKN;DNAJC2;ATXN7;AMFR;MAPKAPK2;NFE2L2;EP300;TAF7;CREBBP;SIRT1;CDK9;DNAJB6
prerank,Negative Regulation Of Cellular Response To Growth Factor Stimulus (GO:0090288),-0.32987644095324675,-1.0441927637451542,0.3387096774193548,0.9476596635436442,1.0,15/63,17.03%,SPRY2;THBS1;SMAD6;RBPMS2;PPARG;NEDD4;WNT1;BAMBI;SMURF2;SLIT2;MMRN2;APLN;CHRDL1;SPRY3;NOG
prerank,Vacuolar Acidification (GO:0007035),-0.38843388846287896,-1.043890326240107,0.45,0.9472389702068694,1.0,3/29,5.11%,SLC11A1;ATP6V0D2;DMXL2
prerank,Epidermal Growth Factor Receptor Signaling Pathway (GO:0007173),0.35764377902945266,1.0432644067926327,0.4230769230769231,0.989384396780591,1.0,8/41,12.51%,HBEGF;FAM83B;PIGR;NCK2;FAM83A;PTK2;TGFA;SOS1
prerank,Regulation Of Cilium Assembly (GO:1902017),0.3202769532412793,1.0430326972114097,0.4090909090909091,0.9879252021221132,1.0,18/71,24.91%,EVI5;TBC1D30;TBC1D8;HTT;KIF24;GDI2;TBC1D20;TBC1D2;CDK10;TAPT1;TBC1D16;INTU;KCTD17;TCHP;DYNC2LI1;TBC1D24;TBC1D10B;CYLD
prerank,Skin Development (GO:0043588),-0.34253209613841784,-1.0425646276326603,0.3508771929824561,0.9506284049661909,1.0,10/61,10.22%,COL1A1;COL5A1;GATA6;ITGB4;COL1A2;ADAM9;AKR1C3;PPP3CA;CERS3;COL5A3
prerank,T Cell Migration (GO:0072678),-0.4482143520613098,-1.0425265371441759,0.46551724137931033,0.9493058240435245,1.0,7/17,27.18%,CXCL16;CXCL11;CCR6;XG;PIK3CG;MSN;SLC12A2
prerank,Positive Regulation Of Developmental Growth (GO:0048639),0.3317331734695818,1.0421657046929973,0.4,0.9890025161305869,1.0,14/48,17.90%,SYT3;RASAL1;CPNE9;GH1;ZP3;RIMS2;L1CAM;SHTN1;SEMA7A;MAP3K13;SYT17;TWF2;INSR;LEP
prerank,mRNA Polyadenylation (GO:0006378),-0.4192649839980255,-1.042135708546467,0.4107142857142857,0.949301075265483,1.0,8/24,20.17%,PAPOLB;TENT4B;TUT1;PEX2;TENT2;MTPAP;CDC73;WDR33
prerank,Positive Regulation Of Cholesterol Efflux (GO:0010875),-0.42630972338084644,-1.0421355539795703,0.45454545454545453,0.9478247127845102,1.0,5/20,8.33%,APOA1;PPARG;ABCA8;NFKBIA;CES1
prerank,Phosphorylation (GO:0016310),0.2481588304763968,1.0421054391949274,0.25925925925925924,0.986846330729326,1.0,89/416,18.06%,EPHB1;CDC42BPA;CSF2RA;CDK14;CDKL2;PAK6;PIM1;TTBK1;EPHB3;CSF2RB;MAPK8;PEAK3;HK3;AURKB;DGKK;HCK;XYLB;MYLK3;PIM2;CTSG;PRKAR1B;PLK1;CDK4;TAF11;DAPK1;EPHA4;HKDC1;CAMK2D;CDK5;BIRC5;HK2;PRAG1;FGFR1;CDK1;DGKZ;LRRK1;IRAK3;STRADB;EPHA10;CSNK2B;GALK2;TAF4B;ERN2;DGKI;CHEK2;CAMKK2;PRRT1;CSK;MAP3K13;RPS6KA1;PLK2;PTK2;MAST1;PDK4;HK1;NTRK1;GSK3A;TRIB2;MKNK2;TESK2;ILK;CDCA8;PAK1;HIPK1;TRIB1;CAMK1;JAK3;ACVR2A;DYRK1B;PTK6;CDK10;HTR2B;MARK2;CDC25B;PRKCI;STK36;IKBKB;GRK6;NADK;LIPE;WNK3;SHPK;INSR;TOP1;BCKDK;MEX3B;DGKA;AKT1;ATM
prerank,Positive Regulation Of Hormone Secretion (GO:0046887),-0.44188764771529426,-1.041597086311686,0.38596491228070173,0.9482534989433712,1.0,6/17,10.65%,RASL10B;EDN3;ILDR1;PPARG;NMB;EDN1
prerank,Positive Regulation Of Cell Division (GO:0051781),0.3665411572905992,1.0412973512887997,0.3333333333333333,0.9873087035465502,1.0,15/40,25.41%,KIF14;CIT;RACGAP1;CDC14C;HTR2B;CDC25B;CDC6;OR2A4;ECT2;PKP4;CXCR5;MAP10;RXFP3;SPAST;CDC14B
prerank,Tube Closure (GO:0060606),0.3798528366713181,1.0410935801391001,0.35135135135135137,0.9858228699445869,1.0,5/28,8.90%,VANGL2;VASP;DYNLL1;PRICKLE1;PLXNB2
prerank,Neurotransmitter Secretion (GO:0007269),0.3591355984039565,1.0408252873657131,0.3469387755102041,0.9846826392500738,1.0,10/40,13.17%,SYN1;RPH3A;SNCA;SYN2;CDK5;NRXN2;RPH3AL;RIMS2;SNAPIN;PCLO
prerank,Positive Regulation Of Nitric-Oxide Synthase Activity (GO:0051000),0.4143623900300629,1.0404917923095616,0.4090909090909091,0.9836153160395489,1.0,6/16,17.97%,NPR3;GCH1;DHFR;FCER2;HTR2B;AKT1
prerank,Positive Regulation Of Epithelial Cell Apoptotic Process (GO:1904037),-0.4311858589544154,-1.0402480728356156,0.4489795918367347,0.9508337143742202,1.0,2/21,1.24%,PLA2R1;THBS1
prerank,Regulation Of Peptidyl-Serine Phosphorylation Of STAT Protein (GO:0033139),-0.4339901328924003,-1.0401338056632103,0.45098039215686275,0.949839485869943,1.0,4/18,9.97%,IFNA6;IFNA7;IFNG;IFNA2
prerank,Positive Regulation Of Interleukin-12 Production (GO:0032735),0.3552717097970229,1.0398158104960544,0.42105263157894735,0.9838562201866196,1.0,11/32,13.16%,SCIMP;IRF5;MAPK11;HLA-G;CD40;LGALS9;CCR7;HSPD1;IL16;TLR2;TLR4
prerank,Inorganic Anion Transport (GO:0015698),-0.349806795507124,-1.0398048089280894,0.41935483870967744,0.9494206251828868,1.0,12/56,13.11%,CLCNKA;SLC11A1;SLC26A1;FXYD1;SLC34A2;SLC34A3;TTYH1;SLC34A1;BEST1;SLC17A3;SLC26A4;FXYD3
prerank,Positive Regulation Of Osteoclast Differentiation (GO:0045672),-0.4414814182237465,-1.0397501911725617,0.43137254901960786,0.9481935579377057,1.0,4/18,7.77%,TYROBP;TRAF6;IFNG;PPP3CA
prerank,Positive Regulation Of Wound Healing (GO:0090303),-0.37025894969214945,-1.0394842868357725,0.37735849056603776,0.9476517395040804,1.0,14/38,20.18%,CLEC7A;THBS1;DUOX2;HRAS;REG3A;F2R;VTN;CLDN3;FERMT1;DUOX1;RREB1;PRKCE;SERPINE1;ARFGEF1
prerank,Protein Import Into Nucleus (GO:0006606),-0.3315645259762064,-1.0392439558921167,0.417910447761194,0.9470166460192936,1.0,20/76,24.95%,RANBP17;CBLB;NUP62;RGPD5;NXT1;BCL3;KPNA7;RGPD8;RPL17;KPNA5;NUP54;FAM53C;APLP2;KPNA1;NUP133;NUP35;RANBP6;E2F3;TNPO2;POM121C
prerank,Regulation Of Monoatomic Ion Transmembrane Transporter Activity (GO:0032412),0.3222406300084123,1.0391851689572276,0.46511627906976744,0.9838718284769523,1.0,18/65,19.08%,PTPN3;GSG1L;HCN2;KCNE5;DAPK1;RANGRF;PRRT1;YWHAH;FXYD2;CNIH4;CAPN1;OPRM1;FXYD6;DLG4;NLGN2;WNK3;CHRM3;YWHAE
prerank,Positive Regulation Of Autophagy (GO:0010508),-0.32128474535978047,-1.0391441396414587,0.38571428571428573,0.945814725600922,1.0,10/104,10.76%,KDR;DCN;IRGM;LRRK2;IFNG;TRIM23;ZC3H12A;PRKN;TBK1;RUFY4
prerank,Oligosaccharide Metabolic Process (GO:0009311),-0.3641677924091135,-1.0384967494839816,0.37037037037037035,0.9462886588579021,1.0,11/42,13.80%,AMY1B;FUT9;FUT6;FUT1;ST8SIA6;MAN2C1;ST3GAL3;B3GALT2;FUT4;B4GALT1;GLA
prerank,Regulation Of Actin Cytoskeleton Reorganization (GO:2000249),0.4171960668787796,1.0376533503864358,0.4222222222222222,0.987801264168991,1.0,4/23,10.85%,HCK;CDK5;CARMIL1;CARMIL3
prerank,Protein K63-linked Deubiquitination (GO:0070536),-0.3830683778241918,-1.037486358061532,0.43137254901960786,0.9479424655988241,1.0,11/33,23.93%,YOD1;TNFAIP3;DEPDC1B;SPATA2;BRCA1;USP8;ABRAXAS2;ZRANB1;OTUD7B;USP17L2;OTUD7A
prerank,Positive Regulation Of Metabolic Process (GO:0009893),0.28384443164633777,1.0373386250037642,0.34210526315789475,0.9868035504763248,1.0,20/102,11.51%,TRPM8;ZBTB7B;TSHR;CCR2;ADIPOQ;APC;GNAS;IL4;JCHAIN;DISP3;DIO2;CD36;GRB10;ADIPOR2;IL13;YBX2;MUC1;CMKLR1;BSCL2;IRF4
prerank,Retrotransposon Silencing (GO:0010526),0.39565291067631275,1.0371879853754835,0.40425531914893614,0.9850758230113712,1.0,3/20,5.55%,APOBEC3D;SPOCD1;TDRD12
prerank,Intrinsic Apoptotic Signaling Pathway In Response To Endoplasmic Reticulum Stress (GO:0070059),-0.3547732277311354,-1.0363095424056623,0.3620689655172414,0.950644918228456,1.0,6/30,17.40%,RNF186;ATP2A1;TMEM117;BRSK2;TNFRSF10B;QRICH1
prerank,Negative Regulation Of Immune Response (GO:0050777),0.33559280252924284,1.0350170102066072,0.5142857142857142,0.9912406925687776,1.0,14/64,12.96%,MYO1C;CR1;HLA-DRB1;AURKB;PDCD1;HCK;CCR2;FOXP3;HLA-G;LILRB1;IRAK3;PLK2;TRAFD1;IFNL1
prerank,Neuron Projection Development (GO:0031175),-0.3006839130755266,-1.0346001951190855,0.4375,0.9547994893415006,1.0,33/177,14.69%,ADGRF1;ADGRV1;OLIG3;EPB41L3;MYO16;GAS7;LYN;SHANK1;BHLHE23;LRRK2;NCKAP1;LGI1;GRM7;DOCK7;NEDD4;WNT7A;MAPT;WHRN;NYAP2;RAB6B;ZPR1;CTNND2;TRIO;CDNF;DICER1;STMND1;ZNF335;UHMK1;TSKU;SH3GL2;CNTNAP1;VASH2;TAOK3
prerank,Regulation Of Vascular Endothelial Growth Factor Receptor Signaling Pathway (GO:0030947),-0.42190634982244707,-1.0342704238466691,0.45454545454545453,0.9543160983637389,1.0,6/22,13.59%,IL1B;NEDD4;MT3;VTN;MMRN2;ITGB3
prerank,Positive Regulation Of Tumor Necrosis Factor Superfamily Cytokine Production (GO:1903557),-0.32027732739938886,-1.0340122304425834,0.4696969696969697,0.9537402482715679,1.0,8/78,5.80%,AZU1;CLEC7A;LILRA2;THBS1;TYROBP;IFNGR1;FZD5;IFNG
prerank,Negative Regulation Of DNA Biosynthetic Process (GO:2000279),-0.38847161334645647,-1.0335243997912658,0.36363636363636365,0.9536819817825226,1.0,7/28,10.60%,ACVRL1;STON1;CDKN1A;TENT4B;DACH1;SRC;EXOSC10
prerank,tRNA Methylation (GO:0030488),0.3432359127050987,1.0334609343787506,0.4318181818181818,0.9955157955391198,1.0,15/36,23.81%,TRMT9B;TRMT10A;TRMT13;THUMPD3;TRMT5;DALRD3;TRMT1L;TRMT112;WDR6;METTL2B;TRMT61B;TRMT6;GTPBP3;NSUN2;FTSJ1
prerank,Calcium Ion Import Across Plasma Membrane (GO:0098703),-0.3708663347724314,-1.033114185729575,0.38181818181818183,0.9537331452729219,1.0,6/34,9.25%,SCN5A;SCN4A;TRPV3;TRPV1;SLC8A1;CACNA1A
prerank,Regulation Of Cardiac Conduction (GO:1903779),-0.41727648221988123,-1.0327258754938815,0.3684210526315789,0.9535815624442624,1.0,6/18,22.36%,ATP2A1;ATP2B2;SLC8A1;TRPC1;ATP2A2;RYR2
prerank,Regulation Of Blood Coagulation (GO:0030193),0.3763822013252686,1.0322986704348924,0.41025641025641024,0.9976709760007665,1.0,10/27,16.12%,PLAUR;PLAU;F2RL1;F2;CEL;HPSE;GP1BA;PROC;KNG1;F12
prerank,ATP Metabolic Process (GO:0046034),0.3703397170708587,1.0320781463733935,0.35294117647058826,0.9962650344433933,1.0,10/33,17.96%,NT5E;HSPA1A;ENPP1;FIGNL1;NMNAT1;CTNS;AK4;NADK;HSPA8;NUDT5
prerank,Regulation Of Neuronal Synaptic Plasticity (GO:0048168),0.36329950686529044,1.0303980582585297,0.3333333333333333,1.0,1.0,8/31,18.75%,NOL3;GRIN2D;SLC8A2;DLG4;NCDN;SYP;GRIK2;RAB3GAP1
prerank,Positive Regulation Of Receptor Signaling Pathway Via STAT (GO:1904894),-0.3522097394980137,-1.0302921772282465,0.40816326530612246,0.9604948454071902,1.0,3/35,1.32%,IL26;GHR;PRL
prerank,Negative Regulation Of Amide Metabolic Process (GO:0034249),0.2952366052662915,1.0299756675972391,0.34146341463414637,0.9993567922216869,1.0,9/93,6.24%,RTN3;TYMS;TRIM2;CHRNA7;ZNF540;DAPK1;EPHA4;ATCAY;IGF2BP3
prerank,Cell Cycle G1/S Phase Transition (GO:0044843),0.3205335800963491,1.0295873393954484,0.3829787234042553,0.9986357239276749,1.0,7/52,7.46%,BCAT1;MYC;CDKN3;PIM2;USP26;CDK4;CCNA2
prerank,Vacuolar Transport (GO:0007034),-0.3403559441099572,-1.0294755412472443,0.38596491228070173,0.961980413969793,1.0,20/45,29.24%,ATP6V0D2;SPTBN5;NEDD4;VPS37B;VPS54;NPC1;AP1G1;PCSK9;AP3D1;VPS13C;VPS37D;HGSNAT;VPS52;PSAP;ARSB;LRP1;PIK3R4;VTI1A;VPS53;CHMP1B
prerank,DNA Geometric Change (GO:0032392),-0.3912238638369946,-1.029462857470324,0.3387096774193548,0.9605604899769388,1.0,11/28,25.75%,ASCC1;SUPV3L1;WRN;UPF1;DHX36;IGHMBP2;BLM;HMGB2;MCM9;MRE11;MTERF1
prerank,Regulation Of BMP Signaling Pathway (GO:0030510),0.30931791149343596,1.028722796924895,0.38095238095238093,0.9996227670602787,1.0,9/65,9.01%,BMP4;SCUBE3;CHRD;FOXD1;PCSK6;FSTL3;CCNA2;NOTCH1;ITGA3
prerank,Neuropeptide Signaling Pathway (GO:0007218),0.30511669406986996,1.0286577324233108,0.3333333333333333,0.9975305070247616,1.0,15/58,17.04%,PTGDR2;SSTR3;LTB4R;GPR84;QRFP;CYSLTR2;SSTR2;GPR83;SORCS3;KISS1R;CYSLTR1;PYY;OPRM1;GLRA1;GALR2
prerank,Negative Regulation Of Programmed Cell Death (GO:0043069),-0.2702062609813953,-1.0285173369245335,0.358974358974359,0.9619950148772582,1.0,42/368,12.33%,KDR;CLEC5A;VEGFA;AZU1;RHBDD1;SPRY2;NUPR1;THBS1;SIX4;SMAD6;GATA6;MAGEA4;NKX2-6;FMN2;NUP62;FLT4;LTK;IGF1;PIK3R1;CARD14;FOXE3;HSPA1B;WNT1;ITCH;TNFRSF6B;SMAD5;HPN;ARHGAP21;IL7;SLC7A11;HMGN5;SUPV3L1;SRC;ZNF830;ASNS;ANGPT1;MT3;BCL3;ZNF16;PRR5;IL31RA;SIAH2
prerank,Positive Regulation Of Peptidyl-Serine Phosphorylation Of STAT Protein (GO:0033141),-0.4348831462895487,-1.028432856972531,0.4230769230769231,0.9608577412715393,1.0,4/17,9.97%,IFNA6;IFNA7;IFNG;IFNA2
prerank,Positive Regulation Of Nuclear Division (GO:0051785),-0.45121131048948276,-1.0282050236279148,0.4126984126984127,0.9602798506507224,1.0,4/24,4.38%,NUP62;IL1B;EDN3;IGF1
prerank,"Wound Healing, Spreading Of Cells (GO:0044319)",0.38861721345729505,1.0274782533744535,0.4,0.9994946918875625,1.0,8/23,17.69%,CEACAM1;PDPN;CCNA2;ARHGAP24;PDCD10;MRTFA;DDR1;CD151
prerank,Regulation Of Interleukin-2 Production (GO:0032663),-0.36141970376416116,-1.0270644506159565,0.41379310344827586,0.9625410454846631,1.0,12/46,11.92%,CLEC7A;IL1B;XCL1;CD34;TRAF6;GLMN;TNFAIP3;HAVCR2;PRNP;TBX21;PDE4B;PLCG2
prerank,Positive Regulation Of Glucose Metabolic Process (GO:0010907),0.4295871966815899,1.0264142049855909,0.40425531914893614,1.0,1.0,6/15,19.57%,PTPN2;SLC45A3;GPLD1;AKT1;DDB1;IRS1
prerank,Cardiac Epithelial To Mesenchymal Transition (GO:0060317),-0.43486042025720195,-1.0263063576835942,0.3584905660377358,0.9637176585455093,1.0,7/19,15.25%,TGFB2;HEY2;TGFBR3;FGF8;HEY1;SNAI1;BMP2
prerank,Regulation Of Myotube Differentiation (GO:0010830),-0.45014996402951657,-1.0261025644063566,0.36,0.962922844318768,1.0,5/22,19.01%,RBM24;SIK1;MMP14;TMEM119;SMYD1
prerank,Regulation Of Endoplasmic Reticulum Stress-Induced Intrinsic Apoptotic Signaling Pathway (GO:1902235),-0.39715090391142915,-1.026025009963905,0.375,0.9616852135714238,1.0,5/24,11.25%,MAGEA3;LRRK2;HERPUD1;PRKN;FCGR2B
prerank,Glycosphingolipid Metabolic Process (GO:0006687),-0.390266038817519,-1.0257755675264744,0.41818181818181815,0.9612023667671888,1.0,8/29,14.28%,FUT9;FUT6;GALC;ABCA2;ST3GAL5;B4GALT6;GLA;B4GALNT1
prerank,Protein Catabolic Process (GO:0030163),0.2734844532278554,1.0256765730915947,0.45454545454545453,1.0,1.0,35/100,23.52%,FBXO17;CEACAM1;CTSV;SIAH1;PSMA8;CTSL;CTSH;LGMN;FBXO6;PRSS16;CHEK2;CEL;SLC16A3;CTSB;CLN5;RSPRY1;CLPP;CLN6;VCP;NGLY1;HSPA8;ATE1;DDI2;DDB1;RNF123;PRPF19;MANBA;BNIP3;NEU4;ADAMTS7;CTSD;RNF5;CASP3;CAPN3;STT3B
prerank,Chondroitin Sulfate Metabolic Process (GO:0030204),0.42824396560456346,1.0255309472177483,0.4791666666666667,0.9998666305011542,1.0,7/16,21.04%,CHST15;CHST7;CHST12;CHPF2;UGDH;NDNF;DSE
prerank,Mesoderm Development (GO:0007498),-0.44573299590491183,-1.025102938089625,0.39655172413793105,0.9617770475299391,1.0,1/16,0.24%,VEGFA
prerank,Positive Regulation Of Glucose Transmembrane Transport (GO:0010828),-0.3772706423611868,-1.0249819908840998,0.4406779661016949,0.9607605970738025,1.0,8/31,16.22%,NR4A3;IGF1;PIK3R1;C1QTNF12;IRS2;RHOQ;FGF19;SORBS1
prerank,Transcription By RNA Polymerase III (GO:0006383),0.3443677294424644,1.024751855267667,0.3902439024390244,1.0,1.0,13/28,29.56%,POLR3G;GTF3A;POLR2L;SNAPC2;POLR3K;RO60;IVNS1ABP;SNAPC5;POLR2K;ELL;POLR2F;SNAPC3;GTF3C6
prerank,Associative Learning (GO:0008306),-0.413451582913046,-1.0245259278897414,0.4186046511627907,0.9608459002413737,1.0,2/17,3.37%,SLC6A1;SHANK1
prerank,ncRNA Catabolic Process (GO:0034661),-0.3820363828143716,-1.0244750115212127,0.39622641509433965,0.9597576527947665,1.0,10/33,15.77%,EXOSC3;ZC3H12A;TENT4B;EXOSC6;EXOSC10;DIS3;DICER1;DIS3L;LIN28A;LIN28B
prerank,RNA Metabolic Process (GO:0016070),-0.3031096579488804,-1.0244388445737198,0.46153846153846156,0.9584748287968206,1.0,29/109,20.98%,ALKBH1;EXOSC3;ANG;RBFOX2;ZC3H12A;EXOSC6;SUPV3L1;ZNF830;DDX17;EXOSC10;DIS3;DICER1;RNASEH1;HNRNPL;PRPF4;TENT2;DIS3L;FASTKD2;RBM39;TBRG4;DHX36;IGHMBP2;DUSP11;TFIP11;DNTTIP2;RBMS2;SETX;AGO4;EXOSC9
prerank,Positive Regulation Of T Cell Mediated Immunity (GO:0002711),0.32763360921990203,1.024384530181664,0.40425531914893614,0.9993516346200221,1.0,9/42,8.42%,HLA-A;HLA-DRB1;MAP3K7;HFE;CD1D;CD1E;HLA-G;ZP3;HSPD1
prerank,Positive Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001961),-0.3495192570066379,-1.0242737381997482,0.40350877192982454,0.9577123435906353,1.0,9/42,10.65%,IGF2BP1;IRGM;GFI1;HSPA1B;CXCR4;IL7;USP29;PRKN;EDN1
prerank,Negative Regulation Of Lipid Catabolic Process (GO:0050995),0.38835667898363907,1.0241650737392485,0.40816326530612246,0.9982586658050369,1.0,4/17,12.60%,HCAR2;APOC1;BSCL2;GPLD1
prerank,Mesoderm Formation (GO:0001707),-0.4354032857872723,-1.0237266379001169,0.48936170212765956,0.9580291926153133,1.0,5/18,17.57%,ITGB4;CRB2;ITGB3;SNAI1;BMPR2
prerank,Positive Regulation Of Protein Targeting To Membrane (GO:0090314),-0.4135330361556693,-1.0236073837721196,0.4358974358974359,0.9571181309335121,1.0,8/23,13.82%,CEMIP;HRAS;PDZK1;PRNP;ITGAM;TCAF2;MIEF1;ANK3
prerank,SCF-dependent Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0031146),-0.3458166528741232,-1.0235741331090855,0.390625,0.955816483422545,1.0,2/42,0.60%,FBXO27;FBXO9
prerank,Sulfur Amino Acid Metabolic Process (GO:0000096),-0.4402838419955186,-1.0233138427282342,0.5,0.9550623804281058,1.0,2/16,9.02%,NOX4;CTH
prerank,Golgi To Plasma Membrane Transport (GO:0006893),0.34945323538338896,1.023308969390077,0.3783783783783784,0.998605620604933,1.0,5/47,6.87%,RAB31;EXOC4;KIF13A;GOLPH3L;RAB10
prerank,Monocarboxylic Acid Metabolic Process (GO:0032787),-0.3300744536101919,-1.0231307545416162,0.4307692307692308,0.9542350826964527,1.0,13/94,10.35%,ECHDC3;ME1;VNN1;CYP4F12;GATM;KRT17;IGF1;HOGA1;CPT1B;AOAH;NPC1;ACBD5;GGT5
prerank,Positive Regulation Of Nucleocytoplasmic Transport (GO:0046824),-0.34605433837561783,-1.0217201889607397,0.4032258064516129,0.9573858246146408,1.0,9/43,14.62%,IL1B;PIK3R1;IFNG;NEDD4;ZC3H12A;ZPR1;PRKCD;EFCAB7;EP300
prerank,Regulation Of RNA Metabolic Process (GO:0051252),-0.3227327462537326,-1.0216709710930096,0.35,0.9561816205488273,1.0,24/88,19.02%,RBM20;AHNAK2;ILDR1;RBM38;TMEM98;CLK1;CCNL2;MBNL2;CELF1;CLK4;ZC3H10;METTL4;ATXN7;ILDR2;NOVA2;HNRNPL;RC3H2;PTBP2;AKAP17A;HNRNPH2;HNRNPLL;MBNL3;PDE3A;MITF
prerank,L-amino Acid Transport (GO:0015807),0.37593939199737814,1.0213750069958014,0.3958333333333333,1.0,1.0,8/25,16.91%,SLC1A4;SLC1A1;SLC36A2;SLC38A3;SLC38A5;SLC36A1;SLC6A9;SLC6A20
prerank,Protein Alkylation (GO:0008213),0.3646424155547822,1.0206489169396507,0.44,1.0,1.0,5/22,15.75%,EEF1AKMT1;CSKMT;EEF1AKMT2;PRMT2;PRMT1
prerank,Vesicle Docking (GO:0048278),-0.42508145837903694,-1.020335922224254,0.42857142857142855,0.9595155189953503,1.0,7/19,25.00%,STX1A;CEP83;STX2;STX6;STX16;STX3;STX11
prerank,Regulation Of Autophagosome Maturation (GO:1901096),-0.42844950026841955,-1.0201714095709467,0.4067796610169492,0.9585216274086953,1.0,8/16,30.61%,IRGM;TMEM39A;SMCR8;ATG5;ATG12;CALCOCO2;FYCO1;UVRAG
prerank,Positive Regulation Of Immune Effector Process (GO:0002699),0.3449782234331145,1.0198006171999516,0.3902439024390244,1.0,1.0,11/35,16.96%,HLA-DRB1;CCR2;HLA-DMB;LILRB1;LGALS9;COLEC11;IL12RB1;CFP;FCN1;PHB1;DDX60
prerank,Autonomic Nervous System Development (GO:0048483),-0.44897589951832073,-1.0192176935033002,0.43478260869565216,0.9602404662298917,1.0,4/15,16.79%,SOX4;KIF26A;SEMA3A;SOX8
prerank,Calcium Ion Homeostasis (GO:0055074),-0.32273044271496776,-1.019160641305223,0.43103448275862066,0.9589942650195824,1.0,17/93,15.51%,CCL7;CASQ2;EDN2;EDN3;ATP2A1;CTRC;CCL14;SLC8A1;ATP13A4;EDN1;STIM2;SLC24A3;SLC30A1;CCR1;CALCB;TRPV5;CXCL12
prerank,Positive Regulation Of Binding (GO:0051099),0.28745125527180454,1.0190364677079613,0.4523809523809524,1.0,1.0,15/88,12.71%,DACT1;BMP4;NME1;CDT1;PLAUR;HFE;BLK;TRIB3;TIAM1;MET;SUMO4;CLN5;FKBP1A;DTX3L;AKTIP
prerank,"Synaptic Transmission, Cholinergic (GO:0007271)",0.4153837680452619,1.0187509093470797,0.5,1.0,1.0,4/15,13.04%,CHRNA3;CHRNA7;CHRNA10;NQO1
prerank,Osteoclast Differentiation (GO:0030316),-0.4275869204761951,-1.0186122796881982,0.40350877192982454,0.9593788350254914,1.0,6/22,15.92%,TYROBP;OSCAR;CSF1R;SRC;BMP2;OSTM1
prerank,Activation Of Cysteine-Type Endopeptidase Activity (GO:0097202),-0.41422616441395405,-1.018537160098983,0.42857142857142855,0.9581374947334791,1.0,3/15,7.46%,CASP8;RIPK2;PERP
prerank,Natural Killer Cell Activation (GO:0030101),-0.3589247479635623,-1.018382061748539,0.43859649122807015,0.9572420979403371,1.0,15/43,19.96%,IFNA6;IFNA7;ULBP1;CASP8;PBX1;IFNA2;SLAMF7;NCR1;NCR3;IFNA8;EMP2;ULBP2;KAT7;IFNA14;IFNK
prerank,U2-type Prespliceosome Assembly (GO:1903241),-0.41948440342238696,-1.0183644513559267,0.43859649122807015,0.9558736634105875,1.0,11/23,29.58%,SNIP1;SF3B1;PHF5A;SNRPG;SNRPA1;SF3B4;SNRPB2;DDX46;SF3A2;SNRPD1;SF3A1
prerank,Cell Chemotaxis (GO:0060326),-0.34398966393163954,-1.018337041507799,0.34615384615384615,0.9545685455943653,1.0,6/44,8.04%,VEGFA;AZU1;ENC1;PLXNB3;ARHGEF16;DEFB130A
prerank,Negative Regulation Of Osteoblast Differentiation (GO:0045668),0.34164175908899586,1.0181363594255277,0.4,1.0,1.0,4/30,8.21%,TWIST1;CHRD;SUFU;NOTCH1
prerank,Replication Fork Processing (GO:0031297),0.3242686015614641,1.0173638924102715,0.391304347826087,1.0,1.0,10/45,15.53%,EXD2;EME2;OOEP;EME1;RBBP8;TONSL;CARM1;MUS81;SAMHD1;CENPX
prerank,Glycerophospholipid Metabolic Process (GO:0006650),-0.3403813683694882,-1.0169067235509963,0.3939393939393939,0.9575503035776433,1.0,22/59,26.36%,APOA1;PLA2G4F;CSF1R;PLCB1;PIGA;PIGB;PLA2G4B;PLA1A;PLCD1;GPCPD1;GDPD1;PLA2G15;FAR1;ABHD12;SMPD4;PIGL;SERINC1;SERINC5;CETP;PNPLA3;PRDX6;PIGW
prerank,Regulation Of Long-Term Synaptic Potentiation (GO:1900271),-0.3850426983315993,-1.0166359598149897,0.43137254901960786,0.9570160844230873,1.0,4/27,4.92%,TYROBP;SLC18A3;ADCY1;CYP46A1
prerank,Ceramide Biosynthetic Process (GO:0046513),-0.3550247415004297,-1.0165946988033843,0.40350877192982454,0.9557740622187197,1.0,12/40,14.28%,DEGS2;ALOXE3;ST8SIA6;TLCD3B;SPTSSB;ST3GAL5;PNPLA1;B4GALT4;CERS3;B4GALT6;SAMD8;B4GALNT1
prerank,Positive Regulation Of Stress Fiber Assembly (GO:0051496),-0.35066186385360987,-1.016181332108648,0.3877551020408163,0.9557604080527543,1.0,7/40,13.10%,WNT11;APOA1;ARHGEF10;GPR65;SERPINF2;SORBS3;RHOC
prerank,Histone Deubiquitination (GO:0016578),-0.3800194958290101,-1.0161446336441746,0.43333333333333335,0.9544942725447646,1.0,6/33,14.91%,DEPDC1B;TMEM98;TAF5;BRCA1;ATXN7;TAF7
prerank,Regulation Of Plasminogen Activation (GO:0010755),-0.4263128314693212,-1.0158546526589718,0.45161290322580644,0.9541440558907746,1.0,4/16,9.50%,THBS1;MELTF;HPN;SERPINF2
prerank,Positive Regulation Of Natural Killer Cell Mediated Immunity (GO:0002717),0.3806312820226819,1.0158406307939958,0.5,1.0,1.0,5/23,6.10%,IL21;SH2D1B;PVR;KLRK1;HLA-G
prerank,RNA Polyadenylation (GO:0043631),-0.4007265990773363,-1.0155541332770635,0.43859649122807015,0.9537213726889837,1.0,8/25,20.17%,PAPOLB;TENT4B;TUT1;PEX2;TENT2;MTPAP;CDC73;WDR33
prerank,Ear Morphogenesis (GO:0042471),-0.3885699004834317,-1.0154132088766537,0.42592592592592593,0.9528303763047177,1.0,3/23,4.48%,GSC;PAX8;SOBP
prerank,Positive Regulation Of Axon Extension (GO:0045773),-0.41835943476286186,-1.0153186302401354,0.4230769230769231,0.9517514479392131,1.0,2/18,7.04%,VEGFA;MAPT
prerank,tRNA Processing (GO:0008033),0.3351974896711884,1.0150121435262085,0.4418604651162791,1.0,1.0,24/49,32.89%,POP1;TRMT9B;OSGEP;RPP40;TRPT1;ELP5;PUS3;SARS1;RPP30;METTL2B;TRIT1;NSUN2;FTSJ1;FAM98B;THG1L;FARS2;TRDMT1;TSEN2;ELAC2;HEXIM1;TRNT1;RTCB;QTRT1;ANKRD16
prerank,Regulation Of Chromosome Segregation (GO:0051983),0.39586190373254804,1.0130566687128792,0.4523809523809524,1.0,1.0,8/26,19.03%,RMI2;KIF2C;MKI67;NCAPG;CDCA2;NCAPD2;CDC6;IHO1
prerank,Negative Regulation Of Cold-Induced Thermogenesis (GO:0120163),-0.35451851921533273,-1.0128289920691744,0.423728813559322,0.9587810136201999,1.0,14/44,16.98%,CIDEA;ACTN3;DOCK7;IL18R1;ALDH1A1;IL15;WNT10B;NOVA2;NR1D1;BMAL1;LGR4;IP6K1;ADAM17;PLCL1
prerank,Negative Regulation Of JNK Cascade (GO:0046329),0.3315104443215932,1.01281209369722,0.3953488372093023,1.0,1.0,9/34,21.15%,DACT1;SIRPA;F2RL1;MARVELD3;PRMT1;SH3RF2;MEN1;DNAJA1;NCOR1
prerank,Positive Regulation Of Leukocyte Mediated Cytotoxicity (GO:0001912),0.30814743920987825,1.0127811212986628,0.3673469387755102,1.0,1.0,9/50,6.10%,HLA-A;IL21;HLA-DRB1;PVR;HFE;CD1D;CD1E;KLRK1;HLA-G
prerank,Mitochondrion Disassembly (GO:0061726),-0.3758105217110719,-1.0127771653073985,0.43333333333333335,0.9575652082507635,1.0,10/37,18.31%,MAP1LC3C;ATG2A;SNX7;GABARAPL1;PRKN;WDR45B;CTSK;USP30;RB1CC1;ATG5
prerank,Positive Regulation Of Cell Growth (GO:0030307),0.29770824400701734,1.0122252094847268,0.4878048780487805,1.0,1.0,16/104,10.98%,AKAP6;SYT3;H3-5;S100A8;DNPH1;RASAL1;CPNE9;BRAT1;RIMS2;L1CAM;SHTN1;SEMA7A;S100A9;MAP3K13;RPS6KA1;SFRP1
prerank,Regulation Of Macroautophagy (GO:0016241),-0.319080290493589,-1.011876188898333,0.3939393939393939,0.9589059662822311,1.0,4/93,4.28%,KDR;DCN;ATP6V0D2;LRRK2
prerank,Negative Regulation Of Neuron Apoptotic Process (GO:0043524),0.3298803978414121,1.0117077583201128,0.37209302325581395,1.0,1.0,23/69,21.92%,GPRASP3;FGF20;CX3CR1;KIF14;LGMN;POU4F1;CX3CL1;UNC5B;GRN;NTRK1;RETREG1;WFS1;PRKCI;NONO;PARK7;IL27RA;IL6ST;AGAP2;CNTFR;NDNF;MEF2C;SNX6;MSH2
prerank,Defense Response To Bacterium (GO:0042742),0.27245994313758337,1.0111139087468564,0.39473684210526316,1.0,1.0,44/181,18.13%,CXCL13;H2BC12;HLA-A;S100A8;LCE3C;FCER1G;MR1;CTSG;GBP1;OAS2;GBP6;GSDMA;JCHAIN;DEFB133;PYCARD;IL6R;OAS1;NOD2;LYG2;PLA2G1B;EPPIN;HTN1;S100A9;SLAMF8;ISG15;TLR2;RNASE6;TLR4;S100A14;LYZ;IFNE;MPEG1;CFP;WFDC3;WFDC5;GBP4;LPO;RNASE3;S100A12;ANKRD17;RBCK1;GBP2;SELP;TFEB
prerank,Nuclear Chromosome Segregation (GO:0098813),0.4314514992331417,1.0105285895985079,0.475,1.0,1.0,4/16,10.29%,CENPF;KIF2C;KLHDC8B;TOP2A
prerank,Regulation Of Postsynaptic Membrane Potential (GO:0060078),0.36331451116701535,1.0102455710849523,0.4339622641509434,1.0,1.0,10/33,21.73%,CHRNA3;INSYN1;GRIN2D;GSK3A;FOXM1;GLRA1;RAB3GAP1;NPAS4;MEF2C;NPFF
prerank,Regulation Of Actin Nucleation (GO:0051125),-0.4017292214162785,-1.0096005248807949,0.4339622641509434,0.964511514209694,1.0,3/20,6.45%,SCIN;VIL1;WASHC4
prerank,Cellular Response To Topologically Incorrect Protein (GO:0035967),-0.3893317773173479,-1.0095518547948317,0.4375,0.9633364063304699,1.0,9/21,30.93%,RHBDD1;PRKN;BAG3;DNAJC18;TM7SF3;DNAJB14;ERN1;PACRG;PTPN1
prerank,Maintenance Of Gastrointestinal Epithelium (GO:0030277),-0.446542069237823,-1.0092814704907036,0.39622641509433965,0.9630943719405048,1.0,3/16,3.01%,MUC13;PBLD;MUC6
prerank,Cardiac Ventricle Development (GO:0003231),-0.39904253922452093,-1.0092810434395514,0.4375,0.9617359877769781,1.0,4/17,10.54%,SCN5A;HEY2;PDE2A;HEY1
prerank,Protein Localization To Centrosome (GO:0071539),-0.41259211096163817,-1.0092340797413917,0.41818181818181815,0.9605697543344727,1.0,4/17,16.34%,CEP83;GOLGB1;CSNK1D;CCDC14
prerank,NADP Metabolic Process (GO:0006739),-0.3994474285640739,-1.0091681708939484,0.3898305084745763,0.9595369964152703,1.0,5/18,18.37%,ME1;KRT17;FMO5;NUDT12;NOX1
prerank,Negative Regulation Of Response To Endoplasmic Reticulum Stress (GO:1903573),-0.39338510322260833,-1.0087557026261986,0.43859649122807015,0.9596916943820821,1.0,4/25,9.30%,MAGEA3;LRRK2;HERPUD1;PRKN
prerank,Hydrogen Peroxide Catabolic Process (GO:0042744),0.40087535398080765,1.0082712602625294,0.4883720930232558,1.0,1.0,3/17,7.52%,HBA1;PRDX3;PRDX1
prerank,Embryonic Organ Morphogenesis (GO:0048562),-0.36951542653731245,-1.0081373416478008,0.4375,0.960163320087811,1.0,6/36,11.73%,MFAP5;RBPMS2;DSCAML1;ID2;FOXE1;DYNC2I1
prerank,Positive Regulation Of Neuroblast Proliferation (GO:0002052),-0.43460117131900317,-1.0079545079589658,0.47540983606557374,0.9593803612792771,1.0,2/17,2.58%,VEGFA;VCAN
prerank,Positive Regulation Of Response To Wounding (GO:1903036),-0.38620579853107395,-1.0077928269133771,0.42105263157894735,0.9585132814882182,1.0,4/25,4.50%,CLEC7A;DUOX2;HRAS;REG3A
prerank,Protein Dephosphorylation (GO:0006470),0.28323507773316575,1.007787433286947,0.5,1.0,1.0,46/122,28.63%,PTPRF;PTPN3;PPEF2;PTPN2;PTPRB;PPP2R3A;PTPRH;PTPRK;PTPN13;PTPN6;DUSP7;PTPRD;SDHAF2;PTPN7;PTPN18;TNS2;MTMR7;TIMM50;DUSP18;PPM1G;DAPP1;PPP2CB;PTEN;CTDNEP1;PHPT1;PPP3R2;PTPRM;PPP1CA;PPP5C;SBF1;FBXW11;PTPN9;PPP4R3C;PPM1E;UBASH3B;PPP2R5B;CDC14B;PTPRC;PDXP;PPP2R1A;PPP2R5D;PPM1F;PPM1K;PGAM5;FAM220A;PTPRG
prerank,Central Nervous System Neuron Development (GO:0021954),-0.42936466366920695,-1.00761195778614,0.42105263157894735,0.9577204491501632,1.0,4/17,12.96%,MAPT;PALS1;NOVA2;B4GALT6
prerank,Positive Regulation Of B Cell Proliferation (GO:0030890),0.3376303913753093,1.0070824578132314,0.45454545454545453,1.0,1.0,6/29,10.55%,IL21;TNFRSF4;CD38;IL4;CD40;GPR183
prerank,Cellular Response To Peptide (GO:1901653),-0.3305693034008115,-1.0068878686459561,0.4166666666666667,0.9586081995974075,1.0,13/52,15.15%,VCAM1;IGF1;RIPK2;PRNP;CACNB1;CACNA1A;SRC;FCGR2B;NGFR;NOD1;PTPN22;RPL17;FPR2
prerank,Positive Regulation Of B Cell Activation (GO:0050871),0.3079779280879151,1.0068428775054807,0.42857142857142855,1.0,1.0,9/52,10.55%,IL21;TNFRSF4;CD38;IL4;CD27;CD40;NOD2;SHLD1;GPR183
prerank,Protein Secretion (GO:0009306),0.31782424783829316,1.0067682948746455,0.43902439024390244,1.0,1.0,14/63,17.33%,RAB3B;MON1A;CTAGE6;CTAGE9;OLFM2;FAM3B;RIMS2;STEAP3;PDIA4;RAB3D;PORCN;TANGO2;PARK7;MEN1
prerank,Fat Cell Differentiation (GO:0045444),-0.32739393991020876,-1.0067678557284077,0.43859649122807015,0.9575595921704948,1.0,9/60,9.00%,METRNL;NR4A3;ALOXE3;SMAD6;NR4A2;PPARG;WNT5B;TCF7L2;IL11
prerank,Regulation Of Steroid Metabolic Process (GO:0019218),-0.4107105851157733,-1.0063958403008173,0.48214285714285715,0.9573006848817012,1.0,5/21,12.17%,UGT1A10;RORA;FMO5;ABCG1;RORC
prerank,Growth Hormone Receptor Signaling Pathway (GO:0060396),-0.4284920410751184,-1.006324114970461,0.4,0.9562282356809858,1.0,3/15,5.09%,GHR;LYN;PIK3R1
prerank,Positive Regulation Of Cellular Component Biogenesis (GO:0044089),-0.3085069111133195,-1.0061655660307536,0.4714285714285714,0.9554726016982774,1.0,13/91,15.91%,VEGFA;CLEC7A;VIL1;CLDN19;IFNG;TSG101;SMPD3;CRB3;RHOC;CLDN3;TPPP;MTLN;USP16
prerank,Myeloid Leukocyte Differentiation (GO:0002573),-0.33297204702546557,-1.0060486601734755,0.40298507462686567,0.9545623580633178,1.0,9/64,5.80%,VEGFA;TYROBP;OSCAR;CASP8;PPARG;CSF1R;CLPB;PDE1B;IFNG
prerank,Negative Regulation Of Angiogenesis (GO:0016525),-0.3169704383039059,-1.005863603095469,0.46153846153846156,0.9538964745172697,1.0,10/76,9.37%,SPRY2;THBS1;DCN;PRL;TGFB2;HOXA5;PPARG;SPRED1;SEMA6A;NPR1
prerank,Ventricular Cardiac Muscle Cell Action Potential (GO:0086005),-0.4529899690056233,-1.0052193666367382,0.5106382978723404,0.9547525107584293,1.0,5/16,16.72%,SCN5A;SCN3B;KCNE2;GPD1L;SNTA1
prerank,Negative Regulation Of Protein Modification Process (GO:0031400),-0.32009964491883397,-1.00347054348219,0.4915254237288136,0.9587556469610238,1.0,20/76,17.68%,LYN;PIP5KL1;LRRK2;FXYD1;CDKN1A;MAPT;PRNP;PPP1R16B;ZC3H12A;PRKN;SLIT2;TERF2IP;CDYL;SH3GL2;PPP1R15B;TPPP;SNTA1;SIRT1;PRKAA2;INSM1
prerank,Mitotic Metaphase Plate Congression (GO:0007080),0.32091319265911744,1.0028932192266475,0.44680851063829785,1.0,1.0,12/50,15.24%,CENPE;CHMP4C;CDT1;PSRC1;KIF2C;CDCA5;KIF14;CCNB1;CDCA8;PDCD6IP;KIF18A;SPDL1
prerank,Transport Along Microtubule (GO:0010970),0.3695567720065432,1.002195345199147,0.42857142857142855,1.0,1.0,4/19,17.26%,CAMSAP3;CLIP3;SNAPIN;BLOC1S1
prerank,Limb Development (GO:0060173),-0.40543743129100024,-1.0021325271207284,0.5,0.9615718757934216,1.0,12/27,27.50%,GLI3;KREMEN1;FGF8;NOG;IFT122;MEGF8;PCSK5;LNPK;PTCH1;RSPO2;SALL1;TBX4
prerank,Neural Tube Closure (GO:0001843),0.36648068434592773,1.0016922631465202,0.43243243243243246,1.0,1.0,5/31,8.90%,VANGL2;VASP;DYNLL1;PRICKLE1;PLXNB2
prerank,Protein Localization To Chromosome (GO:0034502),0.3347014300717588,1.0002776495801196,0.3902439024390244,1.0,1.0,19/40,32.54%,PLK1;TONSL;SLF1;LEF1;RPA2;BOD1;APLF;TINF2;SIRT6;HASPIN;MSH2;PARP3;PARP1;RPA1;TPP1;XRCC5;CENPA;ESR1;CHMP7
prerank,Regulation Of Neuron Projection Development (GO:0010975),-0.2954491919042079,-1.0001263697355527,0.453125,0.9665874037530728,1.0,29/165,12.70%,ROR2;FUT9;MAGI2;KNDC1;MARK1;ZDHHC15;DDR2;NDRG4;LYN;CHN1;LTK;NCS1;PLXNB3;LRRK2;CAMK2B;KIF26A;CRMP1;GFI1;CDH2;PTK7;TBR1;BAG5;RET;LZTS3;MT3;ACP4;TWF1;NOVA2;TSKU
prerank,Establishment Or Maintenance Of Apical/Basal Cell Polarity (GO:0035088),-0.4044556250280537,-0.9995284487205165,0.4423076923076923,0.9674071756019877,1.0,9/26,17.38%,PARD3;PARD6G;CRB2;DLG2;PALS1;DLG5;CRB3;DLG1;CRB1
prerank,Natural Killer Cell Activation Involved In Immune Response (GO:0002323),-0.39967969526614194,-0.9992975991051563,0.4791666666666667,0.9668702420110488,1.0,2/22,1.82%,IFNA6;IFNA7
prerank,Glucose Homeostasis (GO:0042593),-0.3171757173278746,-0.9984697405969574,0.4153846153846154,0.9682086954245271,1.0,12/84,8.99%,CMKLR2;PYGL;FOXA3;MBD5;SOX4;PIK3R1;PPARG;BACE2;KLF7;MLXIPL;HNF1A;TCF7L2
prerank,DNA Biosynthetic Process (GO:0071897),0.3802394487119314,0.9983003097275639,0.5,1.0,1.0,5/17,15.45%,TYMS;RRM2B;POLH;POLL;POLD2
prerank,RNA-mediated Gene Silencing (GO:0031047),-0.3553749431649192,-0.9981328771866143,0.46,0.9680098220632029,1.0,6/27,13.99%,TDRD1;FKBP6;TNRC6B;CELF1;DICER1;MOV10L1
prerank,Neurotransmitter Transport (GO:0006836),0.3184088505616985,0.9980336749341953,0.46938775510204084,1.0,1.0,10/48,13.35%,SYN1;SLC1A1;SLC29A4;SLC1A7;SYN2;NRXN2;SLC1A2;SNAPIN;SLC17A7;SLC29A1
prerank,Endocytic Recycling (GO:0032456),-0.34145803089644045,-0.9980060253234903,0.44642857142857145,0.9670948861003534,1.0,22/60,29.38%,EHD2;ARL4C;SNX7;DENND1B;VPS26A;BLTP1;DENND1A;EIPR1;CCDC93;RAB17;STX6;RAB13;STX16;LMTK2;RAB11FIP4;VPS52;EHD1;TRARG1;VTI1A;VPS53;WASHC2C;VPS29
prerank,Negative Regulation Of Epithelial Cell Proliferation (GO:0050680),-0.3313635087813438,-0.9978858317695625,0.3888888888888889,0.9660280953421903,1.0,5/64,1.48%,IL26;NUPR1;THBS1;PRL;TGFB2
prerank,G2/M Transition Of Mitotic Cell Cycle (GO:0000086),0.3275422290715283,0.997616715273966,0.4727272727272727,1.0,1.0,10/38,15.21%,CDK14;TPD52L1;PKMYT1;PLK1;CCNA2;CDK1;CHEK2;CCNB1;FOXM1;CDC25B
prerank,Positive Regulation Of Axonogenesis (GO:0050772),0.3375687821184014,0.9975923241151038,0.3829787234042553,1.0,1.0,9/38,11.19%,PLXNA4;PLXNB1;TIAM1;PLXNB2;L1CAM;SHTN1;SEMA7A;MAP3K13;MAP6
prerank,Phosphate-Containing Compound Metabolic Process (GO:0006796),0.2546843807448451,0.9969966965381972,0.43902439024390244,1.0,1.0,42/176,18.53%,HNMT;HK3;SLC29A4;XYLB;PTPRB;TNFAIP8L3;ENPP1;HKDC1;CYP2W1;ACYP2;DUSP23;CDK5;HK2;IPMK;EPHX2;LCAT;PFKFB2;PSPH;GALK2;PFKFB4;PLA2G4C;PLA2G1B;ACYP1;HK1;PLPP1;PPA1;PFKP;PAK1;PTPRD;ALPP;HTR2B;PFKL;NADK;PLPPR4;SHPK;TOP1;BCKDK;NT5C;NUDT5;AKT1;DUSP18;OCRL
prerank,Regulation Of Wound Healing (GO:0061041),-0.33612706751793814,-0.9969083810886639,0.375,0.9676126326703575,1.0,7/42,5.76%,CLEC7A;DUOX2;VIL1;HRAS;CLDN19;REG3A;TNFAIP3
prerank,Regulation Of Extracellular Matrix Organization (GO:1903053),-0.3921552097689029,-0.9964616332281618,0.43137254901960786,0.96751360880519,1.0,3/22,8.06%,ZNF469;DDR2;LAMA2
prerank,Cellular Response To Starvation (GO:0009267),-0.2957207039719808,-0.995640624223938,0.4393939393939394,0.9690079735678117,1.0,29/121,22.98%,NUAK1;NUPR2;LRRK2;MAP1LC3C;CDKN1A;KLF10;JMY;LARS1;GAS2L1;ZC3H12A;GABARAPL1;ASNS;WDR45B;WRN;PCSK9;PMAIP1;SIRT1;PRKAA2;PPARA;BMPR2;ATG5;SEH1L;ALB;SESN1;SREBF2;FNIP1;PRKD1;WDR24;ATG14
prerank,Positive Regulation Of Protein Import Into Nucleus (GO:0042307),-0.36351999423439735,-0.9956167065200631,0.4126984126984127,0.9677908634591389,1.0,7/27,14.62%,PIK3R1;IFNG;ZC3H12A;ZPR1;PRKCD;EFCAB7;EP300
prerank,Negative Regulation Of NF-kappaB Transcription Factor Activity (GO:0032088),0.2834219813473774,0.99507043221807,0.4444444444444444,1.0,1.0,20/78,17.64%,KLF4;FOXP3;CDKN2A;CYP1B1;PYCARD;FOXJ1;CD200;IRAK3;PRMT2;NLRP3;NWD1;PARP10;CMKLR1;COMMD7;DAP;TAX1BP1;PYDC2;TMSB4X;RBCK1;CCDC22
prerank,Positive Regulation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0043280),0.2784344780405903,0.9947735048317553,0.4722222222222222,1.0,1.0,27/108,13.35%,MYC;S100A8;EGLN3;TNFSF10;BID;SNCA;GRAMD4;KHDC1;DAPK1;PDCD2;DYNLL1;PYCARD;LGALS9;HSPD1;UACA;S100A9;BBC3;NLRP3;SENP1;SORD;ST18;ST20;CASP9;CASP10;DAP;GPER1;PDCD6
prerank,Peptide Catabolic Process (GO:0043171),0.39227047881989,0.9940715933067882,0.4888888888888889,1.0,1.0,4/20,11.93%,ANPEP;LNPEP;CTSH;NAALADL1
prerank,Ribosomal Small Subunit Biogenesis (GO:0042274),-0.3022423900823716,-0.9939798081149168,0.4067796610169492,0.971259837018572,1.0,7/82,12.57%,RPS27L;RPS17;EXOSC10;WDR75;UTP15;PNO1;NOP58
prerank,Regulation Of Glycolytic Process (GO:0006110),-0.34082640687049565,-0.9933458908242682,0.4489795918367347,0.9720193299315403,1.0,5/40,7.14%,NUPR1;SLC4A4;IGF1;IFNG;MLXIPL
prerank,Muscle Organ Development (GO:0007517),0.3011605738340742,0.9933366116355908,0.5,1.0,1.0,6/51,6.09%,HBEGF;MAPK12;BVES;SMTN;EVC;SGCD
prerank,Establishment Of Skin Barrier (GO:0061436),-0.41515753702376856,-0.9930263013117754,0.47540983606557374,0.9717760282130319,1.0,4/18,7.05%,ALOX12;ALOXE3;IL18;SFN
prerank,Positive Regulation Of Glucose Import (GO:0046326),-0.3918454670111914,-0.9926186387905022,0.48214285714285715,0.9716721875430713,1.0,7/25,16.22%,IGF1;PIK3R1;C1QTNF12;IRS2;RHOQ;FGF19;SORBS1
prerank,Regulation Of Type I Interferon-Mediated Signaling Pathway (GO:0060338),0.3492734172434717,0.9925350250082913,0.5,1.0,1.0,16/33,27.75%,RBM47;PTPN2;PTPN6;OAS1;ISG15;TTLL12;SAMHD1;OAS3;STING1;IKBKE;USP18;METTL3;DCST1;CNOT7;STAT2;TRIM56
prerank,Response To Calcium Ion (GO:0051592),-0.30864855930105495,-0.9922723512341098,0.4339622641509434,0.9713329773641176,1.0,16/101,9.82%,ADGRV1;CASQ2;THBS1;ALOX15;SCN5A;ITPKA;SYT15;ADCY1;ADAM9;RASA4;SEC31A;AKR1C3;NEDD4;PPP3CA;CACNA1A;TRPC3
prerank,Synapse Organization (GO:0050808),-0.2958485862384165,-0.9921328265143402,0.4666666666666667,0.9704271142684153,1.0,23/118,12.24%,FARP1;ADGRF1;SLC6A1;DOK7;PPFIBP2;PCDHB13;LRRK2;CACNB4;FZD5;PLXND1;CDH2;NEDD4;PTK7;C5AR1;GPHN;MAPT;CACNB1;PCDHB10;CTNND2;SPOCK2;PCDHB11;F2R;PCDHB9
prerank,Skeletal Muscle Organ Development (GO:0060538),-0.3817711622136672,-0.991870685697515,0.48,0.9699245958278865,1.0,4/27,7.83%,SIX4;MYL11;FOXL2;MYH7B
prerank,Histone H4-K8 Acetylation (GO:0043982),-0.41722151480738645,-0.991511424512674,0.4423076923076923,0.9681790808362966,1.0,5/15,22.92%,JADE3;KANSL2;KAT7;ING5;KANSL1
prerank,Histone H4-K5 Acetylation (GO:0043981),-0.41722151480738645,-0.991511424512674,0.4423076923076923,0.9681790808362966,1.0,5/15,22.92%,JADE3;KANSL2;KAT7;ING5;KANSL1
prerank,poly(A)+ mRNA Export From Nucleus (GO:0016973),-0.4263765875313517,-0.9912264203841373,0.5081967213114754,0.9679982757369844,1.0,5/20,21.00%,DDX25;NXF5;DDX19B;ZC3H11B;NUP133
prerank,Regulation Of Brown Fat Cell Differentiation (GO:0090335),0.38627658947823107,0.9909245118004015,0.49019607843137253,1.0,1.0,2/16,1.69%,ZBTB7B;PIM1
prerank,Regulation Of Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0017015),-0.29880029941154296,-0.990744979444092,0.4745762711864407,0.9683267240257547,1.0,34/107,23.67%,SPRY2;THBS1;SMAD6;PBLD;CIDEA;LATS2;PPARG;SPRED1;BAMBI;PALS1;SMURF2;CDKN1C;PEG10;DKK3;PPM1A;ZEB2;EP300;CREBBP;BMP2;CITED1;SIRT1;SNW1;PPARA;STRAP;ARID4A;ARID4B;ING2;SPRED3;SAP30L;SMURF1;SPRY1;LTBP4;ZNF451;SDCBP
prerank,Response To Transforming Growth Factor Beta (GO:0071559),-0.3579630800283006,-0.9906241048053603,0.5084745762711864,0.967459595561054,1.0,11/35,22.69%,XCL1;ZFHX3;WNT7A;RUNX3;PDE2A;CITED1;ZFP36L2;NR3C1;PDE3A;MAPK7;ZFP36L1
prerank,Respiratory Chain Complex IV Assembly (GO:0008535),0.3324420692886218,0.9905722441511664,0.5348837209302325,1.0,1.0,4/26,10.91%,COX15;COX14;COA5;COA3
prerank,Visual Perception (GO:0007601),-0.29023343891401726,-0.9903834252247609,0.43103448275862066,0.9668416291194145,1.0,15/89,10.96%,ADGRV1;COL1A1;CRYBB1;ZIC2;VAX2;DHRS3;RDH12;GRM6;CABP4;POU6F2;TH;BEST1;CRYBB2;NXNL2;ATXN7
prerank,Regulation Of Dendrite Development (GO:0050773),-0.35737545709553037,-0.9903363498409742,0.49122807017543857,0.9656774839810177,1.0,6/41,7.18%,KNDC1;MARK1;ZDHHC15;KIAA0319;NEDD4;NSMF
prerank,Negative Regulation Of Protein Modification By Small Protein Conjugation Or Removal (GO:1903321),-0.3279874393062485,-0.9902237614641372,0.46808510638297873,0.9647352733425357,1.0,9/51,15.63%,SPRY2;SPOPL;SOX4;TNFAIP3;HSPA1B;BAG5;PRKCG;TRIM21;GTPBP4
prerank,Regulation Of Multicellular Organismal Development (GO:2000026),0.30695840246341244,0.9901750811679125,0.4489795918367347,1.0,1.0,12/57,17.38%,GFI1B;OAS2;SPAAR;CDK1;CD24;RACGAP1;HPSE;TFPT;TNN;INSR;RUVBL2;GATA3
prerank,Fc-gamma Receptor Signaling Pathway Involved In Phagocytosis (GO:0038096),-0.40080344126937306,-0.9900322745416604,0.38636363636363635,0.9640960684079829,1.0,6/19,12.43%,LYN;YES1;SRC;FCGR2B;VAV3;PRKCD
prerank,Regulation Of Epidermal Growth Factor Receptor Signaling Pathway (GO:0042058),0.3265731280590791,0.9898919063066941,0.5121951219512195,1.0,1.0,16/45,19.88%,PTPN3;CEACAM1;FAM83B;PTPN2;PDE6G;PLAUR;RHBDF1;NEU3;MVB12A;GPER1;PTK6;CBL;MVP;SHKBP1;CNOT9;WDR54
prerank,Response To Amino Acid (GO:0043200),0.3557821825418004,0.9898686033587899,0.4883720930232558,1.0,1.0,6/30,16.83%,SH3BP4;SPAAR;MEAK7;LAMTOR2;GLRA1;SLC38A9
prerank,Lytic Vacuole Organization (GO:0080171),0.328615387349647,0.989660977274097,0.5,1.0,1.0,13/35,21.84%,CLVS1;MYO7A;GRN;CLN5;SNAPIN;AKTIP;ZKSCAN3;LYSET;GBA1;TFEB;HOOK2;PI4KB;TMEM106B
prerank,Anterograde Trans-Synaptic Signaling (GO:0098916),0.2614462349811889,0.9894193561142478,0.45454545454545453,1.0,1.0,54/183,20.53%,CHRNA3;SYN1;LPAR3;PDE7B;SYT5;HRH4;CHRNA6;EXOC4;SLC1A1;MYCBPAP;CHRNA5;PCDHB6;MTNR1B;SNCA;GRIK4;SYN2;CHRNA9;GABRR2;CDK5;NRXN2;GABRR1;DRD5;SLC1A2;KCNMB4;PCDHB14;RPS6KA1;PCDHB5;AMPH;HTR3A;CHRNA10;CNP;SLC12A5;RPS6KA2;HTR2B;KIF5A;DLG4;NLGN2;GLRA1;SLC12A7;KCNQ2;PCDHB2;MPZ;NPTX1;GRIK2;CHRM3;CACNA1E;HRH3;GABBR2;GABRR3;HTR1B;SNCG;CACNA1B;APBA2;SLC6A2
prerank,Spliceosomal Complex Assembly (GO:0000245),-0.32156981058662903,-0.9893987694935286,0.5166666666666667,0.9644680017466969,1.0,22/62,28.23%,CELF4;SRPK3;LUC7L2;CRNKL1;CELF5;CELF1;SNIP1;SF3B1;PHF5A;SNRPG;SNRPA1;SRPK2;SETX;SF3B4;SRSF10;SNRPB2;DDX46;SF3A2;SMN1;NR5A1;CELF3;SNRPD1
prerank,Positive Regulation Of Neurogenesis (GO:0050769),0.29572681801074147,0.9889549682780743,0.425,1.0,1.0,16/72,14.61%,GPRASP3;HAPLN4;PLXNA4;HAPLN2;OBSL1;CX3CR1;PLXNB1;TIAM1;RGS14;PLXNB2;CX3CL1;MAP6;GPER1;SOX11;PTPRD;OPRM1
prerank,Positive Regulation Of Protein Localization To Plasma Membrane (GO:1903078),0.3148120488469833,0.9887537040616974,0.5098039215686274,1.0,1.0,22/49,28.28%,ATP2C1;NKD2;STAC;ITGA3;RANGRF;CLIP3;GPER1;PRKCI;WNK3;RACK1;AKT1;RAMP3;EPHA2;ZDHHC8;CNPY4;CNST;PTPN9;SPTBN1;EPHA3;EPHB2;TNF;PDPK1
prerank,Ureteric Bud Morphogenesis (GO:0060675),-0.44119240254251196,-0.9886853127530848,0.5161290322580645,0.965411117965117,1.0,2/17,1.09%,WNT11;PAX8
prerank,Proteolysis Involved In Protein Catabolic Process (GO:0051603),0.2821781304717611,0.9878229987192728,0.5263157894736842,1.0,1.0,20/76,19.24%,CHMP4C;CTSV;NEDD8;PSMA8;CTSL;CTSH;LGMN;CEL;CTSB;ISG15;PDCD6IP;RSPRY1;CLPP;VCP;NGLY1;ATE1;DDI2;DDB1;RNF123;PRPF19
prerank,Positive Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043123),0.2590723274482059,0.9877703839047836,0.5161290322580645,1.0,1.0,42/170,19.68%,S100B;GPRC5B;IKBKG;HLA-DRB1;TNFRSF19;TNFSF10;MAP3K7;ATP2C1;TRIM5;TRIM52;PIM2;NDFIP2;F2RL1;NDFIP1;CD40;LGALS9;CCR7;UBE2V1;CX3CL1;NOD2;PLK2;FKBP1A;CASP10;ROR1;BST2;HTR2B;HMOX1;IKBKB;LTB;S100A12;ANKRD17;TRIM22;RBCK1;SHISA5;CCDC22;INAVA;CARD16;TRADD;MYD88;TMEM101;SLC35B2;ECT2
prerank,Positive Regulation Of Interleukin-6 Production (GO:0032755),0.2989391355164591,0.9874491824170905,0.5357142857142857,1.0,1.0,23/70,19.01%,TWIST1;SCIMP;POU2AF1;F2RL1;PYCARD;TLR8;IL6R;LGALS9;TLR1;HSPD1;IL16;NOD2;POU2F2;CYBA;TSLP;TLR2;TLR4;RIGI;LEP;IL17RA;INAVA;HYAL2;MYD88
prerank,Cellular Response To Interleukin-1 (GO:0071347),-0.31224950090411874,-0.9873598325786761,0.463768115942029,0.9683652837389757,1.0,8/77,5.91%,CCL7;CCL22;IL1B;XCL1;CXCL8;CCL14;TRAF6;PLCB1
prerank,Protein Ubiquitination (GO:0016567),-0.25724824238671995,-0.9871853193077661,0.5217391304347826,0.9675887905293958,1.0,96/419,20.75%,RNF38;FBXO9;ENC1;ASB9;TRIML1;RNF186;RNF220;RNF103;ANKRD9;KLHL13;TRAF6;KBTBD8;TRIM72;ARRDC4;PELI2;ASB11;NEDD4;RNF168;FANCL;DEPDC1B;TRIM23;ITCH;RNF135;BSPRY;FBXL2;ASB5;TRIM7;BRCA1;TOPORS;PRKN;TRIM51G;SPSB4;SMURF2;TRIM60;VPS18;TRIM40;TRIM39;FBXO11;MUL1;AMFR;VCPIP1;PEX2;FANCB;PEX12;NFE2L2;RNF115;TRPC4AP;TRIM10;RNF25;UBOX5;KLHL21;CUL5;RC3H2;FBXO24;RNF4;FBXO28;TRIM21;SDE2;LMO7;MSL2;KLHL7;TNKS;GAN;RCHY1;UBR1;EIPR1;RNF125;SIRT1;TRIM11;FANCC;TRIM61;FBXL3;SH3RF3;KLHL24;HACE1;RNFT1;RLIM;TRAIP;MARCHF8;TRIM6;ASB1;ASB4;FAAP20;UBR3;OTULIN;MARCHF7;RNF141;OBI1;NAE1;DTX4;CBLC;KCTD10;KCTD13;BIRC7;RFPL1;FBXO32
prerank,Regulation Of Transmembrane Transport (GO:0034762),-0.39429035723980876,-0.9871562428889723,0.46808510638297873,0.9663801338357799,1.0,7/28,9.44%,KCNJ14;KCNJ13;KCNJ11;CTTNBP2NL;NEDD4;KCNJ9;CALHM1
prerank,Positive Regulation Of Nitric Oxide Metabolic Process (GO:1904407),-0.3912763437763207,-0.9869297042719247,0.5151515151515151,0.9658115710433648,1.0,5/27,10.65%,CLEC7A;IL1B;IFNG;ASS1;EDN1
prerank,Cellular Response To Insulin Stimulus (GO:0032869),0.2905304424612144,0.9855770675028493,0.46511627906976744,1.0,1.0,27/97,22.53%,TBC1D4;CEACAM1;RAB31;PTPN2;FOXC2;SLC27A4;ENPP1;SH2B2;RAB10;GRB10;TRIB3;SLC39A14;PLA2G1B;PDK4;GSK3A;GPLD1;LPIN3;PRKCI;GRB14;INSR;AKT1;PKLR;IRS1;HDAC9;PIK3R2;LPIN2;SHC1
prerank,Vesicle Budding From Membrane (GO:0006900),0.3464573632513995,0.9848858696197802,0.4523809523809524,1.0,1.0,4/31,16.07%,CHMP4C;GOLPH3L;FNBP1L;TRAPPC3
prerank,Intermediate Filament Organization (GO:0045109),-0.3412438808757016,-0.984682337218544,0.5384615384615384,0.9714428133319783,1.0,4/57,5.69%,KRT23;GFAP;KRT17;KRT15
prerank,Protein Insertion Into ER Membrane (GO:0045048),-0.38534018457666414,-0.9846511154010156,0.4827586206896552,0.9702338569633009,1.0,5/29,17.19%,RAB5IF;CCDC47;EMC6;MMGT1;EMC7
prerank,Regulation Of Translational Initiation (GO:0006446),-0.3201088791467872,-0.9844888116539311,0.40350877192982454,0.9696084836089892,1.0,18/60,24.58%,ALKBH1;MIF4GD;CTIF;CSDE1;UHMK1;PPP1R15B;EIF1B;YTHDF3;PAIP2;EIF5;EIF1;PAIP1;EIF2B2;BZW1;CCL5;NCK1;YTHDF2;DNAJC3
prerank,Regulation Of Neurotransmitter Receptor Activity (GO:0099601),-0.3669124262529805,-0.9844391593351468,0.45614035087719296,0.9685264222241176,1.0,4/37,4.60%,BEGAIN;PSCA;SHANK1;NPTX2
prerank,Regulation Of Intracellular Transport (GO:0032386),0.33377178680425923,0.984437102964555,0.4423076923076923,1.0,1.0,13/35,26.13%,WWC1;ATP9A;MYLK2;NEFH;OCRL;ATP13A2;MAP2;APEX1;SPAG5;SH3TC2;TMEM53;NDEL1;CAPN10
prerank,Regulation Of Nitric-Oxide Synthase Activity (GO:0050999),0.34514363665084274,0.9839480803034574,0.5,1.0,1.0,9/27,17.97%,DDAH2;NPR3;GCH1;NOSIP;DHFR;FCER2;HTR2B;LEP;AKT1
prerank,Response To Reactive Oxygen Species (GO:0000302),0.3003424876739052,0.9838016390009465,0.45454545454545453,1.0,1.0,20/63,25.86%,HBA1;MAPK8;HP;PTPRK;PRDX3;MPV17;CAMKK2;TXNRD2;HMOX1;PRDX5;AKT1;ATM;HYAL2;FYN;FOS;STK25;PTPRN;CAT;RPS3;ROMO1
prerank,Regulation Of Potassium Ion Transport (GO:0043266),-0.40089828274639916,-0.9833331042332222,0.54,0.9708397610590147,1.0,8/26,21.36%,CASQ2;KCNAB1;KCNE2;ANK3;KCNA5;DLG1;FHL1;KIF5B
prerank,Cellular Response To BMP Stimulus (GO:0071773),-0.3132599526929679,-0.9833055883352019,0.43548387096774194,0.9696110243910436,1.0,11/60,15.46%,TGFB2;SMAD6;USP9Y;ACVRL1;PPARG;INHBE;SMAD5;TGFBR3;AMHR2;BMP2;BMPR1B
prerank,Positive Regulation Of Biomineral Tissue Development (GO:0070169),0.3281830427366448,0.9826619282795525,0.5348837209302325,1.0,1.0,13/43,21.75%,BMP4;ODAPH;ALOX5;CCNA2;KL;ISG15;P2RX7;ACVR2A;RXRB;BMP6;CYP27B1;MEF2C;WNT6
prerank,Negative Regulation Of Neurogenesis (GO:0050768),-0.3739299391478792,-0.9826258547980178,0.4888888888888889,0.9704130362605992,1.0,6/26,16.20%,IL1B;MCF2;WNT7A;DYNLT1;THY1;PAX6
prerank,Phagocytosis (GO:0006909),-0.3248379251431612,-0.9823369272799146,0.5230769230769231,0.9701669836121259,1.0,14/65,16.25%,SLC11A1;TYROBP;ALOX15;MSR1;CD93;MST1R;MEGF10;ITGAM;CD302;FCGR2B;ITGB3;RAB11FIP2;ARHGAP12;BLTP1
prerank,Neuromuscular Process (GO:0050905),-0.43090380855889865,-0.982305714289993,0.42857142857142855,0.9689974925181986,1.0,3/17,5.53%,SHANK1;CHRND;PRRT2
prerank,Regulation Of Actin Filament Polymerization (GO:0030833),0.29183858601931273,0.9822601802444362,0.5,1.0,1.0,16/67,17.27%,ARHGAP28;VASP;HCK;NCK2;PYCARD;CARMIL1;CCR7;ESAM;CTTN;CDC42EP1;KANK1;GBA2;MYADM;COTL1;TWF2;KANK4
prerank,Negative Regulation Of Smooth Muscle Cell Proliferation (GO:0048662),-0.35431989111949136,-0.9822314372759833,0.4838709677419355,0.9680717936772679,1.0,14/36,17.66%,NDRG4;IL12A;PPARG;TNFAIP3;CDKN1A;IFNG;ANG;APOD;APLN;IGFBP5;CDKN1B;BMP2;BMPR2;PRKG1
prerank,Positive Regulation Of DNA Biosynthetic Process (GO:2000573),0.3005665751451533,0.982138493785611,0.4444444444444444,1.0,1.0,9/65,10.06%,PARM1;MYC;AURKB;KLF4;FGF2;GINS2;RGCC;CCT5;CHTF8
prerank,Cellular Response To Lipid (GO:0071396),-0.26883230029664074,-0.9817865766456073,0.527027027027027,0.9681503242508956,1.0,43/217,13.67%,WNT11;CFTR;IL1B;IRGM;ADCY2;CXCL8;LYN;CXCL2;RORA;LTK;ATP1A2;TRAF6;ADCY1;FZD7;ADAM9;FZD10;GFI1;TNFAIP3;AKR1C3;PTK7;HSPA1B;WNT5B;CXCL11;CXCL3;ZC3H12A;ZNF35;RET;WNT10B;PF4V1;PDE4B;RORB;CCL2;NRIP1;BCL10;PLCG2;PEX2;CASP7;RORC;FFAR3;CCDC62;NR1D1;PPBP;INSIG1
prerank,Protein Maturation (GO:0051604),0.26321401788212195,0.9817841766657763,0.5151515151515151,1.0,1.0,25/112,18.81%,PHEX;F7;TSPAN5;PCSK6;CTSG;PRPH2;CPN1;KEL;CPM;HSPD1;ADAM19;NLRP3;LMF2;APH1B;NAA50;CASP9;CASP10;ASPRV1;F12;NNAT;TSPAN14;CIAO2A;DDI2;TYSND1;MMEL1
prerank,Negative Regulation Of Epidermal Growth Factor Receptor Signaling Pathway (GO:0042059),0.3582296062962426,0.9815802158081013,0.4222222222222222,1.0,1.0,2/23,2.97%,PTPN3;PTPN2
prerank,Regulation Of Fibrinolysis (GO:0051917),0.40880249603728736,0.9815631614879867,0.4473684210526316,1.0,1.0,8/16,16.12%,PLAUR;PLAU;F11;F2;CEL;PLG;PLAT;F12
prerank,Respiratory Tube Development (GO:0030323),-0.40507455866340386,-0.9809658056430355,0.4745762711864407,0.9691357943406123,1.0,3/24,3.21%,VEGFA;FGF9;CHI3L1
prerank,Establishment Of Epithelial Cell Polarity (GO:0090162),-0.39737307015626583,-0.9806289154278875,0.4727272727272727,0.9690528664918887,1.0,4/18,15.15%,PARD3;CYTH3;RAP2A;FERMT1
prerank,Unsaturated Fatty Acid Metabolic Process (GO:0033559),-0.3288139496003497,-0.9805232579889429,0.4576271186440678,0.9681052745263562,1.0,7/47,9.48%,ALOX15;ALOX12;ALOXE3;CYP4F12;DAGLB;PLA2G4B;AWAT1
prerank,Positive Regulation Of Small Molecule Metabolic Process (GO:0062013),-0.3602171486567324,-0.9804925953090003,0.4883720930232558,0.966894358422396,1.0,11/33,18.22%,SLC4A4;IGF1;APOA1;IFNG;MLXIPL;CES1;IRS2;ADM;PMAIP1;PRKAA2;PRKCE
prerank,Monoatomic Cation Transmembrane Transport (GO:0098655),0.24842282313347602,0.9803085480974997,0.4411764705882353,1.0,1.0,61/258,16.91%,TRPM8;CACNA2D4;COX15;KCNH1;KCNG4;KCNA10;KCNB1;TRPM3;KCNK1;SLC30A3;ATP2C1;SLC29A4;KCNH4;TRPM6;SLC40A1;SLC36A2;SLC24A4;HCN2;CNGB1;KCNG1;HVCN1;SLC12A3;KCNH5;GRIN2D;NALCN;RYR3;SLC8A2;SLC46A1;KCNN3;SLC39A14;ORAI1;KCNH8;KCNH3;KCNH6;KCNK15;FXYD2;FKBP1A;KCNQ5;SLC30A5;KCNN4;SLC39A1;P2RX7;KCNV2;ATP6V0E1;SLC11A2;MCOLN3;SLC36A1;KCNK12;TRPV6;TRPV2;ATP6V0D1;KCNS1;KCNH2;KCNC2;SLC6A9;ATP5MF;SLC12A7;KCNA2;SLC6A14;KCNQ2;SLC6A20
prerank,Positive Regulation Of Interleukin-17 Production (GO:0032740),0.3712185369458393,0.979977199647204,0.4444444444444444,1.0,1.0,6/24,15.08%,ZBTB7B;IL21;NOD2;LY9;PHB1;NR1H4
prerank,Regulation Of Cell-Cell Adhesion Mediated By Cadherin (GO:2000047),-0.41757742798390485,-0.9788725101345542,0.5,0.9703979455736269,1.0,3/16,10.07%,VEGFA;SERPINF2;DENND6A
prerank,Positive Regulation Of Nitric Oxide Biosynthetic Process (GO:0045429),-0.3977671414682048,-0.9788054859633445,0.515625,0.969293231000582,1.0,5/26,10.65%,CLEC7A;IL1B;IFNG;ASS1;EDN1
prerank,Negative Regulation Of Leukocyte Activation (GO:0002695),0.3814651431336608,0.9785708980344612,0.475,1.0,1.0,6/16,13.09%,MILR1;IL4;CD200;GRN;LILRB4;GPER1
prerank,DNA Double-Strand Break Processing (GO:0000729),0.39509612080953393,0.9784839464246421,0.4864864864864865,1.0,1.0,2/15,7.73%,EXD2;RBBP8
prerank,Positive Regulation Of Cell Cycle (GO:0045787),-0.3326304675842563,-0.9783971651857705,0.45454545454545453,0.9691444475351468,1.0,5/64,4.21%,NUPR1;TGFB2;MEIS2;MAGEA4;AURKA
prerank,Positive Regulation Of Vacuole Organization (GO:0044090),-0.3861842528059051,-0.9780250233533873,0.5,0.9689431652953108,1.0,7/21,20.08%,IRGM;ATG2A;SNX7;PIP4K2A;MOAP1;PPP3CB;PIP4K2C
prerank,Purine Ribonucleoside Triphosphate Metabolic Process (GO:0009205),0.32854119036726204,0.9778439941801127,0.4772727272727273,1.0,1.0,9/31,16.57%,NT5E;HSPA1A;ENPP1;GIMAP7;FIGNL1;CTNS;AK4;NADK;HSPA8
prerank,Positive Regulation Of G2/M Transition Of Mitotic Cell Cycle (GO:0010971),-0.39041264832707884,-0.9767016911567512,0.4727272727272727,0.9717263550996558,1.0,3/21,4.93%,STOX1;RAD51B;CDC25A
prerank,Neurogenesis (GO:0022008),-0.35577948655236,-0.9764498976906397,0.5483870967741935,0.9711926184663231,1.0,7/43,8.90%,GCM1;TGFB2;SIX4;MAPT;DAGLB;CXCR4;PALS1
prerank,Regulation Of Natural Killer Cell Mediated Cytotoxicity (GO:0042269),0.3250941388006205,0.9759379796780584,0.4666666666666667,1.0,1.0,7/31,8.05%,IL21;PVR;KLRK1;KLRC1;HLA-G;LILRB1;LGALS9
prerank,Mitotic Sister Chromatid Cohesion (GO:0007064),0.3862484355543162,0.9755490182540572,0.49056603773584906,1.0,1.0,5/19,15.01%,SGO1;CDCA5;STAG2;NAA50;ESCO2
prerank,Negative Regulation Of Insulin Receptor Signaling Pathway (GO:0046627),0.37412563039471347,0.975464635268667,0.5,1.0,1.0,9/25,16.54%,PTPN2;SLC27A4;ENPP1;GRB10;GSK3A;PID1;KANK1;GRB14;TNS2
prerank,Positive Regulation Of Oxidoreductase Activity (GO:0051353),-0.3846461207319105,-0.9752995886313909,0.4576271186440678,0.9734521891111618,1.0,4/21,12.08%,EDN2;EDN3;EDN1;FTMT
prerank,Wound Healing (GO:0042060),-0.30735965888511596,-0.9751310033732213,0.4642857142857143,0.9726808621695023,1.0,15/74,17.93%,SLC11A1;TGFB2;SYTL4;IGF1;TRIM72;FZD7;WNT7A;PPP3CA;DCBLD2;TSKU;ITGB3;EPPK1;JAML;NOG;RAF1
prerank,Response To Cadmium Ion (GO:0046686),0.39619959953410455,0.9748506707163038,0.5714285714285714,1.0,1.0,5/21,15.48%,MAPK8;MT1A;MT1E;MT1G;DAXX
prerank,Regulation Of Translation (GO:0006417),-0.2706592535198999,-0.9746281964012491,0.546875,0.9731725510335122,1.0,47/199,24.28%,RPS27L;DDX25;THBS1;ALKBH1;IGF2BP1;ENC1;PRR16;SOX4;GUF1;NANOS2;CNOT1;BCL3;MIF4GD;CTIF;GZMB;CSDE1;ETF1;IGFBP5;PCIF1;EIF1B;ZCCHC4;LIN28A;NSUN3;GRB7;DUS3L;YTHDF3;PASK;UPF1;DHX36;DDX6;TSFM;PAIP2;EIF5;MRPL13;EIF1;FXR1;PAIP1;EIF2B2;PIWIL2;TSC1;RBM3;PUM3;EIF3C;BZW1;NANOS1;SAMD4A;UPF3A
prerank,Oligodendrocyte Development (GO:0014003),-0.4184171459558514,-0.9745352336867282,0.46938775510204084,0.9723510718961205,1.0,7/15,24.84%,B4GALT6;CNTNAP1;TPPP;ZNF488;EIF2B2;MYRF;EIF2B3
prerank,Ventricular Septum Morphogenesis (GO:0060412),-0.3680943411191933,-0.9745245956376702,0.5185185185185185,0.9711779202335377,1.0,9/27,17.57%,TGFB2;SOX4;HEY2;TGFBR3;HEY1;SLIT2;SLIT1;NOG;BMPR2
prerank,Positive Regulation Of Myeloid Leukocyte Differentiation (GO:0002763),-0.33529590678657967,-0.9743313137686718,0.4807692307692308,0.9704788408661946,1.0,10/39,17.60%,IL34;TRAF6;CASP8;IFNG;PPP3CA;ID2;PF4;CCR1;IL23A;FADD
prerank,Acylglycerol Metabolic Process (GO:0006639),0.3409288500376114,0.9742500405709146,0.46,1.0,1.0,7/37,11.26%,DGAT2;APOC1;DGKK;DGKZ;GALK2;DGKI;ABHD6
prerank,Myeloid Cell Activation Involved In Immune Response (GO:0002275),-0.402809599125572,-0.974240984269997,0.5166666666666667,0.9695070863886952,1.0,3/17,5.80%,LILRA2;TYROBP;IFNG
prerank,Calcium-Independent Cell-Cell Adhesion Via Plasma Membrane Cell-Adhesion Molecules (GO:0016338),-0.43038193766427757,-0.9741555240044929,0.4827586206896552,0.9685900084624263,1.0,4/15,12.39%,CLDN19;CLDN16;CLDN8;CLDN9
prerank,Antimicrobial Humoral Immune Response Mediated By Antimicrobial Peptide (GO:0061844),0.27838236044904996,0.9739204855604979,0.5102040816326531,1.0,1.0,9/60,13.13%,CXCL13;H2BC12;F2;MUC7;PLA2G1B;S100A9;LEAP2;TSLP;RNASE6
prerank,Synaptic Vesicle Transport Along Microtubule (GO:0099517),0.4025180651778246,0.9738675255662932,0.43902439024390244,1.0,1.0,5/15,17.26%,TRIM46;SNAPIN;AP3M2;BLOC1S5;BLOC1S1
prerank,Anterograde Synaptic Vesicle Transport (GO:0048490),0.4025180651778246,0.9738675255662932,0.43902439024390244,1.0,1.0,5/15,17.26%,TRIM46;SNAPIN;AP3M2;BLOC1S5;BLOC1S1
prerank,Positive Regulation Of Multicellular Organismal Process (GO:0051240),-0.2512664332152103,-0.973743628547817,0.5277777777777778,0.968548667140151,1.0,28/364,5.91%,VEGFA;DEF8;LILRA2;PLA2R1;IL26;GHR;COL1A1;PAX8;SLC11A1;PRL;TGFB2;OTX2;SIX4;GATM;IL1B;IL18;ADRB1;LURAP1;NOX5;ZBTB16;EPAS1;PPARG;TERT;OXTR;GLMN;IFNG;GADD45G;PLCB1
prerank,Negative Regulation Of Ras Protein Signal Transduction (GO:0046580),0.3296089448604225,0.9736566250718272,0.5454545454545454,1.0,1.0,9/33,15.53%,RASIP1;ARHGAP44;DYNLL1;ARHGAP24;ITGA3;MET;RIPOR2;KANK1;RASAL3
prerank,Regulation Of Synapse Organization (GO:0050807),0.3434946049828437,0.9735576162946612,0.48936170212765956,1.0,1.0,2/24,5.42%,SLITRK2;EPHA4
prerank,Regulation Of Epithelial To Mesenchymal Transition (GO:0010717),-0.3100996535037674,-0.973541472553727,0.484375,0.9679085335753113,1.0,10/77,9.17%,SPRY2;COL1A1;TGFB2;MARK1;IL1B;CRB2;SPRED1;BAMBI;HPN;PHLDB1
prerank,Regulation Of Cell Growth (GO:0001558),0.24770192366429586,0.973236571503911,0.5,1.0,1.0,20/220,6.06%,CISH;GNG4;AKAP6;SOCS2;CEACAM1;H3-5;PAK6;S100A8;ESR2;ATAD3A;PSRC1;HSPA1A;DNPH1;SH3BP4;EGLN2;CDKN2A;ENPP1;KIF14;CAMK2D;BRAT1
prerank,Regulation Of Inflammatory Response (GO:0050727),0.24530025839599603,0.9729399896385649,0.5294117647058824,1.0,1.0,62/223,18.68%,FFAR2;S100A8;GPRC5B;MYO1C;IL1R1;IL21;ALOX5;KLF4;HCK;PTPN2;CCR2;ADIPOQ;SIRPA;LGALS2;SNCA;IL4;MVK;PYCARD;ZP3;TNFAIP8L2;CXCL17;CD200;IL16;IL13;CX3CL1;NOD2;DAGLA;SEMA7A;S100A9;MFHAS1;NLRP3;ELF4;GRN;NAPEPLD;TSLP;CD200R1;TLR2;FNDC4;PROC;GPER1;TLR4;DDT;NR1H4;SMPDL3B;PYDC2;XIAP;PARK7;IL10RA;TRIM65;IFI35;GBA1;IL1RL2;S100A12;SHPK;TMSB4X;GATA3;IL17RA;IL22RA1;CARD16;ETS1;HYAL2;TRADD
prerank,Positive Regulation Of Neutrophil Migration (GO:1902624),-0.36703216398749355,-0.9719839561968244,0.5272727272727272,0.9716650455233437,1.0,5/22,12.56%,XCL1;CXCL8;DAPK2;XG;FUT4
prerank,Cardiac Muscle Tissue Development (GO:0048738),-0.3507986088866298,-0.9688016972334621,0.46296296296296297,0.98030802721942,1.0,9/47,10.54%,SCN5A;GATA6;MSX2;MYL7;SIK1;HEY2;SMAD5;NDUFV2;HEY1
prerank,Positive Regulation Of Transcription Elongation By RNA Polymerase II (GO:0032968),-0.32120445588127067,-0.9683005485202969,0.4918032786885246,0.9806412249225462,1.0,13/43,25.69%,MED26;CCNT1;MED21;ELL2;MED27;PWWP2B;CDK9;MED9;MED30;CDC73;TCERG1;MED6;CDK13
prerank,Establishment Of Protein Localization To Plasma Membrane (GO:0061951),0.32436548655572295,0.9677585919294502,0.55,1.0,1.0,4/37,6.87%,RAB31;KIF13A;GOLPH3L;RAB10
prerank,Nuclear Membrane Organization (GO:0071763),0.3618960550751651,0.967752085684535,0.5555555555555556,1.0,1.0,12/26,34.58%,CHMP4C;PLK1;GPER1;TMEM43;CHMP2A;SPAST;TOR1A;CHMP6;CHMP7;NEMP1;TOR1B;CHMP5
prerank,Negative Regulation Of Cytokine Production (GO:0001818),0.25356698266628724,0.9676849888707783,0.5333333333333333,1.0,1.0,41/173,15.75%,CEACAM1;CR1;HLA-DRB1;LGALS9C;KLF4;FOXP3;SIRPA;GBP1;SSC5D;TIGIT;F2RL1;AXL;F2;PYCARD;FOXJ1;RGCC;LILRB1;PTPN6;TLR8;CD200;LGALS9;CCR7;IRAK3;CX3CL1;PDCD1LG2;CMKLR1;ELF4;TRIB2;CD200R1;LILRB4;HOMER2;LEF1;IFNL1;TLR4;C1QBP;JAK3;RBX1;SARS1;NR1H4;CUEDC2;BTN2A2
prerank,Protein Deubiquitination (GO:0016579),-0.29250395348452124,-0.9674988843294342,0.5087719298245614,0.9817119561215852,1.0,31/106,22.27%,USP17L13;USP9Y;USP17L11;USP17L15;USP45;YOD1;TNFAIP3;USP17L7;DEPDC1B;SPATA2;USP42;ZC3H12A;USP29;PRKN;OTUD6B;VCPIP1;USP46;JOSD1;ATXN3L;USP16;USP38;USP30;OTULIN;USP8;MINDY2;USP36;ABRAXAS2;ZRANB1;USP1;OTUD7B;USP17L2
prerank,Regulation Of GTPase Activity (GO:0043087),-0.26732609105022137,-0.966687508861554,0.5151515151515151,0.9828317441143557,1.0,22/206,6.49%,CCL7;BCAR3;WNT11;CCL22;RGL4;HRAS;ADRB1;XCL1;LRCH1;CHN2;CHN1;PLXNB3;CCL14;LRRK2;TBC1D15;RAPGEF4;RAPGEF5;RGS1;FZD10;PLXND1;RASA4;DOCK7
prerank,Positive Regulation Of Cell Communication (GO:0010647),-0.38055058356620175,-0.9664473958577696,0.5849056603773585,0.9823077057228224,1.0,7/30,13.82%,GATA6;EDN3;LGI1;RIMS1;NMB;EDN1;ANK3
prerank,Response To Axon Injury (GO:0048678),0.372330839758686,0.9662816991542715,0.4166666666666667,1.0,1.0,4/17,12.50%,RTN4RL1;RTN4RL2;DHFR;NREP
prerank,Negative Regulation Of Protein Localization To Plasma Membrane (GO:1903077),0.3631714812140787,0.9662217976724355,0.4117647058823529,1.0,1.0,5/18,13.86%,GBP1;BCL2L1;CSK;DAB2;PID1
prerank,Regulation Of B Cell Activation (GO:0050864),-0.3796659257452176,-0.9662202236083058,0.5333333333333333,0.9817591720616223,1.0,9/25,19.39%,BANK1;IL4I1;TNFAIP3;MZB1;FCGR2B;SAMSN1;ZFP36L2;THEMIS2;TLR9
prerank,Regulation Of Glucose Transmembrane Transport (GO:0010827),-0.4113759221526063,-0.9659771706197411,0.4727272727272727,0.9813280139612063,1.0,3/17,7.20%,NR4A3;IL1B;C1QTNF12
prerank,Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001959),-0.32060864320963955,-0.9655138740706358,0.36666666666666664,0.9815158316770342,1.0,9/40,12.05%,IGF2BP1;CASP8;TNFAIP3;VRK2;SPATA2;PALM3;IL7;TBK1;MAPKAPK2
prerank,Regulation Of Reactive Oxygen Species Biosynthetic Process (GO:1903426),0.3732592802001826,0.9649736013234405,0.4666666666666667,1.0,1.0,8/25,18.22%,ALOX5;SNCA;SLC5A3;CD36;CYBA;TLR4;PARK7;CCN6
prerank,Positive Regulation Of T Cell Proliferation (GO:0042102),0.2803368680486021,0.9638752981103547,0.5416666666666666,1.0,1.0,14/64,11.22%,CD86;IL21;EBI3;CCR2;HLA-DMB;NCK2;CD1D;IL4;CD80;PYCARD;ZP3;CD24;PDCD1LG2;IL12RB1
prerank,Cholesterol Biosynthetic Process (GO:0006695),-0.3825083789088367,-0.9634975684415017,0.55,0.986074476273897,1.0,7/25,17.42%,NPC1L1;CYP51A1;DHCR7;CES1;SC5D;INSIG1;MVD
prerank,Defense Response To Fungus (GO:0050832),-0.35171704559178657,-0.9634417236807865,0.42857142857142855,0.9849718290295314,1.0,2/26,1.51%,CLEC7A;IGF2BP1
prerank,Regulation Of Ryanodine-Sensitive Calcium-Release Channel Activity (GO:0060314),0.37689590070418916,0.9633312241991792,0.5,1.0,1.0,6/22,15.46%,HRC;CAMK2D;SRI;JPH3;FKBP1A;JSRP1
prerank,Positive Regulation Of Inflammatory Response (GO:0050729),0.2689241655361542,0.9632309055620807,0.5789473684210527,1.0,1.0,27/96,18.68%,S100A8;GPRC5B;MYO1C;IL21;CCR2;LGALS2;SNCA;PYCARD;ZP3;IL16;CX3CL1;C2CD4A;S100A9;NLRP3;GRN;NAPEPLD;TSLP;TLR2;TLR4;DDT;IFI35;S100A12;IL6ST;IL17RA;ETS1;HYAL2;TRADD
prerank,Negative Regulation Of ERK1 And ERK2 Cascade (GO:0070373),-0.3474141448827344,-0.9631559032417597,0.543859649122807,0.9844105686122784,1.0,6/45,8.60%,SPRY2;RPS6KA6;PSCA;LYN;SPRED1;SEMA6A
prerank,Cholesterol Efflux (GO:0033344),-0.3776336297912035,-0.9630615940745201,0.47058823529411764,0.9834664444593135,1.0,6/21,12.70%,APOA1;ABCA8;ABCA5;NPC1;ABCG1;TSKU
prerank,Regulation Of Sodium Ion Transport (GO:0002028),-0.3623150917873074,-0.9626280996866622,0.5272727272727272,0.9833306146590718,1.0,9/33,17.28%,SCN5A;PER1;NEDD4;SIK1;SCN3B;ANK3;GPD1L;SNTA1;DLG1
prerank,Dendrite Morphogenesis (GO:0048813),0.331780403308762,0.9624544859288892,0.5121951219512195,1.0,1.0,5/34,2.65%,EPHB1;NOL3;PHACTR1;EPHB3;CHRNA7
prerank,Triglyceride Homeostasis (GO:0070328),-0.36755877943390636,-0.9615155590417984,0.5,0.9856355099521942,1.0,7/27,17.17%,IL18;RORA;APOA1;MLXIPL;C1QTNF3;MTLN;SIRT1
prerank,Cellular Response To Catecholamine Stimulus (GO:0071870),-0.4055008371256353,-0.9613247326542402,0.49122807017543857,0.9848592737331215,1.0,4/19,11.44%,NR4A3;LRRK2;PRKN;PDE4B
prerank,Kidney Development (GO:0001822),-0.3179311597857237,-0.9612598637153177,0.5517241379310345,0.9837408399699202,1.0,5/66,4.85%,VEGFA;PAX8;TGFB2;ZBTB16;SOX4
prerank,Positive Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:1900087),-0.3525209184715266,-0.961098207587658,0.509090909090909,0.9829434110970272,1.0,6/30,16.78%,STOX1;PLCB1;ADAMTS1;KMT2E;SASS6;UBE2E2
prerank,Positive Regulation Of Apoptotic Process (GO:0043065),0.23878350835858467,0.9607998403518709,0.68,1.0,1.0,48/260,13.58%,PNMA2;BMP4;CTSV;TPD52L1;MAPK8;TNFSF10;TP63;ADIPOQ;APC;IRF5;SIAH1;BID;LGALS2;SLC27A4;CTSL;SNCA;DAPK1;ITGA6;PDCD2;HTT;CDK5;CYP1B1;CTSH;CALHM2;DYNLL1;PYCARD;LILRB1;HTRA4;PHLDA3;HSPD1;FANK1;CASP6;HRK;PRMT2;CEL;RASSF2;CLIP3;TOP2A;SFRP1;GRN;CCAR2;TFPT;CASP9;GPLD1;CARM1;GPER1;C1QBP;DKKL1
prerank,Xenobiotic Catabolic Process (GO:0042178),-0.39353602022694223,-0.9606949231510378,0.4339622641509434,0.9830124869037355,1.0,6/18,21.70%,CYP3A5;CYP3A4;CYP2C9;TPMT;CYP2A6;NUDT15
prerank,Heart Process (GO:0003015),-0.4556010064957705,-0.960388053129234,0.6,0.9827258473456081,1.0,2/15,5.59%,NOX4;MYL7
prerank,Negative Regulation Of Sequestering Of Calcium Ion (GO:0051283),0.3192874720705007,0.9601684897987607,0.5777777777777777,1.0,1.0,6/35,10.55%,GP9;GP5;RYR1;FGF2;CCR7;GP1BA
prerank,Regulation Of Actin Cytoskeleton Organization (GO:0032956),0.28224848252896584,0.9597451549923857,0.4583333333333333,1.0,1.0,22/86,20.09%,PEAK3;ARHGAP44;HCK;EFNA5;EPS8;DYNLL1;CARMIL1;ESAM;CARMIL3;PDGFA;PAK1;ARHGEF19;NEDD9;BST2;CDK10;SLC4A2;CORO1A;TWF2;SIGLEC15;SH3BP1;OR2A4;HAX1
prerank,Fatty Acid Metabolic Process (GO:0006631),-0.2846467360697245,-0.9597166901454143,0.5625,0.9836827870819066,1.0,19/119,13.85%,ECHDC3;ALOX15;ALOX12;ALOXE3;CYP4F12;ACSBG1;HTD2;CPT1B;ELOVL4;MLYCD;CES1;AOAH;ACBD5;ACSM2A;GGT5;LPIN1;PEX2;PHYH;CYP2E1
prerank,Vesicle-Mediated Transport In Synapse (GO:0099003),-0.41537362241521586,-0.959543250659072,0.5471698113207547,0.9829906919469558,1.0,4/16,8.58%,SNAP25;STX1A;CPLX1;RIMS1
prerank,Response To UV-B (GO:0010224),-0.41418000517752396,-0.9593209551278383,0.5147058823529411,0.9823762064188833,1.0,2/16,3.81%,IL12A;MFAP4
prerank,Response To Purine-Containing Compound (GO:0014074),0.3314948731402528,0.9591531745166589,0.43478260869565216,1.0,1.0,5/24,7.74%,RYR1;NT5E;ENPP1;P2RY6;ADORA2A
prerank,Regulation Of Cyclin-Dependent Protein Kinase Activity (GO:1904029),0.32194453873757944,0.9590291235504637,0.5416666666666666,1.0,1.0,9/53,7.46%,CDKN2B;TTBK1;CDKN3;CCNP;PKMYT1;CCNB2;CDKN2A;CCNF;CCNA2
prerank,Mammary Gland Development (GO:0030879),-0.4208700263795372,-0.9589717189095784,0.4782608695652174,0.9820664858189991,1.0,3/19,5.66%,VEGFA;PRL;OXTR
prerank,Synaptic Vesicle Endocytosis (GO:0048488),0.3080465895214956,0.9581024493229661,0.5135135135135135,1.0,1.0,5/40,6.29%,ITSN1;SYT5;PACSIN1;SNCA;CDK5
prerank,Nucleosome Disassembly (GO:0006337),0.3798943924930702,0.9578475266373243,0.4634146341463415,1.0,1.0,1/17,1.29%,NFE2
prerank,Endosome Organization (GO:0007032),-0.31095185289644,-0.9577649664108424,0.5172413793103449,0.9845465732956408,1.0,11/52,22.25%,ANXA8;WASHC4;PLEKHF2;VPS18;DNAJC13;PI4K2A;EXOC8;ANXA8L1;USP8;PLEKHA3;ATP6V1F
prerank,Regulation Of Neurotransmitter Transport (GO:0051588),0.38922838197135884,0.9577534180621194,0.54,1.0,1.0,7/19,20.58%,SYN1;DYSF;KCNMB4;FLOT1;CPLX3;FER1L5;MEF2C
prerank,rRNA Transcription (GO:0009303),0.3633189171632093,0.9569484403696176,0.4727272727272727,1.0,1.0,1/17,2.71%,POLR1G
prerank,Regulation Of Chromosome Organization (GO:0033044),0.3057870576690721,0.9568238187769762,0.525,1.0,1.0,10/43,23.09%,MYC;RMI2;PIF1;NSMCE1;TFPT;SLF1;RUVBL2;SHCBP1L;RUVBL1;BUB1
prerank,Carbohydrate Derivative Catabolic Process (GO:1901136),-0.3883616648606337,-0.9567265636325614,0.46296296296296297,0.9866550469582984,1.0,1/16,0.26%,FBXO27
prerank,Cytokine-Mediated Signaling Pathway (GO:0019221),-0.26815794159379164,-0.9565904922772783,0.59375,0.9858124785988116,1.0,40/248,11.68%,CCL7;IFNA6;IL34;LILRA2;GHR;IL18RAP;IFNA7;CCL22;DUOX2;EDN2;IL1B;IL18;XCL1;CXCL8;LYN;IL12A;EPOR;CXCL2;CCL14;TRAF6;CLCF1;CSF1R;CARD14;PLCB1;NFKBIA;IL18R1;IL12RB2;CXCL11;CXCL3;IL7;IL11;IL15;GPR35;IFNA2;SRC;PF4V1;MT3;YAP1;CCL2;IL5RA
prerank,Regulation Of TOR Signaling (GO:0032006),-0.30101173804843934,-0.9564528937817076,0.5370370370370371,0.9851731517923543,1.0,18/72,23.31%,FBXO9;NUAK1;HTR6;LARS1;PIK3CA;BMAL1;SMCR8;LIN28A;RICTOR;UBR1;SIRT1;PRKAA2;SEH1L;FNIP1;WDR24;PKHD1;DGKQ;TSC1
prerank,"DNA Damage Response, Signal Transduction By P53 Class Mediator Resulting In Cell Cycle Arrest (GO:0006977)",0.36843589685610184,0.9561961040754285,0.5681818181818182,1.0,1.0,5/16,13.80%,GTSE1;CHEK2;MUC1;PLK2;PRAP1
prerank,mRNA 3'-End Processing (GO:0031124),-0.3524365456360321,-0.9560851908651302,0.5283018867924528,0.9852135446864011,1.0,11/40,22.24%,PAPOLB;RPRD1B;TENT4B;TUT1;PEX2;RPRD1A;TENT2;MTPAP;CDC73;WDR33;NUDT21
prerank,Cellular Component Assembly (GO:0022607),-0.2616521061661194,-0.9555442088475743,0.5522388059701493,0.985416900333875,1.0,54/244,21.72%,CALD1;SCIN;PIERCE1;PARD3;SYCE1;OTX2;VIL1;SPAG16;IRGM;SHANK1;MTSS2;ANKS4B;NCKAP1;SLC7A9;LRRC43;RP1L1;WNT7A;RIMS1;RSPH4A;BSN;ESPN;MYO1B;PAWR;YAP1;VCPIP1;TOGARAM1;TEX11;ANK3;IL1RAP;WASF3;EPPK1;CREBBP;PEX14;KNTC1;PICALM;DNAAF1;YTHDF3;SLC2A1;RP1;PALS2;FANCC;NLGN4X;WASL;MITF;NLGN3;RSPH1;PIERCE2;GPAA1;PARD6B;RAC3;SNX9;CD2AP;RANBP9;SYCE2
prerank,Negative Regulation Of G2/M Transition Of Mitotic Cell Cycle (GO:0010972),0.32890848257183025,0.9550720347610597,0.5454545454545454,1.0,1.0,4/28,10.11%,CHMP4C;AURKB;RBBP8;INIP
prerank,Positive Regulation Of Protein Metabolic Process (GO:0051247),-0.265961557676351,-0.9550142698558567,0.6176470588235294,0.9858076790495715,1.0,20/193,9.72%,RPS27L;LILRA2;THBS1;ASB9;IL1B;IL18;APC2;PRR16;SOX4;CASP8;GUF1;TNFAIP3;ASB11;NEDD4;WNT7A;NFKBIA;PERP;ASB5;PRKN;TIPARP
prerank,Endosome To Lysosome Transport Via Multivesicular Body Sorting Pathway (GO:0032510),0.40460743671124527,0.9548288193118584,0.5098039215686274,1.0,1.0,3/15,15.93%,CHMP4C;MVB12A;VCP
prerank,DNA Repair (GO:0006281),0.22633501142023174,0.9546708418903638,0.6956521739130435,1.0,1.0,95/287,27.62%,TICRR;RMI2;APEX2;EXD2;EXO1;GTF2H2C;NUDT1;EME2;CDCA5;MGME1;RRM2B;FANCE;EME1;NHEJ1;TRIP13;FBXO6;RBBP8;CDK1;TP73;UBE2V1;CHEK2;GTF2H5;MC1R;ATRIP;INIP;DTX3L;POLH;EYA1;RNASEH2A;POLL;CETN1;HLTF;MUS81;PMS2;ERCC1;RAD51AP1;RECQL4;H2AX;RPA2;UNG;FANCI;DOT1L;CENPX;TEX264;VCP;PARK7;SMUG1;DCLRE1C;RHNO1;RPA3;INTS3;ERCC2;MEN1;UBE2T;ATM;FANCM;DDB1;APLF;PARP4;OGG1;RAD52;SIRT6;UBE2A;GTF2H4;ATXN3;APEX1;MSH2;NABP1;NTHL1;RAD23A;RFC4;MSH6;PPP5C;RNF8;XRCC1;REXO4;PARP3;EYA3;FANCG;MPG;PCNA;XRCC3;TIMELESS;RPS3;ASCC3;PARP1;DNA2;MACROH2A1;RPA1;PDS5A;MRPL36;RNASEH2C;PARP9;ENDOV;WDHD1
prerank,Positive Regulation Of Establishment Of Protein Localization To Mitochondrion (GO:1903749),0.3344926454793481,0.9542351790423559,0.48717948717948717,1.0,1.0,6/33,13.29%,MAPK8;HSPA1L;BBC3;RAC2;GSK3A;NMT1
prerank,Glycerophospholipid Biosynthetic Process (GO:0046474),-0.297234143074943,-0.9531469334720197,0.5081967213114754,0.9897135633430775,1.0,13/107,10.20%,DGKB;ALOX15;LPCAT2;SLC44A4;SLC44A5;PITPNM3;APOA1;ETNK2;MBOAT2;INPP5J;PCYT1B;DGKE;CHKB
prerank,Transition Metal Ion Transport (GO:0000041),-0.36244752091366716,-0.952917216287575,0.55,0.989260842368447,1.0,6/32,14.28%,SLC11A1;MELTF;TTYH1;SLC39A8;MT3;SLC30A1
prerank,Nuclear Export (GO:0051168),-0.33566282557113153,-0.952777068781102,0.5192307692307693,0.9884472339480544,1.0,8/48,15.92%,RANBP17;NUP62;WASHC4;LSG1;DDX39A;CDKN1B;RANBP3;ANKLE1
prerank,Regulation Of Lipid Biosynthetic Process (GO:0046890),0.34378721031103815,0.9522928742015956,0.49019607843137253,1.0,1.0,7/27,16.82%,CEACAM1;PDK4;EIF6;AVIL;GPER1;ZBTB20;CREBL2
prerank,Regulation Of DNA Replication (GO:0006275),-0.3104591332570746,-0.9519137097531623,0.5538461538461539,0.9898921530717364,1.0,22/74,24.55%,BCAR3;DSCC1;ACVRL1;STON1;JADE3;ATAD5;SLFN11;SMARCA5;GTPBP4;POLE3;ESCO1;TSPYL2;KAT7;BLM;INO80D;OBI1;ING5;RBBP6;NUCKS1;CCDC88A;EREG;BAZ1A
prerank,Peptide Biosynthetic Process (GO:0043043),0.25562721925124093,0.9518992884343683,0.5945945945945946,1.0,1.0,72/152,36.15%,RPL34;IGF2BP3;MRPL51;RPS2;RPS4Y1;RPL41;MRPS33;RPL31;RPL14;MRPL24;RPL13;RPL23A;RPS4Y2;RPS24;SARS1;MRPS21;MRPS5;GGT6;MRPL18;RPS6KB2;MRPS17;MRPL27;DARS1;MRPL52;MRPS18C;MRPL34;MRPL28;RPS15A;DHPS;RPL22;RPS3A;RPL18A;MRPS11;RPL35A;RPS27;RPS3;RPS18;RPS8;RPLP2;MRPL36;RPS16;RPS5;RPS6;MRPS6;MRPS15;MRPS18B;RPL4;RPS10;RPS26;RPL7A;RPS21;RPL38;RPS9;RPL26;RPL19;RPS23;MRPL23;MRPL42;RPS25;RPL32;MRPL11;RPL21;RPL10A;RPS13;RPS11;RPL36;MRPL9;FAU;RPL12;RPS20;ASMT;RPL24
prerank,Regulation Of Tumor Necrosis Factor Production (GO:0032680),-0.27976450628295285,-0.9517495737198695,0.5588235294117647,0.989316339530106,1.0,19/123,12.05%,AZU1;CLEC7A;LILRA2;THBS1;TYROBP;CIDEA;IGF1;CD33;IFNGR1;FZD5;TNFAIP3;IFNG;HAVCR2;ZC3H12A;TLR3;ARG2;DICER1;PLCG2;MAPKAPK2
prerank,Cell-Matrix Adhesion (GO:0007160),-0.29653187750027554,-0.9515921919159731,0.4827586206896552,0.9885678004505453,1.0,24/104,16.22%,ITGB5;PEAK1;ITGB4;CD34;VCAM1;VWA2;ACTN3;ADAM9;NID2;ITGAM;ITGAD;STRC;THBS3;SRC;SGCE;VTN;WHAMM;THY1;ITGB3;ADAMTS13;FERMT1;CDH11;EMP2;SORBS1
prerank,Negative Regulation Of Intracellular Steroid Hormone Receptor Signaling Pathway (GO:0033144),0.31963559766374616,0.951501334631097,0.5813953488372093,1.0,1.0,7/29,14.75%,FOXH1;ZNF366;KANK2;HEYL;SFRP1;DAB2;PHB1
prerank,Regulation Of Proteasomal Protein Catabolic Process (GO:0061136),-0.33814942560573785,-0.9514665486195012,0.43859649122807015,0.9876720056196739,1.0,6/48,11.62%,NUPR1;GLMN;DNAAF4;KCNE2;PRKN;PRKCG
prerank,Zymogen Activation (GO:0031638),-0.3317298393488123,-0.9500112745282903,0.5,0.9910091590798461,1.0,11/43,17.60%,PRSS12;HGFAC;CASP8;RIPK2;PERP;GGT2P;CUZD1;FURIN;MMP14;THBD;FADD
prerank,Epithelial Tube Morphogenesis (GO:0060562),0.32674617515873866,0.9496030544782675,0.48936170212765956,1.0,1.0,5/31,12.71%,RASIP1;BMP4;CSNK2B;MET;PAK1
prerank,Positive Regulation Of GTPase Activity (GO:0043547),-0.2653329597070896,-0.9491939856196091,0.5277777777777778,0.9925166395280722,1.0,25/224,8.08%,CCL7;BCAR3;WNT11;ARHGAP29;CCL22;RGL4;HRAS;ADRB1;XCL1;APC2;MTSS2;CCL14;TBC1D15;RAPGEF4;RAPGEF5;RGS1;FZD10;TBC1D9;ARHGEF10;SIPA1L2;DOCK7;GPR65;LARS1;ARHGEF16;RGS11
prerank,Ventricular Cardiac Muscle Tissue Development (GO:0003229),0.3629799586264179,0.9491768675931735,0.5384615384615384,1.0,1.0,1/23,0.14%,TNNT2
prerank,Positive Regulation Of Cell Development (GO:0010720),0.3429558819200712,0.9490118565945824,0.46153846153846156,1.0,1.0,8/30,14.61%,GPRASP3;BMP4;CX3CR1;RGS14;NIBAN2;GPER1;SOX11;OPRM1
prerank,Intracellular Monoatomic Ion Homeostasis (GO:0006873),-0.38030993267876473,-0.9487623174961218,0.5714285714285714,0.9925723664825802,1.0,6/20,17.68%,CLDN16;SLC39A8;MT3;LETM2;RHAG;CNNM4
prerank,Positive Regulation Of DNA Replication (GO:0045740),-0.42003754817520755,-0.9486592665002764,0.46296296296296297,0.9917873255501161,1.0,2/18,4.14%,BCAR3;STON1
prerank,Negative Regulation Of Osteoclast Differentiation (GO:0045671),0.3786022361910313,0.9485503882054145,0.625,1.0,1.0,7/20,13.16%,LRRC17;IL4;FSTL3;LILRB1;FBN1;LILRB4;TLR4
prerank,Positive Regulation Of Cell Cycle G2/M Phase Transition (GO:1902751),-0.3731874635689587,-0.9482156831786885,0.5370370370370371,0.9920783952702773,1.0,3/24,4.93%,STOX1;RAD51B;CDC25A
prerank,Amino Acid Catabolic Process (GO:0009063),0.3078223006773822,0.9479187383352502,0.5510204081632653,1.0,1.0,12/35,20.79%,HNMT;KMO;PRODH;ETFA;ALDH4A1;SLC25A44;ETFB;ECHS1;GOT2;BCKDK;OTC;ALDH5A1
prerank,Intracellular Cholesterol Transport (GO:0032367),-0.43642236506000537,-0.9478479215272789,0.6086956521739131,0.9918877948822437,1.0,11/16,31.11%,NPC1;ABCG1;PIP4K2A;STARD4;OSBP;SERAC1;LRP6;SYT7;GUCY2C;RELCH;VPS4A
prerank,Negative Regulation Of Anoikis (GO:2000811),-0.392161364928013,-0.9476189862644874,0.5,0.9914266583588741,1.0,4/15,11.46%,TLE1;PIK3R3;SRC;PIK3CA
prerank,Intracellular pH Reduction (GO:0051452),-0.35427730516071615,-0.9473459850594036,0.47692307692307695,0.9909789281469883,1.0,6/32,14.50%,SLC11A1;ATP6V0D2;DMXL2;SLC4A7;GPR89A;GPR89B
prerank,Regulation Of Postsynapse Organization (GO:0099175),0.34408775314883877,0.9473261155958195,0.5384615384615384,1.0,1.0,6/24,13.21%,NOL3;ARHGAP44;EPHA4;CDK5;SRCIN1;ABI3
prerank,Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071900),0.27022615197302335,0.9472033444023186,0.5208333333333334,1.0,1.0,21/112,13.54%,CDKN2B;CDKN3;CCNP;PPEF2;PKMYT1;CCNB2;CDKN2A;SNCA;CCNF;HTT;TCL1A;PYCARD;CCNA2;SLC8A2;PDCD10;TRIB3;TRIB2;CCNB1;SOS1;TRIB1;CAMK1
prerank,Negative Regulation Of Insulin Secretion (GO:0046676),-0.4009348477965148,-0.9469581799633114,0.6271186440677966,0.9909377854752409,1.0,4/15,9.30%,KCNJ11;KLF7;MIDN;PRKN
prerank,Regulation Of Potassium Ion Transmembrane Transporter Activity (GO:1901016),-0.3783154195312194,-0.9468904444777432,0.5272727272727272,0.9899271146655472,1.0,5/24,10.58%,CASQ2;KCNAB1;NEDD4;KCNE2;AKAP9
prerank,Positive Regulation Of T Cell Cytokine Production (GO:0002726),-0.3954188176581673,-0.9468200222059786,0.46153846153846156,0.9889433713270415,1.0,8/21,11.18%,IL1B;IL18;XCL1;TRAF6;FZD5;IL18R1;TBX21;DENND1B
prerank,Protein-Containing Complex Organization (GO:0043933),-0.27283599603875436,-0.9464161715581125,0.5396825396825397,0.9890027550977523,1.0,32/120,23.77%,PARD3;OTX2;VIL1;IRGM;SHANK1;ANKS4B;SLC7A9;RIMS1;YAP1;IL1RAP;WASF3;CREBBP;NUP54;PEX14;KNTC1;PICALM;SLC2A1;PALS2;FANCC;WASL;SEH1L;MITF;NUP133;GPAA1;PARD6B;SNX9;CD2AP;RANBP9;CD74;NUP35;KIFAP3;NEMF
prerank,Arp2/3 Complex-Mediated Actin Nucleation (GO:0034314),-0.39665971692924784,-0.9463162225193004,0.5454545454545454,0.9881447500229588,1.0,4/15,16.18%,JMY;MAGEL2;WHAMM;ARPC5L
prerank,Cellular Response To Chemical Stress (GO:0062197),0.2552804255305379,0.9462275570638151,0.5882352941176471,1.0,1.0,28/86,23.12%,ALDH3B1;MAPK8;LRRC8D;PRR5L;VKORC1L1;HSPA1A;SNCA;PRDX3;DHRS2;PYCR1;SUMO4;NQO1;MGAT3;RBX1;KEAP1;PARK7;PRDX5;ATM;ATP13A2;RAD52;CHCHD2;PPIA;CCS;FAS;AIF1;PYCR2;SLC4A11;TBC1D24
prerank,Negative Regulation Of Cellular Response To Insulin Stimulus (GO:1900077),0.35900446761161553,0.945949288603584,0.5306122448979592,1.0,1.0,9/26,16.54%,PTPN2;SLC27A4;ENPP1;GRB10;GSK3A;PID1;KANK1;GRB14;TNS2
prerank,Response To cAMP (GO:0051591),0.31771019867597244,0.9459090861660711,0.5652173913043478,1.0,1.0,3/37,4.25%,AKAP6;RAPGEF1;HCN2
prerank,Release Of Cytochrome C From Mitochondria (GO:0001836),0.35101577605746925,0.9457753518266693,0.5576923076923077,1.0,1.0,11/18,35.55%,BID;BCL2L1;BBC3;TIMM50;BCL2A1;IFI6;MCL1;BOK;BCL2;BAX;GGCT
prerank,Xenobiotic Transport (GO:0042908),0.34441509940655607,0.9452793502788134,0.46938775510204084,1.0,1.0,3/20,4.07%,ABCC11;SLC29A4;SLC15A2
prerank,Sulfation (GO:0051923),0.41236040724448714,0.9450502516379761,0.5151515151515151,1.0,1.0,5/15,20.41%,SULT2B1;SULT1B1;SULT1A1;SULT1C4;SULT2A1
prerank,Negative Regulation Of Neuron Projection Development (GO:0010977),0.2868491541116069,0.9449312995565398,0.5555555555555556,1.0,1.0,8/50,11.44%,RTN4RL1;RTN4R;EPHA4;BCL11A;PRAG1;RTN4RL2;HDAC2;ADCY6
prerank,'De Novo' Post-Translational Protein Folding (GO:0051084),0.3318952817881273,0.9443375143229118,0.5135135135135135,1.0,1.0,9/30,18.01%,HSPA1A;HSPA1L;CHCHD4;DNAJB5;SDF2L1;HSPA8;HSPE1;HSPA6;SDF2
prerank,Mesenchymal Cell Migration (GO:0090497),0.3439942015832446,0.9438241251952713,0.5116279069767442,1.0,1.0,11/31,16.16%,SEMA6B;SEMA3G;SEMA5A;RADIL;SEMA7A;SEMA5B;SEMA4G;HTR2B;SEMA4F;NRTN;TBX1
prerank,L-alpha-amino Acid Transmembrane Transport (GO:1902475),0.3103885893590215,0.9437342713213982,0.5116279069767442,1.0,1.0,13/39,20.98%,SLC1A4;SLC1A1;SLC1A7;SLC1A2;SLC38A3;SLC17A7;SLC38A5;SLC6A9;SLC38A9;SLC6A20;SLC25A2;SLC6A2;PRAF2
prerank,Negative Regulation Of Nervous System Development (GO:0051961),-0.39773282047250247,-0.9436366855463386,0.5576923076923077,0.9941905084932876,1.0,5/17,16.20%,IL1B;WNT7A;DYNLT1;SLIT1;PAX6
prerank,Regulation Of Protein-Containing Complex Assembly (GO:0043254),-0.28642155635360167,-0.9433699572548032,0.582089552238806,0.9938530260768135,1.0,20/113,20.19%,VEGFA;CLEC7A;GFAP;IRGM;MAPK15;IFNG;BBS10;SRC;VPS18;RHOC;TPPP;EP300;SAR1A;MTLN;TGFBRAP1;INSM1;RAF1;NAPA;TFIP11;SAR1B
prerank,Semaphorin-Plexin Signaling Pathway (GO:0071526),-0.34359356213126785,-0.9427851409723493,0.5,0.9943937711559552,1.0,8/33,9.96%,SEMA3C;SEMA3F;PLXNB3;PLXND1;SEMA4C;NELL2;SEMA6A;PLXNA2
prerank,Icosanoid Metabolic Process (GO:0006690),-0.30905022529614024,-0.9425948187484584,0.4827586206896552,0.9936795126426827,1.0,10/50,13.18%,ALOX15;ALOX12;ALOXE3;CYP4F12;CYP4F8;DAGLB;PLA2G4B;AWAT1;MAPKAPK2;LTC4S
prerank,Positive Regulation Of Cell Cycle G1/S Phase Transition (GO:1902808),-0.3465467732167624,-0.9424827259326527,0.5882352941176471,0.9928453658120221,1.0,9/37,19.22%,STOX1;PLCB1;ADAMTS1;PLCG2;PEX2;KMT2E;SASS6;UBE2E2;CDC73
prerank,Positive Regulation Of Cell-Substrate Adhesion (GO:0010811),-0.3105101313250063,-0.942453551086174,0.5423728813559322,0.991806751964417,1.0,15/69,18.02%,ALOX15;ENC1;FBLN2;CDH13;FUT1;APOA1;UTRN;CASS4;P4HB;ABL1;EMP2;RREB1;JAK2;CCL25;CSPG5
prerank,Cardiac Ventricle Morphogenesis (GO:0003208),0.33054062433974707,0.9424183593970533,0.5714285714285714,1.0,1.0,6/36,11.39%,TNNT2;BMP4;NOTCH1;HEYL;GSK3A;FKBP1A
prerank,Fc Receptor Signaling Pathway (GO:0038093),0.3488929677995292,0.9422681072204757,0.5813953488372093,1.0,1.0,9/26,17.24%,MAPK8;MAP3K7;FCER1G;PIGR;SOS1;LILRA4;IKBKB;KIT;VAV1
prerank,Negative Regulation Of Lipid Metabolic Process (GO:0045833),-0.3824208749414086,-0.9422579342936592,0.5510204081632653,0.9911587161062154,1.0,6/23,9.40%,UGT1A10;CCDC3;IL1B;CIDEA;APOD;PPP2R5A
prerank,Negative Regulation Of Defense Response (GO:0031348),0.27561871030072665,0.9421176313491395,0.625,1.0,1.0,30/104,18.24%,MYO1C;AURKB;ALOX5;KLF4;PTPN2;ADIPOQ;SIRPA;IL4;MVK;TNFAIP8L2;CXCL17;IRAK3;IL13;MFHAS1;NLRP3;ELF4;TRAFD1;FNDC4;PROC;GPER1;C1QBP;NR1H4;SMPDL3B;PYDC2;IL10RA;TRIM65;GBA1;GATA3;AKT1;IL22RA1
prerank,Negative Regulation Of Protein Ubiquitination (GO:0031397),-0.29706104902780867,-0.9420604750729469,0.52,0.990560665742868,1.0,7/51,11.62%,SPRY2;SPOPL;SOX4;TNFAIP3;HSPA1B;BAG5;PRKCG
prerank,Regulation Of T Cell Migration (GO:2000404),0.3598964182170625,0.9414563399965775,0.5106382978723404,1.0,1.0,6/22,14.00%,AIRE;PYCARD;CD200;DOCK8;CD200R1;RIPOR2
prerank,Cardiac Conduction (GO:0061337),-0.3323346060587678,-0.94126329490342,0.4861111111111111,0.9915128832971687,1.0,10/42,16.77%,SLC4A3;SCN5A;DSG2;SCN3B;KCNE2;AKAP9;DSC2;MEF2A;KCNA5;TRPM4
prerank,Regulation Of Cellular Metabolic Process (GO:0031323),0.30607395621301836,0.9399627421984286,0.5918367346938775,1.0,1.0,11/45,14.01%,VASH1;BCO2;CYP1B1;MPV17;GNB3;PDK4;MBOAT7;EIF6;NPC2;PID1;FOXM1
prerank,Regulation Of G2/M Transition Of Mitotic Cell Cycle (GO:0010389),-0.3469273364472214,-0.9397113815219656,0.5272727272727272,0.9950855803962932,1.0,5/35,5.78%,STOX1;GPR132;RAD51B;CDC25A;CDKN1A
prerank,Protein Modification By Small Protein Removal (GO:0070646),-0.2801937829674437,-0.939515560824827,0.5666666666666667,0.9944367385697828,1.0,30/108,22.27%,USP17L13;USP9Y;USP17L11;USP17L15;USP45;YOD1;TNFAIP3;USP17L7;DEPDC1B;USP42;ZC3H12A;USP29;PRKN;OTUD6B;VCPIP1;USP46;JOSD1;ATXN3L;USP16;USP38;SENP5;USP30;COPS2;USP8;USPL1;USP36;ZRANB1;USP1;OTUD7B;USP17L2
prerank,Regulation Of Lipid Catabolic Process (GO:0050994),0.3609183628323422,0.9394703335771525,0.6037735849056604,1.0,1.0,2/20,2.31%,HCAR2;APOC1
prerank,Regulation Of Centrosome Duplication (GO:0010824),0.327135022911161,0.9392690822448809,0.6170212765957447,1.0,1.0,5/30,13.47%,CHMP4C;CCNF;CENPJ;PLK2;PDCD6IP
prerank,Negative Regulation Of Tumor Necrosis Factor Production (GO:0032720),0.2918629826384839,0.938992515680116,0.5833333333333334,1.0,1.0,13/47,13.16%,CHRNA7;SIRPA;IL4;LILRB1;PTPN6;LGALS9;IRAK3;CX3CL1;MC1R;ELF4;LILRB4;LILRA4;TLR4
prerank,Regulation Of Protein Ubiquitination (GO:0031396),-0.276072418866505,-0.938952100881446,0.5873015873015873,0.9948384568551426,1.0,15/108,11.78%,SPRY2;TRAF6;LRRK2;SPOPL;SOX4;RIPK2;TNFAIP3;HSPA1B;BAG5;BRCA1;FBXO33;PRKN;ANGPT1;PRKCG;BCL10
prerank,Positive Regulation Of Mitotic Cell Cycle (GO:0045931),-0.36598929691687965,-0.9388967762884858,0.5636363636363636,0.9938782851925638,1.0,5/27,19.12%,MEIS2;AURKA;ASNS;CCDC57;PKN2
prerank,Translation (GO:0006412),0.23431452040318093,0.9387266504118608,0.7,1.0,1.0,102/230,36.28%,RPL34;IGF2BP3;MRPS26;MRPL51;RPS2;RPS4Y1;RPL41;MRPS33;RPL31;RPL14;MRPL24;MRPS31;RPL13;MRPS9;RPL23A;RPS4Y2;RPS24;SARS1;MRPS21;MRPS5;MRPL48;MRPL18;RACK1;RPS6KB2;MRPS17;MRPL27;DARS1;MRPL52;MRPS18C;MRPL34;MRPL28;RPS15A;GATC;DHPS;RPL22;RPS3A;RPL18A;MRPL58;MRPS25;VARS1;MRPS11;RPL35A;MRPL53;FTSJ1;RPS27;RPS3;MRPL1;NARS1;RPS18;RPS8;FARS2;RPLP2;MRPL36;RPS16;GTPBP2;RPS5;GADD45GIP1;RPS6;EEF1B2;RARS2;EPRS1;MRPS6;UBA52;MRPS2;MRPS15;MRPS18B;RPL4;RPS10;RPS26;RPL7A;RPS21;RPL38;MRPS23;RPS9;RPL26;RPL19;MRPL46;RWDD1;RPS23;MRPL23;MRPL42;RPS25;RPL32;MRPL11;RPL21;MRPS28;RPL10A;RPS13;RPS11;DRG2;RPL36;MRPL9;QARS1;FAU;RPL12;RPL26L1;IARS2;RPS20;ASMT;APEH;RPL24;MRPL57
prerank,Negative Regulation Of Epithelial Cell Migration (GO:0010633),-0.34721105350722453,-0.9385913226197994,0.43548387096774194,0.9935819936794343,1.0,2/31,1.26%,THBS1;DCN
prerank,Regulation Of DNA Methylation-Dependent Heterochromatin Formation (GO:0090308),0.3864240028404006,0.9385478193637694,0.5333333333333333,1.0,1.0,7/16,30.40%,PPHLN1;TET1;KDM1A;SETDB2;MORC2;RESF1;SETDB1
prerank,Regulation Of Viral Genome Replication (GO:0045069),-0.31009109320959855,-0.9385282077167009,0.5576923076923077,0.9926375488975271,1.0,6/67,5.38%,IFNL3;BTBD17;FKBP6;CXCL8;TMEM39A;APOBEC3A
prerank,Positive Regulation Of Lymphocyte Proliferation (GO:0050671),0.279256343960454,0.9384573440354721,0.5476190476190477,1.0,1.0,14/72,10.55%,CD86;IL21;TNFRSF4;HLA-DMB;NCK2;CD38;CD1D;AMH;IL4;CD80;ZP3;CD40;PDCD1LG2;GPR183
prerank,Cellular Response To Amyloid-Beta (GO:1904646),-0.33911696357614224,-0.9381367415344868,0.5333333333333333,0.9926794424640065,1.0,7/31,11.52%,VCAM1;IGF1;PRNP;CACNB1;CACNA1A;FCGR2B;NGFR
prerank,Embryonic Digit Morphogenesis (GO:0042733),0.3505644128197668,0.9379446722130025,0.5135135135135135,1.0,1.0,1/17,0.17%,TWIST1
prerank,Amino Acid Transmembrane Transport (GO:0003333),-0.33354360759287166,-0.9374941055360306,0.5409836065573771,0.9935483861986361,1.0,6/41,8.88%,SLC16A2;SLC7A8;SLC7A9;SLC25A18;SLC22A4;SLC7A11
prerank,Cytoplasmic Microtubule Organization (GO:0031122),-0.31711358917821614,-0.937287594751356,0.5084745762711864,0.9929425423896392,1.0,18/48,27.70%,CEP126;KATNAL1;MAPT;CLIP2;TPPP;SLAIN2;DLG1;CCDC88C;CRIPT;PLK3;CCDC88A;TRDN;CLIP1;CLASP1;TRPV4;KATNBL1;DYNC1H1;TUBGCP5
prerank,Regulation Of G0 To G1 Transition (GO:0070316),0.3291898010003159,0.9370495947941503,0.5531914893617021,1.0,1.0,7/32,17.37%,CDKN2B;RRM2B;HLA-G;ACTL6A;DPF3;RHNO1;SMARCB1
prerank,Protein Export From Nucleus (GO:0006611),-0.32650553931663373,-0.9370267240161447,0.4897959183673469,0.9927088604313203,1.0,1/26,0.68%,RANBP17
prerank,Positive Regulation Of Leukocyte Migration (GO:0002687),-0.3733731077789584,-0.9369516407166573,0.6,0.9918067519644173,1.0,4/29,3.07%,VEGFA;EDN2;EDN3;XCL1
prerank,Fat-Soluble Vitamin Metabolic Process (GO:0006775),0.3390392507719217,0.936861293604446,0.49019607843137253,1.0,1.0,8/23,14.36%,VKORC1L1;CYP24A1;LGMN;CYP4F2;VKORC1;NQO1;GGCX;CYP1A1
prerank,Negative Regulation Of Calcium Ion Transport (GO:0051926),-0.38761563253920095,-0.9364690754576486,0.5471698113207547,0.9922311910487845,1.0,4/16,14.28%,ATP1A2;CD33;MRLN;SLC30A1
prerank,ncRNA-mediated Post-Transcriptional Gene Silencing (GO:0035194),-0.36760457285993386,-0.9362515381636667,0.5652173913043478,0.9917846181714031,1.0,5/18,17.61%,TNRC6B;CNOT1;CELF1;MOV10L1;HELZ
prerank,Purine Nucleotide Metabolic Process (GO:0006163),0.31257193886020657,0.9362407508864495,0.5306122448979592,1.0,1.0,7/32,9.19%,KMO;FHIT;DNPH1;CD38;TP53I3;GART;AMPD2
prerank,Regulation Of Proteolysis (GO:0030162),0.28850847397028545,0.9360658937212923,0.5625,1.0,1.0,11/49,15.70%,PLAUR;PLK1;NEDD8;CDK5;F2;CSTB;HDAC2;PLAT;SPOP;KNG1;CLN6
prerank,"RNA Splicing, Via Transesterification Reactions (GO:0000375)",-0.3738705509915707,-0.9360216643748474,0.5769230769230769,0.9913390790275342,1.0,9/24,27.06%,SF3B1;PRPF4;SLU7;SRRM1;WDR83;SF3B4;SRSF10;PRPF3;MPHOSPH10
prerank,Positive Regulation Of Neural Precursor Cell Proliferation (GO:2000179),-0.35380181882680517,-0.9359234690489677,0.5892857142857143,0.9904070538036487,1.0,2/27,2.58%,VEGFA;VCAN
prerank,MAPK Cascade (GO:0000165),-0.28726937418293186,-0.9352475434428719,0.546875,0.991175579076331,1.0,7/94,4.38%,KDR;HRAS;IL1B;IL18;FGF13;LRRK2;IGF1
prerank,Dorsal/Ventral Pattern Formation (GO:0009953),-0.38380469159070446,-0.935233128730232,0.5254237288135594,0.9900798074896396,1.0,10/23,25.39%,ACVRL1;DSCAML1;FGF8;BMP1;BMPR1B;NOG;LHX1;TLL1;PTCH1;TLL2
prerank,Sphingolipid Biosynthetic Process (GO:0030148),-0.29354882530096854,-0.9348236806132245,0.5161290322580645,0.990041170052318,1.0,13/75,9.53%,FUT9;DEGS2;ALOXE3;FUT6;TLCD3B;SPTSSB;ABCA8;ELOVL4;SPNS2;ST3GAL5;ELOVL6;PNPLA1;CERS3
prerank,Modulation By Host Of Viral Genome Replication (GO:0044827),-0.36586473858984475,-0.9347681791950077,0.54,0.9891030925919736,1.0,10/21,29.17%,FBXL2;ZC3H12A;PRKN;SMC5;TMEM41B;NUCKS1;VAPA;SMC6;YTHDC2;DDX56
prerank,Proteolysis (GO:0006508),-0.24962773189013387,-0.9345513473790175,0.6376811594202898,0.9885927745289327,1.0,58/303,16.90%,ZMPSTE24;ADAMTS19;AZU1;HTRA1;ADGRV1;MMP17;ADAMTS15;TMPRSS7;CELA2A;CTRC;ADAM29;FCN2;HGFAC;CPXM1;CFH;CASP8;ADAM30;CAPN12;BACE2;ADAMTS1;ADAM22;CXCR4;FBXL2;HPN;CTRL;CTRB2;PRSS45P;ACE;ENDOU;RET;LCN1;GGT5;ERAP2;ADAM12;WFDC2;GZMB;CAPN7;CASP7;CPZ;CAPN9;BMP1;FAM111A;FURIN;VASH2;ADAMTS13;PITRM1;CPE;SPRTN;XPNPEP3;SDE2;XPNPEP1;ADAM17;ADAM20;SRGN;ADAMDEC1;CTSK;MMP14;CELA3B
prerank,Response To Copper Ion (GO:0046688),-0.4108371597567213,-0.934288730590507,0.6071428571428571,0.9882489504763143,1.0,4/19,10.94%,MT1HL1;MT1M;PRNP;MT3
prerank,Negative Regulation Of Stress Fiber Assembly (GO:0051497),0.33717498706095683,0.9339176156740426,0.6808510638297872,1.0,1.0,4/23,9.41%,ARHGAP28;RHPN2;DYNLL1;MET
prerank,Regulation Of Transforming Growth Factor Beta Production (GO:0071634),-0.4155641208441356,-0.9334446012885921,0.55,0.9896516027361425,1.0,4/16,9.50%,TGFB2;XCL1;CD46;SERPINF2
prerank,Positive Regulation Of Extracellular Matrix Organization (GO:1903055),-0.39646908533070524,-0.9331818924817197,0.5740740740740741,0.9891188466860885,1.0,2/18,2.65%,DDR2;MELTF
prerank,Positive Regulation Of Cell Death (GO:0010942),0.2721909850814552,0.9331326851636922,0.5263157894736842,1.0,1.0,10/49,15.48%,HBA1;BMP4;HP;ATG9B;SNCA;PRODH;NTRK1;HTATIP2;PHB1;DAXX
prerank,Organic Cyclic Compound Biosynthetic Process (GO:1901362),0.352535450666163,0.9326601201730997,0.56,1.0,1.0,6/28,11.17%,NOXRED1;HSD17B1;MOCOS;PYCR1;GCH1;SCP2
prerank,Protein Heterooligomerization (GO:0051291),0.3552163197686997,0.9324749573026206,0.5769230769230769,1.0,1.0,4/19,19.17%,TMEM120B;CBR4;KCNC2;MAT2A
prerank,Negative Regulation Of Cellular Component Organization (GO:0051129),-0.3225585375806567,-0.9318260391528976,0.5757575757575758,0.9920471593981505,1.0,21/71,26.29%,VEGFA;SPRY2;APOA1;HSPA1B;DNAJB1;SRC;EP300;MTMR2;DNAJB6;RAF1;HSPA2;DNM2;WASL;TFIP11;PRKD1;APOM;CLU;DNAJA4;RDX;RIOK3;ULK1
prerank,Cellular Response To dsRNA (GO:0071359),0.3686435328316369,0.9315225239020845,0.55,1.0,1.0,6/17,21.12%,IFIT1;PQBP1;FLOT1;RIGI;IFNB1;STING1
prerank,Regulation Of Cell Size (GO:0008361),-0.4034370654245011,-0.9313545722319865,0.5263157894736842,0.9924650177790542,1.0,5/24,12.85%,PRR16;LARS1;EDN1;VAV3;RAP1GAP2
prerank,Cellular Response To Copper Ion (GO:0071280),-0.44887180614684385,-0.9310704351431195,0.5818181818181818,0.9920952531674239,1.0,4/15,10.94%,MT1HL1;MT1M;PRNP;MT3
prerank,Purine-Containing Compound Biosynthetic Process (GO:0072522),0.3665060682982156,0.9308913709979147,0.5333333333333333,1.0,1.0,8/17,22.04%,GART;PPAT;PNP;MTHFD1;PAICS;SHMT1;PRPSAP2;ADSL
prerank,Negative Regulation Of Autophagy (GO:0010507),-0.3006151558262642,-0.9308409931897994,0.5230769230769231,0.9915973244649526,1.0,3/60,4.28%,MAGEA3;NUPR1;LRRK2
prerank,Anterograde Axonal Transport (GO:0008089),0.29772650790274124,0.9306268021343258,0.5555555555555556,1.0,1.0,12/39,24.77%,MAP1A;KIF4A;TRIM46;SNAPIN;AP3M2;KIF5A;BLOC1S5;BLOC1S1;APEX1;TRAK2;SPAST;KIF1C
prerank,Response To Hydrogen Peroxide (GO:0042542),0.300547316897308,0.9305571696638326,0.6170212765957447,1.0,1.0,5/44,6.71%,HBA1;HP;SIRPA;CYP1B1;PRDX3
prerank,Regulation Of Membrane Protein Ectodomain Proteolysis (GO:0051043),-0.38604640852925926,-0.9302948317963454,0.6,0.9920376965890205,1.0,4/20,5.80%,SH3D19;IL1B;ADAM9;IFNG
prerank,Focal Adhesion Assembly (GO:0048041),-0.40251839267566336,-0.9302864416466112,0.625,0.9910027085688162,1.0,7/21,16.22%,PEAK1;ACTN3;SRC;WHAMM;THY1;CDH11;SORBS1
prerank,Positive Regulation Of Triglyceride Metabolic Process (GO:0090208),-0.38408162704860216,-0.9302077244832739,0.5882352941176471,0.99014539216946,1.0,9/17,31.45%,DAGLB;PLIN5;CNEP1R1;SLC27A1;PNPLA2;NR1H2;ABHD5;KAT5;NR1H3
prerank,Diterpenoid Metabolic Process (GO:0016101),-0.3422908120453423,-0.9300810746099755,0.45098039215686275,0.9893016966964969,1.0,5/27,9.29%,DHRS3;RDH12;AKR1C3;ALDH1A1;RARRES2
prerank,Response To Type II Interferon (GO:0034341),-0.295227158895503,-0.929827170888275,0.5737704918032787,0.9888797267469794,1.0,5/75,4.01%,CCL7;SLC11A1;CCL22;XCL1;CCL14
prerank,Positive Regulation Of Homotypic Cell-Cell Adhesion (GO:0034112),0.38066379003624207,0.929759780374295,0.5,1.0,1.0,6/16,19.38%,PLAUR;CTSG;PDPN;TNFSF11;IL6ST;MMRN1
prerank,Positive Regulation Of Cellular Biosynthetic Process (GO:0031328),-0.26649633242976817,-0.9297537520285512,0.5797101449275363,0.9878995966376902,1.0,45/171,24.55%,RPS27L;CLEC7A;THBS1;IL1B;CXCL8;IGF1;PRR16;SOX4;GUF1;IFNG;MLXIPL;ASS1;TCF7L2;IRS2;PLIN5;EDN1;BCL3;NR1D1;PCIF1;ZEB2;CDH3;ZCCHC4;SORBS1;YTHDF3;PASK;SIRT1;HTR2A;NNMT;STARD4;FXR1;PXYLP1;ASIP;PIWIL2;CD244;CNEP1R1;RBM3;EPM2AIP1;EIF3C;CCL5;SAMD4A;PDGFB;UPF3A;SLC27A1;HBB;CLU
prerank,Cardiac Muscle Cell Action Potential Involved In Contraction (GO:0086002),-0.3810977250806576,-0.9293423639010501,0.5192307692307693,0.9879339352523725,1.0,6/27,16.72%,SCN5A;SCN3B;KCNE2;GPD1L;KCNA5;SNTA1
prerank,ATP Biosynthetic Process (GO:0006754),0.34401599220856877,0.9292883588495618,0.5,1.0,1.0,12/24,30.16%,ATP5PB;ATP5MC1;ATP5MF;ATP5F1E;ATP5PF;SLC25A13;ATP5F1D;ATP5F1A;ATP5PD;ATP5F1B;ATP5MC2;ALDOA
prerank,Glycoprotein Biosynthetic Process (GO:0009101),0.2695555696648377,0.9291795887067964,0.6410256410256411,1.0,1.0,4/74,3.34%,B3GNT5;SERP2;ST6GALNAC1;ALG3
prerank,Cell Morphogenesis Involved In Neuron Differentiation (GO:0048667),-0.29853680768811847,-0.9291433120364516,0.5172413793103449,0.9874684535038472,1.0,10/73,8.49%,FARP1;PARD3;CDHR1;DSCAML1;ISL2;KLF7;DOCK7;ATL1;WNT7A;CFAP418
prerank,Leukocyte Tethering Or Rolling (GO:0050901),0.3665954301805715,0.9290259160129092,0.5510204081632653,1.0,1.0,6/17,18.96%,CX3CR1;SELL;GCNT1;SELPLG;SELP;JAM2
prerank,Regulation Of Heart Contraction (GO:0008016),0.28191609472448287,0.9288186042340317,0.5714285714285714,1.0,1.0,10/63,11.07%,TNNT2;HRC;CYP2J2;KCNE5;CAMK2D;CELF2;SLC8A2;SRI;CORIN;GSK3A
prerank,Embryonic Limb Morphogenesis (GO:0030326),-0.33921459942119214,-0.928528890582838,0.5806451612903226,0.9880139887477253,1.0,4/33,6.78%,GLI3;TGFB2;CYP26B1;WNT7A
prerank,Regulation Of Protein Localization To Nucleus (GO:1900180),0.2929206580979516,0.9282246655446068,0.6571428571428571,1.0,1.0,12/52,16.06%,BMP4;PLK1;F2;BYSL;CDK1;MFHAS1;SUMO4;DTX3L;LILRB4;WWTR1;ORMDL3;PARK7
prerank,Regulation Of Intracellular Estrogen Receptor Signaling Pathway (GO:0033146),0.32253237852130584,0.928086196828596,0.5909090909090909,1.0,1.0,8/24,21.10%,FOXH1;ZNF366;KANK2;PAK1;CARM1;KMT2D;CNOT9;UFSP2
prerank,Positive Regulation Of Immunoglobulin Production (GO:0002639),0.31059971215634913,0.9277550802854146,0.5581395348837209,1.0,1.0,3/34,3.28%,CD86;IL21;TNFRSF4
prerank,Positive Regulation Of Intracellular Transport (GO:0032388),-0.31019602553516656,-0.9275713627554028,0.5849056603773585,0.9895323343762973,1.0,3/39,6.69%,EHD2;ATP2A1;NEDD4
prerank,Negative Regulation Of Interleukin-1 Beta Production (GO:0032691),-0.3606098207729137,-0.9275198616853924,0.5757575757575758,0.988591736083425,1.0,8/25,16.92%,FFAR1;IGF1;CD33;TNFAIP3;ZC3H12A;CARD18;PYDC1;GHSR
prerank,Positive Regulation Of JNK Cascade (GO:0046330),-0.29448022403243235,-0.9273759321155309,0.5806451612903226,0.9879193554212845,1.0,29/75,23.86%,HRAS;IL1B;FLT4;TRAF6;FZD7;GADD45G;PLCB1;WNT7A;NCF1;SERPINF2;TLR3;GADD45A;FCGR2B;MBIP;TAOK3;LTBR;FGF19;SEMA3A;TRAF4;SLAMF1;SH3RF3;TLR9;EDAR;BIRC7;RIPK1;MTURN;ZNF622;SDCBP;PJA2
prerank,Interferon-Mediated Signaling Pathway (GO:0140888),-0.33085616663311584,-0.9270587514679538,0.5961538461538461,0.9877107510461922,1.0,5/48,5.80%,IFNA6;IFNL3;IFNA7;IFNGR1;IFNG
prerank,BMP Signaling Pathway (GO:0030509),-0.3170285374705244,-0.9268478267866216,0.5925925925925926,0.9872832853299435,1.0,13/56,17.57%,TGFB2;SMAD6;USP9Y;ACVRL1;PPARG;INHBE;SMAD5;TGFBR3;AMHR2;BMP2;BMPR1B;NOG;BMPR2
prerank,Substrate Adhesion-Dependent Cell Spreading (GO:0034446),0.3140163379390571,0.926658679895791,0.56,1.0,1.0,9/35,15.65%,EPHB3;BVES;RADIL;PARVB;KIF14;SRCIN1;ILK;FERMT3;EPHA1
prerank,Phospholipase C-activating G Protein-Coupled Receptor Signaling Pathway (GO:0007200),-0.2982385630286485,-0.9266513723715182,0.5909090909090909,0.9867645322870164,1.0,19/70,18.83%,FPR1;GPR32;OPRL1;C5AR1;GPR65;F2RL2;PLCE1;MC3R;GPR35;P2RY1;F2R;P2RY12;P2RY8;GPR157;FPR2;CHRM2;HTR2A;C3AR1;CXCR2
prerank,Antiviral Innate Immune Response (GO:0140374),-0.33676611177711124,-0.9265143473259578,0.6229508196721312,0.9859935492690661,1.0,8/46,10.43%,IGF2BP1;TRAF6;CLPB;ZDHHC11;RNF135;TRIM7;NMB;TBK1
prerank,Negative Regulation Of Cytokine Production Involved In Immune Response (GO:0002719),0.379263624047721,0.9263639588818314,0.5526315789473685,1.0,1.0,7/16,15.39%,FOXP3;HFE;LILRB1;IRAK3;LILRB4;JAK3;CUEDC2
prerank,Fc-epsilon Receptor Signaling Pathway (GO:0038095),-0.3622910332772613,-0.9263020394799154,0.532258064516129,0.9854543895543708,1.0,6/22,11.92%,NR4A3;LYN;TRAF6;MAPK10;VAV3;PLCG2
prerank,Regulation Of Spindle Organization (GO:0090224),0.36095786316171974,0.9259441969749604,0.6341463414634146,1.0,1.0,6/20,16.47%,TPX2;PSRC1;GPSM2;CENPJ;FSD1;GNAI1
prerank,Negative Regulation Of Telomere Maintenance Via Telomerase (GO:0032211),-0.39205169623160496,-0.9258777512366906,0.6296296296296297,0.9858128161871822,1.0,4/19,10.60%,STON1;TENT4B;SRC;EXOSC10
prerank,Regulation Of Mitotic Cell Cycle (GO:0007346),0.2531354247439775,0.9255495556682115,0.7297297297297297,1.0,1.0,24/124,19.49%,PTPN3;DLGAP5;OBSL1;PKMYT1;PIM2;PLK1;MKI67;CDC20;LGMN;TP73;TTLL12;CCNB1;CKS2;CDK10;ANAPC7;PRMT5;CDC25B;CDCA2;ERCC2;DDB1;YWHAE;BRINP3;RCC1;ASAH2
prerank,Protein Depolymerization (GO:0051261),-0.35222693969499375,-0.9247937412942006,0.6326530612244898,0.9878234540138193,1.0,6/27,13.47%,NCKAP5;VIL1;CFL2;TWF1;STMND1;KIF18B
prerank,Vesicle Transport Along Microtubule (GO:0047496),0.3228591121090638,0.9245002700426042,0.5238095238095238,1.0,1.0,9/22,24.84%,KIF13A;HTT;BICDL2;KIF5A;TRAK2;FBXW11;NDEL1;KIF1C;BICDL1
prerank,Positive Regulation Of Leukocyte Adhesion To Vascular Endothelial Cell (GO:1904996),-0.3896787144788959,-0.9240323802741883,0.5471698113207547,0.9891301555191307,1.0,10/16,34.41%,TRAF6;FUT4;RELA;IL6;ST3GAL4;NFAT5;SELE;IRAK1;MDK;CHST2
prerank,Actin Filament Organization (GO:0007015),0.25203182608522207,0.9239288132429826,0.625,1.0,1.0,34/137,18.40%,SHROOM4;MYO1C;CNN1;MYO1E;MYO5C;MYO7A;CAPG;OOEP;RFLNB;ENAH;EPS8;NEBL;CARMIL1;KASH5;CORO1B;PLA2G1B;PRSS8;RAC2;MYO5B;TLE6;AVIL;XIRP1;NEDD9;PPP1R9B;MYO1A;TCAP;TTN;MYO7B;MYO15A;MARCKSL1;CORO1A;CNN3;SH3BP1;POF1B
prerank,Skeletal Muscle Contraction (GO:0003009),-0.418621016235121,-0.9235593916936771,0.5555555555555556,0.9893114862764758,1.0,4/17,8.43%,TNNC2;TNNT1;MYH7B;STAC2
prerank,Regulation Of Epithelial Cell Differentiation (GO:0030856),0.38017087350215095,0.9229268250085959,0.5714285714285714,1.0,1.0,3/17,8.57%,CEACAM1;MAFG;CD24
prerank,Protein Homotetramerization (GO:0051289),-0.31256245778382774,-0.9228079627050781,0.5692307692307692,0.9901331061620665,1.0,12/46,20.16%,ME1;UPB1;PKD2L1;TRPV1;CTH;TRPV5;USP16;GBP5;GNMT;TRPM4;HCN1;APLP2
prerank,DNA Damage Response (GO:0006974),-0.240657431160997,-0.9219331017120307,0.6794871794871795,0.991707163138294,1.0,86/380,20.74%,RBM24;MACROD2;ALKBH1;HIC1;FMN2;XRCC2;LYN;BACH1;TFDP3;NUPR2;RAD51B;POLE2;MAPK15;USP45;CDKN1A;ZNF668;ETAA1;RNF168;FANCL;DEPDC1B;MAPT;SFN;WNT1;RAD51D;SETD7;CBX1;ZC3H12A;BRCA1;TOPORS;ZBTB40;BCL6;PARP2;GADD45A;BCL3;ZBTB1;YAP1;FOXE1;VCPIP1;MASTL;INSL6;VAV3;MAPKAPK2;PRKCD;SLFN11;FAM111A;SMARCA5;SMC5;TAOK3;SPRTN;MOAP1;ABL1;PSME4;HROB;USP16;ANKLE1;WRN;ADPRS;BCLAF1;POLE3;ERCC3;UBE2E2;CCND1;UPF1;SIRT1;SIRT4;FANCC;PHF1;CSNK1E;IRF3;PIDD1;PPP4R3A;WDR48;BLM;MBD4;CGAS;TRAIP;FAAP20;CDKN2AIP;MCM9;NAE1;TLK2;ING2;DCUN1D5;SETX;SLX1A;GNL1
prerank,"Maturation Of SSU-rRNA From Tricistronic rRNA Transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.3314622389397426,0.9216572787100794,0.6041666666666666,1.0,1.0,13/30,33.20%,WDR46;RPP40;MRPS11;TBL3;DCAF13;RPS8;UTP20;RPS16;PWP2;RRS1;RPS21;KRI1;UTP6
prerank,Negative Regulation Of Phosphatase Activity (GO:0010923),-0.3706544399535177,-0.9215387445600149,0.56,0.9916909657525712,1.0,7/16,27.72%,TGFB2;MASTL;CRY2;FKBP1B;PPP1R1B;PPP1R15A;URI1
prerank,Selective Autophagy (GO:0061912),-0.297319472777008,-0.9213314043012588,0.484375,0.9911844801745668,1.0,20/58,30.43%,IRGM;MAP1LC3C;ATG2A;SNX7;PRKN;PEX2;UFM1;USP30;RB1CC1;ATG5;ATG4D;UBQLN1;ULK2;ATG14;ULK1;WDR81;MAP1LC3B;CALCOCO2;ARFIP2;VHL
prerank,Regulation Of Amyloid-Beta Formation (GO:1902003),0.3130959311006012,0.9212066904555257,0.5102040816326531,1.0,1.0,3/33,5.42%,RTN3;CHRNA7;EPHA4
prerank,Membrane Protein Proteolysis (GO:0033619),-0.34191356895523645,-0.9209978935165891,0.64,0.9910663851670851,1.0,4/33,9.51%,RHBDD1;ADAM9;BACE2;RET
prerank,Rho Protein Signal Transduction (GO:0007266),-0.2978414330617238,-0.9206879782806014,0.5892857142857143,0.9908347748459729,1.0,4/50,3.47%,ARHGAP29;CTNNAL1;COL1A2;CDH13
prerank,Mitochondrial ATP Synthesis Coupled Electron Transport (GO:0042775),0.2802349468088549,0.9204865312015355,0.6444444444444445,1.0,1.0,39/67,34.98%,COX15;NDUFA9;NDUFB3;NDUFA12;SDHAF2;NDUFC1;NDUFS7;NDUFB10;NDUFS2;NDUFB2;NDUFAF1;NDUFB5;NDUFC2;NDUFA6;UQCR10;TAFAZZIN;UQCRB;NDUFB4;NDUFB8;UQCRHL;UQCRH;COA6;COX7C;NDUFA8;SDHC;UQCR11;UQCRQ;NDUFS5;NDUFB6;COX5A;COX6A1;NDUFS4;NDUFS8;COX6C;COX6A2;UQCRC2;COX4I1;UQCRC1;NDUFB1
prerank,Negative Regulation Of Vascular Associated Smooth Muscle Cell Proliferation (GO:1904706),0.3658164800860404,0.9202294686334774,0.5945945945945946,1.0,1.0,2/16,2.25%,BMP4;CNN1
prerank,Cellular Response To Gamma Radiation (GO:0071480),-0.4377978369700347,-0.9202067315408291,0.5686274509803921,0.9910469147474426,1.0,4/15,20.33%,HRAS;YAP1;WRN;TLK2
prerank,Regulation Of Cytokine Production (GO:0001817),-0.2666732055176792,-0.9200786438532677,0.6875,0.9904071456739336,1.0,32/155,16.35%,PLA2R1;IL26;SLC11A1;IGF2BP1;CIDEA;LURAP1;LYN;PER1;NOX5;CASP8;HLA-B;GLMN;IFNG;IL15;ZBTB49;BTNL9;BCL6;ZNF134;TBK1;PATZ1;ZBTB1;FCGR2B;C1QTNF3;LOC102723996;MAPKAPK2;PTGER4;ZBTB37;TRIM21;LGR4;SRGN;ZBTB33;LITAF
prerank,Phospholipid Biosynthetic Process (GO:0008654),0.31107334079065196,0.920001493607335,0.6170212765957447,1.0,1.0,8/26,19.11%,SGMS2;FDPS;DOLPP1;HDHD5;SRD5A3;AGPAT5;FADS1;IDI2
prerank,ncRNA Metabolic Process (GO:0034660),-0.4051476701190957,-0.9197590335192571,0.48,0.9901089881095294,1.0,4/17,11.67%,MAPT;TENT4B;DDX17;DICER1
prerank,Oxidative Phosphorylation (GO:0006119),0.2917844100830788,0.9195301934298417,0.5208333333333334,1.0,1.0,35/60,34.98%,NDUFA9;NDUFB3;ATP5PB;NDUFA12;NDUFC1;ATP5MF;NDUFS7;TEFM;NDUFB10;NDUFS2;ATP5F1E;NDUFB2;NDUFB5;NDUFC2;ATP5PF;NDUFA6;UQCRB;NDUFB4;NDUFB8;NDUFB11;ATP5F1D;UQCRH;ATP5PD;ATP5F1B;NDUFA8;SDHC;NDUFS5;NDUFB6;NDUFS4;NDUFA13;NDUFS8;ATP5MG;UQCRC2;UQCRC1;NDUFB1
prerank,Response To Organonitrogen Compound (GO:0010243),0.2845797967993249,0.9194152532704584,0.6097560975609756,1.0,1.0,6/47,8.32%,CHRNA3;CHRNA7;IRF5;MEAK7;ADORA2A;IRAK3
prerank,Regulation Of Viral Transcription (GO:0046782),-0.38399600006719475,-0.9191897022905805,0.5084745762711864,0.9906610525348352,1.0,7/17,27.27%,LARP7;TRIM21;MID2;UBP1;TRIM11;RSF1;TRIM62
prerank,mRNA Modification (GO:0016556),-0.36577369027816964,-0.9190016102411324,0.5230769230769231,0.9901596003036558,1.0,15/26,26.33%,METTL4;METTL16;WTAP;PCIF1;CMTR1;RPUSD2;RPUSD4;TRMT61A;TRUB1;TRMT10C;METTL8;VIRMA;CBLL1;PUS7L;METTL14
prerank,Monoatomic Cation Transport (GO:0006812),0.3135863084875288,0.9189768404778647,0.58,1.0,1.0,7/38,7.42%,TRPM3;SLC29A4;TRPM6;CNGB1;NDFIP2;GRIN2D;NDFIP1
prerank,Regulation Of Protein Autophosphorylation (GO:0031952),-0.36789846907022083,-0.9188780911693685,0.6166666666666667,0.9893992894211875,1.0,1/30,0.24%,VEGFA
prerank,Negative Regulation Of Type I Interferon Production (GO:0032480),-0.3479990086795488,-0.918807666233379,0.5254237288135594,0.9885729063122017,1.0,5/38,7.73%,TYROBP;IRGM;REL;ITCH;HAVCR2
prerank,Positive Regulation Of Cellular Catabolic Process (GO:0031331),-0.27247178401751143,-0.9187176442041789,0.5909090909090909,0.9877483354468761,1.0,30/142,17.55%,SH3D19;DCN;IL1B;IRGM;SLC4A4;LRRK2;IGF1;ADAM9;IFNG;TRIM23;MLXIPL;ITCH;DAGLB;ZC3H12A;IRS2;CNOT1;SUPV3L1;PLIN5;TBK1;PRKCD;FURIN;TRIM21;MID2;PHKG2;LIN28B;MTLN;UPF1;RB1CC1;PRKAA2;PPARA
prerank,Modulation Of Chemical Synaptic Transmission (GO:0050804),-0.2748023425361937,-0.9186993730741347,0.5901639344262295,0.9867002608298052,1.0,22/115,13.45%,BEGAIN;IQSEC2;IL1B;NRG3;ATP1A2;LRRK2;LGI1;NPTX2;GRM7;CDH2;MCTP2;GRM6;PPP3CA;CPLX1;RIMS1;CACNA1A;AKAP9;TRIO;BTBD9;MAPK8IP2;USP46;SLC4A8
prerank,Antimicrobial Humoral Response (GO:0019730),0.2680766038954582,0.918558997066158,0.7368421052631579,1.0,1.0,19/87,16.78%,CXCL13;H2BC12;HLA-A;CTSG;PRSS3;JCHAIN;F2;MUC7;COLEC11;PLA2G1B;S100A9;LEAP2;TSLP;RNASE6;LYZ;WFDC3;WFDC5;RNASE3;S100A12
prerank,Cellular Response To Glucocorticoid Stimulus (GO:0071385),-0.3921621529838982,-0.9185378739223751,0.5892857142857143,0.9861496193602146,1.0,8/15,30.49%,SSTR4;ZFP36L2;NR3C1;ZFP36L1;AQP1;KLF9;PCK1;BCL2L11
prerank,"Regulation Of Synaptic Transmission, GABAergic (GO:0032228)",0.3435625429511913,0.9180596597708367,0.4666666666666667,1.0,1.0,9/15,33.97%,NALCN;NLGN2;NPAS4;APEX1;ZDHHC12;ZDHHC3;SLC38A1;STXBP1;DRD2
prerank,Proteasomal Protein Catabolic Process (GO:0010498),-0.25350700586701636,-0.9177323481952515,0.6515151515151515,0.9874099628336686,1.0,30/219,14.30%,FBXO9;RHBDD1;ENC1;RNF186;APC2;ANKRD9;SPOPL;TRIM72;PPP2R5C;ZFAND2A;CCDC47;FEM1C;UBXN2A;ITCH;TOPORS;PRKN;SPSB4;SMURF2;RHOBTB3;PELI1;TBX21;SIAH2;PEX12;NFE2L2;NR1D1;KCTD2;BMAL1;RNF4;TRIM21;BRSK2
prerank,Learning (GO:0007612),-0.30321125433986296,-0.9176835386440627,0.5094339622641509,0.9864330618154915,1.0,12/40,21.03%,SLC6A1;FGF13;SHANK1;TH;GPR88;MAPK8IP2;ATXN1L;NLGN4X;CHRNB2;NLGN3;PPP3CB;BRSK1
prerank,Cytosolic Pattern Recognition Receptor Signaling Pathway (GO:0002753),-0.36663615832801677,-0.9176415472399381,0.5666666666666667,0.9854807241656282,1.0,6/23,10.43%,TRAF6;CLPB;TNFAIP3;ITCH;RNF135;TBK1
prerank,Positive Regulation Of Insulin Secretion (GO:0032024),-0.3417712420681997,-0.917495166676484,0.625,0.9847881566164562,1.0,6/39,9.34%,CFTR;DOC2B;FFAR1;SOX4;TCF7L2;IRS2
prerank,Regulation Of Transcription Involved In G1/S Transition Of Mitotic Cell Cycle (GO:0000083),0.38181179957131867,0.917442797194684,0.55,1.0,1.0,3/18,6.29%,CDK14;E2F2;CDK5
prerank,Positive Regulation Of Cell Projection Organization (GO:0031346),-0.2800117378649984,-0.9170705759711119,0.5970149253731343,0.9848357650808242,1.0,16/114,10.88%,ROR2;FUT9;MAGI2;DDR2;NDRG4;LYN;LTK;PLXNB3;CAMK2B;PLXND1;PTK7;CHODL;RET;CUX1;PLXNA2;SLIT2
prerank,Skeletal System Morphogenesis (GO:0048705),-0.3098482095869081,-0.9165905102570399,0.6326530612244898,0.9850397870560869,1.0,4/40,5.58%,LAMA5;RFLNA;DSCAML1;CYP26B1
prerank,Response To dsRNA (GO:0043331),-0.361867417068206,-0.9165361148698506,0.6,0.9841266012362124,1.0,2/23,1.82%,IFNA6;IFNA7
prerank,Triglyceride Metabolic Process (GO:0006641),0.28779433273188265,0.9164350214012589,0.6101694915254238,1.0,1.0,8/41,19.13%,DGAT2;APOC1;GALK2;LPIN3;LIPE;MOGAT3;APOBR;LIPC
prerank,Cellular Response To Decreased Oxygen Levels (GO:0036294),-0.3099664355760507,-0.9163943975663263,0.6551724137931034,0.9835165957440928,1.0,7/71,5.61%,VEGFA;GATA6;FMN2;RORA;EPAS1;PPARG;TERT
prerank,Regulation Of Microtubule-Based Process (GO:0032886),0.3101565950522048,0.9161243009389654,0.6222222222222222,1.0,1.0,4/41,5.21%,CAMSAP3;EFNA5;TRIM36;CDK2AP2
prerank,Iron Ion Transport (GO:0006826),-0.3567975929467099,-0.9154717473238978,0.5573770491803278,0.9853037535586155,1.0,11/23,28.32%,SLC11A1;MELTF;TTYH1;DNM2;FTH1;SCARA5;LMTK2;CLTC;LTF;TFRC;TFR2
prerank,Cartilage Development (GO:0051216),0.29072411358386896,0.9147759502242472,0.6444444444444445,1.0,1.0,7/45,9.56%,BMP4;ITGB8;SULF2;FGF2;OGN;SLC39A14;SLC26A2
prerank,tRNA Wobble Base Modification (GO:0002097),-0.3693280518983967,-0.9146403312646681,0.6170212765957447,0.9866640502875648,1.0,1/15,1.39%,ALKBH1
prerank,Mitotic DNA Damage Checkpoint Signaling (GO:0044773),-0.31876723053072686,-0.9144643680710812,0.5254237288135594,0.986031041293518,1.0,13/56,18.70%,RPS27L;CDKN1A;DEPDC1B;BRCA1;ZNF830;TRIM39;FANCD2;FOXN3;TAOK3;SDE2;CCND1;BLM;DONSON
prerank,Intracellular Calcium Ion Homeostasis (GO:0006874),-0.2820908951488815,-0.9144608758100631,0.5714285714285714,0.9849773203022225,1.0,22/130,15.51%,CCL7;CASQ2;EDN2;EDN3;ATP2A1;CTRC;CCL14;ATP2B2;CCDC47;SLC8A1;MAIP1;ATP13A4;HERPUD1;TRPC3;EDN1;STIM2;SLC24A3;SLC30A1;CCR1;CALCB;TRPC1;CXCL12
prerank,Organic Anion Transport (GO:0015711),-0.2741462323897035,-0.9143795948506277,0.6,0.9841144939161001,1.0,17/85,14.30%,SLC4A3;CFTR;SLC44A4;SLC22A25;SLC4A4;SLC22A7;SLCO1A2;SLC4A7;CALHM1;SLC17A3;SLC39A8;SLC22A3;RHAG;SLCO4C1;SLC4A8;SLC22A11;SLC35A3
prerank,Respiratory System Development (GO:0060541),-0.37913805464991834,-0.9141868243017244,0.6,0.9836414463771239,1.0,3/29,3.21%,VEGFA;FGF9;CHI3L1
prerank,Positive Regulation Of Amyloid Precursor Protein Catabolic Process (GO:1902993),-0.3724145760540634,-0.9140077884824809,0.46153846153846156,0.9830808454132268,1.0,11/21,25.41%,LYN;IFNGR1;IFNG;GSAP;ABCG1;PICALM;EFNA1;SLC2A13;RANBP9;CLU;RELA
prerank,Regulation Of Neurogenesis (GO:0050767),0.27093221894098907,0.9138941738360796,0.6,1.0,1.0,14/64,14.61%,GPRASP3;ASCL1;CX3CR1;HES2;NOTCH1;RGS14;CX3CL1;HEYL;LEF1;GPER1;HLTF;SOX11;MBD1;OPRM1
prerank,Positive Regulation Of Cysteine-Type Endopeptidase Activity (GO:2001056),0.2645902455467727,0.9136656913302262,0.6428571428571429,1.0,1.0,12/63,13.35%,MYC;TTBK1;TNFSF10;GRAMD4;DAPK1;LGMN;PYCARD;UACA;NLRP3;CASP9;GPER1;PDCD6
prerank,Cellular Response To Fatty Acid (GO:0071398),-0.3814905849170866,-0.9124534836689002,0.6206896551724138,0.9857619050778926,1.0,4/15,12.29%,AKR1C2;AKR1C3;ZC3H12A;FFAR3
prerank,Regulation Of JNK Cascade (GO:0046328),0.2538799485538166,0.9116789775503547,0.6875,1.0,1.0,14/108,10.33%,WNT7B;EPHB1;DACT1;TPD52L1;TNFRSF19;SIRPA;F2RL1;CD27;PYCARD;CCR7;MARVELD3;NOD2;RASSF2;MFHAS1
prerank,Ubiquitin-Dependent ERAD Pathway (GO:0030433),-0.2897748118790725,-0.9115743345298495,0.5846153846153846,0.987266149624597,1.0,9/73,14.05%,FBXO27;RNF103;YOD1;HERPUD1;FAM8A1;MAN1A1;FAF2;RHBDD2;DNAJB9
prerank,Protein O-linked Mannosylation (GO:0035269),-0.3981397016093788,-0.9115252476977868,0.5686274509803921,0.9863172095858762,1.0,7/16,29.62%,FKRP;CRPPA;TMTC3;DPM1;LARGE2;FKTN;TMTC2
prerank,Release Of Sequestered Calcium Ion Into Cytosol (GO:0051209),0.3066168789983606,0.9114372973884286,0.7045454545454546,1.0,1.0,6/38,10.55%,GP9;GP5;RYR1;FGF2;CCR7;GP1BA
prerank,I-kappaB kinase/NF-kappaB Signaling (GO:0007249),-0.3142379885998374,-0.9110938874459757,0.6779661016949152,0.9863514407996286,1.0,19/45,25.51%,TRAF6;RIPK2;REL;NFKBIA;FAIM;TBK1;TLR3;BCL3;BCL10;NFKB2;TLR9;TLR7;TIFA;DEFB124;MAP3K14;RELB;ERC1;RELA;NKIRAS1
prerank,Mesenchymal Cell Differentiation (GO:0048762),-0.31041822980627015,-0.9103264336868429,0.58,0.9875308684655844,1.0,7/52,10.58%,SEMA3C;TGFB2;IGF1;HEY2;DLG5;TGFBR3;DDX17
prerank,Phosphatidic Acid Biosynthetic Process (GO:0006654),-0.33709835796795756,-0.9102830373675669,0.5319148936170213,0.9866176913266885,1.0,13/29,30.89%,DGKB;MBOAT2;DGKE;GPAM;DGKG;AGPAT4;GPAT2;DGKQ;SLC27A1;PNPLA3;ABHD5;LPCAT1;DGKH
prerank,Epithelial Cilium Movement Involved In Extracellular Fluid Movement (GO:0003351),-0.3678902047549012,-0.9102353733811148,0.5423728813559322,0.9856515220270122,1.0,9/18,26.04%,CCDC103;CABYR;ODAD4;CFAP53;DNAAF1;SPEF2;CCDC40;NPHP3;CCDC39
prerank,Regulation Of Cellular Localization (GO:0060341),0.2592891614296451,0.9102033018020854,0.625,1.0,1.0,10/69,13.54%,MAPK8;WWC1;TRIM5;OOEP;CAMK2D;ATCAY;TRIM46;FKBP1A;KIAA1614;CAMK1
prerank,Regulation Of Anatomical Structure Morphogenesis (GO:0022603),0.25348824693282657,0.9101411963277504,0.7142857142857143,1.0,1.0,31/124,19.04%,CXCL13;CHRNA3;CEACAM1;NOL3;EPHB3;ARHGAP44;KRIT1;HECW1;EFNA5;VASH1;FGF2;EPHA4;CDK5;PDCD10;SFRP1;SRCIN1;PAK1;ABI3;PID1;HTATIP2;MARK2;ADGRA2;HMOX1;LARP4;TBX1;MTCH2;LEP;ETS1;HECW2;CFL1;OR10J5
prerank,O-glycan Processing (GO:0016266),0.30717221422833524,0.9097574825317704,0.6530612244897959,1.0,1.0,11/40,17.30%,B3GNT5;B3GNT3;GALNT9;ST6GALNAC4;ST6GAL1;C1GALT1C1;GCNT1;GALNT7;GCNT4;ST3GAL2;B4GAT1
prerank,Cholesterol Metabolic Process (GO:0008203),0.26941973522144363,0.9095755691244257,0.7272727272727273,1.0,1.0,20/65,20.97%,SULT2B1;IL4;MVK;CH25H;CYP27A1;SCARF1;LCAT;PMVK;OSBPL1A;SOAT2;GBA2;CLN6;GBA1;LBR;LDLRAP1;ARV1;AKR1D1;GLB1;SULT2A1;HMGCR
prerank,Positive Regulation Of Supramolecular Fiber Organization (GO:1902905),0.25522453471621975,0.9094982639747874,0.6666666666666666,1.0,1.0,15/91,11.20%,VASP;HCK;MYLK3;PSRC1;NCK2;SEMA5A;F2RL1;PYCARD;CARMIL1;CCR7;SYNPO2;CX3CL1;MET;CTTN;CDC42EP1
prerank,miRNA Processing (GO:0035196),-0.32228682711087003,-0.9092389283716569,0.5789473684210527,0.9873767680531172,1.0,7/32,20.69%,PUS10;DICER1;SNIP1;LIN28A;LIN28B;ZC3H7A;AGO4
prerank,DNA-templated DNA Replication (GO:0006261),-0.30055401354521066,-0.9090438078039921,0.6338028169014085,0.9867846680241221,1.0,4/69,4.93%,PRIM2;GINS3;ORC6;POLE2
prerank,Chaperone Cofactor-Dependent Protein Refolding (GO:0051085),0.32964841005392326,0.9088311962774768,0.5641025641025641,1.0,1.0,8/25,18.01%,HSPA1A;HSPA1L;DNAJB5;SDF2L1;HSPA8;HSPE1;HSPA6;SDF2
prerank,Regulation Of Muscle Contraction (GO:0006937),-0.36193086329007806,-0.9086035138094998,0.5454545454545454,0.9869934398214083,1.0,9/25,17.07%,TNNC2;TNNT1;ATP1A2;MYL5;PLCE1;CACNB1;CHRM2;MYBPC3;TNNT3
prerank,Lymphocyte Activation Involved In Immune Response (GO:0002285),-0.36624716066040475,-0.9085171814090862,0.5686274509803921,0.986260762435702,1.0,2/23,1.82%,IFNA6;IFNA7
prerank,B Cell Proliferation (GO:0042100),-0.31414303825034273,-0.9083148865105516,0.49056603773584906,0.9858575509962046,1.0,10/30,21.37%,IFNA6;IFNA7;MS4A1;IFNA2;IFNA8;CD79A;IFNA14;CTPS1;IFNK;CD40LG
prerank,Negative Regulation Of Interleukin-10 Production (GO:0032693),0.36594208905001385,0.9081568318462809,0.6037735849056604,1.0,1.0,6/16,13.63%,FOXP3;LILRB1;PDCD1LG2;TRIB2;LILRB4;JAK3
prerank,Regulation Of Transcription By RNA Polymerase I (GO:0006356),-0.3338426279578919,-0.9079483488981429,0.5636363636363636,0.9857936749355223,1.0,19/29,37.99%,WDR75;UTP15;SF3B1;SMARCA5;CREBBP;MAF1;WDR43;DEK;HEATR1;ATF4;MYBBP1A;BAZ2A;UBTFL1;EIF2AK3;DDX21;LYAR;ERBB2;ERCC6;PHF8
prerank,Regulation Of Ras Protein Signal Transduction (GO:0046578),0.26210580296866093,0.9068482222025379,0.5945945945945946,1.0,1.0,19/75,15.94%,STARD13;SYDE1;KANK2;KIF14;EPS8;DYNLL1;PDCD10;NOTCH1;ETFA;RASGRP4;KBTBD6;STARD8;NTRK1;EPS8L2;FOXM1;KANK1;RASAL3;RASGRF1;OPHN1
prerank,In Utero Embryonic Development (GO:0001701),-0.3523884188685785,-0.906763214282737,0.5614035087719298,0.9881949408791441,1.0,1/25,0.24%,VEGFA
prerank,Regulation Of miRNA-mediated Gene Silencing (GO:0060964),-0.3889954606327273,-0.9067548675652025,0.5,0.9871699153132841,1.0,2/15,9.91%,PPARG;POU5F1
prerank,Positive Regulation Of Chromosome Organization (GO:2001252),0.29964981987349826,0.9066877332188348,0.7222222222222222,1.0,1.0,7/33,20.29%,AURKB;CDK1;NCAPG;NCAPD2;TINF2;SHCBP1L;SIRT6
prerank,Negative Regulation Of Tumor Necrosis Factor Superfamily Cytokine Production (GO:1903556),0.28559420528003676,0.9066056205629709,0.6111111111111112,1.0,1.0,13/49,13.16%,CHRNA7;SIRPA;IL4;LILRB1;PTPN6;LGALS9;IRAK3;CX3CL1;MC1R;ELF4;LILRB4;LILRA4;TLR4
prerank,Positive Regulation Of Natural Killer Cell Mediated Cytotoxicity (GO:0045954),-0.3541093408622801,-0.9065751189279253,0.6271186440677966,0.9866150721763566,1.0,3/20,3.64%,KLRD1;IL12A;KLRC3
prerank,Regulation Of DNA Damage Checkpoint (GO:2000001),-0.36752098701104996,-0.9060301643817912,0.5849056603773585,0.9871051639318492,1.0,4/18,8.85%,ETAA1;TTI2;DEPDC1B;BRCA1
prerank,Regulation Of Delayed Rectifier Potassium Channel Activity (GO:1902259),-0.4052127070672531,-0.9060046559313131,0.5740740740740741,0.9860953973490925,1.0,4/15,13.82%,KCNRG;KCNAB1;KCNE2;ANK3
prerank,Glycoprotein Metabolic Process (GO:0009100),0.29160638952398443,0.9058117994016994,0.5641025641025641,1.0,1.0,14/50,17.30%,FBXO17;PCSK6;ST8SIA1;FBXO6;MAN1C1;ST6GALNAC3;HPSE;GCNT1;GAL3ST4;PARK7;NGLY1;ST8SIA4;ST3GAL2;B4GAT1
prerank,Negative Regulation Of Protein Transport (GO:0051224),0.34442463987901517,0.905317593282635,0.6428571428571429,1.0,1.0,5/25,10.35%,RSAD2;NDFIP2;NDFIP1;RHBDF1;CSK
prerank,Vesicle-Mediated Transport To The Plasma Membrane (GO:0098876),-0.2800353831862085,-0.9043779304123931,0.6129032258064516,0.990089418191677,1.0,20/78,24.61%,EHD2;STEAP2;ARL4C;SNX7;DENND1B;GOLGA7;VPS26A;BLTP1;DENND1A;EIPR1;CCDC93;EXOC8;RAB17;STX6;RAB13;STX16;LMTK2;RAB11FIP4;VPS52;EHD1
prerank,Positive Regulation Of Interleukin-2 Production (GO:0032743),-0.35947718982743815,-0.904364994215254,0.5294117647058824,0.9890894731919119,1.0,6/25,11.92%,CLEC7A;IL1B;TRAF6;GLMN;PDE4B;PLCG2
prerank,Positive Regulation Of Immune System Process (GO:0002684),-0.3433032701819147,-0.9042212157879309,0.5961538461538461,0.988492222733291,1.0,2/25,1.48%,VEGFA;TGFB2
prerank,Regulation Of Receptor Signaling Pathway Via JAK-STAT (GO:0046425),-0.2975534962905065,-0.9037062129411422,0.6,0.9889236871216933,1.0,3/48,1.32%,IL26;GHR;PRL
prerank,Negative Regulation Of Fibroblast Proliferation (GO:0048147),0.3582977636984219,0.9034678113294801,0.5952380952380952,1.0,1.0,3/17,10.98%,MYC;PARP10;SFRP1
prerank,Autophagy Of Mitochondrion (GO:0000422),-0.3192663057305227,-0.9033698496109083,0.5862068965517241,0.9890733411991994,1.0,16/48,27.89%,MAP1LC3C;ATG2A;SNX7;GABARAPL1;PRKN;WDR45B;CTSK;USP30;RB1CC1;ATG5;ATG4D;ATG14;FBXO7;WDR45;ATG12;MAP1LC3B
prerank,Positive Regulation Of NF-kappaB Transcription Factor Activity (GO:0051092),0.2447396427817784,0.9032883663832166,0.7647058823529411,1.0,1.0,37/144,19.01%,S100A8;IKBKG;MAP3K7;TNFRSF11A;TRIM5;TRIM52;HSPA1A;CX3CR1;PRDX3;PYCARD;CD36;CD40;LGALS9;IRAK3;UBE2V1;CX3CL1;NOD2;PLA2G1B;S100A9;NLRP3;MAP3K13;EDA;NTRK1;TNFSF11;TLR2;TLR4;ROR1;PRKCI;IKBKB;RIPK3;S100A12;FLOT1;TRIM22;RBCK1;CARD16;TRADD;MYD88
prerank,Cardiac Muscle Contraction (GO:0060048),0.31576478210275366,0.9030429956425167,0.6060606060606061,1.0,1.0,8/32,15.81%,TNNT2;MYL4;KCNE5;CAMK2D;MYLK2;KCNH2;TCAP;TTN
prerank,Spermatid Development (GO:0007286),0.2933306833093306,0.9026177433198861,0.6595744680851063,1.0,1.0,4/45,7.03%,RIMBP3C;SPACDR;RFX2;RIMBP3B
prerank,rRNA Modification (GO:0000154),0.3613803391770858,0.9024655097832003,0.6,1.0,1.0,8/17,21.47%,NOP10;MRM1;TFB1M;NSUN4;TRMT112;DKC1;METTL5;NHP2
prerank,Regulation Of Neuroblast Proliferation (GO:1902692),-0.37078140423293915,-0.9015946612280652,0.5873015873015873,0.9930109042683062,1.0,3/22,4.28%,VEGFA;VCAN;LRRK2
prerank,Proton Motive Force-Driven Mitochondrial ATP Synthesis (GO:0042776),0.2938379624873462,0.901478547674437,0.625,1.0,1.0,29/52,33.39%,NDUFA9;NDUFB3;ATP5PB;NDUFA12;NDUFC1;ATP5MF;NDUFS7;NDUFB10;NDUFS2;ATP5F1E;NDUFB2;NDUFB5;NDUFC2;ATP5PF;NDUFA6;NDUFB4;NDUFB8;NDUFB11;ATP5F1D;ATP5PD;ATP5F1B;NDUFA8;SDHC;NDUFS5;NDUFB6;NDUFS4;NDUFA13;NDUFS8;ATP5MG
prerank,Lymphocyte Differentiation (GO:0030098),-0.28243056753450835,-0.9012737618389953,0.7358490566037735,0.9927786132276979,1.0,21/88,15.11%,IFNA6;IFNA7;VCAM1;CLCF1;AQP8;SOX4;PIK3R1;PBX1;MS4A1;PAX5;PIK3R3;IL11;IFNA2;PLCG2;GPR89A;ADGRG3;PTPN22;DNAJB9;GPR89B;IFNA8;CEBPG
prerank,Regulation Of Protein Localization To Plasma Membrane (GO:1903076),0.2721425598740436,0.9010394850723871,0.7551020408163265,1.0,1.0,29/76,28.28%,GBP1;CDK5;NKD2;STAC;ITGA3;RANGRF;CLIP3;BCL2L1;GPER1;DAB2;PID1;PRKCI;ACTB;WNK3;LDLRAP1;AKT1;RAMP3;SIRT6;EPHA2;ZDHHC8;CNPY4;PTPN9;SPTBN1;AP2M1;EPHA3;VAMP8;EPHB2;TNF;PDPK1
prerank,Cellular Respiration (GO:0045333),-0.2862300180096178,-0.9009468792238852,0.559322033898305,0.992503728437002,1.0,4/83,2.29%,SDHA;SLC25A14;NR4A3;COX7A2
prerank,Myoblast Differentiation (GO:0045445),-0.3902280833169789,-0.9008315871661904,0.6274509803921569,0.9916914792131427,1.0,4/19,8.99%,SOX15;IGF1;EPAS1;TCF7L2
prerank,Negative Regulation Of Cell-Cell Adhesion (GO:0022408),-0.31738059971697485,-0.9008066959609434,0.5,0.9907734520006849,1.0,5/40,7.33%,VEGFA;PODXL;APOA1;WNT1;ASS1
prerank,Positive Regulation Of Type II Interferon Production (GO:0032729),0.2922988925525452,0.9004717346809541,0.6571428571428571,1.0,1.0,18/56,15.47%,HLA-A;IL1R1;IL21;EBI3;CCR2;F2RL1;PYCARD;LILRB1;ZP3;TLR8;LGALS9;HSPD1;ISG15;IL12RB1;IFNL1;TLR4;HLA-DPA1;BTN3A2
prerank,Neural Crest Cell Migration (GO:0001755),0.3394980309939371,0.9003816163861466,0.6842105263157895,1.0,1.0,11/35,16.16%,SEMA6B;SEMA3G;SEMA5A;RADIL;SEMA7A;SEMA5B;SEMA4G;HTR2B;SEMA4F;NRTN;TBX1
prerank,Positive Regulation Of Cell Adhesion Mediated By Integrin (GO:0033630),0.3788391726065119,0.9003410569511917,0.6578947368421053,1.0,1.0,2/16,4.45%,CXCL13;FOXC2
prerank,Detection Of Mechanical Stimulus (GO:0050982),-0.37193559581259883,-0.9001598228200812,0.5555555555555556,0.9917898805899927,1.0,3/17,7.21%,PKD2L1;CDH2;PKDREJ
prerank,Regulation Of Nucleocytoplasmic Transport (GO:0046822),0.3985317462486545,0.9000144331325556,0.6666666666666666,1.0,1.0,3/16,10.79%,BMP4;PTPN14;IFI27
prerank,Neuron Projection Morphogenesis (GO:0048812),-0.264887865798672,-0.9000063108268681,0.609375,0.9911310685324222,1.0,27/137,14.69%,FARP1;PARD3;EPB41L3;MYO16;GAS7;SHANK1;LRRK2;NCKAP1;DSCAML1;ISL2;KLF7;DOCK7;ATL1;WNT7A;NYAP2;CTNND2;ALCAM;TRIO;DICER1;MAPK8IP2;ZNF335;MEF2A;NRN1;CNTNAP1;ANK3;BRSK2;TAOK3
prerank,Potassium Ion Import Across Plasma Membrane (GO:1990573),-0.32538992511361886,-0.8994434670599732,0.5471698113207547,0.9917057346100505,1.0,7/37,9.96%,KCNJ14;KCNJ13;KCNJ11;ATP1A2;KCNJ9;KCNE2;ATP12A
prerank,Cellular Response To Nerve Growth Factor Stimulus (GO:1990090),0.3615084229901425,0.8994187459775205,0.5625,1.0,1.0,2/19,2.29%,RAPGEF1;TMEM108
prerank,Cellular Response To Unfolded Protein (GO:0034620),-0.37577069918917244,-0.8993837615188527,0.5932203389830508,0.9908343249489635,1.0,2/16,9.30%,RHBDD1;PRKN
prerank,Cellular Response To Organic Cyclic Compound (GO:0071407),-0.2702238445419564,-0.8991478758264925,0.6818181818181818,0.9904137778244441,1.0,29/148,13.67%,ABCB4;CFTR;NR4A3;IL1B;IL18;ADCY2;RORA;ATP1A2;ADCY1;AQP8;TRPV1;HSPA1B;GABRG2;PDE2A;ZC3H12A;BRCA1;TIPARP;DIAPH1;AKAP9;P2RY1;CCL2;NRIP1;CASP7;RORC;CCDC62;GABRB3;P2RY12;IGFBP5;INSIG1
prerank,Regulation Of Amide Metabolic Process (GO:0034248),-0.31236522311825377,-0.8989721440041827,0.6440677966101694,0.9899513817703651,1.0,15/39,32.23%,DDX25;PRKCD;PCIF1;SAMD8;DUS3L;PICALM;TSC1;RBM3;PUM3;ELP4;MSI2;METAP1;ROCK1;ELP1;ELP2
prerank,Glucose Metabolic Process (GO:0006006),-0.29570477750667334,-0.898949033010921,0.6379310344827587,0.9889991477887319,1.0,6/59,9.38%,TKTL1;KRT17;KCNJ11;PGK2;IRS2;APOD
prerank,Intracellular Lipid Transport (GO:0032365),0.3734879891739858,0.8976568571571802,0.6415094339622641,1.0,1.0,5/17,19.87%,GRAMD1C;SLC25A20;NPC2;ARV1;ABCD3
prerank,Chondroitin Sulfate Proteoglycan Biosynthetic Process (GO:0050650),0.3586077057714081,0.8975501814666333,0.6052631578947368,1.0,1.0,5/19,17.28%,CHST15;CHST7;CHST12;CHPF2;UGDH
prerank,Filopodium Assembly (GO:0046847),0.36164962162351605,0.8974755624444583,0.5882352941176471,1.0,1.0,8/17,30.47%,FGD6;S1PR2;PPP1R9B;SPAG6;SPEF1;SRGAP3;FGD3;FGD4
prerank,Positive Regulation Of Lymphocyte Activation (GO:0051251),0.27302649909426185,0.8973352396687483,0.6666666666666666,1.0,1.0,12/42,15.20%,HLA-DRB1;CCR2;HLA-DMB;SIRPA;PYCARD;HSPD1;NOD2;HLA-DQA1;TNFSF11;SIRPG;HLA-DQA2;HLA-DPA1
prerank,Negative Regulation Of Nucleic Acid-Templated Transcription (GO:1903507),0.20900249811533167,0.896901941989567,0.8095238095238095,1.0,1.0,58/437,12.96%,FOXP2;TWIST1;ATP8B1;CREB3L1;GLIS2;BMP4;TSHZ3;ASCL1;IKZF4;TP63;KLF4;MAEL;FOXD1;ADIPOQ;TNFRSF4;ZNF540;FOXP3;CENPF;CD38;CTBP2;CDKN2A;PTPRK;IL4;CBFA2T3;PAX9;CDK5;BIRC5;LIMS1;ZFTA;SPACDR;KCTD1;ZP3;CIPC;PRICKLE1;TRIB3;NOTCH1;ZNF703;NIBAN2;UBE2V1;ERN2;HDAC2;PRMT2;FOXK2;HEYL;CBY1;NMNAT1;SUMO4;SFRP1;CCAR2;ZNF568;ZNF318;ZNF219;ATOH8;COMMD7;LEF1;LOXL3;DAP;IFNL1
prerank,Negative Regulation Of Transferase Activity (GO:0051348),0.3157185257918328,0.8968241477755516,0.6666666666666666,1.0,1.0,14/36,23.35%,CDC20;PRDX3;PIF1;GSK3A;DTX3L;EIF4A2;PARK7;MEN1;TINF2;MYCNOS;BANF1;BUB1B;PHPT1;XRCC1
prerank,"Wnt Signaling Pathway, Planar Cell Polarity Pathway (GO:0060071)",0.3592645033796846,0.896810284183596,0.6052631578947368,1.0,1.0,6/25,8.14%,VANGL2;FZD6;VANGL1;PRICKLE2;PRICKLE1;TIAM1
prerank,Neural Crest Cell Development (GO:0014032),-0.3131110856694478,-0.8965199062020276,0.6440677966101694,0.9942734216066087,1.0,6/42,8.60%,SEMA3C;SEMA3F;KBTBD8;CDH2;SEMA4C;SEMA6A
prerank,Bile Acid Biosynthetic Process (GO:0006699),0.3324991149984604,0.8961764643292044,0.6153846153846154,1.0,1.0,9/24,19.87%,CYP7B1;HSD3B7;CYP27A1;SCP2;CYP8B1;OSBPL1A;AMACR;AKR1D1;ABCD3
prerank,Regulation Of Acute Inflammatory Response (GO:0002673),0.350335965606156,0.8958138297949884,0.5581395348837209,1.0,1.0,6/18,17.33%,FFAR2;IL4;C2CD4A;NLRP3;F12;IL6ST
prerank,B Cell Activation (GO:0042113),-0.2713398005474228,-0.8956032277577123,0.631578947368421,0.995320399072826,1.0,30/90,21.37%,IFNA6;BANK1;IFNA7;VCAM1;CLCF1;AQP8;CASP8;PIK3R1;MS4A1;BTK;PAX5;PIK3R3;IL11;IFNA2;PLCG2;ADGRG3;DNAJB9;IFNA8;CEBPG;AKAP17A;CD79A;LAT2;IFNA14;CTPS1;CHRNB2;BLNK;IFNK;TPD52;LAX1;CD40LG
prerank,tRNA Aminoacylation For Protein Translation (GO:0006418),0.31824881906955005,0.895490323313289,0.6808510638297872,1.0,1.0,13/35,29.12%,TARS3;PARS2;CARS1;DARS2;SARS1;DARS1;VARS1;TARS1;NARS1;FARS2;YARS1;RARS2;EPRS1
prerank,Phosphatidic Acid Metabolic Process (GO:0046473),-0.3243373473648695,-0.8950144600373048,0.58,0.9959929369606437,1.0,15/32,32.95%,DGKB;MBOAT2;DGKE;GPAM;DGKG;AGPAT4;GPAT2;DGKQ;SLC27A1;PNPLA3;ABHD5;LPCAT1;DGKH;PLA2G6;PLA2G2A
prerank,Regulation Of DNA Binding (GO:0051101),0.2845735265247192,0.8949728400357144,0.5652173913043478,1.0,1.0,8/47,12.62%,NME1;MAPK8;CDT1;PLAUR;HJURP;CSNK2B;SUMO4;LEF1
prerank,Regulation Of Triglyceride Biosynthetic Process (GO:0010866),-0.38352014427024533,-0.8944056689266082,0.6274509803921569,0.9964728278069924,1.0,8/16,31.45%,SIK1;PLIN5;SIRT1;CNEP1R1;SLC27A1;NR1H2;KAT5;NR1H3
prerank,Small GTPase Mediated Signal Transduction (GO:0007264),0.2654466740937415,0.8943635548845259,0.7333333333333333,1.0,1.0,26/109,16.06%,RAPGEF1;RIN2;DOK3;KRIT1;DOK5;RAB38;FGF2;RGS19;CDKN2A;CCNA2;TIAM1;SHTN1;RASGRP4;PLD1;PLK2;MRAS;RASGRP3;DOK2;RAPGEFL1;SOS1;RALGPS2;RUNDC3A;ARL3;RASGEF1B;RASGRF1;PARK7
prerank,Positive Regulation Of Immunoglobulin Mediated Immune Response (GO:0002891),-0.37732084076098854,-0.8942899501377605,0.625,0.995794752969908,1.0,2/15,11.75%,XCL1;INSL6
prerank,Positive Regulation Of Pathway-Restricted SMAD Protein Phosphorylation (GO:0010862),-0.3188742309160744,-0.8942455386156497,0.7068965517241379,0.9948635920185817,1.0,6/45,9.06%,MSTN;TGFB2;ACVRL1;PPARG;INHBE;GDF15
prerank,Negative Regulation Of Proteolysis (GO:0045861),-0.31579557366679173,-0.894105485509976,0.6,0.9942415340735995,1.0,4/41,4.64%,MAGEA3;LRRK2;DNAJC1;CST7
prerank,Axonal Transport (GO:0098930),0.2961569462024818,0.8931827224347308,0.7352941176470589,1.0,1.0,12/39,27.27%,TMEM108;KIF4A;DST;SNAPIN;AP3M2;BLOC1S5;BLOC1S1;APEX1;FBXW11;SPAST;SYBU;SOD1
prerank,Regulation Of Hormone Secretion (GO:0046883),-0.38234814794017197,-0.8929566248812935,0.6101694915254238,0.9965518844052287,1.0,6/15,16.77%,EDN3;IL11;NMB;EDN1;FFAR3;SCG5
prerank,Regulation Of Protein Localization (GO:0032880),0.23167298170889408,0.8928681608078948,0.7878787878787878,1.0,1.0,26/94,27.78%,MAPK8;TRIM5;MAP1A;OOEP;HFE;ATCAY;SUMO4;TRIM46;FKBP1A;CAMK1;NEDD9;VCP;TRIM22;RACK1;ATP13A2;GPC1;MAP2;KDM1A;CTSD;TRIM25;TOR1A;PARP1;TESK1;PPM1F;STX10;RFPL2
prerank,Pyroptosis (GO:0070269),0.3137502597392405,0.892854738142815,0.6444444444444445,1.0,1.0,7/27,13.11%,GSDME;GSDMA;PYCARD;CASP6;NLRP3;IFI27;APIP
prerank,Regulation Of Macrophage Activation (GO:0043030),-0.3351399083613119,-0.8928407578575767,0.543859649122807,0.995876515881351,1.0,5/28,12.17%,THBS1;IRGM;ZC3H12A;FCGR2B;IL31RA
prerank,Erythrocyte Differentiation (GO:0030218),-0.32087895000724015,-0.8927210970354102,0.711864406779661,0.9952130941135322,1.0,15/49,25.34%,VEGFA;LYN;ID2;TGFBR3;SH2B3;KMT2E;CEBPG;JAK2;EPO;FLVCR1;MYB;ALAS2;CFLAR;GATA1;SLC25A38
prerank,"Positive Regulation Of DNA-templated Transcription, Elongation (GO:0032786)",-0.2815107265400003,-0.8920171861339133,0.6724137931034483,0.9961123046943126,1.0,22/56,32.09%,MED26;CCNT1;MED21;ELL2;MED27;PWWP2B;CDK9;MED9;KAT7;MED30;CDC73;TCERG1;CCNT2;MED6;BRD4;CDK13;SUPT5H;SUPT16H;MED1;SCAF8;MED14;MED17
prerank,Regulated Exocytosis (GO:0045055),-0.3004811485106858,-0.8919939368008226,0.5671641791044776,0.9951127744709654,1.0,8/49,8.58%,SCIN;SNAP25;LYN;STX1A;SYT15;STEAP2;CPLX1;RIMS1
prerank,Positive Regulation Of Substrate Adhesion-Dependent Cell Spreading (GO:1900026),0.30363299938533805,0.891837047040916,0.6756756756756757,1.0,1.0,8/34,18.61%,LIMS2;LIMS1;CARMIL1;ILK;C1QBP;NEDD9;MYADM;DOCK1
prerank,Regulation Of Primary Metabolic Process (GO:0080090),-0.3116808404469754,-0.8915079326576589,0.5614035087719298,0.9953785947725835,1.0,7/41,13.10%,ADGRF1;PPARG;NR1D2;IRS2;ID2;PLCG2;NR1D1
prerank,Negative Regulation Of Signaling (GO:0023057),-0.3511147726204588,-0.891139050139562,0.6101694915254238,0.995223200580591,1.0,9/28,20.02%,IL1B;KIF26A;PPP3CA;IL11;AP1AR;SOCS5;PCSK9;IGFBP3;PPP3CB
prerank,Homophilic Cell Adhesion Via Plasma Membrane Adhesion Molecules (GO:0007156),-0.3103300611713278,-0.8911165992250762,0.5517241379310345,0.9942276414448675,1.0,8/55,6.74%,PALLD;CDH4;CDH13;PLXNB3;DSG2;DSCAML1;CDH2;PTK7
prerank,Regulation Of Dephosphorylation (GO:0035303),-0.38303336952718814,-0.8902594152323092,0.5555555555555556,0.9955745680909277,1.0,8/15,35.76%,PPP1R16B;SRC;MTMR2;SMG7;SMG6;ROCK1;MTMR9;INPP5K
prerank,Positive Regulation Of DNA Metabolic Process (GO:0051054),-0.28595636985436745,-0.890251541168934,0.6923076923076923,0.9945597112427207,1.0,8/103,8.85%,PRIM2;BCAR3;GINS3;STON1;RNF168;DEPDC1B;ATAD5;BRCA1
prerank,Inorganic Cation Transmembrane Transport (GO:0098662),-0.2446594358142577,-0.8900039847292521,0.7,0.9942172530995378,1.0,50/261,15.73%,SLC6A12;SLC6A1;SLC9A3;SLC11A1;SCNN1B;SCN5A;SCN4A;ASIC4;KCNJ11;KCNG3;NOX5;KCNF1;SCNN1A;ATP2A1;SLC4A4;ASIC1;ATP1A2;TRPV3;AQP8;PKD2L1;SLC30A4;TRPV1;SLC8A1;SLC9C2;SCN3B;KCNE2;HPN;CACNB1;CACNA1A;SLC9A8;TRPC3;ATP12A;SLC6A11;TRPM5;SLC39A8;KCNQ4;ABCC8;MCOLN2;TRPC4AP;RHAG;SLC24A3;SLC4A8;ATP1B4;SLC30A1;TRPC1;KCNK9;SLC6A16;TRPV5;RHCE;SCNN1D
prerank,Positive Regulation Of Peptidyl-Lysine Acetylation (GO:2000758),-0.3497165125246798,-0.8897329866974923,0.6428571428571429,0.9939905877876644,1.0,6/17,20.84%,SOX4;BRCA1;SF3B1;SMARCA5;PRKAA2;GLYR1
prerank,Cellular Response To Metal Ion (GO:0071248),-0.2627006599563023,-0.8893113830931494,0.6923076923076923,0.993983888737022,1.0,16/126,9.30%,MT1HL1;ADGRV1;MT1M;ALOX15;SCN5A;ITPKA;SYT15;LRRK2;ADCY1;RASA4;AKR1C3;PRNP;NCF1;DLG2;CACNA1A;PRKN
prerank,Positive Regulation Of Transcription Regulatory Region DNA Binding (GO:2000679),0.34403443833929903,0.8891506643648972,0.62,1.0,1.0,6/20,17.38%,TWIST1;NIBAN2;POU4F1;PARK7;H1-0;GATA3
prerank,Histone mRNA Metabolic Process (GO:0008334),-0.37361807539786507,-0.8886543461300767,0.6545454545454545,0.9948856602344748,1.0,7/23,18.33%,TENT4B;EXOSC10;ERI1;TUT1;TENT2;UPF1;MTPAP
prerank,Icosanoid Biosynthetic Process (GO:0046456),0.3386333508121975,0.8880481186163546,0.5849056603773585,1.0,1.0,8/18,27.33%,PYCARD;PLA2G1B;FADS1;CYP4A22;CYP2C8;LTA4H;CASP1;MGST3
prerank,Positive Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901992),0.2731899488733147,0.8878791763898777,0.65,1.0,1.0,20/62,22.42%,DLGAP5;UBE2C;ESPL1;CDK4;CDCA5;RRM2B;CDC20;RGCC;CDK1;CENPJ;CCNB1;ANAPC7;CDC25B;ANKRD17;AKT1;TFDP1;DBF4B;RAB11A;TNFSF13B;AIF1
prerank,Aerobic Respiration (GO:0009060),0.2879885016214489,0.8872081745831978,0.574468085106383,1.0,1.0,32/58,35.00%,NDUFA9;NDUFB3;MTFR2;NDUFA12;NDUFC1;NDUFS7;TEFM;NDUFB10;NDUFS2;BLOC1S1;NDUFB2;NDUFB5;NDUFC2;NDUFA6;UQCRB;NDUFB4;NDUFB8;NDUFB11;ATP5F1D;UQCRH;NDUFA8;SDHC;NDUFS5;MDH2;NDUFB6;NDUFS4;NDUFA13;NDUFS8;UQCRC2;UQCRC1;NDUFB1;ME3
prerank,Ceramide Metabolic Process (GO:0006672),-0.3035218173459864,-0.8870226949138245,0.6417910447761194,0.9983830320281525,1.0,8/51,9.53%,DEGS2;ALOXE3;FUT6;TLCD3B;SPTSSB;ABCA2;PNPLA1;CERS3
prerank,B Cell Differentiation (GO:0030183),-0.2787053148496029,-0.8859135855412295,0.6666666666666666,1.0,1.0,16/67,15.11%,IFNA6;IFNA7;VCAM1;CLCF1;AQP8;PIK3R1;MS4A1;PAX5;PIK3R3;IL11;IFNA2;PLCG2;ADGRG3;DNAJB9;IFNA8;CEBPG
prerank,Protein Localization To Golgi Apparatus (GO:0034067),-0.32624869761653935,-0.8855582255510649,0.6842105263157895,1.0,1.0,6/28,16.96%,ZDHHC15;ARL5B;RAB6B;CSNK1D;GBP5;VPS13C
prerank,Cellular Response To Peptide Hormone Stimulus (GO:0071375),-0.2595213159690954,-0.8850843634275363,0.7068965517241379,1.0,1.0,16/86,16.38%,CRHR1;NR4A3;SCNN1B;SCNN1A;NR4A2;PIK3R1;PPARG;IRS2;RHOQ;SRC;LPIN1;PRKCD;INSIG1;SCNN1D;SORBS1;PCSK9
prerank,Regulation Of Rac Protein Signal Transduction (GO:0035020),0.39805617368416046,0.8850032332884317,0.6888888888888889,1.0,1.0,5/15,18.34%,ARHGAP44;ARHGAP24;KBTBD6;RASGRF1;SH3BP1
prerank,Negative Regulation Of Cell-Substrate Adhesion (GO:0010812),-0.31991675691840715,-0.8849268667801854,0.6346153846153846,0.9997204273874989,1.0,4/35,7.17%,THBS1;MELTF;FZD7;WNT1
prerank,Regulation Of Plasma Membrane Bounded Cell Projection Assembly (GO:0120032),0.2817308682747081,0.8849055415259545,0.7380952380952381,1.0,1.0,20/74,25.26%,ATP8B1;EVI5;TBC1D8;CCR7;PLD1;TBC1D20;SH3YL1;TBC1D2;TWF2;TBC1D16;MYO10;P2RX4;INTU;EPHA2;CAPZB;DYNC2LI1;TBC1D24;TBC1D10B;CYLD;WAS
prerank,Regulation Of Cellular Response To Growth Factor Stimulus (GO:0090287),0.34973946207142076,0.8847771679556935,0.5769230769230769,1.0,1.0,6/17,15.76%,PCSK6;DOK5;FSTL3;ITGA3;TMEM204;XIAP
prerank,Receptor-Mediated Endocytosis (GO:0006898),-0.27339671323330617,-0.8834998995262979,0.6716417910447762,1.0,1.0,21/118,15.00%,GRK4;MAGI2;MSR1;ACKR3;CXCL8;STON1;FCHO2;NEDD4;ENTREP1;ITCH;CLEC4M;CXCL16;ITGAM;LDLRAD3;DNAJC6;FCGR2B;STAB2;DNAJC13;VLDLR;HSPG2;ADM
prerank,Protein Complex Oligomerization (GO:0051259),0.2346468314801258,0.883440849341962,0.7027027027027027,1.0,1.0,31/99,25.16%,NOL3;HLA-DRB1;IKZF4;LRRC8D;SNCA;TMEM120B;PYCARD;NLRP3;PDCD6IP;FOXM1;KCNC2;CLDN1;SLC31A1;PRMT1;JMJD6;UGDH;MAT2A;ECT2;KCNC3;STING1;ELAVL1;BEND3;TRMT61B;GSDMD;STOML2;TP53BP1;CHMP2A;EHD3;SPAST;ALAD;PRF1
prerank,Insulin Receptor Signaling Pathway (GO:0008286),-0.32106038973802575,-0.883388168049718,0.6346153846153846,1.0,1.0,8/46,11.46%,BCAR3;PIK3R1;GAB1;PIK3R3;RARRES2;IRS2;RHOQ;PIK3CA
prerank,Cellular Response To Organic Substance (GO:0071310),-0.27914974754838856,-0.8832545292812041,0.6349206349206349,1.0,1.0,17/77,15.30%,GHR;IL1B;IL18;TRAF6;CSF1R;OXTR;NPFFR2;CXCR4;TIPARP;EDN1;SLIT2;CCL2;ZNF16;PLCG2;IGFBP5;NCOA1;SLIT1
prerank,Supramolecular Fiber Organization (GO:0097435),0.22111914143409528,0.8832308013177905,0.9285714285714286,1.0,1.0,53/293,15.92%,TPPP3;FBLN5;ADAMTS14;SHROOM4;MYO1C;CNN1;MYO1E;LOXL1;MYO5C;MYO7A;KIF2C;SIAH1;BID;OOEP;SNCA;KIF14;KRT72;COL18A1;CYP1B1;BFSP2;CARMIL1;CD36;KIF24;KRT73;CAMSAP2;KASH5;CENPJ;CORO1B;TMOD4;PLA2G1B;PRSS8;CLIP3;RAC2;MYO5B;FKBP1A;TLE6;P3H4;FSD1;AVIL;LOXL3;XIRP1;KIF18A;UBASH3A;MBD1;LOXL2;PPP1R9B;MYO1A;DSP;VIM;KIF2A;RIPK3;MYO7B;MYO15A
prerank,"Protein Localization To Chromosome, Telomeric Region (GO:0070198)",-0.4344203657398541,-0.8831199110436545,0.64,1.0,1.0,4/15,16.48%,TERT;TERF2IP;ZNF827;TNKS
prerank,Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000045),0.2528045535999481,0.8830112992490005,0.7209302325581395,1.0,1.0,14/105,9.85%,DACT1;GFI1B;CDKN2B;KLF4;APC;KANK2;CDKN2A;CDK2AP2;KIF14;RGCC;PTPN6;ACTL6A;CENPJ;PRMT2
prerank,Embryonic Skeletal System Morphogenesis (GO:0048704),0.3202779145488139,0.88270099423525,0.6274509803921569,1.0,1.0,2/28,5.85%,TWIST1;HOXB3
prerank,Regulation Of Stem Cell Differentiation (GO:2000736),-0.30713673753644244,-0.8825203718742135,0.6285714285714286,1.0,1.0,1/43,0.36%,RBM24
prerank,Dicarboxylic Acid Metabolic Process (GO:0043648),-0.3079835375906599,-0.8821150759662664,0.6538461538461539,1.0,1.0,11/48,17.93%,SDHA;ME1;HAAO;ASS1;OGDHL;GLUD2;ADHFE1;PHYH;MTHFD2L;NIT2;NAGS
prerank,Signal Release From Synapse (GO:0099643),0.3068262031062867,0.8817977668299597,0.7058823529411765,1.0,1.0,7/35,13.17%,SYN1;SNCA;SYN2;CDK5;NRXN2;SNAPIN;PCLO
prerank,Post-Transcriptional Regulation Of Gene Expression (GO:0010608),-0.29674676062604755,-0.880555355978733,0.6896551724137931,1.0,1.0,15/55,24.85%,DDX25;PER1;CELF1;ZC3H10;METTL16;PCIF1;DUS3L;ZC3H7A;NUDT21;ATG14;TSC1;RBM3;PUM3;NANOS1;ELP4
prerank,RNA 3'-End Processing (GO:0031123),-0.33865098509476516,-0.8802580474668646,0.6458333333333334,1.0,1.0,11/36,22.24%,RPRD1B;TENT4B;SUPV3L1;RPRD1A;LIN28A;TOE1;LIN28B;INTS6L;INTS12;ELAC1;NUDT21
prerank,Positive Regulation Of Neutrophil Chemotaxis (GO:0090023),-0.3572972277433302,-0.8797066268444999,0.631578947368421,1.0,1.0,2/18,3.20%,XCL1;CXCL8
prerank,Regulation Of Transcription Regulatory Region DNA Binding (GO:2000677),-0.3408280831941008,-0.8794603083126228,0.6037735849056604,1.0,1.0,6/26,10.54%,RNF220;MSX2;TRAF6;IGF1;HEY2;HEY1
prerank,Negative Regulation Of Cell Adhesion (GO:0007162),-0.2873055197780191,-0.879408157395683,0.7115384615384616,1.0,1.0,14/70,11.56%,CDH13;PLXNB3;ACVRL1;PODXL;FZD7;PLXND1;RND1;WNT1;ADAM22;SEMA6A;PLXNA2;DUSP1;ANGPT1;TGFBI
prerank,Modulation Of Excitatory Postsynaptic Potential (GO:0098815),0.31686069481719603,0.8791870615329702,0.7073170731707317,1.0,1.0,7/26,15.36%,TMEM108;CHRNA7;GRIN2D;SLC8A2;RIMS2;DLG4;NLGN2
prerank,Lamellipodium Organization (GO:0097581),0.3061834743523726,0.8787294423954326,0.627906976744186,1.0,1.0,11/29,22.40%,PARVB;CARMIL1;CTTN;CYFIP1;ARHGEF4;SNX1;KIT;SPEF1;PHPT1;VCL;WASF1
prerank,Intracellular Iron Ion Homeostasis (GO:0006879),0.2881432967675363,0.8776141443730372,0.6818181818181818,1.0,1.0,13/49,16.70%,MYC;SLC40A1;HFE;ERFE;NDFIP1;SLC46A1;SLC39A14;SLC11A2;SLC22A17;ATP6V0D1;HMOX1;FRRS1;BMP6
prerank,Mitochondrial RNA Metabolic Process (GO:0000959),-0.35134504757973,-0.8771970122186081,0.5932203389830508,1.0,1.0,10/20,33.52%,TWNK;FASTKD5;TFB2M;FASTKD2;TBRG4;MTERF1;MTERF3;TFAM;MTERF2;MTERF4
prerank,Hippo Signaling (GO:0035329),-0.3585684156611982,-0.8769441753792733,0.6444444444444445,1.0,1.0,7/16,27.01%,LATS2;AMOTL1;YAP1;SAV1;DCHS1;MOB1A;LATS1
prerank,DNA Modification (GO:0006304),0.34219787485164527,0.8768637759576736,0.6046511627906976,1.0,1.0,9/17,26.03%,EXOSC5;EXOSC4;UNG;SMUG1;OGG1;NTHL1;PARP3;MPG;PARP1
prerank,Positive Regulation Of Catalytic Activity (GO:0043085),0.31945102010825943,0.8765460946505254,0.6666666666666666,1.0,1.0,6/38,11.80%,MAPK8;SLC5A3;NHEJ1;AZIN2;NOD2;FDX2
prerank,Regulation Of Cardiac Muscle Contraction By Regulation Of The Release Of Sequestered Calcium Ion (GO:0010881),-0.39614954051664025,-0.876256538506381,0.5416666666666666,1.0,1.0,3/15,7.29%,CASQ2;ATP1A2;SLC8A1
prerank,Cellular Response To Oxygen-Containing Compound (GO:1901701),-0.23184448072749808,-0.8757693718441764,0.8125,1.0,1.0,67/391,13.67%,ABCB4;WNT11;ADGRV1;ALOX15;CFTR;NR4A3;SCN5A;IL1B;IRGM;ITPKA;CXCL8;LYN;CXCL2;RORA;LTK;SYT15;TRAF6;ADCY1;AQP8;FZD7;ADAM9;FZD10;GFI1;RASA4;TNFAIP3;TRPV1;AKR1C3;PTK7;MAPT;NSMF;WNT5B;LARS1;NCF1;DLG2;PDE2A;CXCL11;CXCL3;ZC3H12A;ZNF35;CACNA1A;RET;WNT10B;PF4V1;AKAP9;SLIT2;MT3;P2RY1;PDE4B;RORB;CCL2;NRIP1;BCL10;ZNF16;PLCG2;PEX2;CASP7;RORC;FFAR3;PEX12;PRKCD;CCDC62;P2RY12;MEF2A;NR1D1;PPBP;IGFBP5;INSIG1
prerank,Negative Regulation Of Developmental Growth (GO:0048640),-0.34139736249057745,-0.8757143275806183,0.6545454545454545,1.0,1.0,6/29,10.94%,MSTN;FGF13;KIAA0319;CDKN1A;GDF15;MT3
prerank,Positive Regulation Of Cardiac Muscle Hypertrophy (GO:0010613),-0.35655855551578375,-0.8756651635217118,0.5614035087719298,1.0,1.0,5/17,12.78%,NR4A3;IGF1;TRPC3;EDN1;MEF2A
prerank,Regulation Of Cell-Substrate Junction Assembly (GO:0090109),0.3496947129904127,0.8755277913514021,0.673469387755102,1.0,1.0,2/21,3.40%,CAMSAP3;EFNA5
prerank,DNA-templated Transcription Initiation (GO:0006352),-0.2788357331277583,-0.875321211505576,0.6333333333333333,1.0,1.0,24/59,25.94%,MED26;TAF5;TAF13;TBPL2;ELOA;TAF1C;TBPL1;SMARCA5;TFB2M;TAF7;ZFP36L2;ERCC3;MED27;CDK9;CCNH;GTF2H2;RRN3;ZFP36L1;POLR2D;E2F3;RSF1;ELOB;GTF2B;RRN3P2
prerank,Axoneme Assembly (GO:0035082),-0.3165511746939445,-0.8752242094611251,0.6111111111111112,1.0,1.0,7/38,11.77%,PIERCE1;SPAG16;LRRC43;RP1L1;DNAAF6;RSPH4A;TOGARAM1
prerank,Regulation Of Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0090092),0.3090391023661588,0.8752117639742785,0.6851851851851852,1.0,1.0,8/30,15.76%,PCSK6;FSTL3;ZNF703;ITGA3;FKBP1A;NREP;SOX11;XIAP
prerank,Antigen Receptor-Mediated Signaling Pathway (GO:0050851),0.24483750308493585,0.8751202107903834,0.7727272727272727,1.0,1.0,27/119,21.02%,HLA-A;IKBKG;NFAM1;HLA-DRB1;MAP3K7;TRGC2;CD38;MOG;SH2B2;CD79B;BLK;CSK;TRBC1;CD8B;SPPL3;HLA-DPA1;BTN3A2;IKBKB;BTN2A2;BTN2A1;GATA3;RBCK1;MNDA;CD3D;MEF2C;LCK;FYN
prerank,Rescue Of Stalled Ribosome (GO:0072344),0.32531674884015693,0.874768462439446,0.6444444444444445,1.0,1.0,10/23,27.20%,PTRH1;USP10;SKIC3;RACK1;SKIC8;ZNF598;ASCC3;ANKZF1;SKIC2;TRIP4
prerank,Negative Regulation Of Microtubule Depolymerization (GO:0007026),-0.38780432559006806,-0.8743240784851111,0.62,1.0,1.0,3/19,10.96%,FGF13;APC2;ATXN7
prerank,Secondary Alcohol Biosynthetic Process (GO:1902653),-0.3478883514783355,-0.8742120662915434,0.6949152542372882,1.0,1.0,6/24,17.42%,NPC1L1;CYP51A1;DHCR7;CES1;INSIG1;MVD
prerank,Regulation Of Calcium-Mediated Signaling (GO:0050848),-0.32905312044437507,-0.8739035729988636,0.6071428571428571,1.0,1.0,4/26,7.04%,CLEC7A;CDH13;LRRK2;MAPT
prerank,Organonitrogen Compound Biosynthetic Process (GO:1901566),-0.2571617980793988,-0.8738409926135066,0.6984126984126984,1.0,1.0,14/119,9.53%,PAM;DEGS2;LPCAT2;SLC44A4;SLC44A5;APOA1;SPTSSB;GPHN;ELOVL4;ASS1;SPNS2;ELOVL6;PCYT1B;CERS3
prerank,Cellular Response To Nutrient Levels (GO:0031669),-0.2817955197765241,-0.8729245287316966,0.7407407407407407,1.0,1.0,24/76,23.31%,NUPR2;LRRK2;MAP1LC3C;KLF10;JMY;GAS2L1;PRR5;CREBBP;WDR45B;WRN;RICTOR;PCSK9;SIRT1;PRKAB1;PRKAA2;PPARA;BMPR2;PRKAB2;PRKAG2;ALB;SREBF2;FNIP1;ATG14;TSC1
prerank,Heart Trabecula Morphogenesis (GO:0061384),-0.3949161037363314,-0.8728318405630249,0.6481481481481481,1.0,1.0,3/17,10.54%,TGFB2;TGFBR3;HEY1
prerank,Protein Destabilization (GO:0031648),-0.32105133811912295,-0.8727165551472895,0.6551724137931034,1.0,1.0,15/36,21.21%,IRGM;PRNP;PRKN;PYHIN1;MUL1;PEX2;NR1D1;TRIM21;EP300;CREBBP;SIRT1;FBXL3;CDC73;CCDC88C;DAZAP2
prerank,Negative Regulation Of Endothelial Cell Migration (GO:0010596),0.2899479708518054,0.8725383707310362,0.575,1.0,1.0,8/35,9.95%,KRIT1;VASH1;FGF2;RGCC;NOTCH1;CSNK2B;ANGPT4;JUP
prerank,B Cell Receptor Signaling Pathway (GO:0050853),0.2915237191745605,0.8723984418741116,0.6923076923076923,1.0,1.0,5/38,7.04%,NFAM1;CD38;SH2B2;CD79B;BLK
prerank,Proton Motive Force-Driven ATP Synthesis (GO:0015986),0.27610154354723837,0.8723389872651695,0.6739130434782609,1.0,1.0,31/59,33.39%,NDUFA9;NDUFB3;ATP5PB;NDUFA12;ATP5MC1;NDUFC1;ATP5MF;NDUFS7;NDUFB10;NDUFS2;ATP5F1E;NDUFB2;NDUFB5;NDUFC2;ATP5PF;NDUFA6;NDUFB4;NDUFB8;NDUFB11;ATP5F1D;ATP5PD;ATP5F1B;NDUFA8;SDHC;ATP5MC2;NDUFS5;NDUFB6;NDUFS4;NDUFA13;NDUFS8;ATP5MG
prerank,Regulation Of Actin Filament Bundle Assembly (GO:0032231),-0.3333170192543364,-0.8720860081604276,0.603448275862069,1.0,1.0,8/25,25.37%,VIL1;SHANK1;PRKN;PTGER4;ALMS1;TSC1;PFN2;RDX
prerank,Striated Muscle Contraction (GO:0006941),-0.3054930126773458,-0.8719257108711554,0.6666666666666666,1.0,1.0,9/53,8.43%,CASQ2;SCN5A;TNNC2;TNNT1;ATP1A2;SLC8A1;MYH7B;SCN3B;STAC2
prerank,Cellular Response To Calcium Ion (GO:0071277),-0.2897204344283038,-0.8718079259811241,0.6785714285714286,1.0,1.0,8/65,6.67%,ADGRV1;ALOX15;SCN5A;ITPKA;SYT15;ADCY1;RASA4;AKR1C3
prerank,Negative Regulation Of BMP Signaling Pathway (GO:0030514),-0.29382303388811626,-0.8717312761585451,0.6181818181818182,1.0,1.0,11/37,22.60%,SMAD6;RBPMS2;PPARG;WNT1;SMURF2;CHRDL1;NOG;BMPER;SKIL;LRP2;SMURF1
prerank,Regulation Of Smooth Muscle Cell Migration (GO:0014910),-0.37089195305861256,-0.8714532249591476,0.6964285714285714,1.0,1.0,10/18,26.28%,NDRG4;IGF1;SLIT2;VTN;IGFBP5;SERPINE1;IGFBP3;CCL5;PDGFB;LRP1
prerank,Regulation Of Tumor Necrosis Factor-Mediated Signaling Pathway (GO:0010803),-0.2998319659935646,-0.8712975734826535,0.6935483870967742,1.0,1.0,15/47,20.56%,CCDC3;APOA1;CASP8;TNFAIP3;HSPA1B;SPATA2;PRKN;TBK1;MAPKAPK2;PYDC1;PELI3;SPPL2A;TRAIP;OTULIN;BIRC7
prerank,Macroautophagy (GO:0016236),-0.2619322973689331,-0.8710463836047853,0.8032786885245902,1.0,1.0,37/104,31.22%,IRGM;MAP1LC3C;YOD1;ATG16L1;VPS37B;GABARAPL1;PRKN;TSG101;SRC;PIP4K2A;ATG5;VAMP7;EPG5;SNX14;MTMR14;VPS37D;UBQLN1;ATG14;EI24;VPS33B;ULK1;ZFYVE26;ATG12;PIK3R4;MAP1LC3B;VTI1A;CALCOCO2;ILRUN;CHMP1B;PLAA;ATG10;VHL;UVRAG;VPS4A;VPS41;VPS4B;ARL8B
prerank,Histone H4 Acetylation (GO:0043967),-0.309478402616834,-0.8708490596966121,0.7547169811320755,1.0,1.0,14/38,26.22%,JADE3;KANSL2;MBTD1;EPC1;MSL2;MORF4L1;KAT7;NAA40;ING5;MRGBP;KANSL1;MORF4L2;EP400;DMAP1
prerank,Cilium-Dependent Cell Motility (GO:0060285),0.35496046618027044,0.8708477421225699,0.6666666666666666,1.0,1.0,5/18,16.81%,CFAP54;TEKT5;DNAAF2;GAS8;CCDC65
prerank,Regulation Of Exocytosis (GO:0017157),-0.30837727699492157,-0.8705943139234875,0.6610169491525424,1.0,1.0,6/51,8.48%,CFTR;SYTL4;CPLANE2;STXBP6;CPLX1;RAB9A
prerank,Purine Ribonucleotide Catabolic Process (GO:0009154),-0.35545295554938705,-0.8705565581626188,0.64,1.0,1.0,5/25,10.37%,NT5C1A;SUCLA2;MLYCD;PDE2A;NUDT11
prerank,Extracellular Matrix Assembly (GO:0085029),0.33903025764178946,0.8704136687592374,0.6153846153846154,1.0,1.0,1/16,0.72%,FBLN5
prerank,Protein Localization To Microtubule Organizing Center (GO:1905508),-0.36154487680106095,-0.8697895278845157,0.6346153846153846,1.0,1.0,3/15,16.34%,CEP83;CSNK1D;CCDC14
prerank,Regulation Of Cell-Cell Adhesion (GO:0022407),0.3087021505414267,0.8696113820358871,0.7391304347826086,1.0,1.0,8/38,13.40%,CEACAM1;EPHB3;CDH1;EFNA5;FSTL3;PTK2;SIRPG;FERMT3
prerank,Negative Regulation Of Plasma Membrane Bounded Cell Projection Assembly (GO:0120033),0.3202172368135864,0.869234455231162,0.76,1.0,1.0,7/29,14.42%,TBC1D30;ARHGAP44;ARHGAP24;KIF24;GDI2;KANK1;CDK10
prerank,Regulation Of DNA Metabolic Process (GO:0051052),-0.2540933543403172,-0.86889081571738,0.7384615384615385,1.0,1.0,46/123,31.77%,STOX1;DSCC1;ACVRL1;DEPDC1B;TMEM98;TAF5;JADE3;BRCA1;ATXN7;TERF2IP;SMARCA5;SMC5;TAF7;POLE3;UPF1;ESCO1;CDK9;KAT7;INO80D;OBI1;ING5;KPNA1;RBBP6;USP1;NUCKS1;RADX;CCDC88A;BAZ1A;INO80;SMC6;NSMCE3;SUB1;HELB;HDAC8;UIMC1;ATXN7L3;ZBTB38;SMG6;SUPT7L;BAZ2A;USP37;ACTR5;TAF10;SMARCAD1;INO80E;KAT2B
prerank,Protein Phosphorylation (GO:0006468),-0.22620298964542868,-0.8686167135653431,0.8734177215189873,1.0,1.0,52/480,12.50%,KDR;FLT1;GRK4;NUAK1;WNT11;INSRR;PEAK1;TGFB2;PRKACG;MARK1;SRPK3;DDR2;FLT4;LYN;LTK;LATS2;ACVRL1;AURKA;LRRK2;MAK;CAMK2B;MAPK15;MAPK10;CSF1R;GRK7;FAM20C;CCNT1;SIK1;VRK2;CLK1;TAF5;BTK;RUNX3;ACVR1B;TNK1;TGFBR3;TAF13;SRC;TBK1;TLR3;CLK4;SNRK;BRD2;CCL2;PRKCG;GMFB;MASTL;DAPK2;AMHR2;MAPKAPK2;PRKCD;UHMK1
prerank,Nuclear Migration (GO:0007097),0.3490371063693343,0.8684749095045761,0.6136363636363636,1.0,1.0,6/15,23.37%,MBD1;SYNE2;LMNB2;LMNB1;SYNE3;FBXW11
prerank,Regulation Of Cellular Catabolic Process (GO:0031329),-0.27364102382163186,-0.8684094057359769,0.6909090909090909,1.0,1.0,13/61,14.97%,NUPR1;LRRK2;MAPK15;GPR137;MAPT;FBXL2;PRKN;DRAM1;DAPK2;EP300;SMCR8;PIP4K2A;ABL1
prerank,Regulation Of Interleukin-17 Production (GO:0032660),0.30142239480001115,0.8683300839231695,0.6808510638297872,1.0,1.0,8/34,15.08%,ZBTB7B;IL21;FOXP3;NOD2;LY9;TLR4;PHB1;NR1H4
prerank,Regulation Of Epidermal Growth Factor-Activated Receptor Activity (GO:0007176),0.32862345949122185,0.8682707725010153,0.6530612244897959,1.0,1.0,8/23,22.53%,HBEGF;NCK2;TGFA;GPRC5A;CBL;ZGPAT;SNX6;SHC1
prerank,Negative Regulation Of Protein Phosphorylation (GO:0001933),-0.25674965331457156,-0.8672876706100748,0.7068965517241379,1.0,1.0,28/144,15.73%,SPRY2;PARD3;SMAD6;LYN;PIP5KL1;LRRK2;PPARG;CDKN1A;INPP5J;SFN;MLXIPL;SPRED1;PRNP;ZC3H12A;PRKN;AKT1S1;SLIT2;CAMK2N2;TERF2IP;PRKCD;SH3GL2;PPP1R15B;THY1;SAMSN1;SMCR8;TAF7;PYDC1;GPD1L
prerank,Sphingolipid Metabolic Process (GO:0006665),0.2477375978951575,0.8668814137746322,0.6875,1.0,1.0,13/88,13.03%,GAL3ST1;ELOVL7;ALDH3B1;SGMS2;ALOX12B;SPTLC3;KDSR;ST6GALNAC3;ORMDL2;NEU3;PLPP1;GM2A;SPTLC2
prerank,Membrane Fission (GO:0090148),0.28857126323230897,0.8668192014569108,0.6862745098039216,1.0,1.0,2/38,2.70%,CHMP4C;EXOC4
prerank,Negative Regulation Of Lipid Biosynthetic Process (GO:0051055),0.33369551474273135,0.8659621527702014,0.5294117647058824,1.0,1.0,4/22,13.09%,CEACAM1;APOC1;TRIB3;GPER1
prerank,rRNA Methylation (GO:0031167),-0.3314794425749762,-0.8656195582655573,0.6938775510204082,1.0,1.0,6/19,15.07%,FBLL1;METTL16;MRM3;TFB2M;ZCCHC4;NSUN3
prerank,Receptor Clustering (GO:0043113),-0.38353636130744884,-0.8655496104165186,0.6,1.0,1.0,1/18,1.08%,MAGI2
prerank,Neuron Projection Extension (GO:1990138),0.2991990297823088,0.8655495809738817,0.6829268292682927,1.0,1.0,8/37,13.18%,S100B;TMEM108;SEMA5A;CDK5;SPACDR;CYFIP1;SEMA5B;TNN
prerank,Defense Response To Gram-negative Bacterium (GO:0050829),-0.2771703869586038,-0.8654837722526595,0.7413793103448276,1.0,1.0,16/68,19.94%,AZU1;SLC11A1;IRGM;FCN2;PRB3;GALP;RARRES2;IGHM;DEFB127;IL23A;DEFB126;LCE3B;HMGB2;TLR9;EHHADH;SERPINE1
prerank,Positive Regulation Of Proteasomal Protein Catabolic Process (GO:1901800),0.2466967590289102,0.86520393460281,0.7333333333333333,1.0,1.0,19/86,17.53%,HSPA1A;PLK1;FBXO22;CBFA2T3;NKD2;PRICKLE1;TRIB3;HECTD1;RNF180;GSK3A;RNF19A;TRIB2;TRIB1;DAB2;RBX1;KEAP1;VCP;SH3RF2;RACK1
prerank,Pyruvate Metabolic Process (GO:0006090),-0.29121914760871664,-0.8651770671366928,0.7076923076923077,1.0,1.0,5/50,4.43%,ME1;NR4A3;KRT17;PGK2;HOGA1
prerank,Regulation Of Organelle Assembly (GO:1902115),0.2523380757686661,0.8649326940665583,0.6666666666666666,1.0,1.0,12/78,17.32%,EVI5;TBC1D8;HCK;CENPJ;PLK2;TBC1D20;TBC1D2;PDCD6IP;EFNB1;RAB1B;TBC1D12;TBC1D16
prerank,Negative Regulation Of Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0030512),-0.2766373572787624,-0.8649034045923953,0.6507936507936508,1.0,1.0,22/73,23.51%,SPRY2;SMAD6;PBLD;CIDEA;PPARG;SPRED1;BAMBI;SMURF2;PEG10;PPM1A;BMP2;SIRT1;PPARA;STRAP;ARID4A;ARID4B;ING2;SPRED3;SAP30L;SMURF1;SPRY1;ZNF451
prerank,Intracellular Glucose Homeostasis (GO:0001678),0.2935454243207029,0.8642981166213869,0.7727272727272727,1.0,1.0,13/43,19.55%,KCNB1;HK3;LRRC8D;HKDC1;HK2;SLC39A14;FOXK2;HK1;GPER1;ZBTB20;RACK1;UCP2;TRA2B
prerank,Establishment Or Maintenance Of Epithelial Cell Apical/Basal Polarity (GO:0045197),-0.31385249124485043,-0.8642267640985538,0.625,1.0,1.0,10/39,17.38%,PARD3;PARD6G;CRB2;DLG2;PALS1;DLG5;CRB3;RAP2A;DLG1;CRB1
prerank,Regulation Of Vasoconstriction (GO:0019229),-0.3605999003474049,-0.8640386968594258,0.64,1.0,1.0,7/22,20.78%,OXTR;SMTNL1;F2R;ADM;TRPM4;BMPR2;AVPR2
prerank,Response To Cholesterol (GO:0070723),0.36049050201503935,0.8639044084379337,0.6444444444444445,1.0,1.0,3/18,12.60%,GRAMD1C;PMVK;GPLD1
prerank,Regulation Of Monocyte Chemotaxis (GO:0090025),0.30826400332065756,0.8637895697776856,0.6486486486486487,1.0,1.0,6/23,13.39%,CCR2;LGMN;CXCL17;SLAMF8;MOSPD2;S100A14
prerank,Platelet-Derived Growth Factor Receptor Signaling Pathway (GO:0048008),-0.37667999502835037,-0.8636130171668115,0.627906976744186,1.0,1.0,2/15,7.44%,NR4A3;PDGFD
prerank,Regulation Of Regulatory T Cell Differentiation (GO:0045589),0.3087148000954152,0.8633590953309661,0.6170212765957447,1.0,1.0,3/21,6.10%,CR1;FOXP3;HLA-G
prerank,Embryo Development Ending In Birth Or Egg Hatching (GO:0009792),-0.3672612549201365,-0.8624859282701987,0.6086956521739131,1.0,1.0,2/15,1.48%,CELF4;TGFB2
prerank,Positive Regulation Of Mitotic Nuclear Division (GO:0045840),-0.3642744798904187,-0.8624576756287304,0.6557377049180327,1.0,1.0,5/33,4.38%,NUP62;IL1B;EDN3;AURKA;IGF1
prerank,Regulation Of miRNA Transcription (GO:1902893),0.26233823092471337,0.8621970750268996,0.6923076923076923,1.0,1.0,9/59,12.54%,BMP4;MYC;EGR1;KLF4;FGF2;MRTFA;SRF;LILRB4;ATOH8
prerank,Regulation Of Smoothened Signaling Pathway (GO:0008589),0.28622044738670643,0.8614032008753569,0.7575757575757576,1.0,1.0,16/50,18.70%,GLIS2;GLI1;IFT81;EVC;TEDC2;SUFU;CIBAR1;SFRP1;KCTD21;STK36;VCP;GAS8;HERC4;RACK1;PDCL;TUBD1
prerank,Activation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0006919),0.2663051936618287,0.8613920778572097,0.8055555555555556,1.0,1.0,25/67,21.13%,S100A8;EGLN3;BID;SNCA;KHDC1;PDCD2;DYNLL1;PYCARD;HSPD1;S100A9;BBC3;SENP1;SORD;ST20;CASP9;CASP10;DAP;VCP;HSPE1;RACK1;BCL2L13;BEX3;CASP2;LCK;AIFM1
prerank,Negative Regulation Of Ubiquitin-Protein Transferase Activity (GO:0051444),0.3300373445279931,0.861100398100844,0.6346153846153846,1.0,1.0,4/17,21.65%,CDC20;DTX3L;PARK7;BUB1B
prerank,Import Into Cell (GO:0098657),-0.30740445899096025,-0.8610719384444557,0.5833333333333334,1.0,1.0,4/37,2.81%,SLC18A3;SLC16A2;SNAP25;SLC7A8
prerank,Regulation Of Receptor-Mediated Endocytosis (GO:0048259),0.2898087939113404,0.8605244656483715,0.7045454545454546,1.0,1.0,7/37,18.28%,APOC1;HFE;IL4;UNC45A;FLOT1;LDLRAP1;CBL
prerank,Anterior/Posterior Pattern Specification (GO:0009952),-0.2939320199257541,-0.8598911801924404,0.625,1.0,1.0,10/52,18.09%,HOXB6;HOXA5;HEY2;HEY1;HOXB5;HES3;BHLHE40;BMP2;BMPR2;LHX1
prerank,RNA Catabolic Process (GO:0006401),-0.29188343057451366,-0.8598361595063213,0.6363636363636364,1.0,1.0,13/57,16.67%,EXOSC3;NANOS2;HSPA1B;ZPR1;EXOSC6;SUPV3L1;EXOSC10;DIS3;METTL16;RNASEH1;DIS3L;NUDT12;ZFP36L2
prerank,Protein Acetylation (GO:0006473),-0.31866049033986915,-0.8595805571545463,0.5576923076923077,1.0,1.0,10/29,25.51%,DSCC1;MAPT;EP300;CREBBP;SIRT1;ESCO1;ING5;KAT6A;NAA15;GTF2B
prerank,Regulation Of Cell-Matrix Adhesion (GO:0001952),-0.2950046136341513,-0.8592288581316403,0.7307692307692307,1.0,1.0,6/62,6.50%,PEAK1;THBS1;ENC1;CDH13;FUT1;UTRN
prerank,Protein N-linked Glycosylation Via Asparagine (GO:0018279),-0.35293428726220133,-0.8589992981719813,0.625,1.0,1.0,7/23,23.99%,MGAT2;MGAT1;TUSC3;MAGT1;UBE2J1;MGAT5;DPM1
prerank,Long-Chain Fatty Acid Metabolic Process (GO:0001676),-0.27050167081547805,-0.8588794064664951,0.7272727272727273,1.0,1.0,12/75,13.85%,ALOX15;ALOX12;ALOXE3;CYP4F12;ACSBG1;DAGLB;ELOVL6;PLA2G4B;AWAT1;LTC4S;CYP3A4;CYP2E1
prerank,Negative Regulation Of Interleukin-2 Production (GO:0032703),0.32579257695327846,0.8582857730094383,0.725,1.0,1.0,5/20,12.27%,CR1;FOXP3;GBP1;LILRB4;HOMER2
prerank,Phospholipid Transport (GO:0015914),0.27171746489158777,0.8582485804472423,0.7317073170731707,1.0,1.0,9/56,12.51%,ATP8B1;APOC1;ATP9A;TNFAIP8L3;PRELID2;ATP9B;SCP2;ATP10B;NPC2
prerank,fatty-acyl-CoA Biosynthetic Process (GO:0046949),0.3166812629432671,0.8580564192526009,0.6571428571428571,1.0,1.0,1/24,0.13%,ELOVL7
prerank,Regulation Of Behavior (GO:0050795),-0.34132575084463,-0.857099179639192,0.6078431372549019,1.0,1.0,4/18,13.64%,MBD5;ZFHX3;NR1D1;HOXA1
prerank,Positive Regulation Of TOR Signaling (GO:0032008),-0.2929597890726578,-0.8570408761958238,0.6538461538461539,1.0,1.0,12/45,22.49%,HTR6;GPR137;LARS1;PIK3CA;PIP4P1;SMCR8;LIN28A;RICTOR;GPR137C;SEH1L;FNIP1;WDR24
prerank,Actin Cytoskeleton Reorganization (GO:0031532),-0.28712188269333283,-0.857036022463217,0.7407407407407407,1.0,1.0,3/51,2.40%,CXADR;INSRR;AUTS2
prerank,Activation Of Phospholipase C Activity (GO:0007202),0.339673719653405,0.856779999162834,0.72,1.0,1.0,6/25,16.69%,CD86;P2RY6;RASGRP4;HTR2B;PHB1;AVPR1A
prerank,Cellular Response To Molecule Of Bacterial Origin (GO:0071219),0.23388084332086048,0.8563137158101168,0.8275862068965517,1.0,1.0,19/112,13.72%,CXCL13;CD86;MAPK8;SIRPA;CTSG;LY96;CX3CR1;CD80;AXL;PYCARD;LILRB1;NOD2;PDCD1LG2;NLRP3;TLR2;CD180;TLR4;LDOC1;CARD17P
prerank,Negative Regulation Of Translation (GO:0017148),-0.2582630559827578,-0.8553784698187893,0.7049180327868853,1.0,1.0,20/106,21.16%,RBM24;IGF2BP1;ENC1;TNRC6B;NANOS2;CNOT1;CELF1;GZMB;METTL16;IGFBP5;PCIF1;LIN28A;GRB7;YTHDF3;DHX36;DDX6;PAIP2;MRPL13;AGO4;FXR1
prerank,Cholesterol Transport (GO:0030301),-0.2942447529807218,-0.8550338644780412,0.6545454545454545,1.0,1.0,8/48,9.82%,MSR1;APOA1;NPC1L1;ABCA8;ABCA5;CES1;NPC1;ABCG1
prerank,Positive Regulation Of Protein Binding (GO:0032092),0.2750715988305424,0.8549013669831083,0.8461538461538461,1.0,1.0,9/56,12.71%,DACT1;BMP4;HFE;BLK;TRIB3;TIAM1;FKBP1A;DTX3L;AKTIP
prerank,Regulation Of Insulin Receptor Signaling Pathway (GO:0046626),0.2822025031935154,0.8547857366151864,0.6428571428571429,1.0,1.0,11/42,16.54%,ZBTB7B;PTPN2;SLC27A4;ENPP1;ERFE;GRB10;GSK3A;PID1;KANK1;GRB14;TNS2
prerank,Cellular Response To Hexose Stimulus (GO:0071331),0.32922331119909337,0.8545535688624474,0.7446808510638298,1.0,1.0,8/25,19.55%,KCNB1;SLC39A14;GPER1;SLC2A5;ZBTB20;RACK1;UCP2;TRA2B
prerank,Protein Deacetylation (GO:0006476),0.2954181654294364,0.8541978177190303,0.6666666666666666,1.0,1.0,13/39,25.99%,TBL1XR1;HDAC2;HDAC11;SIRT5;HDAC10;GATAD2B;SIRT6;HDAC9;SUDS3;HDAC5;HDAC1;RBBP4;TBL1X
prerank,T Cell Differentiation (GO:0030217),-0.2776614389300255,-0.8541880599107468,0.7017543859649122,1.0,1.0,11/45,17.60%,GLI3;SOX4;TCF7;PIK3R1;PIK3R3;SOX13;GPR89A;PTPN22;GPR89B;ZFP36L2;FADD
prerank,Positive Regulation Of Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0090100),-0.27983048065174,-0.854063915229409,0.7857142857142857,1.0,1.0,20/88,17.57%,THBS1;MSTN;TGFB2;ACVRL1;KIAA0319;PPARG;CRB2;INHBE;GDF15;ACVR1B;CDKN1C;ZEB2;EP300;CREBBP;BMP2;CITED1;ADAM17;JAK2;SNW1;BMPR2
prerank,Positive Regulation Of Cellular Response To Transforming Growth Factor Beta Stimulus (GO:1903846),-0.3166243175924184,-0.8538262634727697,0.6481481481481481,1.0,1.0,8/24,20.33%,THBS1;CDKN1C;ZEB2;EP300;CREBBP;CITED1;SNW1;ING2
prerank,Positive Regulation Of Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0030511),-0.3166243175924184,-0.8538262634727697,0.6481481481481481,1.0,1.0,8/24,20.33%,THBS1;CDKN1C;ZEB2;EP300;CREBBP;CITED1;SNW1;ING2
prerank,Aerobic Electron Transport Chain (GO:0019646),0.2561166413701353,0.853820614669654,0.7777777777777778,1.0,1.0,36/65,34.98%,COX15;NDUFA9;NDUFB3;SDHAF2;NDUFC1;NDUFS7;NDUFB10;NDUFS2;NDUFB2;NDUFAF1;NDUFB5;NDUFC2;NDUFA6;UQCR10;UQCRB;NDUFB4;NDUFB8;UQCRHL;UQCRH;COX7C;NDUFA8;SDHC;UQCR11;UQCRQ;NDUFS5;NDUFB6;COX5A;COX6A1;NDUFS4;NDUFS8;COX6C;COX6A2;UQCRC2;COX4I1;UQCRC1;NDUFB1
prerank,Cellular Response To Tumor Necrosis Factor (GO:0071356),-0.25235721982488,-0.8534264362071095,0.746031746031746,1.0,1.0,23/112,17.65%,CCL7;CCL22;XCL1;CXCL8;CHI3L1;CCL14;TRAF6;LRRK2;CARD14;NFKBIA;ZC3H12A;BRCA1;CCL2;NFE2L2;NR1D1;PYDC1;TNFSF18;ZFP36L2;TRAF4;JAK2;SIRT1;CCL25;CCL16
prerank,ERBB Signaling Pathway (GO:0038127),0.2971477965239787,0.8533804788610645,0.6666666666666666,1.0,1.0,12/50,18.32%,HBEGF;FAM83B;PIGR;NCK2;FAM83A;PTK2;TGFA;SOS1;PTK6;AKT1;CBL;MVP
prerank,Acetylcholine Receptor Signaling Pathway (GO:0095500),0.33722743085126666,0.852857209579447,0.6122448979591837,1.0,1.0,2/21,2.65%,CHRNA3;CHRNA7
prerank,Double-Strand Break Repair (GO:0006302),0.2256200568534048,0.8528219457652051,0.8461538461538461,1.0,1.0,47/167,23.92%,RMI2;EXD2;EME2;CDCA5;EME1;NHEJ1;TRIP13;RBBP8;RAD54B;CHEK2;INIP;NSMCE1;DTX3L;TONSL;EYA1;SLF1;POLL;MUS81;ERCC1;RAD51AP1;RECQL4;H2AX;RPA2;SAMHD1;VCP;REV3L;DCLRE1C;RPA3;ATP23;INTS3;AP5S1;SEM1;ATM;APLF;RAD52;PRPF19;AUNIP;SFPQ;SIRT6;TOP3A;NABP1;TP53BP1;PPP5C;RNF8;ZSWIM7;PARP3;EYA3
prerank,Negative Regulation Of Lymphocyte Activation (GO:0051250),0.32734600114597956,0.8527410718637305,0.7105263157894737,1.0,1.0,7/23,13.69%,CTSG;TIGIT;FOXJ1;TNFAIP8L2;LST1;JAK3;SOX11
prerank,DNA Catabolic Process (GO:0006308),0.35460161991025896,0.8527112609637533,0.66,1.0,1.0,8/18,25.27%,ENDOG;TREX2;CECR2;MUS81;ISG20;DFFB;REXO4;DNASE1L2
prerank,Regulation Of Cell Morphogenesis (GO:0022604),-0.32299177057362405,-0.8526514285114927,0.6779661016949152,1.0,1.0,3/30,3.49%,SH3D19;VIL1;ZNF135
prerank,Fatty Acid Catabolic Process (GO:0009062),0.26866566021819005,0.8523518222184752,0.6818181818181818,1.0,1.0,20/61,28.20%,ADIPOQ;SLC27A4;MCAT;ECI2;SCP2;LPIN3;ACADM;AIG1;ECHS1;HADHB;ACOX1;ABCD3;DECR1;LPIN2;ACAT1;ECI1;HAO1;SLC25A17;HSD17B4;ACADS
prerank,Negative Regulation Of DNA Binding (GO:0043392),-0.32308742257428585,-0.852167745897864,0.673469387755102,1.0,1.0,13/28,32.13%,MSX2;NFKBIA;HEY2;HEY1;TNKS;JAK2;HMGA2;GATA1;RSF1;SUMO3;ILRUN;SUMO1;TFAP4
prerank,Detection Of Visible Light (GO:0009584),0.3496379575775715,0.8521337824149544,0.6666666666666666,1.0,1.0,3/16,6.84%,CACNA2D4;CNGB1;EYS
prerank,Negative Regulation Of Protein Polymerization (GO:0032272),0.31484779690329007,0.851761679711967,0.7647058823529411,1.0,1.0,9/24,21.26%,SNCA;CLIP3;KANK1;EML2;MYADM;TWF2;KANK4;MAP2;PFN1
prerank,Defense Response To Gram-positive Bacterium (GO:0050830),0.26486699234026395,0.851754986253948,0.6590909090909091,1.0,1.0,15/73,17.80%,H2BC12;HLA-A;LCE3C;MR1;CTSG;GBP6;LYG2;PLA2G1B;TLR2;RNASE6;LYZ;MPEG1;GBP4;RNASE3;GBP2
prerank,Gluconeogenesis (GO:0006094),-0.3276926653312602,-0.851555960340076,0.6909090909090909,1.0,1.0,2/32,3.19%,KRT17;PGK2
prerank,Endosome Transport Via Multivesicular Body Sorting Pathway (GO:0032509),0.3466743830115975,0.8509738352947931,0.7073170731707317,1.0,1.0,4/23,17.35%,CHMP4C;MVB12A;VCP;TMEM50B
prerank,rRNA Catabolic Process (GO:0016075),-0.3525425979814328,-0.8508481779769883,0.6379310344827587,1.0,1.0,11/19,31.61%,EXOSC3;EXOSC6;EXOSC10;DIS3;DIS3L;EXOSC9;SLFN13;SLFN12;ZCCHC7;TRIR;EXOSC2
prerank,Positive Regulation Of Hydrolase Activity (GO:0051345),-0.24841183257369562,-0.8508101673274551,0.7611940298507462,1.0,1.0,17/168,8.08%,CCL7;BCAR3;WNT11;CCL22;RGL4;HRAS;ADRB1;XCL1;CCL14;APOA1;RAPGEF4;RAPGEF5;RGS1;FZD10;DOCK7;LARS1;RGS11
prerank,Regulation Of calcineurin-NFAT Signaling Cascade (GO:0070884),-0.32381685126862453,-0.850361089894812,0.6666666666666666,1.0,1.0,5/32,7.91%,CLEC7A;IGF1;STIMATE;PPP3CA;PRNP
prerank,Cell-Substrate Junction Assembly (GO:0007044),-0.351567695907205,-0.849986759776439,0.6744186046511628,1.0,1.0,9/28,18.00%,PEAK1;ITGB4;ACTN3;SRC;WHAMM;THY1;CDH11;SORBS1;COL17A1
prerank,Nucleic Acid-Templated Transcription (GO:0097659),-0.32571809382576,-0.8497327320527318,0.7666666666666667,1.0,1.0,5/39,9.04%,PAX8;NR4A2;MLF1;TERT;TOPORS
prerank,Endocytosis (GO:0006897),0.2070985131086846,0.8494362363662176,0.9615384615384616,1.0,1.0,36/182,17.62%,CEACAM4;CLEC9A;TMEM108;MYO1E;MYCBPAP;ATP9A;DNER;MERTK;AXL;P2RY6;CD36;SCARF1;ADORA2A;NCKIPSD;LRP3;ATP9B;MET;ARHGAP27;ASGR1;CTTN;AMPH;M6PR;PLD4;RABEPK;TLR4;DAB2;AP3M2;CUBN;SNX18;IL10RA;JMJD6;CORO1A;RINL;INSR;SYP;LDLRAP1
prerank,Clathrin-Dependent Endocytosis (GO:0072583),0.2953067318727516,0.8494174356611393,0.631578947368421,1.0,1.0,2/27,2.62%,ITSN1;SIGLEC1
prerank,Regulation Of G Protein-Coupled Receptor Signaling Pathway (GO:0008277),0.2750992061917296,0.8493254062395365,0.6666666666666666,1.0,1.0,16/66,15.95%,GNG4;RGS16;PDE6G;SLC24A4;FRMPD1;RGS14;SLC39A14;GUCY2D;RASGRP4;KLK5;RPGRIP1L;GPER1;NMT1;PHB1;PPP1R9B;GRK6
prerank,Response To BMP (GO:0071772),0.32544979457130413,0.8492723577846183,0.6666666666666666,1.0,1.0,7/20,22.27%,BMP4;SFRP1;ACVR2A;BMP6;SMAD9;ADAMTS7;RUNX2
prerank,Regulation Of Embryonic Development (GO:0045995),-0.28984723510155525,-0.8492496661630707,0.6617647058823529,1.0,1.0,17/61,26.11%,RPS6KA6;OTX2;PLCB1;CRB2;PHLDB1;CCSAP;MBIP;DHX36;LHX1;KAT14;INO80D;SEPTIN7;CLASP1;INO80;YEATS2;NPHP3;PHLDB2
prerank,Protein N-linked Glycosylation (GO:0006487),-0.28357776162051407,-0.8488312242572357,0.78125,1.0,1.0,5/61,3.85%,FUT9;GFPT2;MGAT2;FUT6;MGAT1
prerank,Regulation Of Transport (GO:0051049),0.27540740912375056,0.8487913763169808,0.7878787878787878,1.0,1.0,14/44,21.56%,USP6;WWC1;SNCA;CDK5;DISP3;TRAT1;PLD1;ACTG1;LYSET;RAB25;ARL6IP5;DNAJA1;ICA1L;RAB11A
prerank,Negative Regulation Of Cytokine Production Involved In Inflammatory Response (GO:1900016),0.3290818248076076,0.8486610366848091,0.64,1.0,1.0,5/19,15.39%,SIRPA;F2;PYCARD;LILRB4;CUEDC2
prerank,Cellular Response To Ionizing Radiation (GO:0071479),-0.29100546977582975,-0.8485226277660741,0.6964285714285714,1.0,1.0,12/51,22.54%,HRAS;CDKN1A;DEPDC1B;BRCA1;GADD45A;YAP1;WRN;SIRT1;BLM;TLK2;NUCKS1;TNKS1BP1
prerank,T Cell Receptor Signaling Pathway (GO:0050852),0.24358163621377632,0.8483620028064355,0.7317073170731707,1.0,1.0,32/88,28.28%,HLA-A;IKBKG;HLA-DRB1;MAP3K7;TRGC2;MOG;CSK;TRBC1;CD8B;SPPL3;HLA-DPA1;BTN3A2;IKBKB;BTN2A2;BTN2A1;GATA3;RBCK1;CD3D;LCK;FYN;CD276;STOML2;CTLA4;ICOSLG;TXK;PTPRC;RNF31;BTN3A3;CD3G;EIF2B4;FCHO1;PLCG1
prerank,Regulation Of Cell Death (GO:0010941),0.28759252710989797,0.848090742051822,0.7941176470588235,1.0,1.0,7/53,9.07%,HBA1;CHMP4C;CHRNA7;HP;SNCA;PRODH;CASP6
prerank,Myeloid Cell Differentiation (GO:0030099),0.279337829278298,0.847595516664783,0.7619047619047619,1.0,1.0,8/56,10.33%,CDKN2B;SLC1A5;PTPN2;PRDX3;CEBPE;RASGRP4;RACGAP1;MFHAS1
prerank,Cell Junction Organization (GO:0034330),-0.2857141482258364,-0.8475702447877529,0.7037037037037037,1.0,1.0,3/57,1.48%,CXADR;SLC6A1;TGFB2
prerank,Nucleotide-Sugar Biosynthetic Process (GO:0009226),-0.3562841127332206,-0.8474488390851737,0.7090909090909091,1.0,1.0,1/15,1.02%,GFPT2
prerank,Negative Regulation Of Chemotaxis (GO:0050922),-0.33617869810492285,-0.8473335522403199,0.7090909090909091,1.0,1.0,3/30,1.24%,SEMA3C;SEMA3F;THBS1
prerank,Protein Glycosylation (GO:0006486),0.22459117216107313,0.8463469569458354,0.8571428571428571,1.0,1.0,10/137,7.28%,B3GNT5;GAL3ST1;SERP2;ST6GALNAC1;B3GNT3;ALG3;B3GALT9;GALNT9;ST8SIA1;MAN1C1
prerank,Response To Interferon-Beta (GO:0035456),0.2944497144005925,0.8462541237396621,0.6571428571428571,1.0,1.0,12/28,30.37%,IFITM1;PLSCR1;OAS1;BST2;IFITM2;MNDA;IFNB1;IKBKE;IFNAR1;IFNAR2;IFITM3;CAMK2A
prerank,Positive Regulation Of Locomotion (GO:0040017),-0.31663274536878727,-0.8447943550586271,0.6229508196721312,1.0,1.0,8/28,16.26%,THBS1;DUOX2;CSF1R;RARRES2;SPOCK2;P2RY12;NTN1;DUOX1
prerank,Positive Regulation Of miRNA Metabolic Process (GO:2000630),-0.28619130856583236,-0.8447789367213158,0.7719298245614035,1.0,1.0,8/49,13.14%,PRL;TGFB2;HRAS;PPARG;TERT;ZC3H12A;NGFR;APLN
prerank,Cellular Response To Alkaloid (GO:0071312),-0.37931543562756653,-0.844621327894823,0.5957446808510638,1.0,1.0,4/15,12.15%,CASQ2;TRPV1;SLC8A1;CASP7
prerank,Regulation Of Viral Entry Into Host Cell (GO:0046596),0.2717768484447827,0.8443176163354441,0.8,1.0,1.0,4/38,8.05%,HLA-DRB1;TRIM5;IFITM1;LGALS9
prerank,Lysosomal Lumen Acidification (GO:0007042),0.32578473416536985,0.8441618263162033,0.7073170731707317,1.0,1.0,8/18,35.19%,GRN;CLN5;CLN6;ATP6V0B;TCIRG1;PPT1;ATP6V0A1;ATP6V1A
prerank,Positive Regulation Of Vascular Endothelial Growth Factor Production (GO:0010575),-0.35595160409364124,-0.8440843985875217,0.7068965517241379,1.0,1.0,4/21,8.85%,IL1B;FLT4;RORA;BRCA1
prerank,Negative Regulation Of Axon Extension Involved In Axon Guidance (GO:0048843),-0.36999790244053377,-0.8438136909498476,0.6923076923076923,1.0,1.0,4/18,8.60%,SEMA3C;SEMA3F;SEMA4C;SEMA6A
prerank,Endomembrane System Organization (GO:0010256),-0.24665737612667354,-0.8437484523587735,0.8095238095238095,1.0,1.0,49/188,22.53%,ANXA8;LRRK2;MAPK15;SPTBN5;SEC31A;SPTSSB;WASHC4;ATL1;UBXN2A;GOLGA6B;GOLGA8N;ARHGAP21;GARIN4;BAG5;RAB6B;PLEKHF2;GOLGA8M;RAB30;GOLGB1;VPS18;DNAJC13;ANK3;TRIP11;LYSMD3;GOLGA8A;TRAPPC11;CSNK1D;SRGN;AP3D1;GOLGA8S;PI4K2A;DYNC2H1;EXOC8;ANXA8L1;HACE1;BNIP1;SEC16B;SYNE1;LEMD2;USP8;ARFGEF1;SEC31B;JAGN1;ATP8B4;SMPD4;GOLGA8J;PLEKHA3;PRKD1;COG1
prerank,Regulation Of SMAD Protein Signal Transduction (GO:0060390),-0.3290446391365385,-0.8434439546713327,0.7333333333333333,1.0,1.0,3/26,5.23%,PBLD;KIAA0319;PPARG
prerank,Regulation Of Protein Metabolic Process (GO:0051246),0.24843187348643414,0.8428000894676533,0.7631578947368421,1.0,1.0,18/90,18.78%,MAPK8;CNDP1;CHRNA7;KLF4;PLAUR;NEDD8;UHRF1;CHEK2;CYFIP1;RBM4B;FKBP1A;ELP5;SPOP;WFS1;GBA1;AKT1;NFKB1;PM20D2
prerank,Regulation Of Pathway-Restricted SMAD Protein Phosphorylation (GO:0060393),-0.2871575761801982,-0.8427964729553856,0.7704918032786885,1.0,1.0,7/57,9.06%,MSTN;TGFB2;SMAD6;ACVRL1;PPARG;INHBE;GDF15
prerank,Positive Regulation Of Bone Mineralization (GO:0030501),0.28580698796246057,0.8427722608369584,0.7083333333333334,1.0,1.0,11/38,20.58%,BMP4;ALOX5;CCNA2;KL;ISG15;P2RX7;ACVR2A;RXRB;BMP6;CYP27B1;MEF2C
prerank,Negative Regulation Of Cell Cycle (GO:0045786),0.2479898173260798,0.8413971405418692,0.7894736842105263,1.0,1.0,7/80,5.22%,PTPN3;BMP4;CDT1;APC;PLK1;CDKN2A;PTPRK
prerank,Negative Regulation Of Protein Secretion (GO:0050709),-0.3159703385451022,-0.8410864148612256,0.7288135593220338,1.0,1.0,7/37,12.20%,IL1B;KCNJ11;IL12A;CYP51A1;MIDN;PRKN;F2R
prerank,Cellular Response To Lipopolysaccharide (GO:0071222),-0.2488679575821261,-0.8410688536019788,0.7777777777777778,1.0,1.0,23/119,13.23%,IL1B;IL18;IRGM;CXCL8;LYN;CXCL2;TRAF6;ADAM9;GFI1;TNFAIP3;CXCL11;CXCL3;ZC3H12A;PF4V1;PDE4B;CCL2;BCL10;PLCG2;PEX2;CASP7;NR1D1;PTPN22;PPBP
prerank,Response To Fatty Acid (GO:0070542),0.3093893427917291,0.8407740183263842,0.625,1.0,1.0,7/19,22.99%,FFAR2;PDK4;PID1;NR1H4;IRS1;SCD;PPP5C
prerank,Negative Regulation Of Ion Transmembrane Transporter Activity (GO:0032413),-0.334229443836548,-0.8407168449710726,0.6666666666666666,1.0,1.0,6/21,18.46%,CASQ2;NEDD4;TCAF2;PCSK9;PRKCE;EPO
prerank,Macromolecule Biosynthetic Process (GO:0009059),0.22240658702237676,0.8404163388214527,0.9,1.0,1.0,85/181,36.15%,TYMS;EXT2;RPL34;IGF2BP3;MRPL51;RPS2;RPS4Y1;RPL41;MRPS33;RPL31;RPL14;POLL;MRPL24;GCNT1;RPL13;RPL23A;RPS4Y2;RPS24;SARS1;MRPS21;MRPS5;POLD2;GAL3ST4;ST3GAL2;MRPL18;B4GAT1;RPS6KB2;MRPS17;MRPL27;DARS1;MRPL52;MRPS18C;MRPL34;ALAS1;MRPL28;RPS15A;DHPS;RPL22;RPS3A;RPL18A;MRPS11;RPL35A;RPS27;RPS3;RPS18;EIF4G2;RPS8;RPLP2;MRPL36;RPS16;GTPBP2;POLD1;RPS5;RPS6;EEF1B2;MRPS6;MRPS15;MRPS18B;RPL4;RPS10;RPS26;RPL7A;RPS21;RPL38;RPS9;RPL26;RPL19;RPS23;MRPL23;MRPL42;RPS25;RPL32;MRPL11;RPL21;RPL10A;RPS13;RPS11;B4GALT5;RPL36;MRPL9;FAU;RPL12;RPS20;ASMT;RPL24
prerank,Positive Regulation Of Excitatory Postsynaptic Potential (GO:2000463),-0.3477105870199562,-0.840329225464962,0.7321428571428571,1.0,1.0,3/18,8.58%,SHANK1;WNT7A;RIMS1
prerank,Regulation Of Receptor Signaling Pathway Via STAT (GO:1904892),0.34378513477434613,0.8400304366331547,0.6382978723404256,1.0,1.0,4/16,15.50%,CRLF2;TSLP;JAK3;DOT1L
prerank,Negative Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071901),-0.27264353006379716,-0.8398360738126573,0.7164179104477612,1.0,1.0,20/78,17.17%,SPRY2;PKIG;IL1B;LYN;LATS2;RGS2;PPARG;CDKN1A;SLC8A1;INCA1;SH2B3;DUSP1;GADD45A;CD300A;PRKCD;CDKN1B;BMP2;PKIB;SPRY3;SIRT1
prerank,Chondrocyte Differentiation (GO:0002062),0.3026589990531113,0.8398276819037548,0.7674418604651163,1.0,1.0,6/26,16.03%,BMP4;SULF2;SLC39A14;SLC26A2;GPLD1;SOX6
prerank,Negative Regulation Of Proteasomal Protein Catabolic Process (GO:1901799),0.302073738786219,0.839753150425605,0.7368421052631579,1.0,1.0,9/35,21.36%,FHIT;MAP1A;HFE;PHF20L1;CCAR2;OPHN1;PARK7;EIF3H;LAMP3
prerank,Macromolecule Catabolic Process (GO:0009057),0.24052343374810087,0.8393124522834011,0.8378378378378378,1.0,1.0,30/84,27.42%,SIAH1;SNX25;LGMN;EXOSC5;PRSS16;TREX2;CHEK2;SLC16A3;MVB12A;CLN5;RNASEH2A;RNASE6;MUS81;EXOSC4;CLN6;RNASE3;ISG20;DFFB;APEX1;RNF5;CASP3;REXO4;CAPN3;XRN2;DNASE1L2;KIF16B;EXOSC1;USE1;RNASEH2C;TPP1
prerank,Regulation Of Nitric Oxide Biosynthetic Process (GO:0045428),-0.31782504672148765,-0.8387886956043854,0.7142857142857143,1.0,1.0,6/37,10.65%,CLEC7A;IL1B;IFNG;ASS1;ZC3H12A;EDN1
prerank,Nuclear Membrane Reassembly (GO:0031468),0.3170030040535819,0.8381754951025051,0.7407407407407407,1.0,1.0,1/23,0.98%,CHMP4C
prerank,Epidermis Development (GO:0008544),0.24997324298709733,0.8381701067070716,0.75,1.0,1.0,10/72,12.19%,EMP1;HLA-DRB1;GLI1;ATP2C1;CASP14;KRTAP5-9;ALDH3A2;HDAC2;KLK5;FLG2
prerank,Glycolipid Biosynthetic Process (GO:0009247),-0.2969445429782868,-0.8378729377876624,0.7213114754098361,1.0,1.0,10/40,12.96%,FUT9;FUT6;ST8SIA6;PGAP2;PIGA;PIGP;ST3GAL5;PIGB;TP53INP2;B4GALT6
prerank,Adenylate Cyclase-Inhibiting G Protein-Coupled Receptor Signaling Pathway (GO:0007193),-0.2900695154106927,-0.8377569594990917,0.7377049180327869,1.0,1.0,11/47,15.75%,NPY1R;RGS1;GRM7;OPRL1;PDE2A;HTR1A;CHRM4;FFAR3;P2RY12;FPR2;CHRM2
prerank,Central Nervous System Neuron Differentiation (GO:0021953),-0.33360855195758116,-0.8376030744500352,0.6981132075471698,1.0,1.0,7/25,18.16%,KNDC1;NR4A2;MAPT;PALS1;NOVA2;LHX1;MDGA1
prerank,Glutamate Receptor Signaling Pathway (GO:0007215),0.3104782795869992,0.8375335866258339,0.6666666666666666,1.0,1.0,5/31,12.27%,KCNB1;GRIK4;GRIN2D;GRIN3B;HOMER2
prerank,Regulation Of Protein Transport (GO:0051223),0.3284622490044196,0.8374000948097736,0.7692307692307693,1.0,1.0,11/28,27.84%,NDFIP2;NDFIP1;RHBDF1;HSPA8;ATP13A2;DNAJA1;SIRT6;SH3TC2;NDEL1;PPM1F;TNF
prerank,Histone Modification (GO:0016570),0.23573646258853864,0.8370496602467358,0.8823529411764706,1.0,1.0,24/79,25.99%,AURKB;TBL1XR1;ACTL6A;HDAC2;PHF20L1;ENY2;HDAC11;CARM1;CPA4;RUVBL2;GATAD2B;SIRT6;UBE2A;ING4;RUVBL1;BRD8;SUDS3;TADA3;HDAC5;HDAC1;VPS72;RBBP4;TAF6L;TBL1X
prerank,Cellular Response To Type I Interferon (GO:0071357),0.281700480570806,0.8368263167548543,0.6792452830188679,1.0,1.0,8/38,11.12%,IFNA21;IFNA10;IFIT1;IFITM1;OAS2;IFNW1;IFI27;IFNA4
prerank,Skeletal Muscle Tissue Development (GO:0007519),-0.31036289749325124,-0.8367890392098313,0.7358490566037735,1.0,1.0,5/35,7.83%,SIX4;MYL11;FOXL2;PPP3CA;MYH7B
prerank,Homologous Chromosome Segregation (GO:0045143),0.3307665767361413,0.8367097057921975,0.675,1.0,1.0,5/17,15.21%,TERB1;PRDM9;KASH5;PSMC3IP;PTTG1
prerank,Negative Regulation Of MAPK Cascade (GO:0043409),-0.2669347319704602,-0.8363890596367565,0.7941176470588235,1.0,1.0,19/99,15.25%,SPRY2;RPS6KA6;PSCA;IL1B;LYN;DUSP2;RGS2;PPARG;SPRED1;DUSP5;SEMA6A;DUSP8;SH2B3;DUSP1;CD300A;PRKCD;TIMP3;WNK2;BMP2
prerank,Plasma Membrane Repair (GO:0001778),-0.3457250382371643,-0.8358879326781706,0.68,1.0,1.0,2/21,4.72%,SYTL4;TRIM72
prerank,T Cell Activation (GO:0042110),-0.24793788432678382,-0.835747857867247,0.803030303030303,1.0,1.0,7/109,5.09%,CXADR;IFNA6;CLEC7A;IFNA7;SOX4;CASP8;PIK3R1
prerank,Ubiquitin-Dependent Protein Catabolic Process Via The Multivesicular Body Sorting Pathway (GO:0043162),-0.3078412860081793,-0.8351573555362296,0.7090909090909091,1.0,1.0,6/33,14.11%,MVB12B;NEDD4;VPS37B;TSG101;RNF115;UBAP1
prerank,Fc-gamma Receptor Signaling Pathway (GO:0038094),-0.31803406103505893,-0.8351079953181857,0.660377358490566,1.0,1.0,6/23,12.43%,LYN;YES1;SRC;FCGR2B;VAV3;PRKCD
prerank,Porphyrin-Containing Compound Biosynthetic Process (GO:0006779),0.3473463754232352,0.8348610475799394,0.8085106382978723,1.0,1.0,9/21,26.07%,COX15;ABCB6;HMBS;RSAD1;ALAS1;COX10;ALAD;CPOX;UROD
prerank,Multivesicular Body Organization (GO:0036257),0.2924053263154905,0.8346605134985868,0.7254901960784313,1.0,1.0,11/30,29.49%,CHMP4C;MVB12A;PDCD6IP;VPS36;RAB11A;CHMP2A;RAB27A;STAM2;SNF8;VPS37C;CHMP6
prerank,Regulation Of Cold-Induced Thermogenesis (GO:0120161),-0.24030356165184324,-0.8344180697811591,0.8611111111111112,1.0,1.0,31/140,17.94%,VEGFA;GATM;IL18;CIDEA;ADRB1;ACTN3;EPAS1;OXTR;GADD45G;DOCK7;IL18R1;ALDH1A1;CXCR4;ELOVL6;IL15;WNT10B;LPIN1;NOVA2;NR1D1;BMAL1;ZNF516;LGR4;IP6K1;ADAM17;KDM3A;PLCL1;JAK2;PWWP2B;PRKAB1;THRA;PRKAB2
prerank,Protein Localization To Cell Periphery (GO:1990778),0.2251808070959569,0.8341632978915825,0.8709677419354839,1.0,1.0,31/132,21.91%,RAB3B;KCNB1;TSPAN5;CDH1;ADIPOQ;ZDHHC23;PACSIN1;PRPH2;TTC7B;NKD2;RAB10;RAB40B;ANK1;JUP;ZDHHC22;RAB3D;ARL3;MYADM;IKBKB;WNK3;FLOT1;SPTBN4;TSPAN14;DPP6;RAMP3;WDR19;TTC7A;ITGB1BP1;EPHA2;RAB11A;RAPGEF6
prerank,Regulation Of Mitochondrial Membrane Potential (GO:0051881),-0.3093150447097369,-0.8340619625864684,0.7288135593220338,1.0,1.0,9/39,17.74%,STOX1;PIP5KL1;LRRK2;MAPT;SLC25A36;ABL1;MTLN;PMAIP1;RTL10
prerank,Negative Regulation Of Transport (GO:0051051),0.2739375746437553,0.8336038796228934,0.65,1.0,1.0,5/37,7.81%,SNCA;NDFIP2;NDFIP1;LILRB1;TRAT1
prerank,Regulation Of Macromolecule Biosynthetic Process (GO:0010556),-0.2769781875256767,-0.8335259970901309,0.7580645161290323,1.0,1.0,19/51,32.23%,DDX25;JADE3;PCIF1;DUS3L;RB1CC1;KAT7;MITF;ING5;TSC1;RBM3;PUM3;GATA1;ELP4;ULK1;MSI2;METAP1;MED1;ELP1;ELP2
prerank,Regulation Of Chemotaxis (GO:0050920),-0.3252306413467216,-0.8333020604003217,0.711864406779661,1.0,1.0,5/27,12.72%,THBS1;CXCR4;RARRES2;NOVA2;P2RY12
prerank,Heart Contraction (GO:0060047),-0.29596802460555827,-0.8332358451180512,0.7,1.0,1.0,6/39,8.26%,CASQ2;SCN5A;ATP1A2;MYL7;SLC8A1;SCN3B
prerank,Transcription By RNA Polymerase II (GO:0006366),-0.23071906848052498,-0.8329264205947321,0.8823529411764706,1.0,1.0,59/186,26.26%,GCM1;CEBPD;PPARG;FOXE3;MED26;C5AR1;CCNT1;TAF5;GLIS3;RPRD1B;ELL2;PAX5;TAF1A;TAF13;ZBTB1;ELOA;HSF2BP;FOXE1;TAF1C;PEX2;RPRD1A;GTF2A1L;TBPL1;NCOA1;TRIP11;TAF7;MNT;GMEB2;ERCC3;RREB1;MED27;CDK9;NCBP3;THRA;LHX1;TSC22D1;COPS2;CCNH;CDC73;POLR2B;SETX;GTF2H2;NCOA2;CCNT2;POLR2D;E2F3;SNAPC4;POLR2C;ELP4;ARRB2;SNAPC1;ELOB;GTF2B;DEK;NFIC;SUPT5H;MNAT1;TCFL5;NR1H2
prerank,Dopamine Metabolic Process (GO:0042417),-0.33954281885354143,-0.8328761194688918,0.660377358490566,1.0,1.0,3/17,9.30%,TGFB2;TH;PRKN
prerank,Regulation Of Synaptic Vesicle Exocytosis (GO:2000300),0.3242517496649952,0.8322961258665204,0.8421052631578947,1.0,1.0,4/17,12.27%,SYN1;RIMS2;SEPTIN5;SNAPIN
prerank,Regulation Of Vascular Associated Smooth Muscle Cell Proliferation (GO:1904705),-0.3097951392069656,-0.8322623287698414,0.7049180327868853,1.0,1.0,9/36,14.87%,NR4A3;FGF9;IGF1;PPARG;CDKN1A;MEF2D;APLN;IGFBP5;CDKN1B
prerank,Placenta Development (GO:0001890),-0.32964757723181454,-0.8322029684033322,0.6326530612244898,1.0,1.0,5/20,15.44%,PLAC1;PPARG;ANG;APELA;CITED1
prerank,GPI Anchor Biosynthetic Process (GO:0006506),-0.32424939524016516,-0.8321987675638667,0.7777777777777778,1.0,1.0,12/29,26.46%,PGAP2;PIGA;PIGP;PIGB;TP53INP2;MPPE1;GPAA1;PIGL;PIGH;DPM1;PIGW;PIGS
prerank,Lipid Catabolic Process (GO:0016042),-0.3174058551279584,-0.8319698410782415,0.6727272727272727,1.0,1.0,5/19,13.35%,PNLIPRP1;CES1;AOAH;PLA1A;CYP3A4
prerank,Mitotic Nuclear Division (GO:0140014),0.27774137644092073,0.8318335460487772,0.7666666666666667,1.0,1.0,7/45,9.82%,SGO1;UBE2C;ESPL1;PLK1;EPS8;KLHDC8B;ZWINT
prerank,Regulation Of Release Of Sequestered Calcium Ion Into Cytosol By Sarcoplasmic Reticulum (GO:0010880),-0.34799546897228073,-0.8318249187940805,0.6346153846153846,1.0,1.0,3/21,7.29%,CASQ2;ATP1A2;SLC8A1
prerank,Positive Regulation Of Cell-Cell Adhesion (GO:0022409),0.2662178872976919,0.8313654500040376,0.7884615384615384,1.0,1.0,6/42,12.11%,CXCL13;PLAUR;FSTL3;CX3CL1;TNFSF11;SIRPG
prerank,Positive Regulation Of ERBB Signaling Pathway (GO:1901186),-0.3239140164256544,-0.8310323707106048,0.5806451612903226,1.0,1.0,2/23,2.66%,BCAR3;NUP62
prerank,Regulation Of Cell Cycle G1/S Phase Transition (GO:1902806),0.25674669581187903,0.8309523638834335,0.8157894736842105,1.0,1.0,13/71,17.37%,CDKN2B;GLI1;APC;CDKN2A;KIF14;PTPN6;ACTL6A;MN1;DPF3;METTL13;PSME2;TM4SF5;SMARCB1
prerank,Regulation Of NIK/NF-kappaB Signaling (GO:1901222),0.23835748536692927,0.8303543693593453,0.8571428571428571,1.0,1.0,20/81,19.17%,CD86;MYO1C;TNFSF14;LIMS1;CD27;PYCARD;LGALS9;NOD2;UACA;RASSF2;NLRP3;TLR2;ILK;TLR4;PHB1;PYDC2;IFI35;TMSB4X;TRADD;TRIP6
prerank,Regulation Of Organelle Organization (GO:0033043),0.23407228833790186,0.8302591322723717,0.8709677419354839,1.0,1.0,12/100,12.14%,CAMSAP3;CAPN6;S100A8;SYDE1;TMED9;PLXNB1;PDCD10;CAMSAP2;S100A9;PTK2;ARL6IP1;TFPT
prerank,Regulation Of Aerobic Respiration (GO:1903715),-0.3519893784123759,-0.8301495971112334,0.7021276595744681,1.0,1.0,2/16,4.40%,COX7A2;ACTN3
prerank,DNA-templated Transcription (GO:0006351),-0.23346186539322789,-0.8291857122391793,0.9154929577464789,1.0,1.0,58/192,26.25%,GCM1;PAX8;NR4A2;MLF1;CEBPD;FOXE3;CCNT1;TAF5;GLIS3;PAX5;TOPORS;TAF1A;TAF13;TBPL2;HSF2BP;FOXE1;TAF1C;MEF2A;GTF2A1L;TBPL1;SMARCA5;TWNK;TRIP11;TFB2M;TAF7;MNT;GMEB2;EPC1;ZFP36L2;ERCC3;RREB1;SPTY2D1;CDK9;THRA;LHX1;TSC22D1;COPS2;CCNH;POLR2B;SETX;XAB2;GTF2H2;ZFP36L1;EREG;CCNT2;POLR2D;POLR2C;RSF1;ARRB2;DIDO1;SMN1;GTF2B;GTF3C4;DEK;MTERF1;NFIC;MNAT1;TCFL5
prerank,Synaptic Vesicle Exocytosis (GO:0016079),-0.3109071390979605,-0.828750396318176,0.7678571428571429,1.0,1.0,6/39,8.58%,SNAP25;STX1A;DOC2B;PRRT2;CPLX1;RIMS1
prerank,Aorta Morphogenesis (GO:0035909),-0.3547390958735278,-0.8283506274235282,0.7321428571428571,1.0,1.0,7/16,26.96%,HEY2;HEY1;TGFBR2;MYLK;LRP1;PROX1;ENG
prerank,Regulation Of Stress-Activated MAPK Cascade (GO:0032872),0.2674837958483977,0.8282108418952434,0.7727272727272727,1.0,1.0,7/51,9.50%,EPHB1;SCIMP;MYC;F2RL1;PDCD10;LGALS9;NOD2
prerank,Protein Homooligomerization (GO:0051260),0.22532445713968277,0.8281821108202083,0.9411764705882353,1.0,1.0,37/121,25.26%,NOL3;RYR1;STEAP4;SLC1A5;IKZF4;AMH;HLA-G;PYCARD;RYR3;TK1;SLC1A2;CBY1;NLRP3;APIP;CBR4;PDCD6IP;FOXM1;SAMHD1;KCNC2;PRMT1;SIGMAR1;JMJD6;SHMT1;ECT2;ACOT13;ELAVL1;BEND3;TRMT61B;GSDMD;TP53BP1;CHMP2A;ALDH9A1;EHD3;SPAST;ALAD;PRF1;THG1L
prerank,Sulfur Compound Transport (GO:0072348),-0.3268075143658937,-0.8280972324564942,0.68,1.0,1.0,3/21,6.63%,SLC19A3;SLC26A1;SLC22A1
prerank,Positive Regulation Of Establishment Of Protein Localization (GO:1904951),0.3351028483447669,0.827373068537198,0.7321428571428571,1.0,1.0,8/17,28.86%,CENPJ;CCT5;DKC1;CCT7;CCT4;CCT3;TNF;CEP135
prerank,Mitochondrial Fusion (GO:0008053),0.3117870661604281,0.8270243284242765,0.6326530612244898,1.0,1.0,9/18,26.71%,PLD6;MFN1;STOML2;BCL2A1;MIGA2;THG1L;MFN2;RCC1L;MCL1
prerank,Positive Regulation Of Granulocyte Chemotaxis (GO:0071624),0.2954976134496807,0.8269773070087555,0.7,1.0,1.0,6/20,14.00%,IL4;CCR7;RAC2;MOSPD2;S100A14;RIPOR2
prerank,Regulation Of Cellular Response To Transforming Growth Factor Beta Stimulus (GO:1903844),-0.31965481797132905,-0.8267350469079794,0.7692307692307693,1.0,1.0,5/23,13.32%,LATS2;PPARG;PALS1;SMURF2;DKK3
prerank,Regulation Of Mitochondrial Outer Membrane Permeabilization Involved In Apoptotic Signaling Pathway (GO:1901028),0.3197439288172919,0.8264952350442539,0.6888888888888889,1.0,1.0,6/18,23.77%,HSPA1A;SLC25A4;GSK3A;SLC25A5;TMEM14A;SLC25A6
prerank,Double-Strand Break Repair Via Homologous Recombination (GO:0000724),0.21802566633502957,0.8259518466042647,0.8857142857142857,1.0,1.0,29/110,20.10%,RMI2;EXD2;MCM4;GINS2;RBBP8;RAD54B;INIP;NSMCE1;TONSL;SLF1;POLL;MUS81;RAD51AP1;RECQL4;GINS4;RPA2;SAMHD1;REV3L;RPA3;INTS3;AP5S1;SEM1;CDC45;FANCM;MCM3;RAD52;RAD21L1;AUNIP;SFPQ
prerank,Vesicle Cargo Loading (GO:0035459),0.29501882497998044,0.825758364976547,0.7692307692307693,1.0,1.0,5/23,14.72%,CTAGE6;KIF13A;CTAGE9;TBC1D20;SEC24D
prerank,Positive Regulation Of Alpha-Beta T Cell Proliferation (GO:0046641),0.329498459778616,0.824929739225793,0.6875,1.0,1.0,3/17,8.05%,HLA-A;EBI3;LGALS9
prerank,Response To Ionizing Radiation (GO:0010212),0.2549198428808846,0.8248971025796251,0.7894736842105263,1.0,1.0,20/72,23.92%,MYC;TICRR;BRAT1;NHEJ1;FIGNL1;INIP;EYA1;RAD51AP1;H2AX;INTS7;RHNO1;INTS3;MEN1;ATM;ECT2;SLC6A2;MSH2;NABP1;RNF8;EYA3
prerank,mRNA Splice Site Recognition (GO:0006376),-0.30974021649794437,-0.8248736223573082,0.7407407407407407,1.0,1.0,3/29,8.19%,CELF4;LUC7L2;CELF5
prerank,Regulation Of Telomere Maintenance (GO:0032204),0.2720983753199494,0.8248515831169897,0.717391304347826,1.0,1.0,7/38,20.29%,MYC;PIF1;NSMCE1;SLF1;ERCC1;TINF2;SIRT6
prerank,Positive Regulation Of Transcription By RNA Polymerase I (GO:0045943),-0.3023560437019398,-0.824561084695379,0.7884615384615384,1.0,1.0,17/32,37.99%,WDR75;UTP15;SF3B1;SMARCA5;NOL11;WDR43;DEK;HEATR1;ATF4;MYBBP1A;UBTFL1;EIF2AK3;DDX21;LYAR;ERBB2;ERCC6;PHF8
prerank,Regulation Of Cellular Senescence (GO:2000772),0.2874120398864275,0.8244481408024845,0.7272727272727273,1.0,1.0,4/35,6.10%,TWIST1;VASH1;AMH;HLA-G
prerank,Regulation Of Mitochondrial Translation (GO:0070129),0.3039938779878786,0.8235495766337162,0.6904761904761905,1.0,1.0,5/22,13.23%,UQCC2;RMND1;COA3;RPUSD3;C1QBP
prerank,Response To Nutrient Levels (GO:0031667),0.2766220740474395,0.8234803620190997,0.7735849056603774,1.0,1.0,4/32,7.16%,KCNB1;SCTR;GH1;MEAK7
prerank,Calcium Ion Transmembrane Import Into Cytosol (GO:0097553),-0.25422169837115416,-0.8232677861463462,0.8035714285714286,1.0,1.0,14/77,12.20%,SCN5A;SCN4A;XCL1;TRPV3;PLCB1;TRPV1;PLCH2;SLC8A1;PLCE1;CACNA1A;PLCB4;PLCD1;PLCG2;F2R
prerank,Oligodendrocyte Differentiation (GO:0048709),-0.34552419120880046,-0.8219749097695482,0.5833333333333334,1.0,1.0,7/19,24.84%,SOX13;TPPP;SOX8;ZNF488;EIF2B2;MYRF;EIF2B3
prerank,Keratan Sulfate Metabolic Process (GO:0042339),-0.3839843464294152,-0.8212457465807066,0.7083333333333334,1.0,1.0,4/16,9.13%,CHST5;CHST6;B4GALT4;ST3GAL3
prerank,Regulation Of Microtubule Cytoskeleton Organization (GO:0070507),0.28058206967188154,0.8211331780776109,0.76,1.0,1.0,4/39,5.21%,CAMSAP3;EFNA5;TRIM36;CDK2AP2
prerank,mRNA Transcription By RNA Polymerase II (GO:0042789),-0.30996443002727603,-0.8211051850928817,0.711864406779661,1.0,1.0,9/37,17.86%,PPARG;FOXE3;C5AR1;TAF5;TAF13;ZBTB1;NCOA1;TAF7;NCBP3
prerank,Protein Transport (GO:0015031),0.19773625461532413,0.8209674514404878,1.0,1.0,1.0,64/302,23.65%,ARL11;RAB3B;RAB31;ARRDC5;MON1A;CENPF;RAB38;RD3;CTAGE6;KIF13A;GOLPH3L;TMED9;CTAGE9;LMAN2L;RAB10;RAB28;CD36;OLFM2;CTSA;USO1;ARL5C;STEAP3;CTTN;YWHAH;PDIA4;SNX27;PDCD6;UNC93B1;RAB3D;RAB1B;CALCRL;VMP1;SCAMP5;SNX1;SNX18;MYH9;TANGO2;IL10RA;ACD;MEN1;TIMM50;PAM16;SEC23IP;ARL17A;HIKESHI;SNX31;RAMP3;ARL6IP5;DNAJC15;COG7;SNX6;RIC1;MIA2;BBS1;BBS2;UNC119;STX12;PREB;GSDMD;HERC2;SIL1;SLC10A7;CHMP2A;TOM1
prerank,Muscle Tissue Morphogenesis (GO:0060415),0.32635534731803933,0.8209549814394701,0.6888888888888889,1.0,1.0,6/16,16.16%,BMP4;NOTCH1;MYLK2;TCAP;TTN;TBX1
prerank,Positive Regulation Of Transport (GO:0051050),-0.2825093436452248,-0.820933401368451,0.6956521739130435,1.0,1.0,3/50,3.86%,SCIN;CALY;DOC2B
prerank,intra-Golgi Vesicle-Mediated Transport (GO:0006891),-0.28557364609419195,-0.8203233591914365,0.7192982456140351,1.0,1.0,4/33,11.51%,RAB6C;RAB6B;GOSR1;RAB6D
prerank,Negative Regulation Of Viral Genome Replication (GO:0045071),0.25912709586527577,0.8199499731471008,0.8095238095238095,1.0,1.0,15/53,20.48%,APOBEC3D;IFIT1;RSAD2;IFITM1;OAS2;PLSCR1;OAS1;ISG15;BST2;APOBEC3B;IFITM2;ISG20;OAS3;BANF1;IFNB1
prerank,RNA Export From Nucleus (GO:0006405),-0.2755681382862779,-0.8194959789241496,0.7575757575757576,1.0,1.0,10/63,21.00%,DDX25;NUP62;DDX39A;NXT1;THOC3;NXF5;UPF1;NCBP3;DDX19B;NUP133
prerank,Positive Regulation Of Protein Transport (GO:0051222),-0.2615489979225199,-0.8191841740137376,0.7450980392156863,1.0,1.0,6/68,7.03%,TGFB2;SYTL4;IGF1;CD33;ADAM9;ANG
prerank,Positive Regulation Of Fibroblast Proliferation (GO:0048146),0.2876606416036871,0.8190186527137459,0.6808510638297872,1.0,1.0,6/27,12.45%,MYC;CDK4;AMH;PLA2G1B;S100A6;PDGFA
prerank,Connective Tissue Development (GO:0061448),-0.2938654088699131,-0.8185950832228063,0.6779661016949152,1.0,1.0,8/35,16.79%,CHI3L1;ZBTB16;COL11A2;RORC;TRIP11;ZNF516;PGRMC2;SOX8
prerank,Protein Localization To Lysosome (GO:0061462),0.27358345122260747,0.8183942115603988,0.7560975609756098,1.0,1.0,4/40,12.85%,NCOA4;SH3BP4;M6PR;MFSD1
prerank,Regulation Of cAMP-mediated Signaling (GO:0043949),-0.3443669192879556,-0.8182815475662276,0.6792452830188679,1.0,1.0,4/18,10.81%,GPR61;PDE2A;PDE11A;GPR62
prerank,Apoptotic Nuclear Changes (GO:0030262),0.34097377757389313,0.8182282036565509,0.6444444444444445,1.0,1.0,5/16,13.09%,ENDOG;ERN2;CECR2;TOP2A;GPER1
prerank,Cellular Response To Interleukin-6 (GO:0071354),0.3321153449931063,0.8180420785163143,0.6428571428571429,1.0,1.0,7/22,18.74%,IL6R;ST18;SELPLG;PID1;PHB1;IL6ST;NFKB1
prerank,Regulation Of Mitotic Nuclear Division (GO:0007088),-0.2878819173100046,-0.8179120342782658,0.7272727272727273,1.0,1.0,8/54,10.65%,NUP62;IL1B;EDN3;AURKA;IGF1;FBXO43;DUSP1;EDN1
prerank,Cellular Response To Amino Acid Stimulus (GO:0071230),0.2789608039448715,0.8177434946140898,0.7209302325581395,1.0,1.0,8/35,21.02%,SH3BP4;SPAAR;STAMBPL1;LAMTOR2;GLRA1;SLC38A9;SESN3;FYN
prerank,Leukotriene Metabolic Process (GO:0006691),0.32072286309549736,0.8170080171356939,0.8297872340425532,1.0,1.0,4/20,9.68%,ALOX5;PTGR1;CYP4F2;PLA2G1B
prerank,Regulation Of Dendrite Morphogenesis (GO:0048814),0.30049675408588955,0.8167549600404477,0.7083333333333334,1.0,1.0,3/31,3.18%,CHRNA3;OBSL1;HECW1
prerank,Positive Regulation Of Response To Stimulus (GO:0048584),-0.2540463639942289,-0.8166473941303363,0.7627118644067796,1.0,1.0,8/71,9.18%,ECHDC3;TGFB2;IER5;REG3A;RNF168;DEPDC1B;BRCA1;IL15
prerank,Negative Regulation Of Cell Projection Organization (GO:0031345),0.25813000381865203,0.8166008711173667,0.8367346938775511,1.0,1.0,8/46,11.44%,RTN4RL1;RTN4R;EPHA4;PRAG1;RTN4RL2;HDAC2;YWHAH;ADCY6
prerank,Positive Regulation Of Epithelial To Mesenchymal Transition (GO:0010718),0.2915313686266634,0.816220393648596,0.8333333333333334,1.0,1.0,12/45,14.55%,TWIST1;PDPN;RGCC;TIAM1;NOTCH1;ZNF703;PTK2;TGFB1I1;WWTR1;LEF1;DAB2;LOXL2
prerank,Regulation Of Inflammatory Response To Antigenic Stimulus (GO:0002861),0.30033473786288933,0.815682548488629,0.7659574468085106,1.0,1.0,2/16,2.94%,HLA-DRB1;HCK
prerank,Cell Surface Receptor Signaling Pathway Involved In Heart Development (GO:0061311),0.34436002063743243,0.8144868867028389,0.7058823529411765,1.0,1.0,3/16,10.10%,BMP4;NOTCH1;HEYL
prerank,Integrin-Mediated Signaling Pathway (GO:0007229),0.2484298084164909,0.8140394483851997,0.8444444444444444,1.0,1.0,16/83,13.77%,CEACAM1;ITGB8;HCK;ITGA2B;DST;ITGA6;ITGBL1;ITGA3;SEMA7A;ITGA2;PTK2;ISG15;ILK;FERMT3;DAB2;NEDD9
prerank,Cellular Response To Cadmium Ion (GO:0071276),0.31413317228442666,0.813700906319864,0.7333333333333333,1.0,1.0,6/22,17.97%,MAPK8;MT1A;MT1E;MT1G;DAXX;AKT1
prerank,Positive Regulation Of calcineurin-NFAT Signaling Cascade (GO:0070886),0.3062097335514366,0.8132332867410392,0.7058823529411765,1.0,1.0,1/18,0.27%,AKAP6
prerank,Positive Regulation Of Calcineurin-Mediated Signaling (GO:0106058),0.3062097335514366,0.8132332867410392,0.7058823529411765,1.0,1.0,1/18,0.27%,AKAP6
prerank,Negative Regulation Of Response To Stimulus (GO:0048585),-0.2634143190161505,-0.8132017335964903,0.7358490566037735,1.0,1.0,17/51,20.63%,LYN;APOA1;KIF26A;KLF7;SH2B3;SLIT2;FCGR2B;THY1;SMCR8;SOCS5;AQP11;VPS13C;SIRT1;IGFBP3;APLP2;MAP2K5;MAPK7
prerank,DNA Duplex Unwinding (GO:0032508),-0.2962836317597024,-0.8123904059174049,0.7647058823529411,1.0,1.0,11/39,19.95%,GINS3;ASCC1;SUPV3L1;TWNK;MCM6;WRN;ERCC3;UPF1;IGHMBP2;BLM;MCM9
prerank,Mitochondrial Calcium Ion Homeostasis (GO:0051560),-0.32962476447981937,-0.8121647537086873,0.6666666666666666,1.0,1.0,2/20,8.07%,ATP2A1;MAIP1
prerank,RNA Transport (GO:0050658),0.2622704171715767,0.812068048585044,0.8636363636363636,1.0,1.0,4/37,12.42%,NOL3;XPO5;DDX39B;TST
prerank,Plasma Membrane Organization (GO:0007009),-0.26025097067577535,-0.8120373435324989,0.8,1.0,1.0,5/68,4.72%,EHD2;SYTL4;EPB41L3;COL5A1;TRIM72
prerank,Bile Acid Metabolic Process (GO:0008206),0.2996836797331244,0.8116249764101295,0.7647058823529411,1.0,1.0,10/30,19.87%,CYP7B1;HSD3B7;CYP27A1;SCP2;CYP8B1;OSBPL1A;GBA2;AMACR;AKR1D1;ABCD3
prerank,Regulation Of JUN Kinase Activity (GO:0043506),0.2597282140422055,0.8116224098302275,0.7368421052631579,1.0,1.0,3/43,2.99%,MAP3K7;PPEF2;TNFRSF11A
prerank,Receptor Internalization (GO:0031623),-0.28711567473400434,-0.8115582984866042,0.7368421052631579,1.0,1.0,6/49,7.21%,GRK4;CXCL8;CCL14;NEDD4;ENTREP1;ITCH
prerank,Positive Regulation Of Nitrogen Compound Metabolic Process (GO:0051173),-0.2894042849833285,-0.8111128933523729,0.7647058823529411,1.0,1.0,5/32,8.34%,PAX8;IFNG;WNT7A;NFKBIA;HPN
prerank,Vitamin Transport (GO:0051180),-0.2900551672240519,-0.8108341008301825,0.7580645161290323,1.0,1.0,4/37,6.63%,SLC19A3;APOA1;NPC1L1;SLC22A1
prerank,Vesicle-Mediated Transport (GO:0016192),-0.21179569999298867,-0.8107248515063802,0.9342105263157895,1.0,1.0,91/395,22.57%,PRSS12;EHD2;SYTL4;ANXA8;FMN2;ARL14;SNAP25;SYTL2;CALY;STX1A;SPIRE2;DOC2B;CCL14;LRRK2;CTAGE15;SPTBN2;AP1S3;CEP83;WASHC4;STEAP2;TRIM23;CYTH3;NSG2;CPLX1;RHOBTB1;ARL5B;PLEKHF2;SYTL3;TSG101;ARL4D;RHOQ;RAB30;RASSF9;VPS18;GOSR1;NSG1;DENND1B;AP1G1;RAB12;AP4S1;NCALD;GPRASP1;SPAG9;STAB2;RBSN;DENND3;PIP4K2A;CCR1;CSNK1D;TGFBRAP1;STX2;BLTP1;PICALM;DENND1A;AP3D1;RIN3;RAB4A;AP3B1;SPIRE1;DNM3;CSNK1E;EXOC8;BLOC1S2;RAB17;IFT27;ANXA8L1;DNM2;WASL;NAPA;VAMP7;INPPL1;EPG5;HIP1R;ALMS1;ARFGEF1;STX6;JAGN1;HEATR5A;SORT1;RAB13;SNX9;SCARA5;ARF1;EQTN;HEATR5B;ARFGAP3;PRKD1;LRP2;AP3B2;STX16;STX3
prerank,Regulation Of Glucose Metabolic Process (GO:0010906),-0.3177895779190249,-0.8107221772219336,0.7254901960784313,1.0,1.0,9/28,17.17%,RORA;MLYCD;PRKN;IRS2;RORC;FOXK1;PMAIP1;GNMT;SIRT1
prerank,Sterol Biosynthetic Process (GO:0016126),-0.3175147200491917,-0.810493157174966,0.7936507936507936,1.0,1.0,8/28,19.76%,NPC1L1;CYP51A1;DHCR7;CES1;FAXDC2;INSIG1;MVD;PRKAG2
prerank,Regulation Of Osteoclast Differentiation (GO:0045670),0.26891747714264524,0.8103392638915979,0.7608695652173914,1.0,1.0,10/40,13.77%,TNFRSF11A;LRRC17;IL4;FSTL3;POU4F1;FBN1;TNFSF11;LILRB4;TLR4;NEDD9
prerank,Late Endosome To Vacuole Transport Via Multivesicular Body Sorting Pathway (GO:0032511),0.2734502233307817,0.8101159084052056,0.7659574468085106,1.0,1.0,12/24,36.08%,CHMP4C;MVB12A;TMEM50B;VPS36;STAM2;SNF8;VPS37C;CHMP6;CHMP7;LEPROT;CHMP5;VPS37A
prerank,Regulation Of Histone Deacetylation (GO:0031063),0.27682088965392093,0.8100652774890462,0.8372093023255814,1.0,1.0,2/21,5.87%,FOXP3;CAMK2D
prerank,Tight Junction Assembly (GO:0120192),-0.2882226380287877,-0.809899851749468,0.711864406779661,1.0,1.0,8/47,13.48%,PARD3;CLDN19;CLDN16;ILDR1;CLDN8;CLDN34;CLDN9;CLDN3
prerank,Regulation Of Innate Immune Response (GO:0045088),0.2458899542051082,0.8092370746623692,0.8444444444444444,1.0,1.0,15/76,16.59%,MYO1C;AURKB;SH2D1B;TASL;CD1D;PLSCR1;PTPN6;TLR8;IRAK3;TRAFD1;POLR3G;POLR3B;SAMHD1;XIAP;IFI35
prerank,Regulation Of Cardiac Muscle Contraction By Calcium Ion Signaling (GO:0010882),-0.35834332590173623,-0.8091655321893215,0.7021276595744681,1.0,1.0,3/19,7.29%,CASQ2;ATP1A2;SLC8A1
prerank,Nitrogen Compound Transport (GO:0071705),-0.23437616823731638,-0.8087453520383091,0.8260869565217391,1.0,1.0,23/159,13.20%,SLC6A12;SLC3A1;SLC11A1;SLC19A3;SLC7A3;SLC43A2;SLC18A2;SLC7A8;SLC26A1;AQP8;ARRDC4;SLC22A1;ARRDC2;SLC22A4;SNX7;SLC15A3;SLC17A3;EDN1;ZG16;SLC26A4;SLC15A4;SLC22A3;RHAG
prerank,Microtubule Depolymerization (GO:0007019),-0.33961461604627696,-0.8086722157426007,0.6530612244897959,1.0,1.0,4/16,13.47%,NCKAP5;KIF19;STMND1;KIF18B
prerank,Regulation Of Monoatomic Cation Transmembrane Transport (GO:1904062),0.2855395231694089,0.8086631126335547,0.7560975609756098,1.0,1.0,9/34,17.67%,HRC;HCN2;KCNE5;GRIN2D;RANGRF;GNB2;KCNH2;WNK3;DPP6
prerank,Regulation Of Axonogenesis (GO:0050770),-0.2777667614033329,-0.8084702370852395,0.8,1.0,1.0,10/42,14.30%,CHN1;PLXNB3;PLXND1;CDH2;MCF2;CHODL;PLXNA2;SLIT2;THY1;BRSK2
prerank,Triglyceride Biosynthetic Process (GO:0019432),0.29927368569643775,0.8083982581450072,0.6428571428571429,1.0,1.0,4/17,22.05%,DGAT2;LPIN3;MOGAT3;LPIN2
prerank,Monoubiquitinated Protein Deubiquitination (GO:0035520),-0.2982667072711537,-0.808086057388783,0.7230769230769231,1.0,1.0,11/32,31.77%,TMEM98;TAF5;ATXN7;TAF7;USP16;USP1;ATXN7L3;SUPT7L;TAF10;USP47;KAT2B
prerank,Positive Regulation Of Ossification (GO:0045778),0.26811851282636817,0.8079916298499975,0.8043478260869565,1.0,1.0,10/41,16.70%,BMP4;ALOX5;CCNA2;KL;ISG15;P2RX7;SOX11;ACVR2A;RXRB;BMP6
prerank,Memory (GO:0007613),-0.2820790926301541,-0.8078870282368349,0.7424242424242424,1.0,1.0,7/52,8.22%,SLC6A1;FGF13;SHANK1;PLCB1;MAPT;PRNP;TH
prerank,Ureteric Bud Development (GO:0001657),-0.3539999701378239,-0.8067390934949014,0.711864406779661,1.0,1.0,1/17,0.81%,WNT11
prerank,Positive Regulation Of Lipid Metabolic Process (GO:0045834),-0.31582542674773906,-0.8067046088074851,0.7413793103448276,1.0,1.0,6/23,17.55%,IL1B;EEF1A2;MLXIPL;SORBS1;SIRT4;PPARA
prerank,Cell Junction Maintenance (GO:0034331),0.33103084728540255,0.806659222380064,0.7619047619047619,1.0,1.0,5/15,15.43%,F2RL1;CBLN3;CLDN1;NLGN2;MYADM
prerank,Autophagy Of Nucleus (GO:0044804),-0.3597007114377369,-0.8063869387869016,0.6666666666666666,1.0,1.0,8/18,26.29%,ATG2A;SNX7;WDR45B;RB1CC1;ATG5;ULK2;WDR45;ULK1
prerank,Regulation Of Protein Modification Process (GO:0031399),-0.2837709148092696,-0.8061941375587741,0.7666666666666667,1.0,1.0,16/42,30.05%,LYN;IGF1;SPRED1;PPP1R16B;RB1CC1;CCDC88C;FNIP1;HPF1;ATG14;CCDC88A;FER;ULK1;SPRED2;FKTN;ATG10;ACER2
prerank,RNA Methylation (GO:0001510),-0.2609251960535216,-0.8055150341738122,0.7704918032786885,1.0,1.0,24/62,26.42%,THUMPD2;FBLL1;RBM15;METTL4;METTL16;WTAP;TGS1;PCIF1;TFB2M;ZCCHC4;CMTR1;NSUN3;SNRPG;LCMT2;TARBP1;METTL6;TRMT61A;TRMT10C;METTL8;VIRMA;CBLL1;NSUN6;METTL14;TRMT12
prerank,Protein-Containing Complex Disassembly (GO:0032984),-0.2550638047265969,-0.8052415024723586,0.8076923076923077,1.0,1.0,24/62,31.21%,IRGM;MAP1LC3C;FRAT1;TSG101;PEX2;PEX12;ETF1;RPL17;PEX14;NAPA;VAMP7;EPG5;SNX14;FRAT2;UBQLN1;ATG14;VPS33B;PEX10;PIK3R4;MAP1LC3B;CHMP1B;UVRAG;VPS4A;VPS4B
prerank,DNA Unwinding Involved In DNA Replication (GO:0006268),0.3024348735839536,0.8050760515720046,0.725,1.0,1.0,7/20,18.79%,MCM4;GINS2;GINS1;RECQL4;GINS4;CDC45;MCM3
prerank,Regulation Of Cell Cycle (GO:0051726),0.1979041800395555,0.8048282846044176,1.0,1.0,1.0,63/291,22.19%,MAPK12;BMP4;MYC;CDKN3;DLGAP5;CDT1;SCAND3;PIM2;PLK1;CDK4;CDKN2A;PTPRK;CCNF;CDC20;CDK5;BEX1;IFNW1;LILRB1;ETFA;ZNF703;TP73;ACTL6A;POU4F1;FIGNL1;CEL;AFAP1L2;SFRP1;TTLL12;CKS2;TFPT;GPER1;WDR12;FOXM1;RPS6KA2;PTK6;CDK10;LIN9;ANAPC7;PPP1R9B;XIAP;RNF167;ACTB;PLAGL1;ANKRD17;RUVBL2;MEN1;GATA3;RACK1;LEP;ATM;YWHAE;BRINP3;ASAH2;THAP5;TGM1;RPS15A;ING4;NEK9;CKS1B;RUVBL1;TNFSF13B;BRD8;RAD23A
prerank,DNA Recombination (GO:0006310),0.2617092509330522,0.8047246558955937,0.7608695652173914,1.0,1.0,13/41,21.92%,RMI2;EXO1;ENDOG;RBBP8;RAD54B;ERCC1;HMGB3;THAP9;HDAC10;RHNO1;RAD52;TOP3A;MSH2
prerank,Iron-Sulfur Cluster Assembly (GO:0016226),0.2811667654964182,0.804570684854901,0.8409090909090909,1.0,1.0,6/27,17.58%,BOLA1;NDOR1;FDX2;LYRM4;CIAO3;CIAO2A
prerank,Metallo-Sulfur Cluster Assembly (GO:0031163),0.2811667654964182,0.804570684854901,0.8409090909090909,1.0,1.0,6/27,17.58%,BOLA1;NDOR1;FDX2;LYRM4;CIAO3;CIAO2A
prerank,Epithelial To Mesenchymal Transition (GO:0001837),-0.2928026615792112,-0.8043983161901475,0.7058823529411765,1.0,1.0,10/46,17.03%,TGFB2;IGF1;HEY2;DLG5;TGFBR3;HEY1;DDX17;SNAI1;BMP2;NOG
prerank,Cholesterol Homeostasis (GO:0042632),-0.2563313068916671,-0.8039212287844257,0.873015873015873,1.0,1.0,13/68,13.98%,IL18;RORA;APOA1;NPC1L1;ABCA5;ABCA2;CES1;NPC1;ABCG1;TSKU;NR1D1;INSIG1;MINAR2
prerank,Lipid Droplet Organization (GO:0034389),-0.31381784486954056,-0.8035223247509626,0.7758620689655172,1.0,1.0,10/29,26.13%,CIDEA;PLIN5;FAF2;FITM1;PRKAA2;SFI1;RAB18;CDS1;PNPLA2;PNPLA3
prerank,Protein Localization To Plasma Membrane (GO:0072659),0.215100340822958,0.8034503274473045,0.7096774193548387,1.0,1.0,14/127,9.95%,RAB3B;KCNB1;TSPAN5;CDH1;ADIPOQ;ZDHHC23;PACSIN1;PRPH2;TTC7B;NKD2;RAB10;RAB40B;ANK1;JUP
prerank,Negative Regulation Of Catabolic Process (GO:0009895),-0.2577310270202865,-0.8030986948559518,0.8688524590163934,1.0,1.0,8/69,11.62%,NUPR1;FMN2;IL1B;CIDEA;CYP51A1;TRIM40;TRIM39;PRKCG
prerank,Regulation Of Cell Cycle Phase Transition (GO:1901987),-0.3435618648796283,-0.8030561232749028,0.7592592592592593,1.0,1.0,8/24,17.25%,MLF1;CDKN1A;TRIM39;ZNF16;DBF4;CDKN1B;ERCC3;TCIM
prerank,Negative Regulation Of Actin Filament Bundle Assembly (GO:0032232),-0.32039874428569687,-0.8029846651445585,0.7192982456140351,1.0,1.0,4/25,9.30%,CGNL1;SHANK1;PIK3R1;PRKN
prerank,Regulation Of Exosomal Secretion (GO:1903541),-0.3280762702346135,-0.8029784300257967,0.6896551724137931,1.0,1.0,4/18,10.76%,IFNG;PRKN;TSG101;SMPD3
prerank,Positive Regulation Of Defense Response To Virus By Host (GO:0002230),0.3006851704812885,0.802332026396225,0.7659574468085106,1.0,1.0,8/28,17.60%,IL4;ZDHHC1;LILRB1;PQBP1;IL12RB1;DTX3L;TRIM22;RIGI
prerank,Post-Translational Protein Modification (GO:0043687),-0.29598658016989327,-0.8018156747934335,0.75,1.0,1.0,9/48,17.36%,RHBDD1;DSCC1;PARP8;FAM20C;PARP2;PRKCD;TNKS;JAK2;ESCO1
prerank,Intracellular Sterol Transport (GO:0032366),0.3141671188504749,0.8009704684826415,0.7407407407407407,1.0,1.0,1/15,0.77%,GRAMD1C
prerank,Microtubule Polymerization Or Depolymerization (GO:0031109),-0.3147232646059686,-0.8009327644295886,0.7288135593220338,1.0,1.0,7/26,13.63%,NCKAP5;FGF13;MAPT;ZNF207;STMND1;KIF18B;TPPP
prerank,Positive Regulation Of Growth (GO:0045927),0.23794270099640505,0.8003301146676393,0.8809523809523809,1.0,1.0,9/78,10.98%,AKAP6;H3-5;S100A8;DNPH1;GH1;BRAT1;S100A9;RPS6KA1;SFRP1
prerank,Sensory Perception Of Sound (GO:0007605),0.2296967493147379,0.7999832708168421,0.8372093023255814,1.0,1.0,25/87,17.86%,GSDME;MYO7A;SLC26A5;BIRC5;CLIC5;USP53;MARVELD2;WDR1;EPS8L2;EYA1;HOMER2;POU3F4;ZNF354A;ROR1;MKKS;RIPOR2;EML2;MYO1A;WFS1;MYO7B;KIT;TIMM13;TBX1;SPTBN4;TPRN
prerank,Regulation Of Double-Strand Break Repair (GO:2000779),0.22345201205759238,0.7997538204176692,0.8863636363636364,1.0,1.0,21/88,25.26%,TWIST1;OOEP;ACTL6A;FIGNL1;ATRIP;DPF3;SLF1;FOXM1;RAD51AP1;RPA2;OTUB2;RUVBL2;SMARCB1;SIRT6;KDM1A;RUVBL1;BRD8;VPS72;TRIP12;TIMELESS;WAS
prerank,Peptidyl-Proline Modification (GO:0018208),0.28103642537663,0.7986720951105313,0.7659574468085106,1.0,1.0,9/25,20.83%,FKBP7;PPIAL4A;PPIAL4F;FKBP1A;PPIL1;PPIAL4G;PPWD1;PPIL3;PPIA
prerank,Regulation Of Neutrophil Chemotaxis (GO:0090022),-0.3017510688243966,-0.7985702940396718,0.734375,1.0,1.0,4/24,11.79%,XCL1;CXCL8;SLIT2;DAPK2
prerank,Detection Of Chemical Stimulus Involved In Sensory Perception Of Taste (GO:0050912),-0.2873017227983926,-0.7979791218088518,0.8392857142857143,1.0,1.0,11/39,17.82%,CST1;PKD2L1;TAS2R42;TAS2R38;TAS2R60;TAS2R10;TAS2R4;TAS2R3;TAS2R20;TAS2R7;TAS2R30
prerank,Negative Regulation Of Cell Motility (GO:2000146),-0.24681174275466833,-0.7976853566156581,0.859375,1.0,1.0,32/126,20.83%,WNT11;MAGI2;CLDN19;PLXNB3;PIP5KL1;MAPK15;DACH1;SRGAP1;DLG5;SLIT2;NGFR;MMRN2;RAP2A;THY1;IGFBP5;CLDN3;EPPK1;GTPBP4;CDH11;NOG;RAP2C;ARID4A;TCAF1;MITF;ARPIN;SERPINE1;ARID4B;ING2;ARID2;PTPRU;SAP30L;ARHGAP4
prerank,Positive Regulation Of Chromosome Segregation (GO:0051984),0.31844830892622034,0.7975746693472744,0.8076923076923077,1.0,1.0,5/18,18.07%,CDK1;NCAPG;CCNB1;NCAPD2;CDC6
prerank,Nucleotide Biosynthetic Process (GO:0009165),-0.2938077208767613,-0.7974796086129223,0.7592592592592593,1.0,1.0,4/19,15.88%,ME1;SLC4A7;PRPS1L1;PRPS2
prerank,Cellular Response To Oxidative Stress (GO:0034599),0.2260010131069504,0.7972227324952785,0.9090909090909091,1.0,1.0,33/114,23.23%,ALDH3B1;MAPK8;PRR5L;VKORC1L1;HSPA1A;SNCA;PTPRK;DAPK1;PRDX3;MPV17;CAMKK2;DHRS2;PYCR1;SUMO4;NQO1;MGAT3;KEAP1;HMOX1;PARK7;PRDX5;AKT1;ATM;ATP13A2;RAD52;CHCHD2;PPIA;CCS;FOS;AIF1;PYCR2;SLC4A11;TBC1D24;ARNT
prerank,Negative Regulation Of Inflammatory Response To Antigenic Stimulus (GO:0002862),0.30062575865472474,0.7968835374511362,0.7777777777777778,1.0,1.0,2/15,2.94%,HLA-DRB1;HCK
prerank,Regulation Of Oxidative Stress-Induced Intrinsic Apoptotic Signaling Pathway (GO:1902175),-0.33859893116984974,-0.7963109622098722,0.7321428571428571,1.0,1.0,7/15,21.48%,VNN1;BAG5;NFE2L2;P4HB;SIRT1;MAPK7;UBQLN1
prerank,Lymphocyte Proliferation (GO:0046651),0.26540540312247635,0.7960050493320544,0.8478260869565217,1.0,1.0,9/37,11.12%,IFNA21;IFNA10;TNFRSF4;TNFSF14;IFNW1;CD40;HSPD1;ELF4;IFNA4
prerank,Vesicle Organization (GO:0016050),-0.24701351241074082,-0.795990287583562,0.8793103448275862,1.0,1.0,22/91,22.52%,ANXA8;CD34;WASHC4;PLEKHF2;VPS18;GOSR1;DNAJC13;SAR1A;SRGN;PICALM;PI4K2A;EXOC8;ANXA8L1;WASL;VAMP7;USP8;SAR1B;STX6;TRAPPC2;SORT1;PLEKHA3;STX16
prerank,Protein Processing (GO:0016485),-0.24117309686071842,-0.7958704566273967,0.8840579710144928,1.0,1.0,22/108,17.80%,ZMPSTE24;PRSS12;HGFAC;CPXM1;BACE2;GGT2P;CPZ;BMP1;FAM111A;FURIN;ADAMTS13;PITRM1;CPE;SPRTN;XPNPEP3;SDE2;ADAM17;SRGN;PCSK9;MMP14;THBD;PIDD1
prerank,mRNA Transcription (GO:0009299),-0.2916815656119553,-0.795858306665739,0.7192982456140351,1.0,1.0,8/42,14.91%,PPARG;FOXE3;C5AR1;TAF5;TAF13;ZBTB1;NCOA1;TAF7
prerank,Positive Regulation Of Interferon-Alpha Production (GO:0032727),0.29965435631144377,0.7956728989051591,0.7380952380952381,1.0,1.0,5/21,13.16%,IRF5;IRF7;TLR8;HSPD1;TLR4
prerank,Regulation Of Small GTPase Mediated Signal Transduction (GO:0051056),-0.23777645491784952,-0.7955499267735605,0.8166666666666667,1.0,1.0,16/116,11.85%,PLEKHG6;ARHGAP29;CGNL1;NUP62;ARHGEF28;CHN2;ARHGAP8;CHN1;ARHGEF10;MCF2;ARHGAP21;PLCE1;SRC;SLIT2;TRIO;VAV3
prerank,Positive Regulation Of Ras Protein Signal Transduction (GO:0046579),-0.2614998563556382,-0.7954848755288163,0.8166666666666667,1.0,1.0,8/46,12.87%,AUTS2;IGF1;APOA1;GPR65;F2RL2;GPR35;F2R;P2RY8
prerank,Melanosome Assembly (GO:1903232),-0.3057398570185037,-0.7953292464431193,0.7192982456140351,1.0,1.0,6/18,24.25%,AP1S3;AP1G1;AP3D1;AP3B1;HPS6;HPS4
prerank,Negative Regulation Of Transposition (GO:0010529),0.30677588287114926,0.7951390502949268,0.7948717948717948,1.0,1.0,4/24,9.64%,APOBEC3D;SPOCD1;TDRD12;PIWIL4
prerank,Regulation Of Phosphorylation (GO:0042325),-0.25487590530269505,-0.7951236182024957,0.7931034482758621,1.0,1.0,24/78,23.96%,LDB2;THBS1;LYN;IGF1;FZD7;GLMN;CDKN1A;ANG;BCL10;CDKN1C;SRPX2;CDKN1B;EMP2;ANKLE2;SIRT1;CCDC88C;CDKN2D;FNIP1;ATG14;CCDC88A;SDCBP;CCL5;EREG;LDB1
prerank,Sensory Perception Of Bitter Taste (GO:0050913),-0.2823682430512994,-0.7947207917146796,0.7627118644067796,1.0,1.0,11/37,17.82%,CST1;TAS2R42;TAS2R38;TAS2R60;CALHM1;TAS2R10;TAS2R4;TAS2R3;TAS2R20;TAS2R7;TAS2R30
prerank,Sterol Homeostasis (GO:0055092),-0.25507081224323386,-0.7946637172098336,0.8688524590163934,1.0,1.0,13/69,13.98%,IL18;RORA;APOA1;NPC1L1;ABCA5;ABCA2;CES1;NPC1;ABCG1;TSKU;NR1D1;INSIG1;MINAR2
prerank,Intracellular Protein Transmembrane Transport (GO:0065002),-0.2826004956657616,-0.7943619601388195,0.7796610169491526,1.0,1.0,18/46,29.78%,TOMM20L;PEX1;GRPEL1;PEX2;PEX12;SEC63;PEX14;TIMM21;RTN2;TIMM17A;PEX13;PEX16;DNLZ;TOMM70;PEX10;SEC61G;TIMM44;SEC61A2
prerank,Negative Regulation Of Cytoskeleton Organization (GO:0051494),-0.2997762066195329,-0.7943027478956133,0.7727272727272727,1.0,1.0,11/26,24.56%,SHANK1;PRKN;SLIT2;PIK3CA;TWF1;PRKCD;ARPIN;HIP1R;SSH1;PFN2;CLASP1
prerank,Negative Regulation Of Immune System Process (GO:0002683),0.2711931597216625,0.7942898010265015,0.7906976744186046,1.0,1.0,11/41,15.57%,PDCD1;FOXP3;HLA-G;CD200;IRAK3;MFHAS1;LILRB4;GPR108;GPER1;HMOX1;SMPDL3B
prerank,Negative Regulation Of Organelle Assembly (GO:1902116),0.2696492815097418,0.7937638631146016,0.7804878048780488,1.0,1.0,9/36,14.42%,TBC1D30;STYXL1;KIF24;PHF23;RBM14;USP10;GDI2;MDM1;CDK10
prerank,Regulation Of Cysteine-Type Endopeptidase Activity (GO:2000116),0.3291037384379205,0.7936538709143838,0.7948717948717948,1.0,1.0,3/22,9.38%,TTBK1;PYCARD;CST2
prerank,Negative Regulation Of Intrinsic Apoptotic Signaling Pathway (GO:2001243),-0.2574783160609972,-0.7930772935410805,0.8103448275862069,1.0,1.0,14/58,20.63%,MAGEA3;LRRK2;BAG5;HERPUD1;PRKN;SRC;NFE2L2;DDIAS;SNAI1;CXCL12;SIRT1;EPO;CDKN2D;MAPK7
prerank,Regulation Of Ventricular Cardiac Muscle Cell Membrane Repolarization (GO:0060307),-0.3419227151013462,-0.7930706589393401,0.7636363636363637,1.0,1.0,2/17,8.34%,SCN5A;KCNE2
prerank,Sulfur Compound Biosynthetic Process (GO:0044272),-0.26839538973635574,-0.7928543249327279,0.8596491228070176,1.0,1.0,11/65,11.86%,GGTLC3;CHST5;CHSY3;CHST6;GGT2P;B4GALT4;CTH;ST3GAL3;GGT5;ANGPT1;METTL16
prerank,Regulation Of Reactive Oxygen Species Metabolic Process (GO:2000377),-0.2766889694593648,-0.7927990907803109,0.8076923076923077,1.0,1.0,10/53,10.97%,THBS1;CDKN1A;AKR1C3;ZC3H12A;BRCA1;NOXA1;PRKN;PLIN5;MT3;GADD45A
prerank,snRNA 3'-End Processing (GO:0034472),-0.32828045932730787,-0.7915798002402934,0.7192982456140351,1.0,1.0,7/20,20.98%,EXOSC3;EXOSC6;TUT1;TOE1;INTS6L;INTS12;EXOSC9
prerank,Response To Exogenous dsRNA (GO:0043330),-0.28830176376387323,-0.7915731849286994,0.7818181818181819,1.0,1.0,10/33,19.96%,IFNA6;IFNA7;IFNA2;TLR3;MUL1;IFNA8;ZCCHC3;IFNA14;CGAS;IFNK
prerank,DNA Repair-Dependent Chromatin Remodeling (GO:0140861),-0.33122908729983164,-0.7915039777950847,0.6724137931034483,1.0,1.0,4/16,17.37%,RNF168;DEPDC1B;PARP2;PHF1
prerank,Rac Protein Signal Transduction (GO:0016601),-0.32640462836262335,-0.7913268557287372,0.7115384615384616,1.0,1.0,2/17,4.30%,CDH13;NCKAP1
prerank,Organonitrogen Compound Catabolic Process (GO:1901565),0.22311359743066098,0.7912176790292733,0.84375,1.0,1.0,24/74,24.24%,ANPEP;SIAH1;LNPEP;GGACT;ETFA;PRSS16;CHEK2;SLC16A3;NAGK;CLN5;NAALADL1;TST;GNPDA1;ETFB;CLN6;BCKDK;RENBP;LIPC;ENPEP;ENPP2;RNF5;CASP3;CAPN3;LTA4H
prerank,Peptidyl-Lysine Trimethylation (GO:0018023),-0.328412022991431,-0.7909084031074263,0.8214285714285714,1.0,1.0,5/15,22.85%,FAM86B1;VCPKMT;EEF2KMT;ETFBKMT;PRDM7
prerank,Negative Regulation Of Cellular Biosynthetic Process (GO:0031327),-0.22917770751112054,-0.7903970867695639,0.835820895522388,1.0,1.0,29/130,17.87%,IGF2BP1;ENC1;ACVRL1;GFI1;CDKN1A;NANOS2;AKR1C3;C1QTNF12;SIK1;ZC3H12A;BRCA1;DACH1;CNOT1;C1QTNF3;GZMB;UBR4;IGFBP5;SNAI1;GLA;PCIF1;EP300;LIN28A;FGF19;GRB7;SIRT1;MPV17L;BMPR2;DHX36;DDX6
prerank,Microtubule Bundle Formation (GO:0001578),-0.28613594670294407,-0.7903761986993737,0.7959183673469388,1.0,1.0,11/49,11.77%,PIERCE1;NCKAP5;GAS2L2;SPAG16;LRRC43;RP1L1;GAS2L1;RSPH4A;CCSER2;ZNF207;TOGARAM1
prerank,Peptidyl-Lysine Methylation (GO:0018022),0.26673725226529255,0.790250830319312,0.7547169811320755,1.0,1.0,7/26,19.32%,EEF1AKMT3;EEF1AKMT1;CSKMT;EEF1AKMT2;EHMT2;SETD3;ATPSCKMT
prerank,Carboxylic Acid Catabolic Process (GO:0046395),0.32924911947313473,0.7892194233218669,0.813953488372093,1.0,1.0,7/17,18.95%,ETFA;NAGK;TST;GNPDA1;ETFB;BCKDK;RENBP
prerank,acyl-CoA Metabolic Process (GO:0006637),-0.30773052135491297,-0.7887560544620953,0.8245614035087719,1.0,1.0,5/28,16.79%,SUCLA2;MLYCD;ACSM2A;ACOT9;ACOT12
prerank,Negative Regulation Of Endopeptidase Activity (GO:0010951),-0.265022873044752,-0.7887367319173796,0.7586206896551724,1.0,1.0,8/56,13.83%,ANXA8;CST1;CRB2;SERPINF2;SPOCK2;MT3;VTN;TIMP3
prerank,Calcium-Ion Regulated Exocytosis (GO:0017156),-0.3109558198854878,-0.7886500802118512,0.7894736842105263,1.0,1.0,3/25,3.86%,SCIN;SYT15;DOC2B
prerank,Regulation Of Activated T Cell Proliferation (GO:0046006),-0.30239323067037854,-0.7883464990433631,0.8235294117647058,1.0,1.0,5/33,7.91%,IGFBP2;IL18;IGF1;PPP3CA;PRNP
prerank,Regulation Of Calcium Ion Transmembrane Transport (GO:1903169),0.3101287482798897,0.7881454014753342,0.6666666666666666,1.0,1.0,2/19,5.87%,HRC;CAMK2D
prerank,Negative Regulation Of Protein-Containing Complex Assembly (GO:0031333),-0.2731420765503519,-0.7877900569339045,0.8243243243243243,1.0,1.0,13/53,17.93%,SMAD6;IRGM;PRRT2;FBXL2;SRC;ZNF827;PTGER4;PPM1A;EP300;PYDC1;TRIM11;THRA;RAF1
prerank,Positive Regulation Of Lipid Catabolic Process (GO:0050996),-0.33306253417275966,-0.7877498613751903,0.7333333333333333,1.0,1.0,7/18,17.55%,IL1B;DAGLB;IRS2;PLIN5;PRKCD;MTLN;PPARA
prerank,Regulation Of Ubiquitin-Protein Transferase Activity (GO:0051438),0.2797541759334001,0.7876379792486102,0.8048780487804879,1.0,1.0,5/32,11.58%,PLK1;CDC20;TRIB3;RPS2;DTX3L
prerank,Regulation Of Secretion By Cell (GO:1903530),0.25827318735565175,0.7873599475450307,0.8048780487804879,1.0,1.0,17/61,21.69%,SYN1;RAB3B;DYSF;KCNMB4;RIMS2;RHBDF1;SEPTIN5;RAB3D;SEPTIN4;SEPTIN1;CPLX3;SIRT6;FER1L5;MEF2C;SEPTIN2;RIC1;APEX1
prerank,Inositol Phosphate Metabolic Process (GO:0043647),-0.33860935172139406,-0.7873537380014823,0.7627118644067796,1.0,1.0,6/21,21.19%,ITPKA;INPP5J;NUDT11;IP6K1;IP6K2;NUDT4
prerank,Protein Localization (GO:0008104),0.1875257397894483,0.7872653988203837,1.0,1.0,1.0,30/342,10.39%,ARL11;ITSN1;ATP8B1;VANGL2;FBLN5;RAB31;ATG9B;INSC;MYO7A;PACSIN1;RAB38;KIF13A;TMED9;PTPRK;TNS4;FOXJ1;RAB28;MAL;GRIN3B;LAMTOR2;ESAM;MARVELD3;CTSA;USO1;CORO1B;ARL5C;PRRT1;CBY1;CTTN;YWHAH
prerank,Regulation Of B Cell Proliferation (GO:0030888),-0.28300125901188466,-0.7870511641637725,0.8305084745762712,1.0,1.0,10/44,11.85%,TYROBP;LYN;CLCF1;IL7;IRS2;MZB1;TNFRSF13C;FCGR2B;CD300A;VAV3
prerank,Negative Regulation Of Protein Kinase Activity (GO:0006469),0.21956623757307983,0.7869788653507704,0.9069767441860465,1.0,1.0,31/86,29.06%,CEACAM1;PTPRB;SNCA;PYCARD;TRIB3;GSKIP;SRCIN1;TRIB2;LILRB4;WWTR1;TRIB1;PTK6;EPHA1;PARK7;AKT1;MVP;HYAL2;PPIA;ITGB1BP1;PPM1E;UBASH3B;PTPRC;CEP85;MACROH2A1;EPHB2;DEPTOR;TESK1;PPM1F;PDPK1;TRIM27;SH3BP5
prerank,Negative Regulation Of Protein Metabolic Process (GO:0051248),0.2123171582464333,0.7865918363379786,0.9666666666666667,1.0,1.0,29/140,19.65%,TYMS;TRIM2;ZNF540;DAPK1;EPHA4;IGF2BP3;CDK5;F2;AZIN2;IRAK3;CSTB;PHF20L1;PFDN6;DHFR;PLAT;NQO1;VBP1;TIA1;PHB1;KNG1;RACK1;AGAP2;AKT1;TRIM71;NFKB1;TOB1;SERBP1;SHMT1;CNOT9
prerank,Positive Regulation Of Translational Initiation (GO:0045948),-0.32266541610124544,-0.7862677475898565,0.782608695652174,1.0,1.0,5/17,25.98%,UHMK1;YTHDF3;CCL5;YTHDF2;SH3BGRL
prerank,Endosomal Transport (GO:0016197),-0.22778256584183476,-0.7859322013672473,0.9230769230769231,1.0,1.0,46/175,25.27%,EHD2;ANXA8;CALY;RAB6C;WASHC4;MAGEL2;NSG2;VPS54;ARL4C;RAB9A;SNX7;RAB6B;RHOBTB3;RASSF9;GOSR1;NSG1;DENND1B;RAB6D;VPS26A;SPAG9;RBSN;BLTP1;PICALM;DENND1A;EIPR1;CCDC93;BLOC1S2;RAB17;ANXA8L1;BET1L;ALMS1;STX6;HEATR5A;SORT1;RAB13;SNX9;PLEKHA3;HEATR5B;STX16;LMTK2;CLTCL1;RAB11FIP4;VPS52;EHD1;ERC1;AP5Z1
prerank,Dephosphorylation (GO:0016311),0.20159999946409818,0.7859194486071364,0.972972972972973,1.0,1.0,36/142,23.73%,PTPN3;PPEF2;PTPRB;PPP2R3A;PTPRH;PTPRK;PTPN13;DUSP23;EPHX2;PTPN6;PSPH;PLPP1;PTPRD;ALPP;SDHAF2;PTPN7;PTPN18;PLPPR4;MTMR7;NT5C;TIMM50;DUSP18;PPM1G;DAPP1;PPP2CB;PTEN;CTDNEP1;PHPT1;PPP3R2;PTPRM;PPP1CA;PPP5C;SBF1;FBXW11;PTPN9;PPP4R3C
prerank,Positive Regulation Of Reproductive Process (GO:2000243),-0.3032579886999311,-0.7857357333500338,0.8225806451612904,1.0,1.0,2/29,5.91%,VEGFA;PLCB1
prerank,Regulation Of Arp2/3 Complex-Mediated Actin Nucleation (GO:0034315),0.2778156271352741,0.7855363228256318,0.7446808510638298,1.0,1.0,5/26,10.85%,WASHC2A;CARMIL1;CORO1B;CYFIP1;CARMIL3
prerank,Regulation Of Vacuole Organization (GO:0044088),-0.34652561554813144,-0.7850212513907909,0.6909090909090909,1.0,1.0,1/16,2.25%,RNF186
prerank,mRNA Export From Nucleus (GO:0006406),-0.2606963804933802,-0.7848975952948699,0.8153846153846154,1.0,1.0,10/60,21.00%,DDX25;DDX39A;NXT1;THOC3;NXF5;UPF1;NCBP3;DDX19B;ZC3H11B;NUP133
prerank,Response To Fibroblast Growth Factor (GO:0071774),0.3054387091101261,0.7847515961292885,0.775,1.0,1.0,7/19,21.16%,IER2;SFRP1;TBX1;HYAL2;DLL4;NDNF;ITGB1BP1
prerank,Multivesicular Body Assembly (GO:0036258),0.2794577766865881,0.7847383993319846,0.8367346938775511,1.0,1.0,10/29,29.49%,CHMP4C;MVB12A;PDCD6IP;VPS36;RAB11A;CHMP2A;STAM2;SNF8;VPS37C;CHMP6
prerank,Monoatomic Anion Transport (GO:0006820),-0.27477064812237945,-0.7843067609571888,0.8833333333333333,1.0,1.0,9/54,13.11%,CLCNKA;SLC26A1;FXYD1;TTYH1;SLC34A1;BEST1;SLC17A3;SLC26A4;FXYD3
prerank,Regulation Of Cellular Component Biogenesis (GO:0044087),0.2703557754811613,0.7830970876693579,0.7777777777777778,1.0,1.0,5/37,10.90%,RAPGEF1;HJURP;CD36;NOTCH1;FAM110C
prerank,Protein Targeting (GO:0006605),-0.24280518042374621,-0.7828275880913783,0.9137931034482759,1.0,1.0,22/128,16.96%,PARD3;ZDHHC15;ZFAND2A;AP1S3;ZDHHC11;NACAD;VPS37B;LTBP2;ZDHHC11B;PEX1;NCF1;RASSF9;GOLGA7;PEX12;MAN1A1;AP4S1;TOMM5;PITRM1;SEC63;AP3D1;AQP11;VPS13C
prerank,Regulation Of Microtubule Polymerization Or Depolymerization (GO:0031110),0.2980851309406409,0.7828209389084542,0.75,1.0,1.0,10/26,22.79%,CAMSAP3;MAP1A;CAMSAP2;SKA1;GBA2;FKBP4;MAPRE3;MAP2;MAP1S;ARL2
prerank,Negative Regulation Of Axonogenesis (GO:0050771),-0.3206788473877509,-0.7820889116517546,0.8269230769230769,1.0,1.0,10/22,26.29%,FGF13;KIAA0319;MCF2;MT3;THY1;ULK2;PTPRS;RNF6;MAG;ULK1
prerank,"mRNA Splicing, Via Spliceosome (GO:0000398)",-0.21737503288378537,-0.7820239981280449,0.9402985074626866,1.0,1.0,68/205,32.03%,CELF4;SRPK3;CRNKL1;CWF19L1;DDX39A;RSRC1;DDX17;U2AF1;SNIP1;NOVA2;SF3B1;TGS1;PRPF4;SLU7;PPIE;SDE2;PHF5A;SNRNP27;SNW1;SNRPG;CENATAC;RNPC3;STRAP;GEMIN4;FRA10AC1;SNRPA1;SRRM1;SRPK2;TFIP11;WDR83;XAB2;PRPF40A;SF3B4;FRG1;CWF19L2;SYF2;COIL;AQR;SRSF10;DHX35;SNRPB2;DDX46;PNN;BCAS2;TSSC4;SF3A2;SMN1;CDK13;PRPF3;METTL14;SRSF2;ESS2;NR5A1;RBM19;SNRPD1;SRSF7;SF3A1;SRSF3;RBM17;ZCCHC8;DHX8;CWC15;MFAP1;SRSF8;USP39;BUD31;DDX20;ZMAT2
prerank,Protein Localization To Cell Junction (GO:1902414),-0.32017285595682415,-0.7818026732874855,0.78,1.0,1.0,3/23,9.51%,CGNL1;SHANK1;BSN
prerank,Regulation Of Nervous System Development (GO:0051960),-0.2749785632587069,-0.7816912352091203,0.8135593220338984,1.0,1.0,11/43,13.96%,IL1B;DOCK7;HEY2;LGI4;ZPR1;HEY1;YAP1;TENM4;HES3;BMAL1;BHLHE40
prerank,Leukocyte Adhesion To Vascular Endothelial Cell (GO:0061756),0.30329081634222604,0.7814904636449964,0.627906976744186,1.0,1.0,6/19,18.96%,CX3CR1;SELL;GCNT1;SELPLG;SELP;JAM2
prerank,Lipid Translocation (GO:0034204),-0.3018455329259656,-0.7814662612669316,0.8181818181818182,1.0,1.0,2/23,3.48%,ABCB4;ABCB1
prerank,Positive Regulation Of Cyclin-Dependent Protein Kinase Activity (GO:1904031),-0.31621122895147535,-0.7810422645017303,0.7307692307692307,1.0,1.0,1/18,0.63%,STOX1
prerank,Negative Regulation Of miRNA Metabolic Process (GO:2000629),-0.313005210397177,-0.7804548917676921,0.7358490566037735,1.0,1.0,7/21,25.41%,PPARG;POU5F1;TENT2;NFIB;PPARA;PDGFB;RELA
prerank,Regulation Of Cellular Component Size (GO:0032535),0.25784039184375857,0.7796513875637239,0.7068965517241379,1.0,1.0,10/41,22.97%,RAB3B;PEX11G;EPS8;PEX11B;SNAPIN;VAV1;BLOC1S1;ATP13A2;PTEN;PPP1CA
prerank,Negative Regulation Of Axon Extension (GO:0030517),-0.3149338510784073,-0.7794121015383535,0.8076923076923077,1.0,1.0,6/29,10.94%,SEMA3C;SEMA3F;KIAA0319;SEMA4C;SEMA6A;MT3
prerank,Positive Regulation Of Signaling (GO:0023056),0.2703377981083472,0.7790045217599973,0.8181818181818182,1.0,1.0,12/37,19.40%,BVES;ANXA2;SNCA;CD80;RIMS2;ILK;SOX11;DLG4;GATA3;GRIK2;OCRL;RAMP3
prerank,Response To Peptide (GO:1901652),0.26297622614091054,0.7786478310550644,0.7843137254901961,1.0,1.0,13/35,27.93%,CHRNA7;IRF5;NOD2;GNAI1;INAVA;RAMP3;IRS1;CACNA1B;FYN;STAT6;STAT5B;STAT2;EIF2B4
prerank,Protein Import Into Mitochondrial Matrix (GO:0030150),-0.33593441455534306,-0.7785693619065982,0.6949152542372882,1.0,1.0,9/18,33.57%,TOMM20L;GRPEL1;TIMM21;TIMM17A;DNLZ;TOMM70;TIMM44;TOMM20;TIMM23
prerank,TOR Signaling (GO:0031929),0.27927776443943975,0.7780933642995621,0.74,1.0,1.0,10/29,28.94%,PRR5L;MEAK7;LAMTOR2;GATA3;RPS6KB2;LARP1;RPTOR;MLST8;FLCN;RPS6
prerank,Negative Regulation Of Peptide Hormone Secretion (GO:0090278),-0.33735998747032175,-0.7775684807091515,0.7647058823529411,1.0,1.0,3/15,9.30%,KCNJ11;MIDN;PRKN
prerank,Monoubiquitinated Histone H2A Deubiquitination (GO:0035522),-0.3047385378587691,-0.7774161501609047,0.7833333333333333,1.0,1.0,4/26,14.91%,TMEM98;TAF5;ATXN7;TAF7
prerank,Monoubiquitinated Histone Deubiquitination (GO:0035521),-0.3047385378587691,-0.7774161501609047,0.7833333333333333,1.0,1.0,4/26,14.91%,TMEM98;TAF5;ATXN7;TAF7
prerank,Regulation Of Muscle Cell Differentiation (GO:0051147),0.28833748579124585,0.7767512957596755,0.8181818181818182,1.0,1.0,4/22,11.78%,MAPK12;MAPK11;NID1;SRF
prerank,Carbohydrate Derivative Transport (GO:1901264),0.2955492940340739,0.7761915228888525,0.7777777777777778,1.0,1.0,4/17,13.35%,SLC15A2;NPC2;SLC25A19;SLC29A1
prerank,Protein O-linked Glycosylation (GO:0006493),-0.25003538333833575,-0.7757650999789885,0.864406779661017,1.0,1.0,17/89,16.16%,FUT9;GXYLT2;FUT6;GCNT3;ST8SIA6;GALNT13;GALNT3;FKRP;ST6GALNAC2;ST3GAL3;B3GALT2;GALNT16;OGA;POFUT2;GALNT6;MGAT5B;POGLUT3
prerank,Regulation Of Protein Catabolic Process (GO:0042176),-0.23692577897580802,-0.7757293181211915,0.9508196721311475,1.0,1.0,15/120,11.62%,GFAP;ASB9;FMN2;APC2;EEF1A2;TNFAIP3;DNAAF4;CYP51A1;ASB11;NEDD4;ASB5;PRKN;TIPARP;TRIM40;PRKCG
prerank,Negative Regulation Of Cyclin-Dependent Protein Kinase Activity (GO:1904030),-0.30323137991227717,-0.7756531559717831,0.639344262295082,1.0,1.0,5/19,14.87%,LATS2;CDKN1A;INCA1;CDKN1C;CDKN1B
prerank,Diol Biosynthetic Process (GO:0034312),0.30656740383238046,0.7752864474294011,0.7857142857142857,1.0,1.0,7/17,20.03%,SPTLC3;GCH1;DHFR;SPTLC2;GBA1;ASAH2;SPTSSA
prerank,Negative Regulation Of Protein Depolymerization (GO:1901880),-0.32821553049591096,-0.7751102675285999,0.7169811320754716,1.0,1.0,4/22,11.46%,FGF13;APC2;ATXN7;PIK3CA
prerank,Dendritic Cell Chemotaxis (GO:0002407),-0.34654115343241887,-0.7749838093471272,0.7777777777777778,1.0,1.0,10/15,24.55%,CXCR4;CCR6;CCR1;TRPM4;CXCR2;CCR5;CXCR1;PIK3CG;CCL5;CLU
prerank,Modulation By Host Of Symbiont Process (GO:0051851),0.24579487374702397,0.7743971484642047,0.8297872340425532,1.0,1.0,5/41,12.62%,ST6GALNAC1;TAF11;CX3CR1;NAPEPLD;LEF1
prerank,Regulation Of Heart Rate By Cardiac Conduction (GO:0086091),0.2631147472748664,0.7739349036699849,0.8181818181818182,1.0,1.0,8/37,15.11%,HCN2;KCNJ5;KCNE5;CAMK2D;JUP;KCNH6;KCNH2;DSP
prerank,Regulation Of Sodium Ion Transmembrane Transporter Activity (GO:2000649),-0.27428516214773546,-0.7736233414697543,0.7931034482758621,1.0,1.0,12/33,18.22%,FGF13;FXYD1;UTRN;NEDD4;FGF14;SCN3B;FXYD3;WNK2;GPD1L;PCSK9;FXYD7;PRKCE
prerank,Regulation Of rRNA Processing (GO:2000232),-0.34461524258408366,-0.7735866069117991,0.7708333333333334,1.0,1.0,7/15,27.16%,WDR75;UTP15;USP36;YTHDF2;WDR43;RIOK2;HEATR1
prerank,Regulation Of Neuron Migration (GO:2001222),-0.307537770969028,-0.7735131089709115,0.8392857142857143,1.0,1.0,5/28,8.60%,SRGAP2C;CAMK2B;KIF26A;NSMF;SEMA6A
prerank,Regulation Of Filopodium Assembly (GO:0051489),-0.29140136172359776,-0.7734103866278252,0.7454545454545455,1.0,1.0,10/41,18.50%,SRGAP2C;PIK3R1;PPP1R16B;RHOQ;PRKCD;MYO3B;DAAM2;TENM2;RAB17;WASL
prerank,Ras Protein Signal Transduction (GO:0007265),-0.22747802568667896,-0.7733482828187008,0.9019607843137255,1.0,1.0,12/140,5.78%,ARHGAP29;ART4;RGL4;HRAS;CTNNAL1;COL1A2;CDH13;NCKAP1;IGF1;RAPGEF4;RAPGEF5;CDKN1A
prerank,Positive Regulation Of Protein Localization To Membrane (GO:1905477),-0.2453485933872259,-0.7732127179533291,0.8490566037735849,1.0,1.0,15/76,13.82%,CEMIP;HRAS;PDZK1;PIK3R1;IFNG;PRNP;ITGAM;ARHGEF16;STAC2;PRKN;TCAF2;MIEF1;GZMB;EFCAB7;ANK3
prerank,Microtubule Polymerization (GO:0046785),0.2626049950375845,0.7731088565568447,0.7894736842105263,1.0,1.0,2/34,2.62%,TPPP3;TPX2
prerank,Maintenance Of Blood-Brain Barrier (GO:0035633),0.2846732031922917,0.7727119409414273,0.7317073170731707,1.0,1.0,7/26,18.96%,SLC1A1;ESAM;TJP2;ACTG1;CLDN1;WNK3;JAM2
prerank,Chromosome Organization (GO:0051276),0.25566002782082375,0.7726794943567523,0.9019607843137255,1.0,1.0,13/44,22.74%,MYC;H4C9;TOP2A;H1-5;H1-3;CDCA8;H3C1;DOT1L;H1-0;H1-2;AIFM1;MSH2;MSH6
prerank,Organelle Assembly (GO:0070925),-0.20920540884545613,-0.7716175386685881,0.9722222222222222,1.0,1.0,58/312,19.80%,EHD2;NME8;CPLANE2;SPAG16;IRGM;CD34;MAP1LC3C;MAK;AP1S3;TEKT3;CEP83;ATG16L1;ATG2A;CEP126;UBXN2A;VPS37B;ABLIM3;GABARAPL1;TBC1D31;CFAP43;TSG101;CFAP58;RUFY4;ARL13B;AP1G1;DYNC2I1;TOGARAM1;TP53INP2;EMC6;TMEM250;CFAP161;WDR90;UBAP1;ALPK1;FHDC1;PARVA;CPLANE1;PCNT;WDR45B;TMEM41B;DNAAF1;YTHDF3;AP3D1;DYNC2H1;AP3B1;ARMC9;RB1CC1;TTC21B;IFT122;CCDC57;RAB17;IFT27;ATG5;RAB8B;ATP2A2;KIF3A;UBXN10;RILPL1
prerank,Response To Organic Cyclic Compound (GO:0014070),0.24282248324581462,0.7713887135525476,0.8571428571428571,1.0,1.0,7/57,7.74%,PAQR8;SOCS2;SLC1A1;GH1;CYP24A1;CYP1B1;ADORA2A
prerank,Protein Acylation (GO:0043543),0.2543056753801101,0.7710557680687891,0.7446808510638298,1.0,1.0,12/37,24.72%,ZDHHC23;ZDHHC1;HHAT;NAA80;ZDHHC16;ZDHHC22;PORCN;ZDHHC9;ING4;ZDHHC8;ZDHHC12;NAA10
prerank,Positive Regulation Of Intracellular Protein Transport (GO:0090316),-0.23249782161622004,-0.770498293456293,0.9076923076923077,1.0,1.0,32/125,21.71%,CEMIP;HRAS;IL1B;PDZK1;PIK3R1;FZD5;IFNG;PRNP;ITGAM;ZC3H12A;ZPR1;TCAF2;MIEF1;GZMB;PRKCD;EFCAB7;ANK3;EP300;PCNT;SAR1A;BAG3;TCAF1;TOMM7;SEC16B;XPO4;SAR1B;TMEM30B;SREBF2;TMEM30A;USP36;ARIH2;PLK3
prerank,Negative Regulation Of Notch Signaling Pathway (GO:0045746),-0.31337187358708224,-0.7700999517566819,0.8245614035087719,1.0,1.0,15/26,33.22%,TSPAN15;CCNC;HEY1;NRARP;MMP14;TCIM;EGFL7;YTHDF2;ARRB1;ZBTB7A;LFNG;CDK3;GATA2;DLK2;MAGEA1
prerank,Regulation Of Cell-Substrate Adhesion (GO:0010810),-0.26336343532349,-0.7698853157736353,0.7636363636363637,1.0,1.0,4/42,7.17%,ALOX15;FBLN2;FZD7;WNT1
prerank,Regulation Of Sodium Ion Transmembrane Transport (GO:1902305),-0.2946276336115585,-0.7698583574421625,0.7241379310344828,1.0,1.0,9/26,17.36%,SCN5A;FXYD1;UTRN;SCN3B;FXYD3;GPD1L;SNTA1;DLG1;FXYD7
prerank,Establishment Of Melanosome Localization (GO:0032401),0.31009255815218695,0.7691890388602419,0.7608695652173914,1.0,1.0,5/15,24.27%,MKKS;BLOC1S5;RAB11A;BBS2;RAB27A
prerank,Monocarboxylic Acid Catabolic Process (GO:0072329),-0.31498537592321607,-0.7689191181419656,0.7636363636363637,1.0,1.0,5/19,17.69%,HOGA1;CYP26B1;LPIN1;PLA2G15;NUDT19
prerank,Monocarboxylic Acid Biosynthetic Process (GO:0072330),-0.2610688808566466,-0.7687862692785908,0.8412698412698413,1.0,1.0,8/62,9.35%,OSBPL6;GATM;HTD2;HOGA1;CYP46A1;ELOVL4;MLYCD;ACSM2A
prerank,Regulation Of Epithelial Cell Migration (GO:0010632),-0.2723546855047518,-0.7687139204693759,0.8214285714285714,1.0,1.0,13/49,19.77%,TGFB2;VIL1;IFNG;SRC;CAPN7;PLCG2;GLUL;EMP2;RREB1;BMPR2;MCC;PRKCE;BMPER
prerank,Fatty Acid Biosynthetic Process (GO:0006633),0.22986365586910043,0.7682961124921123,0.8372093023255814,1.0,1.0,19/62,22.71%,ELOVL7;ALOX5;OLAH;MCAT;ACSM2B;PLA2G1B;CYP1A2;ACSM3;CBR4;CYP1A1;FADS1;DECR2;LIPC;ASAH2;ACOT7;ABCD3;GSTM4;ELOVL1;SCD
prerank,RNA Modification (GO:0009451),0.2590977227609311,0.7682401195895623,0.775,1.0,1.0,19/50,27.77%,NOP10;TRMT9B;OSGEP;MRM1;TFB1M;AARS1;ELP5;PUS3;SARS1;JMJD6;HNRNPAB;METTL2B;TRIT1;NSUN2;FTSJ1;METTL3;THG1L;TRDMT1;FTSJ3
prerank,Positive Regulation Of Amyloid-Beta Formation (GO:1902004),-0.32312018482459853,-0.7679325437763437,0.7407407407407407,1.0,1.0,9/17,25.41%,IFNGR1;IFNG;GSAP;ABCG1;PICALM;EFNA1;SLC2A13;CLU;RELA
prerank,Receptor Metabolic Process (GO:0043112),0.327361570537148,0.767294895830765,0.7608695652173914,1.0,1.0,5/19,15.18%,SNX25;LGMN;MVB12A;PHETA2;PLEKHJ1
prerank,Positive Regulation Of Viral Life Cycle (GO:1903902),-0.3076877994148825,-0.7657652945938223,0.7049180327868853,1.0,1.0,6/20,17.24%,VPS37B;TSG101;CD209;FURIN;P4HB;TRIM11
prerank,Ventricular Cardiac Muscle Tissue Morphogenesis (GO:0055010),0.2790790049822738,0.7656069313468298,0.8604651162790697,1.0,1.0,1/32,0.14%,TNNT2
prerank,Sphingosine Metabolic Process (GO:0006670),0.28444695290812017,0.7652716277298733,0.75,1.0,1.0,6/19,20.03%,SPTLC3;PLPP1;SPTLC2;GBA1;ASAH2;SPTSSA
prerank,Regulation Of Neural Precursor Cell Proliferation (GO:2000177),0.28496840730547807,0.7646062464871332,0.8461538461538461,1.0,1.0,7/20,20.94%,TAFA1;DISP3;SHCBP1;TRIM71;DLL4;TAFA3;KDM1A
prerank,Plasma Membrane Bounded Cell Projection Organization (GO:0120036),0.21221691431014628,0.764570807750851,0.9459459459459459,1.0,1.0,33/126,23.12%,ATP1B2;TMEM108;ATCAY;CDK5;CARMIL1;CNTNAP2;CCR7;PQBP1;POU4F1;L1CAM;CORO1B;CTTN;CYFIP1;FRY;SNAPIN;PPP1R9B;BLOC1S5;PRMT1;NRTN;RASGRF1;OPHN1;NCDN;GBA1;BLOC1S1;RAB25;LIMA1;MAP2;RAB11A;CCDC32;PHPT1;PTPRM;CATIP;TBC1D24
prerank,Negative Regulation Of Stem Cell Population Maintenance (GO:1902455),0.2939576073041697,0.7642676214706069,0.8571428571428571,1.0,1.0,6/20,25.15%,HDAC2;TET1;LOXL2;SUDS3;HDAC1;RBBP4
prerank,Proteasome-Mediated Ubiquitin-Dependent Protein Catabolic Process (GO:0043161),-0.19824454060553307,-0.7642013438617857,0.9875,1.0,1.0,38/317,14.12%,FBXO27;FBXO9;RNF186;APC2;RNF103;ANKRD9;SPOPL;TRIM72;PPP2R5C;ZFAND2A;YOD1;FEM1C;UBXN2A;ITCH;FBXL2;TOPORS;HERPUD1;PRKN;SPSB4;SMURF2;RHOBTB3;PELI1;TBX21;AMFR;FAM8A1;SIAH2;PEX12;NFE2L2;MAN1A1;TRPC4AP;FAF2;RHBDD2;CUL5;KCTD2;BMAL1;RNF4;DNAJB9;AKIRIN2
prerank,Cellular Response To Mechanical Stimulus (GO:0071260),-0.26590272419613875,-0.7641406917728168,0.8688524590163934,1.0,1.0,10/48,14.98%,IL1B;TMEM150C;CASP8;PDE2A;TLR3;GADD45A;BCL10;PTGER4;TNFRSF10B;LTBR
prerank,Glycerophospholipid Catabolic Process (GO:0046475),-0.30071610703459556,-0.7639591757558744,0.7543859649122807,1.0,1.0,10/25,27.51%,PLA2G4F;PLA2G4B;GPCPD1;GDPD1;PLA2G15;SMPD4;PNPLA8;ABHD12B;PRDX6;PLA2G4A
prerank,Sensory Perception Of Mechanical Stimulus (GO:0050954),0.22538661527785178,0.7634994572788227,0.9230769230769231,1.0,1.0,23/84,17.86%,GSDME;MYO7A;SLC26A5;BIRC5;CLIC5;USP53;MARVELD2;WDR1;EPS8L2;EYA1;HOMER2;POU3F4;ZNF354A;ROR1;RIPOR2;EML2;MYO1A;WFS1;MYO7B;TIMM13;TBX1;SPTBN4;TPRN
prerank,Organophosphate Biosynthetic Process (GO:0090407),-0.28135302168295545,-0.7632304118316687,0.8545454545454545,1.0,1.0,9/32,19.18%,DDR2;ITPKA;GPHN;GK5;MOCS2;FITM1;IP6K1;IP6K2;AGPAT4
prerank,Positive Regulation Of Rho Protein Signal Transduction (GO:0035025),-0.2837010623435653,-0.7630503025529872,0.8214285714285714,1.0,1.0,6/27,12.87%,APOA1;GPR65;F2RL2;GPR35;F2R;P2RY8
prerank,Positive Regulation Of Monooxygenase Activity (GO:0032770),-0.303565823846058,-0.7617115884565278,0.8305084745762712,1.0,1.0,3/25,5.80%,IL1B;TERT;IFNG
prerank,Organic Hydroxy Compound Biosynthetic Process (GO:1901617),-0.2802821127982312,-0.7616455396299269,0.8103448275862069,1.0,1.0,5/41,6.67%,ALOX15;ALOX12;OSBPL6;CYP46A1;AKR1C3
prerank,Regulation Of Calcium Ion Transport (GO:0051924),0.24326151681171396,0.7612531632731251,0.8717948717948718,1.0,1.0,12/54,16.49%,HRC;CASR;LILRB1;GRIN3B;IL16;EFHB;ORAI1;SRI;HOMER2;FCRL3;WFS1;WNK3
prerank,Diacylglycerol Metabolic Process (GO:0046339),-0.280846379761907,-0.7603220557136028,0.8367346938775511,1.0,1.0,7/23,17.45%,DGKB;DAGLB;PLCE1;DGKE;GPAM;DGKG;PLA2G15
prerank,Protein Sumoylation (GO:0016925),-0.27411863332699005,-0.7600021005522506,0.7903225806451613,1.0,1.0,8/44,17.35%,RNF212;STX1A;TOPORS;SMC5;PIAS1;SENP5;TRPM4;KIAA1586
prerank,Regulation Of Cardiac Muscle Cell Membrane Repolarization (GO:0099623),-0.321942867716008,-0.7599067511462898,0.7307692307692307,1.0,1.0,4/21,16.72%,SCN5A;KCNE2;KCNA5;SNTA1
prerank,Regulation Of Stress Fiber Assembly (GO:0051492),-0.2515412394612456,-0.7585517806811101,0.9629629629629629,1.0,1.0,10/71,13.41%,WNT11;CGNL1;APOA1;PIK3R1;ARHGEF10;GPR65;SERPINF2;SORBS3;RHOC;PTGER4
prerank,Sister Chromatid Segregation (GO:0000819),0.2616130760711378,0.7584829780900666,0.8780487804878049,1.0,1.0,7/34,15.13%,SGO1;ESPL1;PLK1;ZWINT;TOP2A;KIF18A;NUSAP1
prerank,Type I Interferon-Mediated Signaling Pathway (GO:0060337),-0.2908403089475664,-0.7584646610891372,0.7872340425531915,1.0,1.0,2/37,1.82%,IFNA6;IFNA7
prerank,Positive Regulation Of DNA-binding Transcription Factor Activity (GO:0051091),-0.2086337579361545,-0.7582023043452926,0.9861111111111112,1.0,1.0,33/230,15.59%,VEGFA;CLEC7A;IL18RAP;ZIC2;DDR2;IL1B;IL18;RNF220;TRAF6;ADCY1;RIPK2;PPARG;CARD14;HSPA1B;JMY;WNT1;IL18R1;BTK;EDN1;TERF2IP;BCL10;PLCG2;RHEBL1;NOD1;RNF25;IL1RAP;TRIM21;EP300;MID2;ANKRD42;CEBPG;BMP2;RIPK4
prerank,Regulation Of Autophagy Of Mitochondrion (GO:1903146),0.3038602999158452,0.7578866109353072,0.825,1.0,1.0,6/19,20.09%,HTT;CAMKK2;GSK3A;VDAC1;PARK7;HAX1
prerank,Negative Regulation Of Phosphorylation (GO:0042326),0.22866715174837687,0.7576337046297414,0.9318181818181818,1.0,1.0,8/74,6.71%,BMP4;CDKN2B;PRR5L;SIRPA;CDKN2A;PTPN13;DYNLL1;PRDX3
prerank,Positive Regulation Of Interleukin-8 Production (GO:0032757),-0.2590352868563842,-0.7574218430872123,0.8636363636363636,1.0,1.0,9/60,12.48%,CLEC7A;LILRA2;IL1B;CHI3L1;HSPA1B;TLR3;BCL10;F2R;NOD1
prerank,Regulation Of Lysosomal Lumen pH (GO:0035751),0.2758237273101102,0.7568862976018621,0.8648648648648649,1.0,1.0,7/25,22.64%,TASL;GRN;CLN5;CLN6;ATP6V0B;SLC45A2;OCA2
prerank,Golgi Organization (GO:0007030),-0.23047113305784994,-0.7567967732559094,0.9,1.0,1.0,32/124,22.53%,YIPF4;LRRK2;SPTBN5;YIPF7;UBXN2A;GOLGA6B;GOLGA8N;ARHGAP21;GARIN4;BAG5;RAB6B;GOLGA8M;RAB30;GOLGB1;VCPIP1;TRIP11;LYSMD3;FHDC1;GOLGA8A;TRAPPC11;CSNK1D;GOLGA8S;PI4K2A;DYNC2H1;HACE1;SEC16B;SYNE1;ATP8B4;PLK3;GOLGA8J;PRKD1;COG1
prerank,Peptidyl-Serine Modification (GO:0018209),-0.21927510514135362,-0.756659362047349,0.9846153846153847,1.0,1.0,46/162,24.15%,PRKACG;MARK1;SRPK3;LATS2;AURKA;LRRK2;CAMK2B;GALNT13;GALNT3;VRK2;TBK1;PRKCG;MASTL;MAPKAPK2;GALNT16;PRKCD;UHMK1;MYO3B;CDC7;MGAT5B;CSNK1D;POGLUT3;RICTOR;TNKS;PNCK;NTMT1;CSNK1E;CAMK1G;PRKCE;TLK1;PKN2;SRPK2;TLK2;CAMK4;BRSK1;ULK2;TGFBR2;PRKD1;PKN3;LMTK2;DGKQ;MBOAT4;NEK6;PKN1;GRK2;PDGFB
prerank,Cellular Response To Xenobiotic Stimulus (GO:0071466),0.2727442300603762,0.75655113725813,0.7083333333333334,1.0,1.0,7/25,20.58%,MYC;ADIPOQ;GPLD1;KCNH2;VAV1;HTR1B;MEF2C
prerank,Epidermal Cell Differentiation (GO:0009913),0.24385243845456842,0.7564920353695739,0.8461538461538461,1.0,1.0,13/46,24.18%,ST14;GLI1;FGFR1;OPN3;HDAC2;DSP;CLIC4;ERCC2;UGCG;TGM1;EPHA2;CASP3;HDAC1
prerank,Regulation Of Calcium Ion Transmembrane Transporter Activity (GO:1901019),0.27994614148491,0.7562777949374048,0.7884615384615384,1.0,1.0,4/29,11.39%,HRC;CAMK2D;JPH3;FKBP1A
prerank,Axonemal Dynein Complex Assembly (GO:0070286),-0.2770932241267263,-0.7562532991847296,0.7547169811320755,1.0,1.0,12/34,26.04%,DNAAF4;DNAAF6;ODAD4;ODAD2;ZMYND10;CCDC63;DNAAF1;CFAP73;DNAI3;ODAD1;CCDC40;CCDC39
prerank,Positive Regulation Of Viral Process (GO:0048524),-0.25503364480768803,-0.7558682590771274,0.8387096774193549,1.0,1.0,12/40,24.75%,FKBP6;TMEM39A;CD209;TMEM250;PPIE;PPARA;ATG5;PKN2;SRPK2;ADARB1;CCL5;RSF1
prerank,Cellular Response To Salt (GO:1902075),-0.2385450480564722,-0.7556777269181723,0.8793103448275862,1.0,1.0,17/105,12.78%,ADGRV1;ALOX15;SCN5A;ITPKA;SYT15;ADCY1;RASA4;TRPV1;AKR1C3;DLG2;ZC3H12A;CACNA1A;P2RY1;ZNF16;PLCG2;P2RY12;MEF2A
prerank,Positive Regulation Of DNA Recombination (GO:0045911),0.2259269820260086,0.7549451734104132,0.9512195121951219,1.0,1.0,14/51,26.03%,PRDM9;OOEP;ACTL6A;SHLD1;RAD51AP1;RUVBL2;ERCC2;RUVBL1;BRD8;TP53BP1;VPS72;TIMELESS;WAS;PARP1
prerank,Positive Regulation Of Catabolic Process (GO:0009896),-0.24169143267257054,-0.7545868992359919,0.8970588235294118,1.0,1.0,10/78,9.87%,ASB9;IL1B;APC2;TNFAIP3;ASB11;NEDD4;ASB5;PRKN;TIPARP;PYHIN1
prerank,Negative Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001960),0.23123374187443616,0.7540576215983619,0.8125,1.0,1.0,26/57,28.42%,ARG1;PTPN2;F2RL1;IRAK3;OAS1;ISG15;TTLL12;PADI2;SAMHD1;PYDC2;XIAP;CARD16;IL1RN;OAS3;PPP2CB;USP18;METTL3;CYLD;DCST1;CNOT7;PTPRC;PARP14;UXT;STAT2;H2BC11;SIGIRR
prerank,Presynaptic Endocytosis (GO:0140238),0.2599810580243421,0.7538311159801254,0.9,1.0,1.0,7/31,15.94%,SYT5;PACSIN1;SNCA;CDK5;AP2S1;NLGN2;OPHN1
prerank,Heparan Sulfate Proteoglycan Biosynthetic Process (GO:0015012),0.2911831111477773,0.7533157576217119,0.8113207547169812,1.0,1.0,7/22,24.89%,EXT2;HS3ST3A1;GLCE;UGDH;HS3ST1;HS6ST1;HS3ST3B1
prerank,Regulation Of Double-Strand Break Repair Via Homologous Recombination (GO:0010569),0.21841528834673846,0.7529111812569219,0.918918918918919,1.0,1.0,19/71,26.03%,RMI2;OOEP;ACTL6A;FIGNL1;SHLD1;RAD51AP1;RPA2;ACTB;RUVBL2;SIRT6;KDM1A;RUVBL1;BRD8;TP53BP1;VPS72;UBQLN4;TIMELESS;WAS;PARP1
prerank,Receptor Recycling (GO:0001881),-0.3317098389753602,-0.7524576480287799,0.7962962962962963,1.0,1.0,6/16,22.66%,PEX1;NSG1;PEX2;PEX12;PLEKHA3;LMTK2
prerank,Nuclear-Transcribed mRNA Catabolic Process (GO:0000956),-0.24344626933832741,-0.752080654749086,0.8571428571428571,1.0,1.0,31/85,30.86%,ZC3H12A;TENT4B;EXOSC6;PAN2;CNOT1;EXOSC10;ERI1;CTIF;TUT1;CNOT6L;CSDE1;RC3H2;TENT2;DCP1A;UPF1;SMG8;MTPAP;PATL1;EXOSC9;TNKS1BP1;ZFP36L1;SAMD4A;UPF3A;HBS1L;PNRC2;SMG7;SMG6;CNOT2;CNOT4;DCP1B;DIS3L2
prerank,Cellular Response To Hydrogen Peroxide (GO:0070301),-0.2603607033629906,-0.7520157761167515,0.8301886792452831,1.0,1.0,14/33,27.66%,TNFAIP3;OSER1;EDN1;NFE2L2;PRKCD;SIRT1;MAPK7;SETX;RIPK1;CLU;AQP1;RELA;IL6;PLEKHA1
prerank,Translesion Synthesis (GO:0019985),-0.2959820138971499,-0.7519541429937964,0.7547169811320755,1.0,1.0,5/23,16.72%,USP43;POLE2;ZBTB1;SPRTN;RCHY1
prerank,Organophosphate Ester Transport (GO:0015748),0.27317755403903415,0.7512830076525016,0.8163265306122449,1.0,1.0,11/25,27.74%,TNFAIP8L3;PRELID2;SCP2;NPC2;SLC25A19;PRELID1;PITPNM1;PITPNB;PITPNA;PCTP;PLTP
prerank,Response To Organophosphorus (GO:0046683),0.3094270119009259,0.7509967780012059,0.851063829787234,1.0,1.0,5/18,12.93%,TYMS;NT5E;ENPP1;TRIM16;P2RX7
prerank,Protein Localization To Nucleus (GO:0034504),-0.23181608525874833,-0.7497730264993373,0.9166666666666666,1.0,1.0,25/119,24.95%,RANBP17;COL1A1;SIX4;NUP62;TOPORS;NXT1;BCL3;KPNA7;PEX2;AKIRIN2;KPNA5;WRN;NOL8;FAM53C;APLP2;RAP1GDS1;KPNA1;NUP133;TOR1AIP1;RANBP6;CNEP1R1;XPA;E2F3;TNPO2;POM121C
prerank,Protein Tetramerization (GO:0051262),-0.2544623805370304,-0.7491895622717631,0.9387755102040817,1.0,1.0,12/66,16.77%,ME1;UPB1;PKD2L1;TRPV1;FKRP;MS4A1;CTH;TRPV5;USP16;GBP5;GNMT;TRPM4
prerank,"Regulation Of Synaptic Transmission, Glutamatergic (GO:0051966)",0.23959274798612185,0.749072036074828,0.86,1.0,1.0,10/50,16.72%,TSHZ3;CCR2;CDK5;GRIN2D;DGKZ;DGKI;NLGN2;OPHN1;RNF167;PLPPR4
prerank,Cilium Assembly (GO:0060271),-0.21045038869977664,-0.7490164058934454,1.0,1.0,1.0,47/233,19.97%,EHD2;PIERCE1;NME8;CPLANE2;SPAG16;MAK;LRRC43;RP1L1;TEKT3;CEP83;CEP126;GORAB;ABLIM3;RSPH4A;BBS10;BBOF1;TBC1D31;CFAP43;CFAP58;ARL13B;DYNC2I1;TOGARAM1;TMEM250;ZMYND10;CFAP161;WDR90;ALPK1;CC2D2B;FHDC1;PARVA;CPLANE1;PCNT;CSNK1D;DNAAF1;RP1;DYNC2H1;ARMC9;TTC21B;IFT122;CCDC57;RAB17;IFT27;RAB8B;KIF3A;UBXN10;RILPL1;RSPH1
prerank,Negative Regulation Of Cellular Metabolic Process (GO:0031324),-0.2549192891536437,-0.7489255419012733,0.8285714285714286,1.0,1.0,8/45,10.94%,NUPR1;ACTN3;TERT;WNT1;BRCA1;PRKN;PLIN5;MT3
prerank,Regulation Of Interleukin-8 Production (GO:0032677),-0.23862380319266005,-0.7487295137147365,0.8857142857142857,1.0,1.0,12/79,13.21%,CLEC7A;LILRA2;IL1B;CHI3L1;CD33;HSPA1B;TLR3;BCL3;BCL10;F2R;NOD1;PTPN22
prerank,mRNA Transport (GO:0051028),-0.25797102359463137,-0.7486295330259863,0.8793103448275862,1.0,1.0,12/57,22.69%,DDX25;DDX39A;NXT1;PEG10;THOC3;NXF5;UPF1;NCBP3;DDX19B;KIF5C;NUP133;ZFP36L1
prerank,"Nuclear-Transcribed mRNA Catabolic Process, Deadenylation-Dependent Decay (GO:0000288)",-0.2813389392473733,-0.7475876064155854,0.7884615384615384,1.0,1.0,16/39,31.91%,EXOSC3;PAN2;DIS3;CNOT6L;RC3H2;NT5C3B;DCP1A;PATL1;EXOSC9;TNKS1BP1;SAMD4A;CNOT2;CNOT4;DCP1B;EXOSC2;RC3H1
prerank,Maintenance Of Protein Localization In Organelle (GO:0072595),0.3093561861566194,0.7474983548446851,0.8723404255319149,1.0,1.0,5/18,23.93%,HK2;HK1;TAF8;ARL2;KDELR2
prerank,Positive Regulation Of Double-Strand Break Repair (GO:2000781),-0.22988872445730435,-0.7469628808408645,0.9,1.0,1.0,23/84,26.22%,FMN2;SPIRE2;INSL6;FANCB;BCL7A;MBTD1;EPC1;MORF4L1;SIRT1;SMCHD1;SPIRE1;WDR48;DPF1;ARID2;FUS;MRGBP;SMARCC2;HELQ;ARID1B;MORF4L2;SMARCC1;EP400;DMAP1
prerank,Zinc Ion Transmembrane Transport (GO:0071577),0.27667254172711714,0.7469000927765789,0.8444444444444444,1.0,1.0,4/21,12.57%,SLC30A3;SLC39A14;SLC30A5;SLC39A1
prerank,Cell Morphogenesis Involved In Differentiation (GO:0000904),0.28358184227865035,0.7467641507857051,0.9069767441860465,1.0,1.0,8/24,24.69%,SIPA1L3;OPHN1;POF1B;RAB25;MEF2C;EPHA2;RILPL2;METTL3
prerank,Response To Amyloid-Beta (GO:1904645),-0.260274104334801,-0.7462597196369574,0.94,1.0,1.0,7/39,11.52%,VCAM1;IGF1;PRNP;CACNB1;CACNA1A;FCGR2B;NGFR
prerank,G Protein-Coupled Acetylcholine Receptor Signaling Pathway (GO:0007213),0.3138236158171845,0.7457966699235095,0.9148936170212766,1.0,1.0,6/16,19.51%,HRH4;RGS10;OPRM1;GNA11;CHRM3;HRH3
prerank,Amyloid Fibril Formation (GO:1990000),0.29491187274948727,0.7457342867261946,0.8378378378378378,1.0,1.0,5/22,15.85%,SIAH1;SNCA;CD36;FKBP1A;RIPK3
prerank,Positive Regulation Of Lymphocyte Differentiation (GO:0045621),0.235377725833756,0.7455651356740254,0.9,1.0,1.0,4/39,8.60%,IL4;AXL;CD27;ACTL6A
prerank,Response To Glucose (GO:0009749),-0.2566032060685477,-0.7455343366441676,0.847457627118644,1.0,1.0,10/44,17.74%,THBS1;KLRG1;SOX4;TCF7L2;IRS2;ZNF236;LIN28A;UNC13B;PRKAA2;SLC30A8
prerank,Glycerolipid Catabolic Process (GO:0046503),-0.31651672060472386,-0.7451382321292037,0.8076923076923077,1.0,1.0,4/18,12.83%,PLA2G4F;PLA2G4B;GPCPD1;GDPD1
prerank,Positive Regulation Of T Cell Differentiation (GO:0045582),-0.23617799610875423,-0.7447358442525759,0.8928571428571429,1.0,1.0,8/63,11.15%,GLI3;VNN1;SOX4;IL4I1;IL7;CD46;BCL6;ZBTB1
prerank,DNA Metabolic Process (GO:0006259),0.1884227176622913,0.7445247610606756,1.0,1.0,1.0,95/284,28.31%,TYMS;TICRR;NT5E;RMI2;EXD2;MCM10;EXO1;MCM4;NUDT1;RRM2B;FAM111B;ENDOG;DCTPP1;FBXO6;RBBP8;CDK1;TOP3B;ACTL6A;PRIM1;TREX2;ATRIP;INIP;TOP2A;TFPT;POLH;RNASEH2A;POLL;HLTF;MUS81;ERCC1;RAD51AP1;RECQL4;RPA2;SAMHD1;UNG;HMGB3;POLD2;DOT1L;THAP9;VCP;PARK7;DCLRE1C;RPA3;INTS3;RUVBL2;TOP1;MEN1;SMARCB1;CDC45;UBE2T;ATM;DDB1;APLF;PARP4;ISG20;MCM3;ORC4;OGG1;RAD52;DFFB;UBE2A;GTF2H4;TOP3A;APEX1;RUVBL1;MSH2;NABP1;NTHL1;RFC4;MSH6;REXO4;PARP3;FANCG;XRCC3;MCM5;TIMELESS;DNASE1L2;RPS3;RBMS1;PARP1;RAN;DNA2;NOC3L;PARG;MACROH2A1;RPA1;PDS5A;MRPL36;ENDOV;WDHD1;TERF1;POLD1;XRCC5;SP100;RPA4
prerank,Nucleocytoplasmic Transport (GO:0006913),-0.2574289044340193,-0.7440552820514061,0.819672131147541,1.0,1.0,11/49,23.77%,NUP62;AHCTF1;LSG1;RSRC1;CDKN1B;NUP54;CITED1;SEH1L;NUP133;NUP35;NEMF
prerank,Regulation Of Fibroblast Proliferation (GO:0048145),0.2447239463309881,0.743343881647556,0.9142857142857143,1.0,1.0,8/45,12.45%,MYC;CDK4;AMH;PLA2G1B;PARP10;SFRP1;S100A6;PDGFA
prerank,cGMP-mediated Signaling (GO:0019934),0.3001944392181558,0.7430644480118244,0.8541666666666666,1.0,1.0,4/16,15.09%,CD36;IRAG1;HTR2B;KCNC2
prerank,Positive Regulation Of miRNA Transcription (GO:1902895),-0.26156502487360916,-0.7425416346939925,0.9090909090909091,1.0,1.0,4/43,5.61%,PRL;TGFB2;PPARG;TERT
prerank,RNA Processing (GO:0006396),-0.212747177868318,-0.7422569685734974,0.9701492537313433,1.0,1.0,68/181,32.23%,EXOSC3;TENT4B;EXOSC6;RSRC1;CELF1;YJU2B;ZNF830;DDX17;EXOSC10;U2AF1;FBXO11;DIS3;SF3B1;HNRNPL;PRPF4;SLU7;RP9;FASTKD5;DIS3L;LIN28A;FASTKD2;LIN28B;RBM39;TBRG4;SNRPG;RNPC3;YJU2;DUSP11;SNRPA1;SRRM1;SRPK2;TFIP11;DNTTIP2;RBMS2;SETX;EXOSC9;FUS;TCERG1;SF3B4;ADARB1;NUDT21;RBM3;HNRNPUL1;AKAP8L;BCAS2;SF3A2;PRPF3;SRSF2;H2AB1;SRRM4;MPHOSPH10;CELF3;BICD1;SNRPD1;SRSF7;SF3A1;NOL9;RNGTT;ZCCHC8;PABPN1;DHX8;DDX54;EXOSC2;USP39;DDX20;ALKBH5;PPIG;ZCRB1
prerank,Negative Regulation Of Telomere Maintenance Via Telomere Lengthening (GO:1904357),-0.29501177178565013,-0.7419704596399136,0.7678571428571429,1.0,1.0,4/25,10.60%,STON1;TENT4B;SRC;EXOSC10
prerank,Negative Regulation Of Macromolecule Biosynthetic Process (GO:0010558),0.21131463262720815,0.7412180951918813,0.8863636363636364,1.0,1.0,19/95,19.65%,TYMS;TRIM2;ADIPOQ;ZNF540;ENPP1;DAPK1;EPHA4;IGF2BP3;NIBAN2;HDAC2;GSK3A;DHFR;TIA1;RACK1;TRIM71;TOB1;SERBP1;SHMT1;CNOT9
prerank,Glycosaminoglycan Biosynthetic Process (GO:0006024),-0.25546362928232336,-0.7408322559901673,0.8688524590163934,1.0,1.0,8/56,10.67%,CEMIP;CHST5;IL1B;CHSY3;CHST6;B4GALT4;ST3GAL3;ANGPT1
prerank,Positive Regulation Of Stem Cell Proliferation (GO:2000648),0.2848834071361085,0.740749503239112,0.8837209302325582,1.0,1.0,4/16,13.69%,N4BP2L2;PDCD2;NANOG;SOX11
prerank,Endothelial Cell Proliferation (GO:0001935),0.30237958455853253,0.7407358411070694,0.8222222222222222,1.0,1.0,5/17,15.17%,BMP4;SEMA5A;ANGPT4;LOXL2;HMOX1
prerank,Positive Regulation Of Programmed Cell Death (GO:0043068),-0.20581289228838792,-0.7403643144485532,0.9857142857142858,1.0,1.0,15/237,5.81%,FRZB;CLEC7A;SCIN;HTRA1;IGF2BP1;PXT1;LATS2;PIP5KL1;LRRK2;FOXL2;SOX4;CASP8;HOXA5;IFNG;GADD45G
prerank,"Retrograde Vesicle-Mediated Transport, Golgi To Endoplasmic Reticulum (GO:0006890)",0.22857056755897384,0.7401455850371988,0.8611111111111112,1.0,1.0,17/48,31.29%,ATP9A;GOLPH3L;HTT;ATP9B;ERGIC3;COG4;RER1;COG7;KDELR2;KIF1C;COPB2;PITPNB;USE1;LMAN2;SEC22B;KDELR1;RAB43
prerank,Regulation Of Cytokine Production Involved In Inflammatory Response (GO:1900015),-0.2595008776024382,-0.7400735081103249,0.8305084745762712,1.0,1.0,5/43,9.38%,CLEC7A;PER1;ZC3H12A;PSG4;APOD
prerank,Regulation Of Cell Differentiation (GO:0045595),-0.20888981594197592,-0.7397699911282165,0.9516129032258065,1.0,1.0,21/188,10.58%,SCIN;GCM1;EDN3;APC2;LTK;ZFHX3;ST7;CEBPD;MBOAT2;SIK1;MEGF10;HEY2;RUNX3;NR1D2;PHLDB1;SERPINF2;ID2;FGF8;SPOCK2;HEY1;DDX17
prerank,Protein Targeting To Vacuole (GO:0006623),-0.2741033079111659,-0.7395315577434047,0.819672131147541,1.0,1.0,3/33,7.39%,IRGM;NEDD4;VPS37B
prerank,Negative Regulation Of RNA Biosynthetic Process (GO:1902679),0.3109404187463543,0.7388925548460161,0.8837209302325582,1.0,1.0,1/15,0.92%,APOBEC3D
prerank,Cellular Response To Inorganic Substance (GO:0071241),0.3061443446308083,0.7387130591007356,0.8421052631578947,1.0,1.0,6/18,29.46%,AOC1;KCNC2;DDI2;TIMELESS;CDK2;DDI1
prerank,Very Long-Chain Fatty Acid Metabolic Process (GO:0000038),0.25316152381235285,0.7382637544864431,0.8333333333333334,1.0,1.0,3/31,8.35%,ELOVL7;SLC27A4;CYP4F2
prerank,Interstrand Cross-Link Repair (GO:0036297),-0.2689969043200513,-0.7382636366447102,0.7843137254901961,1.0,1.0,11/35,21.70%,RNF168;FANCL;FANCB;FAAP24;FANCD2;HROB;FANCC;DCLRE1A;FAAP20;MCM9;NUCKS1
prerank,Sulfur Compound Catabolic Process (GO:0044273),-0.2983258636029186,-0.7375248894042331,0.8823529411764706,1.0,1.0,2/20,7.35%,SUCLA2;MLYCD
prerank,Cellular Response To Steroid Hormone Stimulus (GO:0071383),0.27080570604577087,0.7374846087949104,0.8611111111111112,1.0,1.0,2/24,3.84%,BMP4;HSPA1A
prerank,Retinoid Metabolic Process (GO:0001523),0.26535024441511895,0.7371476345763309,0.8863636363636364,1.0,1.0,11/37,21.23%,ALDH8A1;BCO2;CYP1B1;DHRS4L1;NAPEPLD;RDH11;LRAT;RDH13;AKR1B10;CYP4V2;DHRS4
prerank,Regulation Of Transcription Initiation By RNA Polymerase II (GO:0060260),-0.24753852769159326,-0.7366798248733543,0.9074074074074074,1.0,1.0,13/56,18.29%,MED26;MED21;HEY2;TAF5;HNF1A;TAF13;PPM1D;TAF7;MED13;MED27;MED9;DHX36;MED30
prerank,Interleukin-1-Mediated Signaling Pathway (GO:0070498),0.3005483769399418,0.7364449837760814,0.875,1.0,1.0,9/19,23.59%,IL1R1;MAP3K7;IRAK3;ST18;IKBKB;MYD88;RPS6KA4;TNIP2;IRAK4
prerank,Positive Regulation Of Ion Transmembrane Transporter Activity (GO:0032414),-0.2849624480801031,-0.7364049515056088,0.8928571428571429,1.0,1.0,8/31,14.73%,CFTR;PDZK1;IFNG;AKAP9;EDN1;CCL2;ANK3;WNK2
prerank,Cytosolic Transport (GO:0016482),-0.2208419199344209,-0.7359896506918637,0.921875,1.0,1.0,41/122,30.06%,RAB6C;MAGEL2;VPS54;RAB9A;RAB6B;RHOBTB3;GOSR1;AP1G1;RAB6D;VPS26A;SPAG9;RBSN;PIP4K2A;MON2;EMP2;VPS13C;BET1L;STX6;HEATR5A;SORT1;PLEKHA3;HEATR5B;STX16;LMTK2;ATG14;CLTCL1;WDR91;VPS52;ERC1;CLTC;WDR81;BAIAP3;PIK3R4;VTI1A;RAB5A;VPS53;SYT7;WASHC2C;VPS29;DCTN1;PXK
prerank,Negative Regulation Of Cell Migration (GO:0030336),-0.22084548256185021,-0.7359029582583759,0.9428571428571428,1.0,1.0,36/155,20.83%,WNT11;MAGI2;CLDN19;NDRG4;PLXNB3;PIP5KL1;ACVRL1;MAPK15;DACH1;SRGAP1;DLG5;SLIT2;NGFR;MMRN2;RAP2A;THY1;IGFBP5;CLDN3;EPPK1;GTPBP4;CDH11;NOG;RAP2C;MCC;ARID4A;TCAF1;MITF;ARPIN;SERPINE1;IGFBP3;ARID4B;ING2;ARID2;PTPRU;SAP30L;ARHGAP4
prerank,Acylglycerol Biosynthetic Process (GO:0046463),-0.2749138881489156,-0.735465432878268,0.82,1.0,1.0,10/22,27.51%,ANG;PLCE1;LPIN1;GPAM;PLA2G15;GPAT2;DGAT1;PNPLA2;PNPLA3;PLA2G4A
prerank,Regulation Of Centrosome Cycle (GO:0046605),-0.29319025991745734,-0.7351157658086129,0.8245614035087719,1.0,1.0,3/23,7.80%,AURKA;RAB6C;CCNL2
prerank,Negative Regulation Of Carbohydrate Metabolic Process (GO:0045912),-0.28546114094909764,-0.7348249739701251,0.9130434782608695,1.0,1.0,6/29,17.55%,NUPR1;C1QTNF12;SIK1;C1QTNF3;EP300;PPARA
prerank,Regulation Of Programmed Cell Death (GO:0043067),-0.2060253703211252,-0.7338803792472658,1.0,1.0,1.0,43/187,21.11%,USP17L13;PAX8;NUP62;CIDEA;STYK1;LRRK2;ACTN3;OSGIN1;USP17L11;USP17L15;USP17L7;CCNL2;USP42;PRKN;AKT1S1;BCL3;FBXO11;DAPK2;TNFSF9;ACER3;TNFRSF10B;MBTD1;MOAP1;ALPK2;XPNPEP1;CITED1;EPC1;RBM25;PHLPP1;MORF4L1;SIRT1;GAS1;ZDHHC17;IRF3;RAF1;DPP8;ALB;NAE1;BIRC7;ANP32E;USP36;PLK5;MRGBP
prerank,Regulation Of Macromolecule Metabolic Process (GO:0060255),-0.21629833404678805,-0.7336876473625947,0.9852941176470589,1.0,1.0,27/152,18.30%,STOX1;IGF2BP1;TRIML1;EDN3;NKAPL;IGF1;PEG3;SLC8A1;ZC3H12A;NPC1;TRIM51G;AFF2;POU5F1;ADNP2;NFKBID;ZNF827;NOVA2;ZNF335;TSKU;ALPK2;HNRNPDL;MTMR2;KDM6A;TRIM11;INSM1;LHX1;C1D
prerank,Nuclear Transport (GO:0051169),-0.27309411468571626,-0.7331499625534706,0.8727272727272727,1.0,1.0,8/38,23.18%,NUP62;AHCTF1;RSRC1;NUP54;CITED1;SEH1L;NUP133;NUP35
prerank,Protein Localization To Organelle (GO:0033365),-0.21945914250805743,-0.7327878945930923,0.9285714285714286,1.0,1.0,7/136,5.50%,COL1A1;TUB;SIX4;RNF186;LRRK2;CCDC47;CNTLN
prerank,Cellular Response To Sterol (GO:0036315),0.30408980069854774,0.732579633951036,0.8444444444444444,1.0,1.0,1/15,0.77%,GRAMD1C
prerank,Negative Regulation Of Response To Biotic Stimulus (GO:0002832),-0.26473772815296415,-0.7321883122968013,0.847457627118644,1.0,1.0,10/44,20.24%,LILRA2;IRGM;TNFAIP3;ITCH;MUL1;TRIM21;PPM1B;ATG5;CGAS;DTX4
prerank,Protein Targeting To Lysosome (GO:0006622),0.26587166617220437,0.7319230023075095,0.85,1.0,1.0,3/25,16.57%,NCOA4;M6PR;HSPA8
prerank,Negative Regulation Of Viral Process (GO:0048525),-0.2423682570422615,-0.7319186062690443,0.9245283018867925,1.0,1.0,14/60,20.60%,IFNL3;BTBD17;APOBEC3A;LARP7;FAM111A;TRIM21;MID2;APOBEC3H;UBP1;TRIM11;APOBEC3F;TRIM6;SRPK2;N4BP1
prerank,Positive Regulation Of DNA-templated Transcription Initiation (GO:2000144),0.22954336377449852,0.7316993610383686,0.9545454545454546,1.0,1.0,14/55,24.31%,TWIST1;TAF11;TAF4B;MED11;SRF;MED20;FOSL1;MED22;TAF8;MDC1;ZNHIT1;TAF1;MED18;MED10
prerank,GPI Anchor Metabolic Process (GO:0006505),-0.27970446312806413,-0.731551472673234,0.8620689655172413,1.0,1.0,10/26,26.36%,PGAP2;PIGA;PIGP;PIGB;TP53INP2;MPPE1;PIGL;PIGH;DPM1;PIGW
prerank,Regulation Of Heterotypic Cell-Cell Adhesion (GO:0034114),-0.3028429276781386,-0.7310460207958145,0.8490566037735849,1.0,1.0,6/24,20.63%,IL1B;APOA1;THY1;CEACAM6;MAP2K5;MAPK7
prerank,Positive Regulation By Host Of Viral Process (GO:0044794),-0.29320636920461096,-0.7308136740727361,0.8524590163934426,1.0,1.0,1/17,2.52%,KRT17
prerank,Regulation Of Response To Cytokine Stimulus (GO:0060759),0.3117229859034214,0.7300538968227333,0.8367346938775511,1.0,1.0,2/15,8.57%,KLF4;CD24
prerank,Apical Junction Assembly (GO:0043297),-0.25084888263933697,-0.7300030491678354,0.864406779661017,1.0,1.0,8/49,13.48%,PARD3;CLDN19;CLDN16;CLDN8;CLDN34;CLDN9;RHOC;CLDN3
prerank,Negative Regulation Of Release Of Cytochrome C From Mitochondria (GO:0090201),0.2904761923521915,0.7299583695804188,0.7954545454545454,1.0,1.0,1/15,0.79%,NOL3
prerank,Negative Regulation Of Proteolysis Involved In Protein Catabolic Process (GO:1903051),0.2684319266645441,0.7293664740619993,0.9019607843137255,1.0,1.0,6/24,22.32%,HFE;EPHA4;OPHN1;LAMP3;PDCL3;TAF1
prerank,Phosphatidylinositol Metabolic Process (GO:0046488),-0.2427569501273676,-0.7291473626453172,0.875,1.0,1.0,17/61,27.10%,PITPNM3;CSF1R;PLCB1;INPP5J;PLCD1;PIP4P1;PLCG2;MTMR2;PI4K2A;INPPL1;MTMR14;PI4KA;CDS1;SLC27A1;SYNJ2;PIGW;SACM1L
prerank,Bicellular Tight Junction Assembly (GO:0070830),-0.2648574100516943,-0.7284792628084847,0.9137931034482759,1.0,1.0,7/42,13.48%,PARD3;CLDN19;CLDN16;CLDN8;CLDN34;CLDN9;CLDN3
prerank,Positive Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001238),0.2544711982698715,0.7280840879711179,0.8648648648648649,1.0,1.0,14/30,27.86%,TNFSF10;BID;PYCARD;SFRP1;GPER1;TLR4;LTB;HYAL2;TNFSF12;TRAF2;CYLD;TLR6;TNF;DEDD2
prerank,Protein-Containing Complex Assembly (GO:0065003),-0.19389449172372594,-0.7274997962451795,1.0,1.0,1.0,50/314,17.60%,MIS12;RAB5IF;PARD3;CASQ2;OTX2;VIL1;COX7A2;IRGM;CALY;SHANK1;ANKS4B;LRRK2;STXBP6;SLC7A9;FCHO2;CCDC103;MAPT;DNAAF6;NSG2;RIMS1;ZC3H12A;RSPH4A;NPC1;BBS10;SRC;MZB1;ANGPT1;NSG1;OTUD6B;YAP1;MAPK8IP2;HIGD1C;CENPC;IL1RAP;WASF3;HOPX;CREBBP;TRAPPC11;CXCL12;CSNK1D;PTGES3L;PEX14;KNTC1;PICALM;DNAAF1;SLC2A1;PALS2;PLEKHA7;FANCC;FADD
prerank,Regulation Of Cell Adhesion Mediated By Integrin (GO:0033628),-0.2731872058912002,-0.7272416106589098,0.8333333333333334,1.0,1.0,9/32,22.26%,TGFB2;LYN;ADAM9;RET;P2RY12;EFNA1;SERPINE1;RAC3;PIK3CG
prerank,Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043122),-0.2026099287500941,-0.7271521349910693,1.0,1.0,1.0,61/226,23.39%,CLEC7A;NUP62;IL1B;IRGM;LURAP1;PER1;RORA;TLE1;TRAF6;CASP8;RIPK2;REL;TNFAIP3;PELI2;ZC3H12A;PRKN;TBK1;SLC39A8;PELI1;TRIM39;TERF2IP;MUL1;BCL10;PLCG2;F2R;GPR89A;NOD1;RHOC;NR1D1;PPM1A;ALPK1;TRIM21;TNFRSF10B;MID2;LTBR;LITAF;CARD19;TRAF4;SIRT1;PPM1B;ZDHHC17;FADD;DHX36;PIDD1;MIER1;TRIM6;TLR9;SLC20A1;EDAR;RFPL1;GOLT1B;TIFA;RIPK1;OTUD7B;CXXC5;RFPL3;PRKD1;MAP3K3;CD74;MAP3K14;NEK6
prerank,Regulation Of Vascular Endothelial Growth Factor Production (GO:0010574),-0.29765836002730095,-0.7268850075928828,0.8275862068965517,1.0,1.0,4/23,8.85%,IL1B;FLT4;RORA;BRCA1
prerank,Mitochondrial Translation (GO:0032543),0.21336137741171401,0.7263771545920256,1.0,1.0,1.0,37/96,34.35%,MRPS26;MRPL51;MRPS33;MRPL24;MRPS31;MRPS9;MRPS21;MRPS5;MRPL48;MRPL18;MRPS17;MRPL27;MRPL52;MRPS18C;MRPL34;MRPL28;GATC;MRPL58;MRPS25;MRPS11;MRPL53;MRPL1;MRPL36;GADD45GIP1;RARS2;MRPS6;MTIF3;MRPS2;MRPS15;MRPS18B;MRPS23;MRPL46;DROSHA;MRPL23;MRPL42;MRPL11;MRPS28
prerank,Proteoglycan Biosynthetic Process (GO:0030166),-0.26271096120622583,-0.7255972747516273,0.8301886792452831,1.0,1.0,18/32,35.32%,IGF1;CHST10;B3GAT1;CSGALNACT2;BMPR1B;BMPR2;PXYLP1;XYLT1;EXT1;B3GAT2;SLC35D2;B4GALT7;FOXL1;NDST3;CHST9;GAL3ST3;CSGALNACT1;CHST13
prerank,Protein Insertion Into Membrane (GO:0051205),-0.30181125667371445,-0.7253153823243776,0.8392857142857143,1.0,1.0,3/19,8.07%,CCDC47;REEP1;MAIP1
prerank,Stem Cell Differentiation (GO:0048863),0.23479474264578426,0.7250414699554572,0.9090909090909091,1.0,1.0,10/38,20.58%,BATF;MEOX1;SFRP1;SOX21;EPOP;HTR2B;KIT;ELL3;METTL5;MEF2C
prerank,Regulation Of Release Of Sequestered Calcium Ion Into Cytosol (GO:0051279),0.2415688449249912,0.7248518801681523,0.9534883720930233,1.0,1.0,9/49,13.09%,HRC;SNCA;CAMK2D;F2;CX3CL1;SRI;JPH3;FKBP1A;GPER1
prerank,Chromatin Organization (GO:0006325),0.1766629545924429,0.7246230032915355,1.0,1.0,1.0,48/261,21.87%,MYC;SMARCA1;ASF1B;H2BC13;FOXP3;TTI1;H2BC17;VCX;H2BC3;ACTL6A;HDAC2;H2BC9;H4C9;BRDT;CECR2;NASP;PARP10;TET1;PADI2;TFPT;DPF3;HDAC11;H1-5;HIRIP3;PAK1;H3C1;H3C14;H2AX;H3-4;DAXX;HDAC10;RUVBL2;TOP1;SMARCB1;PCGF6;NUDT5;H2BC15;H2BC14;GATAD2B;H4C7;BANF1;SFPQ;NPM2;CFDP1;IWS1;ING4;RUVBL1;ZNHIT1
prerank,Protein Palmitoylation (GO:0018345),0.2575970198031898,0.7241828331682549,0.96,1.0,1.0,11/30,23.36%,ZDHHC23;ZDHHC1;HHAT;ZDHHC16;GOLGA7B;ZDHHC22;PORCN;ZDHHC9;ZDHHC24;ZDHHC8;ZDHHC12
prerank,Regulation Of Autophagy (GO:0010506),-0.20105821096312812,-0.7241280835454806,0.9864864864864865,1.0,1.0,29/234,14.90%,MAGEA3;NUPR1;DCN;GFAP;ATP6V0D2;IRGM;LRRK2;MAPK15;FZD5;EEF1A2;GPR137;IFNG;NEDD4;MAPT;TRIM23;FBXL2;ZC3H12A;PRKN;TBK1;DRAM1;DAPK2;VPS26A;PTPN22;FOXK1;TRIM21;EP300;SMCR8;PIP4K2A;MID2
prerank,Negative Regulation Of Intrinsic Apoptotic Signaling Pathway By P53 Class Mediator (GO:1902254),-0.30895212762532265,-0.7240763740963031,0.8771929824561403,1.0,1.0,6/15,23.16%,PRKN;SIRT1;TRIAP1;MARCHF7;ING2;CD74
prerank,Negative Regulation Of Fat Cell Differentiation (GO:0045599),-0.2848269038483551,-0.7239638242237109,0.8571428571428571,1.0,1.0,9/32,17.17%,RORA;WNT1;WNT10B;TRIO;YAP1;BMAL1;BMP2;ZFP36L2;SIRT1
prerank,Phospholipid Metabolic Process (GO:0006644),0.210795055625894,0.7237412324961875,0.95,1.0,1.0,14/65,21.38%,TNFAIP8L3;CYP2W1;LIPG;LCAT;PLA2G4C;PLA2G1B;PLD1;PLPP1;PLPPR4;AGPAT5;FADS1;IDI2;ENPP2;AGPAT1
prerank,Protein K48-linked Ubiquitination (GO:0070936),-0.23419754617455155,-0.7236249700142461,0.8955223880597015,1.0,1.0,13/70,19.29%,FBXO9;TNFAIP3;ITCH;TOPORS;PRKN;PELI1;RNF115;RNF4;TRIM21;UBE2E3;UBE2E2;HACE1;TRIM6
prerank,Epigenetic Regulation Of Gene Expression (GO:0040029),-0.23458456960250118,-0.7234121762916247,0.96,1.0,1.0,26/79,29.34%,H1-8;GLMN;RNF168;DIRAS3;INSL6;ZNF335;PPM1D;EP300;EPC1;PHF1;SMYD5;KAT7;CREBZF;GLYR1;KDM1B;ARID1B;ZFP57;N6AMT1;MTA1;BMI1;SPHK2;IGF2;SMARCD1;TDG;RBBP5;HDAC4
prerank,Steroid Biosynthetic Process (GO:0006694),0.23725507686070957,0.723177473544249,0.9230769230769231,1.0,1.0,14/48,21.45%,CYP7B1;HSD17B1;HSD3B7;CH25H;CYP27A1;SCP2;PMVK;CYP8B1;OSBPL1A;AMACR;AKR1D1;ABCD3;HMGCR;FDXR
prerank,Positive Regulation Of Response To Endoplasmic Reticulum Stress (GO:1905898),-0.2788922821468064,-0.7229840622288699,0.803921568627451,1.0,1.0,11/18,35.66%,PIK3R1;FCGR2B;PMAIP1;RNFT1;NCK1;ERN1;RNF185;BCL2L11;XBP1;USP13;TMEM259
prerank,Phospholipid Dephosphorylation (GO:0046839),-0.2935337589293765,-0.7227079961043085,0.8275862068965517,1.0,1.0,6/29,16.43%,INPP5J;PLPPR2;PLPPR3;PIP4P1;PLPP5;MTMR2
prerank,tRNA Modification (GO:0006400),0.21975941717921652,0.7220633996208969,0.926829268292683,1.0,1.0,20/67,23.81%,TRMT9B;TRMT10A;GON7;OSGEP;TRMT13;THUMPD3;CTU1;PUSL1;ELP5;PUS1;PUS3;SARS1;TRMT112;WDR6;METTL2B;TRIT1;TRMT6;GTPBP3;NSUN2;FTSJ1
prerank,Peptidyl-Lysine Modification (GO:0018205),0.2013458695814849,0.7217824415054042,0.9722222222222222,1.0,1.0,24/91,23.16%,LOXL1;EEF1AKMT3;EEF1AKMT1;BCL11A;EEF1AKMT2;SUMO4;SENP1;NSMCE1;EYA1;P3H4;SLF1;LOXL3;SIRT5;LOXL2;PARK7;NNAT;HDAC10;BLOC1S1;ATPSCKMT;HDAC9;UBA2;PIAS3;SAE1;PLOD3
prerank,Positive Regulation Of Protein Localization To Nucleus (GO:1900182),-0.23288686505806194,-0.7215901228034204,0.9032258064516129,1.0,1.0,18/71,20.38%,PIK3R1;TERT;IFNG;ZC3H12A;TCF7L2;ZPR1;LARP7;PYHIN1;YAP1;NGFR;PRKCD;EFCAB7;EP300;CREBBP;BAG3;KAT7;PPP3CB;CCT6A
prerank,Regulation Of Stem Cell Proliferation (GO:0072091),-0.31987532312742295,-0.7215185585681264,0.8181818181818182,1.0,1.0,6/16,26.50%,TERT;YAP1;HMGB2;ZFP36L1;HMGA2;FBLN1
prerank,mRNA Processing (GO:0006397),-0.20367650308876425,-0.7212751385320587,1.0,1.0,1.0,69/207,32.03%,CRNKL1;RPRD1B;CWF19L1;DDX39A;RSRC1;CELF1;U2AF1;FBXO11;SNIP1;NOVA2;RPRD1A;SF3B1;PRPF4;SLU7;RNMT;CMTR1;PPIE;PHF5A;TBRG4;SNRNP27;SNW1;SNRPG;CENATAC;RNPC3;FRA10AC1;SNRPA1;SRRM1;TFIP11;WDR83;XAB2;TCERG1;PRPF40A;SF3B4;FRG1;CWF19L2;SYF2;NUDT21;AQR;SRSF10;DHX35;SNRPB2;DDX46;PNN;BCAS2;SF3A2;PRPF3;METTL14;SRSF2;ERN1;H2AB1;SRRM4;ESS2;NR5A1;RBM19;SNRPD1;SRSF7;RAMAC;SF3A1;SRSF3;RNGTT;ZCCHC8;DHX8;CWC15;MFAP1;SRSF8;USP39;BUD31;ALKBH5;ZMAT2
prerank,Positive Regulation Of Cell Cycle Process (GO:0090068),0.20829837749366129,0.7209644547864692,1.0,1.0,1.0,30/114,21.72%,AURKB;OOEP;RRM2B;KIF14;PLSCR1;BIRC5;CIT;RGCC;GPSM2;CENPJ;RACGAP1;NCAPG;CDC14C;TGFA;E2F7;CDCA8;NUSAP1;CDC25B;RHNO1;INSR;NCAPD2;CDC6;OR2A4;ECT2;NPM2;PKP4;DBF4B;CXCR5;MAP10;SPAG5
prerank,Regulation Of Protein Export From Nucleus (GO:0046825),-0.2884011460115766,-0.7208338603251716,0.8035714285714286,1.0,1.0,6/22,20.42%,IL1B;FRAT1;UHMK1;BAG3;XPO4;FRAT2
prerank,Negative Regulation Of Secretion By Cell (GO:1903531),-0.2566290286549505,-0.7206415413073556,0.8846153846153846,1.0,1.0,7/40,14.64%,IL12A;STXBP6;GRM7;CYP51A1;IL11;SLC30A1;SMCR8
prerank,Regulation Of Protein Localization To Membrane (GO:1905475),0.2653450501954689,0.7201681300762995,0.8947368421052632,1.0,1.0,9/28,25.83%,GBP1;SLC5A3;CDK5;LDLRAP1;GPC1;SIRT6;FYN;SPTBN1;VAMP8
prerank,Regulation Of Erythrocyte Differentiation (GO:0045646),-0.2713994257537341,-0.7199839311472875,0.94,1.0,1.0,10/36,24.36%,LYN;HOXA5;HSPA1B;ACVR1B;ZNF16;BRD1;HMGB2;ZFP36L1;LDB1;GATA1
prerank,Melanosome Organization (GO:0032438),-0.26396253732080466,-0.7198029044528619,0.819672131147541,1.0,1.0,11/36,24.25%,AP1S3;BACE2;LYST;PMEL;AP1G1;AP3D1;AP3B1;BLOC1S2;ASIP;HPS6;HPS4
prerank,Regulation Of DNA Recombination (GO:0000018),0.22658385256526892,0.7192368774229784,0.9318181818181818,1.0,1.0,12/43,22.74%,IL4;FIGNL1;H1-5;H1-3;RAD51AP1;RPA2;H1-0;H1-2;SIRT6;KDM1A;MSH2;MSH6
prerank,Non-Membrane-Bounded Organelle Assembly (GO:0140694),-0.21790179985618058,-0.7192281836086964,0.9866666666666667,1.0,1.0,30/128,21.85%,MIS12;PGM5;NUP62;MAPT;GOLGA6B;GOLGA8N;NPC1;GOLGA8M;HAUS2;CSDE1;CENPC;FITM1;GOLGA8A;HAUS3;CSNK1D;GRB7;TNKS;YTHDF3;GOLGA8S;DDX6;MYH6;PATL1;SH3PXD2B;HAUS8;G3BP2;SFI1;STARD9;FXR1;DAZAP2;GOLGA8J
prerank,Negative Regulation Of Calcium Ion Transmembrane Transport (GO:1903170),-0.29307344584240125,-0.7190257000595386,0.9107142857142857,1.0,1.0,5/18,21.45%,ATP1A2;PPP3CA;EPO;PPP3CB;FKBP1B
prerank,Negative Regulation Of Microtubule Polymerization Or Depolymerization (GO:0031111),0.2652582090176118,0.7189704162701772,0.8269230769230769,1.0,1.0,8/29,21.81%,TPX2;SNCA;CAMSAP2;CLIP3;EML2;FKBP4;MAP2;SPEF1
prerank,Protein Stabilization (GO:0050821),-0.19859444257493175,-0.7189111460559918,1.0,1.0,1.0,45/194,24.84%,TYROBP;IRGM;IGF1;APOA1;SOX4;PIK3R1;PER3;AAK1;CTNND1;HSPA1B;TTI2;BAG5;USP29;PRKN;WNT10B;PYHIN1;MT3;TRIM39;MUL1;ZNF207;GOLGA7;PRKCD;PARVA;EP300;RPL17;GTPBP4;TSPAN1;EFNA1;BAG1;BAG3;CCNH;HIP1R;MARCHF7;CCT6A;USP36;GNAQ;CDC37L1;COA8;TSC1;PFN2;PDRG1;HPS4;PLPP3;CLU;NAA15
prerank,Positive Regulation Of NLRP3 Inflammasome Complex Assembly (GO:1900227),0.27608517132567256,0.7186561417883477,0.8222222222222222,1.0,1.0,8/18,29.77%,MAPK8;CD36;TLR4;MYD88;TLR6;DHX33;NEK7;USP50
prerank,Regulation Of Early Endosome To Late Endosome Transport (GO:2000641),-0.30608971151006287,-0.7185046887679267,0.7916666666666666,1.0,1.0,10/18,35.18%,SRC;DNAJC13;MTMR2;RDX;MSN;DENND10;RAB21;VPS11;MAPK3;EZR
prerank,Sterol Transport (GO:0015918),-0.29310834035666544,-0.7174830075155739,0.7924528301886793,1.0,1.0,4/24,9.07%,MSR1;APOA1;NPC1L1;NPC1
prerank,Regulation Of Gluconeogenesis (GO:0006111),-0.2682665359083267,-0.7171893821034053,0.9298245614035088,1.0,1.0,9/30,23.09%,C1QTNF12;SIK1;C1QTNF3;EP300;GNMT;SIRT1;NNMT;FBP1;DGKQ
prerank,Endoplasmic Reticulum To Golgi Vesicle-Mediated Transport (GO:0006888),0.19857326576313838,0.7168765975822877,1.0,1.0,1.0,26/112,23.97%,CTAGE6;TMED9;CTAGE9;LMAN2L;YIF1A;IER3IP1;USO1;RANGRF;TEX261;CNIH4;TBC1D20;LMAN1L;PDCD6;RAB1B;SEC24D;ERGIC3;TRAPPC3;PGAP1;GOSR2;TRAPPC6A;YIF1B;MIA2;PREB;SEC24A;KDELR2;SPAST
prerank,Regulation Of Hematopoietic Progenitor Cell Differentiation (GO:1901532),-0.2910679339026511,-0.7164761254569632,0.875,1.0,1.0,10/17,30.66%,ITCH;DHX36;MYB;YTHDF2;METTL14;KITLG;SETD1A;OSM;KAT5;FOXC1
prerank,Alpha-Amino Acid Catabolic Process (GO:1901606),-0.29618879050016955,-0.7163788549563458,0.8269230769230769,1.0,1.0,3/25,5.26%,THNSL2;HOGA1;IL4I1
prerank,Negative Regulation Of Small Molecule Metabolic Process (GO:0062014),-0.2703878344365329,-0.7155955659494463,0.88,1.0,1.0,4/32,7.52%,NUPR1;ACTN3;C1QTNF12;SIK1
prerank,Negative Regulation Of Signaling Receptor Activity (GO:2000272),-0.267894700660669,-0.7155611064241632,0.8793103448275862,1.0,1.0,6/25,20.27%,CBLB;PPARG;TSG101;SOCS5;PPARA;CBLC
prerank,Regulation Of Small Molecule Metabolic Process (GO:0062012),-0.2583046915256838,-0.7154877968392725,0.8235294117647058,1.0,1.0,13/40,23.09%,RORA;MLYCD;PRKN;FMO5;ABCG1;RORC;FOXK1;EP300;SIRT1;PPARA;PRKAG2;ACADVL;DGKQ
prerank,Negative Regulation Of DNA Recombination (GO:0045910),-0.25115959897083007,-0.7152667230674805,0.9629629629629629,1.0,1.0,12/40,24.65%,H1-8;H1-1;TERF2IP;INSL6;FANCB;ZSCAN4;SMCHD1;BLM;CGAS;RADX;MSH3;KLHL15
prerank,Detection Of Chemical Stimulus Involved In Sensory Perception Of Bitter Taste (GO:0001580),-0.2586505143823182,-0.7149946540256434,0.875,1.0,1.0,10/36,17.82%,CST1;TAS2R42;TAS2R38;TAS2R60;TAS2R10;TAS2R4;TAS2R3;TAS2R20;TAS2R7;TAS2R30
prerank,Regulation Of Hippo Signaling (GO:0035330),0.26781333323064693,0.7148398686183233,0.8666666666666667,1.0,1.0,4/24,16.95%,WWC1;CIT;SOX11;VGLL4
prerank,DNA-templated Transcription Elongation (GO:0006354),-0.27487603611451145,-0.7142937398304233,0.86,1.0,1.0,12/26,37.89%,PEX2;ERCC3;CDK9;CDC73;ELP4;SUPT5H;SUPT16H;TCEA2;ELP2;ELOF1;EAF2;GTF2F2
prerank,Protein Localization To Membrane (GO:0072657),-0.21145244024149012,-0.7142751186485125,1.0,1.0,1.0,24/180,15.00%,EHD2;MAGI2;EPB41L3;ZDHHC15;PDZK1;FGF13;EFR3B;CYP46A1;FCHO2;TSPAN15;SCN3B;ARL5B;PALS1;RAB6B;NPC1;P2RY1;RAB12;CRB3;RAP2A;THY1;ANK3;WDR72;CPE;NUP54
prerank,Transcription Initiation-Coupled Chromatin Remodeling (GO:0045815),0.24252513616723087,0.7139103251883522,0.9047619047619048,1.0,1.0,10/34,26.94%,NIBAN2;RBM14;PADI2;TRMT112;MEN1;SMARCB1;DPY30;VPS72;SGF29;MACROH2A1
prerank,Cellular Response To Low-Density Lipoprotein Particle Stimulus (GO:0071404),-0.30079906035936466,-0.7136253935734121,0.8275862068965517,1.0,1.0,3/20,8.33%,CDH13;PPARG;CES1
prerank,Translational Elongation (GO:0006414),-0.24780124254747088,-0.7135523181358596,0.9583333333333334,1.0,1.0,16/41,29.25%,EEF1A2;EIF5AL1;RNF25;RCHY1;EIF5A2;TSFM;TUFM;GTPBP1;NEMF;MRPL44;LTN1;EIF5A;MTRFR;GFM1;HBS1L;EEF2K
prerank,Lipid Biosynthetic Process (GO:0008610),0.20435789401232918,0.7133338095345843,0.9387755102040817,1.0,1.0,17/70,21.45%,HSD17B1;OLAH;MVK;MCAT;ACSM2B;PLA2G1B;SCP2;ACSM3;DOLPP1;CBR4;ACSS2;AGPAT5;FADS1;IDI2;LIPC;HMGCR;FDXR
prerank,Regulation Of Cation Channel Activity (GO:2001257),-0.25608644370546896,-0.7130587687121602,0.9230769230769231,1.0,1.0,9/51,10.65%,FGF13;KCNAB1;CACNB4;CABP4;FGF14;KCNE2;CACNB1;CACNA1A;EDN1
prerank,Positive Regulation By Host Of Viral Transcription (GO:0043923),-0.30519284189379403,-0.7128879648969666,0.8392857142857143,1.0,1.0,6/16,21.70%,HPN;ZNF639;EP300;CDK9;SNW1;NUCKS1
prerank,Integrated Stress Response Signaling (GO:0140467),0.2645213455592435,0.7127218836703713,0.9215686274509803,1.0,1.0,11/28,28.20%,NFE2;BATF;CEBPE;NFE2L3;FOSL1;IMPACT;MAFB;FOS;EIF2AK4;MAP3K20;EIF2S1
prerank,Regulation Of Transcription Elongation By RNA Polymerase II (GO:0034243),-0.21996897519358233,-0.7123729363257841,0.9454545454545454,1.0,1.0,19/77,26.12%,RNF168;MED26;CCNT1;MED21;ELL2;LARP7;MED27;PWWP2B;CDK9;MED9;INTS12;MED30;CDC73;TCERG1;LDB1;WDR43;MED6;CDK13;SUPT5H
prerank,Negative Regulation Of Cell Death (GO:0060548),-0.23918479341923343,-0.7121692098219455,0.859375,1.0,1.0,5/59,10.94%,CCN5;NUP62;HSPA1B;PRKN;MT3
prerank,Regulation Of Interferon-Alpha Production (GO:0032647),0.2718674391377646,0.7120848653470585,0.8285714285714286,1.0,1.0,6/26,13.16%,IRF5;IRF7;TLR8;HSPD1;LILRA4;TLR4
prerank,Regulation Of DNA Biosynthetic Process (GO:2000278),0.2611819840451988,0.711061646895115,0.8695652173913043,1.0,1.0,8/32,21.28%,ADIPOQ;FGF2;RGCC;NIBAN2;PDGFA;ATM;PARP4;ING4
prerank,DNA Replication (GO:0006260),0.19869940534965605,0.710560768016705,1.0,1.0,1.0,31/71,33.87%,TICRR;MCM4;FAM111B;CDK1;RNASEH2A;POLL;RECQL4;RPA2;POLD2;REV3L;RPA3;TOP1;RFC4;MCM5;RBMS1;DNA2;RPA1;WDHD1;POLD1;RPA4;WDR18;RECQL5;CDK2;CHEK1;ORC5;MCMBP;POLB;MCM7;CDK2AP1;POLDIP2;WRNIP1
prerank,Regulation Of Transcription By RNA Polymerase III (GO:0006359),-0.25851109722430987,-0.7101340552846034,0.8688524590163934,1.0,1.0,11/26,34.13%,SF3B1;SMARCA5;ZFP36L2;DHX36;MAF1;DEK;POLR3C;ZC3H8;MYBBP1A;ZNF345;DDX21
prerank,Negative Regulation Of Supramolecular Fiber Organization (GO:1902904),0.21764906232657474,0.709746368111614,0.975,1.0,1.0,18/66,21.81%,TPX2;PLEKHH2;SNCA;CAMSAP2;CLIP3;PFDN6;VBP1;KANK1;EML2;MYADM;HSPA8;CORO1A;TWF2;KANK4;LIMA1;MAP2;PFN1;SPEF1
prerank,Positive Regulation Of Dephosphorylation (GO:0035306),-0.2774618050747959,-0.708759157012322,0.8771929824561403,1.0,1.0,8/28,18.97%,NSMF;PPP1R16B;PPP2R5A;SRC;PRKCD;BMP2;ANKLE2;CAMTA1
prerank,Cellular Response To Interferon-Beta (GO:0035458),-0.27542511124660873,-0.708182863003359,0.8888888888888888,1.0,1.0,2/21,9.87%,IRGM;PYHIN1
prerank,Regulation Of Glucose Import (GO:0046324),0.2512575465403322,0.7080085059921101,0.9459459459459459,1.0,1.0,12/36,19.57%,ENPP1;ERFE;GRB10;PLA2G1B;GSK3A;PID1;PRKCI;CREBL2;INSR;LEP;AKT1;IRS1
prerank,"Maturation Of 5.8S rRNA From Tricistronic rRNA Transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.29688165004045397,-0.7072171461941128,0.86,1.0,1.0,3/21,10.61%,EXOSC3;EXOSC10;ERI1
prerank,Glutamate Metabolic Process (GO:0006536),0.2736855876134722,0.7071188924281951,0.8888888888888888,1.0,1.0,8/19,29.97%,PRODH;DGLUCY;TAT;GOT2;ALDH5A1;ALDH18A1;GLS;OAT
prerank,Modulation By Host Of Viral Process (GO:0044788),-0.2814927821618919,-0.7070871607629379,0.8363636363636363,1.0,1.0,8/21,30.62%,KRT17;PAIP1;PI4KA;NUCKS1;FASN;LTF;RAB5A;ZNF502
prerank,Endoplasmic Reticulum Organization (GO:0007029),0.21521078092046786,0.7068308209531441,0.9166666666666666,1.0,1.0,4/54,9.26%,RTN3;GET3;RAB10;SHTN1
prerank,Long-Term Memory (GO:0007616),0.26754654374249454,0.706830412901465,0.825,1.0,1.0,2/19,8.39%,NOL3;RGS14
prerank,Regulation Of Type I Interferon Production (GO:0032479),-0.2446635355118946,-0.7065535218498237,0.9166666666666666,1.0,1.0,13/57,20.24%,TYROBP;IRGM;ITCH;TBK1;PTPN22;TRIM21;ZCCHC3;RNF125;IRF3;ATG5;CGAS;GPATCH3;DTX4
prerank,Positive Regulation Of Protein Localization To Cell Periphery (GO:1904377),0.22934024109444354,0.7065517542769402,0.9361702127659575,1.0,1.0,21/49,28.28%,NKD2;STAC;GPSM2;ITGA3;RANGRF;CLIP3;GPER1;PRKCI;GNAI1;WNK3;AKT1;RAMP3;EPHA2;ZDHHC8;CNPY4;PTPN9;SPTBN1;EPHA3;EPHB2;TNF;PDPK1
prerank,Positive Regulation Of Dendritic Spine Development (GO:0060999),-0.31184896686667235,-0.7061220029664059,0.8392857142857143,1.0,1.0,4/19,11.60%,SHANK1;CAMK2B;DLG5;LLPH
prerank,Cellular Component Disassembly (GO:0022411),0.23866412191326225,0.7054424405732167,0.9545454545454546,1.0,1.0,5/43,10.64%,CTSV;CTSG;CAPG;PLG;KLK5
prerank,mRNA Metabolic Process (GO:0016071),-0.226051351715734,-0.7052851280809633,0.9655172413793104,1.0,1.0,24/83,26.88%,NANOS2;HSPA1B;ANG;CELF1;U2AF1;FBXO11;METTL16;NUDT12;ZFP36L2;TBRG4;AGO4;TCERG1;SF3B4;NUDT21;AKAP8L;EREG;YTHDF2;SF3A2;NUDT16L1;PRPF3;SRSF2;ERN1;H2AB1;SRRM4
prerank,Regulation Of Lipid Storage (GO:0010883),-0.2923275197779751,-0.7047257214637018,0.8461538461538461,1.0,1.0,7/19,20.57%,PPARG;NFKBIA;ZC3H12A;PLIN5;ITGB3;SIRT1;C3
prerank,Regulation Of Protein Modification By Small Protein Conjugation Or Removal (GO:1903320),0.2437114523691547,0.7039744091322975,0.9473684210526315,1.0,1.0,5/29,15.48%,EGR1;HSPA1A;COPS6;COPS7A;DAXX
prerank,Keratinocyte Differentiation (GO:0030216),0.23668092851046035,0.7038187483484307,0.9333333333333333,1.0,1.0,9/35,22.86%,ST14;FGFR1;OPN3;DSP;CLIC4;UGCG;TGM1;EPHA2;CASP3
prerank,Purine Nucleotide Biosynthetic Process (GO:0006164),-0.27206439443592045,-0.703469390951121,0.9038461538461539,1.0,1.0,5/21,15.88%,HAAO;SLC4A7;PRPS1L1;QPRT;PRPS2
prerank,Negative Regulation Of Signal Transduction In Absence Of Ligand (GO:1901099),-0.3023615547842107,-0.703051931089302,0.8928571428571429,1.0,1.0,3/21,6.79%,IL1B;TERT;HSPA1B
prerank,Negative Regulation Of Extrinsic Apoptotic Signaling Pathway In Absence Of Ligand (GO:2001240),-0.3023615547842107,-0.703051931089302,0.8928571428571429,1.0,1.0,3/21,6.79%,IL1B;TERT;HSPA1B
prerank,Chaperone-Mediated Protein Complex Assembly (GO:0051131),0.27822603787239186,0.7020937583476203,0.8695652173913043,1.0,1.0,5/19,18.67%,HSPA1A;HSPD1;PFDN6;MKKS;NDUFAF1
prerank,Negative Regulation Of Viral-Induced Cytoplasmic Pattern Recognition Receptor Signaling Pathway (GO:0039532),-0.3080740550521148,-0.7018161902783893,0.8571428571428571,1.0,1.0,2/15,5.76%,IRGM;TNFAIP3
prerank,Negative Regulation Of Peptidase Activity (GO:0010466),0.22693447057220673,0.7016518525007401,0.95,1.0,1.0,10/51,17.97%,SERPINI1;CSTB;EPPIN;CTSB;TIMP1;TIMP2;SERPINB5;KNG1;PARK7;AKT1
prerank,Plasma Membrane Bounded Cell Projection Assembly (GO:0120031),0.18238303708914702,0.7012678777029249,1.0,1.0,1.0,57/264,22.42%,CFAP54;EMP1;DZIP1;ABLIM1;CEP19;TEKT5;FGD6;IFT81;CFAP298;PARVB;CCDC28B;DUSP23;CFAP221;RFX2;FOXJ1;CARMIL1;KIF24;NOTCH1;CIBAR1;CENPJ;SHTN1;TMEM107;CYFIP1;CDC14C;ARHGEF4;FNBP1L;AVIL;P2RX7;TMEM17;S1PR2;MKKS;MBD1;POC1B;ATP6V0D1;PPP1R9B;ARL3;STK36;OPHN1;KIT;CCDC65;IFT80;OCRL;DYNC2I2;WDR54;WDR19;SPAG6;CCNO;INTU;SEPTIN2;SPEF1;BBS1;RAPGEF6;BBS2;ATAT1;IQUB;VCL;AIF1
prerank,Negative Regulation Of DNA Metabolic Process (GO:0051053),0.22009820431311022,0.7012259046249057,0.9615384615384616,1.0,1.0,11/45,18.07%,ADIPOQ;DFFA;DPPA3;S100A11;NIBAN2;H1-5;H1-3;ERCC1;H1-0;H1-2;CDC6
prerank,"Negative Regulation Of DNA-templated Transcription, Elongation (GO:0032785)",-0.28594423318543066,-0.6998372801306656,0.8518518518518519,1.0,1.0,2/18,9.44%,RNF168;LARP7
prerank,Membrane Protein Ectodomain Proteolysis (GO:0006509),-0.29149998520772974,-0.6995357479112808,0.851063829787234,1.0,1.0,5/21,19.82%,ADAM9;BACE2;ADAM17;SPPL2A;APH1A
prerank,Positive Regulation Of Carbohydrate Metabolic Process (GO:0045913),-0.2518930890726341,-0.6985280398071848,0.8431372549019608,1.0,1.0,5/33,9.34%,SLC4A4;IGF1;IFNG;MLXIPL;IRS2
prerank,Positive Regulation Of Protein Ubiquitination (GO:0031398),0.20224564146194443,0.6983637496411872,1.0,1.0,1.0,19/81,19.34%,PLK1;NDFIP2;NDFIP1;PRICKLE1;TRIB3;PHF23;RPS2;GSK3A;FKBP1A;PDCD6;RBX1;WFS1;FANCI;CENPX;XIAP;INAVA;FANCM;SEPTIN4;DERL1
prerank,Cellular Response To Light Stimulus (GO:0071482),-0.22946961007001904,-0.6975206337790554,0.9666666666666667,1.0,1.0,13/60,17.71%,RHBDD1;CDC25A;NEDD4;GPR88;ZBTB1;RHO;PRKCD;RGR;EP300;CREBBP;SDE2;DHX36;TRIAP1
prerank,Smoothened Signaling Pathway (GO:0007224),-0.2513913119048563,-0.6974954332954851,0.9523809523809523,1.0,1.0,2/33,5.00%,GLI3;PKD2L1
prerank,"Vesicle Targeting, Rough ER To cis-Golgi (GO:0048207)",0.2744094655132026,0.6971526203873096,0.8979591836734694,1.0,1.0,11/19,38.44%,PDCD6;TRAPPC3;TRAPPC6A;PREB;TRAPPC1;PEF1;TRAPPC8;TRAPPC12;TRAPPC4;TRAPPC2B;PPP6C
prerank,COPII Vesicle Coating (GO:0048208),0.2744094655132026,0.6971526203873096,0.8979591836734694,1.0,1.0,11/19,38.44%,PDCD6;TRAPPC3;TRAPPC6A;PREB;TRAPPC1;PEF1;TRAPPC8;TRAPPC12;TRAPPC4;TRAPPC2B;PPP6C
prerank,Organelle Fusion (GO:0048284),-0.26060742078977245,-0.6971225257512755,0.8363636363636363,1.0,1.0,3/26,11.00%,CIDEA;MIEF1;VPS18
prerank,Histone Acetylation (GO:0016573),-0.2247807346398266,-0.696974557891176,0.9705882352941176,1.0,1.0,22/58,30.65%,TMEM98;TAF5;ATXN7;MBIP;EP300;TAF7;MBTD1;CREBBP;EPC1;POLE3;MORF4L1;KAT14;NAA40;MRGBP;MORF4L2;YEATS2;EP400;DMAP1;ATXN7L3;KAT5;SUPT7L;TAF10
prerank,Negative Regulation Of Protein Localization To Membrane (GO:1905476),0.26068733170402025,0.6967637444671051,0.9375,1.0,1.0,4/23,13.86%,GBP1;BCL2L1;DAB2;PID1
prerank,Protein Targeting To Membrane (GO:0006612),-0.23906494987430607,-0.6965862201559565,0.9365079365079365,1.0,1.0,7/71,8.27%,PARD3;ZDHHC15;ZDHHC11;NACAD;VPS37B;ZDHHC11B;NCF1
prerank,Plasma Membrane Invagination (GO:0099024),-0.27463820802615074,-0.694712078231563,0.9019607843137255,1.0,1.0,9/25,21.22%,MSR1;SPIRE2;ITGAM;FCGR2B;ARHGAP12;SPIRE1;VAMP7;ALKBH4;SNX9
prerank,Negative Regulation Of Intrinsic Apoptotic Signaling Pathway In Response To DNA Damage (GO:1902230),0.23952916017521259,0.6943248190444803,0.9361702127659575,1.0,1.0,5/23,14.46%,AMH;MUC1;BCL2L1;CCAR2;ZNF385A
prerank,Organic Substance Transport (GO:0071702),-0.2008461072632775,-0.6940205882574477,0.9491525423728814,1.0,1.0,23/187,10.90%,SLC18A2;SLC22A25;ABCA6;MFSD2B;ATP2A1;ATP2B2;AQP8;ABCA9;SLC22A7;ARRDC4;ABCA8;SLC47A2;SLC22A1;SLCO1A2;ABCA5;ABCA2;ARRDC2;SLC22A4;SPNS2;SNX7;TRPC3;SLC17A3;ZG16
prerank,Regulation Of Protein Import Into Nucleus (GO:0042306),0.22274251912990767,0.6939081510015889,0.9743589743589743,1.0,1.0,4/37,9.95%,BMP4;CDH1;SUFU;JUP
prerank,Positive Regulation Of Viral Genome Replication (GO:0045070),-0.25824011261986807,-0.6938406903640617,0.9322033898305084,1.0,1.0,8/29,23.79%,FKBP6;TMEM39A;PPIE;PPARA;PKN2;SRPK2;ADARB1;CCL5
prerank,Negative Regulation Of Telomere Maintenance (GO:0032205),-0.2967861123432168,-0.6936496418872279,0.8245614035087719,1.0,1.0,6/15,31.31%,TERF2IP;TNKS;SLX1A;TNKS2;SMG6;SLX4
prerank,Protein Peptidyl-Prolyl Isomerization (GO:0000413),-0.2815140208268178,-0.6935945541685729,0.8679245283018868,1.0,1.0,5/20,15.42%,PPIL6;PPIAL4E;PPIAL4H;PPIE;NKTR
prerank,Regulation Of NLRP3 Inflammasome Complex Assembly (GO:1900225),-0.26473074182932854,-0.6932156206952277,0.9253731343283582,1.0,1.0,7/31,16.53%,IRGM;DEPDC1B;FBXL2;PLCG2;PTPN22;PYDC1;GBP5
prerank,Protein Transmembrane Import Into Intracellular Organelle (GO:0044743),-0.2740477866385266,-0.692866024797274,0.8727272727272727,1.0,1.0,12/32,27.00%,TOMM20L;PEX1;GRPEL1;PEX2;PEX12;PEX14;TIMM21;TIMM17A;PEX16;DNLZ;TOMM70;PEX10
prerank,Establishment Of Protein Localization To Organelle (GO:0072594),-0.21595353385425675,-0.6928348799481293,0.9384615384615385,1.0,1.0,3/82,2.66%,RANBP17;ZDHHC15;NUP62
prerank,Negative Regulation Of Interleukin-1 Production (GO:0032692),-0.26813997083741975,-0.6923694937912674,0.873015873015873,1.0,1.0,8/29,16.92%,FFAR1;IGF1;CD33;TNFAIP3;ZC3H12A;CARD18;PYDC1;GHSR
prerank,Regulation Of Keratinocyte Proliferation (GO:0010837),-0.26728429309510765,-0.692019770895965,0.8490566037735849,1.0,1.0,10/21,35.33%,REG3A;CDH3;EPPK1;PRKD1;ZFP36L1;KLF9;NOTCH2;MED1;MDK;FGFR2
prerank,Innate Immune Response-Activating Signaling Pathway (GO:0002758),-0.3075965844662045,-0.6915542627114359,0.8870967741935484,1.0,1.0,1/16,0.73%,LILRA2
prerank,Positive Regulation Of Small GTPase Mediated Signal Transduction (GO:0051057),0.28257811243103026,0.6898944923583719,0.8823529411764706,1.0,1.0,6/16,21.58%,NOTCH1;RASGRP4;NTRK1;RASGRF1;RASGRP1;TGM2
prerank,Gene Expression (GO:0010467),0.16637996481256076,0.688902081308435,1.0,1.0,1.0,112/292,34.34%,TSPAN5;PRPH2;ENPP1;CELF2;RPL34;IGF2BP3;EXOSC5;HSPD1;MRPL51;HNRNPF;RPS2;DDX39B;RPS4Y1;NLRP3;LMF2;HNRNPH3;RPL41;MRPS33;RPL31;CASP9;RPL14;CASP10;H3C1;MRPL24;RPL13;RPL23A;RPS4Y2;RPS24;SARS1;EXOSC4;MRPS21;MRPS5;ANGPT2;MRPL18;ADARB2;TSPAN14;RPS6KB2;DKC1;MRPS17;MRPL27;DARS1;MRPL52;MRPS18C;MRPL34;NXT2;MRPL28;RPS15A;THOC7;TGM2;DHPS;RPL22;RPS3A;RPL18A;THOC6;CASP3;MRPS11;ABCC6;RPL35A;NUP107;NUP160;RPS27;HNRNPH1;CASP1;XRN2;RPS3;SYNCRIP;RBMS1;EXOSC1;RPS18;GALNT2;RPS8;EIF4A3;RPLP2;RNASEL;MRPL36;ZNG1E;RPS16;DEDD2;RPS5;RBM6;SNRNP40;RPS6;MRPS6;MRPS15;MRPS18B;DNAJB11;RPL4;ATXN1;RPS10;RPS26;RPL7A;ELAVL4;RPS21;RPL38;SMG5;RPS9;RPL26;RPL19;NUP88;RPS23;SORL1;MRPL23;MRPL42;RPS25;RPL32;THOC2;GLE1;AGFG1;FYTTD1;MRPL11;RBM15B;RPL21
prerank,Recombinational Repair (GO:0000725),0.19319649825419236,0.687963439741734,1.0,1.0,1.0,24/94,22.00%,RMI2;EXD2;RBBP8;RAD54B;INIP;NSMCE1;TONSL;SLF1;POLL;RAD51AP1;RECQL4;RPA2;SAMHD1;REV3L;RHNO1;RPA3;INTS3;AP5S1;SEM1;RAD52;AUNIP;SFPQ;TOP3A;NABP1
prerank,Regulation Of Histone Modification (GO:0031056),-0.2788591335736498,-0.6878493310833584,0.873015873015873,1.0,1.0,7/18,33.46%,MBIP;KAT14;HPF1;YEATS2;KAT2B;MYOCD;NFYC
prerank,Nucleotide-Excision Repair (GO:0006289),0.20410295131272044,0.6874148883129515,1.0,1.0,1.0,22/56,32.84%,GTF2H2C;GTF2H5;POLL;CETN1;ERCC1;RPA2;RPA3;ERCC2;DDB1;OGG1;GTF2H4;NTHL1;RAD23A;RPA1;MRPL36;POLD1;RPA4;RAD23B;RNF111;POLR2I;POLB;ERCC4
prerank,Negative Regulation Of Cell Communication (GO:0010648),-0.2963488806430333,-0.6868722531644912,0.8771929824561403,1.0,1.0,3/22,9.00%,IL1B;KIF26A;IL11
prerank,Establishment Of Protein Localization To Membrane (GO:0090150),-0.2452597638348088,-0.6863833208358338,0.8703703703703703,1.0,1.0,9/68,9.07%,PARD3;ZDHHC15;ZDHHC11;NACAD;VPS37B;REEP1;ZDHHC11B;NCF1;NPC1
prerank,Negative Regulation Of miRNA Transcription (GO:1902894),-0.2757820094509321,-0.6861426513421165,0.8867924528301887,1.0,1.0,6/20,25.41%,PPARG;POU5F1;NFIB;PPARA;PDGFB;RELA
prerank,Tail-Anchored Membrane Protein Insertion Into ER Membrane (GO:0071816),0.27065137673515266,0.6860191335739061,0.8913043478260869,1.0,1.0,2/16,11.63%,GET3;EMC8
prerank,Fatty Acid Transport (GO:0015908),0.2418213012882156,0.6858302371238799,0.9375,1.0,1.0,5/35,7.85%,SLC27A4;SLCO2A1;FABP2;CD36;RBP7
prerank,Positive Regulation Of Transcription By RNA Polymerase III (GO:0045945),-0.2902711694909335,-0.6854375192147086,0.8043478260869565,1.0,1.0,7/15,37.51%,SF3B1;SMARCA5;DEK;ZC3H8;MYBBP1A;DDX21;ERCC6
prerank,fatty-acyl-CoA Metabolic Process (GO:0035337),-0.27025641614727436,-0.6850252804863868,0.85,1.0,1.0,6/18,18.85%,HTD2;ACSM2A;NUDT19;ACSL3;FAR1;SLC27A2
prerank,Cellular Response To Radiation (GO:0071478),-0.2437815595683029,-0.6848440209886282,0.9310344827586207,1.0,1.0,11/44,22.54%,CDKN1A;DEPDC1B;BRCA1;GPR88;GADD45A;RHO;RGR;SIRT1;BLM;OPN1LW;TNKS1BP1
prerank,Regulation Of Microtubule Depolymerization (GO:0031114),-0.28588982036852845,-0.6848248173340656,0.8653846153846154,1.0,1.0,2/23,3.33%,FGF13;APC2
prerank,Mitophagy (GO:0000423),-0.28836447508294655,-0.6837169004431966,0.7962962962962963,1.0,1.0,6/16,34.47%,PRKN;ATG4D;ATG14;MAP1LC3B;ARFIP2;LRBA
prerank,Mitochondrial Gene Expression (GO:0140053),0.1923614335555332,0.6836290484541303,0.9375,1.0,1.0,30/101,29.87%,MRPS26;MRPL51;MRPS33;MRPL24;MRPS31;MRPS9;MRPS21;MRPS5;TEFM;MRPL48;MRPL18;MRPS17;MRPL27;MRPL52;MRPS18C;MRPL34;MRPL28;GATC;MRPL58;MRPS25;MRPS11;MRPL53;MRPL1;MRPL36;GADD45GIP1;RARS2;MRPS6;MRPS2;MRPS15;MRPS18B
prerank,Heart Looping (GO:0001947),0.23408329462177643,0.6829791376848943,0.8809523809523809,1.0,1.0,9/35,22.39%,VANGL2;NOTCH1;SRF;MKKS;TBX2;APLNR;MEF2C;SMO;SETDB2
prerank,Cilium Organization (GO:0044782),-0.19155912624552307,-0.6805476798496257,1.0,1.0,1.0,39/218,19.80%,EHD2;NME8;CPLANE2;SPAG16;AURKA;MAK;TEKT3;CEP83;CEP126;ABLIM3;TBC1D31;CFAP43;CFAP58;CFAP126;ARL13B;CFAP61;DYNC2I1;TOGARAM1;TMEM250;CFAP161;WDR90;ALPK1;FHDC1;PARVA;CPLANE1;PCNT;DNAAF1;DYNC2H1;CEP78;ARMC9;TTC21B;IFT122;CCDC57;RAB17;IFT27;RAB8B;KIF3A;UBXN10;RILPL1
prerank,Regulation Of Cellular Biosynthetic Process (GO:0031326),-0.21722100781965697,-0.6800402457383437,0.9523809523809523,1.0,1.0,18/67,24.85%,DDX25;CXCL8;JADE3;CES1;FFAR3;PCIF1;DUS3L;JAK2;SIRT1;KAT7;MITF;ING5;C3;TSC1;RBM3;PUM3;CCL5;ELP4
prerank,Positive Regulation Of Calcium Ion Transmembrane Transport (GO:1904427),-0.251823462698325,-0.6798396065646988,0.8909090909090909,1.0,1.0,9/41,15.14%,CEMIP;XCL1;GRM6;PPP3CA;CXCL11;TRPC3;F2R;THY1;TRPC1
prerank,Positive Regulation Of Organelle Organization (GO:0010638),-0.23754626474412305,-0.6792757626839877,0.896551724137931,1.0,1.0,13/33,30.61%,IRGM;DOC2B;SORBS3;SMCR8;LNPK;KATNBL1;LMAN1;HTRA2;CALCOCO2;FYCO1;SYNJ1;RAB3GAP2;UVRAG
prerank,Regulation Of Stem Cell Population Maintenance (GO:2000036),0.2093877513474922,0.6788998579545239,0.9473684210526315,1.0,1.0,13/55,26.33%,MYC;ACTL6A;HDAC2;TET1;LOXL2;SMARCB1;SIRT6;ELAVL1;SUDS3;HDAC1;RBBP4;TAF6L;CNOT3
prerank,Sensory Perception Of Pain (GO:0019233),-0.28767673778242764,-0.6783831808509859,0.9464285714285714,1.0,1.0,4/19,12.38%,MRGPRX2;OPRL1;CCL2;PTGES
prerank,Peptidyl-Glutamic Acid Modification (GO:0018200),-0.28152589725014676,-0.6776579577841579,0.9565217391304348,1.0,1.0,5/21,12.52%,TTLL10;AGTPBP1;TTLL2;TTLL13;TTLL11
prerank,Negative Regulation Of NIK/NF-kappaB Signaling (GO:1901223),0.24913325323495542,0.6772173296013506,0.9795918367346939,1.0,1.0,10/26,27.42%,MYO1C;UACA;NLRP3;PYDC2;IFI35;TMSB4X;HDAC9;CYLD;NLRP2;TSPAN6
prerank,Establishment Of Protein Localization To Mitochondrion (GO:0072655),0.2136360700456813,0.6771389695965297,0.9090909090909091,1.0,1.0,14/44,26.91%,HK2;CHCHD4;HSPD1;HK1;TIMM13;TIMM50;PAM16;AKT1;DNAJC15;TIMM8B;TIMM23B;ROMO1;MFN2;TIMM10
prerank,Autophagosome Maturation (GO:0097352),-0.2281590269710456,-0.6763857684294953,0.9642857142857143,1.0,1.0,15/44,31.21%,IRGM;MAP1LC3C;TSG101;VAMP7;EPG5;ATP2A2;SNX14;UBQLN1;VPS33B;PIK3R4;MAP1LC3B;CHMP1B;UVRAG;VPS4A;VPS4B
prerank,Lamellipodium Assembly (GO:0030032),0.24928208652354375,0.6761634955334989,0.8809523809523809,1.0,1.0,9/24,24.90%,PARVB;CARMIL1;CYFIP1;ARHGEF4;KIT;SPEF1;VCL;SRGAP3;ABLIM2
prerank,Polyol Metabolic Process (GO:0019751),0.26672391313904126,0.675680591280376,0.918918918918919,1.0,1.0,2/16,6.80%,SLC5A3;IPMK
prerank,Nucleobase-Containing Compound Catabolic Process (GO:0034655),-0.23047998135148395,-0.6755592929869998,0.9384615384615385,1.0,1.0,10/43,21.75%,EXOSC3;EXOSC6;SUPV3L1;EXOSC10;DIS3;RNASEH1;DIS3L;EXOSC9;NUDT15;DNASE1
prerank,Regulation Of Trans-Synaptic Signaling (GO:0099177),-0.251785444441733,-0.6747261984991745,0.9423076923076923,1.0,1.0,6/33,13.45%,IQSEC2;NRG3;PPP3CA;CACNA1A;BTBD9;SLC4A8
prerank,Glutamine Family Amino Acid Metabolic Process (GO:0009064),0.22780977894796764,0.6743048728586355,0.851063829787234,1.0,1.0,10/29,23.55%,DDAH2;PRODH;DGLUCY;ALDH4A1;TAT;GOT2;UCP2;ALDH5A1;ADSL;ALDH18A1
prerank,Organelle Transport Along Microtubule (GO:0072384),-0.23948964156285418,-0.6741311932941657,0.9354838709677419,1.0,1.0,9/38,21.36%,MAPT;ARHGAP21;DYNC1I1;RHOT2;NDE1;PEX14;BLOC1S2;BORCS8;KIF5B
prerank,peptidyl-S-diacylglycerol-L-cysteine Biosynthetic Process From Peptidyl-Cysteine (GO:0018231),-0.2893204996411078,-0.6732250518479233,0.9019607843137255,1.0,1.0,4/22,11.73%,ZDHHC15;ZDHHC11;ZDHHC11B;GOLGA7
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.2893204996411078,-0.6732250518479233,0.9019607843137255,1.0,1.0,4/22,11.73%,ZDHHC15;ZDHHC11;ZDHHC11B;GOLGA7
prerank,Phosphatidylinositol Biosynthetic Process (GO:0006661),-0.20789481011398056,-0.6731599263320426,0.9552238805970149,1.0,1.0,29/93,24.73%,EFR3B;ITPKA;PITPNM3;PIK3R1;PGAP2;INPP5J;PIGA;PIGP;PIK3R3;PIGB;PIK3CA;TP53INP2;PLCG2;SOCS5;IP6K1;MTMR2;PI4K2A;MPPE1;IP6K2;INPPL1;MTMR14;PI4KA;PIGL;PIGH;PIK3CG;CDS1;DPM1;SLC27A1;HYCC1
prerank,Import Into Nucleus (GO:0051170),-0.2178207395819135,-0.6730409055642973,0.9375,1.0,1.0,14/71,24.95%,RANBP17;NUP62;NXT1;BCL3;KPNA7;KPNA5;FAM53C;APLP2;KPNA1;NUP133;RANBP6;E2F3;TNPO2;POM121C
prerank,Regulation Of Steroid Biosynthetic Process (GO:0050810),0.2900336635988195,0.6730106071805008,0.8695652173913043,1.0,1.0,1/15,1.56%,EGR1
prerank,snRNA Processing (GO:0016180),0.2752210515556416,0.6723530584955706,0.875,1.0,1.0,9/17,30.21%,INTS7;USB1;INTS3;INTS6;INTS14;INTS9;INTS13;INTS11;INTS8
prerank,Membrane Organization (GO:0061024),0.18945776757262037,0.671607891587531,1.0,1.0,1.0,43/163,26.28%,CHMP4C;KIF20A;CR1;GCA;EXOC4;ATP2C1;ANXA2;GRIN3B;AZIN2;CIBAR1;USO1;MVB12A;ATP10B;FNBP1L;PDCD6IP;TOR1AIP2;PRKCI;SYNGR2;MYADM;TMEM170A;HSPA8;SYP;TMEM43;TIMM50;LMNB2;OCRL;RTP5;MITD1;VPS36;LMNB1;CTDNEP1;ESYT1;SNAP23;TMCC1;CHMP2A;DPP4;SPAST;SPTBN1;AP2M1;TOR1A;STAM2;MFN2;SNF8
prerank,Positive Regulation Of Release Of Sequestered Calcium Ion Into Cytosol (GO:0051281),-0.24819646338747722,-0.6711750670905492,0.8666666666666667,1.0,1.0,6/32,15.14%,CEMIP;XCL1;CXCL11;F2R;THY1;TRPC1
prerank,Glycosaminoglycan Catabolic Process (GO:0006027),-0.2876263655218012,-0.6702782739780467,0.9818181818181818,1.0,1.0,2/15,10.79%,CEMIP;CEMIP2
prerank,Telomere Maintenance Via Telomere Lengthening (GO:0010833),-0.256944574903133,-0.6683404819926438,0.8103448275862069,1.0,1.0,4/26,13.86%,STON1;TERT;TERF2IP;ZSCAN4
prerank,Negative Regulation Of Tumor Necrosis Factor-Mediated Signaling Pathway (GO:0010804),-0.281138515371858,-0.6677130454322512,0.9,1.0,1.0,6/20,20.56%,CCDC3;APOA1;PYDC1;PELI3;TRAIP;BIRC7
prerank,Negative Regulation Of G Protein-Coupled Receptor Signaling Pathway (GO:0045744),0.26957268694422376,0.667220218789236,0.851063829787234,1.0,1.0,4/20,10.77%,SNCA;RGS14;MET;RPGRIP1L
prerank,Protein Deacylation (GO:0035601),0.2328319087983299,0.6664805118127167,0.9736842105263158,1.0,1.0,7/20,24.18%,SIRT5;HDAC10;LYPLA1;SIRT6;HDAC9;LYPLA2;HDAC1
prerank,Negative Regulation Of Cyclin-Dependent Protein Serine/Threonine Kinase Activity (GO:0045736),-0.26545460106905994,-0.666156596443795,0.85,1.0,1.0,4/18,14.87%,LATS2;CDKN1A;INCA1;CDKN1B
prerank,Regulation Of Insulin Secretion Involved In Cellular Response To Glucose Stimulus (GO:0061178),0.2593066676345186,0.6654456081179013,0.8666666666666667,1.0,1.0,6/24,17.49%,HLA-DRB1;EFNA5;GPLD1;C2CD2L;NR1H4;ADCY5
prerank,Microtubule Nucleation (GO:0007020),-0.2717713116056529,-0.6651224529989602,0.8769230769230769,1.0,1.0,9/23,24.56%,HAUS2;TPPP;CSNK1D;SLAIN2;NDE1;CCDC57;NEDD1;RANBP9;CLASP1
prerank,Response To Glucocorticoid (GO:0051384),-0.2528311435485183,-0.6649707797339351,0.8813559322033898,1.0,1.0,9/23,30.49%,SSTR4;SLIT2;SLIT1;ZFP36L2;NR3C1;ZFP36L1;IL6;IL10;BCL2L11
prerank,Phospholipid Catabolic Process (GO:0009395),-0.2750168700050215,-0.6642099772647405,0.8163265306122449,1.0,1.0,6/26,16.48%,PLA2G4F;PLA2G4B;SMPD3;GPCPD1;GDPD1;PLBD1
prerank,Regulation Of DNA Repair (GO:0006282),-0.1895862150498936,-0.6635017361196288,1.0,1.0,1.0,42/125,31.77%,RNF168;DEPDC1B;TMEM98;TAF5;BRCA1;ATXN7;BCL7A;TAF7;MBTD1;CEBPG;EPC1;MORF4L1;SIRT1;SMCHD1;CDK9;KAT7;INO80D;DPF1;ARID2;MRGBP;USP1;RADX;SMARCC2;ARID1B;MORF4L2;INO80;CCDC117;DEK;SMARCC1;EP400;DMAP1;ATR;SMARCD1;UIMC1;ATXN7L3;KAT5;SUPT7L;ACTR5;TAF10;INO80E;UBR5;KAT2B
prerank,Protein Quality Control For Misfolded Or Incompletely Synthesized Proteins (GO:0006515),0.2450543922197035,0.6626047322071874,0.9545454545454546,1.0,1.0,9/27,28.33%,CLPP;VCP;NGLY1;DERL1;ATXN3;RNF5;TOR1A;ANKZF1;BAG6
prerank,Proteoglycan Metabolic Process (GO:0006029),-0.2560124244411929,-0.6599302271957499,0.8695652173913043,1.0,1.0,14/23,35.32%,IGF1;CHST10;CSGALNACT2;BMPR1B;BMPR2;XYLT1;CHST14;B4GALT7;FOXL1;B3GALT6;CHST9;GAL3ST3;CSGALNACT1;CHST13
prerank,Response To ATP (GO:0033198),-0.2781288943216216,-0.6590657361030241,0.9074074074074074,1.0,1.0,5/20,12.72%,KCNJ11;TRPV1;TRPC3;P2RY1;P2RY12
prerank,Negative Regulation Of Kinase Activity (GO:0033673),-0.21264104174535378,-0.6590235186189952,1.0,1.0,1.0,13/62,15.21%,MAPT;SFN;SPRED1;IRS2;PPP2R5A;AKT1S1;CAMK2N2;CDKN1C;THY1;SMCR8;CDKN1B;TAF7;PYDC1
prerank,Response To Gamma Radiation (GO:0010332),-0.270437088823785,-0.6589813213483807,0.8448275862068966,1.0,1.0,5/21,20.33%,HRAS;YAP1;FANCD2;WRN;TLK2
prerank,Extrinsic Apoptotic Signaling Pathway (GO:0097191),-0.22106463561645084,-0.6589005628688159,0.9814814814814815,1.0,1.0,12/65,17.95%,TGFB2;IL12A;CASP8;IFNG;TLR3;TNFRSF10B;MOAP1;SIVA1;JAK2;FADD;BLOC1S2;BAG3
prerank,Response To UV (GO:0009411),-0.20165316102079733,-0.6584955720704847,0.9830508474576272,1.0,1.0,34/98,28.41%,RHBDD1;IL12A;MFAP4;CDC25A;NEDD4;BCL3;ZBTB1;PRKCD;EP300;SPRTN;CREBBP;SDE2;WRN;ERCC3;CCND1;DHX36;TRIAP1;CDKN2D;N4BP1;GTF2H2;BRSK1;USP1;XPA;AQP1;PCLAF;RELA;INO80;FEN1;REV1;NSMCE3;ATR;ERCC5;CIRBP;ATF4
prerank,mRNA Catabolic Process (GO:0006402),-0.23143723953571407,-0.6583801888445128,0.9666666666666667,1.0,1.0,13/43,26.41%,NANOS2;HSPA1B;SUPV3L1;EXOSC10;METTL16;NUDT12;ZFP36L2;UPF1;AGO4;EXOSC9;YTHDF2;NUDT16L1;ERN1
prerank,Fluid Transport (GO:0042044),-0.2719058972212673,-0.6574864142492737,0.9444444444444444,1.0,1.0,3/15,16.87%,AQP8;AVP;AQP11
prerank,Positive Regulation Of Cartilage Development (GO:0061036),0.26701673503686824,0.6574004094049526,0.9130434782608695,1.0,1.0,4/17,17.08%,BMP4;LOXL2;SOX6;TAPT1
prerank,Regulation Of Protein Kinase Activity (GO:0045859),-0.19148438386271008,-0.6573984480754347,0.9491525423728814,1.0,1.0,19/115,18.12%,AZU1;DDR2;LRRK2;CDKN1A;C5AR1;SFN;SPRED1;PLCE1;AKT1S1;CAMK2N2;THY1;SMCR8;TAF7;PYDC1;TRAF4;SIRT1;SMG8;TSPYL2;RAP2C
prerank,Regulation Of Vesicle-Mediated Transport (GO:0060627),0.19467649749081561,0.6568668504855725,1.0,1.0,1.0,19/84,21.69%,RAB3B;USP6;ATP9A;PACSIN1;RIMS2;PLD1;CD22;SEPTIN5;RAB3D;AP2S1;LYSET;OPHN1;SEPTIN4;OCRL;RAB25;SEPTIN1;SEPTIN2;RAB11A;APEX1
prerank,Intrinsic Apoptotic Signaling Pathway (GO:0097193),-0.19589742672437346,-0.6561429665267079,0.9848484848484849,1.0,1.0,14/104,14.94%,HIC1;RNF186;ATP2A1;TMEM117;CDKN1A;JMY;SFN;BRCA1;TOPORS;PRKCD;CUL5;BRSK2;TNFRSF10B;MOAP1
prerank,Regulation Of Defense Response To Virus By Host (GO:0050691),0.2219062839458258,0.6558461814951412,0.9782608695652174,1.0,1.0,9/37,18.29%,IL4;ZDHHC1;LILRB1;PQBP1;IL12RB1;DTX3L;TRIM22;RIGI;NT5C2
prerank,Positive Regulation Of Blood Coagulation (GO:0030194),-0.2778651030724208,-0.6558391891803899,0.9,1.0,1.0,4/21,12.35%,THBS1;SERPINF2;F2R;VTN
prerank,Regulation Of Extrinsic Apoptotic Signaling Pathway In Absence Of Ligand (GO:2001239),-0.27687702050004986,-0.6557843448536291,0.9090909090909091,1.0,1.0,4/26,9.51%,IL1B;TERT;HSPA1B;RET
prerank,Cellular Response To Fibroblast Growth Factor Stimulus (GO:0044344),0.21479896143391009,0.6556293774749101,0.9705882352941176,1.0,1.0,15/50,21.16%,FGF2;FGF20;FGFR1;KL;SFRP1;SHCBP1;FLRT2;TBX1;FIBP;TRIM71;HYAL2;FGF6;DLL4;NDNF;ITGB1BP1
prerank,Extracellular Matrix Disassembly (GO:0022617),0.22697705442841534,0.6546432534726886,0.9791666666666666,1.0,1.0,5/41,10.64%,CTSV;CTSG;CAPG;PLG;KLK5
prerank,Positive Regulation Of SMAD Protein Signal Transduction (GO:0060391),-0.2861619404630918,-0.6537562930978877,0.8113207547169812,1.0,1.0,2/17,5.23%,KIAA0319;PPARG
prerank,Regulation Of DNA-templated Transcription Elongation (GO:0032784),0.21204707081476004,0.6529630645182266,0.9761904761904762,1.0,1.0,16/44,30.51%,DDX39B;CCAR2;INTS7;INTS3;INTS6;ELL3;INTS14;INTS9;HTATSF1;INTS13;PARP1;ELL;INTS11;HMGN1;INTS8;SRCAP
prerank,Zinc Ion Transport (GO:0006829),0.24456578659952294,0.6518693703613836,0.8809523809523809,1.0,1.0,4/23,12.57%,SLC30A3;SLC39A14;SLC30A5;SLC39A1
prerank,Mitochondrial Membrane Organization (GO:0007006),0.21550139108437444,0.6513840303933847,0.98,1.0,1.0,9/32,22.67%,CIBAR1;SLC25A4;BCL2L1;APOOL;TIMM50;SLC25A5;MTX2;BNIP3;TAFAZZIN
prerank,Positive Regulation Of Cell Cycle Phase Transition (GO:1901989),-0.2864797927621785,-0.6501071580848878,0.8490566037735849,1.0,1.0,4/15,19.22%,ZNF16;PLCG2;PEX2;CDC73
prerank,Non-Motile Cilium Assembly (GO:1905515),0.24629212486440272,0.6497590976923957,0.9591836734693877,1.0,1.0,5/31,14.33%,VANGL2;TMEM107;RPGRIP1L;TMEM17;MBD1
prerank,Melanosome Localization (GO:0032400),0.26475656071236797,0.649423968647336,0.8809523809523809,1.0,1.0,5/17,24.27%,MKKS;BLOC1S5;RAB11A;BBS2;RAB27A
prerank,Nuclear Envelope Organization (GO:0006998),0.257858534713517,0.6487674074221496,0.8974358974358975,1.0,1.0,9/17,35.66%,TMEM170A;TMEM43;LMNB2;LMNB1;TOR1A;NEMP1;TOR1B;DMPK;NUP155
prerank,Endosome To Lysosome Transport (GO:0008333),-0.23852234785598378,-0.6484844145677591,0.9298245614035088,1.0,1.0,23/55,32.57%,CCL14;LYST;PLEKHF2;TSG101;VPS18;RAB12;GPRASP1;DENND3;TGFBRAP1;AP3D1;VAMP7;EPG5;SORT1;ATG14;TPCN2;VPS33B;PXK;VPS41;VPS4B;ARL8B;VPS11;RAB7A;CACNG4
prerank,Alpha-Amino Acid Metabolic Process (GO:1901605),-0.24567181912045713,-0.6480673401936345,0.8813559322033898,1.0,1.0,2/28,7.33%,NOX4;ASS1
prerank,Positive Regulation Of Microtubule Polymerization (GO:0031116),0.23621898945321845,0.6475795788781841,0.9767441860465116,1.0,1.0,4/29,12.71%,PSRC1;HSPA1A;MET;PAK1
prerank,Peptidyl-Serine Phosphorylation (GO:0018105),-0.18851910124340632,-0.6473780106443271,1.0,1.0,1.0,40/154,24.15%,PRKACG;MARK1;SRPK3;LATS2;AURKA;LRRK2;CAMK2B;VRK2;TBK1;PRKCG;MASTL;MAPKAPK2;PRKCD;UHMK1;MYO3B;CDC7;CSNK1D;RICTOR;TNKS;PNCK;CSNK1E;CAMK1G;PRKCE;TLK1;PKN2;SRPK2;TLK2;CAMK4;BRSK1;ULK2;RIPK1;TGFBR2;PRKD1;PKN3;LMTK2;DGKQ;NEK6;PKN1;GRK2;PDGFB
prerank,N-acetylglucosamine Metabolic Process (GO:0006044),-0.28603585766363504,-0.6467715206449399,0.9056603773584906,1.0,1.0,3/15,13.11%,CHST5;CHST6;OGA
prerank,Peptide Metabolic Process (GO:0006518),0.21969432376309153,0.6458033436589518,1.0,1.0,1.0,14/50,24.43%,ANPEP;CPN1;LNPEP;CPM;CLN5;NAALADL1;MGAT3;SPPL3;MIPEP;SPCS1;ENPEP;LTA4H;SPCS2;MME
prerank,Leukocyte Cell-Cell Adhesion (GO:0007159),-0.23960366601757677,-0.6455134147070738,0.8870967741935484,1.0,1.0,4/31,10.11%,VCAM1;CLECL1P;CLEC4M;CD209
prerank,Negative Regulation Of Interleukin-8 Production (GO:0032717),0.25985323962719475,0.6454454237109848,0.9787234042553191,1.0,1.0,2/17,5.35%,KLF4;SSC5D
prerank,Hexose Biosynthetic Process (GO:0019319),-0.24121277403170616,-0.6452173494036928,0.9636363636363636,1.0,1.0,2/35,3.19%,KRT17;PGK2
prerank,Response To Alcohol (GO:0097305),-0.2434195486350513,-0.6443392271557723,0.9333333333333333,1.0,1.0,7/27,22.30%,TH;TGFBR3;SLIT2;SLIT1;CHRNB2;CCR5;TGFBR2
prerank,Positive Regulation Of Transcription Initiation By RNA Polymerase II (GO:0060261),-0.21822145837458776,-0.6437253885866039,0.9629629629629629,1.0,1.0,10/51,18.29%,MED26;MED21;TAF5;HNF1A;TAF13;TAF7;MED13;MED27;MED9;MED30
prerank,Protein Neddylation (GO:0045116),0.2503326725350138,0.6436870961274055,0.9259259259259259,1.0,1.0,4/22,14.18%,NEDD8;COPS6;COPS7A;RBX1
prerank,Protein Exit From Endoplasmic Reticulum (GO:0032527),0.23899004233133947,0.6431938302834727,0.95,1.0,1.0,6/24,22.36%,TMED9;TECPR2;RANGRF;VCP;DERL1;PREB
prerank,"Negative Regulation Of Gene Expression, Epigenetic (GO:0045814)",0.20522872618225238,0.6429204672658582,1.0,1.0,1.0,18/49,29.88%,UHRF1;DPPA3;PPHLN1;H1-0;KMT2D;LMNB2;SIRT6;LMNB1;HDAC9;HDAC5;HELLS;PHF19;MACROH2A1;SUV39H2;MORC2;TRIM27;CHEK1;HMGB1
prerank,Pore Complex Assembly (GO:0046931),0.2596811359129049,0.6421645597154713,0.9215686274509803,1.0,1.0,7/18,26.33%,P2RX7;TMEM170A;RTN4;GSDMD;NUP107;NDC1;PDZD11
prerank,post-Golgi Vesicle-Mediated Transport (GO:0006892),-0.21180209820858037,-0.641829174407883,0.9841269841269841,1.0,1.0,10/55,18.49%,STEAP2;VPS54;MYO1B;GOLGA7;MON2;AP3D1;VPS13C;CCDC93;EXOC8;DNM2
prerank,Negative Regulation Of Peptidyl-Serine Phosphorylation (GO:0033137),-0.2747928792672683,-0.6416965532837291,0.9215686274509803,1.0,1.0,4/17,15.73%,INPP5J;MLXIPL;GADD45A;GPD1L
prerank,Response To Unfolded Protein (GO:0006986),-0.23309152583297726,-0.6412651891712182,0.9666666666666667,1.0,1.0,4/43,9.30%,RHBDD1;DNAJB1;HERPUD1;PRKN
prerank,Protein Mannosylation (GO:0035268),-0.2609736873701129,-0.640530950647424,0.8571428571428571,1.0,1.0,9/20,34.37%,FKRP;CRPPA;TMTC3;DPM1;LARGE2;FKTN;TMTC2;DPY19L4;DPM3
prerank,Positive Regulation Of Erythrocyte Differentiation (GO:0045648),0.23066142629607658,0.6405264207030824,0.9591836734693877,1.0,1.0,5/26,18.31%,HSPA1A;MAPK11;ACVR2A;PRMT1;ETS1
prerank,Positive Regulation Of Telomere Maintenance Via Telomerase (GO:0032212),0.22113108664910144,0.6401378979686927,0.8571428571428571,1.0,1.0,12/32,29.30%,AURKB;CCT5;ATM;FBXO4;HNRNPA1;CCT7;CCT4;CCT3;NEK7;XRCC5;CCT2;MAPK1
prerank,protein-DNA Complex Organization (GO:0071824),0.1941550943525351,0.6400313712838754,0.9545454545454546,1.0,1.0,7/58,12.47%,MYC;TCF4;VCX;PARP10;HDAC11;H1-5;HIRIP3
prerank,Telomere Organization (GO:0032200),0.19048306013143132,0.6397157754993534,1.0,1.0,1.0,32/63,35.00%,ACTL6A;H4C9;TFPT;H3C1;RECQL4;RPA2;DOT1L;DCLRE1C;RPA3;RUVBL2;ATM;TINF2;SIRT6;APEX1;RUVBL1;PARP3;PARP1;DNA2;RPA1;TERF1;XRCC5;SP100;MCRS1;PTGES3;ACTR8;LTO1;ERCC4;POT1;EZH1;PRKDC;H3-3A;CTC1
prerank,Regulation Of Lymphocyte Differentiation (GO:0045619),0.23823282964760306,0.6386631369403231,0.8888888888888888,1.0,1.0,4/19,16.20%,CCR2;SLAMF8;FCRL3;PRELID1
prerank,Negative Regulation Of Wound Healing (GO:0061045),0.2293053690931126,0.6385236692162557,0.9285714285714286,1.0,1.0,5/26,14.89%,ALOX5;FGF2;CD109;PROC;KNG1
prerank,Nucleic Acid Phosphodiester Bond Hydrolysis (GO:0090305),0.24934072458053877,0.6385219009624226,0.8888888888888888,1.0,1.0,5/24,19.03%,EXD2;ENPP1;RNASE6;EDC3;IHO1
prerank,Regulation Of Glycogen Biosynthetic Process (GO:0005979),0.22494828793936775,0.6374995980013763,0.9215686274509803,1.0,1.0,6/24,19.57%,ENPP1;PPP1R3G;GSK3A;INSR;PPP1R3E;IRS1
prerank,Substantia Nigra Development (GO:0021762),-0.23583464699459622,-0.6374444320325489,0.9433962264150944,1.0,1.0,5/41,10.21%,FGF9;GNB4;SYPL2;CHKB;ZNF148
prerank,Neuron Maturation (GO:0042551),-0.253707873213231,-0.6373697597482306,0.8653846153846154,1.0,1.0,6/16,26.88%,RND1;LGI4;B4GALT6;C3;MTCH1;SRRM4
prerank,Maturation Of SSU-rRNA (GO:0030490),0.21428901734104056,0.6372702525450082,0.9433962264150944,1.0,1.0,38/38,78.61%,WDR46;IGF2BP3;SRFBP1;MRPS11;DCAF13;RPS8;RPS16;PWP2;NAT10;NOB1;SPPL2B;UTP6;WDR3;DHX37;UTP25;SNU13;RPS14;LOC102724159;RPS19;RRP36;TSR2;TSR3;LSM6;RPS28;RIOK1;DDX52;TSR1;UTP4;NGDN;NOL10;NOP14;HEATR1;MPHOSPH10;RIOK2;RIOK3;UTP3;WDR43;NOL11
prerank,Insulin Secretion (GO:0030073),-0.25987951627437544,-0.6367804358939941,0.9333333333333333,1.0,1.0,5/18,20.15%,KLRG1;PTPRN2;RAB11FIP2;SLC30A8;SELENOT
prerank,Protein Localization To Cell Surface (GO:0034394),-0.26100381347886226,-0.6364715073591115,0.9473684210526315,1.0,1.0,1/25,0.81%,WNT11
prerank,Histone H2A Acetylation (GO:0043968),-0.26095486932722023,-0.6364176516822881,0.94,1.0,1.0,9/20,29.43%,MBTD1;EPC1;MORF4L1;NAA40;MRGBP;MORF4L2;EP400;DMAP1;KAT5
prerank,Positive Regulation Of Protein Localization (GO:1903829),-0.19930974980938698,-0.6361072416842684,0.984375,1.0,1.0,16/83,18.15%,TYROBP;NUP62;PDZK1;MAPT;TCF7L2;PRKN;PYHIN1;YAP1;NGFR;CEP120;CREBBP;CROCC;GPD1L;CDK9;PRKAA2;KAT7
prerank,Morphogenesis Of An Epithelium (GO:0002009),0.23143107111571756,0.6360635111961327,0.9574468085106383,1.0,1.0,3/27,12.19%,AIRE;ACTG1;FLG2
prerank,Modification-Dependent Protein Catabolic Process (GO:0019941),0.17136517718988317,0.6359817231139996,1.0,1.0,1.0,57/191,29.48%,ASB2;UBE2C;SIAH1;NEDD8;NDFIP2;FBXO22;UHRF1;NDFIP1;MARVELD3;ISG15;RNF19A;DTX3L;LNX1;RBX1;SPSB1;UBE2L6;KEAP1;KCTD21;RNF167;PCYOX1L;HERC4;CBL;DDB1;BFAR;RNF217;UBE2A;ATXN3;RNF148;UBL7;TNFSF13B;TAF1;RNF5;RNF8;TRIM25;RPS27AP5;RNF20;PPP1R11;RNF146;UBQLN4;UBE2R2;NEDD4L;TRIP12;ZNRF4;RNF133;DCST1;RNF144B;RPGR;KLHL25;UBE2L5;UBB;TOLLIP;ARRDC1;BAG6;RNF144A;HERC6;MIB1;UBA52
prerank,Positive Regulation Of JUN Kinase Activity (GO:0043507),0.22773425430373057,0.6359382808402665,1.0,1.0,1.0,4/30,12.71%,MAP3K7;TNFRSF11A;MAP3K13;PAK1
prerank,"Protein Alpha-1,2-Demannosylation (GO:0036508)",-0.27152944961358894,-0.6336977323573404,0.9130434782608695,1.0,1.0,2/16,12.41%,RNF103;MAN1A1
prerank,Regulation Of B Cell Receptor Signaling Pathway (GO:0050855),0.27741061032091324,0.6331065475542123,0.9795918367346939,1.0,1.0,4/16,14.11%,NFAM1;CD22;GCSAM;FCRL3
prerank,Histone Deacetylation (GO:0016575),0.22162988012042398,0.6330087919016734,0.9722222222222222,1.0,1.0,10/35,25.99%,TBL1XR1;HDAC2;HDAC11;GATAD2B;SIRT6;SUDS3;HDAC5;HDAC1;RBBP4;TBL1X
prerank,Embryonic Heart Tube Morphogenesis (GO:0003143),-0.2273208136440347,-0.6330073128677984,0.9655172413793104,1.0,1.0,17/39,26.96%,NDRG4;CCDC103;DNAAF1;MEGF8;TBX6;BBS5;TGFBR2;RYR2;SOX18;DVL2;CCDC40;MICAL2;NPHP3;CCDC39;AHI1;IHH;ENG
prerank,"mRNA Cis Splicing, Via Spliceosome (GO:0045292)",0.25811525516846046,0.6325083024022539,0.94,1.0,1.0,9/17,35.29%,SRSF1;DCPS;CLNS1A;SRSF12;WBP4;SNRNP200;SART1;PSIP1;HNRNPC
prerank,Peroxisome Organization (GO:0007031),-0.25164032108720574,-0.632175247308372,0.9464285714285714,1.0,1.0,9/24,27.00%,PEX1;PEX2;PEX12;TMEM135;PEX14;SEC16B;PEX3;PEX16;PEX10
prerank,Positive Regulation Of Protein Modification By Small Protein Conjugation Or Removal (GO:1903322),-0.1999010419760176,-0.6321530780503473,0.9692307692307692,1.0,1.0,17/76,21.79%,TRAF6;LRRK2;RIPK2;ZC3H12A;BRCA1;FBXO33;ANGPT1;MUL1;BCL10;DCUN1D2;SPRTN;PIAS1;RCHY1;DCUN1D5;BIRC7;UBQLN1;PAXIP1
prerank,Negative Regulation Of Oxidative Stress-Induced Cell Death (GO:1903202),0.2464596630353226,0.6312498992265967,0.9047619047619048,1.0,1.0,6/20,21.02%,NOL3;PYCR1;PARK7;GPR37L1;PPIA;FYN
prerank,Negative Regulation Of Striated Muscle Cell Differentiation (GO:0051154),-0.2836981549323291,-0.630557253238034,0.8983050847457628,1.0,1.0,4/16,18.95%,FZD7;BMP2;FRS2;TMEM119
prerank,Lysosomal Transport (GO:0007041),-0.19662189788379722,-0.6302156583592383,1.0,1.0,1.0,27/101,26.28%,CCL14;SPTBN5;NEDD4;VPS54;NPC1;PLEKHF2;PRKN;TSG101;VPS18;AP1G1;RAB12;GPRASP1;RBSN;DENND3;TGFBRAP1;PCSK9;VAMP7;EPG5;SORT1;HGSNAT;ATG14;SLC30A2;VPS52;PSAP;ARSB;VPS33B;LRP1
prerank,DNA Synthesis Involved In DNA Repair (GO:0000731),-0.25302041879768306,-0.6298061746478527,0.9285714285714286,1.0,1.0,8/27,22.08%,USP43;ZBTB1;SPRTN;HROB;WRN;SIRT1;FAAP20;RFC3
prerank,Negative Regulation Of Intracellular Protein Transport (GO:0090317),-0.2440395054677997,-0.6295925945872485,0.9285714285714286,1.0,1.0,4/24,16.83%,LRRK2;APOD;INSIG1;UFM1
prerank,Protein Targeting To Mitochondrion (GO:0006626),0.18690321417071182,0.6295357098517785,0.9787234042553191,1.0,1.0,13/59,21.62%,PRICKLE4;CHCHD4;HSPD1;TIMM13;MTCH2;TIMM50;PAM16;MIPEP;DNAJC15;TIMM8B;MTX2;AIFM1;TIMM23B
prerank,Protein Polyubiquitination (GO:0000209),-0.1753660015161334,-0.6287159035182174,1.0,1.0,1.0,66/222,30.44%,FBXO9;RNF186;TRAF6;ARRDC4;TNFAIP3;PELI2;NEDD4;RNF168;MAGEL2;ITCH;RNF135;BRCA1;TOPORS;PRKN;PELI1;MUL1;AMFR;PEX12;RNF115;RNF25;UBOX5;RC3H2;RNF4;FBXO28;TRIM21;UBE2E3;TNKS;UBE2E2;TRAF4;RNF125;PELI3;HACE1;MARCHF8;TRIM6;CDC27;RFPL1;ANAPC10;ARIH2;RNF166;RFPL3;SMURF1;UBE2J1;FBXO7;ARIH1;RNF6;MARCHF6;NHLRC3;ANAPC2;RNF34;ANKIB1;TRAF1;PEX10;TNKS2;RNF26;TRIM62;UBE2E1;IRF2BP1;ANAPC11;RNF185;UBE2G1;UBE2Q2;UBE2D1;TRIM3;TTC3;RNF19B;UBE3C
prerank,Regulation Of Isotype Switching (GO:0045191),0.2451495337232047,0.6283486532218568,0.9512195121951219,1.0,1.0,2/15,10.40%,IL4;SHLD1
prerank,Negative Regulation Of Leukocyte Cell-Cell Adhesion (GO:1903038),-0.28500954185971933,-0.6278814264758596,0.8596491228070176,1.0,1.0,7/19,20.98%,IL4I1;ASS1;ILDR2;PTPN22;PAG1;PPARA;LAX1
prerank,Positive Regulation Of Filopodium Assembly (GO:0051491),-0.25696487279648855,-0.6265325332038686,0.8679245283018868,1.0,1.0,5/25,18.50%,PIK3R1;RHOQ;MYO3B;TENM2;WASL
prerank,Determination Of Heart Left/Right Asymmetry (GO:0061371),0.21880848673609432,0.6255674909539171,0.9512195121951219,1.0,1.0,9/37,22.39%,VANGL2;NOTCH1;SRF;MKKS;TBX2;APLNR;MEF2C;SMO;SETDB2
prerank,Cellular Response To Amino Acid Starvation (GO:0034198),0.19911894296063248,0.625161085501924,1.0,1.0,1.0,18/41,34.30%,MAPK8;DAP;RNF167;TFEB;SESN3;IMPACT;FAS;RNF152;EIF2AK4;NPRL2;EIF2S1;MIOS;FLCN;MAPK1;SESN2;RRAGA;MTOR;DEPDC5
prerank,Mitotic G2/M Transition Checkpoint (GO:0044818),0.20274073339293583,0.6251544398944026,1.0,1.0,1.0,11/46,22.14%,TICRR;PLK1;RBBP8;CDK1;INIP;INTS3;ATM;CDC6;CLSPN;NABP1;TNFSF13B
prerank,Negative Regulation Of Protein Localization (GO:1903828),0.21799974053262042,0.6245448361361838,0.9215686274509803,1.0,1.0,18/40,34.55%,MAP1A;MFHAS1;GDI2;LILRB4;RIPOR2;VCP;SIRT6;YWHAZ;NEDD4L;GPM6B;BTF3;MACROH2A1;FLCN;TAX1BP3;PIAS4;MTOR;LEPROT;SPI1
prerank,Regulation Of Telomere Capping (GO:1904353),-0.24514434472368823,-0.623841516162419,0.8833333333333333,1.0,1.0,9/22,34.32%,MAPK15;PKIB;TNKS;TNKS2;MAP2K7;PRKCQ;SMG6;MAP3K4;MAPK3
prerank,Multivesicular Body Sorting Pathway (GO:0071985),-0.25357842299674777,-0.6232546861668068,0.9361702127659575,1.0,1.0,1/24,1.55%,SYTL4
prerank,Motile Cilium Assembly (GO:0044458),-0.2590504599740666,-0.6222477631258874,0.9122807017543859,1.0,1.0,8/16,29.33%,BBOF1;ZMYND10;DNAAF1;BBS5;CCDC40;CCDC39;RSPH9;E2F4
prerank,Regulation Of Intracellular Steroid Hormone Receptor Signaling Pathway (GO:0033143),-0.25210922684171366,-0.6216004498709322,0.96,1.0,1.0,7/21,27.01%,DNAAF4;SAFB2;EP300;UFM1;PKN1;RNF6;LATS1
prerank,Ubiquitin-Dependent Protein Catabolic Process (GO:0006511),-0.1621445351575566,-0.6198101598022864,1.0,1.0,1.0,109/362,30.44%,FBXO9;RNF186;MVB12B;APC2;ANKRD9;SPOPL;TRIM72;PPP2R5C;ZFAND2A;TNFAIP3;FEM1C;NEDD4;RNF168;UBXN2A;ITCH;VPS37B;TOPORS;HERPUD1;PRKN;TSG101;SPSB4;SMURF2;RHOBTB3;PELI1;TBX21;FBXO11;AMFR;SIAH2;PEX12;NFE2L2;RNF115;TRPC4AP;RNF25;UBR4;RC3H2;KCTD2;BMAL1;RNF4;UBAP1;RNF128;RCHY1;FBXO8;RNF125;SIRT1;RNF150;FBXW4;HACE1;RLIM;UBR3;NAE1;CBLC;KCTD10;KCTD13;ZRANB1;ARIH2;TRIM9;RBBP6;VPS37D;PSMA6;RNF166;OTUD7B;GET4;SMURF1;WDR91;FBXO7;FBXO10;PJA2;HERC3;OTUD7A;WDR26;KLHL15;ARIH1;RNF6;MARCHF6;ARRB2;NHLRC3;MTA1;RNF34;RNF215;SH3BGRL;ANKIB1;PSMD12;MYLIP;UBD;PEX10;RNF26;UBE2E1;WDR81;PSMC4;HERC5;FEM1B;ANAPC11;ARRB1;RNF185;CHMP1B;UBQLNL;UBE2G1;KAT5;RNF7;PLAA;UBE2D1;APPBP2;COP1;CNOT4;TRIM3;TTC3;RNF19B;FBXO21;UBE3C
prerank,Phosphatidylinositol Dephosphorylation (GO:0046856),-0.2854867661770044,-0.6197466843476119,0.9137931034482759,1.0,1.0,7/16,30.74%,INPP5J;PIP4P1;MTMR2;SYNJ2;SACM1L;SYNJ1;PMPCA
prerank,Intracellular Zinc Ion Homeostasis (GO:0006882),-0.26414128319910246,-0.6188565276319392,0.94,1.0,1.0,5/17,22.99%,SLC39A8;MT3;SLC30A1;SLC30A8;SLC30A2
prerank,Synaptic Vesicle Recycling (GO:0036465),-0.2258893558764384,-0.618519439887372,0.9672131147540983,1.0,1.0,20/43,30.99%,STX1A;STON1;FCHO2;WNT7A;BLTP1;AP3D1;DNM3;NLGN4X;DNM2;SYT2;NLGN3;AP3B2;SYNJ2;NLGN4Y;AP2B1;RAB5A;SYT7;SYNJ1;RAB3A;VAMP2
prerank,Regulation Of B Cell Differentiation (GO:0045577),-0.2479602948784869,-0.618395616430865,0.9464285714285714,1.0,1.0,6/19,22.69%,IL4I1;ID2;ZFP36L2;MMP14;TLR9;ZFP36L1
prerank,Fatty Acid Oxidation (GO:0019395),-0.2097720853633786,-0.6180430553717656,0.9833333333333333,1.0,1.0,2/52,1.55%,ALOX15;ALOX12
prerank,Regulation Of Telomere Maintenance In Response To DNA Damage (GO:1904505),0.23674241228035894,0.6174813186466726,0.9285714285714286,1.0,1.0,5/15,31.30%,TFPT;RUVBL2;RUVBL1;MCRS1;ACTR8
prerank,Vesicle Fusion (GO:0006906),-0.19532538908268227,-0.6156039318645324,0.9682539682539683,1.0,1.0,29/78,31.99%,YIPF4;STXBP6;YIPF7;SAMD9;VPS18;GOSR1;RAB12;PIP4K2A;TGFBRAP1;VAMP7;RAB8B;STX6;RAB13;STX16;VPS33B;SYT4;VTI1A;SYT7;CHMP1B;UVRAG;RAB8A;VAMP2;VPS4A;VPS41;ARL8B;TSNARE1;RAB20;VPS11;RAB7A
prerank,Regulation Of Catabolic Process (GO:0009894),-0.23867650082517106,-0.615509080382274,0.9534883720930233,1.0,1.0,10/22,37.45%,RARRES2;FURIN;CENATAC;ODC1;WDR91;LATS1;FAF1;ZDHHC2;FAM83D;SCARB2
prerank,Positive Regulation Of DNA Repair (GO:0045739),-0.1910844854049967,-0.6147284928783807,0.9833333333333333,1.0,1.0,20/86,25.87%,FMN2;SPIRE2;RNF168;DEPDC1B;BRCA1;PRKCG;BCL7A;CEBPG;SIRT1;SMCHD1;SPIRE1;INO80D;DPF1;ARID2;USP1;SMARCC2;ARID1B;INO80;CCDC117;SMARCC1
prerank,Negative Regulation Of Mitochondrion Organization (GO:0010823),0.19759511950949588,0.6144501615228687,1.0,1.0,1.0,10/37,23.77%,NOL3;HSPA1A;SLC25A4;BCL2L1;PRELID1;AKT1;SLC25A5;BNIP3;TMEM14A;SLC25A6
prerank,Mitochondrial Cytochrome C Oxidase Assembly (GO:0033617),0.22133615313844363,0.6134856107516479,0.9767441860465116,1.0,1.0,5/22,19.69%,COX14;COA5;COA3;SMIM20;TMEM223
prerank,Regulation Of Endocytosis (GO:0030100),0.1932545367016141,0.6131833402083988,1.0,1.0,1.0,12/65,17.69%,HCK;PACSIN1;SNCA;LILRB1;CLIP3;CD22;DAB2;AP2S1;SCAMP5;OPHN1;FLOT1;CD151
prerank,"Nuclear-Transcribed mRNA Catabolic Process, Exonucleolytic (GO:0000291)",-0.2810257587083322,-0.612560208171372,0.9591836734693877,1.0,1.0,4/17,14.01%,EXOSC3;EXOSC6;DIS3;NT5C3B
prerank,Negative Regulation Of Ossification (GO:0030279),-0.24434178493403097,-0.6122775887021131,0.9661016949152542,1.0,1.0,4/23,16.77%,SMAD6;CCR1;SRGN;TRPM4
prerank,Peptidyl-Threonine Dephosphorylation (GO:0035970),-0.25960657779452834,-0.6098973471080803,0.94,1.0,1.0,4/17,17.41%,DUSP5;PPM1A;PPM1D;PPM1B
prerank,Regulation Of Proteolysis Involved In Protein Catabolic Process (GO:1903050),0.23392081576572737,0.6091600834188781,0.9591836734693877,1.0,1.0,4/23,16.67%,EPHA4;RHBDF1;PSME2;GBA1
prerank,Intracellular Protein Transport (GO:0006886),-0.1644537035826687,-0.6090343073887854,1.0,1.0,1.0,75/318,25.22%,RANBP17;ARL14;NUP62;STX1A;MAP1LC3C;RAB24;RAB6C;AP1S3;SEC31A;TRIM23;VPS37B;ARL4C;LTBP2;MAIP1;ARL5B;RAB6B;FAM91A1;TSG101;ARL4D;DNAJC27;NXT1;RASSF9;BCL3;RAB6D;NGFR;GRPEL1;KPNA7;VPS26A;AP4S1;SLU7;UBAP1;AKIRIN2;KPNA5;SAR1A;RANBP3;ANKLE1;STX2;SCG5;AP3D1;AP3B1;BAG3;RAB17;IFT27;TIMM21;NAPA;FAM53C;TLK1;XPO4;APLP2;RTN2;SAR1B;STX6;SEC31B;KPNA1;NUP133;SNX9;VPS37D;TIMM17A;ARF1;ARFGAP3;STX16;STX3;SMURF1;CD74;HOMER3;RANBP6;RAB18;HPS4;E2F3;EHD1;TNPO2;COPA;POM121C;STX11;SCFD1
prerank,Negative Regulation Of Protein Tyrosine Kinase Activity (GO:0061099),-0.2400238092257776,-0.6088099207694146,0.9016393442622951,1.0,1.0,4/23,14.85%,CBLB;TSG101;THY1;SOCS5
prerank,Regulation Of Keratinocyte Differentiation (GO:0045616),0.22830600564535664,0.6074074541441039,0.9583333333333334,1.0,1.0,8/25,28.62%,ZBED2;TRIM16;AQP3;CYP27B1;HOXA7;ETV4;MACROH2A1;ERRFI1
prerank,Golgi Vesicle Transport (GO:0048193),0.15366179958970363,0.6067615689273321,1.0,1.0,1.0,41/192,24.77%,ATP9A;CTAGE6;GOLPH3L;TMED9;HTT;CTAGE9;LMAN2L;NKD2;YIF1A;IER3IP1;USO1;ATP9B;RANGRF;TEX261;CNIH4;TBC1D20;LMAN1L;PDCD6;RAB1B;SEC24D;ERGIC3;ARL3;SNX1;TRAPPC3;COG4;RER1;PGAP1;GOSR2;TRAPPC6A;YIF1B;COG7;MIA2;SNAP23;PREB;SEC24A;SLC10A7;EHD3;KDELR2;SPAST;COG6;KIF1C
prerank,Regulation Of Protein-Containing Complex Disassembly (GO:0043244),0.23056925818971027,0.606061255412295,1.0,1.0,1.0,4/18,21.85%,IRAK3;GBA1;INSR;BNIP3
prerank,N-glycan Processing (GO:0006491),0.2199105388067122,0.6056238792824226,0.9166666666666666,1.0,1.0,2/18,7.28%,ST8SIA1;MAN1C1
prerank,Negative Regulation Of Protein Dephosphorylation (GO:0035308),0.2416462359947439,0.6035778329097466,0.9803921568627451,1.0,1.0,6/19,23.33%,STYXL1;MFHAS1;FKBP1A;BOD1;YWHAE;PPP1R11
prerank,snRNA Metabolic Process (GO:0016073),0.23308943071576113,0.6035601039425924,1.0,1.0,1.0,9/21,30.21%,INTS7;INTS3;INTS6;INTS14;INTS9;INTS13;INTS11;SNAPC3;INTS8
prerank,Sphingolipid Catabolic Process (GO:0030149),-0.24552522377358377,-0.603200540348663,0.9137931034482759,1.0,1.0,6/15,30.05%,SMPD3;GLA;ACER3;SMPD4;ASAH1;ACER2
prerank,Chromatin Remodeling (GO:0006338),-0.16833891181898814,-0.6031693646072918,1.0,1.0,1.0,74/221,31.49%,H1-8;PER1;GLMN;RNF168;DEPDC1B;SATB2;SETD7;PARP2;ZBTB1;ZNF827;ZNF335;JARID2;SLFN11;BCL7A;SF3B1;SNAI1;SMARCA5;CHD2;BRPF1;POLE3;KDM6A;PWWP2B;HIRA;BAZ2B;PHF1;CDK9;MIER1;BICRAL;INO80D;SRPK2;CHD6;DPF1;ARID2;HCFC2;KDM2B;PAXIP1;KDM5A;SMARCC2;HPF1;CHD7;RYBP;LIN54;MTA2;BAZ1A;RSF1;ARID1B;ZNF274;KDM4B;HDGF;INO80;MTA1;DEK;BMI1;YEATS2;SMARCC1;MYSM1;CHD1;PCGF2;SMARCD1;KDM4E;TDG;NFAT5;HDAC4;KAT5;ZBTB7A;MYBBP1A;BAZ2A;ACTR5;WAC;CGGBP1;SMARCAD1;INO80E;KDM5C;UBR5
prerank,Positive Regulation Of Lipid Biosynthetic Process (GO:0046889),-0.19883165757617965,-0.6028243357536139,1.0,1.0,1.0,15/38,31.77%,MLXIPL;PLIN5;SORBS1;SIRT4;PPARA;HSD17B13;CNEP1R1;SLC27A1;NR1H2;APOE;CGA;PCK1;KAT5;NR1H3;KAT2B
prerank,Regulation Of Single Stranded Viral RNA Replication Via Double Stranded DNA Intermediate (GO:0045091),-0.2549216021571131,-0.6027877712256816,0.9322033898305084,1.0,1.0,2/17,5.38%,CXCL8;APOBEC3A
prerank,Positive Regulation Of Telomere Maintenance Via Telomere Lengthening (GO:1904358),0.19710532379429258,0.6026552906699543,0.9318181818181818,1.0,1.0,12/35,29.30%,AURKB;CCT5;ATM;FBXO4;HNRNPA1;CCT7;CCT4;CCT3;NEK7;XRCC5;CCT2;MAPK1
prerank,ncRNA Processing (GO:0034470),0.17192253583750752,0.6013119898482738,1.0,1.0,1.0,38/99,33.56%,POP1;IGF2BP3;BYSL;EXOSC5;RPL14;RPS24;EXOSC4;INTS7;INTS3;INTS6;DKC1;RPP30;TSEN34;INTS14;INTS9;RPL35A;RPS27;NOP56;DCAF13;XRN2;INTS13;THG1L;PELP1;FARS2;UTP20;RPS16;INTS11;WDR18;TSEN2;RPS6;NOB1;INTS8;SPPL2B;RPL26;RRP12;NOLC1;PIH1D2;RPS25
prerank,Positive Regulation Of TORC1 Signaling (GO:1904263),-0.22677100674148615,-0.6008853897175379,0.9791666666666666,1.0,1.0,6/27,22.49%,GPR137;LARS1;PIP4P1;GPR137C;SEH1L;WDR24
prerank,Glial Cell Development (GO:0021782),-0.23620626133479194,-0.6008090507598338,0.9333333333333333,1.0,1.0,7/23,24.84%,MXRA8;TPPP;CSPG5;ZNF488;EIF2B2;MYRF;EIF2B3
prerank,Cytoplasmic Translational Initiation (GO:0002183),-0.22543481288366973,-0.5996334331225933,0.9649122807017544,1.0,1.0,8/29,29.40%,EIF2S3B;MIF4GD;EIF2S3;EIF5;EIF3C;EIF2B3;EIF3B;EIF3J
prerank,Fibroblast Growth Factor Receptor Signaling Pathway (GO:0008543),-0.2218301272365883,-0.5987162907994635,0.9508196721311475,1.0,1.0,8/34,20.65%,FGF9;GALNT3;FGF17;FGF8;FGF19;NOG;FRS2;SETX
prerank,Protein Lipidation (GO:0006497),-0.19922833597335235,-0.5970945846150201,1.0,1.0,1.0,21/60,28.50%,ZDHHC15;ATG16L1;PGAP2;PIGA;PIGP;PIGB;TP53INP2;GLUL;WDR45B;MPPE1;ZDHHC17;ATG5;PIGL;PIGH;DPM1;SELENOK;WDR45;PIGW;ZDHHC18;ATG12;ZDHHC21
prerank,Endoplasmic Reticulum To Cytosol Transport (GO:1903513),-0.27112709897682064,-0.5966304706761999,0.9615384615384616,1.0,1.0,3/15,20.39%,HERPUD1;FAF2;DERL2
prerank,Histone H3 Acetylation (GO:0043966),-0.21603037464551417,-0.5959428595906642,0.9838709677419355,1.0,1.0,12/35,31.77%,TMEM98;TAF5;MBIP;TAF7;POLE3;KAT14;LDB1;YEATS2;ATXN7L3;SUPT7L;TAF10;KAT2B
prerank,Regulation Of Potassium Ion Transmembrane Transport (GO:1901379),-0.23193450782453423,-0.5947135748807332,0.9838709677419355,1.0,1.0,3/29,8.34%,KCNAB1;NEDD4;KCNE2
prerank,Organelle Membrane Fusion (GO:0090174),-0.2317158926319007,-0.5942874341363409,1.0,1.0,1.0,10/26,31.39%,GOSR1;VCPIP1;VAMP7;STX6;STX16;STX3;SYT4;SYT7;VAMP2;TSNARE1
prerank,DNA Methylation (GO:0006306),0.22918089876967362,0.5917941200473729,0.9523809523809523,1.0,1.0,7/19,28.88%,SPOCD1;EHMT2;BEND3;FOS;HELLS;MTRR;EHMT1
prerank,Establishment Of Protein Localization To Vacuole (GO:0072666),-0.23472298838191424,-0.5909829551009718,1.0,1.0,1.0,5/27,21.47%,VPS37B;TSG101;UBAP1;VPS13C;VPS37D
prerank,Organelle Fission (GO:0048285),-0.2507819332281852,-0.5854770834045894,0.9259259259259259,1.0,1.0,4/22,11.35%,MTFP1;PRKN;MIEF1;MUL1
prerank,Vesicle-Mediated Transport Between Endosomal Compartments (GO:0098927),-0.22553078836590804,-0.5832401636730686,0.9473684210526315,1.0,1.0,9/24,31.99%,EMP2;LMTK2;ATG14;WDR91;WDR81;PIK3R4;RAB5A;PXK;RAB7A
prerank,N-terminal Protein Amino Acid Acetylation (GO:0006474),0.2393181637613116,0.5831312725281931,0.875,1.0,1.0,7/15,31.84%,NAA80;NAA50;NAA10;LSM8;NAA20;NAA30;NAA11
prerank,Female Gamete Generation (GO:0007292),-0.21781608034325783,-0.5827809976392948,0.9672131147540983,1.0,1.0,2/31,5.99%,FMN2;NANOS2
prerank,Early Endosome To Late Endosome Transport (GO:0045022),-0.22608522802269002,-0.581513599840709,0.9454545454545454,1.0,1.0,9/23,31.99%,EMP2;LMTK2;ATG14;WDR91;WDR81;PIK3R4;RAB5A;PXK;RAB7A
prerank,Positive Regulation Of Organelle Assembly (GO:1902117),-0.18860985339422456,-0.580342274932994,1.0,1.0,1.0,10/61,15.72%,NUP62;ATG2A;SNX7;CNOT1;CNOT6L;CEP120;PIP4K2A;MOAP1;CROCC;SASS6
prerank,Response To Peptide Hormone (GO:0043434),-0.19984277275467643,-0.5794779015084758,1.0,1.0,1.0,16/52,24.98%,CELA2A;REG3A;TGFBR3;SRC;IGFBP5;CITED1;SLC2A1;SIRT1;SORT1;EIF2B2;ZFP36L1;TSC1;POMC;SLC27A1;EIF2B3;STAT4
prerank,Regulation Of Ubiquitin-Dependent Protein Catabolic Process (GO:2000058),0.1905379791616409,0.5786316960776593,0.9777777777777777,1.0,1.0,9/41,24.41%,HFE;DESI1;PTK2;CCDC22;PTEN;PDCL3;RAD23A;TAF1;UBQLN4
prerank,Regulation Of TORC1 Signaling (GO:1903432),-0.18925007829987114,-0.5780607722926504,1.0,1.0,1.0,11/48,23.09%,GPR137;LARS1;NPC1;PIP4P1;SMCR8;GPR137C;SEH1L;CASTOR3P;SESN1;WDR24;DGKQ
prerank,Regulation Of Centriole Replication (GO:0046599),-0.257518169464421,-0.5776657838310724,0.9285714285714286,1.0,1.0,2/18,8.85%,NUP62;BRCA1
prerank,Organelle Disassembly (GO:1903008),-0.19207966967797402,-0.5775133011993184,1.0,1.0,1.0,14/54,27.73%,AURKA;ATG2A;SNX7;DENR;UFM1;RB1CC1;PRKAA2;KIF5B;ULK2;PLK3;PNPLA2;ULK1;RRP7A;HBS1L
prerank,Ribonucleoprotein Complex Biogenesis (GO:0022613),0.15402937196682284,0.5767069772714893,1.0,1.0,1.0,50/114,37.64%,LTV1;WDR46;IGF2BP3;BYSL;RBIS;RPL14;WDR12;RPS24;GTF3A;SHQ1;NOP16;RPS15A;RPF2;RPS3A;DIMT1;RPL35A;TBL3;RPS27;NOP56;RPS8;PAK1IP1;MRPL36;UTP20;RPS16;PWP2;RPS5;NOL7;RRS1;RPS6;NAT10;SPPL2B;RPL38;RPS9;RPL26;LTO1;RPS23;UTP6;RPS25;CUL4A;RPS13;RPS11;ZNF658;RPL26L1;FBL;EBNA1BP2;WDR3;BMS1;HEATR3;EMG1;SURF6
prerank,Regulation Of Endopeptidase Activity (GO:0052548),0.18055446508503692,0.5765427664866779,1.0,1.0,1.0,11/60,18.64%,SERPINI1;TIMP1;APH1B;PSMA3;TIMP2;SERPINB5;KNG1;PSME2;PRELID1;AKT1;ATP13A2
prerank,Cellular Response To Glucose Stimulus (GO:0071333),-0.21823682500883934,-0.5752503669231552,1.0,1.0,1.0,8/33,17.55%,SOX4;PTPRN2;MLXIPL;RAB11FIP2;ZNF236;LIN28A;UNC13B;PRKAA2
prerank,Mitotic G2 DNA Damage Checkpoint Signaling (GO:0007095),-0.23858549495213024,-0.5734075024681939,0.9827586206896551,1.0,1.0,9/30,21.03%,CDKN1A;DEPDC1B;BRCA1;TRIM39;FOXN3;TAOK3;BLM;DONSON;BRSK1
prerank,Response To Amino Acid Starvation (GO:1990928),0.18258951344895724,0.5732307049226723,1.0,1.0,1.0,18/40,34.30%,MAPK8;DAP;TFEB;SESN3;IMPACT;FAS;RNF152;LARP1;EIF2AK4;NPRL2;EIF2S1;MIOS;FLCN;MAPK1;SESN2;RRAGA;MTOR;DEPDC5
prerank,Positive Regulation Of Telomere Maintenance (GO:0032206),0.16651005840511104,0.5729363541993282,1.0,1.0,1.0,9/52,21.77%,AURKB;ACTL6A;TFPT;ERCC1;RUVBL2;ATM;TINF2;SIRT6;RUVBL1
prerank,Regulation Of T Cell Differentiation (GO:0045580),-0.18601131875427243,-0.5726266081092815,0.9838709677419355,1.0,1.0,6/47,11.15%,TCF7;IL7;PSG4;IFNA2;TBX21;ZBTB1
prerank,Regulation Of Telomere Maintenance Via Telomere Lengthening (GO:1904356),-0.24086192344730484,-0.5718960750542273,0.9661016949152542,1.0,1.0,6/17,31.31%,TNKS;DHX36;SLX1A;TNKS2;SMG6;SLX4
prerank,Maintenance Of Protein Location In Nucleus (GO:0051457),-0.23041953943655574,-0.5704675102747289,0.9411764705882353,1.0,1.0,7/18,36.49%,TOPORS;SYNE1;TAF3;SUPT7L;MORC3;SUN1;ARL2BP
prerank,Cellular Response To UV (GO:0034644),-0.1876906693332792,-0.5693426552410696,1.0,1.0,1.0,13/77,17.71%,RHBDD1;MFAP4;CDC25A;CDKN1A;NEDD4;ZBTB1;PRKCD;EP300;CREBBP;SDE2;SIRT1;DHX36;TRIAP1
prerank,Cellular Response To Misfolded Protein (GO:0071218),0.22686396857994257,0.5683240642773172,0.9782608695652174,1.0,1.0,6/19,28.33%,VCP;DERL1;ATXN3;RNF5;TOR1A;BAG6
prerank,miRNA-mediated Gene Silencing (GO:0035195),0.2036713697320845,0.5648252210165354,1.0,1.0,1.0,3/26,12.65%,XPO5;EIF6;CNOT8
prerank,Regulation Of Protein Localization To Cell Surface (GO:2000008),-0.21924808239882715,-0.5635434458019587,0.9803921568627451,1.0,1.0,1/30,1.37%,TYROBP
prerank,Protein Autoprocessing (GO:0016540),0.23283066689457244,0.5634823480255869,0.9333333333333333,1.0,1.0,3/16,16.12%,CTSL;CASP6;F12
prerank,Regulation Of Systemic Arterial Blood Pressure (GO:0003073),0.23683574339078414,0.5573310290884853,0.9841269841269841,1.0,1.0,5/15,18.80%,GSK3A;SLC2A5;KLK1;PLCB3;GPR37L1
prerank,Cellular Response To Reactive Oxygen Species (GO:0034614),-0.1795715573270752,-0.5571092519445204,1.0,1.0,1.0,25/72,27.66%,TNFAIP3;MAPT;NCF1;OSER1;EDN1;MT3;PEX2;PEX12;NFE2L2;PRKCD;PEX14;SIRT1;MPV17L;MPV17L2;MAPK7;SETX;RIPK1;PEX13;CLU;AQP1;RELA;FER;PEX10;IL6;PLEKHA1
prerank,Spindle Assembly (GO:0051225),-0.17850588322249492,-0.5568065511167608,1.0,1.0,1.0,23/76,27.70%,ARHGEF10;GOLGA6B;GOLGA8N;GOLGA8M;HAUS2;ZNF207;GOLGA8A;HAUS3;CSNK1D;TNKS;GOLGA8S;HAUS8;STARD9;ABRAXAS2;GOLGA8J;NEK6;CLASP1;INO80;MZT1;HAUS6;MAPRE2;GOLGA8H;TUBGCP5
prerank,Regulation Of Protein Targeting To Mitochondrion (GO:1903214),-0.20804530108898084,-0.5563019726976499,1.0,1.0,1.0,10/38,27.79%,LRRK2;FZD5;PRKN;TOMM7;SREBF2;USP36;ARIH2;HPS4;LMAN1;HTRA2
prerank,Positive Regulation Of Isotype Switching (GO:0045830),-0.240771107404382,-0.5522167679190445,0.9583333333333334,1.0,1.0,2/15,11.75%,CLCF1;INSL6
prerank,Negative Regulation Of TOR Signaling (GO:0032007),-0.18994596064484187,-0.5514166486913696,1.0,1.0,1.0,12/51,23.31%,NUAK1;NPC1;BMAL1;UBR1;SIRT1;PRKAA2;SEH1L;CASTOR3P;SESN1;FNIP1;WDR24;TSC1
prerank,"RNA Splicing, Via Transesterification Reactions With Bulged Adenosine As Nucleophile (GO:0000377)",-0.15726337438513424,-0.5504208174970766,1.0,1.0,1.0,54/174,32.03%,CRNKL1;CWF19L1;DDX39A;RSRC1;U2AF1;SNIP1;NOVA2;SF3B1;PRPF4;SLU7;PPIE;PHF5A;SNRNP27;SNW1;SNRPG;CENATAC;RNPC3;FRA10AC1;SNRPA1;SRRM1;TFIP11;WDR83;XAB2;PRPF40A;SF3B4;FRG1;CWF19L2;SYF2;AQR;SRSF10;DHX35;SNRPB2;DDX46;PNN;BCAS2;SF3A2;PRPF3;METTL14;SRSF2;ESS2;NR5A1;RBM19;SNRPD1;SRSF7;SF3A1;SRSF3;ZCCHC8;DHX8;CWC15;MFAP1;SRSF8;USP39;BUD31;ZMAT2
prerank,Telomere Maintenance (GO:0000723),-0.1836759673145151,-0.5461532862096007,1.0,1.0,1.0,16/68,26.03%,STON1;TERT;RAD51D;TERF2IP;ZNF827;INSL6;ZSCAN4;SMC5;WRN;BLM;INO80D;SLX1A;HUS1B;MRE11;INO80;SMC6
prerank,RNA Splicing (GO:0008380),0.1431929224235552,0.5437470084495072,1.0,1.0,1.0,18/97,25.41%,NOL3;DHX16;SNRNP25;DDX39B;HNRNPH3;CCAR2;PDCD7;PPP1R9B;PRMT1;USB1;TRA2B;SFPQ;TXNL4A;SNRPD2;IVNS1ABP;MBNL1;ZMAT5;SYNCRIP
prerank,Purine Ribonucleotide Biosynthetic Process (GO:0009152),-0.1844439206913301,-0.5427028641627106,0.9838709677419355,1.0,1.0,3/54,4.37%,ADCY2;ADSS1;ADCY1
prerank,Regulation Of Telomere Maintenance Via Telomerase (GO:0032210),-0.17519535098503758,-0.540845108906388,1.0,1.0,1.0,5/51,10.60%,STON1;MAPK15;TENT4B;SRC;EXOSC10
prerank,Histone Lysine Methylation (GO:0034968),0.1913483635747471,0.5405487635780486,0.9767441860465116,1.0,1.0,8/32,22.39%,DOT1L;EHMT2;KMT2D;BOD1;MEN1;SKIC8;DPY30;SETDB2
prerank,RNA-templated DNA Biosynthetic Process (GO:0006278),0.20393063981618262,0.5403923095518354,0.9782608695652174,1.0,1.0,9/19,33.25%,NOP10;PIF1;DKC1;NHP2;RPA1;TERF1;PTGES3;HSP90AB1;POT1
prerank,Telomere Maintenance Via Telomerase (GO:0007004),0.20393063981618262,0.5403923095518354,0.9782608695652174,1.0,1.0,9/19,33.25%,NOP10;PIF1;DKC1;NHP2;RPA1;TERF1;PTGES3;HSP90AB1;POT1
prerank,Negative Regulation Of Double-Strand Break Repair Via Homologous Recombination (GO:2000042),0.21920854161860304,0.5388211045628951,0.975,1.0,1.0,2/21,10.40%,RMI2;SHLD1
prerank,"Retrograde Transport, Endosome To Golgi (GO:0042147)",-0.16604913834129617,-0.5371664659991794,1.0,1.0,1.0,28/88,29.99%,RAB6C;MAGEL2;VPS54;RAB9A;RAB6B;RHOBTB3;GOSR1;RAB6D;VPS26A;SPAG9;RBSN;BET1L;STX6;HEATR5A;PLEKHA3;HEATR5B;STX16;CLTCL1;VPS52;ERC1;CLTC;LMAN1;BAIAP3;VTI1A;VPS53;WASHC2C;VPS29;DCTN1
prerank,Purine Nucleoside Bisphosphate Metabolic Process (GO:0034032),-0.21431773333552728,-0.5370118059366569,0.9655172413793104,1.0,1.0,4/23,16.79%,MLYCD;ACSM2A;ACOT9;ACOT12
prerank,Ribonucleoside Bisphosphate Metabolic Process (GO:0033875),-0.21431773333552728,-0.5370118059366569,0.9655172413793104,1.0,1.0,4/23,16.79%,MLYCD;ACSM2A;ACOT9;ACOT12
prerank,Negative Regulation Of TORC1 Signaling (GO:1904262),0.19840040094738398,0.5368822026892929,1.0,1.0,1.0,10/24,31.07%,SPAAR;RNF167;SESN3;RNF152;CASTOR1;DEPTOR;NPRL2;MIOS;SEC13;SESN2
prerank,Long-Chain Fatty Acid Transport (GO:0015909),-0.224324450477544,-0.5364460529645685,0.98,1.0,1.0,2/23,5.23%,CPT1B;PPARG
prerank,Cyclic Nucleotide Biosynthetic Process (GO:0009190),-0.21546488174706507,-0.5351774195536375,1.0,1.0,1.0,7/19,28.53%,ADCY2;NPR1;GUCY2F;ADCY9;NPPB;NPPA;GUCY2C
prerank,Protein Targeting To ER (GO:0045047),-0.2067881269631175,-0.5343344493554877,1.0,1.0,1.0,5/23,22.32%,ZFAND2A;MAN1A1;SEC63;SGTB;GET4
prerank,Endoplasmic Reticulum Calcium Ion Homeostasis (GO:0032469),-0.21172809120095187,-0.5342855513700561,1.0,1.0,1.0,5/20,25.13%,CCDC47;HERPUD1;ATP2A2;RAP1GDS1;SELENOK
prerank,Regulation Of Viral Life Cycle (GO:1903900),0.21107889883491804,0.5333387979833262,1.0,1.0,1.0,5/21,23.06%,TRIM5;TRIM22;PPIA;LAMP3;TRIM25
prerank,Modulation By Symbiont Of Entry Into Host (GO:0052372),-0.2314913557794219,-0.533230804584492,0.967741935483871,1.0,1.0,5/19,22.31%,CXCL8;TRIM21;TRIM6;RFPL1;RFPL3
prerank,Regulation Of Striated Muscle Contraction (GO:0006942),-0.2097524868732082,-0.5319468081646771,0.9682539682539683,1.0,1.0,5/25,23.95%,ATP1A2;MYBPC3;TNNT3;RYR2;GRK2
prerank,Regulation Of Chromatin Organization (GO:1902275),-0.207085243521902,-0.5316744310641818,0.9423076923076923,1.0,1.0,7/26,22.92%,METTL4;KANSL2;MSL2;TLK1;RLIM;TLK2;KANSL1
prerank,Positive Regulation Of Protein Targeting To Mitochondrion (GO:1903955),0.1886630545664137,0.5307521874554376,1.0,1.0,1.0,3/30,11.07%,HSPA1L;RAC2;GSK3A
prerank,Positive Regulation Of Microtubule Polymerization Or Depolymerization (GO:0031112),0.19539712561376232,0.5306339781480763,0.9523809523809523,1.0,1.0,3/25,12.71%,PSRC1;MET;PAK1
prerank,Transcription By RNA Polymerase I (GO:0006360),-0.22772782893150412,-0.5295171418226392,0.9787234042553191,1.0,1.0,5/15,30.77%,TAF1C;SPTY2D1;RRN3;RRN3P2;UBTFL1
prerank,Postreplication Repair (GO:0006301),-0.2275129660752125,-0.5284575756669413,1.0,1.0,1.0,5/21,20.17%,USP43;ZBTB1;SPRTN;FAAP20;WDR33
prerank,Positive Regulation Of Autophagosome Assembly (GO:2000786),-0.22557549100752836,-0.5277425208149643,0.9767441860465116,1.0,1.0,4/16,20.08%,SNX7;PIP4K2A;MOAP1;PIP4K2C
prerank,Response To Light Stimulus (GO:0009416),-0.1826635727991814,-0.5269107950935128,1.0,1.0,1.0,19/54,28.29%,CPT1B;MAPK10;GPR88;RHO;RGR;CRY2;SPRTN;ERCC3;CDKN2D;GTF2H2;BRSK1;USP1;OPN1LW;TYR;PCLAF;FECH;REV1;ERCC5;CIRBP
prerank,Vesicle Coating (GO:0006901),0.18425727689142035,0.5259963745058095,1.0,1.0,1.0,12/28,36.76%,PDCD6;AP3M2;TRAPPC3;TRAPPC6A;PREB;TRAPPC1;PEF1;TRAPPC8;TRAPPC12;TRAPPC4;AP3S2;TRAPPC2B
prerank,Heterochromatin Organization (GO:0070828),0.1769317094080246,0.5199397137571681,1.0,1.0,1.0,10/37,24.80%,UHRF1;HDAC2;LOXL2;H1-0;KMT2D;LMNB2;LMNB1;SETDB2;HDAC5;TRIP12
prerank,Transcription Elongation By RNA Polymerase II (GO:0006368),-0.1932536236522584,-0.5192502652859526,1.0,1.0,1.0,11/28,37.89%,PEX2;ERCC3;CDK9;CDC73;ELP4;SUPT5H;SUPT16H;ELP2;ELOF1;EAF2;GTF2F2
prerank,tRNA Aminoacylation (GO:0043039),-0.21757703999044178,-0.5191150980713766,0.9827586206896551,1.0,1.0,5/22,23.87%,LARS1;RARS1;WARS2;YARS2;HARS2
prerank,Mitochondrial Transport (GO:0006839),-0.17260757106567362,-0.5182950190328968,1.0,1.0,1.0,12/53,23.94%,MAIP1;PRKN;TOMM5;PITRM1;KIFBP;PMAIP1;FLVCR1;TOMM7;SPG7;TIMM17A;FBXO7;SLC25A16
prerank,Positive Regulation Of Double-Strand Break Repair Via Homologous Recombination (GO:1905168),-0.1829912026432404,-0.517714887428847,1.0,1.0,1.0,12/36,26.22%,FANCB;MBTD1;EPC1;MORF4L1;WDR48;ARID2;FUS;MRGBP;HELQ;MORF4L2;EP400;DMAP1
prerank,Cellular Response To Nitrogen Compound (GO:1901699),0.2132817651543642,0.5101394181449898,1.0,1.0,1.0,5/16,29.46%,NR1H4;DAXX;DDI2;TIMELESS;DDI1
prerank,Membrane Fusion (GO:0061025),0.19493105717158216,0.5076330432574241,1.0,1.0,1.0,2/25,9.03%,GCA;USO1
prerank,Internal Peptidyl-Lysine Acetylation (GO:0018393),-0.1825161974367776,-0.5066802024337259,0.9833333333333333,1.0,1.0,15/37,31.77%,EP300;MBTD1;CREBBP;EPC1;MORF4L1;KAT7;KAT14;MRGBP;MORF4L2;YEATS2;EP400;DMAP1;KAT5;TAF10;KAT2B
prerank,Regulation Of DNA Strand Elongation (GO:0060382),0.19494618191897256,0.5055228336823799,0.9736842105263158,1.0,1.0,16/16,80.52%,TFPT;RUVBL2;RUVBL1;MCRS1;ACTR8;POT1;INO80C;YY1;NFRKB;INO80B;UCHL5;INO80E;ACTR5;INO80;NUCKS1;INO80D
prerank,Ribosome Biogenesis (GO:0042254),0.13488823289820404,0.5043822246239175,1.0,1.0,1.0,64/150,37.64%,LTV1;WDR46;IGF2BP3;VCX;BYSL;EXOSC5;RBIS;RPL14;WDR12;RPS24;EXOSC4;GTF3A;DKC1;NOP16;RPS15A;RPF2;RPS3A;DIMT1;RPL35A;TBL3;RPS27;NOP56;DCAF13;XRN2;RPS8;PELP1;PAK1IP1;MRPL36;UTP20;RPS16;PWP2;RPS5;EIF2S1;NOL7;WDR18;RRS1;RPS6;NAT10;NOB1;SPPL2B;RPS9;RPL26;LTO1;RRP12;NOLC1;RPS23;UTP6;PIH1D2;RPS25;CUL4A;RPS13;RPS11;ZNF658;DDX10;RPL26L1;FBL;EBNA1BP2;WDR3;NOC4L;BMS1;HEATR3;DDX47;EMG1;SURF6
prerank,"Nuclear-Transcribed mRNA Catabolic Process, Nonsense-Mediated Decay (GO:0000184)",0.17586820039408202,0.503282463187631,1.0,1.0,1.0,10/28,32.59%,PNRC1;SKIC3;DHX34;SKIC8;SMG9;SKIC2;EIF4A3;EIF3E;UPF3B;SMG5
prerank,Establishment Of Protein Localization To Endoplasmic Reticulum (GO:0072599),0.2005780195910281,0.5026453649713317,0.9795918367346939,1.0,1.0,5/16,24.39%,RAB10;SRPRB;RAB3GAP1;SPCS1;SPCS2
prerank,Regulation Of Protein Neddylation (GO:2000434),-0.21808329535556603,-0.501807151971622,0.9636363636363636,1.0,1.0,5/18,28.38%,EPAS1;DCUN1D2;DCUN1D5;DCUN1D1;COPS8
prerank,Neural Crest Cell Differentiation (GO:0014033),-0.2101790998180743,-0.4985399414613436,1.0,1.0,1.0,1/17,4.45%,KBTBD8
prerank,Regulation Of Protein Dephosphorylation (GO:0035304),-0.17926147690440267,-0.4940531835842357,1.0,1.0,1.0,9/38,23.35%,NSMF;PPP1R2C;PPP1R16B;PPP2R5A;PRKCD;ANKLE2;CAMTA1;TSC1;CNEP1R1
prerank,Negative Regulation Of Protein Localization To Nucleus (GO:1900181),0.18262315344932173,0.4940459256020128,1.0,1.0,1.0,6/22,23.55%,SUFU;MFHAS1;LILRB4;MDFIC;SIRT6;YWHAZ
prerank,Acylglycerol Catabolic Process (GO:0046464),0.18884356213849646,0.4934233295865476,1.0,1.0,1.0,5/21,22.33%,DAGLA;ABHD6;LIPE;LIPC;LYPLA2
prerank,Reticulophagy (GO:0061709),-0.21173207924815898,-0.49304534761787117,0.9636363636363636,1.0,1.0,5/16,26.29%,SNX7;UFM1;RB1CC1;ULK2;ULK1
prerank,Amyloid Precursor Protein Metabolic Process (GO:0042982),0.21372876540288377,0.4921972620013984,0.9795918367346939,1.0,1.0,3/17,17.62%,ADAM19;APH1B;LDLRAP1
prerank,Negative Regulation Of Phosphoprotein Phosphatase Activity (GO:0032515),0.20165866193196078,0.49117442924749005,0.9795918367346939,1.0,1.0,7/20,30.08%,STYXL1;FKBP1A;IKBKB;PPP1R14D;PPP1R11;TNF;PTPA
prerank,Gamma-Aminobutyric Acid Signaling Pathway (GO:0007214),0.20281769852037612,0.48801200954068114,0.9545454545454546,1.0,1.0,8/18,33.78%,GABRR1;GNAI2;GABBR2;GABRR3;GABRB1;GABRE;GABRA6;GPR156
prerank,Regulation Of RIG-I Signaling Pathway (GO:0039535),-0.20984733865723662,-0.48379184932191716,0.9811320754716981,1.0,1.0,4/18,22.27%,ZCCHC3;RNF125;GPATCH3;USP17L2
prerank,Maturation Of 5.8S rRNA (GO:0000460),-0.215543397265351,-0.48358188154639425,0.9574468085106383,1.0,1.0,2/16,10.60%,NEDD4;EXOSC10
prerank,Positive Regulation Of Stem Cell Population Maintenance (GO:1902459),0.15375968038042762,0.4829026480148365,1.0,1.0,1.0,8/39,25.15%,ACTL6A;HDAC2;TET1;SMARCB1;SIRT6;SUDS3;HDAC1;RBBP4
prerank,NAD Biosynthetic Process (GO:0009435),0.19404584784393542,0.482122710310833,1.0,1.0,1.0,10/17,39.58%,NMNAT1;PARP10;NAPRT;SLC22A13;PARP9;KYNU;SLC5A8;NMNAT3;PTGIS;NAMPT
prerank,Cytoskeleton-Dependent Intracellular Transport (GO:0030705),-0.2064317873886354,-0.48134700064525526,0.9821428571428571,1.0,1.0,3/20,11.79%,TUBA1A;DYNC1I1;TUBA1C
prerank,Protein Insertion Into Mitochondrial Membrane (GO:0051204),0.17184334027329146,0.4786970905639145,1.0,1.0,1.0,7/28,26.91%,PRICKLE4;TIMM13;MTCH2;TIMM8B;MTX2;ROMO1;TIMM10
prerank,Regulation Of Mitochondrial Membrane Permeability (GO:0046902),0.19271407258271683,0.4782261391660804,0.975609756097561,1.0,1.0,8/18,31.42%,SLC25A4;BCL2L1;SLC25A5;BNIP3;THEM4;CAMK2A;HEBP2;TMEM102
prerank,Regulation Of Meiotic Cell Cycle (GO:0051445),-0.20567180197221552,-0.47557310822303717,1.0,1.0,1.0,7/20,31.51%,SPATA22;DUSP1;CDC27;ANAPC10;ANAPC2;ANAPC11;FZR1
prerank,Golgi To Endosome Transport (GO:0006895),-0.2064764412732772,-0.4713055261760013,0.9824561403508771,1.0,1.0,3/15,21.05%,MON2;VPS13C;SORT1
prerank,Positive Regulation Of Cilium Assembly (GO:0045724),-0.20076160150254038,-0.4676987132676513,1.0,1.0,1.0,7/22,27.54%,ZMYND10;CEP120;CROCC;SEPTIN7;CCDC88A;CCP110;SAXO1
prerank,tRNA Metabolic Process (GO:0006399),0.1904202450046542,0.4666432047730444,0.9795918367346939,1.0,1.0,2/19,7.92%,POP1;DARS2
prerank,DNA-templated Transcription Termination (GO:0006353),0.174296351982282,0.46634134472983774,0.9782608695652174,1.0,1.0,5/15,24.89%,PRMT5;PCF11;POLR3K;MED18;XRN2
prerank,Nucleus Organization (GO:0006997),-0.16703704701353111,-0.4662552670512783,1.0,1.0,1.0,9/44,23.18%,CEP55;ATXN7;NUP54;SEH1L;SYNE1;LEMD2;NUP133;USP36;NUP35
prerank,Inner Mitochondrial Membrane Organization (GO:0007007),-0.16087380852286826,-0.463487073059277,1.0,1.0,1.0,3/34,12.26%,MICOS10;MAIP1;MTX3
prerank,rRNA Processing (GO:0006364),-0.1439485377439035,-0.4553642248811557,1.0,1.0,1.0,28/100,32.30%,EXOSC3;RPS17;NEDD4;EXOSC10;ERI1;UTP15;DIS3;NOP58;WDR55;PIN4;NOL8;C1D;MAK16;EXOSC9;NOL11;ESF1;RIOK3;RIOK2;MPHOSPH10;RRP7A;NOP14;SBDS;NOL9;POP4;DDX54;EXOSC2;WDR74;UTP4
prerank,Regulation Of Clathrin-Dependent Endocytosis (GO:2000369),-0.21131899959944556,-0.4530732689718883,1.0,1.0,1.0,1/15,4.01%,CCL14
prerank,Histone H3-K4 Methylation (GO:0051568),0.17100337385034878,0.4456586127427854,1.0,1.0,1.0,26/26,82.92%,KMT2D;BOD1;MEN1;SKIC8;DPY30;NCOA6;WDR5B;HCFC1;PAGR1;WDR82;KMT2C;WDR5;CXXC1;NFYA;KMT2B;NFYB;KMT2A;NFYC;RBBP5;SETD1A;SETD1B;BOD1L1;PRDM7;PAXIP1;HCFC2;KDM6A
prerank,rRNA Metabolic Process (GO:0016072),-0.14130890519950837,-0.44492335090936375,1.0,1.0,1.0,12/90,18.29%,EXOSC3;RPS17;MAPT;EXOSC6;EXOSC10;UTP15;DIS3;NOP58;DIS3L;WDR55;PIN4;NOL8
prerank,Extrinsic Apoptotic Signaling Pathway Via Death Domain Receptors (GO:0008625),-0.17178502714307148,-0.44200418203211067,0.9787234042553191,1.0,1.0,6/30,21.05%,CASP8;TNFRSF10B;MOAP1;FADD;BLOC1S2;SORT1
prerank,Ribosomal Large Subunit Assembly (GO:0000027),-0.1760682758580388,-0.43983247549525467,1.0,1.0,1.0,8/21,39.04%,FASTKD2;BRIX1;PPAN;DHX30;RPL6;MRM2;RPL10;MDN1
prerank,Regulation Of Nucleotide-Excision Repair (GO:2000819),-0.16613389680945695,-0.438796039189364,1.0,1.0,1.0,8/26,28.50%,BCL7A;KAT7;DPF1;ARID2;SMARCC2;ARID1B;SMARCC1;SMARCD1
prerank,Nuclear-Transcribed mRNA poly(A) Tail Shortening (GO:0000289),0.17209033372612972,0.4324609796537672,1.0,1.0,1.0,6/20,26.33%,CNOT8;CNOT11;CNOT9;CNOT10;CNOT7;CNOT3
prerank,Double-Strand Break Repair Via Nonhomologous End Joining (GO:0006303),-0.1559618345388012,-0.43147477385267896,1.0,1.0,1.0,10/41,25.75%,RNF168;KDM2A;SMC5;DCLRE1A;DNTT;HMGB2;XRCC4;HELQ;MRE11;IFFO1
prerank,Protein K11-linked Ubiquitination (GO:0070979),-0.16489525316508596,-0.4257327582751186,0.984375,1.0,1.0,14/29,37.44%,PRKN;RNF4;UBE2E3;UBE2E2;CDC27;ANAPC10;ANAPC2;RNF26;ANAPC11;FZR1;UBE2B;CDC16;UBE2W;UBE2S
prerank,Regulation Of Double-Strand Break Repair Via Nonhomologous End Joining (GO:2001032),-0.16621515700407502,-0.4229719811585699,1.0,1.0,1.0,5/25,25.66%,INSL6;SMCHD1;TFIP11;HMGA2;NUDT16L1
prerank,Spliceosomal snRNP Assembly (GO:0000387),0.14454271684786602,0.42203612225062975,1.0,1.0,1.0,11/37,29.70%,GEMIN7;PRMT5;LSM2;USP4;PRPF19;SNRPD2;GEMIN5;CLNS1A;PRPF31;PRMT7;SRSF12
prerank,Heterochromatin Formation (GO:0031507),0.15438163729434784,0.42150864408887256,1.0,1.0,1.0,7/28,24.80%,UHRF1;H1-0;KMT2D;LMNB2;LMNB1;HDAC5;TRIP12
prerank,Coenzyme A Metabolic Process (GO:0015936),0.1762287509238731,0.4116788264731692,1.0,1.0,1.0,15/15,82.39%,PANK1;ACOT7;PANK4;NUDT7;PANK3;NUDT8;PANK2;DCAKD;COASY;PPCS;CROT;ACLY;SLC25A16;NUDT19;PPCDC
prerank,Response To Ethanol (GO:0045471),-0.17223967321793968,-0.40992434566563746,1.0,1.0,1.0,3/17,19.08%,TH;DRD4;CHRNB2
prerank,Ribosomal Large Subunit Biogenesis (GO:0042273),0.12812045918498252,0.4048818277004069,1.0,1.0,1.0,11/50,28.75%,EIF6;RPL14;RPL23A;WDR12;GTF3A;NOP16;RPF2;RPL35A;PAK1IP1;RRP15;RRS1
prerank,COPII-coated Vesicle Budding (GO:0090114),-0.13577572518046366,-0.3880224950253937,1.0,1.0,1.0,6/36,20.76%,SEC31A;TRAPPC11;SAR1A;CSNK1D;TRAPPC2;SEC31B
prerank,Maturation Of LSU-rRNA (GO:0000470),-0.16115065939662665,-0.3784037036183503,1.0,1.0,1.0,3/20,20.92%,NEDD4;RBM34;MAK16
prerank,Regulation Of Phosphatase Activity (GO:0010921),0.14753460702992094,0.3746779740924312,1.0,0.9997239561535516,1.0,1/19,5.71%,HTT
prerank,Regulation Of Calcium Ion Import (GO:0090279),-0.16836536447766326,-0.3706457915643845,1.0,0.9996814842832401,1.0,3/18,15.51%,CCL2;SLC30A1;CXCL12
